<SEC-DOCUMENT>0001193125-22-092102.txt : 20220331
<SEC-HEADER>0001193125-22-092102.hdr.sgml : 20220331
<ACCEPTANCE-DATETIME>20220331172649
ACCESSION NUMBER:		0001193125-22-092102
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		61
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220331
DATE AS OF CHANGE:		20220331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SES AI Corp
		CENTRAL INDEX KEY:			0001819142
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39845
		FILM NUMBER:		22794513

	BUSINESS ADDRESS:	
		STREET 1:		35 CABOT RD.
		CITY:			WOBURN
		STATE:			MA
		ZIP:			01801
		BUSINESS PHONE:		(339) 298-8750

	MAIL ADDRESS:	
		STREET 1:		35 CABOT RD.
		CITY:			WOBURN
		STATE:			MA
		ZIP:			01801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Ivanhoe Capital Acquisition Corp.
		DATE OF NAME CHANGE:	20200723
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>d251271d10k.htm
<DESCRIPTION>FORM 10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:ses="http://www.ivanhoecapitalacquisition.com/20211231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 10-K</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style=""><div style='display: none'><ix:header><ix:hidden><ix:nonFraction name="ses:CommonStockNumberOfVotesPerShare" id="hidden42197942" contextRef="PAsOn12_31_2021" unitRef="Unit_Day" decimals="INF">10</ix:nonFraction><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_01_2021To12_31_2021">false</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="P01_01_2021To12_31_2021">FY</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_01_2021To12_31_2021">0001819142</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="hidden42198043" contextRef="P01_01_2021To12_31_2021">MA</ix:nonNumeric><ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" id="hidden42198049" contextRef="P01_01_2021To12_31_2021">No</ix:nonNumeric><ix:nonNumeric name="dei:EntityVoluntaryFilers" id="hidden42198051" contextRef="P01_01_2021To12_31_2021">No</ix:nonNumeric><ix:nonNumeric name="dei:EntityCurrentReportingStatus" id="hidden42198053" contextRef="P01_01_2021To12_31_2021">Yes</ix:nonNumeric><ix:nonNumeric name="dei:EntityInteractiveDataCurrent" id="hidden42198055" contextRef="P01_01_2021To12_31_2021">Yes</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="ses-20211231.xsd" /><link:linkbaseRef xlink:type="simple" xlink:href="ses-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="ses-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="ses-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /><link:linkbaseRef xlink:type="simple" xlink:href="ses-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" /></ix:references><ix:resources><xbrli:context id="PAsOn12_31_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_08_2020To12_31_2020" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-08</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_11_2021To01_11_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-11</xbrli:startDate> <xbrli:endDate>2021-01-11</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn04_09_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-04-09</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2021" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_07_2020" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-07-07</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleDebtMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:PrivatePlacementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:PublicWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis" >us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >ses:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:AdministrativeSupportAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis" >ses:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis" >ses:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:PrivatePlacementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_IvanhoeCapitalAcquisitionCorpMemberdeiLegalEntityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >ses:IvanhoeCapitalAcquisitionCorpMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_WorkingCapitalLoansWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:PrivatePlacementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >ses:SponsorMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:AdministrativeSupportAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:AdministrativeSupportAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >ses:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis" >ses:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis" >ses:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis" >us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:RelatedPartyLoansMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >ses:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-08</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_08_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-08</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_08_2020To12_31_2020_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:AdministrativeSupportAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-08</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_08_2020To12_31_2020_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:PrivatePlacementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-08</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_08_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-08</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-08</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_08_2020To12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-08</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-11</xbrli:startDate> <xbrli:endDate>2021-01-11</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_11_2021To01_11_2021_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-11</xbrli:startDate> <xbrli:endDate>2021-01-11</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-11</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_11_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >ses:SponsorMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-11</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_11_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis_IvanhoeCapitalAcquisitionCorpMemberdeiLegalEntityAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis" >us-gaap:IPOMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis" >ses:IvanhoeCapitalAcquisitionCorpMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-11</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >ses:SponsorMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-22</xbrli:startDate> <xbrli:endDate>2020-07-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_22_2020To07_22_2020_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >ses:SponsorMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-22</xbrli:startDate> <xbrli:endDate>2020-07-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >ses:SponsorMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-22</xbrli:startDate> <xbrli:endDate>2020-07-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-22</xbrli:startDate> <xbrli:endDate>2020-07-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-22</xbrli:startDate> <xbrli:endDate>2020-07-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MinimumMembersrtRangeAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >ses:SponsorMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-22</xbrli:startDate> <xbrli:endDate>2020-07-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MaximumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MaximumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-22</xbrli:startDate> <xbrli:endDate>2020-07-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MinimumMembersrtRangeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis" >srt:MinimumMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-22</xbrli:startDate> <xbrli:endDate>2020-07-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_22_2020To07_22_2020_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >ses:SponsorMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-07-22</xbrli:startDate> <xbrli:endDate>2020-07-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:RelatedPartyLoansMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-07-22</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis_WorkingCapitalLoansWarrantMemberusgaapClassOfWarrantOrRightAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:RelatedPartyLoansMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis" >ses:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-07-22</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_22_2020_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >ses:SponsorMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-07-22</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P12_16_2020To12_16_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >ses:SponsorMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-12-16</xbrli:startDate> <xbrli:endDate>2020-12-16</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_06_2021To01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >ses:SponsorMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-06</xbrli:startDate> <xbrli:endDate>2021-01-06</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis" >ses:FounderSharesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >ses:SponsorMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-01-06</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn04_09_2021_ChiefExecutiveOfficerMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis" >srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-04-09</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn04_09_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleDebtMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-04-09</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P04_09_2021To04_09_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis" >us-gaap:ConvertibleDebtMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-04-09</xbrli:startDate> <xbrli:endDate>2021-04-09</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_28_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-28</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn03_28_2022_CommonClassBMemberusgaapStatementClassOfStockAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-28</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis" >us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_07_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-07-07</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_07_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:CommonStockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis" >us-gaap:CommonClassBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-07-07</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_07_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-07-07</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn07_07_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" > <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819142</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis" >us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-07-07</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_USD" > <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_shares" > <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Day" > <xbrli:measure>utr:Day</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_pure" > <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Year" > <xbrli:measure>utr:Year</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_USD_per_Share" > <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit><xbrli:unit id="Unit_vote" > <xbrli:measure>ses:vote</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Month" > <xbrli:measure>utr:Month</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Y" > <xbrli:measure>utr:Y</xbrli:measure> </xbrli:unit></ix:resources></ix:header></div><div> <div style="background-color:white;display: inline;"> <div style="margin-top: 0pt; margin-bottom: 17pt;;font-weight: bold;;font-size: .83em;"><a href="#toc">Table of Contents</a></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <div style="margin-top: 4pt; margin-bottom: 0pt; font-size: 16pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">UNITED STATES </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 16pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">SECURITIES AND EXCHANGE COMMISSION </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Washington, D.C. 20549 </div></div> <div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div> </div> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 16pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">FORM <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:DocumentType" contextRef="P01_01_2021To12_31_2021">10-K</ix:nonNumeric></div> </div></div> <div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div> </div> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">(Mark One) </div></div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:DocumentAnnualReport" contextRef="P01_01_2021To12_31_2021" format="ixt:booleantrue">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </div></div> </td> </tr> </table> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">For the fiscal year ended <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="P01_01_2021To12_31_2021" format="ixt:datemonthdayyearen"><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="P01_01_2021To12_31_2021" format="ixt:datemonthdayen">December 31</ix:nonNumeric>, <ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="P01_01_2021To12_31_2021">2021</ix:nonNumeric></ix:nonNumeric> </div></div> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">OR </div></div> <div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:DocumentTransitionReport" contextRef="P01_01_2021To12_31_2021" format="ixt:booleanfalse">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: left; line-height: normal;"><div style="font-weight:bold;display:inline;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to </div></div> </td> </tr> </table> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Commission File Number <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="P01_01_2021To12_31_2021">001-39845</ix:nonNumeric></div> </div></div> <div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div> </div> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 20pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_01_2021To12_31_2021">SES AI Corporation</ix:nonNumeric> </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(Exact name of registrant as specified in its Charter) </div></div> <div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div> </div> <div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="P01_01_2021To12_31_2021" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="P01_01_2021To12_31_2021">95-1567584</ix:nonNumeric></div></div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">(State or other jurisdiction of</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">incorporation or organization)</div></div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">(I.R.S. Employer</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Identification No.)</div></div> </td> </tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td colspan="2" style="height:6pt"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:top;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P01_01_2021To12_31_2021">35 Cabot Road</ix:nonNumeric></div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 9pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P01_01_2021To12_31_2021">Woburn</ix:nonNumeric>, <span style="-sec-ix-hidden:hidden42198043">MA</span></div></div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P01_01_2021To12_31_2021">01801</ix:nonNumeric></div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Address of principal executive offices)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Zip Code)</div></div></td> </tr> </table> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric name="dei:CityAreaCode" contextRef="P01_01_2021To12_31_2021">339</ix:nonNumeric>) <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P01_01_2021To12_31_2021">298-8750</ix:nonNumeric></div> </div></div> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Securities registered pursuant to Section&#160;12(b) of the Act: </div></div> <div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:35%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:31%"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Title of each class</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Trading</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Symbol(s)</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Name of each exchange</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">on which registered</div></div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:Security12bTitle" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis">Class A common stock, par value $0.0001 per share</ix:nonNumeric></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:TradingSymbol" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis">SES</ix:nonNumeric></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" format="ixt-sec:exchnameen">The New York Stock Exchange</ix:nonNumeric></div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:Security12bTitle" contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementClassOfStockAxis">Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50</ix:nonNumeric></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:TradingSymbol" contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementClassOfStockAxis">SES WS</ix:nonNumeric></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementClassOfStockAxis" format="ixt-sec:exchnameen">The New York Stock Exchange</ix:nonNumeric></div></div></td> </tr> </table> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Securities registered pursuant to Section&#160;12(g) of the Act: None </div></div> <div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div> </div> <div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;YES&#160;&#160;&#9744;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden:hidden42198049">NO</span>&#160;&#160;&#9746; </div> <div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.&#160;&#160;&#160;&#160;YES&#160;&#160;&#9744;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden:hidden42198051">NO</span>&#160;&#160;&#9746; </div> <div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden:hidden42198053">YES</span>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;NO&#160;&#160;&#9744; </div> <div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-T</div> (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden:hidden42198055">YES</span>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;NO&#160;&#160;&#9744; </div> <div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accelerated</div> filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12b-2</div> of the Exchange Act. </div> <div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:16%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:63%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:16%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:2%"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<td style="vertical-align:bottom">Large&#160;accelerated&#160;filer</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#9744;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Accelerated&#160;filer</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#9744;</td> </tr>
<tr style="font-size:1pt">
<td style="height:3.75pt"></td>
<td colspan="2" style="height:3.75pt"></td>
<td colspan="2" style="height:3.75pt"></td>
<td colspan="2" style="height:3.75pt"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom"><ix:nonNumeric name="dei:EntityFilerCategory" contextRef="P01_01_2021To12_31_2021" format="ixt-sec:entityfilercategoryen"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-accelerated</div> filer</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#9746;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">Smaller&#160;reporting&#160;company</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><ix:nonNumeric name="dei:EntitySmallBusiness" contextRef="P01_01_2021To12_31_2021" format="ixt:booleantrue">&#9746;</ix:nonNumeric></td> </tr>
<tr style="font-size:1pt">
<td style="height:3.75pt"></td>
<td colspan="2" style="height:3.75pt"></td>
<td colspan="2" style="height:3.75pt"></td>
<td colspan="2" style="height:3.75pt"></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">Emerging&#160;growth&#160;company</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="P01_01_2021To12_31_2021" format="ixt:booleantrue">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td> </tr> </table> <div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="P01_01_2021To12_31_2021" format="ixt:booleanfalse">&#9744;</ix:nonNumeric> </div> <div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section&#160;404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;&#160;</div></div>&#9744; </div> <div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a shell company (as defined in Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12b-2</div> of the Exchange Act).&#160;&#160;&#160;&#160;YES&#160;&#160;&#9744;&#160;&#160;&#160;&#160;NO&#160;&#160;<ix:nonNumeric name="dei:EntityShellCompany" contextRef="P01_01_2021To12_31_2021" format="ixt:booleanfalse">&#9746;</ix:nonNumeric> </div> <div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">The aggregate market value of the voting and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-voting</div> stock held by <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-affiliates</div> of the registrant as of June&#160;30, 2021, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, was approximately $<ix:nonFraction name="dei:EntityPublicFloat" contextRef="PAsOn06_30_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">280.6</ix:nonFraction>&#160;million, calculated by using the closing price of the registrant&#8217;s Class&#160;A common stock on such date on the New York Stock Exchange of $10.17. </div> <div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">As of March <div style="letter-spacing: 0px; top: 0px;;display:inline;">2</div>8, 2022, there were <ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="PAsOn03_28_2022_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">303,989,794</ix:nonFraction> shares of the registrant&#8217;s Class&#160;A common stock and <ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="PAsOn03_28_2022_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">43,881,251</ix:nonFraction> shares of the registrant&#8217;s Class&#160;B common stock outstanding. </div> <div style="margin-top: 2pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">DOCUMENTS INCORPORATED BY REFERENCE </div></div> <div style="margin-top:2pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">None. </div> <div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div id="toc" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">Table of Contents </div></div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:12%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:84%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Page</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="3" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#tx251271_1">PART&#160;I </a></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;1.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_2">Business</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;1A.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_3">Risk Factors</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">11</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;1B.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_4">Unresolved Staff Comments</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;2.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_5">Properties</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;3.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_6">Legal Proceedings</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item 4.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_7">Mine Safety Disclosures</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">38</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="3" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#tx251271_8">PART II </a></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item 5.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_9">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item 6.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_10">[Reserved]</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item 7.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_11">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">39</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;7A.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_12">Quantitative and Qualitative Disclosures About Market Risk</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item 8.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_13">Financial Statements and Supplementary Data</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item 9.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_14">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;9A.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_15">Controls and Procedures</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">43</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;9B.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_16">Other Information</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;9C.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_17">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">44</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="3" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#tx251271_18">PART III </a></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;10.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_19">Directors, Executive Officers and Corporate Governance</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">45</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;11.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_20">Executive Compensation</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">51</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;12.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_21">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">56</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;13.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_22">Certain Relationships and Related Transactions, and Director Independence</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">59</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;14.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_23">Principal Accounting Fees and Services</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">61</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="3" style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><a href="#tx251271_24">PART&#160;IV </a></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">63</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;15.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_25">Exhibits, Financial Statement Schedules</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">63</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Item&#160;16.</div> </td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><a href="#tx251271_26">Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</span> Summary</a></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">65</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">i </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> </div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">EXPLANATORY NOTE </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unless otherwise stated or unless the context otherwise requires, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;SES,&#8221; and the &#8220;Company&#8221; refer to SES AI Corporation, a Delaware corporation (f/k/a Ivanhoe Capital Acquisition Corp., a Cayman Islands exempted company (&#8220;Ivanhoe&#8221;)) and its consolidated subsidiaries, after giving effect to the Business Combination (as defined below). </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We were originally formed as a Cayman Islands exempted company in July of 2020 for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, recapitalization or other similar business combination with one or more businesses. On January&#160;11, 2021, we consummated our initial public offering (the &#8220;IPO&#8221;), following which our securities began trading on the New York Stock Exchange (the &#8220;NYSE&#8221;). </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February&#160;3, 2022 (the &#8220;Closing Date&#8221;), Ivanhoe consummated its previously announced business combination (the &#8220;Business Combination&#8221;) with SES Holdings Pte. Ltd., a Singapore private company limited by shares (&#8220;Old SES&#8221;), pursuant to the terms of that certain Business Combination Agreement (as amended, the &#8220;Business Combination Agreement&#8221;) by and among Ivanhoe, Old SES, and Wormhole Amalgamation Sub Pte. Ltd., a Singapore private company limited by shares, and a direct, wholly-owned subsidiary of Ivanhoe (&#8220;Amalgamation Sub&#8221;). </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to the terms of the Business Combination Agreement and in connection with the closing of the Business Combination (the &#8220;Closing&#8221;), (i) Ivanhoe migrated out of the Cayman Islands and domesticated as a Delaware corporation (the &#8220;Domestication&#8221;) by way of continuation and deregistration under Part XII of the Cayman Islands Companies Act and domestication under Section&#160;388 of the Delaware General Corporation Law (&#8220;DGCL&#8221;), (ii) Ivanhoe changed its name to &#8220;SES AI Corporation&#8221; (&#8220;SES,&#8221; or the &#8220;Company&#8221;), and (iii)&#160;Amalgamation Sub merged with and into Old SES, with Old SES as the surviving company (the &#8220;Amalgamation&#8221;) (the time that the Amalgamation became effective is referred to as the &#8220;Effective Time&#8221;). As a result of the Amalgamation, Old SES became our wholly-owned subsidiary. </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">This Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> principally describes the business and operations of the Company following the Business Combination, other than the financial statements and related Management Discussion and Analysis which describe the&#160;business, financial condition, results of operations, liquidity and capital resources of Ivanhoe prior to the Business Combination. Substantially concurrently with the filing of this Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K,</div> we will be filing Amendment No.&#160;1 to our Current Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K,</div> initially filed on February&#160;8, 2022, which will include the audited consolidated financial statements of the Company for the year ended December&#160;31, 2021 and related Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. Interested parties should refer to our Current Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</div> for more information. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ii </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS AND RISK FACTORS SUMMARY&#160; </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">This Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> (this &#8220;Annual Report&#8221;) contains forward-looking statements. These forward-looking statements include, without limitation, statements relating to expectations for future financial performance, business strategies or expectations for our business. These statements are based on the beliefs and assumptions of the management of the Company. Although the Company believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, it cannot assure you that it will achieve or realize these plans, intentions or expectations. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this Annual Report, words such as &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;can&#8221;, &#8220;continue&#8221;, &#8220;could&#8221;, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;forecast&#8221;, &#8220;intend&#8221;, &#8220;may&#8221;, &#8220;might&#8221;, &#8220;plan&#8221;, &#8220;possible&#8221;, &#8220;potential&#8221;, &#8220;predict&#8221;, &#8220;project&#8221;, &#8220;seek&#8221;, &#8220;should&#8221;, &#8220;strive&#8221;, &#8220;target&#8221;, &#8220;will&#8221;, &#8220;would&#8221; and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">You should not place undue reliance on these forward-looking statements. Should one or more of a number of known and unknown risks and uncertainties materialize, or should any of our assumptions prove incorrect, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include, but are not limited to the risks below, which also serves as a summary of the principal risks of an investment in our securities:</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes in domestic and foreign business, market, financial, political and legal conditions, including but not limited to the ongoing conflict between Russia and Ukraine; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">risks relating to the uncertainty of the projected financial information with respect to the Company; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">risks related to the development and commercialization of the Company&#8217;s battery technology and the timing and achievement of expected business milestones; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the effects of competition on the Company&#8217;s business; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the ability of the Company to issue equity or equity-linked securities or obtain debt financing in the future; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the ability of the Company to integrate its products into electric vehicles (&#8220;EVs&#8221;); </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">the risk that delays in the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-manufacturing</div> development of the Company&#8217;s battery cells could adversely affect the Company&#8217;s business and prospects; </div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">potential supply chain difficulties; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">risks resulting from the Company&#8217;s joint development agreements (&#8220;JDAs&#8221;) and other strategic alliances, if such alliances are unsuccessful; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the quickly evolving battery market; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Company&#8217;s ability to accurately estimate future supply and demand for its batteries; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Company&#8217;s ability to develop new products on an ongoing basis in a timely manner; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">product liability and other potential litigation, regulation and legal compliance; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Company&#8217;s ability to effectively manage its growth; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Company&#8217;s ability to attract, train and retain highly skilled employees and key personnel; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the willingness of vehicle operators and consumers to adopt EVs; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">developments in alternative technology or other fossil fuel alternatives; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Company&#8217;s ability to meet certain motor vehicle standards; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">a potential shortage of metals required for manufacturing batteries; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">risks related to the Company&#8217;s intellectual property; </div></div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">risks related to the Company&#8217;s business operations outside the United States, including in China; </div></div></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:1%">&#160;</td>
<td style="width:2%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">the Company has identified a material weakness in its internal control over financial reporting and may identify material weaknesses in the future or otherwise fail to maintain an effective system of internal controls; </div></td></tr></table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">iii </div></div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> </div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em; text-align: left;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">compliance with certain health and safety laws; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes in U.S. and foreign tax laws; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 1%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the other risks described in &#8220;Item 1A. Risk Factors&#8221; in this Annual Report. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">These forward-looking statements are based on information available as of the date of this Annual Report and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. You should not place undue reliance on these forward-looking statements. </div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">TRADEMARKS </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This Annual Report contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this proxy statement/prospectus may appear without the &#174; or <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">&#8482;</div> symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. The use or display of other companies&#8217; trade names, trademarks or service marks is not intended to imply a relationship with, or endorsement or sponsorship of SES by any other companies. </div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">MARKET AND INDUSTRY DATA </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This Annual Report includes market and industry data that SES has derived from publicly available information, various industry publications, other published industry sources and internal data and estimates. Industry publications and other published industry sources generally indicate that the information contained therein was obtained from sources believed to be reliable. Internal data and estimates are based upon information obtained from trade and business organizations and other contacts in the markets in which SES operates and SES plans to operate and SES&#8217;s respective management&#8217;s understanding of industry conditions. Any estimates underlying such market-derived information and other factors could cause actual results to differ materially from those expressed in the independent parties&#8217; estimates and in our estimates. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sources of certain key industry and market data contained in this Annual Report are listed below: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Alliance Bernstein, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Electric Revolution</div></div> 2020: <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Driving the Infinite Loop</div></div>, March 2020. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Alliance Bernstein, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">EV Tracker &#8211; Full Year 2020: EV sales hit 3 million (+40% YoY) despite pandemic, as December hits all-time high (+120% YoY)</div></div>, February 2021. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">BlackRock, Insights: <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Here to Stay</div></div>, February 2021. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">International Energy Agency, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Global EV Outlook 2021: Trends and developments in electric vehicle markets</div></div>, 2021. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">U.S. Department of Energy, <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Alternative Fuels Data Center: Batteries for Hybrid and Plug-In Electric Vehicles</div></div>. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">iv </div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em; text-align: left;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"></div></div><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;"></a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div id="tx251271_1" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PART I </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_2" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;1.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Business. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Overview </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">SES is a global leader in the development and&#160;production of high-performance, Lithium-Metal <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(&#8220;Li-Metal&#8221;)</div> rechargeable batteries for electric vehicles and other applications. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Since our founding in 2012, we have been committed to developing the world&#8217;s most advanced EV batteries. Our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> batteries have been designed to combine the high energy density of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> with cost-effective, large-scale manufacturability of conventional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Lithium-ion</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(&#8220;Li-ion&#8221;)</div> rechargeable batteries. The results of tests undertaken by third party testing facilities, under instructions provided by Ivanhoe Capital Acquisition Corp. and SES, demonstrate industry-leading <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> energy density, performance and safety. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">We believe that our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> batteries demonstrate industry-leading density and performance and will: </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">deliver a step-change in energy density to deliver a lightweight and compact battery, and substantially eliminate range anxiety of EVs; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provide fast-charge capability to reduce charging times significantly, to a charge of 80% in less than 15 minutes; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">incorporate advanced artificial intelligence (&#8220;AI&#8221;) powered safety management software, which will accurately monitor state of health of the battery and apply appropriate self-healing protocols; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">use similar manufacturing processes as required for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion,</div> but is expected to be substantially less costly than conventional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> at scale due to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal&#8217;s</div> high energy density; </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">achieve rapid market adoption due to our strategic partnerships, including with leading global OEMs, such as GM, Hyundai and Honda; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">capitalize on the innovation occurring in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion,</div> including improvements in energy density, manufacturing efficiency and cost reduction, as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> shares similar cathode and manufacturing process with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion.</div> </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">We have developed what we believe to be the world&#8217;s most advanced <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery technology, and we have the management team in place to become a leading provider of batteries. Our third-party tested, differentiated battery technology is designed for manufacturing at scale, and will help to promote the transition from the global dependence on fossil fuel-based automotive vehicles to clean and efficient EVs. SES is supported by strategic and financial investors, including energy and chemicals conglomerate SK Inc. (&#8220;SK&#8221;), mining and manufacturing company Tianqi Lithium HK Co. Ltd. (&#8220;Tianqi&#8221;), semiconductor equipment manufacturer Applied Materials, Inc., investment firms Vertex Ventures Holdings (&#8220;Vertex&#8221;) and Temasek Holdings Limited (&#8220;Temasek&#8221;), affiliates of automotive suppliers LG Corporation (&#8220;LG&#8221;) and Foxconn Technology Group, and global original equipment manufacturers (&#8220;OEMs&#8221;) General Motors Company (&#8220;GM&#8221;), Hyundai Motor Company (&#8220;Hyundai&#8221;), Honda Motor Co. Ltd. (&#8220;Honda&#8221;), Geely Auto Group and SAIC Motors. Among that group, each of GM, Hyundai and Honda are parties to existing JDAs with SES. Our headquarters are located in Boston, and most of our executive management is located in the United States. Our operating facilities are located in Boston and Shanghai, and we may build additional facilities in these or other locations. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Industry and Market </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The Energy Transition </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Worldwide electrification is now a clear focus area, with many governments, businesses and investors around the world making commitments to change. The global energy transition will present an expansive commercial opportunity for rechargeable batteries, particularly in the automotive sector. The global number of passenger EVs sold is expected to grow from approximately $2.7 million in 2020 to approximately 90&#160;million EVs in 2040, with the EV battery market expanding from approximately $19&#160;billion to approximately $350&#160;billion in the same period. New battery technology that drives costs down and increases energy density, like ours, will be the key to unlocking this opportunity. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Global Commitment to Electrification </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As an impetus to global electrification efforts, several governments and leading global OEMs alike have announced robust electrification goals, precipitating imminent change. Below is a list of targets set forth, or investments already made, by countries and automobile manufacturers in their efforts to move toward vehicle electrification. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">1 </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div></div> <div style="text-indent: 4%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Governments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">North America </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Canada: All new light-duty cars and passenger trucks sold to be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">zero-emission</div> by 2035. </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United States: $174&#160;billion proposed to boost the EV market and halve greenhouse gas emissions by 2030. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Europe and Middle East </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denmark: Denmark has urged the European Union to ban the sale of all petrol and diesel cars by 2040. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Finland: 30% market share for EVs by 2030, including personal vehicles, trucks and buses. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">France: Ban on gasoline and diesel vehicle sales by 2040. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Germany: 10&#160;million EVs and one million electric car charge points by 2030. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Iceland: Reduce carbon emissions by 40% by 2030 and become carbon-neutral by 2040. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ireland: Ban on sales of new petrol and diesel cars by 2030 and become carbon neutral by 2050. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Israel: Eliminate imports of gas and diesel vehicles and coal-fired electricity generation by 2030. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Netherlands: All new petrol and diesel cars to be emission free by 2030. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Norway: EVs to account for 100% of all car sales by 2025 (already accounting for 58% of all car sales in March 2019). </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">United Kingdom: Ban on selling new petrol, diesel or hybrid cars by 2035. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Asia Pacific </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Australia: A$1.9&#160;billion investment package already approved, including A$1.6&#160;billion for renewable energy. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">China: 20% of new cars sold by 2025 to be electrified. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">India: Various regulatory programs to increase EV sales to 30% of total new cars by 2030. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Japan: All new passenger cars sold to be electric or hybrid by the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-2030s.</div> </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Singapore: Phase out petrol and diesel vehicles by 2040. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">South Korea: 33% of new vehicle sold to be electric or hydrogen-fueled by 2030. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Leading Global OEMs </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">GM: Launch more than 30 new EV models by 2025 and sell only <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">zero-emission</div> light-duty vehicles by 2035. </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Hyundai: Fully electrify lineup in major global markets by 2040. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Toyota: 70% of vehicle sales to be from EVs in 2030. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ford: Invest $29&#160;billion in EVs and autonomous vehicles by 2025 and become carbon neutral by 2050. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investors </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Beyond government and corporate action, many investors around the world have increasingly focused on the energy transition as an investment opportunity and have poured record amounts into funds aimed at helping the environment. For example, from January through November 2020, investors in mutual funds and ETFs invested $288&#160;billion globally in sustainable assets, a 96% increase over the whole of 2019, and certain investors have called on companies to disclose a plan for how their business model will be compatible with a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">net-zero</div> economy. Moreover, EVs have become increasingly popular among consumers, who increased their spending on EVs to $120&#160;billion in 2020, a 50% increase from 2019, according to the International Energy Agency&#8217;s &#8220;Global EV Outlook 2021.&#8221; </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2 </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Total Addressable Market </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Thanks to these public and private sector efforts, the global market for EV batteries is anticipated to experience substantial growth characterized by increasing battery pack sizes and decreasing costs. This will be driven by growing EV adoption, as the global number of passenger EVs sold is expected to rise from approximately 2.7 million in 2020 to approximately 90&#160;million in 2040. During this same period, the average battery pack size is projected to increase from 45 kWh / EV to 56 kWh / EV, while the cost of each EV battery pack is anticipated to fall from $150 / kWh to $70 / kWh. The resulting rise in demand for EV batteries is predicted to increase the total addressable market from its 2020 size of approximately $19 billion to an expected approximate $350&#160;billion in 2040. We believe that our superior technology will allow us to play a leading role in this process, while creating value for both our stockholders and society at large. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Story </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Our company was founded in 2012 by Dr.&#160;Qichao Hu through his work in the laboratory of Dr.&#160;Donald Sadoway, an accomplished professor of materials chemistry at the Massachusetts Institute of Technology (&#8220;MIT&#8221;). The following year, SES was newly formed based on the work begun at MIT. SES raised a Series A funding round, while Dr.&#160;Hu was named among the 2013 Forbes 30 Under 30 for his work on polymer ionic liquid rechargeable <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> batteries. In 2013, we <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-located</div> with A123 Venture Technologies, a technology incubator, to leverage its facility to incubate SES&#8217;s early-stage technology development. SES raised Series B funding in 2015, attracting strategic investors including GM, SAIC Motors and Applied Materials. SES&#8217;s first prototyping battery facility opened in Boston in 2016, while further Series C and C+ funding rounds engaged Temasek and Tianqi in 2017 and SK in 2018, respectively. We capitalized on this momentum, inaugurating our second battery prototyping facility in Shanghai in 2019. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-right: 1%; margin-bottom: 0pt;">Our company has made strategic advances across several fronts in 2021. SES entered into JDAs with three leading global OEMs&#8212;GM, Hyundai and Honda&#8212;while simultaneously raising Series D and D+ funding. We also announced our business combination with Ivanhoe Capital Acquisition Corp. With nine years of research and development, we have ambitious plans for the future. With the start of manufacturing by our 1 GWh pilot facility (our &#8220;Pilot Facility&#8221;) and 30 GWh Expansion I Facility approaching, we believe that SES is on the way to becoming a global leader in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery production through our combination of world-class technology and manufacturability at scale. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">In 2022, we completed our Business Combination with Old SES, upon which we changed our name to &#8220;SES AI Corporation.&#8221; In connection with the closing of the Business Combination, our shares and warrants started trading on the NYSE under the symbols &#8220;SES&#8221; and &#8220;SES WS,&#8221; respectively. Our website can be found at https://ses.ai/. The references to the SEC&#8217;s and our website are inactive textual references only, and information contained therein or connected thereto is not incorporated into this Annual Report.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Technology </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We believe that SES <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> is the next generation battery technology for EVs. Our unique approach to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> is designed to deliver high energy density batteries and high manufacturability at the same time. The unique and differentiated design of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery, enabled by advanced, proprietary and patented materials and software breakthrough, gives us the confidence that SES will be able to deliver batteries to its customers at scale while matching or exceeding their expectations on performance, safety and cost. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">3 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="color: red; letter-spacing: 0px; top: 0px;;display:inline;">
<img alt="" src="g251271g84e14.jpg" style="width: 584px; height: 260px;"/></div> </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Conventional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> technology is currently being used in most commercially available EVs. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> typically uses a metal oxide-based or phosphate-based cathode, and graphite or graphite/silicon-based anodes. The anode and cathode are separated by a polymer-based separator. Finally, the whole cell is filled with a liquid electrolyte that conducts lithium ions from anode to cathode as the vehicle is being driven (or battery is being discharged), and from cathode to anode as the vehicle (or the battery) is being charged. Conventional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> cells have been instrumental in kick starting the current EV market, and are being manufactured at scale at capacities of hundreds of GWh today. However, the automotive industry and its customers are yearning for a battery with higher energy density to improve the electric driving range (the distance that a vehicle can be driven on a single charge) while reducing battery cost to enable mass-adoption. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> is widely considered and accepted as the EV battery technology capable of achieving the highest energy density. In fact, switching the current <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> graphite/silicon anode with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> will currently result in the highest possible energy density for any given cathode in lithium chemistry. Lithium metal is the lightest unengineered pure metal on earth. Also, since the lithium ions do not have to diffuse in and out of the anode host material (like in the case of graphite or silicon in conventional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion),</div> the battery cells made with lithium metal anode can be very compact and light. This combination of lightweight and compact anode results in the highest possible gravimetric (Watt-hour (&#8220;Wh&#8221;)/kg) and volumetric (Wh/liter) energy density, respectively, for any given cathode in lithium chemistry. </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="color: red; letter-spacing: 0px; top: 0px;;display:inline;">
<img alt="" src="g251271g68u75.jpg" style="width: 590px; height: 248px;"/></div> </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">One approach to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal,</div> known as &#8220;solid-state <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal,&#8221;</div> primarily relies on solid-state materials. The solid-state material refers to the phase (solid) within which lithium ions transport from anode to cathode (during discharge) or cathode to anode (during charge). Conventional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> technology uses liquid electrolytes (not solid electrolytes), and such lithium ion transport is in the liquid phase. Approaches that use solid electrolytes generally suffer from either not having sufficient conductivity at room and lower than room temperatures, poor interface between electrolyte and electrode, inability to suppress lithium dendrites when the solid electrolyte film is thin, and lack of demonstrated manufacturability of thin, large format films and multi-layer cells at scale. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">In stark contrast, SES&#8217;s approach to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> preserves the high energy density benefits of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> while utilizing a cell design that primarily uses a liquid electrolyte in the cathode and separator to transport the lithium ions. There is also a protective anode coating between the anode and the separator, which consists of solid-state electrolyte materials. Hence, we call our approach <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">&#8220;Li-Metal,&#8221;</div> as it utilizes both liquid and solid electrolyte in the cell simultaneously. This approach results not only in improved energy density due to using lithium metal anode, but also superior performance at room and lower than room temperatures, and enables manufacturing at scale just like <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> is manufactured at scale today. In fact, we have been successfully making <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">multi-Ah,</div> multi-layer cells using our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> approach for many years. In addition to materials, SES&#8217;s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">AI-powered</div> safety software adds an additional layer of battery health monitoring and safety protection. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The key breakthrough in SES <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> cells is its unique and patented liquid electrolyte. This electrolyte is developed internally at SES with many years of scientific research and development. We use a high-concentration, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">solvent-in-salt</div></div> electrolyte. SES&#8217;s proprietary liquid electrolyte molecules and formula turns convention on its head. While liquid electrolyte used in conventional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> cells is volatile and flammable, SES liquid electrolyte has low volatility and is self-extinguishing. Conventional liquid electrolytes are primarily made up of organic solvent with low concentration of salt to aid lithium ion conduction. SES&#8217;s liquid electrolyte primarily consists of salt with a very minute amount of proprietary solvent molecule. This new type of high-concentration <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">solvent-in-salt</div></div> liquid electrolyte is fundamentally different from conventional liquid electrolyte. It maintains the manufacturability advantage of liquid electrolyte in conventional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> manufacturing, but can enable <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> due to its stability on lithium metal. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">SES&#8217;s proprietary and patented electrolyte helps resolve the issue that has plagued <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> adoption and progress for decades. With repeated charge and discharge cycles, lithium metal anodes are known to develop needle-like mossy structures known as &#8220;dendrites,&#8221; which can penetrate the separator and short-circuit the battery cell. Our electrolyte not only significantly slows down the growth of dendrites, but it also changes its morphology from &#8220;mossy lithium,&#8221; or sharp dendrites, to &#8220;dense deposition,&#8221; or a smooth lithium metal surface. This significantly increases cell cycle life and safety. </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="color: red; letter-spacing: 0px; top: 0px;;display:inline;">
<img alt="" src="g251271g11x83.jpg" style="width: 593px; height: 250px;"/></div> </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In addition to the electrolyte, our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery cells use a proprietary anode coating that helps provide another layer of protection against dendrites and makes lithium plating denser during charging, as well as an advanced <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">AI-powered</div> algorithm to accurately monitor the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">state-of-health</div></div> of the battery cells and detect any impending dendrite-related (or other) safety issues much earlier. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="color: red; letter-spacing: 0px; top: 0px;;display:inline;">
<img alt="" src="g251271g49h79.jpg" style="width: 577px; height: 235px;"/></div> </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The rest of the cell is assembled using our proprietary ultra-thin wide-width lithium metal anode, a conventional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">state-of-the-art</div></div></div> separator and a cathode. With the exception of the lithium metal anode, all materials and components utilized in our battery cells are either already being manufactured at scale or have the capability to be easily manufactured at scale without the need for intensive research and development, or development of new equipment. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">To our knowledge, SES <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery cells are the only <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> cells demonstrated to meet or exceed the preliminary OEM target requirements for energy density, low temperature discharge, room temperature fast charge and discharge, cycle life and safety. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">This unique combination of high-energy density <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> in a hybrid design enables a battery that is expected to be: </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">light and compact</div></div></div></div>, with high energy density of at least 400 Wh/kg and 1000 Wh/liter; </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">durable and safe</div></div></div></div>, with the ability to meet stringent cycle life, overall lifetime and safety targets for next generation EVs; </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">capable of fast charge</div></div></div></div>, charging up to 80% in less than 15 minutes; </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">capable of high power discharge</div></div></div></div>, at room and low temperatures; </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">low-cost</div></div></div></div></div>, taking advantage of existing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> manufacturing scale and best-practices to enable cost-reduction; </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">capitalizing on the innovation occurring in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div></div></div></div></div>, in terms of incremental improvement in energy density, supply chain development, cost reduction and manufacturing efficiency, since the cathode and cell manufacturing process are the same as in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion;</div> and </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">smarter</div></div></div></div>, with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">AI-powered</div> health monitoring software that can predict safety incidents in real time and make appropriate safety recommendations. </div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Competitive Strengths </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Differentiated battery technology</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">.</div></div> As described above, our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> batteries are expected to be lighter, more energy dense, safer, faster-charging, and lower cost solution than <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> batteries, and to include smart technology. Our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery technology has projected energy density of 400 Wh/kg / 1,000 Wh/L (illustrative EV range of approximately 540 miles) in large 100 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Amp-hour</div> (&#8220;Ah&#8221;) cells, which we believe will help to enable the expansion of an electrified world. Our current 4 Ah multi-layer battery cells have demonstrated energy density of 370 Wh/kg / 700 Wh/L in third-party testing, along with fast charging up to 80% charge in less than 15 minutes, bolstering our confidence in our ability to achieve industry-leading performance. Our batteries are expected to be significantly cheaper in the long-term, while providing fast-charge capabilities, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">best-in-class</div></div> durability and a high degree of safety.</div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Designed for manufacturing at scale</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">.</div></div> Over the last nine years of research and development, we have strived to develop a technology that is not only differentiated, but also scalable and manufacturable. As of December&#160;31, 2021, we had produced more than 15,000 multi-layer <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery cells using our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion-like</div></div> production line demonstrating that our batteries are not only playing a leading role in the industry, but are also practical. </div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="color: red; letter-spacing: 0px; top: 0px;;display:inline;">
<img alt="" src="g251271g41v83.jpg" style="width: 605px; height: 231px;"/></div> </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Strategic partnerships</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">.</div></div> We believe that our products will experience swift market adoption due to our current strategic partnerships with leading global OEMs GM, Hyundai and Honda. To our knowledge, we are the only company working on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> technology that has entered into <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-Sample</div> JDAs for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> technology with major OEMs.&#160;We plan to collaborate with other OEMs to expedite such adoption and increase market acceptance of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery over time. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">High barriers to entry</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">.</div></div> We have spent approximately $100&#160;million of capital over the last nine years to establish high barriers to protect our technological advantage. As of December&#160;31, 2021, we have been granted 56 patents, with 61 patent applications pending, 53 trademark applications pending and 25 trade secrets. For more information, see &#8220;- Our Intellectual Property&#8221; below. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">World-class management team</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">.</div></div> Our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">best-in-class</div></div> team includes both scientists and engineers with training from the world&#8217;s foremost academic institutions and exceptional industry experience. Leading our business operations are our founder and Chief Executive Officer Dr.&#160;Qichao Hu (our &#8220;Founder&#8221;), who earned his PhD in Applied Physics from Harvard University and his BS in Physics from MIT, and our President and Chief Operating Officer Rohit Makharia, who previously spent 19 years with GM, 12 of which he spent focusing on fuel cell and battery EVs. Our research, development, engineering and manufacturing efforts are spearheaded by Chief Technology Officer Yongkyu Son, who has 19 years of experience in cell development including with Apple, SK Innovation (&#8220;SKI&#8221;) and Samsung SDI, and Chief Science Officer Dr.&#160;Hong Gan, who has 25 years of battery research and development experience in both national labs and industry, during which he made key contributions to silicon based <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-sulfur</div> technologies. For more information, see &#8220;Combined Company Management and Governance After the Business Combination.&#8221; </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Growth Strategy </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Our mission is to facilitate the widespread adoption of sustainable electric transportation both on land and in air by creating the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">best-in-class,</div></div> high energy density <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> batteries centered around long-range performance and safety. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Commercialization roadmap</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">. </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Battery development for OEMs</div></div>.&#160;The results of tests undertaken by third-party testing facilities under instructions provided by Ivanhoe Capital Acquisition Corp. and SES demonstrate industry-leading <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> energy density, performance and safety. We are currently working to develop and produce <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-Sample</div> batteries with specifications required by OEMs for their EVs, with the goal of enabling commercial production in 2025. For more information on collaborations with these OEMs, see &#8220;- Our Partnerships&#8221; below. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-Sample</div> batteries are prototypes developed for OEMs based on OEMs&#8217; technical specifications, and they would fully meet those technical specifications. These are in contrast with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">B-Sample</div> batteries, which would be functional prototypes allowing full drivability and tested in actual vehicles, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">C-Sample</div> batteries, which would be fully functional, mature samples for mass production. As we remain focused on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-Sample</div> battery development, we do not yet have any arrangements with OEMs to manufacture consumer-ready batteries for their EVs. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Battery manufacturing at scale</div></div>. We will also continue to enhance our production processes to enable volume manufacturing in a cost-effective manner. We expect to complete our Pilot Facility by 2023, which we expect to be 100% <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">SES-owned</div> and operated. We plan to concurrently develop a 10 GWh joint venture plant that we expect to be operational in 2025 and that will ramp up to 30 GWh by 2027 (our Expansion I Facility), which we expect to be located in the United States. Additionally, we expect to complete a 30 GWh facility in 2026 that will ramp to 70 GWh by 2028 (our Expansion II Facility), which would represent an additional expansion of our existing facilities. In total, we expect to have more than 100 GWh of capacity by 2028. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Partnership development and expansion</div></div>. As discussed below under &#8220;Our Partnerships,&#8221; while we will continue to strengthen our partnerships with GM, Hyundai and Honda in the use of our battery technology, we intend to work closely with other OEMs to make our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery widely available over time. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cost reduction</div></div>. Cost reduction remains an important underpinning of EV market growth and our future growth. Currently, we have no long-term supply arrangements, and expect to negotiate long-term supply contracts as volume grows. For more information, see &#8220;Our Suppliers&#8221; below. However, in addition to arrangements with suppliers, we plan to explore opportunities for partial vertical integration both upstream and downstream. Vertical integration is used by <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> battery cell makers to reduce their costs, increase their competitiveness and streamline product development and commercialization for OEMs, by acquiring upstream and downstream participants in their supply chains. Upstream, we intend to explore integrating vendors of key materials of our cells and providers of key equipment and engineering capabilities, such as cell assembly, anode processing, chemical processing and safety testing. Downstream, we plan to explore integrating providers of key engineering capabilities, such as battery <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">state-of-health</div></div> monitoring software, charging optimization software, battery module development and recycling. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Continued battery innovation</div></div>. We intend to continue leveraging our world-class science, engineering and manufacturing expertise to innovate future products that will continue to provide leading technology coupled with manufacturability. We continue to invest in research and development in areas such as cell chemistry and structure, battery materials, AI software and advanced manufacturing, to build on our intellectual property portfolio. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Partnerships </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We intend to work closely with OEMs and other strategic partners to develop and produce our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery cells, with the aim of making them widely available in EVs over time. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Existing JDAs </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We have maintained a strong partnership with GM since 2015, when GM led our Series B financing, and since then, GM has invested approximately $70&#160;million in our company, including a $50&#160;million investment in our Series D funding round and a $10&#160;million investment in the private placement transaction in connection with the Business Combination (the &#8220;PIPE Financing&#8221;), via GM&#8217;s affiliates and subsidiaries. GM is one of the world&#8217;s largest car companies, and has voiced its desire to be a leader in EVs. GM has announced plans to launch more than 30 new EV models by 2025 and only sell <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">zero-emission</div> vehicles by 2035. Our collaboration initially involved close technical and research and development collaboration on SES&#8217;s battery technology. In February 2021, we entered into a JDA with GM, valued at over $50&#160;million, under which we will work with GM to jointly develop an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-Sample</div> battery cell. For more information on the GM entities party to the transaction, see &#8220;Certain Relationships and Related Transactions&#8212;SES Related Person Transactions&#8212;GM Joint Development Agreement.&#8221; </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">We have also fostered a partnership with Hyundai, another global automobile leader. In December 2020, we entered into a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-A-Sample</div></div> JDA with Hyundai. In May 2021, Hyundai made an investment of $50&#160;million in our Series D plus funding round and signed an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-Sample</div> JDA, under which we and Hyundai are collaborating to jointly develop an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-Sample</div> battery cell. Hyundai also purchased $50&#160;million of our Class&#160;A common stock in the PIPE Financing. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In December 2021, Honda became the third global automobile leader to enter into an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-Sample</div> JDA with us. Honda purchased $75&#160;million of our Class&#160;A common stock in the PIPE Financing as the single largest PIPE Financing investor. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The JDAs with GM, Hyundai and Honda do not represent commitments by these OEMs to purchase our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery cells, and are focused only on development. Although the JDAs set timeframes for the attainment of certain development milestones, these timeframes are objectives only and may be subject to ongoing elaboration and change by the parties. The JDAs also do not prohibit GM, Hyundai, Honda or SES from entering into additional agreements with other third parties. To our knowledge, neither GM, Hyundai nor Honda has entered into additional agreements with other third parties for the development of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-Sample</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> batteries. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">8 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other Investments and Partnerships </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition to the above investments from GM, Hyundai and Honda, we have received total investments from OEMs Geely and SAIC Motors of approximately $30&#160;million and total investments from other strategic and financial investors, including SK, LG, Foxconn, Tianqi, Applied Materials, Temasek and Vertex, of approximately $165&#160;million (in each case, inclusive of PIPE Financing). </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As discussed above under &#8220;Our Growth Strategy&#8212;Commercialization roadmap - Battery manufacturing at scale,&#8221; we expect to form strategic joint ventures with one or more battery makers or OEMs to support the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">build-out</div> of our Expansion I Facility. We plan for our Expansion I Facility to be a joint venture with an OEM strategic partner and that we will supply our own coated anode and electrolyte to the facility, and for our Expansion II Facility to be 100% <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">SES-owned</div> and operated. We expect to use the proceeds from the Business Combination for our Expansion I Facility. We anticipate a combination of debt and equity financing to fund the remaining facilities. Like our current partners and stockholders, we believe that any and all future partners will provide us with important support and resources in developing and scaling our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery technology. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Research and Development </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We conduct research and development at our facilities in Boston and Shanghai, and expect to eventually build additional facilities in other parts of the world. Research and development activities concentrate on making further improvements to our battery technology, including improvements to battery performance and cost. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our research and development efforts currently include, but are not limited to, programs in the following areas. </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Scale-up</div></div></div></div></div>: Our design is further being customized with and validated by OEMs.&#160;Based on our collaborations with OEMs, we believe that a roughly 100 Ah <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cell-size</div> manufactured at GWh scale (five to seven <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cells-per-minute)</div></div> is needed to achieve commercialization in EVs at a large, global scale. We are developing processes and equipment to scale up the manufacturing of current cell design from three to nine Ah capacity to approximately 100 Ah. </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Module and pack design</div></div></div></div>: <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> cells must be integrated into modules and packs as part of their integration into vehicles. Our active development efforts are focused on the integration of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> cells into modules to enable our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> cells perform as intended once they are integrated into modules and vehicles. </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Advanced AI software and battery management systems (&#8220;BMS&#8221;)</div></div></div></div>: Software is critical to the ongoing monitoring of battery health and safety. We continue to develop advanced AI algorithms to diagnose battery cell-related health issues, develop advanced control algorithms and charging methods to enhance cycle life and safety, and port such software on to a BMS that can integrated into a battery pack. </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Advanced materials and coatings</div></div></div></div>: We continue to research and develop advanced electrolyte and anodes to further improve cycle life and safety. In addition, we continue to develop novel methods of laminating or depositing lithium metal anode that can be deployed at commercial GWh scale. </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cathode materials and design</div></div></div></div>: We continue to develop our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> cells for a variety of different cathode materials, cathode design and cathode processing methods that can provide ultra-high energy density and/or significant cost-reduction. </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Lithium metal recycling</div></div></div></div>: Along with other battery components that are already being recycled today, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> foil will also need to be recycled in the future. We continue to explore methods of recycling that are productive and cost-effective. </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Intellectual Property </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We rely on a combination of the intellectual property protections afforded by patent, trademark and trade secret laws in the United States and other jurisdictions, as well as license agreements and other contractual protections, to establish, maintain and enforce rights in our proprietary technologies. As of December&#160;31, 2021, we have been granted 56 patents, with 61 patent applications pending, and have 44 registered or allowed trademarks, with 53 trademark applications pending. We also rely substantially on unpatented proprietary technology, including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">know-how</div> or trade secrets, with 25 trade secrets as of December&#160;31, 2021. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">We possess patents, licenses and/or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">know-how</div> covering the following proprietary technologies: </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cell design</div></div></div></div>, including physical format, component layout, application tuning, cell formation and support structures. </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Materials</div></div></div></div>, including salt preparation and purification, design of synthetic solvents, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">state-of-the</div></div> art electrolyte formulations, lithium foil production, separator composition and anodes. </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">9 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Battery management</div></div></div></div>, including charge/discharge profiles, rapid charging, safety systems and algorithms, telemetry harvesting and big data analysis. </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Environmental</div></div></div></div>, including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">low-impact</div> production of cell materials and recyclability of spent materials. </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Our commercial success depends in part on our ability to obtain and maintain proprietary or intellectual property protection for our designs and technology. Our policy is to protect our proprietary and intellectual property position by, in addition to filing patent applications in various jurisdictions related to our proprietary technology, relying on trade secrets, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">know-how</div> and continuing technological innovation. We may not be able to prevent unauthorized use of our intellectual property, which could harm our business and competitive position. For a more comprehensive discussion of the risks related to our intellectual property, please see &#8220;Risk Factors&#8212;Risks Relating to SES&#8217;s Business and Industry&#8212;Risks Relating to Intellectual Property.&#8221; </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Suppliers </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Currently, we are in product development and our product design has yet to be finalized, so our volume demand is limited and we do not have long-term supply arrangements. As volume demand grows, we expect to negotiate long-term supply contracts. For our current product development needs, we source from third-party suppliers for raw materials, components and equipment necessary to develop and manufacture our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> battery cells. See &#8220;&#8212;Our Growth Strategy&#8212;Commercialization roadmap&#8212;Cost reduction&#8221; above. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Human Capital </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We believe that our employees are among the best in the EV battery industry. Currently, we employ approximately 126 employees globally. By headcount, approximately <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">two-thirds</div> of our employees are located in the United States, approximately <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-third</div> are located in China and a remaining handful of employees are located in each of South Korea and Singapore. All of our executive management is located in the United States, other than our Chief Legal&#160;&amp; Corporate Officer, who is located in Singapore. Although we do not currently have definitive plans, as our joint development of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> batteries with certain U.S. and South Korean OEMs continues to progress, we would expect to launch future research facilities and, eventually, commercial production manufacturing facilities, in the United States and South Korea, while also significantly increasing our employee headcount in those locations. Currently, approximately 75% of our employees worldwide are engaged in research and development and related functions, with expertise in all aspects of the development process, including materials science, chemistry, engineering and software. More than half of these employees hold advanced engineering and scientific degrees, including many from the world&#8217;s top universities, and have extensive experience from large <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> companies. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We understand that our industry leadership is ultimately rooted in people. Competition for qualified personnel in the technology space is intense, and our success depends in large part on our ability to recruit, develop and retain a productive and engaged workforce. Accordingly, attracting and retaining truly original thinkers and top performing doers, investing in our employees and their well-being, keeping them motivated, offering competitive compensation and benefits, promoting diversity and inclusion, and adopting progressive human capital management practices constitute core elements of our corporate strategy. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We seek team members who are passionate about electric transportation and battery technologies, and have the humility and discipline to be building blocks in our fast-paced and challenging business operations. We value diversity and recognize the importance of fostering a positive, inclusive culture. As such, we have actively taken steps toward eliminating unconscious bias in our hiring and promotion processes while enabling us to add and promote team members who demonstrate behaviors aligned with our values. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">While SES has grown in size significantly, at its core it retains its early-stage <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">start-up</div> culture. It attracts and honors employees that want to make a dent in the universe. In addition to competitive compensation and benefits, we set challenging yet meaningful goals for our employees and help them push their limits, as we believe the best and brightest are fundamentally driven by the desire to solve tough, meaningful problems, be part of an exciting movement and make a real impact in the industry. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The health and safety of our employees is paramount at SES. As part of our continuing goal to reduce workplace incidents, we are committed to a culture of safe work practices and improving safety in all of our locations. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We intend to make significant investments in research and development and the recruitment of top technical and engineering talent to improve our battery technology. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">10 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Facilities </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Our headquarters are located in Boston, and most of our executive management is located in the United States. Our operating facilities are located in Boston and Shanghai. Both properties are leased, with the Boston lease and the Shanghai lease each expiring in 2026. Our Boston facility focuses on chemistry, materials and algorithm research and development, as well as engaging with OEMs worldwide, including GM, Hyundai and Honda. Our Shanghai facility focuses on supply chain development, manufacturing process development, cell product development, software, BMS and module development. We are building our 1 GWh Pilot Facility in China for the development of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-commercial-production</div> battery cells, which we expect to be completed in 2023. We have also set up an office in Seoul focused on supply chain, customer relations and our collaboration with partners in the region. As our joint development of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> batteries with certain U.S. and South Korean OEMs continues to progress, we also expect to launch future research facilities and, eventually, commercial production manufacturing facilities, in the United States and South Korea, while also significantly increasing our headcount in those locations. Specifically, we expect to enter into a joint venture with one or both of our OEM partners to build our Expansion I Facility in the United States. We expect to build the first 10 GWh portion of our Expansion I Facility in the United States in 2023 and 2024, with plans for such facility to be operational by 2025. SES expects that this Expansion I Facility will be located in the United States, as the Expansion I Facility would target the U.S. automotive market (the largest EV market for its OEM partners). </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In addition to our 1 GWh Pilot Facility (which we are building in Shanghai) and our planned 30 GWh and 70 GWh facilities, we are planning to build a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-production</div> facility in South Korea. We continue to assess our ongoing facilities needs and may build new facilities or lease additional facilities in our current or other locations according to our manufacturing needs and the needs of any OEMs with whom we enter into collaborations. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Competition </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The battery market, like the EV market it services, is fast-growing, extremely competitive and driven by the innovation of both large incumbents and emerging entrants like SES. Contemporary Amperex Technology Co. (&#8220;CATL&#8221;), SKI, LG Energy Solutions, Panasonic and Samsung SDI are among the existing suppliers of batteries to the EV industry. Although their offerings tend to be conventional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion,</div> they could develop <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> batteries that would directly compete with our offerings. Additionally, the efforts of OEMs, including Tesla, Nio, Rivian and Toyota, to develop their own EV battery production capabilities could reduce demand for SES&#8217;s technology if they are successful. Newer entrants, including Northvolt, Sila Nanotechnologies, Solid Power, QuantumScape, Ganfeng Lithium and WeLion, are supplying next-generation batteries that could compete with ours, and others could feasibly emerge. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">We acknowledge that incumbents and emerging entrants may have greater resources to invest in advancing their technologies, access to more potential customers, or strategic relationships with OEMs (or other third parties) that may give them a competitive edge. We further acknowledge that these disparities, where they exist, have the potential to harm our business, results of operations or financial condition. However, SES combines the technology innovation of emerging entrants with the practical execution capability of incumbents, and we believe that SES, with its determination and focus, will be able to be successful in the competitive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> space. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Government Regulation and Compliance </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There are government regulations pertaining to battery safety, transportation of batteries, use of batteries in vehicles, factory safety and disposal of hazardous materials. We will ultimately have to comply with these regulations to sell our batteries into the market. For more information, see &#8220;Risk Factors&#8212;Risks Relating to SES&#8217;s Business and Industry&#8212;Risks Relating to Regulation and Legal Compliance&#8221; discussing regulations and regulatory risks related to export controls (including our export controls compliance program), environmental, health and safety, anti-corruption, anti-bribery, data collection, trade and tax law compliance. </div></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_3" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;1A.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk Factors. </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We have identified the following risks and uncertainties that may have a material adverse effect on our business, financial condition, results of operations or reputation. The risks described below are not the only risks we face. Additional risks not presently known to us or that we currently believe are not material may also significantly affect our business, financial condition, results of operations or reputation. Our business could be harmed by any of these risks. The risk factors described below should be read together with the other information set forth in this Annual Report, including our consolidated financial statements and the related notes, as well as in other documents that we file with the SEC. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">11 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks Relating to SES&#8217;s Business and Industry </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risks Relating to our Business Plan </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We have a history of no revenues and of net losses, and expect to continue to incur losses for the foreseeable future. While we expect to become profitable eventually, our projections are based on internal assumptions that may prove incorrect, and we may never achieve or maintain profitability. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We incurred net losses of approximately $13.9&#160;million for the year ended December&#160;31, 2020 and $31.3&#160;million for the year ended December&#160;31, 2021, and had an accumulated deficit of approximately $63.0&#160;million from our inception through December&#160;31, 2020 and $94.3&#160;million from our inception through December&#160;31, 2021. As discussed in &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;- Our Technology</div></div>,&#8221; to date, we have only validated capabilities of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal</div> battery cell technology and have not <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">produced&#160;Li-Metal&#160;batteries</div> for sale. As a result, we have yet to generate any revenue from our business operations, and since inception, we have not achieved profitable operations or positive cash flows from our operations. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Our plan is to effect the production at scale and commercialization of our battery technology in three phases, each involving manufacturing capacity with higher output (under current plans, more than 100 GWh), over multiple years (under current plans, through 2028). Under this growth plan, we believe that we will continue to incur operating and net losses each quarter until at least 2026, the year following the one in which we expect to begin generating revenue as part of our Expansion I Facility becomes operational at 10 GWh of capability. For more information, see &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business&#8212;Our Growth Strategy</div></div>.&#8221; This plan and the related revenue and other financial projections reflect current estimates of future performance, based on certain financial and operational assumptions. Given our limited operating history, there can be no assurance that the actual results will be in line with our expectations. As discussed in other risk factors in this section, factors that could impact the timing and levels of our profitability include, but are not limited to: the level of demand for our products; the performance of our products; the projected supply materials for our products; a reduction in the cost <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of&#160;Li-ion;&#160;average</div> selling prices of EVs and our products; projected production capacities of our facilities; our collaboration with OEMs; the projected gross margin achievable upon sale of our products; and the extent to which growth of EV markets and continued shift in consumer preference will conform with projections. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additionally, we expect the rate at which we will incur losses to be significantly higher in future periods as we, among other things, continue to incur significant expenses in connection with the design, development and manufacturing of our batteries, including any significant unplanned or accelerated expenses and new strategic investments expand our research and development activities; invest in manufacturing capabilities; build up inventories of components for our batteries; invest in supply chain; increase our sales and marketing activities; develop our distribution infrastructure; and increase our general and administrative functions to support our growing operations. We may find that these efforts are more expensive than we currently anticipate or that these efforts may not result in revenues, which would further increase our losses, thus affecting the value of your investment. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We will need substantial additional capital in the future to fund our business, and may be unable to meet our future capital requirements, impairing our financial position and results of operations. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The development, design, manufacture and sale of batteries is a capital-intensive business. We expect to require financing to sustain substantial operating expenses, without generating sufficient revenues, to cover expenditures for a number of years. We plan to finance our operations with a combination of proceeds from the Business Combination, capital from investors, and if required, loans from financial institutions, as well as anticipated future revenue from product sales. Our ability to successfully develop our products, commence commercial operations and expand our business will depend on many factors, including our working capital needs, the availability of equity and/or debt financing and, over time, our ability to generate positive cash flows from operations. We believe that our cash on hand will be sufficient to meet our working capital and capital expenditure requirements for a period of at least 12 months, and also sufficient to fund our operations and our construction of our Pilot Facility and the majority of our Expansion I Facility. However, additional funding may be required for a variety of reasons. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Over time, we expect that we will need to raise additional funds through a variety of possible methods, including, but not limited to, entry into joint ventures or other strategic arrangements, the issuance of equity, equity-related or debt securities or receipt of credit from financial institutions. These funds are expected to finance our principal sources of liquidity, ongoing costs such as research and development relating to our batteries and the construction of manufacturing facilities, including the creation of the remainder of our Expansion I Facility and all of our Expansion II Facility. For more information, see &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business&#8212;Our Growth Strategy.</div></div>&#8221; We cannot be certain that additional capital will be available on attractive terms, if at all, when needed, which could be dilutive to stockholders. We may be forced to decrease our level of investment in product development or scale back our operations, which could have an adverse impact on our business and financial prospects. Furthermore, the cost of debt could be higher than anticipated, which could negatively affect our earnings. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">12 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Our&#160;Li-Metal</div> technology is untested in actual EVs, and may ultimately prove unworkable. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">To our knowledge, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal</div> battery cells are the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">only&#160;Li-Metal</div> cells with published performance and safety test results from tests conducted by third-party testing facilities. The results of these tests show that our multi-layer cells meet or exceed the preliminary OEM target requirements for energy density, low temperature discharge, room temperature fast charge and discharge, cycle life and safety. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Additionally,&#160;Li-Metal</div> is widely considered and accepted as the EV battery technology capable of achieving the highest energy density. However, we have not <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">produced&#160;Li-Metal</div> batteries for use by an actual EV, and no one has successfully demonstrated use of high energy <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">density&#160;Li-Metal&#160;batteries</div> in EVs. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Our&#160;Li-Metal&#160;battery</div> cell technology may prove unworkable when used in actual EVs, which would substantially undercut our business, operating results, financial condition and prospects, and could effectively eliminate the value of your investment. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If our batteries fail to perform as expected, our ability to develop, market and sell our batteries could be harmed. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Once commercial production of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;battery</div> technology commences, our batteries may contain defects in design and manufacture that may cause them to not perform as expected or that may require repairs, recalls, and design changes. Our battery cells are inherently complex and incorporate technology and components that have not been used for other applications and that may contain defects and errors, particularly when first introduced. For more information, see &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business&#8212;Our Technology.</div></div>&#8221; Due to our limited operating history, we have a restricted frame of reference from which to evaluate the long-term performance of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;batteries.</div> There can be no assurance that we will be able to detect and fix any defects in our batteries prior to the sale to potential consumers. If our batteries fail to perform as expected, we could lose design wins and customers may delay deliveries, terminate further orders or initiate product recalls, each of which could adversely affect our sales and brand and could adversely affect our business, financial condition, operating results and prospects. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We are unable to predict user behavior when driving EVs <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">with&#160;Li-Metal&#160;technology.</div> </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">While <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">conventional&#160;Li-ion&#160;battery</div> technology has been tested in many applications for several <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">decades,&#160;Li-Metal&#160;is</div> completely new. Even if we work with OEMs to thoroughly <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">test&#160;Li-Metal&#160;cells</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">using&#160;pre-determined&#160;conditions,</div> there is no guarantee that users in the field will not drive outside of recommended driving conditions and unintentionally abuse the batteries. In such events, performance and safety may be compromised, thus having a materially negative impact on our business, financial condition, operating results and prospects. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Delays in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;pre-manufacturing&#160;development</div> of our battery cells could adversely affect our business and prospects. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We have entered into JDAs with GM, Hyundai and Honda to jointly <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">develop&#160;A-Sample&#160;Li-Metal&#160;batteries,</div></div> with the expectation that such development will culminate in the widespread use of our technology in future EVs with these major OEMs, and eventually with other large OEMs.&#160;For more information, see &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business&#8212;Our Partnerships</div></div>.&#8221; However, as we are still in the developmental stages with each of GM, Hyundai and Honda, we do not currently have existing arrangements to produce <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;cells</div> for their vehicles, and production-ready models of our batteries will not be available until sufficiently tested and approved for inclusion in future OEMs&#8217; EVs. Each time we produce a battery with a higher output, the product must undergo <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">extensive&#160;pre-manufacturing&#160;development</div> and testing. Anything that delays the consistent development and testing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of&#160;pre-manufacturing&#160;battery</div> cells samples at increasingly higher outputs, such as technology or engineering issues, could alter our prospects and adversely affect our business. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may not be able to engage target OEM customers successfully and to convert such contacts into meaningful orders in the future. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our success, and our ability to increase revenue and operate profitably, depends in part on our ability to identify OEM target customers and convert such contacts into meaningful orders or expand on current customer relationships. In some cases, our battery cells may be delivered to certain customers on a sampling basis, where they have the ability to evaluate whether our products meet their performance requirements before committing to joint development and meaningful orders. Our ongoing success depends on whether our target customers are willing to begin and continue using our battery technology, as well as whether their product lines continue to incorporate our products. Thus, our efforts to expand our manufacturing and sales to GM, Hyundai and Honda (with whom we have JDAs) or to other OEMs may not be successful, and may never result in products that achieve market acceptance, create additional revenue or become profitable, thus harming our financial results and prospects. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">13 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Our research and development efforts strive to create products that are on the cutting edge of technology and meeting the evolving requirements of our customers, but competition in our industry is high. To secure acceptance of our products, we must also constantly develop and introduce cost-effective, increasingly more <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">scalable&#160;Li-Metal&#160;batteries</div> with enhanced functionality and performance to meet evolving industry standards. If we are unable to retain target customers, or convert early trial deployments into meaningful orders, our business, financial condition, operating results and prospects could be materially adversely affected. In addition, we may not receive adequate assistance from OEMs to commercialize our products successfully, which could impair our results of operations. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If we are unable to integrate our products into EVs manufactured by OEM customers, our results of operations could be impaired. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our batteries will be composed of modules assembled from battery cells, which we produce and intend to manufacture at scale. OEMs often require unique configurations or custom designs for batteries for their EVs. Once we enter into contracts with OEMs to produce batteries for their EVs, we expect to tailor the design of our batteries specifically to the EVs that these OEM customers manufacture. This development process requires not only substantial lead time between the commencement of design efforts for customized batteries and the commencement of volume shipments of the battery cells to the customer, but also the cooperation and assistance of the OEMs in order to determine the requirements for each specific application. Technical problems may arise that affect the acceptance of our product by the OEMs.&#160;If we are unable to design and develop products that meet the OEMs&#8217; requirements, we may lose opportunities to obtain purchase orders, and our reputation and prospects may be damaged. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may not be able to establish new, or maintain existing, supply relationships for necessary raw materials, components or equipment or may be required to pay costs for raw materials, components or equipment that are more expensive than anticipated, which could delay the introduction of our product and negatively impact our business. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Currently, we are in product development and our product design has yet to be finalized, so our volume demand is limited and we do not have long-term supply arrangements. As volume demand grows, we expect to negotiate long-term supply contracts. For our current product development needs, we source from third-party suppliers for raw materials, components and equipment necessary to develop and manufacture <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;battery</div> cells. For more information, see &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business&#8212;Our Suppliers</div></div>.&#8221; </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">To the extent that, when our volume demand so requires, we are unable to enter into long-term agreements with our current or future suppliers on beneficial terms, or such suppliers experience difficulties ramping up their supply to meet our long-term requirements, we may need to seek alternative sources for necessary raw materials, components or equipment necessary to develop and manufacture <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;battery</div> cells, produce the raw materials or additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">components&#160;in-house,&#160;or</div> redesign our proposed products to accommodate available substitutes or at reasonable cost. To the extent that our suppliers experience any delays in providing or developing their products, we could also experience delays in delivering on our timelines. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Moreover, the price of purchased raw materials, components and equipment could fluctuate significantly due to circumstances beyond our control. Substantial increases in prices would increase our operating costs and negatively impact our prospects. Any disruption in supply could also temporarily disrupt future research and development activities or production of our batteries until an alternative supplier is able to meet our requirements. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Changes in business conditions, unforeseen circumstances and governmental changes, as well as other factors beyond our control or which we do not presently anticipate, could affect our suppliers&#8217; ability to deliver raw materials, components or equipment to us on a timely basis. For instance, we may be impacted by currency fluctuations, trade barriers, tariffs or shortages and other general economic or political conditions, such as the ongoing military conflict between Russia and Ukraine, which may limit our ability to obtain key raw materials or components for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal</div> batteries or significantly increase freight charges and other costs and expenses associated with our business. Any of the foregoing could materially and adversely affect our business, financial condition, operating results and prospects. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our ability to manufacture <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;batteries</div> at scale depends on our ability to build, operate and staff our facilities successfully. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We expect to start building our Pilot Facility in 2022 in Shanghai and to build additional facilities in other countries to meet the expected demand for our products. For more information, see &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business&#8212;Our Growth Strategy</div></div>&#8221; and &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">- Our Facilities</div></div>.&#8221; Because we expect to rely heavily on complex machinery, well-trained personnel and well-managed supply chain for our operations in these facilities, our production will involve a significant degree of uncertainty and risk in terms of operational performance and costs. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">14 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our manufacturing facilities are expected to consist of large-scale machinery combining many components. Such machinery will require us to make intensive capital expenditures prior to our ability to earn any revenues. The manufacturing facility machinery may suffer unexpected malfunctions from time to time and will depend on repairs and spare parts to resume operations, which may not be available when needed. Additionally, unexpected malfunctions of the manufacturing facility equipment may significantly affect the intended operational efficiency, thus materially and adversely affecting our business, financial condition and operating results. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The production of our facilities will also require us to hire and train highly-skilled personnel to operate such facilities, including engineers, workers, and indirect laborers. Recruiting and training such skilled staff will take significant cost and time, and an inability to do so timely or at all will inhibit the successful operation of these facilities, thus negatively affecting our business. In addition, the manufacturing of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;batteries</div> at our Pilot Facility and other facilities will require us to obtain various production licenses and permits, receive the necessary internal approvals from our customers regarding specifications and enter into agreements for the supply of raw materials, components and manufacturing tools and supplies. If we do not complete such steps timely, our manufacturing timeline or output could be significantly delayed or inhibited. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Finally, the production of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;batteries</div> at scale with our forecasted cost advantage, compared to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">conventional&#160;Li-ion&#160;cells,</div> will require us to achieve rates of throughput, use of electricity and consumables, yield, and rate of automation demonstrated for mature batteries and battery material. As we have not <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">produced&#160;Li-Metal&#160;batteries</div> at scale, our ability to achieve such rates is untested and subject to significant constraints and uncertainties. Operational performance and costs can be difficult to predict and are often influenced by factors outside of our control, such as, but not limited to, environmental hazards and remediation, costs associated with commissioning of machines, damages or defects in electronic systems, industrial accidents, fire and seismic activity and natural disasters, and problems with equipment vendors. Should operational risks materialize, they may result in lower yield, which would negatively affect our revenue growth and profitability as projected. Additionally, they could cause personal injury to or death of workers, the loss of manufacturing equipment, damage to manufacturing facilities, monetary losses, delays and unanticipated fluctuations in production, environmental damage, administrative fines, increased insurance costs and potential legal liabilities, all of which could have a material adverse effect on our business, financial condition, operating results and prospects. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We have pursued and may continue to pursue JDAs and other strategic alliances, which could have an adverse impact on our business if they are unsuccessful. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We have entered into strategic alliances, and may in the future enter into additional strategic alliances. For example, as further discussed in &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">-Our</div> Partnerships</div></div>,&#8221; we have JDAs with GM, Hyundai and Honda. We expect to form strategic joint ventures with one or more battery makers or OEMs to support <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;build-out&#160;of</div> our Expansion I Facility. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">While offering potential benefits, these current and future strategic alliances with battery manufacturers, OEMs and others could subject us to a number of risks, including risks associated with sharing proprietary <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">information,&#160;non-performance&#160;by</div> our partners and costs of establishing and maintaining new strategic alliances, any of which may materially and adversely affect our business. We may have limited ability to monitor or control the actions of our partners and, to the extent any of them suffers negative publicity or harm to their reputation from events relating to their business, we may also suffer negative publicity or harm to our reputation by virtue of our association with them. For example, if we rely on our partners&#8217; manufacturing facilities, those operations would be outside of our control. We could experience delays if our partners do not meet agreed-upon timelines or experience capacity constraints, and in turn, we could lose customers and face reputational harm. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Further, there is risk of potential disputes with any partners with whom we collaborate, and we could be affected by adverse publicity related to our partners, whether or not such publicity is related to their collaboration with us. Our ability to build a premium brand successfully could also be adversely affected by perceptions about the quality of our partners&#8217; products. In addition, because we rely on our partners and third parties to meet our quality standards, there can be no assurance that we will successfully maintain quality standards. Any of the foregoing could adversely affect our business, financial condition, operating results and prospects. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">15 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The EV battery market continues to evolve and is highly competitive, and certain other battery manufacturers have significantly greater resources than we do. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The EV battery market, like the EV market it services, is fast-growing, extremely competitive and driven by the innovation of both large incumbents and emerging entrants like SES. For more information, see &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business -Competition</div></div>.&#8221; <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-ion</div> battery technology has been widely adopted and our current competitors have, and future competitors may have, greater resources than we do and may also be able to devote greater resources to the development of their current and future technologies. These competitors also may have greater access to customers and may be able to establish cooperative or strategic relationships amongst themselves or with third parties that may further enhance their resources and competitive positioning. In <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">addition,&#160;Li-ion&#160;battery</div> manufacturers may continue to reduce cost and expand supply of conventional batteries and therefore reduce the prospects for our business or negatively impact our ability to sell our products at a market-competitive price and yet with sufficient margins. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">A number of development-stage companies are also seeking to develop new technologies <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">for&#160;Li-Metal&#160;batteries.</div> Potential new entrants are seeking to develop new technologies for cathodes, anodes, electrolytes and additives. Some of these companies have established relationships with OEMs and are in varying stages of development. Additionally, many OEMs are researching and investing in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">conventional&#160;Li-ion</div> batteries <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">and/or&#160;Li-Metal&#160;battery</div> efforts and, in some cases, in battery development and production. Furthermore, other companies are developing alternative technologies such as advanced diesel, ethanol, fuel cells or compressed natural gas, as well as potential improvements in the fuel economy of the internal combustion engine. We expect competition in battery technology and EVs to intensify due to increased demand for these vehicles and a regulatory push for EVs, continuing globalization, and consolidation in the worldwide automotive industry. Developments in alternative technologies or improvements in battery technology made by competitors may materially adversely affect the sales, pricing and gross margins of our batteries. If a competing technology is developed that has superior operational or price performance, our business will be harmed. Similarly, if we fail to accurately predict and ensure that our battery technology can address customers&#8217; changing needs or emerging technological trends, or if our customers fail to achieve the benefits expected from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;batteries,</div> our business will be harmed. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may not be able to estimate accurately the future supply and demand for our batteries, which could result in a variety of inefficiencies in our business and hinder our ability to generate revenue. If we fail to predict accurately our manufacturing requirements, we could incur additional costs or experience delays. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">It is difficult to predict our future revenues and appropriately budget for our expenses, and we may have limited insight into trends that may emerge and affect our business. We anticipate being required to provide forecasts of our demand to our current and future suppliers prior to the scheduled delivery of products to potential customers. Currently, there is no historical basis for making judgments on the demand for our batteries or our ability to develop, manufacture, and deliver batteries, or our profitability in the future. If we overestimate our requirements, our suppliers may have excess inventory, which may increase our costs. If we underestimate our requirements, our suppliers may have inadequate inventory, which could interrupt manufacturing of our products and result in delays in shipments and revenues or potential liability for late delivery. In addition, lead times for raw materials, components and manufacturing equipment may vary significantly and depend on factors such as the specific supplier, contract terms and demand for each raw material, component or manufacturing equipment at a given time. Any of the foregoing could result in delays in the delivery of batteries to our potential customers, which would harm our business, financial condition, operating results and prospects. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may not be able to plan accurately our manufacturing based on our future sales contracts, which may result in excess product inventory or product shortages. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Once we begin commercializing our products, our customers&#8217; final purchase orders may not be consistent with our estimates. If these final purchase orders substantially differ from our estimates at that point in time, we may have excess product inventory or product shortages. Excess product inventory could result in unprofitable sales or write-offs, as our products, which are customized, are susceptible to obsolescence due to their limited shelf life. Because we have no operating history with respect to manufacturing for sale for any OEM, we may also be unable to forecast accurately the pace of manufacturing or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;take-up&#160;of</div> our products by them. Additionally, EV batteries are susceptible to price declines. Producing additional products to make up for any product shortages within a short time frame may be difficult, making us unable to fulfill the purchase orders, especially due to the customized nature of our products. In either case, our business, financial condition, operating results and prospects may be adversely affected. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">16 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If we cannot develop new products on an ongoing basis in a timely manner and at favorable margins, including those not currently contemplated by our growth plan, we may not be able to compete effectively. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We have made and continue to make investments in research and development with the goal of further innovation and cost reduction. For information on our current technology, see &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business&#8212;Our Technology</div></div>&#8221; and &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">- Our Research and </div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Development</div></div>.&#8221; Our ability to create newer products and line extensions and to sustain currently contemplated products is affected by whether we can, amongst other things: </div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">develop and fund research and technological innovations; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">receive and maintain necessary intellectual property protections; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">obtain governmental approvals and registrations; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">comply with governmental regulations; and </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">anticipate customer needs and preferences successfully. </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The failure to develop and launch successful new products could hinder the growth of our business and any delay in the development or launch of a new product could also compromise our competitive position. If competitors introduce new or enhanced products that significantly outperform ours, or if they develop or apply manufacturing technology that permits them to manufacture at a significantly lower cost relative to ours, we may be unable to compete successfully in the market segments affected by these changes. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Certain components of our batteries pose safety risks that may cause accidents. We may be subject to financial and reputational risks due to product recalls and product liability claims, and we could face substantial liabilities that exceed our resources. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Due to the high energy density inherent in lithium-based batteries, our batteries can pose certain safety risks, including the risk of fire. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Our&#160;state-of-the-art&#160;software</div></div></div> is designed to accurately monitor and predict most safety incidents. Nevertheless, accidents causing death or personal injury or property damage can occur, and no high energy density battery will ever be 100% safe. For example, with repeated charge and discharge <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cycles,&#160;Li-Metal&#160;anodes</div> are known to develop needle-like mossy structures known as &#8220;dendrites,&#8221; which can penetrate the separator and short-circuit the battery cell. Although we incorporate safety procedures in the research, development, manufacture and transportation of batteries that are designed to minimize safety risks&#160;- for example, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;battery</div> technology is designed to slow down the growth of dendrites and change their morphology&#160;-&#160;the manufacture or use of our products may still cause accidents. Any accident, whether occurring at the manufacturing facilities or from the use of our products, may result in significant production interruption, delays or claims for substantial damages caused by personal injuries or property damage. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Product liability claims, even those without merit or those that do not involve our products, could harm our business, financial condition, operating results and prospects. The automobile industry in particular experiences significant product liability claims, and we face inherent risk of exposure to claims in the event that our battery products do not perform or are claimed not to have performed as expected. As is true for other commercial vehicle suppliers, we expect in the future that our battery products will be installed on vehicles that will be involved in crashes resulting in death or personal injury. Additionally, product liability claims that affect our competitors may cause indirect adverse publicity for us and our products. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A successful product liability claim against us could require us to pay a substantial monetary award. We may not be able to cover any substantial monetary judgment against us. Moreover, a product liability claim against us or our competitors could generate substantial negative publicity about our products and business and could have a material adverse effect on our brand, business, prospects, financial condition and operating results. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may incur significant costs based on the warranties we may supply in our products and services. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Battery manufacturers are expected to give warranties that are reflective of the warranties given by OEMs to buyers of their vehicles. With respect to our battery products, we expect to offer warranties against any defects due to product malfunction or workmanship. We expect to provide a reserve for these potential warranty expenses, which is based on an analysis of historical warranty issues. There will be no assurance that future warranty claims will be consistent with past history, and in the event we experience a significant increase in warranty claims, there is no assurance that our reserves will be sufficient. This could have a material adverse effect on our business, financial condition and operating results. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">17 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If we fail to effectively manage eventual growth, then our business, results of operations and financial condition could be adversely affected. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Our future success depends upon our ability to grow, and if we are unable to manage our growth effectively, we may incur unexpected expenses and be unable to meet our eventual customers&#8217; requirements, all of which could materially adversely affect our business, financial condition, operating results and prospects. To manage our current and anticipated future growth effectively, we must continue to maintain and enhance our infrastructure, financial and accounting systems and controls. We must also attract, train and retain a significant number of scientists, engineers, sales and marketing personnel, customer support personnel, professional services personnel, technical personnel and management personnel, and the availability of such personnel may be constrained. For more information, see &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">- Our business depends substantially on the continuing efforts of our senior executives and other key personnel as well as the ability to attract, train and retain highly skilled employees and key personnel</div></div>.&#8221; </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As we continue to grow, including from the integration of employees and businesses acquired in connection with future acquisitions, we may find it difficult to maintain important aspects of our corporate culture, which could negatively affect our profitability and our ability to retain and recruit qualified personnel who are essential for our future success. If we do not effectively manage our growth, we may not be able to execute on our growth plan, respond to competitive pressures, take advantage of market opportunities, satisfy customer requirements or manufacture high-quality products. Additionally, we may not be able to expand and upgrade our infrastructure to accommodate future growth. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Failure to effectively manage our growth could also lead us to over-invest or under-invest in development and operations; result in weaknesses in our infrastructure, systems or controls; give rise to operational mistakes, financial losses, loss of productivity or business opportunities; and result in loss of employees and reduced productivity of remaining employees. Our growth is expected to require significant capital expenditures, which may lower our earnings, and may divert financial resources from other projects such as the development of new products and services. If we are unable to manage our growth effectively, our expenses may increase more than expected, our revenue may not increase or may grow more slowly than expected and we may be unable to implement our business strategy. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our business depends substantially on the continuing efforts of our senior executives and other key personnel as well as the ability to attract, train and retain highly skilled employees and key personnel. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Our success depends on our ability to attract and retain our executive officers, key employees and other qualified personnel, and our operations may be severely disrupted if we lost their services. As we build our brand and become better known, there is increased risk that competitors or other companies will seek to hire our personnel. All of our executives and engineering staff are subject <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to&#160;non-competition&#160;agreements,</div> but we may face the challenge that many companies face of enforcing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">these&#160;non-competition&#160;agreements.</div> The failure to attract, integrate, train, motivate and retain these personnel could seriously harm our business and prospects. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">To execute our business plan, we must attract and retain highly qualified personnel in research and development, sales and marketing, production and other leadership roles. Competition for these employees is intense, and we may not be successful in attracting and retaining qualified personnel. We have from time to time in the past experienced, and we expect to continue to experience, difficulty in hiring and retaining highly skilled employees with appropriate qualifications in relevant industries. Many of the companies with which we compete for experienced personnel have greater resources than we have. In addition, in making employment decisions, particularly in high-technology industries, job candidates often consider the value of the equity they are to receive in connection with their employment. Employees may be more likely to leave us if the shares they own or the shares underlying their equity incentive awards have significantly appreciated or significantly reduced in value. A significant talent pool consists of nationals from countries that may require a license from the United States Bureau of Industry and Security to work with our technology, which raises the cost of hiring due to the uncertainty that a license may not be granted and the candidate would be unemployable in the role envisioned. For more information, see &#8220; <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">- Risks Relating to Regulation and Legal Compliance&#8212;Governmental trade controls, including export and import controls, sanctions, customs requirements and related regimes, could subject us to liability or loss of contracting privileges, limit our ability to transfer technology or compete</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;in certain markets and affect our ability to hire qualified personnel</div></div>.&#8221; If we fail to attract new personnel, or fail to retain and motivate our current personnel, our business and growth prospects could be harmed. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, we are highly dependent on the services of Dr.&#160;Qichao Hu, our Founder and Chief Executive Officer, and other senior technical and management personnel, including our executive officers, who may take significant amounts of time to replace. If Dr.&#160;Hu or other key personnel were to depart, we may not be able to successfully attract and retain senior leadership necessary to grow our business. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">18 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we do not maintain and continue to develop our corporate culture as we grow and evolve, it could also harm our ability to foster the innovation, creativity and teamwork we believe that we need to support our growth. Additions of executive-level management, significant numbers of new employees, our workforce reduction and higher employee turnover could significantly and adversely impact our culture. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risks Relating to the EV Industry </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our future growth and success depend on the willingness of vehicle operators and consumers to adopt EVs. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our growth is highly dependent upon the adoption of EVs by commercial vehicle and specialty vehicle operators and consumers. If the markets for EVs do not develop as we expect or develop more slowly than we expect, our business, prospects, financial condition and operating results will be harmed, because demand for our products and services will not increase as expected or may even be reduced. The market for alternative fuel vehicles is relatively new, rapidly evolving, characterized by rapidly changing technologies, price competition, numerous competitors, evolving government regulation and industry standards, frequent new vehicle announcements and changing consumer demands and behaviors. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other factors may influence the adoption of EVs, including, but not limited to: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">perceptions about EV quality, design and performance, especially if adverse events or accidents occur that are linked to the quality or safety of EVs; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">volatility in sales of EVs; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the costs of purchasing and maintaining EVs; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">perceptions about vehicle safety in general, namely, safety issues that may be attributed to the use of advanced technology, including vehicle electronics; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">negative perceptions of EVs, such as that they are more expensive than nonelectric vehicles and are only affordable with government subsidies or that they have failed to meet customer expectations; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the limited range over which EVs may be driven on a single battery charge and the effects of weather on this range; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the decline of an EV&#8217;s range resulting from deterioration over time in the battery&#8217;s ability to hold a charge; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">concerns about electric charging infrastructure availability and reliability, which could derail past and present efforts to promote EVs as a practical solution to vehicles which require gasoline; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">concerns about charging station standardizations, convenience and cost influencing consumers&#8217; perceptions regarding the convenience of EV charging stations; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">concerns of potential customers about the susceptibility of battery packs to damage from improper charging, as well as the lifespan of battery packs and the cost of their replacement; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">concerns regarding comprehensive vehicular insurance coverage related to EVs; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">developments in alternative technologies, such as advanced diesel, ethanol, fuel cells or compressed natural gas, or improvements in the fuel economy of the internal combustion engine, which could adversely affect sales of EVs; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the environmental consciousness of consumers; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the availability and volatility in the cost of natural gas, diesel, coal, oil, gasoline and other fuels relative to electricity, such as the sharp reduction in prices for gasoline in 2020 and the recent sharp increase in such prices; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the availability of tax and other governmental incentives to purchase and operate EVs or future regulation requiring increased use of nonpolluting vehicles; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">concerns regarding the value and costs for upkeep of EVs in the used car market; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the availability of enough skilled labor in after-sale maintenance and repair services of EVs; and </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">macroeconomic factors. </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Any of these factors could impair the development of the EV market, lowering demand. In anticipation of an expected increase in the demand for EVs in the next few years, we plan to develop, test, manufacture and commercialize <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;battery</div> technology. However, the markets we expect to target, primarily those in North America, Europe and Asia may not achieve the level of growth we expect. If any market fails to achieve our expected level of growth, we may have excess manufacturing capacity and may not be able to generate enough revenue to achieve or sustain our profitability. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">19 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Developments in alternative technology or other fossil fuel alternatives may adversely affect the demand for our battery products. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant developments in alternative technologies, such as fuel cell technology, advanced diesel, ethanol or natural gas, or breathing batteries, may materially and adversely affect our business, financial condition, operating results and prospects in ways that we may not currently anticipate. Existing and other battery technologies, fuels or sources of energy may emerge as customers&#8217; preferred alternatives to our battery products. Any failure by us to develop new or enhanced technologies or processes, or to react to changes in existing technologies, could materially delay our development and introduction of new and enhanced alternative products, which could result in decreased revenue and a loss of market share to our competitors. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our research and development efforts may not be sufficient to adapt to changes in alternative fuel and EV technology. As technologies evolve, we plan to upgrade or adapt our energy solutions with the latest technology, in particular lighter weight modules and packs, advanced cooling methods, more sophisticated safety management software, more efficient manufacturing process, and advanced battery chemistry, which may also negatively impact the adoption of our other products. However, we may not compete effectively with alternative systems if we are not able to develop, source and integrate the latest technology into our battery products. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The battery efficiency of EVs declines over time, which may negatively influence potential customers&#8217; decisions whether to purchase an EV. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Over time, vehicles using our batteries will see performance decline as the battery ages. Furthermore, excessive fast charging (for example, repeatedly using super chargers) can adversely affect the performance of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;Li-Metal&#160;battery</div> technology by degrading the battery over time. If these sources of performance decline dissuade potential customers from buying EVs built using our batteries, it could negatively impact our capacity for future sales. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If the EVs in which our batteries are installed do not meet certain motor vehicle standards, our business, operating results and prospects could be adversely affected. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our products are expected to be used as components in EVs. All vehicles sold must comply with applicable international, federal, and state motor vehicle safety standards, which vary by national and other jurisdictions. In the United States, vehicles that meet or exceed all federally mandated safety standards are certified under the federal regulations. Rigorous testing and the use of approved materials and equipment are among the requirements for achieving federal certification. Failure by our eventual EV manufacturing customers to satisfy motor vehicle standards could have a material adverse effect on our business and operating results. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Moreover, we may incur our own significant costs in complying with these regulations. Laws and regulations related to the EV industry and alternative energy are currently evolving and we face risks associated with changes to these laws and regulations. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">To the extent laws and regulations become more stringent or otherwise change, our products or the vehicles into which they are incorporated may not comply with applicable international, federal, state or local laws, which would have an adverse effect on our business. Compliance with changing laws and regulations could be burdensome, time consuming and expensive. To the extent compliance with new laws and regulations is cost prohibitive, our business, financial condition, operating results and prospects would be adversely affected. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Internationally, there may be laws and regulations in jurisdictions we have not yet entered or laws of which we are unaware in jurisdictions we have entered that may restrict our sales or other business practices. Even for those jurisdictions we have analyzed, the laws and regulations in this area can be complex, difficult to interpret and may change over time. Continued regulatory limitations and other obstacles interfering with our or our eventual customers&#8217; ability to sell products could have a negative and material impact on our business, financial condition, operating results and prospects. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">20 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our ability to market our products will depend on the establishment of charging station networks meeting the needs of EVs using our products. If any of the charging station networks are not compatible with such products and technologies, our sales could be adversely affected. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We design, develop, and manufacture electric power batteries for EVs. However, we do not manufacture chargers or charging poles that are necessary for using our products. In addition, we will rely on third parties, such as city governments, utility providers and private investors, to build charging stations for EVs using our products. If no charging station networks are built in markets in which OEMs using our products target their EVs, there would be little demand for electric battery products in those areas. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Further, existing charging station networks have not been established under a uniform standard and it could diminish our sales if any of the networks are not compatible with EVs using our products and technologies. In order for our fast-charging batteries to become widely adopted in electric passenger cars, a critical mass of compatible fast-charging stations must be installed and in operation in any given urban area where our OEM customers plan to enter. Establishing a network of fast-charging stations requires significant capital investment and government approvals. It also requires government regulators to believe that the merits of fast-charging stations support the costs of such construction. If a sufficient number of charging stations that accommodate EVs using our products and technologies cannot be built up and be functional in a timely manner, it will be difficult for us to retain our existing customers and to attract new customers. As a result, our business, financial condition, operating results and prospects may be materially and adversely affected. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If emerging standards in charging station networks are not compatible with our current products or in development products and technologies, we may miss market opportunities and our financial performance will suffer. If other EV battery companies&#8217; products and services, including industry-standard technologies or other new standards, emerge or become dominant in any of these areas, or differing standards emerge in global markets, demand for our technology and products could diminish. As standards emerge, such as those in China including specifications for hardware, connecting equipment and service networks, and standards for communication and inspection, compatibility of prior fast-charging stations could be made obsolete. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We also incorporate materials and components manufactured by third parties into our products. If there are quality issues with respect to these third-party materials and components included in our batteries, we may not discover the issue until after our products have been shipped and installed. In addition, we may have little or no recourse against these third-party suppliers arising out of warranty claims made by our customers. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The Biden Administration has put forth ambitious goals for advancing new battery technology, which may lead to a shortage of the metals required for manufacturing batteries. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Biden Administration has put forth ambitious goals for investing in &#8220;clean energy,&#8221; including goals to replace gasoline-operated vehicles with EVs, which would likely depend significantly on battery technology. In order to meet these ambitious goals, a secure supply chain of raw materials, including copper and nickel, will need to be obtained. Developing mines for these materials can take a significant amount of time. If production of battery technology increases faster than this supply chain can be secured, it may lead to a shortage of these raw materials, which could negatively affect our business. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risks Relating to Intellectual Property </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our patent applications may not result in issued patents or our patent rights may be challenged, invalidated or limited in scope, any of which could have a material adverse effect on our ability to prevent others from competing or interfering with the commercialization of our products. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Our key technological innovations, including innovations that are currently commercialized in our products and innovations that we plan to deploy in the future, are described in our issued patents and pending patent applications, as well as patent applications that we plan to file in the future. For more information, see &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business&#8212;Intellectual Property</div></div>.&#8221; The process of applying for and obtaining a patent is expensive, time consuming and does not always result in patent claims as expected or needed. We may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost, in a timely manner, or in all jurisdictions where protection may be commercially advantageous, or we financially may not be able to protect our proprietary rights at all. There is also no assurance that the pending applications will result in issued patents. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">21 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">In addition, the issuance of a patent does not give us the right to practice the patented invention. Third parties may have blocking patents that could prevent us from marketing our products and practicing our technology. Alternatively, third parties may seek to market their products similar to or otherwise competitive with our products. In these circumstances, we may need to defend and/or assert our patents, including by filing lawsuits alleging patent infringement. In any of these types of proceedings, a court or agency with jurisdiction may find our patents invalid and/or unenforceable. Even if we have valid and enforceable patents, these patents still may not provide protection against competing products or processes sufficient to achieve our business objectives. We do not <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">currently&#160;co-own&#160;any</div> patents, but under the terms of our <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">JDAs,&#160;co-ownership</div> of patents and patent applications with third parties is possible in the future. If the other owners are unwilling to join us in an enforcement action, we may be unable to enforce our jointly owned patent rights against infringers. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Such&#160;co-owners</div> may be able to license their rights to other third parties, including our competitors, and our competitors could market competing products and technology. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Further, to the extent that we endeavor to enforce our currently issued patent or any patents that are issued in the future, the alleged infringer is likely to assert that it has not infringed any claim of the applicable patent(s) and that the applicable patent(s) is in any event invalid or unenforceable. There can be no assurance that we will overcome those defenses. If one or more of our patents are held to be invalid or unenforceable, or if claims of those patents are interpreted narrowly, or if patents fail to issue from our pending applications, our competitiveness and value may also be undermined. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We rely heavily on our intellectual property portfolio, including unpatented proprietary technology. If we are unable to protect our intellectual property rights from unauthorized use, our business and competitive position would be harmed. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We may not be able to prevent unauthorized use of our intellectual property, which could harm our business and competitive position. We rely upon a combination of the intellectual property protections afforded by patent, trademark and trade secret laws in the United States and other jurisdictions, as well as license agreements and other contractual protections, to establish, maintain and enforce rights in our proprietary technologies. For more information, see &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">-Our</div> Intellectual Property</div></div>.&#8221; </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">We also rely substantially on unpatented proprietary technology, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">including&#160;know-how&#160;or</div> trade secrets. We seek to protect our intellectual property rights in various ways, including through nondisclosure and invention assignment agreements with our employees and consultants and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">through&#160;non-disclosure&#160;agreements</div> with business partners and other third parties. We cannot ensure that these agreements will provide meaningful protection for our trade <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">secrets,&#160;know-how&#160;or</div> other proprietary information in the event of any unauthorized use, misappropriation, or disclosure of such trade <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">secrets,&#160;know-how&#160;or</div> other proprietary information. There can be no assurance that employees, consultants, vendors and customers have executed such agreements or have not breached or will not breach their agreements with us, that we will have adequate remedies for any breach, or that our trade secrets will not otherwise become known or independently developed by competitors. The theft or unauthorized use or publication of our trade secrets and other confidential business information could reduce the differentiation of our products and harm our business, the value of our investment in development or business acquisitions could be reduced and third parties might make claims against us related to losses of their confidential or proprietary information. Any of the foregoing could materially and adversely affect our business. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additionally, despite our efforts to protect our proprietary rights, third parties may attempt to copy or otherwise obtain and use our intellectual property. Monitoring unauthorized use of our intellectual property is difficult and costly, and the steps we have taken or will take to prevent misappropriation may not be sufficient. Any enforcement efforts we undertake, including litigation, could be time-consuming and expensive and could divert management&#8217;s attention, which could harm our business, results of operations and financial condition. In addition, existing intellectual property laws and contractual remedies may afford less protection than needed to safeguard our intellectual property portfolio. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may need to defend ourselves against intellectual property infringement claims, which may be time-consuming and could cause us to incur substantial costs. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Companies, organizations or individuals, including our current and future competitors, may hold or obtain patents, trademarks or other proprietary rights that would prevent, limit or interfere with our ability to make, use, develop or sell our products, which could make it more difficult for us to operate our business. From time to time, we may receive claims or inquiries from holders of patents or trademarks claiming that and/or inquiring whether we are infringing their proprietary rights and/or seeking court declarations that they do not infringe upon our intellectual property rights. Companies holding patents or other intellectual property rights relating to batteries, electric motors or electronic power management systems may bring suits alleging infringement of such rights or otherwise asserting their rights and seeking licenses. In addition, if we are determined to have infringed upon a third party&#8217;s intellectual property rights, we may be required to do one or more of the following: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">cease selling, incorporating or using products that incorporate the challenged intellectual property; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">22 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">pay damages; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">obtain a license from the holder of the infringed intellectual property right, which license may not be available on reasonable terms or at all; or </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">redesign our batteries. </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the event of a successful claim of infringement against us and our failure or inability to obtain a license to the infringed technology, our business, prospects, operating results and financial condition could be materially adversely affected. In addition, any litigation or claims, whether or not valid, could result in substantial costs and diversion of resources and management&#8217;s attention. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may face risks relating to protecting our intellectual property in various countries. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Patent, trademark and trade secret laws vary significantly throughout the world. A number of foreign countries do not protect intellectual property rights to the same extent as do the laws of the United States. Therefore, our intellectual property rights may not be as strong or as easily enforced outside of the United States, and efforts to protect against the unauthorized use of our intellectual property rights, technology, and other proprietary rights may be more expensive and difficult outside of the United States. Some courts inside and outside the United States may be less willing or unwilling to protect trade secrets and agreement terms that <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">address&#160;non-competition&#160;are</div> difficult to enforce in many jurisdictions and might not be enforceable in certain cases. Failure to adequately protect our intellectual property rights could result in our competitors using our intellectual property to offer products, potentially resulting in the loss of some of our competitive advantage and a decrease in our revenue, which would adversely affect our business, financial condition, operating results and prospects. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may face risks relating to protecting our intellectual property due to the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ongoing&#160;COVID-19&#160;pandemic.</div> </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">As a result of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ongoing&#160;COVID-19&#160;pandemic,</div> certain domestic and foreign intellectual property authorities have amended their filing requirements and other procedures, including, but not limited to, extending deadlines and waiving fees. These accommodations have not been applied uniformly across all intellectual property authorities globally, and the effectiveness and duration of existing action is unclear. Further, the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ongoing&#160;COVID-19&#160;pandemic</div> has created uncertainty with respect to the uninterrupted operation of domestic and foreign intellectual property authorities, which, among other things, may cause delayed processing of renewal and application filings. Our inability to establish and maintain current and future intellectual property rights may have an adverse effect on the growth and reputation of our business. Further, the constantly evolving nature of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;COVID-19&#160;pandemic</div> may change its effect on our intellectual property rights over time in ways that cannot be reasonably anticipated or mitigated. This could have an adverse effect on our business, results of operations, and financial condition. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Risks Relating to our International Operations </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">International expansion of our business exposes us to business, regulatory, political, operational, financial and economic risks associated with doing business outside of the United States. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">While we are incorporated as a Delaware corporation, we have significant operations outside the United States. Battery manufacturing is capital intensive, and to reduce dilution and financial burden, SES has been applying for appropriate government financial support. We currently have an operating facility in Shanghai focused on indigenous research and development, manufacturing process development, and supply chain development. We also plan to do business, build facilities or otherwise commence operations in other countries including South Korea. We plan to seek government financial support to cover the expense of facility construction and operation as much as possible. Also, due to geopolitical considerations, we may be required to introduce certain commercial inefficiencies into our operations. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are subject to, and could become further subject to, various legal, political, regulatory and social requirements and economic conditions both inside and outside the United States. Expansion into new markets requires significant resources and management&#8217;s attention, as well as significant expenditures, including for the establishment of local operating entities, hiring of local employees and establishment of facilities in advance of generating any revenue. Some of the risks associated with international operations in China and/or other countries, such as in the development, manufacturing, marketing or sale of our products, include, but are not limited to: </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">23 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">general trade tensions between the United States and China have been escalating, and new legislation or regulations in either jurisdiction could impose additional restrictions and costs on our ability to operate in one or both jurisdictions, or even foreclose operations entirely; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-U.S.&#160;countries</div> have enacted and could enact legislation or impose regulations or other restrictions, including unfavorable labor regulations or tax policies (such as Chinese regulations prohibiting our operating company from paying dividends out of accumulated distributable profits unless 10% of such profits (up to half of the company&#8217;s registered capital) are set aside annually, under Article 166 of China&#8217;s Company Law), which could have an adverse effect on our ability to conduct business in or expatriate profits from those countries; </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">tax rates in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">certain&#160;non-U.S.&#160;countries</div> may exceed those in the United States <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">and&#160;non-U.S.&#160;earnings</div> may be subject to withholding requirements or the imposition of tariffs, exchange controls, or other restrictions, including restrictions on repatriation; </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">the regulatory or judicial authorities <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of&#160;non-U.S.&#160;countries</div> may not enforce legal rights and recognize business procedures in a manner to which we are accustomed or would reasonably expect; </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">we may have difficulty complying with a variety of laws and regulations <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in&#160;non-U.S.&#160;countries,</div> some of which may conflict with laws in the United States; </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes in political and economic conditions may lead to changes in the business environment in which we operate, as well as changes in currency exchange rates; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in the case of China, the degree of significant government control over China&#8217;s economic growth through restrictions and limitations on foreign investment in certain industries, control over the allocation of resources, control over payment of foreign currency-denominated obligations, implementation of monetary policy, data localization and privacy requirements, technology transfer requirements, national security laws, influence over the courts and preferential treatment of particular industries or companies, could materially affect our liquidity, access to capital, intellectual property and ability to operate our business; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in the case of China, data localization requirements and restrictions on the use of foreign technology applications have already been enacted by the Chinese government, and restrictions on the use of Chinese technology and applications that have been or may be adopted in the future by the United States, may make it difficult to efficiently coordinate complex manufacturing supply chains in a global setting; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">restrictions or denials on visas for our personnel, limiting our ability to train and pass along proprietary information efficiently; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">differences in software usage and export controls, making it difficult to share certain engineering documents and resources between global subsidiaries; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the adoption and expansion of trade restrictions, the occurrence or escalation of a &#8220;trade war,&#8221; or other governmental action related to tariffs or trade agreements or policies among the governments of the United States and other countries, such as China, could adversely impact our raw material prices, our ability to manufacture our products, and demand for our products in China, the U.S. and other global markets; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes to export controls and/or failure to obtain export licenses in the United States, China or other countries in which we do business could adversely affect our access to raw materials, ability to manufacture and ship our products or increase our costs to conduct research&#160;and development; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">regulatory changes and economic conditions following &#8220;Brexit&#8221; (the United Kingdom&#8217;s exit from the European Union), including uncertainties as to its effect on trade laws, tariffs, and taxes, could create instability and volatility in the global financial and currency markets, conflicting or redundant regulatory regimes in Europe and political instability; and </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">natural disasters or international conflict, including terrorist acts, could interrupt our research and development, manufacturing or commercialization or endanger our personnel. </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our ability to deal with these issues could be affected by existing or new U.S. laws and the need to protect our intellectual property and assets. In addition, we may be more susceptible to these risks to the extent we target emerging countries and regions, which may be subject to a relatively higher risk of political instability, economic volatility, crime, corruption, and social and ethnic unrest, all of which are exacerbated in many cases by a lack of an independent and experienced judiciary and uncertainties in how local law is applied and enforced. The materialization of any such risks could have an adverse impact on our business, financial condition, operating results and prospects. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">24 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Changes in the economic and political policies of the Chinese government could have a significant impact on our operations in China, where we conduct research and development. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We conduct certain research and development activities in our facility in Shanghai, China. We believe that our research and development activities at our current facility in Shanghai and our direct ownership in our wholly-owned Chinese subsidiary, SolidEnergy Systems (Shanghai) Co., Ltd. (&#8220;SES Shanghai&#8221;), materially comply with all applicable legal and regulatory requirements. However, our ability to carry out our research and development activities in China may be materially harmed by changes in Chinese laws and regulations, including those relating to taxation, import and export tariffs and controls, the environment, land use rights, property and other matters. The Chinese government, including at both the national and local levels, has exercised and continues to exercise substantial control over virtually every sector of the Chinese economy via regulation and state ownership. Although China&#8217;s government has in recent years implemented measures emphasizing the utilization of market forces for economic reform, it continues to regulate economic growth heavily in China by, among other things, allocating resources, controlling the payment of foreign currency-denominated obligations and setting monetary policy. Future governmental actions, including any decision not to continue to support recent economic reforms and/or to return to a more centrally planned economy, regional or local variations in the implementation of such economic policies, or new, stricter regulations or interpretations of existing regulations could significantly affect economic conditions in China and materially impair our ability to conduct research and development activities there. These actions could make it more difficult for us to operate our current research and development facility or Pilot Facility in Shanghai in an efficient and cost-effective manner or empower the Chinese government or the provincial or local governments of the Shanghai jurisdiction where we operate to enact a temporary or permanent shut-down of those facilities. If that were to occur, we would need to redirect our research and development efforts to facilities in other locations, which, although feasible, could result in certain additional expenditures and possible unexpected delays in our research and development efforts, thus negatively impacting our business and results of operations. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As we may be subject to additional, yet undetermined, laws and regulations in China, compliance may also require us to obtain additional permits and licenses, complete or update registrations with relevant regulatory authorities, adjust our research and development operations, and/or allocate additional internal resources to monitor developments in the relevant regulatory environment. Under the stringent regulatory environment in China, it may take much more time for the relevant regulatory authorities to approve new applications for permits and licenses, and complete or update registrations, and we cannot assure you that we will be able to comply with these laws and regulations in a timely manner or at all. The failure to comply with these laws and regulations may delay, or possibly prevent, our ability to conduct our research and development activities in China. The occurrence of any of these events could materially impair our business and results of operations. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additionally, we may be subject to Chinese export control laws and regulations, which may prevent the export of certain technologies and services outside of China without a license for the export of such technologies and/or services. Complying with such export control laws and regulations may be time-consuming and result in the delay of our production timelines and have a materially adverse effect on our business and results of operations. If we fail to comply with these laws and regulations, we and even some of our employees may be subject to both civil and/or criminal penalties, including the loss of export or import privileges, fines and, in extreme cases, the incarceration of responsible employees or managers. Moreover, we cannot assure you that will be able to obtain any required export control licenses. Any decreased use of our technology and products, limitation on our ability to export or sell our technology and products, or limitation on our ability to import raw materials, components or equipment would likely adversely affect our business, financial condition, operating results and prospects. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We could experience losses associated with our intellectual property in relation to our operations in China. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We rely upon the fair interpretation and enforcement of patent, copyright, trademark and trade secret laws in the U.S., similar laws in other countries, and agreements with employees, customers, suppliers, licensors and other parties. Such reliance serves to establish and maintain the intellectual property rights associated with the technology that we develop and ultimately sell. However, the laws and courts of certain countries at times do not protect intellectual property rights or respect contractual agreements to the same extent as the laws of the U.S. Therefore, in certain jurisdictions we may not be able to protect our intellectual property rights against counterfeiting or enforce our contractual agreements with other parties. Specifically, as discussed above, the Company conducts research and development operations in China. Article VII of the National Intelligence Law of China requires every commercial entity in China, by simple order of the Chinese government, to act as an agent of the government by committing espionage, technology theft, or whatever else the government deems to be in the national interest of China. If the Chinese government were to require the appropriation of certain of our intellectual property in the national interest, this could lead to material adverse effects on our operations and competitive positions. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">25 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Implementation of labor laws and regulations in China may adversely affect our business and results of operations. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to the labor contract law of China that took effect in January 2008, its implementation rules that took effect in September 2008 and its amendment that took effect in July 2013, employers are subject to stricter requirements in terms of signing labor contracts, minimum wages, paying remuneration, determining the term of employees&#8217; probation and unilaterally terminating labor contracts. Due to lack of detailed interpretative rules and uniform implementation practices and broad discretion of the local competent authorities, it is uncertain as to how the labor contract law and its implementation rules will affect our current employment policies and practices. Our employment policies and practices may violate the labor contract law or its implementation rules, and we may thus be subject to related penalties, fines or legal fees. Compliance with the labor contract law and its implementation rules may increase our operating expenses, in particular our personnel expenses. In the event that we decide to terminate some of our employees or otherwise change our employment or labor practices, the labor contract law and its implementation rules may also limit our ability to effect those changes in a desirable or cost-effective manner, which could adversely affect our business and results of operations. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As the interpretation and implementation of these laws and regulations are still evolving, we cannot assure you that our employment practice will at all times be deemed in full compliance with labor-related laws and regulations in China, which may subject us to labor disputes or government investigations. If we are deemed to have violated relevant labor laws and regulations, we could be required to provide additional compensation to our employees and our business, financial condition and results of operations could be adversely affected. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Further, labor disputes, work stoppages or slowdowns at our operations facilities or any of our third-party service providers could significantly disrupt daily operation or our battery development plans and have materially adverse effects on our business. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The unavailability, reduction or elimination of, or uncertainty regarding, government and economic incentives or subsidies available to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">us,&#160;end-users&#160;or</div> OEMs could have a material adverse effect on our business, financial condition, operating results and prospects. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In 2019, in connection with our establishment of our Shanghai facility, the first two years of rent on the facility totaling approximately RMB7.1&#160;million was borne by the Jiading district local government which also took on certain renovations to the facility at the cost of approximately RMB4.3&#160;million such that it is suitable for our use. In 2020, we also received an incentive award of RMB10,000 under the Jiading Industrial Zone Development Potential Award from the Jiading district local government. We intend to apply for further grants in the future in the jurisdictions in which we operate. Government incentives and subsidies are granted in connection with government&#8217;s efforts to promote the development of the local economy and other policies. Some local government incentives and subsidies may be challenged by higher-level government authorities. Therefore, government incentives and subsidies may be modified or terminated at the sole discretion of the relevant governmental authorities. Additionally, because laws, regulations and policies with respect to incentives and subsidies may change, we cannot be sure that government incentives and subsidies will continue to be available. In the event that we cease to receive any government incentives or subsidies, any current or future incentive or subsidy is reduced, or any of our current or future incentives or subsidies are challenged, our business, financial condition and operating results may be adversely affected. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Additionally, we believe that, currently, the availability of government incentives and subsidies available <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to&#160;end-users&#160;and</div> OEMs is an important factor considered by customers when purchasing EVs, and that growth in the battery market will depend in part on the availability and amounts of these subsidies and incentives for EVs. Any further reduction or elimination of government and economic incentives or subsidies may result in the diminished competitiveness of the alternative fuel vehicle industry generally or EVs that use our batteries in particular. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Currently, government programs, including in China and Europe, favor the purchase of EVs, including through disincentives that discourage the use of gasoline-powered vehicles. If such government programs are reduced or eliminated, or the available benefits thereunder are exhausted earlier than anticipated, demand for EVs may decrease and our anticipated sales of EV battery products could be adversely affected. In addition, OEM customers may delay taking delivery of our battery products if they believe that certain EV incentives will be available at a later date, which may adversely affect our business, financial condition, operating results and prospects. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">26 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Risks Relating to Regulation and Legal Compliance</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our operations expose us to litigation, environmental and other legal compliance risks. Compliance with laws and regulations can be expensive, and our failure to comply with these laws and regulations may result in monetary damages and fines, adverse publicity and a material adverse effect on our business. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are subject to a variety of litigation, environmental, health and safety and other legal compliance risks. These risks include, among other things, possible liability relating to product liability matters, personal injuries, intellectual property rights, contract-related claims, health and safety liabilities, environmental matters and compliance with U.S. and foreign laws, competition laws and laws governing improper business practices. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Our operations in the United States and China may be subject environmental laws and regulations, including laws and regulations relating to water, discharges, emissions, chemicals, hazardous materials, natural resources, remediation and contamination. Compliance with these laws can be difficult and costly. For example, battery life cycle management regulations and regulations governing the transport of batteries may impose substantial requirements on our operations in the United States. Our operations may be required to obtain and comply with environmental permits, many of which may be difficult and expensive to obtain and must be renewed on a periodic basis. A failure to comply with these laws, regulations or permits could result in substantial liabilities, including fines, penalties, the suspension or loss of permits, and possibly orders to cease <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;non-compliant&#160;operations.</div> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a business with international reach, we are subject to complex laws and regulations in jurisdictions in which we operate. Those laws and regulations may be interpreted in different ways. They may also change from time to time, as may related interpretations and other guidance. Changes in laws or regulations could result in higher expenses and payments, and uncertainty relating to laws or regulations may also affect how we conduct our operations and structure our investments and could limit our ability to enforce our rights. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in environmental and climate laws or regulations, including laws relating to greenhouse gas emissions, could lead to new or additional investment in manufacturing designs, subject us to additional costs and restrictions, including increased energy and raw materials costs, and could increase environmental compliance expenditures. We are subject to various environmental laws and regulations on air emission, waste water discharge, solid waste, noise and the disposal of hazardous materials. Cobalt and lithium are toxic materials that are important raw materials in our batteries. We also use, generate and discharge other toxic, volatile and hazardous chemicals and wastes in our research, development and manufacturing activities. Under China and U.S. environmental regulations, we are required to maintain the pollutant emission levels at the facility within the levels prescribed by the relevant governmental authorities and obtain a pollution discharge permit for water and air emissions. In addition, certain laws and regulations require enterprises like us that generate hazardous wastes to engage companies which are licensed and qualified to process the hazardous wastes, and to collect, store, dispose of and transfer the hazardous waste. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If we fail to comply with national and local environmental protection laws and regulations, the relevant governmental authorities may impose fines or deadlines to cure instances of noncompliance, and may even order us to cease operations if we fail to comply with their requirements. In particular, any breach by us in connection with requirements relating to the handling of hazardous wastes may subject us to monetary damages and fines. In addition, if any third party suffers any loss as a result of our pollutant emission practices, our improper handling of hazardous wastes or our noncompliance with environmental regulations, such third parties may seek damages from us. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There can be no assurance that we will be able to comply with all environmental laws and regulations at all times as the environmental legal regime is evolving and becoming more stringent, especially in China and the United States. Therefore, if these or other governments where we do business impose more stringent regulations in the future, we will have to incur additional substantial costs and expenses in order to comply with new regulations, which may negatively affect our results of operations. If we fail to comply with any of the present or future environmental regulations in any material aspect or cause any loss to any third parties due to our pollutant emission practices, improper handling of hazardous wastes or other environmental noncompliance, we may suffer from negative publicity and may be required to pay substantial fines, pay damages to such third parties, or suspend or even cease operations Failure to comply with environmental laws and regulations may materially and adversely affect our business, financial condition, operating results and prospects. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">27 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Failure to comply with certain health and production safety laws and regulations governing hazardous materials could materially adversely affect our business and results of operations. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the sourcing of our products throughout the world, we process, store, dispose of and otherwise use large amounts of hazardous materials. As a result, we are subject to extensive and evolving health and production safety laws and regulations governing, among other things: the health of our employees and safety production requirements regarding the generation, handling, storage, use and transportation of hazardous materials. Compliance with these laws and regulations results in ongoing costs. Failure to comply with these laws or regulations, or to obtain or comply with the relevant permits, could result in fines, criminal charges or other sanctions by regulators. Furthermore, we may be ordered to rectify a noncompliance within a stipulated deadline; and if we fail to do so, we may be ordered to cease operations. Our ongoing compliance with health and safety laws, regulations and permits could require us to incur significant expenses, limit our ability to modify or expand our facilities or continue manufacturing and make other capital improvements. In addition, private parties, including current or former employees, could bring personal injury or other claims against us due to the presence of, or exposure to, hazardous substances used, stored or disposed of by us or contained in our products. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We are subject to U.S. and foreign anti-corruption, anti-bribery, anti-money laundering, financial and economic sanctions and similar laws and regulations. We can face criminal liability and other serious consequences for violations, which can harm our business. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We are subject to anti-corruption, anti-bribery, anti-money laundering, financial and economic sanctions and similar laws and regulations in various jurisdictions in which we conduct or in the future may conduct activities, including the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), the U.K. Bribery Act 2010, and other anti-corruption laws and regulations in countries in which we conduct activities. Anti-corruption laws prohibit us and our officers, directors, employees, contractors and business partners acting on our behalf, including agents, from corruptly offering, promising, authorizing or providing, directly or indirectly, anything of value to a &#8220;foreign official&#8221; for the purposes of influencing official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. These laws also require companies to make and keep books, records and accounts that accurately reflect transactions and dispositions of assets and to maintain a system of adequate internal accounting controls. These laws also <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">prohibit&#160;non-governmental&#160;&#8220;commercial&#8221;</div> bribery and soliciting or accepting bribes. A violation of any of these laws or regulations could result in substantial civil and criminal fines and penalties, imprisonment, the loss of export or import privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm and other consequences and adversely affect our business, financial condition, operating results and reputation. Our policies and procedures designed to ensure compliance with these laws and regulations may not be sufficient and our directors, officers, employees, representatives, consultants, agents, and business partners could engage in improper conduct for which we may be held responsible. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As we increase our international cross-border business and expand our operations abroad, we may continue to engage with business partners, suppliers and third-party intermediaries to market our services and to obtain necessary permits, licenses and other regulatory approvals. In addition, we or our third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities. We can be held liable for the corrupt or other illegal activities of these third-party intermediaries, our employees, representatives, contractors, partners and agents, even if we do not explicitly authorize such activities. There can be no assurance that our employees and agents will not take actions in violation of our policies and applicable law, for which we may be ultimately held responsible. As we increase our international business, our risks under these laws may increase. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Detecting, investigating and resolving actual or alleged violations of anti-corruption, anti-bribery, anti-money laundering or financial and economic sanctions laws can require a significant diversion of time, resources and attention from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">management.&#160;Non-compliance&#160;with</div> these laws could subject us to whistleblower complaints, adverse media coverage, investigations, subpoenas received, enforcement actions, prosecution and severe fines, damages and administrative, civil and criminal sanctions, collateral consequences, remedial measures and legal expenses, all of which could materially and adversely affect our business, financial condition, operating results and reputation. In addition, changes in these laws in the future could adversely impact our business and investments in the SES securities. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Governmental trade controls, including export and import controls, sanctions, customs requirements and related regimes, could subject us to liability or loss of contracting privileges, limit our ability to transfer technology or compete in certain markets and affect our ability to hire qualified personnel. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our technology and products, including components of our products, are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations and various economic and trade sanctions regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Control. U.S. export control laws and regulations and economic sanctions prohibit the shipment of certain U.S. products, technologies and services to U.S. embargoed or sanctioned countries, governments and persons, as well as to various countries and persons due to national security and foreign policy concerns. In particular, U.S. export control laws apply to cells with an energy density greater than 350 Wh/kg, and require a license for the export of technology and cells exceeding that threshold to many locations outside the United States, including China and Singapore. Some of our technology and products are thus presently subject to this license requirement under U.S. export controls. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">28 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Complying with export control and sanctions regulations for a particular sale may be time-consuming and result in the delay or loss of sales opportunities. We have set up an export controls compliance program internally. If we fail to comply with these laws and regulations, we and even some of our employees could be subject to substantial civil and/or criminal penalties, including the possible loss of export or import privileges, fines, which may be imposed on us and responsible employees or managers and, in extreme cases, the incarceration of responsible employees or managers. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A significant talent pool is comprised of nationals from countries that may require a license from the Bureau of Industry and Security to work with our technology (such as China, India, Russia, South Korea and Japan), which raises the cost of hiring due to the uncertainty that a license may not be granted and the candidate would be unemployable in the role envisioned. In addition, changes in our products or solutions or changes in applicable export or import laws and regulations may create delays or prohibitions in the introduction and sale of our products and solutions in international markets, increase costs due to changes in import and export duties and taxes, prevent our customers from deploying our products and solutions or, in some cases, prevent the export or import of our products and solutions to certain countries, governments or persons altogether. Any change in export or import laws and regulations, shift in the enforcement or scope of existing laws and regulations, or change in the countries, governments, persons or technologies targeted by such laws and regulations, could also result in decreased use of our products and solutions, decreased ability to export or sell our products and solutions to customers, and decreased ability to import components or parts critical to the manufacture of our products. Any decreased use of our technology and products, limitation on our ability to export or sell our technology and products, or limitation on our ability to import raw materials, components or equipment would likely adversely affect our business, financial condition, operating results and prospects. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Changes in U.S. and foreign tax laws, particularly under the curent U.S. presidential administration, could have a material adverse effect on our business, cash flow, results of operations or financial conditions. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We (as well as certain of our subsidiaries, including our subsidiary that is organized as a Singapore company) are subject to federal, state and local taxes in the United States and are also subject to tax in certain foreign jurisdictions. Changes to U.S. tax laws, including limitations on the ability of taxpayers to claim and utilize foreign tax credits and the deferral of certain tax deductions until earnings outside of the United States are repatriated to the United States, as well as changes to U.S. federal income tax laws that may be enacted in the future, especially under the Biden Administration, could impact the tax treatment of our foreign earnings. Due to our international business activities, any changes in the taxation of such activities may increase our worldwide effective tax rate and adversely affect our financial position and results of operations. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant judgment is required in evaluating our tax positions and our worldwide provision for taxes. During the ordinary course of business, there are many activities and transactions for which the ultimate tax determination is uncertain. In addition, our tax obligations and effective tax rates could be adversely affected by changes in the relevant tax, accounting and other laws, regulations, principles and interpretations, including those relating to income tax nexus, if our earnings are lower than anticipated in jurisdictions where we have lower statutory rates and higher than anticipated in jurisdictions where it has higher statutory rates, by changes in foreign currency exchange rates, or by changes in the valuation of its deferred tax assets and liabilities. We may be audited in various jurisdictions, and such jurisdictions may assess additional taxes against us. Although we believe our tax estimates are reasonable, the final determination of any tax audits or litigation could be materially different from our historical tax provisions and accruals, which could have a material adverse effect on our operating results or cash flows in the period or periods for which a determination is made. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Changes in tax laws or regulations that are applied adversely to us or our customers could materially adversely affect our business, financial condition, operating results and prospects.</div></div></div></div> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in corporate tax rates, the realization of net deferred tax assets relating to our operations, the taxation of foreign earnings, and the deductibility of expenses under future tax reform legislation could have a material impact on the value of our deferred tax assets, could result in significant&#160;one-time&#160;charges in the current or future taxable years, and could increase our future tax expense, which could have a material adverse effect on our business, financial condition, operating results, and prospects. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Certain U.S. state tax authorities may assert that we have a state nexus and seek to impose state and local income taxes which could harm our results of operations.</div></div></div></div> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is a risk that certain state tax authorities where we do not currently file a state income tax return could assert that we are liable for state and local income taxes based upon income or gross receipts allocable to such states. States are becoming increasingly aggressive in asserting a nexus for state income tax purposes. If a state tax authority successfully asserts that our activities give rise to a nexus, we could be subject to state and local taxation, including penalties and interest attributable to prior periods. Such tax assessments, penalties and interest may adversely impact our results of operations. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Risks </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The uncertainty in global economic conditions and the risks relating to health epidemics, including <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;COVID-19</div> pandemic, could have a material adverse effect on our business and results of operations. Our ability to operate in any respect may be interrupted by the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">current&#160;COVID-19&#160;pandemic.</div> </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">We face various risks relating to public health issues, including epidemics, pandemics, and other outbreaks, including the ongoing <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic. The effects and potential effects <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of&#160;COVID-19,&#160;include,</div> but are not limited to, its impact on general economic conditions, trade and financing markets and changes in customer behavior, and significant uncertainty in the overall continuity in business operations. The spread <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of&#160;COVID-19&#160;has</div> also disrupted the manufacturing, delivery and overall supply chain of EV manufacturers and suppliers and EV batteries, and has led to a global decrease in vehicle sales in markets around the world. In particular, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;COVID-19&#160;crisis</div> may cause a decrease in demand for EV batteries if fleet operators delay purchases of vehicles or if fuel prices for internal combustion engine vehicles remain at levels that do not create an incentive to accelerate the migration from internal combustion engine vehicles to EVs, an increase in costs resulting from the efforts of manufacturers of EVs or EV batteries to mitigate the effects <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of&#160;COVID-19,&#160;delays</div> in EV manufacturers&#8217; schedules to full commercial production of EVs and disruptions to these supply chains, among other negative effects. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">29 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The pandemic has resulted in government authorities implementing many measures to contain the spread <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of&#160;COVID-19,&#160;including</div> travel bans and restrictions, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">quarantines,&#160;shelter-in-place&#160;and&#160;stay-at-home&#160;orders,</div></div></div></div> business closures and other public health safety measures. These measures may be in place for a significant period of time and may be reinstituted if conditions deteriorate, which could adversely affect <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;start-up&#160;and</div> manufacturing plans. As a precaution, we took certain preventive measures in light of this pandemic and reduced our operational activities during the year ended December&#160;31, 2021. In particular, we temporarily reduced employee compensation, recommended that <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">all&#160;non-essential&#160;personnel</div> work from home, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">reduced&#160;in-person&#160;participation</div> in research and development activities. As a result, our personnel costs and travel related costs were lower in 2021. We also were required to implement additional safety protocols for essential workers, which resulted in delays in the timing of project execution. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Following <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;re-opening&#160;of&#160;non-essential&#160;businesses</div></div> and the easing of restrictions <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">on&#160;non-essential&#160;in-person&#160;work,</div></div> since the beginning of the year ended December&#160;31, 2021, we have ramped up research and development hiring and increased our investment <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in&#160;in-person&#160;work.</div> However, measures that have been relaxed may be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-implemented</div> <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">if&#160;COVID-19&#160;continues</div> to spread. If, as a result of these measures, we have to limit the number of employees and contractors at any research and development or manufacturing facility at a given time, it could cause a delay in our development, testing and manufacturing efforts and a delay in our product schedule. If our workforce is unable to work effectively, including due to illness, quarantines, government actions or other restrictions in connection <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">with&#160;COVID-19,&#160;our</div> operations will be adversely affected. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The extent to which <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;COVID-19&#160;pandemic</div> may continue to affect our business will depend on continued developments, which are uncertain and cannot be predicted. Even after <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;COVID-19</div> pandemic has subsided, we may continue to suffer an adverse effect to our business due to its global economic effect, including any economic recession. If the immediate or prolonged effects of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the&#160;COVID-19&#160;pandemic</div> have a significant adverse impact on government finances, it would create uncertainty as to the continuing availability of incentives related to EV purchases and other governmental support programs. In addition, a recurrence <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of&#160;COVID-19&#160;cases</div> or an emergence of additional variants or strains could cause other widespread or more severe impacts depending on where infection rates are highest. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Theft, loss or misuse of personal data about our employees, contractors, customers, or other third parties could increase our expenses, damage our reputation, or result in legal or regulatory proceedings. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Any claim that our products are subject to a cybersecurity risk, whether valid or not, could damage our reputation and adversely impact our revenues and results of operations. We manage and store various proprietary information and sensitive or confidential data relating to our business as well as information from our suppliers and customers. Despite the security measures and compliance programs we currently maintain and monitor, breaches of our or any of our third party suppliers&#8217; security measures or the accidental loss, inadvertent disclosure or unapproved dissemination of proprietary information or sensitive or confidential data about us or our customers or suppliers, including the potential loss or disclosure of such information or data as a result of fraud, trickery or other forms of deception, could expose us or our customers or suppliers to a risk of loss or misuse of this information, disruption of business operations, result in litigation, regulatory scrutiny, and potential liability for us, damage our brand and reputation or otherwise harm our business. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If we experience a significant cybersecurity breach or disruption in our information systems or any of our partners&#8217; information systems, our business could be adversely affected. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Malicious actors may be able to penetrate our network and misappropriate or compromise our confidential information or that of third parties, create system disruptions or cause shutdowns. Malicious actors also may be able to develop and deploy viruses, worms and other malicious software programs that attack our products or otherwise exploit any security vulnerabilities of our products. While we employ a number of protective measures, including firewalls, network infrastructure vulnerability scanning, anti-virus and endpoint detection and response technologies, these measures may fail to prevent or detect attacks on our systems due to the frequent evolving nature of cybersecurity attacks. Although these measures are designed to ensure the confidentiality, integrity and availability of our information and technology systems, there is no assurance that these measures will detect all threats or prevent a cybersecurity attack in the future, which could adversely affect our business, reputation, operations or products. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">30 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, our hardware and software or third party components and software that we utilize in our products may contain defects in design or manufacture, including &#8220;bugs&#8221; and other problems that could unexpectedly interfere with the operation or security of the products. The costs to us to eliminate or mitigate cyber or other security problems, bugs, viruses, worms, malicious software programs and security vulnerabilities could be significant and, if our efforts to address these problems are not successful, could result in interruptions, delays, cessation of service and loss of existing or potential customers that may impede our sales, manufacturing, distribution or other critical functions. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">To the extent we experience cybersecurity incidents in the future, our relationships with our partners, suppliers and eventual customers may be materially impacted, our brand and reputation may be harmed and we could incur substantial costs in investigating, responding to and remediating the incidents, and in resolving any regulatory investigations or disputes that may arise with respect to them, any of which would cause our business, operations, or products to be adversely affected. In addition, the cost and operational consequences of implementing and adding further data protection measures could be significant. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks Relating to Our Common Stock and Warrants </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Provisions in our Certificate of Incorporation (the &#8220;Charter&#8221;) and Delaware law may inhibit a takeover attempt which could limit the price investors might be willing to pay in the future for our common stock and could entrench management. </div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Our Charter and Bylaws contain provisions to limit the ability of others to acquire control of us or cause us to engage in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">change-of-control</div></div> transactions, including, among other things: </div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provisions that authorize our board of directors (the &#8220;Board&#8221;), without action by our stockholders, to authorize by resolution the issuance of shares of preferred stock and to establish the number of shares to be included in such series, along with the preferential rights determined by our Board; provided that, our Board may also, subject to the rights of the holders of preferred stock, authorize shares of preferred stock to be increased or decreased by the approval of the Board and the affirmative vote of the holders of a majority in voting power of the outstanding shares of capital stock of the corporation; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provisions that permit only a majority of our Board, the Chairperson of the Board or the Chief Executive Officer to call special stockholder meetings; provided, that for so long as Dr. Qichao Hu and certain entities affiliated with Dr. Hu (the &#8220;SES Founder Group&#8221;) beneficially own at least 50% of the voting power of the then outstanding shares of our capital stock, special meetings of stockholders may also be called by or at the request of stockholders holding a majority of the voting power of the issued and outstanding shares of our capital stock; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provisions that impose advance notice requirements and other requirements and limitations on the ability of stockholders to propose matters for consideration at stockholder meetings; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">a staggered board whereby our directors are divided into three classes, with each class subject to retirement and reelection once every three years on a rotating basis. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">31 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">These provisions could have the effect of depriving our stockholders of an opportunity to sell their shares at a premium over prevailing market prices by discouraging third parties from seeking to obtain control of us in a tender offer or similar transaction. With our staggered Board, at least two annual meetings of stockholders will generally be required in order to effect a change in a majority of our directors. Our staggered Board can discourage proxy contests for the election of our directors and purchases of substantial blocks of our shares by making it more difficult for a potential acquirer to gain control of our Board in a relatively short period of time. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our Founder and Chief Executive Officer, Dr.&#160;Qichao Hu, has control over all stockholder decisions because he controls a substantial majority of our voting stock due to our dual class stock. </div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Dr.&#160;Hu, directly or indirectly through entities affiliated with him, has the ability to control the outcome of all matters submitted to our stockholders for approval, including the election, removal, and replacement of directors and any merger, consolidation, or sale of all or substantially all of our assets. As our Chief Executive Officer, Dr.&#160;Hu has control over <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">our&#160;day-to-day&#160;management</div></div> and the implementation of major strategic investments, subject to authorization and oversight by our board of directors. As a board member and officer, Dr.&#160;Hu also owes a fiduciary duty to our stockholders and must act in good faith in a manner he reasonably believes to be in the best interests of our stockholders. However, Dr.&#160;Hu is still entitled to vote his shares, and his concentrated control could delay, defer, or prevent a change of control, merger, consolidation, or sale of all or substantially all of our assets that our other stockholders support. Conversely, this concentrated control could allow the SES Founder Group, members of the SES Founder Group or their permitted transferees to consummate such a transaction or otherwise vote in a way that our other stockholders do not support. This was designed to shepherd our long-term growth amidst significant near term fluctuations and uncertainty in the market. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our Charter provides, subject to limited exceptions, that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for certain stockholder litigation matters, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or stockholders. </div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Charter requires, to the fullest extent permitted by law, that derivative actions brought in our name, actions against directors, officers and employees for breach of fiduciary duty and other similar actions may be brought only in the Court of Chancery in the State of Delaware (the &#8220;Chancery Court&#8221;) and, if brought outside of Delaware, the stockholder bringing the suit will be deemed to have consented to the personal jurisdiction of the Chancery Court and having service of process made upon such stockholder in any such action on such stockholder&#8217;s counsel. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock shall be deemed to have notice of and consented to these forum provisions. Notwithstanding the foregoing, our Charter provides that the exclusive forum provision does not apply to suits brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Section&#160;27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Additionally, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) against us or any of our directors, officers, other employees or agents. However, there is uncertainty as to whether a court would enforce the exclusive forum provisions relating to causes of actions arising under the Securities Act. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Although we believe this exclusive forum provision benefits us by providing increased consistency in the application of Delaware law in the types of lawsuits to which it applies, it may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims. Alternatively, if a court were to find the choice of forum provision contained in our Charter to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results and financial condition. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">An active trading market for our securities may not continue , which would adversely affect the liquidity and price of our securities. </div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The price of SES&#8217;s securities has fluctuated and may continue to fluctuate significantly due to the market&#8217;s reaction to the consummation of the Business Combination and general market and economic conditions. An active trading market for SES&#8217;s securities may not be sustained. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">32 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><div style="font-style:italic;display:inline;">We have incurred and will continue to incur increased costs related to becoming and operating as a public company, and our management will be required to devote substantial additional time to new compliance initiatives and corporate governance practices. Moreover, we have identified a material weakness in our internal control over financial reporting, and we may experience additional material weaknesses or significant deficiencies, or otherwise fail to develop or maintain an effective system of internal controls in the future, which could result in material misstatements of our consolidated financial statements, adversely affect investor confidence in us and adversely affect the market price of our securities. </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have incurred and will continue to incur significant legal, accounting and other expenses that Old SES did not incur as a private company. We are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Protection Act, as well as rules adopted, and to be adopted, by the SEC and the NYSE. Our management and other personnel have devoted and will need to continue to devote a substantial amount of time to these compliance initiatives. Moreover, we expect these rules and regulations to substantially increase our legal and financial compliance costs and to make certain activities more time-consuming and costly, which will increase our operating expenses. For example, these rules and regulations applicable to public companies may make it more difficult and more expensive for us to obtain director and officer liability insurance and we will likely incur additional costs to maintain sufficient insurance coverage as a public company. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective internal controls are necessary for us to provide reliable financial reports, prevent fraud and errors in our financial statements and operate successfully as a public company. In connection with the preparation of our fiscal year 2021 financial statements, we identified a material weakness in our internal control over financial reporting, which we are currently working to remediate, related to certain errors in our historical financial calculation of stock-based compensation expense and stock-based compensation disclosures during the three and nine months ended September&#160;30, 2021. These errors led us to conclude that the financial statements during the three and nine months ended September&#160;30, 2021 should be restated. In light of the foregoing, and in order to comply with the requirements of being a public company, we are undertaking and will continue to undertake various actions, such as implementing additional internal controls and procedures and hiring additional compliance, accounting and financial staff with appropriate public company experience and technical knowledge. The measures we take to remediate the deficiency in our internal control over financial reporting and to implement and maintain effective internal controls may not be sufficient to satisfy our obligations as a public company and produce reliable financial reports, and we may not be able to implement the required controls in a timely fashion. If we experience any additional material weaknesses or significant deficiencies or otherwise fail to develop or maintain an effective system of internal controls in the future, we may need to disclose such matters investors may lose, which may adversely confidence in us and our financial statements, which could adversely affect the value of our securities. In addition, if we cannot provide reliable financial reports or prevent fraud and errors in our financial statements, our reputation and operating results could be materially adversely affected. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, as a public company, we are required to comply with SEC rules that implement Sections 308 and&#160;404 of the Sarbanes-Oxley Act. Under these rules, management is required to certify financial and other information in our quarterly and annual reports and is required to make a formal assessment of the effectiveness of our internal control over financial reporting in connection with the filing of our annual reports. Additionally, once we cease to be an emerging growth company, we are required to include a report on internal control over financial reporting issued by our independent registered public accounting firm. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For as long as we remain an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), we it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies.&#8221; We will remain an emerging growth company until the earlier of (1)&#160;the last day of the fiscal year (a)&#160;following January 11, 2026, the fifth anniversary of the completion of Ivanhoe&#8217;s IPO, (b)&#160;in which we have total annual gross revenue of at least $1.07&#160;billion, or (c)&#160;in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held <div style="white-space:nowrap;display:inline;">by&#160;non-affiliates&#160;exceeds</div> $700&#160;million as of the prior June&#160;30, and (2)&#160;the date on which we have issued more than $1.0&#160;billion <div style="white-space:nowrap;display:inline;">in&#160;non-convertible&#160;debt</div> securities during the prior three-year period. To the extent we choose not to use exemptions from various reporting requirements under the JOBS Act, or if we no longer can be classified as an &#8220;emerging growth company,&#8221; we expect that we will incur additional compliance costs, which will reduce our ability to operate profitably. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">33 </div> </div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">As an &#8220;emerging growth company,&#8221; we cannot be certain if the reduced disclosure requirements applicable to &#8220;emerging growth companies&#8221; will make our common stock less attractive to investors. </div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As an &#8220;emerging growth company,&#8221; we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies, including not being required to obtain an assessment of the effectiveness of our internal controls over financial reporting from our independent registered public accounting firm pursuant to Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards, which we have elected to do. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We cannot predict if investors will find our Class&#160;A common stock less attractive because we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active market for our common stock, our share price may be more volatile and the price at which our securities trade could be less than if we did not use these exemptions. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">As a public reporting company, we are subject to rules and regulations established from time to time by the SEC and the NYSE regarding our internal control over financial reporting. If we fail to establish and maintain effective internal control over financial reporting and disclosure controls and procedures, we may not be able to accurately report our financial results, or report them in a timely manner. </div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are a public reporting company subject to the rules and regulations established from time to time by the SEC and the NYSE. These rules and regulations require, among other things, that we establish and periodically evaluate procedures with respect to our internal control over financial reporting. Public company reporting obligations place a considerable burden on our financial and management systems, processes and controls, as well as on our personnel. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, as a public company we are required to document and test our internal control over financial reporting pursuant to Section&#160;404 of the Sarbanes-Oxley Act so that our management can certify as to the effectiveness of our internal control over financial reporting, which requires us to document our internal control over financial reporting. Likewise, our independent registered public accounting firm will be required to provide an attestation report on the effectiveness of our internal control over financial reporting at such time as we cease to be an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, if we are an &#8220;accelerated filer&#8221; or &#8220;large accelerated filer&#8221; at such time. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We expect to incur costs related to our internal control over financial reporting in the upcoming years to further improve our internal control environment. If we identify deficiencies in our internal control over financial reporting or if we are unable to comply with the requirements applicable to us as a public company, including the requirements of Section&#160;404 of the Sarbanes-Oxley Act, in a timely manner, we may be unable to accurately report our financial results, or report them within the timeframes required by the SEC. If this occurs, we also could become subject to sanctions or investigations by the SEC or other regulatory authorities. In addition, if we are unable to assert that our internal control over financial reporting is effective, or if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, or express an adverse opinion, investors may lose confidence in the accuracy and completeness of our financial reports, we may face restricted access to the capital markets and our stock price may be adversely affected. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The NYSE may delist our securities from trading on its exchange, which could limit investors&#8217; ability to make transactions in its securities and subject SES to additional trading restrictions. </div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Currently, our Class&#160;A common stock and public warrants are listed on the NYSE under the symbols &#8220;SES&#8221; and &#8220;SES WS.&#8221; In order to continue the list of these securities on the NYSE, we are required to maintain certain financial, distribution and stock price levels. Generally, we are required to maintain a minimum market capitalization (generally $50,000,000) and a minimum number of holders of our securities (generally 300 public holders). If NYSE delists our securities from trading on its exchange and we are not able to list its securities on another national securities exchange, we expect our securities could be quoted on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">an&#160;over-the-counter&#160;market.</div></div> If this were to occur, we could face significant material adverse consequences, including: </div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">a limited availability of market quotations for our securities; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">reduced liquidity for our securities; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">34 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">a determination that our common stock is a &#8220;penny stock&#8221; which will require brokers trading in our common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">a limited amount of news and analyst coverage; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">a decreased ability to issue additional securities or obtain additional financing in the future. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as &#8220;covered securities.&#8221; Since our Class&#160;A common stock and public warrants are listed on the NYSE, they are covered securities. However, if our securities were no longer listed on the NYSE, they would not be covered securities and we would be subject to regulation in each state in which we offer our securities. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">If our performance does not meet market expectations, the price of our securities may decline. </div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If our performance does not meet market expectations, the price of our Class&#160;A common stock may decline. Additionally, if an active market for our Class&#160;A common stock develops and continues, the trading price of SES common stock could be volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control. Any of the factors listed below could have a material adverse effect on an investment in SES Class&#160;A common stock and shares of our Class A common stock may trade at prices significantly below the price paid for them. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Factors affecting the trading price of our Class&#160;A common stock may include: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">actual or anticipated fluctuations in our quarterly financial results or the quarterly financial results of companies perceived to be similar to us; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes in the market&#8217;s expectations about our operating results; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">success of competitors; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">our operating results failing to meet market expectations in a particular period; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes in financial estimates and recommendations by securities analysts concerning SES or the payments industry and market in general; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">operating and stock price performance of other companies that investors deem comparable to SES; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">our ability to market new and enhanced products on a timely basis; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes in laws and regulations affecting our business; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">commencement of, or involvement in, litigation; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">changes in our capital structure, such as future issuances of securities or the incurrence of additional debt; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the volume of shares of our Class&#160;A common stock available for public sale; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">any significant change in our Board or management; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">sales of substantial amounts of our Class&#160;A common stock by our directors, executive officers or significant stockholders or the perception that such sales could occur; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">general economic and political conditions such as recessions, interest rates, fuel prices, international currency fluctuations and acts of war or terrorism including disruptions resulting from the conflict between Russia and Ukraine. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Broad market and industry factors may depress the market price of our Class&#160;A common stock irrespective of our operating performance. The stock market in general and the NYSE have experienced price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of the particular companies affected. The trading prices and valuations of these stocks, and of our securities, may not be predictable. A loss of investor confidence in the market for EV battery stocks or the stocks of other companies which investors perceive to be similar to SES could depress our stock price regardless of our business, prospects, financial conditions or results of operations. A decline in the market price of our Class&#160;A common stock also could adversely affect its ability to issue additional securities and our ability to obtain additional financing in the future. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">35 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our public warrants may never be in the money, and they may expire worthless. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The exercise price for our warrants is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$11.50&#160;per-share,&#160;subject</div> to adjustment, which exceeds the market price of our Class&#160;A common stock, which was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$9.53&#160;per-share&#160;based</div> on the closing price of our Class&#160;A common stock on the NYSE on March 28, 2022. There can be no assurance that the public warrants will ever be in the money prior to their expiration and, as such, the warrants may expire worthless. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may redeem unexpired public warrants prior to their exercise at a time that is disadvantageous to the warrant holders, thereby making the warrants worthless. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We may redeem outstanding warrants (excluding any private placement warrants held by the Ivanhoe Capital Sponsor LLC (the &#8220;Sponsor&#8221;) or its permitted transferees) at any time after they become exercisable and prior to their expiration, at $0.01 per warrant, provided that the last reported sales price (or the closing bid price of our Class A common stock in the event our Class A common stock is not traded on any specific trading day) of our Class A common stock equals or exceeds <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$18.00&#160;per-share&#160;for</div> any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30&#160;trading-day&#160;period</div> ending on the third business day prior to the date we send proper notice of such redemption, provided that on the date we give notice of redemption and during the entire period thereafter until the time we redeem the warrants, there is an effective registration statement under the Securities Act covering the shares of our Class&#160;A common stock issuable upon exercise of the warrants and a current prospectus relating to them is available. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of the outstanding warrants could force a warrant holder: (i)&#160;to exercise its warrants and pay the exercise price therefore at a time when it may be disadvantageous for it to do so, (ii)&#160;to sell its warrants at the then-current market price when it might otherwise wish to hold its warrants or (iii)&#160;to accept the nominal redemption price which, at the time the outstanding warrants are called for redemption, will be substantially less than the market value of its warrants. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Warrants to purchase SES common stock became exercisable on March&#160;3, 2022, which could increase the number of shares eligible for future resale in the public market and result in dilution to stockholders. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">As of the closing of the Business Combination, there were 14,213,280 warrants outstanding. Each warrant entitles its holder to purchase one share of Class&#160;A common stock at an exercise price of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">$11.50&#160;per-share&#160;and</div> will expire at 5:00 p.m., New York time, five years after the closing of the Business Combination or earlier upon redemption of our Class&#160;A common stock or our liquidation. To the extent warrants are exercised, additional shares of Class&#160;A common stock will be issued, which will result in dilution to our then existing stockholders and increase the number of shares eligible for resale in the public market. Sales of substantial numbers of such shares in the public market could depress the market price of our Class&#160;A common stock. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">A significant portion of our total outstanding shares are restricted from immediate resale but may be sold into the market in the near future. This could cause the market price of our common stock to drop significantly, even if our business is doing well. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Sales of a substantial number of shares of our Class&#160;A common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our common stock. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are party to a registration rights agreement with the SES Founder Group, the Sponsor and certain other holders of SES. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Although the SES Founder Group, the Sponsor and each other stockholder party to the registration rights agreement is prohibited from transferring any securities of SES until the earlier of the date that is 180 days following the Closing Date, these shares may be sold under a registration statement after the expiration or early termination or release of the respective <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">applicable&#160;lock-up&#160;under</div> the registration rights agreement. As restrictions on resale end and the registration statements are available for use, the market price of Class&#160;A common stock could decline if the holders of currently restricted shares sell them or are perceived by the market as intending to sell them. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">36 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Our ability to meet expectations and projections in any research or reports published by securities or industry analysts, or a lack of coverage by securities or industry analysts, could result in a depressed market price and limited liquidity for our common stock. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The trading market for our Class&#160;A common stock will be influenced by the research and reports that industry or securities analysts may publish about us, our business, our market, or our competitors. If no securities or industry analysts commence coverage of SES, our stock price would likely be less than that which would be obtained if we had such coverage and the liquidity, or trading volume of our common stock may be limited, making it more difficult for a stockholder to sell shares at an acceptable price or amount. If any analysts do cover SES, their projections may vary widely and may not accurately predict the results we actually achieve. The share price or our Class&#160;A common stock may decline our actual results do not match the projections of research analysts covering us. Similarly, if one or more of the analysts who write reports on SES downgrades our stock or publishes inaccurate or unfavorable research about our business, our share price could decline. If one or more of these analysts ceases coverage of SES or fails to publish reports on us regularly, our share price or trading volume could decline. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The SES Founder Group is a large and significant stockholder and, as a result, we are a &#8220;controlled company&#8221;, which exempts us from certain obligations to comply with certain corporate governance requirements. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">As of March 28, 2022, the SES Founder Group owned approximately 12.8% of our outstanding common stock and 56.5% of the total voting power. Accordingly, we are a &#8220;controlled company&#8221; for purposes of the NYSE listing requirements. As such, we are exempt from the obligation to comply with certain corporate governance requirements, including the requirements that a majority of our board of directors must consist of independent directors, and that we have nominating and compensation committees that are each composed entirely of independent directors. These exemptions do not modify the requirement for a fully independent audit committee. If we cease to be a &#8220;controlled company,&#8221; we must comply with the independent board committee requirements as they relate to the nominating and compensation committees, subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">certain&#160;&#8220;phase-in&#8221;&#160;periods.</div> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We are controlled or substantially influenced by the SES Founder Group, whose interests may conflict with other stockholders. The concentrated ownership of our Class&#160;A common stock could prevent stockholders from influencing significant decisions. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The SES Founder Group has the ability to control the outcome of most matters requiring stockholder consent. This was designed to help shepherd SES for long-term growth. Moreover, for so long as it holds at least a majority of SES&#8217;s outstanding common stock, the SES Founder Group has the ability, through the Board, to control decision-making with respect to SES&#8217;s business direction and policies. Matters over which the SES Founder Group, directly or indirectly, exercise control include: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the election of SES&#8217;s board of directors and the appointment and removal of our officers; </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">37 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">mergers and other business combination transactions requiring stockholder approval, including proposed transactions that would result in our stockholders receiving a premium price for their shares; and </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">amendments to SES&#8217;s certificate of incorporation or increases or decreases in the size of our board of directors. </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Even if the SES Founder Group&#8217;s ownership subsequently falls below 50%, the SES Founder Group may continue to be able to strongly influence or effectively control our decisions. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">We may be subject to securities litigation, which is expensive and could divert management&#8217;s attention. </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The share price of our Class&#160;A common stock may be volatile and, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. SES may be the target of this type of litigation in the future. Litigation of this type could result in substantial costs and diversion of management&#8217;s attention and resources, which could have a material adverse effect on its business, financial condition, results of operations and prospects. Any adverse determination in litigation could also subject us to significant liabilities. </div></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_4" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;1B.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unresolved Staff Comments. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">None. </div></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_5" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;2.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Properties. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Our principal business location is in Boston, MA, which is subject to a written lease agreement with an unrelated third party. We have no other offices. Our operating facilities are located in Boston, MA and Shanghai, People&#8217;s Republic of China. Both properties are leased, with the Boston lease and the Shanghai lease each expiring in 2026. Our Boston facility focuses on chemistry, materials and algorithm research and development, as well as engaging with OEMs worldwide, including GM, Hyundai and Honda. Our Shanghai facility focuses on supply chain development, manufacturing process development, cell product development, software, BMS and module development. We are building our 1 GWh Pilot Facility in China for the development of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-commercial-production</div> battery cells, which we expect to be completed in 2023. We have also set up an office in Seoul, South Korea focused on supply chain, customer relations and our collaboration with partners in the region. As our joint development of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Li-Metal</div> batteries with certain U.S. and South Korean OEMs continues to progress, we also expect to launch future research facilities and, eventually, commercial production manufacturing facilities, in the United States and South Korea. </div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_6" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;3.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Legal Proceedings. </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">From time to time, we may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.&#160;&#160;&#160;&#160; </div></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_7" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;4.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Mine Safety Disclosures. </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Not applicable. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">38 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div id="tx251271_8" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PART II </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_9" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;5.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Market Information </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our Class&#160;A common stock is traded on The New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;SES.&#8221; Our public warrants are traded on the NYSE under the symbol &#8220;SES WS.&#8221; </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Holders </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of March 28, 2022, there were 141 holders of record of our Class&#160;A common stock and one holder of record of our public warrants. Such numbers do not include DTC participants or beneficial owners holding shares through nominee names. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is no public market for our Class&#160;B common stock and one holder of record of our Class&#160;B common stock as of March 28, 2022. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Dividends </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We have not paid any cash dividends on our shares of Class&#160;A common stock to date and do not anticipate paying any cash dividends for the foreseeable future. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition as well as general business conditions. The payment of any cash dividends will be within the discretion of the Board at such time. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Securities Authorized for Issuance Under Equity Compensation Plans </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2021, Ivanhoe had no securities authorized for issuance under equity compensation plans. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Sales of Unregistered Securities; Use of Proceeds from Registered Offerings </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We did not issue any equity securities during the year ended December&#160;31, 2021 that were not registered under the Securities Act and that have not otherwise been described in a Quarterly Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> or a Periodic Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K.</div> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Equity Performance Graph </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item. </div></div> <div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_10" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;6.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">[Reserved]. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_11" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;7.</div></div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">References in this section to the &#8220;Company,&#8221; &#8220;SES AI Corporation,&#8221; &#8220;Ivanhoe Capital Acquisition Corp.,&#8221; &#8220;Ivanhoe,&#8221; &#8220;our,&#8221; &#8220;us&#8221; or &#8220;we&#8221; refer to Ivanhoe Capital Acquisition Corp. The following discussion and analysis of Ivanhoe&#8217;s financial condition and results of operations should be read in conjunction with the audited consolidated financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cautionary Note Regarding Forward-Looking Statements </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">All statements other than statements of historical fact included in this Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> including, without limitation, statements under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; regarding the Company&#8217;s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. When used in this Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K,</div> words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend&#8221; and similar expressions, as they relate to us or the Company&#8217;s management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company&#8217;s management. Actual results could differ materially from those contemplated by the forward- looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on the Company&#8217;s behalf are qualified in their entirety by this paragraph. </div></div></div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">39 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Overview </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2021, we were a blank check company, incorporated as a Cayman Islands exempted company on July&#160;8, 2020, and formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recent Developments </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February&#160;3, 2022, we consummated the previously announced business combination (the &#8220;Business Combination&#8221;) pursuant to that certain Business Combination Agreement dated July&#160;12, 2021 (the &#8220;Business Combination Agreement&#8221;), by and among Ivanhoe, Wormhole Amalgamation Sub Pte. Ltd., a Singapore private company limited by shares and our direct wholly-owned subsidiary (&#8220;Amalgamation Sub&#8221;), and SES Holdings Pte. Ltd. (&#8220;SES&#8221;), a Singapore private company limited by shares. In connection with the closing of the Business Combination (the &#8220;Closing&#8221;), a business combination between the Company, Amalgamation Sub and SES was effectuated through the merger of Amalgamation Sub with and into SES, with SES continuing as the surviving company. On the Closing Date, we changed our name from Ivanhoe Capital Acquisition Corp. to &#8220;SES AI Corporation&#8221;. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">See our Current Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</div> filed with the SEC on February&#160;1, 2022. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liquidity and Capital Resources </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of December&#160;31, 2021, we had approximately $100,000 in our operating bank account and working deficit of approximately $200,000. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our liquidity needs to date have been satisfied through a contribution of $25,000 from Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of $500,000 from the Sponsor pursuant to the Note, and the proceeds from the consummation of the Private Placement not held in the Trust Account. We repaid the Note in full on January&#160;15, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, provide us Working Capital Loans. On April&#160;9, 2021, we issued an unsecured convertible promissory note (the &#8220;Convertible Note&#8221;) to our Chief Executive Officer, pursuant to which we may borrow up to $1,500,000 for ongoing expenses reasonably related to our business and the consummation of the Business Combination. The Convertible Note does not bear any interest. All unpaid principal under the Convertible Note will be due and payable in full on the earlier of (i)&#160;January&#160;11, 2023 and (ii)&#160;the effective date of the Business Combination (such earlier date, the &#8220;Maturity Date&#8221;). As of December&#160;31, 2021, $945,000 was drawn on the convertible note&#8212;related party, presented at its fair value of approximately $1.2&#160;million on the accompanying consolidated balance sheets. Subsequently, the loan was repaid in full with cash at the closing of our Business Combination no February&#160;3, 2022. There were no amounts outstanding under the Convertible Note as of December&#160;31, 2020. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Based on the foregoing, management believes that we will have sufficient working capital and borrowing capacity from our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks and Uncertainties </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Management continues to evaluate the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on our financial position, results of our operations and/or search for a target company, the specific impact is not readily determinable as of the date of the consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Results of Operations </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Our entire activity since inception up to December&#160;31, 2021 was in preparation for our formation and the Initial Public Offering, and since the closing of the Initial Public Offering, the search for a business combination target, including activities in connection with the proposed acquisition of SES. We have neither engaged in any operations nor generated any revenues to date. We will not generate any operating revenues until after completion of our initial business combination. We will generate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of interest income on the investments held in the trust account from the proceeds of the Initial Public Offering. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a business combination. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">40 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the year ended December&#160;31, 2021, we had net loss of approximately $11.5&#160;million, which consisted of general and administrative expenses of approximately $7.2&#160;million, general and administrative expenses to related party of $120,000, net loss from the change in fair value of convertible note to related party of approximately $210,000, net loss from the change in fair value of the derivative liabilities of approximately $3.2&#160;million, offering costs to derivative warrant liabilities of approximately $855,000, and investment income on the Trust Account of approximately $58,000. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the period from July&#160;8, 2020 (inception) through December&#160;31, 2020, we had net loss of approximately $32,000, which consisted of general and administrative expenses. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Contractual Obligations </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Registration and Shareholder Right</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">s</div></div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any Class&#160;A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The holders of these securities were entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. We will bear the expenses incurred in connection with the filing of any such registration statements. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Underwriting Agreement </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We granted the underwriters a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">45-day</div> option from the date of the Initial Public Offering prospectus to purchase up to 3,600,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On January&#160;11, 2021, the underwriter fully exercised its over-allotment option. The underwriters were entitled to an underwriting discount of $0.20 per unit, or approximately $5.5&#160;million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $9.7&#160;million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Critical Accounting Estimates </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Derivative Warrant Liabilities </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC Topic 480 &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;) and ASC Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-15</div> &#8220;Derivatives and Hedging &#8212; Embedded Derivatives&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-assessed</div> at the end of each reporting period. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The warrants issued in connection with the Initial Public Offering (the &#8220;Public Warrants&#8221;) and the Private Placement Warrants (as defined in Note 4) (collectively, the &#8220;Warrant&#8221;) are recognized as derivative liabilities in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40.</div> Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised, and any change in fair value is recognized in the Company&#8217;s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class&#160;A Ordinary Shares Subject to Possible Redemption </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC Topic 480 &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;) and ASC Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-15</div> &#8220;Derivatives and Hedging &#8212; Embedded Derivatives&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-assessed</div> at the end of each reporting period. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">41 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The warrants issued in connection with the Initial Public Offering (the &#8220;Public Warrants&#8221;) and the Private Placement Warrants (as defined in Note 4) (collectively, the &#8220;Warrant&#8221;) are recognized as derivative liabilities in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40.</div> Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised, and any change in fair value is recognized in the Company&#8217;s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Net Income (Loss) per Ordinary Share </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We comply with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; We have two classes of ordinary shares, which are referred to as Class&#160;A ordinary shares and Class&#160;B ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding for the respective period. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 14,213,333 Class&#160;A ordinary shares in the calculation of diluted income (loss) per ordinary share, because their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per share ordinary for the year ended December&#160;31, 2021 and for the period from July&#160;8, 2020 through December&#160;31, 2020. Accretion associated with the redeemable Class&#160;A ordinary shares is excluded from earnings per ordinary share as the redemption value approximates fair value. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Adopted Accounting Standards </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2020-06,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt-Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</div></div>, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. We early adopted the ASU on January&#160;21, 2021 (inception). Adoption of the ASU did not impact our financial position, results of operations or cash flows. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Issued Accounting Standards </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying consolidated financial statements. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Off-Balance</div> Sheet Arrangements </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">As of December&#160;31, 2021, we did not have any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">off-balance</div> sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K.</div> </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">JOBS Act </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an &#8220;emerging growth company&#8221; and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies. As a result, the consolidated financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">42 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an &#8220;emerging growth company,&#8221; we choose to rely on such exemptions we may not be required to, among other things, (i)&#160;provide an auditor&#8217;s attestation report on our system of internal controls over financial reporting pursuant to Section&#160;404, (ii) provide all of the compensation disclosure that may be required of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii)&#160;comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the consolidated financial statements (auditor discussion and analysis) and (iv)&#160;disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO&#8217;s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an &#8220;emerging growth company,&#8221; whichever is earlier. </div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_12" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;7A.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative and Qualitative Disclosures About Market Risk. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We are a smaller reporting company as defined by Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">12b-2</div> of the Exchange Act and are not required to provide the information otherwise required under this item. </div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_13" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;8.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial Statements and Supplementary Data. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The consolidated financial statements required to be filed pursuant to this Item 8 are appended to this Annual Report and incorporated herein by reference. An index of those financial statements is found in Item 15. </div></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_14" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;9.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">None. </div></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_15" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;9A.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Controls and Procedures. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Evaluation of Disclosure Controls and Procedures </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-right: 1%; margin-bottom: 0pt;">Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of Ivanhoe&#8217;s disclosure controls and procedures as of the end of the fiscal quarter ended December&#160;31, 2021, as such term is defined in Rules <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13a-15(e)</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">15d-15(e)</div> under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer concluded that during the period covered by this Annual Report, Ivanhoe&#8217;s disclosure controls and procedures were not effective as of December&#160;31, 2021, because of a material weakness in its internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company&#8217;s annual or interim consolidated financial statements will not be prevented or detected on a timely basis. Specifically, our management has concluded that Ivanhoe&#8217;s internal controls around the interpretation and accounting for certain complex financial instruments issued by it was not effectively designed or maintained. This material weakness resulted in the restatement of Ivanhoe&#8217;s audited balance sheet as of January&#160;11, 2021, as previously revised in its Quarterly Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> for the quarterly period ended March&#160;31, 2021, filed with the SEC on June&#160;14, 2021 and its interim consolidated financial statements for the quarters ended March&#160;31, 2021, June&#160;30, 2021, and September&#160;30, 2021. Additionally, this material weakness could result in a misstatement of the carrying value of equity, equity-linked instruments and related accounts and disclosures, and presentation of earnings per share that would result in a material misstatement of the consolidated financial statements that would not be prevented or detected on a timely basis. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">43 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Management&#8217;s Report on Internal Controls Over Financial Reporting </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As required by SEC rules and regulations implementing Section 404 of the Sarbanes-Oxley Act, our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with U.S. GAAP. Our internal control over financial reporting includes those policies and procedures that: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%;">&#160;</td>
<td style="width: 5%; vertical-align: top;;text-align:left;">(1)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company, </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%;">&#160;</td>
<td style="width: 5%; vertical-align: top;;text-align:left;">(2)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%;">&#160;</td>
<td style="width: 5%; vertical-align: top;;text-align:left;">(3)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our financial statements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of Ivanhoe&#8217;s internal control over financial reporting at December 31, 2021. In making these assessments, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control &#8212; Integrated Framework (2013). Based on our assessments and those criteria, management determined that Ivanhoe&#8217;s internal controls over financial reporting were not effective as of December 31, 2021, because of a material weakness in its internal control over financial reporting. Specifically, our management has concluded that Ivanhoe&#8217;s control around the interpretation and accounting for certain complex financial instruments issued by the Company was not effectively designed or maintained. This material weakness resulted in the restatement of Ivanhoe&#8217;s consolidated balance sheet as of January 11, 2021, and its interim consolidated financial statements for the quarters ended March 31, 2021, June 30, 2021, and September 30, 2021. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This Annual Report on Form 10-K does not include an attestation report of internal controls from our independent registered public accounting firm due to our status as an emerging growth company under the JOBS Act. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Changes in Internal Control over Financial Reporting </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">There were no changes in our internal control over financial reporting (as such term is defined in Rules <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13a-15(f)</div> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">15d-15(f)</div> of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting except as noted below. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management performed additional accounting and financial analyses and other post-closing procedures including consulting with subject matter experts related to the accounting for certain complex features of the Class A ordinary shares and warrants. Management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation and improvement of our internal control over financial reporting. While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we have expanded and will continue to improve these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards. </div></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_16" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;9B.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other Information. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">None. </div></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_17" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;9C.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Not applicable. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">44 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx251271_18">PART III </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top;text-align:left;" id="tx251271_19"><div style="font-weight:bold;display:inline;">Item&#160;10.</div></td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Directors, Executive Officers and Corporate Governance. </div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following sets forth certain information, as of the date of this report, concerning the directors and officers of SES AI Corporation (formerly known as Ivanhoe Capital Acquisition Corp.). Ages are shown as of December&#160;31, 2021. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:33%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:63%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <div style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman">Name</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">Age</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"> <div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">Position</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Dr.&#160;Qichao Hu</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">36</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chief Executive Officer and Chairman</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Rohit Makharia</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">44</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">President and Chief Operating Officer</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Jing Nealis</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">42</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chief Financial Officer</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Joanne Ban</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">42</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chief Legal and Corporate Officer</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Yongkyu Son</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">47</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chief Technology Officer</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Dr.&#160;Hong Gan</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">61</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Chief Science Officer</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Dr.&#160;Jang Wook Choi</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">46</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Robert Friedland</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">71</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Kent Helfrich</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">57</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Eric Luo</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">56</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Dr.&#160;Jiong Ma</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">58</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Michael Noonen</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top;text-align:center;">58</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Director</td></tr> </table> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Dr.</div></div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;Qichao Hu</div></div>. Dr.&#160;Hu serves as the Company&#8217;s Chief Executive Officer and Chairman of the Board. Dr.&#160;Hu has served as Founder, Chief Executive Officer and Director of SES since 2012. Dr.&#160;Hu is also a board member on the MIT Enterprise Forum Cambridge. Dr.&#160;Hu is recipient of<div style="font-style:italic;display:inline;"> MIT Technology Review</div>&#8217;s &#8220;Innovators Under 35&#8221; and was named among the 2013<div style="font-style:italic;display:inline;"> Forbes</div> &#8220;30 Under 30.&#8221; Dr.&#160;Hu earned his PhD in Applied Physics from Harvard University, and his BS in Physics from MIT. We believe that Dr.&#160;Hu is qualified to serve both as a member of our management team and the Board because of his visionary leadership of SES from inception to date, his scientific and managerial expertise in the EV battery development industry, his innovative plans for SES&#8217;s future and his ability to execute on those plans. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Rohit Makharia</div></div>. Mr.&#160;Makharia serves as the Company&#8217;s President and Chief Operating Officer. He currently serves as the President and Chief Operating Officer of SES, a position he has held since March 2021. Mr.&#160;Makharia served as Senior Investment Manager and Partner at GM Ventures, which is a shareholder of SES, from 2014 to 2021. During his tenure at GM Ventures, he served on the board of multiple early-stage and high-growth companies, including SES, as a Director or an Observer. He previously led the battery cell development at GM Global Battery Systems from 2012 to 2014, served as Manager&#160;&amp; Senior Staff Engineer, Electrochemical Energy Lab from 2007 to 2012, and Project/Senior Engineer, Fuel Cell Activities, from 2002 to 2006. Mr.&#160;Makharia earned a MS from University of Rochester in Chemical Engineering and a BS from Mumbai University in 1999. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">45 </div> </div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc"></a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Jing Nealis</div></div></div></div>. Ms.&#160;Nealis serves as the Company&#8217;s Chief Financial Officer. She currently serves as SES&#8217;s Chief Financial Officer, a position she has held since March 2021. Ms.&#160;Nealis served as Senior Director, Corporate Finance at View Inc., from 2019 until March 2021. Previously, she served as Chief Financial Officer of SunPower Systems International Ltd. from 2017 until 2019, after having served in the same role in the International Division of Shunfeng International Clean Energy Ltd from 2014 until 2017. From 2012 to 2014, Ms.&#160;Nealis was Finance Director/Global Tax Director of Suntech Power, prior to which she was a manager at Deloitte from 2006 to 2012 and worked at Deloitte offices in Chicago, Shanghai, and Hong Kong. Ms.&#160;Nealis earned her MS in Accounting from the University of Hawaii and her Bachelor&#8217;s in International Business from China University of Petroleum in Beijing. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Joanne Ban</div></div></div></div>. Ms.&#160;Ban serves as the Company&#8217;s Chief Legal and Corporate Officer. She currently serves as Chief Legal and Corporate Officer of SES, a position she has held since 2020. Ms.&#160;Ban previously served as SES&#8217;s Vice President Legal&#160;&amp; Corporate Development from 2019 to 2020, and prior to that, was a consultant to SES in her role as a Partner at garage3 ventures in 2018 and 2019. From 2013 to 2017, Ms.&#160;Ban was General Counsel at Heptagon Advanced Micro-Optics Pte. Ltd. Prior to that, Ms.&#160;Ban was in legal practice in Beijing, China and Singapore with White&#160;&amp; Case LLP. Ms.&#160;Ban holds dual EMBAs from Tsinghua University School of Economics and Management and INSEAD and her LLB from National University of Singapore. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Yongkyu Son</div></div></div></div>. Mr.&#160;Son serves as the Company&#8217;s Chief Technology Officer. He currently serves as SES&#8217;s Chief Technology Officer, a position he has held since 2020. Prior to that, he was SES&#8217;s Director of Cell Engineering from 2018 to 2020 and SES&#8217;s Principal Engineer from 2016 to 2018. Mr.&#160;Son led LV battery at Apple Inc. from 2015 to 2016. He previously served as a Senior Research Scientist at Johnson Controls Inc. from 2010 to 2015 leading an awarded DOE project&#8212;Low cost manufacturing as a principle investigator. He had worked as a cell development engineer at Samsung SDI from 2002 to 2006 and as a material development team manager at A123 Korea from 2008 to 2009 and as a senior cell engineer at SK Innovation from 2009 to 2010 leading PHEV battery development project. Mr.&#160;Son earned an MS in Chemistry from Sungkyunkwan University. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Dr.</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;Hong Gan</div></div></div></div>. Dr.&#160;Gan serves as the Company&#8217;s Chief Science Officer. He currently serves as SES&#8217;s Chief Science Officer, a position he has held since 2020. Dr.&#160;Gan was previously SES&#8217;s Director of Research&#160;&amp; Development from 2018 to 2020. From 2013 to 2018, he was Group Leader of the Energy Storage Group at the Sustainable Energy Department at the Brookhaven National Laboratory, and from 2011 to 2013, he was Senior Director of Research&#160;&amp; Development at Enevate Corporation. From 1993 to 2011, Dr.&#160;Gan held various positions at Greatbatch Medical, culminating in his roles as Director, Battery Research and Director, Research&#160;&amp; Development Power Sources, Primary Battery. Dr.&#160;Gan earned his PhD in Chemistry from the University of Chicago in 1990, and his BS in Chemistry from Peking University in 1982. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Dr.</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;Jang Wook Choi</div></div></div></div>. Dr.&#160;Choi serves as a director of the Company, a position he has held since February 2022. Since September 2020, Dr.&#160;Choi has served as Professor at Seoul National University, where he was previously Associate Professor from 2017 to 2020. Prior to joining Seoul National University, he was Associate Professor from 2012 until 2017 and Assistant Professor from 2010 until 2012 at Korea Advanced Institute of Science and Technology. Dr.&#160;Choi received his PhD in Chemical Engineering from California Institute of Technology and BS in Chemical Engineering from Seoul National University. We believe that Dr.&#160;Choi is qualified to serve as a director of our Board because of his extensive academic experience and expertise in chemistry, engineering and battery technologies. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Robert Friedland</div></div></div></div>. Mr.&#160;Friedland serves as a director of the Company, a position he has held since February 2022. Mr.&#160;Friedland has over 25 years of experience and has been recognized by leaders of the international financial sector and mineral resource industries as an entrepreneurial explorer, technology innovator and company builder. Mr.&#160;Friedland&#8217;s experience is extensive. Mr.&#160;Friedland is the Director, President and CEO of Ivanhoe Capital Corporation (&#8220;Ivanhoe Capital&#8221;) (since July 1988), the executive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Co-Chairman</div> (since September 2018) (previously the Executive Chairman from May 2012 until September 2018) of Ivanhoe Mines Ltd. and the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Co-Chair</div> Director of SK Global Entertainment, Inc. (since February 2017). Under Mr.&#160;Friedland&#8217;s tenure, Ivanhoe Capital has invested in a diverse portfolio of businesses. Additionally, Mr.&#160;Friedland has been the Chief Executive Officer of High Power Exploration Inc. (&#8220;HPX&#8221;) since December 2015. HPX is applying proprietary, geophysical technologies to rapidly evaluate underground geological targets and accelerate exploration programs targeting mineral and water resources. Mr.&#160;Friedland is also the Director, Chairman and President of Ivanhoe Pictures, Inc. (since May 2013), and a Director (since December 2016) and Chairman (since June 2018) of VRB Energy Inc. As one of the most recognized mining personalities and achievers in the world, Mr.&#160;Friedland is dedicated to serving on numerous boards in the natural resources sector. These positions include as a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Co-Chairman</div> and Director of Clean TeQ Holdings Limited (since September 2016), a Director of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">I-Pulse</div> Inc. (since April 2008) and a Director of Kietta SAS (since November 2009), as well as the Chairman of Gold X Mining Corp. (since June 2020). Mr.&#160;Friedland graduated with a degree in political science from Reed College. We believe that Mr.&#160;Friedland is qualified to serve as on our board of directors because of his depth of experience in both executive positions and serving on numerous boards. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">46 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Kent E. Helfrich.</div></div></div></div> Mr.&#160;Helfrich serves as a director of the Company, a position he has held since February 2022. Mr.&#160;Helfrich was appointed Chief Technology Officer and Vice President, Global Research and Development of GM and President of GM Ventures in 2021. In these roles, Mr.&#160;Helfrich is responsible for innovation and technology solutions in the development of GM vehicles. From 2019 until 2021, Mr.&#160;Helfrich served as GM&#8217;s Executive Director of Global Electrification and Battery Systems, where he was responsible for GM electrified vehicle hardware development and the overall electric vehicle propulsion calibration and driving performance. Mr.&#160;Helfrich previously served as Executive Director, Connected Ecosystem Integration at GM from 2016 until 2019, where he oversaw the GM mobile and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">in-vehicle</div> applications and the information technology back office. Prior to rejoining GM in 2016, Mr.&#160;Helfrich was Vice President and Chief Technology Officer at Flex Ltd. (&#8220;Flex&#8221;) from 2014 until 2016. Before joining Flex, Mr.&#160;Helfrich served in various roles at GM, where he was globally responsible for all unstyled electrical systems in the vehicle, as well as defining electrical architecture and software architecture strategies. Mr.&#160;Helfrich earned his BS in Electrical Engineering from Ohio State University and MBA from the Fuqua School of Business at Duke University. We believe that Mr.&#160;Helfrich is qualified to serve as a director of our Board because of his experience in executive leadership positions and expertise in information technology, innovation and software solutions. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Eric Luo.</div></div></div></div> Mr.&#160;Luo serves as a director of the Company, a position he has held since February 2022. From 2017 until 2021, Mr.&#160;Luo served as Chairman and Chief Executive Officer of GCL System Integration Limited, GCL New Energy USA (&#8220;GCL&#8221;), an international energy conglomerate specializing in clean and sustainable energy. Prior to his position at GCL, Mr.&#160;Luo served as the Chief Executive Officer and Board Member of Shunfeng International Clean Energy Limited (SFCE), a Hong Kong-based supplier of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">law-carbon</div> and energy saving integrated solutions from 2015 to 2017. Mr.&#160;Luo received his MBA from Michigan State University and BS in Operational Management from Zhejiang Gongshang University. We believe that Mr.&#160;Luo is qualified to serve as a director of our Board because of his experience in executive leadership positions and expertise in clean and sustainable energy. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Dr.</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;Jiong Ma.</div></div></div></div> Dr.&#160;Ma serves as a director of the Company, a position she has held since February 2022. Since 2021, Dr.&#160;Ma has served as a Founder and Chief Executive Officer of Chavant Capital Acquisition Corp. (NASDAQ: CLAY) (&#8220;Chavant&#8221;), a special purpose acquisition company seeking to invest in a high growth technology companies. From 2008 to 2020, Dr.&#160;Ma served as a Partner at Braemar Energy Ventures (&#8220;Braemar&#8221;), a venture capital firm investing in early to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-stage</div> technology companies operating in the mobility, power, resources and infrastructure sectors. At Braemar, Dr.&#160;Ma focused on investments in digitization of industry, resource efficiency, mobility, renewable energy infrastructure, and deeptech. Prior to joining Braemar, Dr.&#160;Ma served in the Venture Capital Group at 3i Group plc (&#8220;3i&#8221;), a global private equity firm, from 2004 to 2008, where she was responsible for investment in the information technology and cleantech sectors. Prior to 3i, Dr.&#160;Ma served as Senior Manager of the Optical Networking Group, Technology and Business Leadership at Lucent Technologies and Bell Labs, where she was responsible for product portfolio strategy, new product launches for Optical and Data Networking, and research and product development. Dr.&#160;Ma was also a founding team member of Onetta, a fiber networks company. Dr.&#160;Ma has served on the boards of Chavant and Anavex Life Sciences (NASDAQ: AVXL) since 2021. Dr.&#160;Ma received her PhD in electrical engineering from the University of Colorado at Boulder, MS in electrical engineering from the Worcester Polytechnic Institute in Massachusetts and BS in Physics from Lanzhou University. We believe that Dr.&#160;Ma is qualified to serve as a director of our Board because of her extensive experience in research, operations and venture capital, particularly in the technology industry. </div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Michael Noonen.</div></div></div></div> Mr.&#160;Noonen serves as a director of the Company, a position he has held since February 2022. Since June 2019, Mr.&#160;Noonen has served as Chief Executive Officer of MixComm Inc., a leader in RFSOI mmWave solutions based in New Jersey, which was acquired by Sivers Semiconductors in February 2022. Mr.&#160;Noonen brings 25 years of experience in leading technology businesses. Mr.&#160;Noonen has held various leadership positions, including as chairman and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-founder</div> of Silicon Catalyst from 2013 to 2015, the world&#8217;s first semiconductor incubator and the EE Times 2015 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Start-up</div> of the Year, and as chairman of the board of Socle in Taiwan in 2013 (which was acquired by Foxconn), and was also previously Executive Vice President of Global Products, Design, Sales&#160;&amp; Marketing at GlobalFoundries from 2011 to 2013. From 2008 and 2011, Mr.&#160;Noonen served as Executive Vice President of Worldwide Sales and Marketing at NXP Semiconductors (NASDAQ: NXPI). He also currently serves on the board of Graph Audio and previously served on the board of Energous (NASDAQ: WATT) from 2019 to 2021. Mr.&#160;Noonen received his B.S. from Colorado State University in Electrical Engineering and was named the College of Engineering Distinguished Alumni in 2012, was elected to the Global Semiconductor Alliance Board of Directors and holds multiple patents in the areas of Internet telephony and video communications. We believe Mr.&#160;Noonen is qualified to serve as a director of our Board because of his experience in executive leadership positions and expertise in information technology, innovation and the electronics industry. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">47 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Limitations on Liability and Indemnification of Officers and Directors </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Upon the closing of the Business Combination, we entered into indemnification agreements with each of our directors and executive officers. The indemnification agreements require us to indemnify our directors and executive officers to the fullest extent permitted by Delaware law. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Delaware General Corporation Law (the &#8220;DGCL&#8221;) authorizes corporations to limit or eliminate the personal liability of directors of corporations and their stockholders for monetary damages for breaches of directors&#8217; fiduciary duties, subject to certain exceptions. SES&#8217;s Certificate of Incorporation (the &#8220;Charter&#8221;) includes a provision that eliminates the personal liability of directors for damages for any breach of fiduciary duty as a director where, in civil proceedings, the person acted in good faith and in a manner that person reasonably believed to be in or not opposed to the best interests of SES or, in criminal proceedings, where the person had no reasonable cause to believe that his or her conduct was unlawful. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The bylaws of SES (the &#8220;Bylaws&#8221;) provide that SES must indemnify and advance expenses to SES&#8217;s directors and officers to the fullest extent authorized by the DGCL. SES also is expressly authorized to carry directors&#8217; and officers&#8217; liability insurance providing indemnification for SES directors, officers, and certain employees for some liabilities. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The limitation of liability, advancement and indemnification provisions in the Charter and Bylaws may discourage stockholders from bringing lawsuit against directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit SES and its stockholders. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is currently no pending material litigation or proceeding involving any of SES&#8217;s directors, officers, or employees for which indemnification is sought. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We also maintain a directors&#8217; and officers&#8217; insurance policy pursuant to which our directors and officers are insured against liability for actions taken in their capacities as directors and officers. We believe these provisions in the Charter, Bylaws and these indemnification agreements are necessary to attract and retain qualified persons as directors and officers. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Corporate Governance </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our corporate governance is structured in a manner that we believe closely aligns our interest with those of our stockholders. Notable features of this corporate governance include: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">we have independent director representation on our audit, compensation and nominating and corporate governance committees, and our independent directors meet regularly in executive sessions without the presence of our corporate officers or <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-independent</div> directors; and </div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at least one of our directors qualifies as an &#8220;audit committee financial expert&#8221; as defined by the SEC. </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Election of Officers </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Each executive officer serves at the discretion of our board of directors and holds office until his or her successor is duly appointed or until his or her earlier resignation or removal. There are no family relationships among any of our directors and executive officers. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Board Composition </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our board of directors consists of seven directors. Each of our current directors will continue to serve as a director until the election and qualification of his or her successor or until his or her earlier death, resignation or removal. The authorized number of directors may be changed by resolution of our board of directors. Vacancies on our board of directors may be filled by resolution of our board of directors. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">48 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our board consists of (i)&#160;Dr.&#160;Hu, (ii)&#160;Mr.&#160;Friedland, (iii)&#160;Dr.&#160;Choi, (iv)&#160;Mr.&#160;Helfrich, (v)&#160;Mr.&#160;Luo, (vi)&#160;Dr.&#160;Ma and (vii)&#160;Mr.&#160;Noonen. Mr.&#160;Helfrich was nominated by GM Ventures (to serve as a Class&#160;II director) pursuant to its contractual nominating rights. For more information, see &#8220;Certain Relationships and Related Transactions&#8212;SES Related Person Transactions&#8212;Director Nomination Agreement.&#8221; </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our board of directors has affirmatively determined that each of Drs. Ma and Choi and Messrs. Luo, Friedland and Noonen is an &#8220;independent director&#8221; under the NYSE listing rules applicable to board members. For more details, see the section entitled &#8220;Independence of our Board of Directors.&#8221; </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our board of directors is divided into three classes with only one class of directors being elected in each year, and with each class (except for those directors appointed prior to our first annual meeting of stockholders) serving a three-year term: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">our Class&#160;I directors are Dr.&#160;Ma, Mr.&#160;Noonen and Mr.&#160;Luo, and their terms will expire at the first annual meeting of stockholders following the date of the proxy statement; </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">our Class&#160;II directors are Dr.&#160;Choi and Mr.&#160;Helfrich and their terms will expire at the second annual meeting of stockholders following the date of the proxy statement; and </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 10%;">&#160;</td>
<td style="width: 2%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">our Class&#160;III directors are Dr.&#160;Hu and Mr.&#160;Friedland and their terms will expire at the third annual meeting of stockholders following the date of the proxy statement. </div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the staggered board, only one class of directors will be elected at each annual meeting of stockholders, with the other classes continuing for the remainder of their respective terms. At any meeting of stockholders at which directors are to be elected, the number of directors elected may not exceed the greatest number of directors then in office in any class of directors. The members of each class will hold office until the annual meeting stated above when their term expires and until their successors are elected and qualified. At each succeeding annual meeting of the stockholders, the successors to the class of directors whose term expires at that meeting will be elected by plurality vote of all votes cast at such meeting to hold office for a term expiring at the annual meeting of stockholders held in the third year following the year of their election and until their successors are elected and qualified. Subject to the rights, if any, of the holders of any series of preferred stock to elect additional directors under circumstances specified in a preferred stock designation, directors may be elected by the stockholders only at an annual meeting of stockholders. </div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our board of directors is chaired by Dr. Hu. Our board of directors believes that combining the positions of Chief Executive Officer and Chairman helps to ensure that our board of directors and management act with a common purpose. In addition, our board of directors believes that a combined Chief Executive Officer and Chairman is better positioned to act as a bridge between management and our board of directors, facilitating the regular flow of information. Our board of directors also believes that it is advantageous to have a chairperson with significant history with and extensive knowledge of SES, as is the case with Dr. Hu. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Independence of our Board of Directors </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Based on information provided by each director concerning his or her background, employment, and affiliations, our board of directors has determined that the board of directors meets independence standards under the applicable rules and regulations of the SEC and the listing standards of NYSE. In making these determinations, our board of directors considered the current and prior relationships that each <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employee</div> director has with our company and all other facts and circumstances our board of directors deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-employee&#160;director,</div> and the transactions involving them described in the section titled &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Certain Relationships and Related Party Transactions.</div></div>&#8221; </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Board Committees </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our board of directors has four standing committees: an audit committee; a compensation committee; a nominating and corporate governance committee; and a strategic investment and partnership committee. Each of the committees reports to the board of directors as it deems appropriate and as the board of directors may request. The composition, duties and responsibilities of these committees are set forth below. In the future, our board of directors may establish other committees, as it deems appropriate, to assist it with its responsibilities. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">49 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Audit Committee </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The members of our audit committee are Mr.&#160;Luo, Dr.&#160;Ma and Mr.&#160;Noonen. Mr.&#160;Luo is the chair of our audit committee. The audit committee provides assistance to our board of directors in fulfilling its legal and fiduciary obligations in matters involving our accounting, auditing, financial reporting and legal compliance functions by approving the services performed by our independent registered public accounting firm and reviewing their reports regarding our accounting practices and systems of internal accounting controls. The audit committee also oversees the audit efforts of our independent registered public accounting firm and takes those actions as it deems necessary to satisfy itself that the independent registered public accounting firm is independent of management. Subject to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">phase-in</div> rules and a limited exception, the rules of NYSE and Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10A-3</div> of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors. All of the members of our audit committee are independent under the applicable NYSE and SEC rules. All of the members of our audit committee also meet the requirements for financial literacy under the applicable rules and regulations of the SEC and NYSE. In addition, Mr.&#160;Luo qualifies as our &#8220;audit committee financial expert,&#8221; as such term is defined in Item 407 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K.</div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Compensation Committee </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The members of our compensation committee are Mr.&#160;Luo, Dr.&#160;Ma and Mr.&#160;Noonen. Dr.&#160;Ma is the chair of our compensation committee. The compensation committee determines general compensation policies and the compensation provided to our officers. The compensation committee also makes recommendations to board of directors regarding director compensation. In addition, the compensation committee reviews and determines security-based compensation for our directors, officers, employees and consultants and will administer our equity incentive plans. Our compensation committee also oversee our corporate compensation programs. All members of our compensation committee satisfy the NYSE&#8217;s independence standards for compensation committee members. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Nominating and Corporate Governance Committee </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The members of our nominating and corporate governance committee are Dr. Hu, Dr. Ma and Mr. Luo. Dr. Hu is the chair of our nominating and corporate governance committee. The nominating and corporate governance committee is responsible for making recommendations to our board of directors regarding candidates for directorships and the size and composition of the board. In addition, the nominating and corporate governance committee is responsible for overseeing our corporate governance and reporting and making recommendations to the board of directors concerning corporate governance matters. Dr. Ma and Mr. Luo are independent under the NYSE listing rules applicable to board members. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Strategic Investment and Partnership Committee </div></div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The members of our strategic investment and partnership committee are Dr. Hu, Dr. Ma, Mr. Luo and Mr. Noonen. Dr. Hu is the chair of our strategic investment and partnership committee. The strategic investment and partnership committee is responsible for overseeing the execution of strategic partnerships and transactions and approving M&amp;A transactions, investments, joint ventures, strategic collaborations and partnerships or similar transactions proposed by our management, within parameters set for the committee from time to time by our board. The committee also provides oversight and guidance to management regarding the execution of our transactions and annual and long-term business and financial plans, and reviews and discusses transactions and related strategies with our management to make appropriate recommendations to our board of directors. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Role of Our Board of Directors in Risk Oversight </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">One of the key functions of board of directors is informed oversight of our risk management process. Our board of directors administers this oversight function directly through our board of directors as a whole, as well as through various standing committees of our board of directors that address risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring and assessing strategic risk exposure, and our audit committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. The audit committee also has the responsibility to review with management the process by which risk assessment and management is undertaken, monitor compliance with legal and regulatory requirements, and review the adequacy and effectiveness of our internal controls over financial reporting. Our nominating and corporate governance committee is responsible for periodically evaluating our company&#8217;s corporate governance policies and systems in light of the governance risks that our company faces and the adequacy of our policies and procedures designed to address such risks. Our compensation committee assesses and monitors whether any of our compensation plans, policies and programs comply with applicable legal and regulatory requirements. Our strategic investment and partnership committee is responsible for periodically reviewing the performance of completed transactions (including integration of such acquired businesses, to the extent applicable) with our management. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Code of Business Conduct and Ethics for Employees, Executive Officers, and Directors </div></div></div> <div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Our board of directors has adopted a Code of Business Conduct and Ethics (the &#8220;Code of Conduct&#8221;), applicable to all of our employees, executive officers and directors, including our Chief Executive Officer, Chief Financial Officer and other executive and senior financial officers. The Code of Conduct is available on our website under the heading &#8220;Investors&#8221; at <div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">https://ses.ai</div>. Any amendments to the Code of Conduct, or any waivers of its requirements, will be disclosed on our website to the extent required by applicable rules and exchange requirements. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">50 </div></div> </div> </div> <div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div> <hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Corporate Governance Guidelines </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We have adopted a set of corporate governance guidelines to provide the framework for the governance of our Board and to assist our Board in the exercise of its responsibilities. These guidelines reflect our Board&#8217;s commitment to monitoring the effectiveness of policy and decision-making both at the board and management levels, with a view to enhancing stockholder value over the long term. The corporate governance guidelines are available on our website under the heading &#8220;Investors&#8221; at <div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">https://ses.ai</div>. </div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_20" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;11.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Executive Compensation. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Introduction </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">None of Ivanhoe&#8217;s directors or named executive officers received any cash compensation for services rendered to Ivanhoe for the fiscal year ended December&#160;31, 2021 (&#8220;Fiscal 2021&#8221;). </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This section discusses the material components of the executive compensation program in Fiscal 2021 for the executive officers of Old SES who were, for Fiscal 2021, &#8220;named executive officers&#8221; (defined as SES&#8217;s Founder and Chief Executive Officer and its two most highly compensated executive officers other than him, who were serving as of December&#160;31, 2021). This section also provides certain compensation information for the fiscal year ending December&#160;31, 2022 (&#8220;Fiscal 2022&#8221;) for these Fiscal 2021 named executive officers, who serve as executive officers of SES following the Business Combination. References to &#8220;SES&#8221; in this section include both Old SES and SES following the Business Combination, depending on the time period being discussed. </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This discussion may contain forward-looking statements that are based on SES&#8217;s current plans, considerations, expectations and determinations regarding future compensation programs. Actual compensation programs that SES adopts in the future may differ materially from the historical, existing and currently planned programs summarized or referred to in this discussion. </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The primary objectives of SES&#8217;s executive compensation programs are to attract and retain talented executives to effectively manage and lead SES. The compensation packages for SES&#8217;s named executive officers generally include a base salary, annual cash bonuses, equity awards and other benefits and perquisites. </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our named executive officers for Fiscal 2021 were: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dr.&#160;Qichao Hu, SES&#8217;s Founder and Chief Executive Officer and a director of SES; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Mr.&#160;Rohit Makharia, SES&#8217;s President and Chief Operating Officer, who joined SES in this role in March 2021; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ms.&#160;Jing Nealis, SES&#8217;s Chief Financial Officer, who joined SES in this role in March 2021. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">All of these executive officers currently have the same roles as our executive officers as a result of the Business Combination. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Summary Compensation Table </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides summary information concerning compensation of the named executive officers for services rendered to Old SES during Fiscal 2021. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 44%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="font-family: &quot;Times New Roman&quot;;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Name and Principal <br/>Position</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Year</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Salary<br/>($)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(1)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Bonus<br/>($)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(2)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock<br/>Awards<br/>($)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Option<br/>Awards<br/>($)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Equity</div><br/>Incentive Plan<br/>Compensation</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">($)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(4)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">All Other<br/>Compensation<br/>($)</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(5)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total<br/>($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dr.&#160;Qichao Hu<br/></div></div><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Founder, Chief Executive Officer and Director</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2021</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">328,333</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;<br/></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;<br/></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;<br/></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">166,667</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">184,446</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">679,446</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2020</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">241,667</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;<br/></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;<br/></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;<br/></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,277</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,903</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">427,847</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rohit Makharia<br/></div></div><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">President and Chief Operating Officer</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2021</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">275,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">674,170</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">73,125</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">156,448</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,328,743</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="4" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Jing Nealis<br/></div></div><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Chief Financial Officer</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2021</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">289,423</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,480,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">112,809</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">78,750</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,120,982</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">51 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:96%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(1)<br/> <div style="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">(2)</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount reflects the named executive officer&#8217;s base salary earned during Fiscal 2021.</div> <div style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Amount reflects (i)&#160;in the case of Dr.&#160;Hu, a bonus of $35,417 for performance from January&#160;1, 2021 to March&#160;31, 2021, a $175,000 annual performance bonus for performance from April 1, 2021 to March 31, 2022, prorated to $131,250 for the portion of that period in Fiscal 2021, (ii) in the case of Mr. Makharia, a sign-on bonus of $150,000 in connection with his joining SES in March 2021 and a $97,500 annual performance bonus for performance from April 1, 2021 to March 31, 2022, prorated to $73,125 for the portion of that period in Fiscal 2021, and (iii) in the case of Ms. Nealis, a sign-on bonus of $150,000 in connection with her joining SES in March 2021 and a $105,000 annual performance bonus for performance from April 1, 2021 to March 31, 2022, prorated to $78,750 for the portion of that period in Fiscal 2021,</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(3)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Amount represents the aggregate grant date fair value of restricted share or stock option awards made to the named executive officer computed in accordance with Financial Accounting Standards Codification Topic 718, Compensation&#160;-&#160;Stock Compensation (&#8220;Topic 718&#8221;). The fair value of options was calculated using the Black-Scholes value on the grant date. As required by SEC rules, awards are reported in the year of grant.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(4)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Amount reflects the prorated portion of an annual performance bonus based on performance from April&#160;1, 2021 to March&#160;31, 2022, (i) in the case of Dr.&#160;Hu, of $175,000 (prorated to $131,250 for the portion of that period in Fiscal 2021), (ii) in the case of Mr.&#160;Makharia, $97,500 (prorated to $73,125 for the portion of that period in Fiscal 2021) and (iii)&#160;in the case of Ms.&#160;Nealis, $105,000 (prorated to $78,750 for the portion of that period in Fiscal 2021).</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">(5)</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Amounts shown in this column represent (i)&#160;for all named executive officers, the aggregate amount of a monthly allowance for subsidized childcare benefits and other related benefits, and (ii)&#160;for Dr.&#160;Hu and Mr.&#160;Makharia, certain other personal benefits. This allowance is also provided to certain other key employees of the Company. See &#8220;Narrative Disclosure to Summary Compensation Table&#160;-&#160;Other Benefits.&#8221;</td></tr> </table> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Narrative Disclosure to Summary Compensation Table </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Our compensation for our executive officers has the following components: base salary, annual cash bonus opportunities, equity compensation, employee benefits, executive perquisites and severance benefits. Base salaries, employee benefits, executive perquisites and severance benefits are designed to attract and retain senior management talent. We also use annual cash bonuses and equity awards to promote performance-based pay that aligns the interests of our named executive officers with the long-term interests of its equity-owners and to enhance executive retention. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><div style="font-style:italic;display:inline;">Employment Agreements </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SES entered into employment agreements with Dr.&#160;Hu, Mr.&#160;Makharia and Ms.&#160;Nealis on May&#160;4, 2021, February&#160;15, 2021 and February&#160;16, 2021, respectively, providing for the terms of their <div style="white-space:nowrap;display:inline;">at-will</div> employment with SES and including (i)&#160;annual base salary, (ii)&#160;eligibility for an annual performance bonus, (iii)&#160;participation in SES&#8217;s benefit plans and vacation in accordance with SES&#8217;s policies and (iv)&#160;severance benefits in the event of certain terminations of employment. Each of Mr.&#160;Makharia&#8217;s and Ms.&#160;Nealis&#8217;s agreements also included a <div style="white-space:nowrap;display:inline;">sign-on</div> bonus of $150,000, as well as an entitlement to reimbursement of relocation and/or other related <div style="white-space:nowrap;display:inline;">sign-on</div> expenses. Although Dr.&#160;Hu received a base salary, bonus and similar benefits in the fiscal year ended December 31, 2020, he was not party to an employment agreement with SES in that year. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><div style="font-style:italic;display:inline;">Base Salaries </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SES&#8217;s named executive officers received in Fiscal 2021 and currently receive a base salary to compensate them for services rendered to SES. The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role and responsibilities. In March 2021, the Company increased Dr.&#160;Hu&#8217;s annual base salary and hired Mr.&#160;Makharia and Ms.&#160;Nealis. As such, the annual base salary for Dr.&#160;Hu for 2021 was $250,000 (through February&#160;28, 2021) and $350,000 (beginning March&#160;1, 2021), the annual base salaries for Mr.&#160;Makharia and Ms.&#160;Nealis for 2021 were $325,000 and $350,000, respectively, and Dr.&#160;Hu, Mr.&#160;Makharia and Ms.&#160;Nealis earned in 2021 aggregate salary payments of $328,333, $275,000 and $289,423, respectively. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><div style="font-style:italic;display:inline;">Annual Bonuses </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SES provided in Fiscal 2021 and currently provides incentive compensation to its named executive officers in the form of annual performance bonuses, determined by SES&#8217;s board of directors or compensation committee, based on both individual performance of the named executive officer and the overall performance of SES, generally in accordance with performance milestones established by SES&#8217;s board or compensation committee. The performance goals differ from executive to executive, and each executive&#8217;s target annual bonus opportunity is equal to a predetermined percentage of his or her base salary. Near the beginning of each year, the board or compensation committee selects the performance targets, target amounts, target award opportunities and other terms and conditions of annual bonuses for the named executive officers, subject to the terms of their employment agreements. Following the end of each year, the board or compensation committee determines the extent to which the performance targets were achieved and the amount of the award that is payable to the named executive officers. The bonuses may be paid in cash or equity at the discretion of the board or compensation committee. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Historically, the annual bonuses have covered performance from April 1 of one fiscal year until March 31 of the following fiscal year. For the period from April 1, 2021 to March 31, 2022, the target annual bonus opportunities for Dr. Hu, Mr. Makharia and Ms. Nealis were 50%, 30% and 30%, respectively, of annual base salary for Fiscal 2021. For Fiscal 2021, the annual cash bonus earned by each named executive officer was as follows: for Dr. Hu, $131,250 (based on a payout of $175,000 for the performance period from April 1, 2021 to March 31, 2022, prorated for Fiscal 2021); for Mr. Makharia, $73,125 (based on a payout of $97,500 for the performance period from April 1, 2021 to March 31, 2022, prorated for Fiscal 2021); and for Ms. Nealis, $78,750 (based on a payout of $105,000 for the performance period from April 1, 2021 to March 31, 2022, prorated for Fiscal 2021). Dr. Hu also received $35,417 for performance from January 1, 2021 to March 31, 2021, based on a target bonus opportunity of 50% of his base salary of $250,000 from January 1, 2021 to February 28, 2021 and 50% of his base salary of $350,000 from March 1, 2021 to March 31, 2021. For the actual payouts of the annual performance bonuses for April 1, 2022 to March 31, 2022, see footnote 2 to the Summary Compensation Table. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">52 </div> </div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Equity Awards </div></div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">SES previously maintained the 2018 Share Incentive Plan (the &#8220;2018 Plan&#8221;), which provided for the discretionary grant of incentive stock options, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-statutory</div> stock options, and restricted share awards to eligible employees, officers, directors, consultants or advisors of SES, including the named executive officers. In March 2021, the Company amended the 2018 Plan with the 2021 Share Incentive Plan (the &#8220;2021 Plan&#8221;). Upon approval of the 2021 Plan, any shares that, as of the date of stockholder approval, were reserved but not issued pursuant to any awards granted under the Company&#8217;s 2018 Plan were rolled into the 2021 Plan. In addition, any shares subject to stock options or similar awards granted under the 2018 Plan that expire or otherwise terminate without having been exercised in full and shares issued pursuant to awards granted under the 2018 Plan that are forfeited or repurchased by the Company shall roll into the 2021 Plan. The 2021 Plan provides for the discretionary grant of incentive stock options, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-statutory</div> stock options, and restricted share awards. </div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In Fiscal 2021, SES granted stock options under the 2018 Plan to Mr.&#160;Makharia and Ms.&#160;Nealis in connection with their joining SES, and a restricted share award under the 2021 Plan to Ms.&#160;Nealis in order to align her equity ownership with that of her executive team peers and further align her interests with those of the Company&#8217;s stockholders. For information on the grant dates, vesting terms and expiration terms, as applicable, of these equity awards, as well as other outstanding stock options under the 2018 Plan, see the Outstanding Equity Awards at Fiscal <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-End</div> Table. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Pension Benefits </div></div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SES&#8217;s named executive officers did not in Fiscal 2021 and currently do not participate in, or otherwise receive any benefits under, any pension or retirement plan sponsored by SES. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Nonqualified Deferred Compensation </div></div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">SES&#8217;s named executive officers did not in Fiscal 2021 and currently do not participate in, or earn any benefits under, a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-qualified</div> deferred compensation plan sponsored by SES. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Retirement Plan </div></div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SES maintains a qualified contributory retirement plan, established to qualify as a deferred salary arrangement under Section&#160;401(k) of the Internal Revenue Code of 1986, as amended. The plan covers all employees, including SES&#8217;s named executive officers, who may contribute up to the maximum statutory limits imposed by the Internal Revenue Code (including in the fiscal year ended December 31, 2020). SES did not in Fiscal 2021 and does not currently provide match contributions under the 401(k) plan. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other Benefits </div></div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The health, safety and well-being of employees is paramount at SES. SES provided in Fiscal 2021 and currently provides to all of its employees, including its named executive officers, certain broad-based benefits that are intended to attract and retain employees while providing them with health and welfare security. Other than the retirement plan discussed above, broad-based employee benefits are expected to include medical, dental and other benefits. In addition, SES offers a general allowance to certain key employees, including the named executive officers, which are intended to be used for subsidized childcare benefits and other related benefits, and is designed to give these employees the additional support needed to balance building a career and raising a family. For Fiscal 2021, the general allowance amounts for Dr.&#160;Hu, Mr.&#160;Makharia and Ms.&#160;Nealis were, per month, $15,000, $15,000 and $10,000. These amounts were paid in full each month and not as reimbursements for expenses incurred by the named executive officer. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;">Outstanding Equity Awards at Fiscal <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Year-End</div> </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides information regarding outstanding equity awards made to SES&#8217;s named executive officers as of December&#160;31, 2021 (taking into account the conversion of Old SES restricted shares and Old SES options in the Business Combination). </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">53 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 43%;"></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Option Awards</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock Awards</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Name</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Grant Date</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Securities</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Underlying</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unexercised</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Options</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercisable<br/>(#)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Securities</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Underlying</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unexercised</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Options</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unexercisable<br/>(#)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Option</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Exercise</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Price<br/>($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Option</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Expiration<br/>Date</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares of</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">That Have</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Not Vested<br/>(#)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Market</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Value of</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares of</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">That Have</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Not Vested<br/>($)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dr.&#160;Qichao Hu</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4/1/2020</td>
<td style="vertical-align: bottom; white-space: nowrap;">(1)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">91,554</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.14</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3/31/2030</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rohit Makharia</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3/1/2021</td>
<td style="vertical-align: bottom; white-space: nowrap;">(2)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,091,082</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.16</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2/28/2031</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Jing Nealis</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2/10/2021</td>
<td style="vertical-align: bottom; white-space: nowrap;">(2)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,186,555</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.16</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2/9/2031</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;<br/></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8/16/2021<br/></td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;<br/>(3)&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212; &#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,483,194</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,480,000</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Reflects stock options that were granted under the 2018 Plan to compensate grantees, including Dr.&#160;Hu, for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19-related</div></div> salary cuts. The stock options became fully vested on the date of grant. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reflects time-based stock options that were granted under the 2018 Plan and vest 25% on the first anniversary of the grant date and in equal monthly installments over the following 36 months. For more information, see &#8220;Potential Payments Upon Termination or Change in Control&#8212;Equity Awards.&#8221; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(3)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Reflects a restricted share award that was granted under the 2021 Plan and vests 25% on the first anniversary of the grant date and in equal monthly installments over the following 36 months. For more information, see &#8220;Potential Payments Upon Termination or Change in Control&#8212;Equity Awards.&#8221; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Potential Payments Upon Termination or Change in Control </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Severance </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Under each named executive officer&#8217;s employment, in the event that SES terminates a named executive officer without cause or in the event that any named executive officer resigns for good reason (each of &#8220;cause&#8221; and &#8220;good reason&#8221; as defined the named executive officer&#8217;s offer letters), such named executive officer would receive, in addition to accrued but unpaid base salary, earned but unpaid annual bonus, and reimbursement for all reasonable and necessary expenses incurred in connection with the named executive officer&#8217;s performance, the following: (i)&#160;continuation of annual base salary for a period of 12 months following the termination date for Dr.&#160;Hu, 12 months following the termination date for Mr.&#160;Makharia and 9 months following the termination date for Ms.&#160;Nealis; and (ii)&#160;reimbursement of SES&#8217;s portion for continued health insurance coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 for a period of 12 months for Dr.&#160;Hu, 12 months for Mr.&#160;Makharia and 12 months for Ms.&#160;Nealis, or an earlier date if such named executive officer has secured alternate health insurance coverage. Severance is subject to the execution and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-revocation</div> of a release of claims in favor of SES. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Equity Awards </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">With respect to the stock options granted to the named executive officers in Fiscal 2021 and the fiscal year ended December 31, 2020, such options will terminate on the earliest to occur of (i)&#160;the date of the expiration of the option (i.e., 10 years after the date of grant), (ii) 30 days following the termination of the named executive officer&#8217;s employment by SES for cause (as defined in the option award), (iii) 90 days after the date of a voluntary termination of employment by the named executive officer, (iv) 90 days after the date of a termination of the named executive officer&#8217;s employment by SES without cause (as defined in the option award), or (v) 180 days after the permanent and total disability or death of the named executive officer. </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Further, with respect to the stock options granted to Mr.&#160;Makharia and Ms.&#160;Nealis in Fiscal 2021, in the event of a termination without cause by SES or a resignation by the named executive officer for good reason, these options will accelerate and become 50% vested upon such a termination. In the event of a merger, acquisition or Initial Public Offering (but not the Business Combination), Mr.&#160;Makharia&#8217;s and Ms.&#160;Nealis&#8217;s options will become fully vested and exercisable. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">54 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">With respect to the restricted share award granted to Ms.&#160;Nealis in Fiscal 2021, in the event of a termination without cause by SES or a resignation by her for good reason, the award will vest 50% upon such a termination. In the event of a merger, acquisition or Initial Public Offering (but not the Business Combination), her restricted share award will become fully vested and exercisable. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Director Compensation for Fiscal 2021 </div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">SES did not pay compensation to any of its directors in Fiscal 2021, other than Dr.&#160;Hu, who was paid for his role as Chief Executive Officer. For information on Dr.&#160;Hu&#8217;s compensation, see the Summary Compensation Table. SES has historically reimbursed all of its directors for any reasonable expenses incurred by them in connection with services provided in such capacity. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Compensation Arrangements for Fiscal 2022 </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><div style="font-style:italic;display:inline;">Executive Officer Compensation </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Beginning in Fiscal 2022, decisions with respect to the compensation of SES&#8217;s executive officers, including our named executive officers, are made by the compensation committee of our board of directors. The actual compensation of our named executive officers depends on the judgment of the members of the compensation committee and such compensation is also generally governed by our executive officers&#8217; employment agreements, as in effect from time to time, including as described above. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For Fiscal 2022, the annual base salaries for Dr. Hu, Mr. Makharia and Ms. Nealis are $530,000, $505,000 and $470,000, respectively, the target annual bonus opportunities for Dr. Hu, Mr. Makharia and Ms. Nealis are 100%, 60% and 60%, respectively, of annual base salary. The performance period for the annual bonuses is January 1, 2022 to December 31, 2022. These base salaries reflect, for Fiscal 2022, the elimination of the standalone monthly general allowance and the addition of its annualized amount to base salary. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The compensation committee of the board also plans to make an initial equity grants to our executive officers, which are expected to be formally approved in the second quarter of Fiscal 2022 under SES AI Corporation 2021 Incentive Award Plan. The grants are expected to be composed 50% of time-based restricted stock units (&#8220;RSUs&#8221;) and 50% of performance-based restricted stock units (&#8220;PSUs&#8221;), with the following aggregate grant date fair values: for Dr. Hu, $10 million; for Ms. Nealis, $4 million; for Ms. Ban, $4 million; for Mr. Son, $5 million; and for Dr. Gan, $5 million. These grant date fair values assume a payout of 100% of PSUs granted, which is the maximum amount that may be earned. The RSUs will vest in three equal annual installments starting one year from the date of grant, subject to the executive officer&#8217;s continued service on each such vesting date. The PSUs will vest in one installment following a three-year performance period from the date of grant, subject to the achievement of share price performance targets and the executive officer&#8217;s continued service on such vesting date. A specified percentage of the target number of PSUs will vest based on the average closing price of our shares of Class A Common Stock (the &#8220;Average Closing Price&#8221;) during any consecutive 100-calendar-day period within the three-year performance period (with the percentage vesting based on certain threshold Average Closing Prices (the &#8220;Share Price Thresholds&#8221;)), assuming that the Average Closing Price during the last 30-calendar-day period in the three-year performance period also exceeds the highest Share Price Threshold achieved during any 100-calendar-day period. Otherwise, the number of PSUs that vest at the end of the three-year performance period will be based upon the Average Closing Price during the last 30 calendar days, using the same list of Share Price Thresholds. Any incremental shares of Class A Common Stock that do not vest based on the Average Closing Price in the last 30 calendar days, but would have vested based on the 100-calendar-day Average Closing Price, will subsequently be eligible to vest (subject to the executive officer&#8217;s continued service through the vesting date) if, at any point before the fifth anniversary of the grant date, the Average Closing Price during a 30-calendar-day period ends up exceeding the highest Share Price Threshold previously achieved during the 100-calendar-day period. The Share Price Thresholds are as follows: under $12.5, 0%; $12.5 or greater, 10%; $15 or greater, 20%; $17.5 or greater, 30%; $20 or greater, 40%; $22.5 or greater, 50%; $25 or greater, 60%; $27.5 or greater, 70%; $30 or greater, 80%; $32.5 or greater, 90%; and $35 or greater, 100%. Beginning in Fiscal 2022, we have also adopted stock ownership guidelines applicable to our executive officers, non-employee directors and certain members of senior management, to align further the incentives of our management and board with those of our public stockholders. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">55 </div> </div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc"></a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><div style="font-style:italic;display:inline;">Director Compensation </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Beginning in 2022, our non-employee directors will receive a combination of cash compensation and equity for their service on our board in accordance with industry practice and standards. All non-employee directors will receive a base annual cash retainer of $45,000, and if our chairman is a non-employee director, he/she will receive an additional $50,000 annually. Each member of the audit committee will receive an annual cash retainer of $10,000 (with the chair of the audit committee receiving an additional $12,500 annually), each non-employee member of the compensation committee will receive an annual cash retainer of $7,500 (with the chair of the compensation committee receiving an additional $7,500 annually), and each non-employee member of the nominating and corporate governance committee will receive an annual cash retainer of $5,000 (with the chair of the nominating and corporate governance committee receiving an additional $5,000). Cash fees will be paid quarterly, with a pro rata fee applicable to service for less than a whole quarter. Additionally, all non-employee directors will receive an initial equity grant in the form of RSUs with a value of $300,000 in connection with joining the board of directors and an annual equity award in the form of RSUs with a value of $150,000 startig tin the second year of board service. All such RSUs will vest, vesting fully in one installment one year after the grant date subject to the director&#8217;s continued service on such vesting date. We also reimburse all directors for reasonable transportation and lodging expenses actually incurred to attend meetings of our board or committees. </div> <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top;text-align:left;" id="tx251271_21"><div style="font-weight:bold;display:inline;">Item&#160;12.</div></td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. </div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information known to us regarding the beneficial ownership of our Class&#160;A common stock and Class&#160;B common stock, as of March 28, 2022, by: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each of our current directors; </div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each of our named executive officers; </div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">all of our current directors and executive officers as a group; and </div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">each person or &#8220;group&#8221; (as such term is used in Section&#160;13(d)(3) of the Exchange Act) who is a beneficial owner of more than 5% of the outstanding Class&#160;A common stock or Class&#160;B common stock. </div></td></tr></table> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security. Under those rules, beneficial ownership includes securities that the individual or entity has the right to acquire, such as through the exercise of warrants or stock options, within 60 days of the record date. Shares subject to warrants or options that are currently exercisable or exercisable within 60 days of the record date that vest within 60 days of the record date are considered outstanding and beneficially owned by the person holding such warrants or options for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except as noted by footnote, and subject to community property laws where applicable, based on the information provided to us, the persons and entities named in the table below have sole voting and investment power with respect to all shares shown as beneficially owned by them. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The beneficial ownership of shares of our Class&#160;A common stock is based on 303,989,794 shares of our Class&#160;A common stock, including 23,691,182 <div style="white-space:nowrap;display:inline;">Earn-Out</div> Shares in the form of Class&#160;A common stock (including restricted Class&#160;A common stock), and 43,881,251 shares of Class&#160;B common stock, including 3,999,796 Founder <div style="white-space:nowrap;display:inline;">Earn-Out</div> Shares, in each case, issued and outstanding as of the date of this Annual Report; the Earn-Out Shares and Founder Earn-Out Shares are issued and held in escrow subject to the satisfaction of certain <div style="white-space:nowrap;display:inline;">earn-out</div> conditions described above and have voting rights while in escrow. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Percentage of voting power is calculated based on one vote per share for each share of Class&#160;A common stock and ten votes per share for each share of Class&#160;B common stock. The table is based upon information supplied by officers, directors and <div style="white-space:nowrap;display:inline;">greater-than-5%</div> beneficial owners, Section&#160;13(d) filings made with the SEC and other SEC filings under Section&#160;16 of the Exchange Act. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">56 </div> </div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 66%;"></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Name and Address of Beneficial Owner</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>shares of<br/>Class A<br/>common<br/>stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% of<br/>Class A<br/>common<br/>stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Number of<br/>Shares of<br/>Class B<br/>common<br/>stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% of<br/>Class B<br/>common<br/>stock</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">% of<br/>Total<br/>Voting<br/>Power**</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Directors&#160;&amp; executive officers<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(1)</div></div></div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dr.&#160;Qichao Hu<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(2)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,981,987</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12.8</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,881,251</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56.5</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Jing Nealis<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(3)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">589,113</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Rohit Makharia<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(4)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,631,681</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dr.&#160;Jang Wook Choi</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Robert Friedland<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(5)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">319,166</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Kent Helfrich</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Eric Luo</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dr.&#160;Jiong Ma</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Michael Noonen</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">All current directors and executive officers as a group (12 individuals)<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(6)</div></div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,893,444</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2.6</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,881,251</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59.1</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Greater-than-5%</div> beneficial owners</div></div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dr.&#160;Qichao Hu<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(2)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,736</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">*</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,881,251</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">56.5</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Long Siang Pte. Ltd. <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(7)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">27,280,647</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3.7</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Vertex Legacy Continuation Fund Pte. Ltd.<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(8)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,256,315</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10.6</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.3</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">General Motors Ventures LLC and General Motors Holdings LLC <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(9)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">33,056,337</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10.9</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.5</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Tianqi Lithium HK Co., Ltd. <div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(10)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,522,386</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">10.0</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.1</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Affiliates of Temasek Holdings (Private) Limited<div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:9.4px">(11)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,675,757</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11.4</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4.7</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;">SK Inc.<div style="font-size: 6.5pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 85%; vertical-align: top;;display:inline;;font-size:6.1px">(12)</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,007,759</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13.8</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">&#8212;&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;">&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5.7</td>
<td style="vertical-align: bottom; white-space: nowrap;">%&#160;</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">*</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Indicates beneficial ownership of less than 1%. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">**</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Percentage of total voting power represents the combined voting power with respect to all shares of Class&#160;A common stock and Class&#160;B common stock, voting as a single class. As described elsewhere in this Annual Report, subject to certain conditions, each share of Class&#160;B common stock is entitled to 10 votes per share and each share of Class&#160;A common stock is entitled to one vote per share. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The business address of each of these stockholders is c/o SES AI Corporation, 35 Cabot Road, Woburn, MA 01801. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Includes (i) 100,736 shares of Class&#160;A common stock, 9,182 of which are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares held directly by Dr.&#160;Qichao Hu; (ii) 30,716,882 shares of our Class&#160;B common stock, 2,799,859 of which are Founder <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares, held directly by Dr.&#160;Hu and (iii)&#160;an aggregate of 13,164,369 shares of Class&#160;B common stock, 1,199,937 of which are Founder <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares, held by various trusts affiliated with Dr.&#160;Hu. These trusts consist of: (i)&#160;Qichao Hu 2021 Irrevocable Trust U/A/D March&#160;31, 2021; (ii) Qichao Hu Family Delaware Trust U/A/D March&#160;31, 2021; and (iii)&#160;Qichao Hu 2021 Annuity Trust March&#160;31, 2021 (collectively, the &#8220;Trusts&#8221;), each owning 4,388,123 shares of Class&#160;B common stock and 399,979 Founder <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares, and the shares of Class A common stock underlying such shares. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">57 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(3)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Consists of 321,358 shares Class&#160;A common stock underlying SES options and 267,755 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 0pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(4)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Consists of 1,920,501 shares of Class&#160;A common stock underlying SES options and 711,180 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 0pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(5)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Consists of (i) 240,000 Class&#160;A ordinary shares of Ivanhoe (purchased in the open market) that were automatically converted on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis into shares of Class&#160;A common stock at Closing and (ii) 79,166 shares of Class&#160;A common stock underlying public warrants. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 0pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(6)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes shares beneficially owned by all directors, named executive officers and other executive officers (namely, Joanne Ban, Hong Gan and Yongkyu Son). </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 0pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(7)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Consists of (i) 24,703,118 shares of Class&#160;A common stock issued at Closing and (ii) 2,477,529 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. Long Siang Pte. Ltd. (&#8220;Long Siang&#8221;) is the record holder of the shares of Class&#160;A common stock. As a shareholder of Long Siang, Xie Huefeng may be deemed to have beneficial ownership over the shares of Class&#160;A common stock directly owned by Long Siang. The principal business address of all persons named in this footnote is 238 Orchard Boulevard, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">#24-05,</div> Singapore 237973. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 0pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(8)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Consists of (i) 29,361,711 shares of Class&#160;A common stock issued at Closing and (ii) 2,894,604 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. Vertex Legacy Continuation Fund Pte. Ltd. (&#8220;VLCF&#8221;) is the record holder of the shares of Class&#160;A common stock. Vertex Legacy Fund (SG) LP (&#8220;VLFSG&#8221;) is the 100% shareholder of VLCF. VLC GP Pte. Ltd. (&#8220;VLCGP&#8221;) is the general partner of VLFSG and has appointed Vertex Ventures SEA Management Pte. Ltd. (&#8220;VVSEAMPL&#8221;) to serve as the fund manager of VLCF. VVSEAMPL is deemed to have dispositive and voting power over the shares of Class&#160;A common stock directly owned by VLCF pursuant to a management agreement between VLFSG and VVSEAMPL, whereby dispositive and voting decisions require the majority approval of the members of an investment committee established by VVSEAMPL. The principal business address of all persons named in this footnote is 250 North Bridge Road, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">#11-01</div> Raffles City Tower, Singapore 179101. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 0pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(9)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Consists of (i) 30,134,387 shares of Class&#160;A common stock issued at Closing and (ii) 2,921,950 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. GM Ventures is the record holder of 21,090,498 shares of Class&#160;A common stock and 2,085,124 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. GM Holdings is the record holder of 9,043,889 shares of Class&#160;A common stock and 836,826 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. GM Ventures is a wholly owned subsidiary of GM Holdings. GM Holdings is a wholly owned subsidiary of General Motors Company (&#8220;GM&#8221;). GM may be deemed to share beneficial ownership over the shares of Class&#160;A common stock directly owned by GM Ventures and GM Holdings, and GM Holdings may be deemed to share beneficial ownership over the shares of Class&#160;A common stock directly owned by GM Ventures. The principal office of each of all persons named in this footnote is 300 Renaissance Center, Detroit, MI, 48265. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 0pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 0pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(10)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Consists of (i) 27,740,256 shares of Class&#160;A common stock issued at Closing and (ii) 2,782,130 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. Tianqi Lithium HK Co., Limited (&#8220;Tianqi HK&#8221;) is the record holder of such shares of Class&#160;A common stock. Tianqi HK is wholly owned by Tianqi Lithium Co., Limited (&#8220;Tianqi Limited&#8221;), and Tianqi Lithium is wholly owned by Tianqi Lithium Corporation (&#8220;Tianqi Lithium&#8221;). Tianqi Lithium and Tianqi Lithium may thus be deemed to share beneficial ownership over the shares of Class&#160;A common stock owned by Tianqi HK. The principal business address of all persons named in this footnote is No.10 East Gaopeng Road, Chengdu, Sichuan 610041, China. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">58 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(11)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Anderson Investments Pte. Ltd. (&#8220;Anderson&#8221;) is the record holder of 25,882,916 shares of Class&#160;A common stock and 2,595,854 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. Aranda Investments Pte. Ltd. (&#8220;Aranda&#8221;) is the record holder of 5,632,129 shares of Class&#160;A common stock and 564,858 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. Anderson is a direct wholly-owned subsidiary of Thomson Capital Pte. Ltd. (&#8220;Thomson&#8221;), which in turn is a direct wholly-owned subsidiary of Tembusu Capital Pte. Ltd. (&#8220;Tembusu&#8221;). Aranda is a direct wholly-owned subsidiary of Seletar Investments Pte. Ltd. (&#8220;Seletar&#8221;), which in turn is a direct wholly-owned subsidiary of Temasek Capital (Private) Limited (&#8220;Temasek Capital&#8221;). Each of Tembusu and Temasek Capital is a direct wholly-owned subsidiary of Temasek Holdings (Private) Limited (&#8220;Temasek Holdings&#8221;). In such capacities, each of Thomson, Tembusu, and Temasek Holdings may be deemed to have beneficial ownership over the shares of Class&#160;A common stock directly owned by Anderson, and each of Seletar, Temasek Capital and Temasek Holdings may be deemed to have beneficial ownership over the shares of Class&#160;A common stock directly owned by Aranda. The principal business address of all persons named in this footnote is 60B Orchard Road, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">#06-18</div> Tower 2, The Atrium@Orchard, Singapore 238891. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">(12)</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Consists of (i) 38,178,731 shares of Class&#160;A common stock issued at Closing and (ii) 3,829,028 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Earn-Out</div> Shares. SK, Inc. is the record holder and ultimate beneficial owner of such shares of Class&#160;A common stock. The principal business address of SK, Inc. is 26, Jong-ro, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Jongno-gu,</div> Seoul, South Korea 03188. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_22" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;13.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain Relationships and Related Transactions, and Director Independence. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ivanhoe Related Person Transactions </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Sponsor Shares and Private Placement Warrants </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January&#160;6, 2021, the Sponsor paid an aggregate of $25,000 for certain expenses on the Company&#8217;s behalf in exchange for the issuance of 6,900,000 Sponsor Shares. In connection with the pricing of the IPO, the Sponsor entered into an IPO Letter Agreement, which was amended in connection with the Business Combination, pursuant to which the Company and the Sponsor agreed to certain transfer restrictions on the securities held by it. </div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Simultaneously with the closing of the Initial Public Offering or IPO, pursuant to the Private Placement Warrants Purchase Agreement, dated as of January&#160;6, 2021, by and between the Company and Sponsor (the &#8220;Private Placement Warrant Purchase Agreement&#8221;), the Company completed the private sale of 5,013,333 private placement warrants to the Sponsor at a purchase price of $1.50 per private placement warrant, generating gross proceeds to the Company of $7,520,000. Please see the section entitled &#8220;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Description of Our Securities</div></div>&#8221; for the terms of the private placement warrants. The issuance of the private placement warrants was made pursuant to the exemption from registration contained in Section&#160;4(a)(2) of the Securities Act of 1933, as amended. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Related Party Loans </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On July&#160;22, 2020, the Sponsor agreed to loan the Company up to $600,000 pursuant to a promissory note (the &#8220;Note&#8221;), which was later amended on December&#160;1, 2020. The Company borrowed $500,000 under the Note. The Note was <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing, unsecured and repaid in full on January&#160;15, 2021. </div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">On April&#160;9, 2021, the Company issued an unsecured convertible promissory note (the &#8220;Convertible Note&#8221;) to the Company&#8217;s former Chief Executive Officer, Robert Friedland, pursuant to which the Company could borrow up to $1,500,000 from Mr.&#160;Friedland for ongoing expenses reasonably related to the business of the Company and the consummation of the Business Combination. The Convertible Note did not bear any interest and was unsecured. All unpaid principal under the Convertible Note was due and payable in full on the earlier of (i)&#160;January&#160;11, 2023 and (ii)&#160;the effective date of the Business Combination (such earlier date, the &#8220;Maturity Date&#8221;). Mr.&#160;Friedland had the option, at any time on or prior to the Maturity Date, to convert any amounts outstanding under the Convertible Note into warrants to purchase the Company&#8217;s shares, at a conversion price of $1.50 per warrant, with each warrant entitling the holder to purchase one share at a price of $11.50 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share,</div> subject to the same adjustments applicable to the private placement warrants sold concurrently with the Company&#8217;s initial public offering. The Company borrowed approximately $1,045,000 under the Note. Mr.&#160;Friedland did not convert any amounts owed under the Convertible Note into warrants, instead, the Note was repaid in cash in full at the Closing. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">59 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Other Transactions </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with the closing of the PIPE, on February&#160;3, 2022, Eric Friedland, the brother of the Company&#8217;s former Chief Executive Officer, Robert Friedland, purchased 150,000 shares of Class&#160;A common stock from the Company, for an aggregate purchase price of $1,500,000, in accordance with the terms of that certain subscription agreement with the Company, dated July&#160;12, 2021. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SES Related Person Transactions </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">GM Joint Development Agreement </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In February 2021, SES executed a JDA with GM Global Technology Operations LLC (&#8220;GM Technology&#8221;) and General Motors Holdings LLC (&#8220;GM Holdings&#8221;), with a budget over $50.0&#160;million, to jointly develop an <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">A-Sample</div> battery cell with a capacity of almost 100 Ah and build out a prototype manufacturing line for GM Technology. GM Technology is an affiliate of GM Ventures and a subsidiary of GM Holdings (GM Ventures and GM Holdings collectively, the &#8220;GM Funds&#8221;), both of which are stockholders of SES. GM Holdings is also a subsidiary of GM. The JDA has an initial term of three years. Under the terms of the JDA, SES will receive reimbursement of research and development and prototype buildout costs. SES will not be required to refund such fees once due to SES regardless of the results of the research and development activities, however, ownership of the prototype line would remain with GM, unless purchased by SES. During the fiscal year ended December&#160;31, 2021, SES invoiced approximately $14.0 million pursuant to the terms of the JDA. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preferred Stock Purchase Agreements </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In April 2021, SES entered into a stock purchase agreement, in which various holders purchased $138.5&#160;million in Series D redeemable convertible preferred stock, $0.000001 par value per share. This included investments by the following investors in the following amounts: $27.0&#160;million by Aranda Investments Pte. Ltd., an entity associated with Temasek Holdings Limited (&#8220;Aranda&#8221;), $50.0&#160;million by the GM Funds collectively, $36.0&#160;million by SK, and $10.0&#160;million by Vertex affiliates Vertex Legacy Continuation Fund Pte. Ltd. (&#8220;Vertex Legacy&#8221;) and Vertex Ventures China IV, L.P. (&#8220;Vertex Ventures&#8221; and, with Vertex Legacy, the &#8220;Vertex Funds&#8221;) collectively. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">PIPE Financing </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In connection with the Business Combination, Ivanhoe entered into the PIPE Financing, which includes subscription agreements with certain institutional and accredited investors who agreed to purchase, immediately prior to the consummation of the Business Combination, an aggregate of 27,450,000 shares of Class&#160;A common stock at a purchase price of $10.00 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share,</div> for aggregate gross proceeds of $275.4&#160;million. This included purchases by the following investors in the following amounts: $10.0&#160;million by the GM Funds, $1.0&#160;million by Long Siang Pte. Ltd. (&#8220;Long Siang&#8221;), $5.0&#160;million by Vertex Legacy and $75.0&#160;million by Honda. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Old SES Shareholder Support Agreement </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concurrently with the execution of the Business Combination Agreement, certain shareholders of Old SES representing the requisite votes necessary to approve the Business Combination, including among others, the GM Funds, Dr.&#160;Hu and his affiliated trusts, Long Siang, the Vertex Funds, SK, the Temasek Funds (Aranda and Anderson Investments Pte. Ltd.) and Tianqi, entered into a support agreement with the Company (formerly known as Ivanhoe Capital Acquisition Corp) and Old SES, pursuant to which each such holder agreed to (i)&#160;vote at any meeting of Old SES&#8217;s shareholders, and in any action by written consent of Old SES&#8217;s shareholders, all of its equity securities in favor of the adoption and approval of the Business Combination Agreement and the transactions contemplated thereby, including the Amalgamation, and not withdraw or rescind such vote or otherwise take action to make such vote ineffective, (ii)&#160;be bound by certain other covenants and agreements related to the Business Combination, (iii)&#160;waive and not to exercise or assert any rights, or make any demand or claims of oppression relating to the Amalgamation or any other transaction contemplated by the Business Combination Agreement that such Shareholder may have (under the Singapore Companies Act or otherwise) by virtue of, or with respect to, any outstanding equity securities of Old SES legally or beneficially owned by such shareholder and (iv)&#160;be bound by certain transfer restrictions with respect to such securities, in each case, on the terms and subject to the conditions set forth in the Support Agreements. Each Old SES shareholder party to the support agreement made certain representations and warranties to the Company. The support agreement terminated upon the consummation of the Business Combination. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">60 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Director Nomination Agreement </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concurrently with the execution of the Business Combination Agreement, the Company and Old SES entered into the Director Nomination Agreement with GM Ventures, pursuant to which, among other things, GM Ventures has the right to nominate one person for election to the Board from and after the Effective Time for so long as GM Ventures together with its affiliates, collectively continue to beneficially own at least 5% of the fully diluted outstanding equity securities of SES. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">A&amp;R Registration Rights Agreement </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At the Closing of the Business Combination, SES, the Sponsor and certain other holders of SES, including, but not limited to, the GM Funds, Dr.&#160;Hu and his affiliated trusts, Long Siang, SK, the Temasek Funds, Tianqi and the Vertex Funds, entered into the Amended and Restated Registration Rights Agreement, dated as of February&#160;3, 2022 (the &#8220;Registration Rights Agreement), pursuant to which, among other things, the Sponsor and such other holders were granted certain customary registration rights, demand rights and piggyback rights with respect to their respective shares of Class&#160;A common stock and any other equity securities of SES. The Registration Rights Agreement also prohibits the transfer (subject to limited exceptions) of the shares of our Class&#160;A common stock and Class&#160;B common stock held by the Sponsor and other holders party to the Registration Rights Agreement, in each case for a period of 180 days following the Closing. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Indemnification Agreements </div></div></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We entered into indemnification agreements with SES directors and executive officers following the Business Combination. For more information, see &#8220;Item 10. Directors, Executive Officers and Corporate Governance&#8212;Limitations on Liability and Indemnification of Officers and Directors.&#8221; </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Policies and Procedures for Related Person Transactions </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">We have adopted a formal written policy that sets forth the policies and procedures for the review and approval or ratification of related party transactions. This policy covers, with certain exceptions set forth in Item 404 of Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-K</div> under the Securities Act, any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we were or are to be a participant, where the amount involved exceeds $120,000 in any fiscal year and a related person had, has or will have a direct or indirect material interest, including without limitation, purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment by us of a related party. The policy provides for the review and approval of any such transactions with related persons, and requires, among other things, that: </div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The audit committee or disinterested members of the board shall review the material facts of all related person transactions. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">In reviewing any related person transaction, the committee will take into account, among other factors that it deems appropriate: the importance and fairness of the transaction to us and the related person; the business rationale for engaging in the transaction; whether the value and terms of the transaction are substantially similar as compared to those of similar transactions previously entered into by us with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-related</div> persons; the extent of the related person&#8217;s interest in the transaction; whether the transaction would likely impair the judgment of a director or executive officer to act in the best interests of us and our stockholders; and the impact on a director&#8217;s or a director nominee&#8217;s independence in the event the related person is a director or director nominee or an immediate family member of the director or director nominee. </div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In connection with its review of any related person transaction, we shall provide the committee or disinterested members of the board with all material information regarding such related person transaction, the interest of the related person and any potential disclosure obligations of ours in connection with such related person transaction. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;">&#160;</td>
<td style="width: 3%; vertical-align: top;;text-align:left;">&#8226;</td>
<td style="width: 1%; vertical-align: top;">&#160;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If a related person transaction will be ongoing, the committee may establish guidelines for our management to follow in its ongoing dealings with the related person. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, under our Code of Conduct, our employees, directors and director nominees will have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. </div></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_23" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;14.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Principal Accounting Fees and Services. </div></div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 9%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following is a summary of fees paid to WithumSmith+Brown, PC for services rendered. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">61 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><div style="font-style:italic;display:inline;">Audit Fees</div>. Audit fees consist of fees billed for professional services rendered for the audit of our <div style="white-space:nowrap;display:inline;">year-end</div> consolidated financial statements, reviews of our quarterly consolidated financial statements and services that are normally provided by our independent registered public accounting firm in connection with statutory and regulatory filings. The aggregate fees billed by WithumSmith+Brown, PC for audit fees, inclusive of required filings with the SEC for the year ended December&#160;31, 2021 and for such filings in addition to services rendered in connection with Ivanhoe&#8217;s initial public offering for the period from July&#160;8, 2020 (inception) to December&#160;31, 2020, totaled approximately $91,000 and&#160;$78,280, respectively. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><div style="font-style:italic;display:inline;">Audit-Related Fees</div>. Audit-related fees consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our <div style="white-space:nowrap;display:inline;">year-end</div> consolidated financial statements and are not reported under &#8220;Audit Fees.&#8221; These services include attest services that are not required by statute or regulation and consultation concerning financial accounting and reporting standards. For the year ended December&#160;31, 2021, audit related fees were approximately $47,000 related to consents in connection with the registration statement on Form <div style="white-space:nowrap;display:inline;">S-4</div> filings. We did not pay WithumSmith+Brown, PC any audit-related fees during the period from July&#160;8, 2020 (inception) to December&#160;31, 2020. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><div style="font-style:italic;display:inline;">Tax Fees</div>. Tax fees consist of fees billed for professional services relating to tax compliance, tax planning and tax advice. We did not pay WithumSmith+Brown, PC any tax fees during the year ended December&#160;31, 2021 and during the period from July&#160;8, 2020 (inception) to December&#160;31, 2020. </div> <div style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><div style="font-style:italic;display:inline;">All Other Fees</div>. All other fees consist of fees billed for all other services. We did not pay WithumSmith+Brown, PC any other fees during the year ended December&#160;31, 2021 and during the period from July&#160;8, 2020 (inception) to December&#160;31, 2020. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style:italic;display:inline;"><div style="white-space:nowrap;display:inline;">Pre-Approval</div> Policies and Procedures </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">In accordance with the Sarbanes-Oxley Act of 2002, our audit committee charter requires the audit committee to <div style="white-space:nowrap;display:inline;">pre-approve</div> all audit and permitted <div style="white-space:nowrap;display:inline;">non-audit</div> services provided by our independent registered public accounting firm, including the review and approval in advance of our independent registered public accounting firm&#8217;s annual engagement letter and the proposed fees contained therein. The audit committee has the ability to delegate the authority to <div style="white-space:nowrap;display:inline;">pre-approve</div> <div style="white-space:nowrap;display:inline;">non-audit</div> services to one or more designated members of the audit committee. If such authority is delegated, such delegated members of the audit committee must report to the full audit committee at the next audit committee meeting all items pre-approved by such delegated members. Since becoming a publicly listed company (following Ivanhoe&#8217;s initial public offering) all of the services performed by our independent registered public accounting firm were <div style="white-space:nowrap;display:inline;">pre-approved</div> by the audit committee. </div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">62 </div> </div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center" id="tx251271_24">PART IV </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top;text-align:left;" id="tx251271_25"><div style="font-weight:bold;display:inline;">Item&#160;15.</div></td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Exhibits, Financial Statement Schedules. </div></td></tr></table> <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(1)</td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Financial Statements </div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements listed in the accompanying Index to Consolidated Financial Statements are filed as part of this Annual Report. </div> <div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">(2)</td>
<td style="vertical-align:top;text-align:left;"> <div style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits </div></td></tr></table> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The exhibits listed below are filed as part of this Annual Report or incorporated herein by reference to the location indicated. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td style="width:89%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center;"> <div style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br/>Number</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center;"> <div style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">2.1&#8224;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1819142/000110465921152265/ivan-20211221xs4a.htm#AnnexA">Business Combination Agreement, dated as of July&#160;12, 2021, among Ivanhoe Capital Acquisition Corp., Wormhole Merger Sub Pte. Ltd. and SES Holdings Pte. Ltd., as amended by Amendment No.&#160;1 thereto, dated September&#160;20, 2021 (incorporated by reference to Exhibit 2.1 to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap;display:inline;">S-4/A</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;333-258691),</span> filed with the Securities and Exchange Commission on January&#160;5, 2022). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">2.2&#8224;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000110465921117936/tm2128114d1_ex2-1.htm">Amendment No.&#160;1 to Business Combination Agreement, dated as of September&#160;20, 2021, among Ivanhoe Capital Acquisition Corp., Wormhole Merger Sub Pte. Ltd. and SES Holdings Pte. Ltd. (incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap;display:inline;">8-K</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on September&#160;21, 2021). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex31.htm">Certificate of Incorporation of SES AI Corporation (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap;display:inline;">8-K</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">3.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex32.htm">Bylaws of SES AI Corporation (incorporated by reference to Exhibit 3.2 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap;display:inline;">8-K</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex41.htm">Amended and Restated Warrant Agreement, dated as of February&#160;3, 2022, by and between the Company and Continental Stock Transfer&#160;&amp; Company, as warrant agent (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap;display:inline;">8-K</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">4.2*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d251271dex42.htm">Description of Securities. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex101.htm">Amended and Restated Registration Rights Agreement, dated February&#160;3, 2022, by and among SES AI Corporation, the Sponsor and certain other holders of SES AI Corporation (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap;display:inline;">8-K</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex102.htm">Form of Director and Executive Officer Indemnification Agreement (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap;display:inline;">8-K</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.3#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex103.htm">SES AI Corporation 2021 Incentive Award Plan (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap;display:inline;">8-K</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.4#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex104.htm">SES Holdings Pte. Ltd. 2021 Share Incentive Plan (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap;display:inline;">8-K</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.5#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex105.htm">Employment Agreement, dated as of March&#160;19, 2021, by and between Dr.&#160;Qichao Hu and SES Holdings Pte. Ltd. (incorporated by reference to Exhibit 10.5 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap;display:inline;">8-K</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.6#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex106.htm">Employment Agreement, dated as of February&#160;16, 2021, by and between Jing Nealis and SES Holdings Pte. Ltd. (incorporated by reference to Exhibit 10.6 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap;display:inline;">8-K</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.7#</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex107.htm">Employment Agreement, dated as of February&#160;15, 2021, by and between Rohit Makharia and SES Holdings Pte. Ltd. (incorporated by reference to Exhibit 10.7 to the Company&#8217;s Current Report on Form <span style="white-space:nowrap;display:inline;">8-K</span> (File <span style="white-space:nowrap;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr></table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">63 </div> </div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 6%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 89%; font-family: &quot;Times New Roman&quot;;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: inline-block; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Exhibit<br/>Number</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: inline-block; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.8#</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex108.htm">Employment Agreement, dated as of May&#160;24, 2016, by and between Yongkyu Son and SolidEnergy Systems Corporation (incorporated by reference to Exhibit 10.8 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.9#</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex109.htm">Employment Agreement, dated as of March&#160;23, 2021, by and between Joanne Ban and SES Holdings Pte. Ltd. (incorporated by reference to Exhibit 10.9 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.10#</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex1010.htm">Employment Agreement, dated as of July&#160;1, 2018, by and between Dr.&#160;Hong Gan and SolidEnergy Systems Corporation (incorporated by reference to Exhibit 10.10 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.11</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000110465921091431/tm2122015d1_ex10-6.htm">Director Nomination Agreement dated as of July&#160;12, 2021, by and among Ivanhoe Capital Acquisition Corp., SES Holdings Pte. Ltd. and General Motors Ventures LLC (incorporated by reference to Exhibit 10.11 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.12</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000110465921091431/tm2122015d1_ex10-7.htm">Board Observation Agreement, dated as of July&#160;12, 2021, by and among Ivanhoe Capital Acquisition Corp., SES Holdings Pte. Ltd. and Hyundai Motor Company (incorporated by reference to Exhibit 10.12 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.13</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/0001819142/000110465921003064/tm212292d1_ex10-1.htm">Letter Agreement, dated January&#160;6, 2021, by and among Ivanhoe, its executive officers and directors and Ivanhoe Capital Sponsor LLC (incorporated by reference to Exhibit 10.13 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.14</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/0001819142/000110465921091431/tm2122015d1_ex10-1.htm">IPO Letter Agreement Amendment, dated as of July&#160;12, 2021, by Ivanhoe Capital Sponsor LLC and the officers and directors of Ivanhoe Capital Acquisition Corp. (incorporated by reference to Exhibit 10.14 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.15</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex1015.htm">English Translation of Shanghai Lease Agreement, dated as of August&#160;28, 2018 (incorporated by reference to Exhibit 10.15 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.16</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex1016.htm">English Translation of Amendment to Shanghai Lease Agreement, dated as of August&#160;28, 2021 (incorporated by reference to Exhibit 10.16 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.17</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex1017.htm">Commercial Lease Agreement, dated as of March&#160;30, 2016, by and between SolidEnergy Systems Corp. and Cummings Properties, LLC (incorporated by reference to Exhibit 10.17 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.18</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex1018.htm">Amendment No.&#160;1 to Commercial Lease Agreement, dated as of January&#160;10, 2020 (incorporated by reference to Exhibit 10.18 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.19</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex1019.htm">Amendment No.&#160;2 to Commercial Lease Agreement, dated as of February&#160;19, 2020 (incorporated by reference to Exhibit 10.19 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.20</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex1020.htm">Amendment No.&#160;3 to Commercial Lease Agreement, dated as of March&#160;26, 2021 (incorporated by reference to Exhibit 10.20 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.21</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex1021.htm">Amendment No.&#160;4 to Commercial Lease Agreement, dated as of December&#160;30 2021 (incorporated by reference to Exhibit 10.21 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.22#</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex1022.htm">Form of Restricted Share Award Grant (incorporated by reference to Exhibit 10.22 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.23#</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex1023.htm">Form of Share Option Award Grant (incorporated by reference to Exhibit 10.23 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">64 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;">
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 4%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 89%; font-family: &quot;Times New Roman&quot;;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: inline-block; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Exhibit<br/>Number</div></div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: inline-block; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div></div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.24#</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex1024.htm">Form of <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Disclosure</span> and <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Competition</span> Agreement (incorporated by reference to Exhibit 10.24 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.25</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1819142/000110465921152265/ivan-20211221xs4a.htm#AnnexB_640494">Sponsor Letter Agreement, dated July&#160;12, 2021, by and between Ivanhoe Capital Acquisition Corp. and Ivanhoe Capital Sponsor LLC (incorporated by reference to Exhibit 10.9 to the Company&#8217;s Registration Statement on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-4/A</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;333-258691),</span> filed with the Securities and Exchange Commission on January&#160;5, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.26</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000110465921091431/tm2122015d1_ex10-5.htm">Support Agreement, dated as of July&#160;12, 2021, by and among Ivanhoe Capital Acquisition Corp. and certain shareholders of the SES Holdings Pte. Ltd. (incorporated by reference to Exhibit 10.12 to the Company&#8217;s Registration Statement on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-4/A</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;333-258691),</span> filed with the Securities and Exchange Commission on January&#160;5, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.27</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000110465921091431/tm2122015d1_ex10-2.htm">Form of Subscription Agreement for Institutional Investors (incorporated by reference to Exhibit 10.13 to the Company&#8217;s Registration Statement on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-4/A</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;333-258691),</span> filed with the Securities and Exchange Commission on January&#160;5, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">10.28</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000110465921091431/tm2122015d1_ex10-3.htm">Form of Subscription Agreement for Individual Investors (incorporated by reference to Exhibit 10.14 to the Company&#8217;s Registration Statement on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-4/A</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;333-258691),</span> filed with the Securities and Exchange Commission on January&#160;5, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">21.1</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="http://www.sec.gov/Archives/edgar/data/1819142/000119312522031167/d294425dex211.htm">List of Subsidiaries of SES AI Corporation (incorporated by reference to Exhibit 21.1 to the Company&#8217;s Current Report on Form <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</span> (File <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;001-39845),</span> filed with the Securities and Exchange Commission on February&#160;8, 2022). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">24.1</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="#sig">Power of Attorney (included on the signature page to this Annual Report). </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">31.1*</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="d251271dex311.htm">Certification of the Principal Executive Officer required by Rule <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13a-14(a)</span> or Rule <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">15d-14(a).</span> </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">31.2*</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="d251271dex312.htm">Certification of the Principal Financial Officer required by Rule <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13a-14(a)</span> or Rule <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">15d-14(a).</span> </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">32.1**</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="d251271dex321.htm">Certification of the Principal Executive Officer required by Rule <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13a-14(b)</span> or Rule <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">15d-14(b)</span> and 18 U.S.C. 1350. </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; white-space: nowrap;">32.2**</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;"><a href="d251271dex322.htm">Certification of the Principal Financial Officer required by Rule <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">13a-14(b)</span> or Rule <span style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">15d-14(b)</span> and 18 U.S.C. 1350. </a></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;">101.INS*</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;">Inline XBRL Instance Document</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;">101.SCH*</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;">Inline XBRL Taxonomy Extension Schema Document</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;">101.CAL*</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;">101.DEF*</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;">Inline XBRL Taxonomy Extension Definition Linkbase Document</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;">101.LAB*</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;">Inline XBRL Taxonomy Extension Label Linkbase Document</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;">101.PRE*</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt; font-size: 0px;"></td>
<td colspan="2" style="height: 6pt; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;">104*</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">*</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Filed herewith. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">&#8224;</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">#</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Indicates management contract or compensatory plan or arrangement. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 4%; vertical-align: top;;text-align:left;">**</td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furnished herewith. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 18pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 18pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="page-break-inside: avoid;">
<td id="tx251271_26" style="width: 10%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item&#160;16.</div></div></td>
<td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;">Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K</div> Summary </div></div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">None. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">65 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align: center;"><div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"><div id="sig" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SIGNATURES </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 44%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td style="width: 4%;"></td>
<td style="vertical-align: bottom;"></td>
<td style="width: 5%;"></td>
<td style="width: 1%; vertical-align: bottom;"></td>
<td style="width: 44%;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td colspan="3" style="vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">SES AI CORPORATION</div></div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;">Date: March 31, 2022</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top;">By:</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/ Qichao Hu</div></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top;">Name:</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top;">Qichao Hu</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top;">Title:</td>
<td style="vertical-align: bottom;">&#160;</td>
<td style="vertical-align: top;">Chief Executive Officer</td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 24pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">POWER OF ATTORNEY </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Joanne Ban and Jing Nealis, and each or any one of them, his or her true and lawful attorneyin-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the United States Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or his or her substitutes or substitute, may lawfully do or cause to be done by virtue hereof. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 33%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 49%; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"></td>
<td style="width: 16%; font-family: &quot;Times New Roman&quot;;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid; white-space: nowrap;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Signature</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Title</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Date</div></div></div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/ Qichao Hu</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">Chief Executive Officer and Chairman</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">March&#160;31, 2022</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;">Qichao Hu</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">(Principal Executive Officer)</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/ Jing Nealis</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">Chief Financial Officer</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">March&#160;31, 2022</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;">Jing Nealis</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">(Principal Financial Officer and Principal Accounting Officer)</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/ Jang Wook Choi</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">Director</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">March&#160;31, 2022</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;">Jang Wook Choi</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/ Robert Friedland</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">Director</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">March&#160;31, 2022</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;">Robert Friedland</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/ Kent Helfrich</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">Director</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">March&#160;31, 2022</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;">Kent Helfrich</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/ Eric Luo</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">Director</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">March&#160;31, 2022</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;">Eric Luo</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/ Jiong Ma</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">Director</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">March&#160;31, 2022</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;">Jiong Ma</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td colspan="2" style="height: 12pt; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/ Michael Noonen</div></div></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">Director</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top;;text-align:center;">March&#160;31, 2022</td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top;;text-align:center;">Michael Noonen</td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td>
<td style="vertical-align: bottom;">&#160;&#160;</td>
<td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">66 </div></div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SES AI Corporation </div></div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">(Formerly Known as Ivanhoe Capital Acquisition Corp.) </div></div></div></div><div id="index" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Index to Consolidated Financial Statements </div></div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;">
<tr style="font-size: 0px;">
<td style="width: 94%;"></td>
<td style="width: 3%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Page&#160;No.</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="display:inline;">&#160;</div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"><div style="display:inline;"></div></td>
<td colspan="4" style="height: 6pt;"><div style="display:inline;"></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Consolidated Financial Statements</div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;"></div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"><div style="display:inline;"></div></td>
<td colspan="4" style="height: 6pt;"><div style="display:inline;"></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><a href="#fin251271_1">Report of Independent Registered Public Accounting Firm WithumSmith + Brown PC (PCAOB No: 100)</a></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><div style="white-space:nowrap;display:inline;">F-2</div></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"><div style="display:inline;"></div></td>
<td colspan="4" style="height: 6pt;"><div style="display:inline;"></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin251271_2">Consolidated Balance Sheets as of December&#160;31, 2021 and 2020</a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">F-3</div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">&#160;</div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"><div style="display:inline;"></div></td>
<td colspan="4" style="height: 6pt;"><div style="display:inline;"></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin251271_3">Consolidated Statements of Operations for the year ended December&#160;31, 2021 and for the period from July&#160;8, 2020 (inception) through December&#160;31, 2020</a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">F-4</div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">&#160;</div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"><div style="display:inline;"></div></td>
<td colspan="4" style="height: 6pt;"><div style="display:inline;"></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin251271_4">Consolidated Statements of Changes in Shareholders&#8217; Deficit for the year ended December&#160;31, 2021 and for the period from July&#160;8, 2020 (inception) through December&#160;31, 2020</a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">F-5</div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">&#160;</div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"><div style="display:inline;"></div></td>
<td colspan="4" style="height: 6pt;"><div style="display:inline;"></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin251271_5">Consolidated Statements of Cash Flows for the year ended December&#160;31, 2021 and for the period from July&#160;8, 2020 (inception) through December&#160;31, 2020</a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">F-6</div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">&#160;</div></td></tr>
<tr style="font-size: 1pt;">
<td style="height: 6pt;"><div style="display:inline;"></div></td>
<td colspan="4" style="height: 6pt;"><div style="display:inline;"></div></td></tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><a href="#fin251271_6">Notes to Consolidated Financial Statements</a></div></div></div></td>
<td style="vertical-align: bottom;"><div style="display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">F-7</div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="display:inline;">&#160;</div></td></tr></table><div style="clear:both;max-height:0pt;"></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div><div style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-1 </div></div></div><div style="margin-top: 1em; margin-bottom: 0em; page-break-before: always;"></div></div><hr style="width: 100%; height: 3px; color: rgb(153, 153, 153);"/><div style="font-size: 13.28px; margin-top: 1.67em; margin-bottom: 1.67em; text-align: left;;font-weight: bold;"><a href="#toc" style="text-indent: 0px;">Table of Contents</a></div><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"></div></div><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div id="fin251271_1" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">To the Shareholders and the Board of Directors of </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SES AI Corporation (formerly known as Ivanhoe Capital Acquisition Corp.) </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Opinion on the Consolidated financial statements </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We have audited the accompanying consolidated balance sheets of SES AI Corporation (formerly known as Ivanhoe Capital Acquisition Corp.) (the &#8220;Company&#8221;) as of December 31, 2021 and 2020, the related consolidated statements of operations, changes in shareholders&#8217; deficit and cash flows for the year ended December 31, 2021 and the period from July 8, 2020 (inception) through December 31, 2020, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the year ended December 31, 2021 and the period from July 8, 2020 (inception) through December 31, 2020, in conformity with accounting principles generally accepted in the United States of America. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis for Opinion </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">/s/ <ix:nonNumeric name="dei:AuditorName" contextRef="P01_01_2021To12_31_2021">WithumSmith+Brown, PC</ix:nonNumeric> </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We have served as the Company&#8217;s auditor since 2020. </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="dei:AuditorLocation" contextRef="P01_01_2021To12_31_2021">New York, New York</ix:nonNumeric> </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">March <div style="letter-spacing: 0px; top: 0px;;display:inline;">3<div style="letter-spacing: 0px; top: 0px;;display:inline;">1</div></div>, 2022 </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PCAOB ID Number <ix:nonNumeric name="dei:AuditorFirmId" contextRef="P01_01_2021To12_31_2021">100</ix:nonNumeric> </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-2 </div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">SES AI CORPORATION </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(FORMERLY KNOWN AS IVANHOE CAPITAL ACQUISITION CORP.) </div></div><div id="fin251271_2" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONSOLIDATED BALANCE SHEETS </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:82%"><div style="line-height: 0pt;">&#160;</div></td>
<td style="vertical-align:bottom;width:1%"><div style="line-height: 0pt;">&#160;</div></td>
<td><div style="line-height: 0pt;">&#160;</div></td>
<td><div style="line-height: 0pt;">&#160;</div></td>
<td><div style="line-height: 0pt;">&#160;</div></td>
<td style="vertical-align:bottom;width:1%"><div style="line-height: 0pt;">&#160;</div></td>
<td><div style="line-height: 0pt;">&#160;</div></td>
<td><div style="line-height: 0pt;">&#160;</div></td>
<td><div style="line-height: 0pt;">&#160;</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="6" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2020</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Assets</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current assets:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">117,282</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">161,271</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">608,904</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">726,186</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">161,271</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments held in Trust Account</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">276,057,966</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs associated with the initial public offering</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DeferredCosts" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">413,039</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Assets</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">276,784,152</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:Assets" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">574,310</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities, Class&#160;A Ordinary Shares Subject to Redemption and Shareholders&#8217; Deficit</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Current liabilities:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">89,017</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">13,785</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due to related party</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">20,532</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">795,586</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">68,346</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Note payable - related party</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">500,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total current liabilities</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">905,135</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">582,131</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">4,888,889</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible note &#8211; related party</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">1,152,680</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred underwriting commissions</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:DeferredUnderwritingFeePayableNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">9,660,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">25,324,530</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total liabilities</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">41,931,234</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:Liabilities" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">582,131</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Commitments and Contingencies</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" xsi:nil="true"></ix:nonFraction></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class&#160;A ordinary shares subject to possible redemption, $<ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:TemporaryEquityParOrStatedValuePerShare" contextRef="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">27,600,000</ix:nonFraction></ix:nonFraction> and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">-<ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction>-</div></div> shares at redemption value of $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">10.00</ix:nonFraction></ix:nonFraction> per share as of December&#160;31, 2021 and December&#160;31, 2020, respectively</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">276,000,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Shareholders&#8217; Deficit:</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Preference shares, $<ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2020" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">1,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class&#160;A ordinary shares, $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class&#160;B ordinary shares, $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">6,900,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2021 and December&#160;31, 2020</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">690</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">690</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">24,310</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accumulated deficit</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">41,147,772</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">32,821</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total shareholders&#8217; deficit</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">41,147,082</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">7,821</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Total Liabilities, Class&#160;A Ordinary Shares Subject to Possible Redemption and Shareholders&#8217; Deficit</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">276,784,152</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">574,310</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td style="vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div></td>
<td>&#160;</td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The accompanying notes are an integral part of these consolidated financial statements. </div></div></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-3 </div></div></div></div><div style="background-color:white;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">SES AI CORPORATION </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(FORMERLY KNOWN AS IVANHOE CAPITAL ACQUISITION CORP.) </div></div> <div id="fin251271_3" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONSOLIDATED STATEMENTS OF OPERATIONS </div></div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:77%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:3%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:3%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Year<br/> Ended<br/> December&#160;31,<br/> 2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For&#160;the&#160;Period<br/> From&#160;July&#160;8,&#160;2020<br/> (Inception)<br/> Through<br/> December&#160;31,&#160;2020</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative expenses</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">7,238,072</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">32,821</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative expenses - related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">120,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Total operating expenses</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">7,358,072</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">32,821</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Other income (expenses):</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income from investments held in Trust Account</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:GainLossOnInvestments" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">57,966</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of derivative warrant liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">3,176,530</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of convertible note &#8211; related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">207,986</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering costs - derivative warrant liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ses:OfferingCostsWarrantsIssuance" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">855,043</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net loss</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">11,539,665</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">32,821</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Basic and diluted weighted average shares outstanding, Class&#160;A ordinary shares</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">26,843,836</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Basic and diluted net loss per ordinary share, Class&#160;A ordinary shares</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.34</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Basic and diluted weighted average ordinary shares outstanding, Class&#160;B ordinary shares</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">6,875,342</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">6,000,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Basic and diluted net loss per ordinary share, Class&#160;B ordinary shares</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.34</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasicAndDiluted" contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.01</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The accompanying notes are an integral part of these consolidated financial statements. </div></div></div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-4 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> </div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">SES AI CORPORATION </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(FORMERLY KNOWN AS IVANHOE CAPITAL ACQUISITION CORP.) </div></div> <div id="fin251271_4" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; DEFICIT </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="font-size: 0px;">
<td style="width: 46%;"></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td>
<td style="width: 2%; vertical-align: bottom;"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="26" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Year Ended December&#160;31, 2021</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="14" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Ordinary Shares</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Additional</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Paid-in</div></div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Capital</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deficit</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td colspan="2" rowspan="3" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shareholders&#8217;</div></div><br/><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Deficit</div></div></div></td>
<td rowspan="3" style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Balance - July 8, 2020 (inception)</div></div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="PAsOn07_07_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn07_07_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="PAsOn07_07_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160; </div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn07_07_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn07_07_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160; </div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn07_07_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160; </div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn07_07_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</div></div></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;">
<td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of Class B ordinary shares to Sponsor</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">6,900,000</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">690</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P07_08_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">24,310</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">25,000</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);">
<td style="vertical-align: top; font-size: 10pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net loss</div></div></div> </td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8212;&#160;&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P07_08_2020To12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">32,821</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">32,821</ix:nonFraction></div></td>
<td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)&#160;</div></td> </tr>
<tr style="font-size: 1px;">
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"></div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> </td>
<td><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td> </tr>
<tr>
<td style="width:46%"> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td>
<td> <div style="line-height: 0pt; margin-bottom: 0px; margin-top: 0px;">&#160;</div> </td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance - December 31, 2020</div></div> </td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt; border-bottom: 2.5pt double black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt; border-bottom: 2.5pt double black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">6,900,000</ix:nonFraction></div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">690</ix:nonFraction></div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">24,310</ix:nonFraction></div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">32,821</ix:nonFraction></div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); border-bottom: 2.5pt double black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">7,821</ix:nonFraction></div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255); padding-bottom: 1.375pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: top; background-color: rgb(204, 238, 255); white-space: nowrap;"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal; white-space: nowrap;">Accretion of Class&#160;A ordinary shares subject to redemption</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="ses:CommonStockSubjectToPossibleRedemptionValue" contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">24,310</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="ses:CommonStockSubjectToPossibleRedemptionValue" contextRef="P01_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">29,575,286</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;">(<ix:nonFraction name="ses:CommonStockSubjectToPossibleRedemptionValue" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">29,599,596</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);">)&#160;</td> </tr>
<tr style="break-inside: avoid; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
<td style="vertical-align: top; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div> </td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">11,539,665</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">)&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">11,539,665</ix:nonFraction></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(255, 255, 255);">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(204, 238, 255);">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Balance - December&#160;31, 2021</div></div> </td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">6,900,000</ix:nonFraction></div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">690</ix:nonFraction></div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;&#160;</td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">41,147,772</ix:nonFraction></div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(204, 238, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">41,147,082</ix:nonFraction></div></div></td>
<td style="white-space: nowrap; vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);">&#160;</td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0px; margin-bottom: 0px; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="background-color: rgb(255, 255, 255);">&#160;</td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The accompanying notes are an integral part of these consolidated financial statements. </div></div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><br/></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-5 </div></div></div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> </div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">SES AI CORPORATION </div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(FORMERLY KNOWN AS IVANHOE CAPITAL ACQUISITION CORP.) </div></div> <div id="fin251271_5" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">CONSOLIDATED STATEMENTS OF CASH FLOWS </div></div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:75%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:5%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:5%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For&#160;the&#160;Year&#160;Ended<br/> December&#160;31, 2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the Period<br/> From&#160;July&#160;8,&#160;2020<br/> (Inception)<br/> Through<br/> December&#160;31,&#160;2020</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash Flows from Operating Activities:</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Net loss</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">11,539,665</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProfitLoss" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">32,821</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Adjustments to reconcile net loss to net cash used in operating activities:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">General and administrative expenses paid by Sponsor in exchange for issuance of Class&#160;B ordinary shares</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">25,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Income from investments held in Trust Account</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">57,966</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of derivative warrant liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">3,176,530</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueAdjustmentOfWarrants" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of convertible note &#8211; related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">207,986</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering costs - derivative warrant liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:OfferingCostsWarrantsIssuance" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">855,043</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:OfferingCostsWarrantsIssuance" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Changes in operating assets and liabilities:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Prepaid expenses</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">608,904</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accounts payable</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">75,232</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Due to related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">20,532</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued expenses</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">684,374</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">6,213</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accrued liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:IncreaseDecreaseInAccruedExpensesRealtedParties" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">4,888,889</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:IncreaseDecreaseInAccruedExpensesRealtedParties" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net cash used in operating activities</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">2,297,949</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">1,608</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash Flows from Investing Activities:</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Cash deposited in Trust Account</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ses:PaymentsForInvestmentOfCashInTrustAccount" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">276,000,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:PaymentsForInvestmentOfCashInTrustAccount" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net cash used in investing activities</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">276,000,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash Flows from Financing Activities:</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Payment of note payable to related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">500,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds received from initial public offering, gross</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:ProceedsReceivedFromInitialPublicOfferingGross" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">276,000,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:ProceedsReceivedFromInitialPublicOfferingGross" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds received from private placement</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">7,520,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering costs paid</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">5,710,734</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds received from note payable to related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:ProceedsReceivedFromNotePayableToRelatedParty" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:ProceedsReceivedFromNotePayableToRelatedParty" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">408,341</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering costs paid</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:OfferingCostsPaid" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ses:OfferingCostsPaid" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">245,462</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Proceeds from convertible note to related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">944,694</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net cash provided by financing activities</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">278,253,960</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">162,879</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Net change in cash</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">43,989</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">161,271</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash - beginning of the period</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">161,271</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="PAsOn07_07_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Cash - end of the period</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">117,282</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">$</div></div></td>
<td style="vertical-align:bottom;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">161,271</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Supplemental disclosure of noncash financing activities:</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs included in accounts payable</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:DeferredOfferingCostsIncludedInAccountsPayable" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:DeferredOfferingCostsIncludedInAccountsPayable" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">13,785</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering costs included in accrued expenses</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:OfferingCostsIncludedInAccountsPayableAccruedExpenses" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">42,867</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:OfferingCostsIncludedInAccountsPayableAccruedExpenses" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">62,133</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred offering costs paid by Sponsor under promissory note</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">91,659</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Deferred underwriting commissions</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:Underwritingcommissiondeferred" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">9,660,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:Underwritingcommissiondeferred" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The accompanying notes are an integral part of these consolidated financial statements </div></div></div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-6 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> </div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">SES AI CORPORATION </div></div><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">(FORMERLY KNOWN AS IVANHOE CAPITAL ACQUISITION CORP.) </div></div><div id="fin251271_6" style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;"><div style="font-weight:bold;display:inline;">NOTES TO CONSOLIDATED BALANCE SHEETS </div></div> <ix:nonNumeric name="us-gaap:NatureOfOperations" contextRef="P01_01_2021To12_31_2021" escape="true" continuedAt="TextSelection_42197800"><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 1&#8212;Description of Organization and Business Operations </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SES AI Corporation, formerly known as Ivanhoe Capital Acquisition Corp. prior to February&#160;3, 2022 (the &#8220;Company&#8221;), is a blank check company incorporated as a Cayman Islands exempted company on July&#160;8, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (&#8220;Business Combination&#8221;). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;28, 2021, the Company formed a wholly owned subsidiary, Wormhole Merger Sub Pte. Ltd., a Singapore private company limited by shares (&#8220;Amalgamation Sub&#8221;). </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Business Operations </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2021, the Company had not yet commenced operations. All activity for the period from July&#160;8, 2020 (inception) through December&#160;31, 2021 relates to the Company&#8217;s formation and the initial public offering (the &#8220;Initial Public Offering&#8221;), which is described below, and since the closing of the Initial Public Offering, the search for a prospective Business Combination, including activities in connection with the proposed acquisition of SES Holdings Pte. Ltd., a Singapore private company limited by shares (&#8220;SES&#8221;). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of interest income on its investments held in the trust account from the proceeds of its Initial Public Offering. The Company incurs expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a business combination. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s sponsor is Ivanhoe Capital Sponsor LLC, a Cayman Islands limited liability company (&#8220;Sponsor&#8221;). The registration statement for the Company&#8217;s Initial Public Offering was declared effective on January&#160;6, 2021. On January&#160;11, 2021, the Company consummated its Initial Public Offering of <ix:nonFraction name="ses:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">27,600,000</ix:nonFraction> units (the &#8220;Units&#8221; and, with respect to the Class&#160;A ordinary shares included in the Units being offered, the &#8220;Public Shares&#8221;), including <ix:nonFraction name="ses:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="P01_11_2021To01_11_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">3,600,000</ix:nonFraction> additional Units to cover over-allotments (the &#8220;Over-Allotment Units&#8221;), at $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">10.00</ix:nonFraction> per Unit, generating gross proceeds of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">276.0</ix:nonFraction>&#160;million, and incurring offering costs of approximately $<ix:nonFraction name="ses:SaleOfStockOtherOfferingCosts" contextRef="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">15.8</ix:nonFraction>&#160;million, of which approximately $<ix:nonFraction name="ses:DeferredOfferingCostsNoncurrent" contextRef="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">9.7</ix:nonFraction>&#160;million was for deferred underwriting commissions (Note 6). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (&#8220;Private Placement&#8221;) of <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">5,013,333</ix:nonFraction> warrants (each, a &#8220;Private Placement Warrant&#8221; and collectively, the &#8220;Private Placement Warrants&#8221;), at a price of $<ix:nonFraction name="ses:ClassOfWarrantOrRightPriceOfWarrantsOrRights" contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">1.50</ix:nonFraction> per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="P07_08_2020To12_31_2020_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">7.5</ix:nonFraction>&#160;million (Note 4). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the closing of the Initial Public Offering and the Private Placement, $<ix:nonFraction name="ses:PaymentsForInvestmentOfCashInTrustAccount" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">276.0</ix:nonFraction>&#160;million ($<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">10.00</ix:nonFraction> per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (&#8220;Trust Account&#8221;) with Continental Stock Transfer&#160;&amp; Trust Company acting as trustee and invested in United States &#8220;government securities&#8221; within the meaning of Section&#160;2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> promulgated under the Investment Company Act of 1940, as amended, or the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i)&#160;the completion of a Business Combination and (ii)&#160;the distribution of the Trust Account as described below. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company&#8217;s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least <ix:nonFraction name="ses:ConditionForFutureBusinessCombinationUseOfProceedsPercentage" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:numdotdecimal">80</ix:nonFraction>% of the net assets held in the Trust Account (excluding the amount of any deferred underwriting discount held in Trust) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires <ix:nonFraction name="ses:ConditionForFutureBusinessCombinationThresholdPercentageOwnership" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:numdotdecimal">50</ix:nonFraction>% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:nonNumeric> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-7 </div> </div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelection_42197800" continuedAt="TextSelectionAppend_42197800_1"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will provide its holders of the Public Shares (the &#8220;Public Shareholders&#8221;) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i)&#160;in connection with a shareholder meeting called to approve the Business Combination or (ii)&#160;by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">10.00</ix:nonFraction> per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $<ix:nonFraction name="ses:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">5,000,001</ix:nonFraction> upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which will be adopted by the Company upon the consummation of the Initial Public Offering (the &#8220;Amended and Restated Memorandum and Articles of Association&#8221;), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares prior to the Initial Public Offering (the &#8220;Initial Shareholders&#8221;) have agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company has agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Company&#8217;s Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a &#8220;group&#8221; (as defined under Section&#160;13 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with respect to more than an aggregate of <ix:nonFraction name="ses:RedemptionLimitPercentageWithoutPriorConsent" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="0" scale="0" format="ixt:numdotdecimal">20</ix:nonFraction>% or more of the Class&#160;A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s Sponsor, executive officers, directors and director nominees agreed not to propose an amendment to the Company&#8217;s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company&#8217;s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem <ix:nonFraction name="ses:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class&#160;A ordinary shares in conjunction with any such amendment. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company is unable to complete a Business Combination within <ix:nonFraction name="ses:Monthstocompleteacquisition" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_Month" decimals="0" scale="0" format="ixt:numdotdecimal">24</ix:nonFraction> months from the closing of the Initial Public Offering, or January&#160;11, 2023 (the &#8220;Combination Period&#8221;), the Company will (i)&#160;cease all operations except for the purpose of winding up, (ii)&#160;as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $<ix:nonFraction name="ses:MaximumAllowedDissolutionExpenses" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">100,000</ix:nonFraction> of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders&#8217; rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in each case to the Company&#8217;s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> </ix:continuation> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-8 </div> </div></div></div><div style="background-color:white;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="background-color:white;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_42197800_1"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the redemption of <ix:nonFraction name="ses:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">100</ix:nonFraction>% of the Company&#8217;s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company&#8217;s taxes payable (less up to $<ix:nonFraction name="ses:MaximumAllowedDissolutionExpenses" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">100,000</ix:nonFraction> of interest to pay dissolution expenses). The Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company&#8217;s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="PAsOn12_31_2021_IvanhoeCapitalAcquisitionCorpMemberdeiLegalEntityAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">10.00</ix:nonFraction> per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="PAsOn12_31_2021_IvanhoeCapitalAcquisitionCorpMemberdeiLegalEntityAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">10.00</ix:nonFraction> per public share and (ii)&#160;the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="P01_01_2021To12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="2" scale="0" format="ixt:numdotdecimal">10.00</ix:nonFraction> per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company&#8217;s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </div> <div style="margin-top: 10pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business Combination </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;3, 2022, we consummated the previously announced business combination (the &#8220;Business Combination&#8221;) pursuant to that certain Business Combination Agreement dated July&#160;12, 2021 (the &#8220;Business Combination Agreement&#8221;), by and among Ivanhoe, Wormhole Amalgamation Sub Pte. Ltd., a Singapore private company limited by shares and our direct wholly-owned subsidiary (&#8220;Amalgamation Sub&#8221;), and SES Holdings Pte. Ltd. (&#8220;SES&#8221;), a Singapore private company limited by shares. In connection with the closing of the Business Combination (the &#8220;Closing&#8221;), a business combination between the Company, Amalgamation Sub and SES was effectuated through the merger of Amalgamation Sub with and into SES, with SES continuing as the surviving company. On the Closing Date, we changed our name from Ivanhoe Capital Acquisition Corp. to &#8220;SES AI Corporation&#8221;. </div> <div style="margin-top: 10pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Risks and Uncertainties </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management continues to evaluate the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div> <div style="margin-top: 10pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Liquidity and Capital Resources </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company successfully consummated its Business Combination on February&#160;3, 2022. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As indicated in the accompanying financial statements, as of December&#160;31, 2021, we had approximately $<ix:nonFraction name="ses:OperatingBankAccounts" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">100,000</ix:nonFraction> in our operating bank account and working deficit of approximately $<ix:nonFraction name="ses:WorkingCapital" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">200,000</ix:nonFraction>. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our liquidity needs to date have been satisfied through a contribution of $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P07_22_2020To07_22_2020_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">25,000</ix:nonFraction> from Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of $<ix:nonFraction name="us-gaap:DueToRelatedPartiesNoncurrent" contextRef="PAsOn07_22_2020_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">500,000</ix:nonFraction> from the Sponsor pursuant to the Note, and the proceeds from the consummation of the Private Placement not held in the Trust Account. We repaid the Note in full on January&#160;15, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, provide us Working Capital Loans. On April&#160;9, 2021, we issued an unsecured convertible promissory note (the &#8220;Convertible Note&#8221;) to our Chief Executive Officer, pursuant to which we may borrow up to $<ix:nonFraction name="ses:MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" contextRef="PAsOn12_31_2021_WorkingCapitalLoansWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">1,500,000</ix:nonFraction> for ongoing expenses reasonably related to our business and the consummation of the Business Combination. The Convertible Note does not bear any interest. All unpaid principal under the Convertible Note will be due and payable in full on the earlier of (i)&#160;January&#160;11, 2023 and (ii)&#160;the effective date of the Business Combination (such earlier date, the &#8220;Maturity Date&#8221;). As of December&#160;31, 2021, $<ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent" contextRef="PAsOn12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">945,000</ix:nonFraction> was drawn on the convertible note&#8212;related party, presented at its fair value of approximately $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction>&#160;million on the accompanying consolidated balance sheets. Subsequently, the loan was repaid in full with cash at the closing of our business combination on February&#160;3, 2022. There were <ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> amounts outstanding under the Convertible Note as of December&#160;31, 2020. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the foregoing, management believes that we will have sufficient working capital and borrowing capacity from our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors to meet our needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, we expect to be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> </ix:continuation> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-9 </div> </div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <ix:nonNumeric name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true" continuedAt="TextSelection_42197799"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 2&#8212;Summary of Significant Accounting Policies </div></div> <ix:nonNumeric name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (&#8220;SEC&#8221;). </div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:ConsolidationPolicyTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Principles of Consolidation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of the Company include its wholly-owned subsidiary, Wormhole Merger Sub Pte. Ltd., which was incorporated in Singapore on June&#160;28, 2021, in connection with the planned business combination. All inter-company accounts and transactions are eliminated in consolidation. </div></ix:nonNumeric> <ix:nonNumeric name="ses:EmergingGrowthCompanyPolicyTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging Growth Company </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:UseOfEstimates" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. </div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had <ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> cash equivalents as of December&#160;31, 2021 and 2020 held outside of the Trust Account. </div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:ConcentrationRiskCreditRisk" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $<ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">250,000</ix:nonFraction>. As of December&#160;31, 2021 and 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:nonNumeric> </ix:nonNumeric> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-10 </div> </div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%"/><div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div></div></div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelection_42197799" continuedAt="TextSelectionAppend_42197799_1"> <ix:nonNumeric name="us-gaap:MarketableSecuritiesPolicy" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Investments Held in Trust Account </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section&#160;2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. </div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:FairValueOfFinancialInstrumentsPolicy" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, &#8220;Fair Value Measurements&#8221; approximates the carrying amounts represented in the balance sheet. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has elected the fair value option to account for its Convertible Note with its Sponsor as defined and more fully described in Note 5. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value are recorded as change in the fair value of Convertible Note&#8212;related party on the consolidated statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management&#8217;s and, if applicable, an independent third-party valuation firm&#8217;s own assumption about the assumptions a market participant would use in pricing the asset or liability. </div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level&#160;1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level&#160;2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level&#160;3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div></ix:nonNumeric> <ix:nonNumeric name="ses:Derivativewarrantliabilitiespolicytextblock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Derivative Warrant Liabilities </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-assessed</div> at the end of each reporting period. Derivative warrant liabilities are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The warrants issued in connection with the Initial Public Offering (the &#8220;Public Warrants&#8221;) and the Private Placement Warrants (as defined in Note 4) (collectively, the &#8220;Warrant&#8221;) are recognized as derivative liabilities in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40.</div> Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised, and any change in fair value is recognized in the Company&#8217;s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:nonNumeric></ix:continuation> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-11 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_42197799_1" continuedAt="TextSelectionAppend_42197799_2"> <ix:nonNumeric name="ses:Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Offering Costs Associated with the Initial Public Offering </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> expenses in the statement of operations. Offering costs associated with the Class&#160;A ordinary shares are charged against their carrying value upon the completion of the Initial Public Offering. Deferred underwriting commissions are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div></ix:nonNumeric> <ix:nonNumeric name="ses:Commonstocksubjecttopossibleredemptionpolicytextblock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Class&#160;A Ordinary Shares Subject to Possible Redemption </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for its Class&#160;A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Class&#160;A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class&#160;A ordinary shares (including Class&#160;A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) are classified as temporary equity. At all other times, Class&#160;A ordinary shares are classified as shareholders&#8217; equity. The Company&#8217;s Class&#160;A ordinary shares feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of December&#160;31, 2021, <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">27,600,000</ix:nonFraction> Class&#160;A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders&#8217; equity (deficit) section of the Company&#8217;s consolidated balance sheets. As of December&#160;31, 2020, there were <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> Class&#160;A ordinary shares subject to possible redemption. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class&#160;A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital (to the extent available) and accumulated deficit. </div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the Cayman Islands is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> unrecognized tax benefits and <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="PAsOn12_31_2020" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> amounts accrued for interest and penalties as of December&#160;31, 2021 and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company&#8217;s tax provision was zero for the period presented. </div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true" continuedAt="TextSelection_42197779"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Net Income (Loss) per Ordinary Shares </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary shares and Class&#160;B ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding for the respective period.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:nonNumeric></ix:continuation> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-12 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> </div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_42197799_2"><ix:continuation id="TextSelection_42197779"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">14,213,333</ix:nonFraction> Class&#160;A ordinary share in the calculation of diluted income (loss) per ordinary share, because their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per share ordinary for the year ended December&#160;31, 2021 and for the period from July&#160;8, 2020 (inception) through the year ended December&#160;31, 2020. Accretion associated with the redeemable Class&#160;A ordinary shares is excluded from earnings per ordinary share as the redemption value approximates fair value. </div> <ix:nonNumeric name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per ordinary share for each class of ordinary shares: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">
<tr>
<td style="width:58%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:4%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:3%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:3%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:4%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">For the Period From<br/> July</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">8, 2020 (Inception)</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Through December&#160;31,<br/> 2020</div></div> </td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For&#160;the&#160;Year&#160;Ended&#160;December&#160;31,<br/> 2021</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per ordinary share:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net loss</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">9,186,727</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">2,352,938</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P07_08_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">32,821</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average ordinary shares outstanding</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">26,843,836</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">6,875,342</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P07_08_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">6,000,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per ordinary share</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.34</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.34</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P07_08_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" sign="-" format="ixt:numdotdecimal">0.01</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric></ix:continuation> <ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Adopted Accounting Standards </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2020-06,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt-Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</div></div>, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. The Company early adopted the ASU on January&#160;21, 2021 (inception). Adoption of the ASU did not impact the Company&#8217;s financial position, results of operations or cash flows. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Issued Accounting Standards </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying consolidated financial statements. </div></ix:nonNumeric></ix:continuation> <ix:nonNumeric name="ses:InitialPublicOfferingTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 3&#8212;Initial Public Offering </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;11, 2021, the Company consummated its Initial Public Offering of <ix:nonFraction name="ses:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">27,600,000</ix:nonFraction> Units, including <ix:nonFraction name="ses:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="P01_11_2021To01_11_2021_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">3,600,000</ix:nonFraction> Over-Allotment Units, at $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">10.00</ix:nonFraction> per Unit, generating gross proceeds of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" contextRef="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">276.0</ix:nonFraction>&#160;million, and incurring offering costs of approximately $<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">15.8</ix:nonFraction>&#160;million, of which approximately $<ix:nonFraction name="ses:DeferredUnderwritingCommissions" contextRef="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">9.7</ix:nonFraction>&#160;million was for deferred underwriting commissions. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Unit consists of <ix:nonFraction name="ses:NumberOfSharesIssuedPerUnit" contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> Class&#160;A ordinary share and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="ses:NumberOfWarrantsIssuedPerUnit" contextRef="P01_01_2021To12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction></div>-third</div> of one redeemable warrant (&#8220;Public Warrant&#8221;). Each whole Public Warrant will entitle the holder to purchase <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="PAsOn12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> Class&#160;A ordinary share at an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn01_11_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis_IvanhoeCapitalAcquisitionCorpMemberdeiLegalEntityAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">11.50</ix:nonFraction> per share, subject to adjustment (see Note 7). </div></ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"></div> <ix:nonNumeric name="ses:PrivatePlacementTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true" continuedAt="TextSelection_42197797"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 4 &#8211; Private Placement </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">5,013,333</ix:nonFraction> Private Placement Warrants, at a price of $<ix:nonFraction name="ses:ClassOfWarrantOrRightPriceOfWarrantsOrRights" contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">1.50</ix:nonFraction> per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $<ix:nonFraction name="ses:ProceedsFromSaleOfUnits" contextRef="P01_01_2021To12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">7.5</ix:nonFraction>&#160;million.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:nonNumeric> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-13 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelection_42197797"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each whole Private Placement Warrant is exercisable for <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> whole Class&#160;A ordinary share at a price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">11.50</ix:nonFraction> per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> for cash and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor and the Company&#8217;s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. </div> </ix:continuation> <ix:nonNumeric name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true" continuedAt="TextSelection_42197796"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 5 &#8211; Related Party Transactions </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Founder Shares </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;22, 2020, the Sponsor paid an aggregate of $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">25,000</ix:nonFraction> for certain expenses on behalf of the Company in exchange for issuance of <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">8,625,000</ix:nonFraction> Class&#160;B ordinary shares (the &#8220;Founder Shares&#8221;). On December&#160;16, 2020, the Sponsor surrendered <ix:nonFraction name="ses:AggregateOfSponsorSharesSurrendered" contextRef="P12_16_2020To12_16_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">2,875,000</ix:nonFraction> Founder Shares to the Company for cancellation for no consideration. On January&#160;6, 2021, the Company effected a share capitalization of <ix:nonFraction name="us-gaap:CommonStockDividendsShares" contextRef="P01_06_2021To01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">1,150,000</ix:nonFraction> shares, resulting in an aggregate of <ix:nonFraction name="ses:AggregateNumberOfSharesOwned" contextRef="PAsOn01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">6,900,000</ix:nonFraction> Founder Shares outstanding. All shares and associated amounts have been retroactively restated to reflect the share surrender and share capitalization. The holders of the Founder Shares have agreed to forfeit up to an aggregate of <ix:nonFraction name="ses:NumberOfSharesSubjectToForfeiture" contextRef="PAsOn01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">900,000</ix:nonFraction> Founder Shares, on a pro rata basis, to the extent that the option to purchase additional units was not exercised in full by the underwriters, so that the Founder Shares would represent <ix:nonFraction name="ses:CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" contextRef="PAsOn01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">20</ix:nonFraction>% of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. On January&#160;11, 2021, the underwriter fully exercised its over-allotment option; thus, these Founder Shares are <ix:nonFraction name="ses:NumberOfSharesSubjectToForfeiture" contextRef="PAsOn01_11_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_shares" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> longer subject to forfeiture. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (i)&#160;(v) with respect to <ix:nonFraction name="ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" contextRef="P07_22_2020To07_22_2020_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">20</ix:nonFraction>% of such shares, until consummation of the initial Business Combination, (w)&#160;with respect to <ix:nonFraction name="ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">20</ix:nonFraction>% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $<ix:nonFraction name="ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">12.00</ix:nonFraction> for any <ix:nonNumeric name="ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" format="ixt-sec:durday">20</ix:nonNumeric> trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" contextRef="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" format="ixt-sec:durday">30</ix:nonNumeric>-trading</div> day period following the consummation of the initial Business Combination (a &#8220;Requisite Trading Period&#8221;), (x) with respect to <ix:nonFraction name="ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" contextRef="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">20</ix:nonFraction>% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $<ix:nonFraction name="ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">14.00</ix:nonFraction> for the Requisite Trading Period, (y)&#160;with respect to <ix:nonFraction name="ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">20</ix:nonFraction>% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $<ix:nonFraction name="ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MinimumMembersrtRangeAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">16.00</ix:nonFraction> for the Requisite Trading Period, and (z)&#160;with respect to the remaining <ix:nonFraction name="ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">20</ix:nonFraction>% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $<ix:nonFraction name="ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MaximumMembersrtRangeAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">18.00</ix:nonFraction> for the Requisite Trading Period, and (ii)&#160;the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the initial Business Combination that results in all of the shareholders having the right to exchange their Class&#160;A ordinary shares for cash, securities or other property; provided that in the event that the per share value of the cash, securities or other property to be received by the shareholders in such liquidation, merger, capital stock exchange or other similar transaction (the &#8220;Per Share Transaction Value&#8221;) is less than $<ix:nonFraction name="ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MinimumMembersrtRangeAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">18.00</ix:nonFraction>, then the Founder Shares will be released from these transfer restrictions to the Initial Shareholders on a pro rata basis as follows: (a)&#160;to the extent not previously released, all Founder Shares that are subject to release upon achievement of any share price performance requirements that are less than the Per Share Transaction Value will be released, and (b)&#160;the number of Founder Shares that would be released upon the achievement of the next share price performance requirement that is higher than the Per Share Transaction Value (the &#8220;Release Threshold&#8221;), multiplied by a fraction, the numerator of which equals (x) 2, minus (y)&#160;the amount by which the Release Threshold exceeds the Per Share Transaction Value, and the denominator of which equals 2, will be released. Any Founder Shares not released pursuant to the preceding sentence will be forfeited and cancelled. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Related Party Loans </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;22, 2020, the Sponsor agreed to loan the Company up to $<ix:nonFraction name="ses:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" contextRef="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">600,000</ix:nonFraction> pursuant to a promissory note (the &#8220;Note&#8221;), which was later amended on December&#160;1, 2020. The Note is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing, unsecured and due upon the closing of the Initial Public Offering. The Company borrowed $<ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent" contextRef="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">500,000</ix:nonFraction> under the Note. On January&#160;15, 2021, the Company repaid the Note in full. Subsequent to the repayment, the facility was no longer available to the Company. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company&#8217;s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lenders&#8217; discretion, up to $<ix:nonFraction name="ses:MaximumLoansConvertibleIntoWarrants" contextRef="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction>&#160;million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $<ix:nonFraction name="ses:ClassOfWarrantOrRightPriceOfWarrantsOrRights" contextRef="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis_WorkingCapitalLoansWarrantMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">1.50</ix:nonFraction> per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:nonNumeric> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-14 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> </div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelection_42197796"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&#160;9, 2021, the Company issued an unsecured convertible promissory note (the &#8220;Convertible Note&#8221;) to the Company&#8217;s Chief Executive Officer, pursuant to which the Company may borrow up to $<ix:nonFraction name="ses:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" contextRef="PAsOn04_09_2021_ChiefExecutiveOfficerMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">1,500,000</ix:nonFraction> for ongoing expenses reasonably related to the business of the Company and the consummation of the Business Combination. The Convertible Note does not bear any interest. All unpaid principal under the Convertible Note will be due and payable in full on the earlier of (i)&#160;January&#160;11, 2023 and (ii)&#160;the effective date of the Business Combination (such earlier date, the &#8220;Maturity Date&#8221;). The Chief Executive Officer will have the option, at any time on or prior to the Maturity Date, to convert any amounts outstanding under the Convertible Note into warrants to purchase the Company&#8217;s Class&#160;A ordinary shares, par value $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn04_09_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD_per_Share" decimals="4" scale="0" format="ixt:numdotdecimal">0.0001</ix:nonFraction> per share, at a conversion price of $<ix:nonFraction name="ses:ConverstionPricePerWarrants" contextRef="P04_09_2021To04_09_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">1.50</ix:nonFraction> per warrant, with each warrant entitling the holder to purchase one Class&#160;A ordinary share at a price of $<ix:nonFraction name="us-gaap:SharePrice" contextRef="PAsOn04_09_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">11.50</ix:nonFraction> per share, subject to the same adjustments applicable to the private placement warrants sold concurrently with the Company&#8217;s initial public offering. As of December&#160;31, 2021, $<ix:nonFraction name="ses:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" contextRef="PAsOn12_31_2021_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">945,000</ix:nonFraction> was drawn on the convertible note&#8212;related party, presented at its fair value of approximately $<ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesNoncurrent" contextRef="PAsOn12_31_2021_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">1.2</ix:nonFraction>&#160;million on the accompanying consolidated balance sheets. Subsequently, the loan was repaid in full with cash at the closing of our business combination on February&#160;3, 2022. There were <ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent" contextRef="PAsOn12_31_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> amounts outstanding under the Convertible Note as of December&#160;31, 2020. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Administrative Support Agreement </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Commencing on the date that the Company&#8217;s securities were first listed on the NYSE through the earlier of consummation of the initial Business Combination and the liquidation, the Company agreed to pay the Sponsor $<ix:nonFraction name="ses:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" contextRef="P07_08_2020To12_31_2020_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">10,000</ix:nonFraction> per month for office space, utilities, secretarial and administrative support services provided to members of the management team. Administrative expenses were included within general and administrative expenses&#8212;related party in the consolidated statements of operations. For the year ended December&#160;31, 2021, the Company incurred $<ix:nonFraction name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" contextRef="P01_01_2021To12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">120,000</ix:nonFraction> in administrative expenses. As of December&#160;31, 2021, $<ix:nonFraction name="us-gaap:DueToRelatedPartiesCurrent" contextRef="PAsOn12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">10,000</ix:nonFraction> has been included in due to related party on the consolidated balance sheets. There were <ix:nonFraction name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" contextRef="P07_08_2020To12_31_2020_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> administrative expenses incurred for the period from July&#160;8, 2020 (inception) through December&#160;31, 2020. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">out-of-pocket</div></div> expenses incurred in connection with activities on the Company&#8217;s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company&#8217;s audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers or directors, or the Company&#8217;s or their affiliates. Any such payments prior to an initial Business Combination will be made from funds held outside the Trust Account. As of December&#160;31, 2021, approximately $<ix:nonFraction name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" contextRef="P01_01_2021To12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">10,000</ix:nonFraction> is included in due to related party on the accompanying consolidated balance sheets. There were no balances outstanding as of December&#160;31, 2020. </div> </ix:continuation> <ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 6&#8212;Commitments and Contingencies </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Registration Rights </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any Class&#160;A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The holders of these securities were entitled to make up to <ix:nonFraction name="ses:MaximumNumberOfDemandsForRegistrationOfSecurities" contextRef="PAsOn12_31_2021" unitRef="Unit_Day" decimals="0" scale="0" format="ixt-sec:numwordsen">three</ix:nonFraction> demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Underwriting Agreement </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company granted the underwriters a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="ses:FairValueMeasurementOptionTerm" contextRef="P07_08_2020To12_31_2020" format="ixt-sec:durday">45</ix:nonNumeric>-day</div> option from the date of the Initial Public Offering prospectus to purchase up to <ix:nonFraction name="ses:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="P07_08_2020To12_31_2020" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="ses:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="P01_11_2021To01_11_2021" unitRef="Unit_shares" decimals="0" scale="0" format="ixt:numdotdecimal">3,600,000</ix:nonFraction></ix:nonFraction> additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On January&#160;11, 2021, the underwriter fully exercised its over-allotment option. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters were entitled to an underwriting discount of $<ix:nonFraction name="ses:UnderwritingCashDiscountPerUnit" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">0.20</ix:nonFraction> per unit, or approximately $<ix:nonFraction name="ses:UnderwriterCashDiscount" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">5.5</ix:nonFraction>&#160;million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $<ix:nonFraction name="ses:DeferredFeePerUnit" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">0.35</ix:nonFraction> per unit, or approximately $<ix:nonFraction name="ses:DeferredOfferingCostsNoncurrent" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="-5" scale="6" format="ixt:numdotdecimal">9.7</ix:nonFraction>&#160;million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. </div></ix:nonNumeric> <ix:nonNumeric name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true" continuedAt="TextSelection_42197794"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 7&#8212;Derivative Warrant Liabilities </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2021, the Company had <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn12_31_2021_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">9,200,000</ix:nonFraction> Public Warrants and <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn12_31_2021_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">5,013,333</ix:nonFraction> Private Warrants outstanding. There were <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction> warrants outstanding as of December&#160;31, 2020.</div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div></ix:nonNumeric> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-15 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) <ix:nonNumeric name="ses:WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" contextRef="P01_01_2021To12_31_2021" format="ixt-sec:durday">30</ix:nonNumeric> days after the completion of a Business Combination or (b) <ix:nonNumeric name="ses:WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" contextRef="P01_01_2021To12_31_2021" format="ixt-sec:durday">12</ix:nonNumeric> months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class&#160;A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than <ix:nonNumeric name="ses:MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" contextRef="P01_01_2021To12_31_2021" format="ixt-sec:durday">15</ix:nonNumeric> business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the Class&#160;A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class&#160;A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class&#160;A ordinary shares issuable upon exercise of the warrants is not effective by the <ix:nonNumeric name="ses:PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" contextRef="P01_01_2021To12_31_2021" format="ixt-sec:durday">60</ix:nonNumeric>th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a &#8220;cashless basis&#8221; in accordance with Section&#160;3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class&#160;A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a &#8220;covered security&#8221; under Section&#160;18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a &#8220;cashless basis&#8221; and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The warrants have an exercise price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">11.50</ix:nonFraction> per share, subject to adjustments, and will expire <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" contextRef="PAsOn12_31_2021" format="ixt-sec:durwordsen">five years</ix:nonNumeric> after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x)&#160;the Company issues additional Class&#160;A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $<ix:nonFraction name="ses:ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">9.20</ix:nonFraction> per Class&#160;A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Initial Shareholders or their affiliates, without taking into account any Founder Shares held by the Initial Shareholders or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly Issued Price&#8221;), (y) the aggregate gross proceeds from such issuances represent more than <ix:nonFraction name="ses:PercentageOfGrossProceedsOnTotalEquityProceeds" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">60</ix:nonFraction>% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of Class&#160;A ordinary shares during the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="ses:ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" contextRef="P01_01_2021To12_31_2021" format="ixt-sec:durday">10</ix:nonNumeric>-trading</div> day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to <ix:nonFraction name="ses:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">115</ix:nonFraction>% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to <ix:nonFraction name="ses:ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:numdotdecimal">180</ix:nonFraction>% of the higher of the Market Value and the Newly Issued Price (See &#8220;&#8212;Redemption of Warrants When the Price Per Class&#160;A Ordinary Share Equals or Exceeds $18.00&#8221; and &#8220;&#8212;Redemption of Warrants When the Price per Class&#160;A Ordinary Share Equals or Exceeds $10.00&#8221;), and the $<div style="letter-spacing: 0px; top: 0px;;display:inline;">10.00</div> per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. (See &#8220;&#8212;Redemption of Warrants When the Price Per Class&#160;A Ordinary Share Equals or Exceeds $10.00&#8221;). </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class&#160;A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until <ix:nonNumeric name="ses:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" contextRef="P01_01_2021To12_31_2021" format="ixt-sec:durday">30</ix:nonNumeric> days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> so long as they are held by the initial purchasers or such purchasers&#8217; permitted transferees. If the Private Placement Warrants are held by someone other than the Initial Shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of warrants when the price per Class&#160;A ordinary share equals or exceeds $<div style="letter-spacing: 0px; top: 0px;;display:inline;">18.00</div>: </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants): </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $<ix:nonFraction name="ses:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction> per warrant; </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon a minimum of <ix:nonNumeric name="ses:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis" format="ixt-sec:durday">30</ix:nonNumeric> days&#8217; prior written notice of redemption to each warrant holder; and </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div>
<table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;">
<tr style="page-break-inside: avoid;">
<td style="width: 5%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="width: 3%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#8226;</div></td>
<td style="width: 1%; vertical-align: top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></td>
<td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">if, and only if, the last reported sale price (the &#8220;closing price&#8221;) of Class&#160;A ordinary shares equals or exceeds $<ix:nonFraction name="ses:SharePricetriggerUsedToMeasureDilutionOfWarrant" contextRef="PAsOn12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">18.00</ix:nonFraction> per share (as adjusted) for any <ix:nonFraction name="ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis" unitRef="Unit_Day" decimals="0" scale="0" format="ixt:numdotdecimal">20</ix:nonFraction> trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis" unitRef="Unit_Day" decimals="0" scale="0" format="ixt:numdotdecimal">30</ix:nonFraction>-trading</div> day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0pt; text-indent: 0px;"></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">F-16 </div></div></div> </div> </div> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"></div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> </div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelection_42197794"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the Class&#160;A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class&#160;A ordinary shares is available throughout the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonNumeric name="ses:RedemptionPeriod" contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis" format="ixt-sec:durday">30</ix:nonNumeric>-day</div> redemption period. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of warrants when the price per Class&#160;A ordinary share equals or exceeds $<ix:nonFraction name="ses:SharePricetriggerUsedToMeasureDilutionOfWarrant" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">10.00</ix:nonFraction>: </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once the warrants become exercisable, the Company may redeem the outstanding warrants: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">in whole and not in part; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">at $<ix:nonFraction name="ses:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">0.10</ix:nonFraction> per warrant upon a minimum of <ix:nonNumeric name="ses:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis" format="ixt-sec:durwordsen">30 days</ix:nonNumeric>&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class&#160;A ordinary shares to be determined by reference to an agreed table based on the redemption date and the &#8220;fair market value&#8221; of Class&#160;A ordinary shares; and </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">if, and only if, the closing price of Class&#160;A ordinary shares equals or exceeds $<ix:nonFraction name="ses:SharePricetriggerUsedToMeasureDilutionOfWarrant" contextRef="PAsOn12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:numdotdecimal">10.00</ix:nonFraction> per share (as adjusted) for any <ix:nonFraction name="ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis" unitRef="Unit_Day" decimals="0" scale="0" format="ixt:numdotdecimal">20</ix:nonFraction> trading days within the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><ix:nonFraction name="ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis" unitRef="Unit_Day" decimals="0" scale="0" format="ixt:numdotdecimal">30</ix:nonFraction>-trading</div> day period ending three trading days before the Company sends the notice of redemption to the warrant holders. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The &#8220;fair market value&#8221; of Class&#160;A ordinary shares for the above purpose shall mean the volume-weighted average price of the Class&#160;A ordinary shares for the <ix:nonFraction name="ses:CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_Day" decimals="0" scale="0" format="ixt:numdotdecimal">10</ix:nonFraction> trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than <ix:nonFraction name="ses:MultiplierUsedInCalculatingWarrantExercisePrice" contextRef="PAsOn12_31_2021" unitRef="Unit_pure" decimals="3" scale="0" format="ixt:numdotdecimal">0.361</ix:nonFraction> Class&#160;A ordinary shares per warrant (subject to adjustment). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </div> </ix:continuation> <ix:nonNumeric name="ses:TemporaryEquityDisclosureTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 8 &#8211; Class&#160;A Ordinary Shares Subject to Possible Redemption&#160;&#160;&#160;&#160; </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s Class&#160;A ordinary shares feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">200,000,000</ix:nonFraction></ix:nonFraction> shares of Class&#160;A ordinary shares with a par value of $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction> per share. Holders of the Company&#8217;s Class&#160;A ordinary shares are entitled to <ix:nonFraction name="ses:CommonStockNumberOfVotesPerShare" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_vote" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> vote for each ordinary share. As of December&#160;31, 2021, there were <ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">27,600,000</ix:nonFraction> shares of Class&#160;A ordinary shares outstanding, which were all subject to possible redemption and are classified outside of permanent equity in the consolidated balance sheet. </div> <ix:nonNumeric name="us-gaap:TemporaryEquityTableTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Class&#160;A ordinary shares subject to possible redemption reflected on the consolidated balance sheet is reconciled on the following table: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr>
<td style="width:82%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:4%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross proceeds from Initial Public Offering</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:ProceedsFromIssuanceOfTemporaryEquity" contextRef="P01_01_2021To12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">276,000,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of Public Warrants at issuance</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ses:TemporaryEquityFairValueOfWarrantsAtIssuance" contextRef="P01_01_2021To12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">14,628,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering costs allocated to Class&#160;A ordinary shares subject to possible redemption</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="ses:TemporaryEquityIssuanceCosts" contextRef="P01_01_2021To12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">14,971,596</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion on Class&#160;A ordinary shares subject to possible redemption amount</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="P01_01_2021To12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">29,599,596</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class&#160;A ordinary shares subject to possible redemption</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">276,000,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true" continuedAt="TextSelection_42197792"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 9&#8212;Shareholders&#8217; Equity (Deficit) </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preference Shares-</div></div></div></div> The Company is authorized to issue <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">1,000,000</ix:nonFraction></ix:nonFraction> preference shares with a par value of $<ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2020" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction> per share. As of December&#160;31, 2021 and 2020, there were <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2021" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="PAsOn12_31_2020" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> preference shares issued or outstanding. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;A Ordinary Shares- </div></div></div></div>The Company is authorized to issue <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">200,000,000</ix:nonFraction></ix:nonFraction> Class&#160;A ordinary shares with a par value of $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction> per share. Holders of the Company&#8217;s Class&#160;A ordinary shares are entitled to <ix:nonFraction name="ses:CommonStockNumberOfVotesPerShare" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_vote" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> vote for each share. At December&#160;31, 2021, there were <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">27,600,000</ix:nonFraction></ix:nonFraction> Class&#160;A ordinary shares issued and outstanding. All issued and outstanding Class&#160;A ordinary shares are subject to possible redemption and have been classified as temporary equity (See Note 8). As of December&#160;31, 2020, there were <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> Class&#160;A ordinary shares issued and outstanding. </div></ix:nonNumeric> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-17 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelection_42197792"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;B Ordinary Shares-</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>The Company is authorized to issue <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></ix:nonFraction> Class&#160;B ordinary shares with a par value of $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:numdotdecimal">0.0001</ix:nonFraction></ix:nonFraction> per share. As of December&#160;31, 2021 and 2020, there were <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:numdotdecimal">6,900,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> Class&#160;B ordinary shares issued and outstanding. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class&#160;A ordinary shares and holders of Class&#160;B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In a vote to continue the company in jurisdiction outside the Cayman Islands (which required the approval of at least two thirds of the votes of all ordinary shares), holders of the Founder Shares will have <span style="-sec-ix-hidden:hidden42197942">ten</span> votes for every Founder Share and holders of the Class&#160;A ordinary shares will have one vote for every Class&#160;A ordinary share. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Class&#160;B ordinary shares will automatically convert into Class&#160;A ordinary shares at the time of the consummation of the initial Business Combination on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, subject to adjustment for share <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-divisions,</div> share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class&#160;A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class&#160;A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class&#160;A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class&#160;A ordinary shares by Public Shareholders), including the total number of Class&#160;A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class&#160;A ordinary shares or equity-linked securities exercisable for or convertible into Class&#160;A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of working capital loans; provided that such conversion of Founder Shares will never occur on a less than <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis. </div> </ix:continuation> <ix:nonNumeric name="us-gaap:FairValueDisclosuresTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true" continuedAt="TextSelection_42197704"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 9&#8212;Fair Value Measurements </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents information about the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. </div> <ix:nonNumeric name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:73%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/> Active Markets<br/> (Level 1)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments held in Trust Account</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">276,057,966</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities - Public Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">16,100,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities - Private Placement Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">9,224,530</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible note &#8211; related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesNoncurrent" contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesNoncurrent" contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesNoncurrent" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">1,152,680</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr> </table> </ix:nonNumeric> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2020, there were <ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" contextRef="PAsOn12_31_2020_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:LiabilitiesFairValueDisclosure" contextRef="PAsOn12_31_2020_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction> assets or liabilities that are measured at fair value on a recurring basis. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level&#160;3 measurement to a Level&#160;1 fair value measurement in February 2021, when the Public Warrants were separately listed and traded. There were <ix:nonFraction name="us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount" contextRef="PAsOn12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" contextRef="P01_01_2021To12_31_2021" unitRef="Unit_USD" decimals="0" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> other transfers to/from Levels 1, 2, and 3 during the year ended December&#160;31, 2021. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level&#160;1 assets include investments in money market funds that invest solely in U.S. government securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The fair value of the Public Warrants as of December&#160;31, 2021 was measured utilizing the Level&#160;1 input of the observable listed trading price for such warrants. </div></ix:nonNumeric> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-18 </div> </div> </div> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> </div> </div> <div> <div style="background-color:white;display: inline;"> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelection_42197704"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level&#160;3 instruments are comprised of derivative warrant liabilities measured at fair value using a Monte Carlo simulation and Black-Scholes Option Pricing Model. The estimated fair value of the Private Placement Warrants and the Public Warrants, prior to being separately listed and traded, was determined using Level&#160;3 inputs. The estimated fair value of warrants that may be issued upon conversion of the Convertible Note was determined using Level&#160;3 inputs. Inherent in a Monte Carlo simulation and Black-Scholes Option Pricing model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Black-Scholes analysis relies upon appropriate inputs derived from the Monte Carlo simulation of the public warrants; namely, the underlying stock price and the implied volatility from the traded Public Warrant price. The Company estimates the volatility of its ordinary shares warrants based on implied volatility from the Company&#8217;s traded warrants and from historical volatility of select peer company&#8217;s ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">zero-coupon</div> yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. </div> <ix:nonNumeric name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides quantitative information regarding Level&#160;3 fair value measurements inputs used in the valuation of the derivative warrant liabilities at their measurement dates: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:75%"></td>
<td style="vertical-align:bottom;width:22%"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;December&#160;31,&#160;2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Option term (in years)</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_Y" decimals="INF" scale="0" format="ixt:numdotdecimal">5.09</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock price</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:numdotdecimal">9.95</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="1" scale="0" format="ixt:numdotdecimal">24.2</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:numdotdecimal">1.26</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividends</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DerivativeLiabilityMeasurementInput" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:numdotdecimal">0.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The change in the fair value of the derivative warrant liabilities measured using Level&#160;3 inputs for the year ended December&#160;31, 2021 is summarized as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities at January&#160;1, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Public and Private Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">22,148,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfer of Public Warrants to Level&#160;1 measurement</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(<ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="0" scale="0" sign="-" format="ixt:numdotdecimal">14,628,000</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of derivative warrant liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">3,176,530</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities at December&#160;31, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">10,696,530</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides quantitative information regarding Level&#160;3 fair value measurements inputs used by the estimated fair value of warrants that may be issued upon conversion of the Convertible Note at their measurement dates: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:75%"></td>
<td style="vertical-align:bottom;width:22%"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;December&#160;31,&#160;2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Option term (in years)</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_Y" decimals="INF" scale="0" format="ixt:numdotdecimal">0.09</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock price</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:numdotdecimal">1.84</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="1" scale="0" format="ixt:numdotdecimal">72.1</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:numdotdecimal">0.06</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividends</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis" unitRef="Unit_pure" decimals="2" scale="0" format="ixt:numdotdecimal">0.00</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The change in the fair value of the convertible note &#8211; related party measured with Level&#160;3 inputs for year ended December&#160;31, 2021 is summarized as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:85%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value at January&#160;1, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesNoncurrent" contextRef="PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction>&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Initial fair value of convertible note - related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:FairValueOfConvertibleDebtWithRelatedParties" contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">944,694</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of convertible note - related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;"><ix:nonFraction name="ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties" contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">207,986</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value of convertible note - related party, December&#160;31, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;<ix:nonFraction name="us-gaap:NotesPayableRelatedPartiesNoncurrent" contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis" unitRef="Unit_USD" decimals="0" scale="0" format="ixt:numdotdecimal">1,152,680</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> </ix:nonNumeric></ix:continuation> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-19 </div> </div> </div> </div> <div style="background-color:white;display: inline;"> <div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div> <hr style="color:#999999;height:3px;width:100%"/> <div style="font-size: .83em;margin-top : 1.67em;margin-bottom : 1.67em;font-weight: bold;"><a href="#toc">Table of Contents</a></div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:nonNumeric name="us-gaap:SubsequentEventsTextBlock" contextRef="P01_01_2021To12_31_2021" escape="true"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 10 - Subsequent Events </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company evaluated subsequent events and transactions that occurred up to the date consolidated financial statements were issued. Based on this evaluation, other than as noted in Note 1, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements. </div></ix:nonNumeric> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">F-20 </div> </div> </div> </div> </div>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>d251271dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DESCRIPTION OF SECURITIES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The
following summary of the material terms of the capital stock of SES AI Corporation (&#147;SES&#148; or the &#147;Company&#148;) is not intended to be a complete summary of the rights and preferences of such securities, and is qualified by reference
to our Charter, our Bylaws and the Warrant Agreement described herein, each of which are incorporated by reference as an exhibit to our annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2021, and
certain provisions of Delaware law. We urge you to read each of our Charter, our Bylaws and the Warrant Agreement described herein in their entirety for a complete description of the rights and preferences of our securities. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Authorized and Outstanding Capital Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SES&#146;s
Certificate of Incorporation (the &#147;Charter&#148;) authorizes the issuance 2,320,000,000 shares of capital stock, consisting of (i) 2,100,000,000 shares of Class&nbsp;A common stock, par value $0.0001 per share, (ii) 200,000,000 shares of
Class&nbsp;B common stock, par value $0.0001 per share, and (iii) 20,000,000 shares of preferred stock, par value $0.0001 per share. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;A common stock </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Voting
Rights </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of Class&nbsp;A common stock are entitled to cast one vote per share. Generally, holders of all classes of SES common stock vote
together as a single class, and an action is approved by SES stockholders if the number of votes cast in favor of the action exceeds the number of votes cast in opposition to the action, while directors are elected by a plurality of the votes cast.
Holders of Class&nbsp;A common stock are not entitled to cumulate their votes in the election of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;B common stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Voting Rights </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of Class&nbsp;B common stock
are<B></B>&nbsp;entitled to cast 10 votes per share. Generally, holders of all classes of SES common stock vote together as a single class, and an action is approved by SES stockholders if the number of votes cast in favor of the action exceeds the
number of votes cast in opposition to the action, while directors are elected by a plurality of the votes cast. Holders of Class&nbsp;B common stock are not entitled to cumulate their votes in the election of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dividend Rights </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Holders of Class&nbsp;A common stock and
Class&nbsp;B common stock will share equally, identically and ratably, if and when any dividend is declared by the SES board of directors (the &#147;Board&#148;) out of funds legally available therefor, subject to restrictions, whether statutory or
contractual (including with respect to any outstanding indebtedness), on the declaration and payment of dividends and to any restrictions on the payment of dividends imposed by the terms of any outstanding preferred stock or any class or series of
stock having a preference over, or the right to participate with, the Class&nbsp;A common stock with respect to the payment of dividends. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidation,
Dissolution and Winding Up </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the liquidation, dissolution, distribution of assets or winding up of SES, each holder of Class&nbsp;A common stock and
Class&nbsp;B common stock will be entitled, pro rata on a per share basis, to all assets of SES of whatever kind available for distribution to the holders of common stock, subject to the designations, preferences, limitations, restrictions and
relative rights of any other class or series of preferred stock of SES then outstanding. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Charter provides that the Board has the authority, without action by the stockholders, to designate and issue shares of preferred stock in one or more
classes or series, and the number of shares constituting any such class or series, and to fix the voting powers, designations, preferences, limitations, restrictions and relative rights of each class or series of preferred stock, including, without
limitation, dividend rights, dividend rates, conversion rights, exchange rights, voting rights, rights and terms of redemption, dissolution preferences, and treatment in the case of a merger, business combination transaction, or sale of SES&#146;s
assets, which rights may be greater than the rights of the holders of the common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of authorizing the Board to issue preferred stock and
determine the rights and preferences of any classes or series of preferred stock is to eliminate delays associated with a stockholder vote on specific issuances. The simplified issuance of preferred stock, while providing flexibility in connection
with possible acquisitions, future financings and other corporate purposes, could have the effect of making it more difficult for a third party to acquire, or could discourage a third party from seeking to acquire, a majority of SES outstanding
voting stock. Additionally, the issuance of preferred stock may adversely affect the holders of Class&nbsp;A common stock by restricting dividends on the Class&nbsp;A common stock, diluting the voting power of the Class&nbsp;A common stock or
subordinating the dividend or liquidation rights of the Class&nbsp;A common stock. As a result of these or other factors, the issuance of preferred stock could have an adverse impact on the market price of Class&nbsp;A common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Warrants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Public Stockholders&#146; Warrants
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each whole warrant entitles the registered holder to purchase one share of Class&nbsp;A common stock at a price of $11.50 per share, subject to
adjustment as discussed below, at any time commencing 30 days after the closing of the business combination, except as discussed in the immediately succeeding paragraph. Pursuant to the Warrant Agreement, a warrant holder may exercise its warrants
only for a whole number of shares of Class&nbsp;A common stock. This means only a whole warrant may be exercised at a given time by a warrant holder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Redemption of Warrants When the Price Per Share of Class&nbsp;A common stock Equals or Exceeds $18.00 </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once the warrants become exercisable, SES may call the warrants for redemption for cash: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in whole and not in part; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a price of $0.01 per warrant; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon a minimum of 30 days&#146; prior written notice of redemption (the
<FONT STYLE="white-space:nowrap">&#147;30-day</FONT> redemption period&#148;) to each warrant holder; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if, and only if, the closing price of the Class&nbsp;A common stock equals or exceeds $18.00 per share for any 20
trading days within a <FONT STYLE="white-space:nowrap">30-trading</FONT> day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SES will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class&nbsp;A common
stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class&nbsp;A common stock is available throughout the <FONT STYLE="white-space:nowrap">30-day</FONT> redemption period. If and when the
warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SES has established the last of the redemption criterion discussed above to prevent a redemption call unless
there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder are entitled to exercise his, her or its warrant
prior to the scheduled redemption date. However, the price of the Class&nbsp;A common stock may fall below the $18.00 redemption trigger price as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A holder of a warrant may notify SES in writing in the event it elects to be subject to a requirement that such holder will not have the right to
exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person&#146;s affiliates), to the warrant agent&#146;s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other
amount as specified by the holder) of the Class&nbsp;A common stock outstanding immediately after giving effect to such exercise. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Anti-Dilution
Adjustments </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the number of outstanding shares of Class&nbsp;A common stock is increased by a share capitalization payable in shares of
Class&nbsp;A common stock, or by a <FONT STYLE="white-space:nowrap">sub-division</FONT> of common stock or other similar event, then, on the effective date of such share capitalization, <FONT STYLE="white-space:nowrap">sub-division</FONT> or similar
event, the number of shares of Class&nbsp;A common stock issuable on exercise of each warrant will be increased in proportion to such increase in the outstanding common stock. A rights offering to holders of common stock entitling holders to
purchase Class&nbsp;A common stock at a price less than the &#147;historical fair market value&#148; (as defined below) will be deemed a share capitalization of a number of shares of Class&nbsp;A common stock equal to the product of (i)&nbsp;the
number of shares of Class&nbsp;A common stock actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class&nbsp;A common stock) multiplied by
(i)&nbsp;one minus the quotient of (x)&nbsp;the price per share of Class&nbsp;A common stock paid in such rights offering and divided by (y)&nbsp;the historical fair market value. For these purposes (i)&nbsp;if the rights offering is for securities
convertible into or exercisable for Class&nbsp;A common stock, in determining the price payable for Class&nbsp;A common stock, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon
exercise or conversion and (ii) &#147;historical fair market value&#148; means the volume weighted average price of Class&nbsp;A common stock as reported during the <FONT STYLE="white-space:nowrap">10-trading</FONT> day period ending on the trading
day prior to the first date on which the Class&nbsp;A common stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to
holders of Class&nbsp;A common stock on account of such Class&nbsp;A common stock (or other securities into which the warrants are convertible), other than (a)&nbsp;as described above, or (b)&nbsp;any cash dividends or cash distributions which, when
combined on a per share basis with all other cash dividends and cash distributions paid on the Class&nbsp;A common stock during the <FONT STYLE="white-space:nowrap">365-day</FONT> period ending on the date of declaration of such dividend or
distribution (as adjusted to appropriately reflect any other adjustments and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise price or to the number of shares of Class&nbsp;A common stock issuable on
exercise of each warrant) does not exceed $0.50 (being 5% of the offering price of the Units in the IPO), then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or
the fair market value of any securities or other assets paid on each Class&nbsp;A common stock in respect of such event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the number of outstanding
shares of Class&nbsp;A common stock is decreased by a consolidation, combination, reverse share <FONT STYLE="white-space:nowrap">sub-division</FONT> or reclassification of Class&nbsp;A common stock or other similar event, then, on the effective date
of such consolidation, combination, reclassification or similar event, the number of Class&nbsp;A common stock issuable on exercise of each warrant will be decreased in proportion to such decrease in outstanding Class&nbsp;A common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Whenever the number of shares of Class&nbsp;A common stock purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise
price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x)&nbsp;the numerator of which will be the number of shares of Class&nbsp;A common stock purchasable upon the exercise of the
warrants immediately prior to such adjustment, and (y)&nbsp;the denominator of which will be the number of shares of Class&nbsp;A common stock so purchasable immediately thereafter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In case of any reclassification or reorganization of the outstanding Class&nbsp;A common stock (other than
those described above or that solely affects the par value of such Class&nbsp;A common stock), or in the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the continuing
corporation and that does not result in any reclassification or reorganization of our outstanding Class&nbsp;A common stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an
entirety or substantially as an entirety in connection with which we are dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in
lieu of the Class&nbsp;A common stock immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of Class&nbsp;A common stock or other securities or property (including cash)
receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately
prior to such event. However, if such holders were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the holders of the warrants shall have the
same right of election as to the kind and amount of securities, cash or other assets for which each warrant are exercisable. Additionally, if less than 70% of the consideration receivable by the holders of Class&nbsp;A common stock in such a
transaction is payable in the form of shares of Class&nbsp;A common stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following
public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes Warrant Value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price
reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value
of the warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The warrants are issued in registered form under the Warrant Agreement. The Warrant Agreement provides that the terms of the warrants
may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least a majority of the then outstanding public warrants to make any change that adversely
affects the interests of the registered holders. You should review a copy of the Warrant Agreement, which is filed as an exhibit to our annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the period ended December&nbsp;31, 2021,
for a complete description of the terms and conditions applicable to the warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The warrants may be exercised upon surrender of the warrant
certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a
cashless basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders do not have the rights or privileges of holders of common stock and any voting rights until they
exercise their warrants and receive Class&nbsp;A common stock. After the issuance of Class&nbsp;A common stock upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by
stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have agreed that, subject to applicable law, any action, proceeding or claim against us arising out of or relating in any way to the
Warrant Agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive
forum for any such action, proceeding or claim. This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States of America are the
sole and exclusive forum. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Private Placement Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants being sold as part of the units
in the IPO. The private placement warrants (including the Class&nbsp;A common stock issuable upon exercise of such warrants) are not transferable, assignable or salable until 30 days after the Closing and they are not redeemable by us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amended and Restated Registration Rights Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the closing of the business combination, SES, Ivanhoe Capital Sponsor LLC (the &#147;Sponsor&#148;) and certain other equityholders of SES
Holdings Pte. Ltd. (&#147;Old SES&#148;) entered into the Amended and Restated Registration Rights Agreement (the &#147;Registration Rights Agreement,&#148; which superseded the Registration Rights Agreement between the Company and the Sponsor that
was entered into in connection with the Company&#146;s IPO), pursuant to which, among other things, the holders signatory thereto were granted certain customary registration rights, demand rights and piggyback rights with respect to their respective
shares of common stock and any other equity securities of the Company. The Registration Rights Agreement also prohibits the transfer (subject to limited exceptions) of the shares of common stock held by the signatories to the Registration Rights
Agreement for a period of 180&nbsp;days following the Closing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exclusive Forum </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Charter provides that, to the fullest extent permitted by law, unless SES otherwise consents in writing, the Court of Chancery (the &#147;Chancery
Court&#148;) of the State of Delaware (or, in the event that the Chancery Court does not have jurisdiction, the federal district for the District of Delaware or other state courts of the State of Delaware) shall, to the fullest extent permitted by
law, be the sole and exclusive forum for any action brought (a)&nbsp;any derivative action or proceeding brought on behalf of the corporation, (b)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other
employee of the corporation to the corporation or the corporation&#146;s stockholders, (c)&nbsp;any action asserting a claim against the corporation, its directors, officers or employees arising pursuant to any provision of the Delaware General
Corporation Law (the &#147;DGCL&#148;) or the Certificate of Incorporation or the bylaws of SES (the &#147;Bylaws&#148;), (d) any action to interpret, apply, enforce or determine the validity of any provisions of the Certificate of Incorporation or
the Bylaws or (e)&nbsp;any action asserting a claim against the corporation, its directors, officers or employees governed by the internal affairs doctrine. Notwithstanding the foregoing, the federal district courts of the United States shall be the
exclusive forum for the resolution of any action, suit or proceeding asserting a cause of action arising under the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of Provisions of the Charter, the Bylaws and Applicable Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain provisions of the Charter, Bylaws, and laws of the State of Delaware, where SES is incorporated, may discourage or make more difficult a takeover
attempt that a stockholder might consider in his or her best interest. These provisions may also adversely affect prevailing market prices for the Class&nbsp;A common stock and the Class&nbsp;B common stock. SES believes that the benefits of
increased protection give SES the potential ability to negotiate with the proponent of an unsolicited proposal to acquire or restructure SES and outweigh the disadvantage of discouraging those proposals because negotiation of the proposals could
result in an improvement of their terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Authorized but Unissued Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Delaware law does not require stockholder approval for any issuance of authorized shares. However, the listing requirements of the New York Stock Exchange (the
&#147;NYSE&#148;), which will apply for so long as the Class&nbsp;A common stock remains listed on the NYSE, require stockholder approval of certain issuances equal to exceeding 20% of the then outstanding voting power or then outstanding number of
shares of common stock. Additional shares that may be used in the future may be issued for a variety of corporate purposes, including future public offerings, to raise additional capital, or to facilitate acquisitions. The existence of authorized
but unissued and unreserved common stock and preferred stock could make more difficult or discourage an attempt to obtain control of SES by means of a proxy contest, tender offer, merger, or otherwise. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dual Class&nbsp;Stock </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described above, the
Charter provides for a dual class common stock structure which provides Class&nbsp;B common stock holders with the ability to control the outcome of matters requiring stockholder approval, even though they own significantly less than a majority of
the shares of outstanding Class&nbsp;A common stock, including the election of directors and significant corporate transactions, such as a merger or other sale of SES or its assets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Number of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Charter and the Bylaws provide that, subject to any rights of holders of preferred stock to elect additional directors under specified circumstances, the
number of directors may be fixed from time to time pursuant to a resolution adopted by the Board; provided, however, that unless approved by (i)&nbsp;if before the first date on which the issued and outstanding shares of Class&nbsp;B common stock
represents less than 50% of the total voting power of the then outstanding shares of capital stock of SES that would then be entitled to vote in the election of directors at an annual meeting of stockholders, the holders of a majority in voting
power of the shares of capital stock of SES that would then be entitled to vote in the election of directors at an annual meeting or by written consent, or (ii)&nbsp;if after the first date on which the issued and outstanding shares of Class&nbsp;B
common stock represents less than 50% of the total voting power of the then outstanding shares of capital stock of SES that would then be entitled to vote in the election of directors at an annual meeting of stockholders, by the holders of <FONT
STYLE="white-space:nowrap">two-thirds</FONT> (2/3) of the voting power of the shares of capital stock of SES that would then be entitled to vote in the election of directors at an annual meeting of stockholders. The initial number of directors was
set at seven. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Requirements for Advance Notification of Stockholder Meetings, Nominations and Proposals </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Bylaws establish advance notice procedures with respect to stockholder proposals and nomination of candidates for election as directors, other than
nominations made by or at the direction of the Board or a committee of the Board. In order to be &#147;properly brought&#148; before a meeting, a stockholder will have to comply with advance notice requirements and provide SES with certain
information. Generally, to be timely, a stockholder&#146;s notice must be received at SES&#146;s principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary of the immediately preceding annual meeting of
stockholders. The Bylaws also specify requirements as to the form and content of a stockholder&#146;s notice. The Bylaws allow the chairman of the meeting at a meeting of the stockholders to adopt rules and regulations for the conduct of meetings
which may have the effect of precluding the conduct of certain business at a meeting if the rules and regulations are not followed. These provisions may also defer, delay, or discourage a potential acquirer from conducting a solicitation of proxies
to elect the acquirer&#146;s own slate of directors or otherwise attempting to influence or obtain control of SES. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Stockholder Action
by Written Consent </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Charter provides that, subject to the terms of any series of SES Preferred Stock, any action required or permitted to be taken
by the stockholders of SES must be effected at an annual or special meeting of the stockholders and may not be effected by written consent in lieu of a meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendment of the Charter and Bylaws </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The DGCL provides
generally that the affirmative vote of a majority of the outstanding shares entitled to vote thereon, voting together a single class, is required to amend a corporation&#146;s certificate of incorporation, unless the certificate of incorporation
requires a greater percentage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Charter provides that it may be amended by SES in the manners provided therein or prescribed by statute. The Charter
provides that the affirmative vote of the holders of a majority of the voting power of the then-outstanding shares of capital stock of SES entitled to vote generally in the election of directors, voting together as a single class, will be required
to amend or repeal, or adopt any provision of the Charter providing for the capital stock of SES, amendment of the Charter, amendment of the Bylaws, board of directors, election of directors, limitation of director liability, indemnification and
special meetings of the stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any of the Class&nbsp;B common stock shares are outstanding, SES will not, without the prior affirmative vote of
the holders of <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares of Class&nbsp;B common stock, voting as a separate class, in addition to any other vote required by applicable law or the Charter, directly or indirectly,
amend, alter, change, repeal, or adopt any provision of the Charter (1)&nbsp;in a manner that is inconsistent with, or otherwise alters or changes, any of the voting, conversion, dividend, or liquidation provisions of the shares of Class&nbsp;B
common stock or other rights, powers, preferences, or privileges of the shares of Class&nbsp;B common stock, (2)&nbsp;to provide for each share of Class&nbsp;A common stock or any other class of common stock to have more than one vote per share or
any rights to a separate class vote of the holders of shares of Class&nbsp;A common stock other than as provided in the Charter or required by the DGCL, or (3)&nbsp;to otherwise adversely impact or affect the rights, powers, preferences, or
privileges of the shares of Class&nbsp;B common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any of the Class&nbsp;A common stock shares are outstanding, SES will not, without the prior affirmative
vote of the majority of the outstanding shares of Class&nbsp;A common stock, voting as a separate class, in addition to any other vote required by applicable law or the Charter, directly or indirectly, amend, alter, change, repeal, or adopt any
provision of the Charter (1)&nbsp;in a manner that is inconsistent with, or otherwise alters or changes, any of the voting, conversion, dividend, or liquidation provisions of the shares of Class&nbsp;A common stock or other rights, powers,
preferences, or privileges of the shares of Class&nbsp;A common stock or (2)&nbsp;to provide for each share of Class&nbsp;B common stock to have more than 10 votes per share or any rights to a separate class vote of the holders of shares of
Class&nbsp;B common stock other than as provided in the Charter or required by the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Charter also provides that the Board shall have the power to
adopt, amend, alter, or repeal the Bylaws by the affirmative vote of a majority of the directors present at any regular or special meeting of the Board at which a quorum is present in any manner not inconsistent with the laws of the State of
Delaware or the Charter. The stockholders of SES are prohibited from adopting, amending, altering, or repealing the Bylaws, or to adopt any provision inconsistent with the Bylaws, unless such action is approved, in addition to any other vote
required by the Charter, by the Requisite Stockholder Consent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Business Combinations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;203 of the DGCL, a corporation is not permitted to engage in a business combination with any interested stockholder for a period of three
years following the time that such interested stockholder became an interested stockholder, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to such time the board of directors of the corporation approved either the business combination or the
transaction which resulted in the stockholder becoming an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the
interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the
interested stockholder) those shares owned (i)&nbsp;by persons who are directors and also officers and (ii)&nbsp;employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the
plan will be tendered in a tender or exchange offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at or subsequent to such time the business combination is approved by the board of directors and authorized at
an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 662/3% of the outstanding voting stock which is not owned by the interested stockholder. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, a &#147;business combination&#148; includes a merger, asset or stock sale or other transaction resulting in a financial benefit to the interested
stockholder. Subject to certain exceptions, an &#147;interested stockholder&#148; is a person who, together with that person&#146;s affiliates and associates, owns, or within the previous three years owned, 15% or more of SES&#146;s outstanding
voting stock. For purposes of this section only, &#147;voting stock&#148; has the meaning given to it in Section&nbsp;203 of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since SES has not
opted out of Section&nbsp;203 of the DGCL, it will apply to SES. As a result, this provision will make it more difficult for a person who would be an &#147;interested stockholder&#148; to effect various business combinations with SES for a
three-year period. This provision may encourage companies interested in acquiring SES to negotiate in advance with the Board because the stockholder approval requirement would be avoided if the Board approves either the business combination or the
transaction which results in the stockholder becoming an interested stockholder. These provisions also may have the effect of preventing changes in the Board and may make it more difficult to accomplish transactions which stockholders may otherwise
deem to be in their best interests. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cumulative Voting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Delaware law, the right to vote cumulatively does not exist unless the Charter specifically authorizes cumulative voting. The Charter does not authorize
cumulative voting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Liability and Indemnification of Officers and Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The DGCL authorizes corporations to limit or eliminate the personal liability of directors of corporations and their stockholders for monetary damages for
breaches of directors&#146; fiduciary duties, subject to certain exceptions. SES&#146;s Charter includes a provision that eliminates the personal liability of directors for damages for any breach of fiduciary duty as a director where, in civil
proceedings, the person acted in good faith and in a manner that person reasonably believed to be in or not opposed to the best interests of SES or, in criminal proceedings, where the person had no reasonable cause to believe that his or her conduct
was unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Bylaws provide that SES must indemnify and advance expenses to SES&#146;s directors and officers to the fullest extent authorized by
the DGCL. SES also is expressly authorized to carry directors&#146; and officers&#146; liability insurance providing indemnification for SES directors, officers, and certain employees for some liabilities. SES believes that these indemnification and
advancement provisions and insurance are useful to attract and retain qualified directors and executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The limitation of liability,
advancement and indemnification provisions in the Charter and Bylaws may discourage stockholders from bringing lawsuit against directors for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of
derivative litigation against directors and officers, even though such an action, if successful, might otherwise benefit SES and its stockholders. In addition, your investment may be adversely affected to the extent SES pays the costs of settlement
and damage awards against directors and officer pursuant to these indemnification provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is currently no pending material litigation or
proceeding involving any of SES&#146;s directors, officers, or employees for which indemnification is sought. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dissenters&#146; Rights of Appraisal and
Payment </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the DGCL, with certain exceptions, SES&#146;s stockholders will have appraisal rights in connection with a merger or consolidation of
SES. Pursuant to the DGCL, stockholders who properly request and perfect appraisal rights in connection with such merger or consolidation will have the right to receive payment of the fair value of their shares as determined by the Delaware Court of
Chancery. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholders&#146; Derivative Actions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the DGCL, any of SES&#146;s stockholders may bring an action in SES&#146;s name to procure a judgment in SES&#146;s favor, also known as a derivative
action, provided that the stockholder bringing the action is a holder of SES&#146;s shares at the time of the transaction to which the action relates or such stockholder&#146;s stock thereafter devolved by operation of law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transfer agent for SES
capital stock is Continental Stock Transfer&nbsp;&amp; Trust Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing of common stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Class&nbsp;A common stock and public warrants are listed on the NYSE under the symbols &#147;SES&#148; and &#147;SES WS,&#148; respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>d251271dex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-31.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 31.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE <FONT STYLE="white-space:nowrap">13a-14</FONT> AND <FONT STYLE="white-space:nowrap">15d-14</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, Qichao Hu, certify that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. I have reviewed
this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2021 of SES AI Corporation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. The registrant&#146;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e))</FONT> and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
the registrant and have: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the
registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over
financial reporting; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. The registrant&#146;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal controls over financial reporting. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Qichao Hu</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Qichao Hu</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer (Principal Executive Officer)</P></TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>d251271dex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-31.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 31.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE <FONT STYLE="white-space:nowrap">13a-14</FONT> AND <FONT STYLE="white-space:nowrap">15d-14</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I, Jing Nealis, certify that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. I have
reviewed this Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2021 of SES AI Corporation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. The registrant&#146;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e))</FONT> and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for
the registrant and have: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the
registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over
financial reporting; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. The registrant&#146;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b.
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal controls over financial reporting. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jing Nealis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jing Nealis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer (Principal Financial Officer)</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>d251271dex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-32.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 32.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>18 U.S.C. 1350 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> of
SES AI Corporation (the &#147;<U>Company</U>&#148;) for the year ended December&nbsp;31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#147;<U>Report</U>&#148;), I, Qichao Hu, Chief Executive Officer of the
Company, certify, pursuant to 18 U.S.C. Section&nbsp;1350, as adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Report fully complies with the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act
of 1934; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the information contained in the Report fairly presents, in all material respects, the financial condition and
results of operations of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Qichao Hu</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Qichao Hu</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer (Principal Executive Officer)</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>d251271dex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-32.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 32.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>18 U.S.C. 1350 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Annual Report of SES AI Corporation (the &#147;Company&#148;) on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#147;Report&#148;), I, Jing Nealis, Chief Financial Officer, certify, pursuant to 18
U.S.C. Section&nbsp;1350, as adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the Report fully complies
with the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the information contained in the
Report fairly presents, in all material respects, the financial condition and results of operations of the Company. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date: March&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jing Nealis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jing Nealis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer (Principal Financial Officer)</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>ses-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 01-April-2022 [02:40:47] {AM}-->
<schema targetNamespace="http://www.ivanhoecapitalacquisition.com/20211231" elementFormDefault="qualified" xmlns:ses="http://www.ivanhoecapitalacquisition.com/20211231" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/CoverPage" id="CoverPage">
<link:definition>1001 - Document - Cover Page</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
<link:definition>1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
<link:definition>1003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations" id="CondensedConsolidatedStatementsOfOperations">
<link:definition>1004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" id="CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit">
<link:definition>1005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows" id="CondensedConsolidatedStatementOfCashFlows">
<link:definition>1006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations" id="DescriptionOfOrganizationAndBusinessOperations">
<link:definition>1007 - Disclosure - Description of Organization and Business Operations</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition>1008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering" id="InitialPublicOffering">
<link:definition>1009 - Disclosure - Initial Public Offering</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement" id="PrivatePlacement">
<link:definition>1010 - Disclosure - Private Placement</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
<link:definition>1011 - Disclosure - Related Party Transactions</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
<link:definition>1012 - Disclosure - Commitments and Contingencies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities" id="DerivativeWarrantLiabilities">
<link:definition>1013 - Disclosure - Derivative Warrant Liabilities</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption" id="ClassAOrdinarySharesSubjectToPossibleRedemption">
<link:definition>1014 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit" id="ShareholdersEquityDeficit">
<link:definition>1015 - Disclosure - Shareholders' Equity (Deficit)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements" id="FairValueMeasurements">
<link:definition>1016 - Disclosure - Fair Value Measurements</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition>1017 - Disclosure - Subsequent Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition>1018 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
<link:definition>1019 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables" id="ClassAOrdinarySharesSubjectToPossibleRedemptionTables">
<link:definition>1020 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
<link:definition>1021 - Disclosure - Fair Value Measurements (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" id="DescriptionOfOrganizationAndBusinessOperationsDetails">
<link:definition>1022 - Disclosure - Description of Organization and Business Operations (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails" id="SummaryOfSignificantAccountingPoliciesDetails">
<link:definition>1023 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails" id="SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails">
<link:definition>1024 - Disclosure - Summary of Significant Accounting Policies - Net income (loss) per share (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails" id="InitialPublicOfferingDetails">
<link:definition>1025 - Disclosure - Initial Public Offering (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails" id="PrivatePlacementDetails">
<link:definition>1026 - Disclosure - Private Placement (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails" id="RelatedPartyTransactionsFounderSharesDetails">
<link:definition>1027 - Disclosure - Related Party Transactions - Founder Shares (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails" id="RelatedPartyTransactionsAdditionalInformationDetails">
<link:definition>1028 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" id="CommitmentsAndContingenciesAdditionalInformationDetails">
<link:definition>1029 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails" id="DerivativeWarrantLiabilitiesAdditionalInformationDetails">
<link:definition>1030 - Disclosure - Derivative Warrant Liabilities - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails" id="ClassAOrdinarySharesSubjectToPossibleRedemptionDetails">
<link:definition>1031 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails" id="ShareholdersEquityDeficitPreferredStockSharesDetails">
<link:definition>1032 - Disclosure - Shareholders' Equity (Deficit) - Preferred Stock Shares (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails" id="ShareholdersEquityDeficitCommonStockDetails">
<link:definition>1033 - Disclosure - Shareholders' Equity (Deficit) - Common stock  (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails" id="FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails">
<link:definition>1034 - Disclosure - Fair Value Measurements - Company's financial assets and liabilities (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails" id="FairValueMeasurementsAdditionalInformationDetails">
<link:definition>1035 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" id="FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails">
<link:definition>1036 - Disclosure - Fair Value Measurements - Level 3 Fair Value Measurements Inputs (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails" id="FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails">
<link:definition>1037 - Disclosure - Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails" id="FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails">
<link:definition>1038 - Disclosure - Fair Value Measurements - Change in the Fair Value of the Convertible note - related party (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="ses-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="ses-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="ses-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="ses-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
<import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
<import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
<import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
<import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<element name="CommonClassaSubjectToRedemptionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_CommonClassaSubjectToRedemptionMember" substitutionGroup="xbrli:item" />
<element name="DeferredUnderwritingFeePayableNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_DeferredUnderwritingFeePayableNoncurrent" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="FairValueAdjustmentOfConvertibleDebtWithRelatedParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="OfferingCostsWarrantsIssuance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_OfferingCostsWarrantsIssuance" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="CommonStockSubjectToPossibleRedemptionValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_CommonStockSubjectToPossibleRedemptionValue" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ProceedsReceivedFromInitialPublicOfferingGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ProceedsReceivedFromInitialPublicOfferingGross" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="ProceedsReceivedFromNotePayableToRelatedParty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ProceedsReceivedFromNotePayableToRelatedParty" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="OfferingCostsPaid" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_OfferingCostsPaid" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="PaymentsForInvestmentOfCashInTrustAccount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_PaymentsForInvestmentOfCashInTrustAccount" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IncreaseDecreaseInAccruedExpensesRealtedParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_IncreaseDecreaseInAccruedExpensesRealtedParties" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="Underwritingcommissiondeferred" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_Underwritingcommissiondeferred" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredOfferingCostsIncludedInAccountsPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_DeferredOfferingCostsIncludedInAccountsPayable" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="OfferingCostsIncludedInAccountsPayableAccruedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="InitialPublicOfferingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_InitialPublicOfferingAbstract" substitutionGroup="xbrli:item" />
<element name="InitialPublicOfferingTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_InitialPublicOfferingTextBlock" substitutionGroup="xbrli:item" />
<element name="PrivatePlacementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_PrivatePlacementAbstract" substitutionGroup="xbrli:item" />
<element name="PrivatePlacementTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_PrivatePlacementTextBlock" substitutionGroup="xbrli:item" />
<element name="TemporaryEquityDisclosureTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_TemporaryEquityDisclosureTextBlock" substitutionGroup="xbrli:item" />
<element name="EmergingGrowthCompanyPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_EmergingGrowthCompanyPolicyTextBlock" substitutionGroup="xbrli:item" />
<element name="Derivativewarrantliabilitiespolicytextblock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_Derivativewarrantliabilitiespolicytextblock" substitutionGroup="xbrli:item" />
<element name="Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" substitutionGroup="xbrli:item" />
<element name="Commonstocksubjecttopossibleredemptionpolicytextblock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_Commonstocksubjecttopossibleredemptionpolicytextblock" substitutionGroup="xbrli:item" />
<element name="PrivatePlacementWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_PrivatePlacementWarrantsMember" substitutionGroup="xbrli:item" />
<element name="WorkingCapitalLoansWarrantMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_WorkingCapitalLoansWarrantMember" substitutionGroup="xbrli:item" />
<element name="SponsorMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_SponsorMember" substitutionGroup="xbrli:item" />
<element name="UnitsIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_UnitsIssuedDuringPeriodSharesNewIssues" substitutionGroup="xbrli:item" />
<element name="DeferredOfferingCostsNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_DeferredOfferingCostsNoncurrent" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="SaleOfStockOtherOfferingCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_SaleOfStockOtherOfferingCosts" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ConditionForFutureBusinessCombinationUseOfProceedsPercentage" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" substitutionGroup="xbrli:item" />
<element name="ConditionForFutureBusinessCombinationThresholdPercentageOwnership" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightPriceOfWarrantsOrRights" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" substitutionGroup="xbrli:item" />
<element name="RedemptionLimitPercentageWithoutPriorConsent" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_RedemptionLimitPercentageWithoutPriorConsent" substitutionGroup="xbrli:item" />
<element name="ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="Monthstocompleteacquisition" type="xbrli:positiveIntegerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_Monthstocompleteacquisition" substitutionGroup="xbrli:item" />
<element name="MaximumAllowedDissolutionExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_MaximumAllowedDissolutionExpenses" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="OperatingBankAccounts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_OperatingBankAccounts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="WorkingCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_WorkingCapital" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" substitutionGroup="xbrli:item" />
<element name="IvanhoeCapitalAcquisitionCorpMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_IvanhoeCapitalAcquisitionCorpMember" substitutionGroup="xbrli:item" />
<element name="DeferredUnderwritingCommissions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_DeferredUnderwritingCommissions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NumberOfSharesIssuedPerUnit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_NumberOfSharesIssuedPerUnit" substitutionGroup="xbrli:item" />
<element name="NumberOfWarrantsIssuedPerUnit" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_NumberOfWarrantsIssuedPerUnit" substitutionGroup="xbrli:item" />
<element name="ProceedsFromSaleOfUnits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ProceedsFromSaleOfUnits" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="FounderSharesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_FounderSharesMember" substitutionGroup="xbrli:item" />
<element name="AggregateNumberOfSharesOwned" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_AggregateNumberOfSharesOwned" substitutionGroup="xbrli:item" />
<element name="CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" substitutionGroup="xbrli:item" />
<element name="PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" substitutionGroup="xbrli:item" />
<element name="AggregateOfSponsorSharesSurrendered" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_AggregateOfSponsorSharesSurrendered" substitutionGroup="xbrli:item" />
<element name="NumberOfSharesSubjectToForfeiture" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_NumberOfSharesSubjectToForfeiture" substitutionGroup="xbrli:item" />
<element name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" substitutionGroup="xbrli:item" />
<element name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" substitutionGroup="xbrli:item" />
<element name="TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" substitutionGroup="xbrli:item" />
<element name="AdministrativeSupportAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_AdministrativeSupportAgreementMember" substitutionGroup="xbrli:item" />
<element name="RelatedPartyLoansMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_RelatedPartyLoansMember" substitutionGroup="xbrli:item" />
<element name="ConverstionPricePerWarrants" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ConverstionPricePerWarrants" substitutionGroup="xbrli:item" />
<element name="MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="MaximumLoansConvertibleIntoWarrants" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_MaximumLoansConvertibleIntoWarrants" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="UnderwriterCashDiscount" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_UnderwriterCashDiscount" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredFeePerUnit" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_DeferredFeePerUnit" substitutionGroup="xbrli:item" />
<element name="MaximumNumberOfDemandsForRegistrationOfSecurities" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_MaximumNumberOfDemandsForRegistrationOfSecurities" substitutionGroup="xbrli:item" />
<element name="FairValueMeasurementOptionTerm" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_FairValueMeasurementOptionTerm" substitutionGroup="xbrli:item" />
<element name="UnderwritingCashDiscountPerUnit" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_UnderwritingCashDiscountPerUnit" substitutionGroup="xbrli:item" />
<element name="LeasesArrangementTypeAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_LeasesArrangementTypeAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="LeasesArrangementTypeDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_LeasesArrangementTypeDomain" substitutionGroup="xbrli:item" />
<element name="PublicWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_PublicWarrantsMember" substitutionGroup="xbrli:item" />
<element name="RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" substitutionGroup="xbrli:item" />
<element name="RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" substitutionGroup="xbrli:item" />
<element name="ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" substitutionGroup="xbrli:item" />
<element name="PercentageOfGrossProceedsOnTotalEquityProceeds" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_PercentageOfGrossProceedsOnTotalEquityProceeds" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" substitutionGroup="xbrli:item" />
<element name="SharePricetriggerUsedToMeasureDilutionOfWarrant" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_SharePricetriggerUsedToMeasureDilutionOfWarrant" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" substitutionGroup="xbrli:item" />
<element name="ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" substitutionGroup="xbrli:item" />
<element name="MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" substitutionGroup="xbrli:item" />
<element name="PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" substitutionGroup="xbrli:item" />
<element name="WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" substitutionGroup="xbrli:item" />
<element name="WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" substitutionGroup="xbrli:item" />
<element name="RedemptionPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_RedemptionPeriod" substitutionGroup="xbrli:item" />
<element name="CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" substitutionGroup="xbrli:item" />
<element name="MultiplierUsedInCalculatingWarrantExercisePrice" type="xbrli:pureItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_MultiplierUsedInCalculatingWarrantExercisePrice" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" substitutionGroup="xbrli:item" />
<element name="CommonStockNumberOfVotesPerShare" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="ses_CommonStockNumberOfVotesPerShare" substitutionGroup="xbrli:item" />
<element name="ProceedsFromIssuanceOfTemporaryEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_ProceedsFromIssuanceOfTemporaryEquity" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="TemporaryEquityFairValueOfWarrantsAtIssuance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_TemporaryEquityFairValueOfWarrantsAtIssuance" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="TemporaryEquityIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_TemporaryEquityIssuanceCosts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="InvestmentClassAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_InvestmentClassAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="InvestmentClassDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="ses_InvestmentClassDomain" substitutionGroup="xbrli:item" />
<element name="FairValueOfConvertibleDebtWithRelatedParties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="ses_FairValueOfConvertibleDebtWithRelatedParties" substitutionGroup="xbrli:item" xbrli:balance="debit" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>ses-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 01-April-2022 [02:40:47] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedStatementOfCashFlows" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows" />
<calculationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaap_GainLossOnInvestments" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_GainLossOnInvestments" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants" use="optional" order="2" weight="-1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xlink:label="loc_SES_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_SES_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" use="optional" order="3" weight="-1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsWarrantsIssuance" xlink:label="loc_SES_OfferingCostsWarrantsIssuance" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_SES_OfferingCostsWarrantsIssuance" use="optional" order="4" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="loc_us-gaap_CostsAndExpenses" use="optional" order="5" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense" use="optional" order="7" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsReceivedFromInitialPublicOfferingGross" xlink:label="loc_SES_ProceedsReceivedFromInitialPublicOfferingGross" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_SES_ProceedsReceivedFromInitialPublicOfferingGross" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts" use="optional" order="5" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsReceivedFromNotePayableToRelatedParty" xlink:label="loc_SES_ProceedsReceivedFromNotePayableToRelatedParty" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_SES_ProceedsReceivedFromNotePayableToRelatedParty" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsPaid" xlink:label="loc_SES_OfferingCostsPaid" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="loc_SES_OfferingCostsPaid" use="optional" order="8" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_ProfitLoss" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_InvestmentIncomeInterest" use="optional" order="11" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xlink:label="loc_SES_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SES_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsWarrantsIssuance" xlink:label="loc_SES_OfferingCostsWarrantsIssuance" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SES_OfferingCostsWarrantsIssuance" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" use="optional" order="15" weight="-1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" use="optional" order="16" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_IncreaseDecreaseInAccruedExpensesRealtedParties" xlink:label="loc_SES_IncreaseDecreaseInAccruedExpensesRealtedParties" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SES_IncreaseDecreaseInAccruedExpensesRealtedParties" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" xlink:label="loc_SES_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SES_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" use="optional" order="21" weight="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="loc_SES_PaymentsForInvestmentOfCashInTrustAccount" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="loc_SES_PaymentsForInvestmentOfCashInTrustAccount" use="optional" order="22" weight="-1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_StockholdersEquity" use="optional" order="1" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_PreferredStockValue" use="optional" order="2" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_CommonStockValue" use="optional" order="3" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_AdditionalPaidInCapital" use="optional" order="4" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit" use="optional" order="5" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" use="optional" order="6" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaap_Liabilities" use="optional" order="7" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_LiabilitiesCurrent" use="optional" order="8" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccountsPayableCurrent" use="optional" order="9" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent" use="optional" order="10" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent" use="optional" order="11" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" use="optional" order="12" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent" use="optional" order="13" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent" use="optional" order="14" weight="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredUnderwritingFeePayableNoncurrent" xlink:label="loc_SES_DeferredUnderwritingFeePayableNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_SES_DeferredUnderwritingFeePayableNoncurrent" use="optional" order="15" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" use="optional" order="16" weight="1" />
</calculationLink>
<calculationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsCurrent" use="optional" order="17" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" use="optional" order="18" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="loc_us-gaap_PrepaidExpenseCurrent" use="optional" order="19" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent" use="optional" order="20" weight="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaap_DeferredCosts" />
<calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets" xlink:to="loc_us-gaap_DeferredCosts" use="optional" order="21" weight="1" />
</calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>ses-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 01-April-2022 [02:40:47] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CoverPage" roleURI="http://www.ivanhoecapitalacquisition.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedStatementOfCashFlows" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#DescriptionOfOrganizationAndBusinessOperations" roleURI="http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#InitialPublicOffering" roleURI="http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#PrivatePlacement" roleURI="http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#RelatedPartyTransactions" roleURI="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CommitmentsAndContingencies" roleURI="http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#DerivativeWarrantLiabilities" roleURI="http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ClassAOrdinarySharesSubjectToPossibleRedemption" roleURI="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ShareholdersEquityDeficit" roleURI="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurements" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SubsequentEvents" roleURI="http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ClassAOrdinarySharesSubjectToPossibleRedemptionTables" roleURI="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsTables" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#DescriptionOfOrganizationAndBusinessOperationsDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SummaryOfSignificantAccountingPoliciesDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#InitialPublicOfferingDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#PrivatePlacementDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#RelatedPartyTransactionsFounderSharesDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#RelatedPartyTransactionsAdditionalInformationDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CommitmentsAndContingenciesAdditionalInformationDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#DerivativeWarrantLiabilitiesAdditionalInformationDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ClassAOrdinarySharesSubjectToPossibleRedemptionDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ShareholdersEquityDeficitPreferredStockSharesDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ShareholdersEquityDeficitCommonStockDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsAdditionalInformationDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" />
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CoverPage">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_1353671" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_1264906" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentType_1264906" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1264907" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityRegistrantName_1264907" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_1264908" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityFilerCategory_1264908" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_1264909" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntitySmallBusiness_1264909" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_1264910" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityEmergingGrowthCompany_1264910" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_1264912" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityCentralIndexKey_1264912" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_1264914" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_AmendmentFlag_1264914" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_1265088" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityExTransitionPeriod_1265088" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_1353661" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentInformationTable_1353661" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1353663" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_1353661" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1353663" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1353666" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1353663" xlink:to="loc_us-gaap_ClassOfStockDomain_1353666" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1353666_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1353663" xlink:to="loc_us-gaap_ClassOfStockDomain_1353666_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1353667" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1353666" xlink:to="loc_us-gaap_CommonClassAMember_1353667" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_1353668" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1353666" xlink:to="loc_us-gaap_CommonClassBMember_1353668" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1353705" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1353666" xlink:to="loc_us-gaap_WarrantMember_1353705" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_1353675" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentAnnualReport_1353675" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_1353676" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentTransitionReport_1353676" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_1353677" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentPeriodEndDate_1353677" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_1353678" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentFiscalYearFocus_1353678" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_1353679" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentFiscalPeriodFocus_1353679" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_1353680" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityFileNumber_1353680" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1353681" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1353681" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_1353682" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityTaxIdentificationNumber_1353682" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_1353683" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_Security12bTitle_1353683" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_1353684" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_TradingSymbol_1353684" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_1353685" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_SecurityExchangeName_1353685" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_1353689" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityAddressAddressLine1_1353689" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_1353690" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityAddressCityOrTown_1353690" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_1353691" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityAddressStateOrProvince_1353691" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_1353692" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityAddressPostalZipCode_1353692" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_1353693" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_CityAreaCode_1353693" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_1353694" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_LocalPhoneNumber_1353694" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_1353697" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_CurrentFiscalYearEndDate_1353697" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_1353698" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_1353698" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_1353699" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityVoluntaryFilers_1353699" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_1353700" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityCurrentReportingStatus_1353700" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_1353701" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityInteractiveDataCurrent_1353701" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_1353702" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityShellCompany_1353702" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_1353703" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityPublicFloat_1353703" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1353704" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1353704" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_1364829" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_AuditorName_1364829" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_1364830" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_AuditorFirmId_1364830" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_1364831" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_AuditorLocation_1364831" use="optional" order="43" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_129" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_125" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_129" xlink:to="loc_us-gaap_StatementTable_125" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_126" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_125" xlink:to="loc_us-gaap_StatementClassOfStockAxis_126" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_127" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_126" xlink:to="loc_us-gaap_ClassOfStockDomain_127" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_127_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_126" xlink:to="loc_us-gaap_ClassOfStockDomain_127_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_128" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_127" xlink:to="loc_us-gaap_CommonClassAMember_128" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonClassaSubjectToRedemptionMember" xlink:label="loc_ses_CommonClassaSubjectToRedemptionMember_135" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_127" xlink:to="loc_ses_CommonClassaSubjectToRedemptionMember_135" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_136" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_127" xlink:to="loc_us-gaap_CommonClassBMember_136" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262682" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_125" xlink:to="loc_dei_LegalEntityAxis_1262682" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262683" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262682" xlink:to="loc_dei_EntityDomain_1262683" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262683_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262682" xlink:to="loc_dei_EntityDomain_1262683_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1269076" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_125" xlink:to="loc_srt_RestatementAxis_1269076" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1269077" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_1269076" xlink:to="loc_srt_RestatementDomain_1269077" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1269077_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_1269076" xlink:to="loc_srt_RestatementDomain_1269077_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_129" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_152" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_Liabilities_152" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_153" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_CommitmentsAndContingencies_153" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_149" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_149" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredUnderwritingFeePayableNoncurrent" xlink:label="loc_ses_DeferredUnderwritingFeePayableNoncurrent_150" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_ses_DeferredUnderwritingFeePayableNoncurrent_150" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_151" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_151" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_133" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_133" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_147" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_133" xlink:to="loc_us-gaap_LiabilitiesCurrent_147" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_146" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_133" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_146" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_145" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_133" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_145" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_144" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_133" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_144" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_143" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_133" xlink:to="loc_us-gaap_AccountsPayableCurrent_143" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_154" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_154" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_134" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_StockholdersEquityAbstract_134" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_157" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_134" xlink:to="loc_us-gaap_AdditionalPaidInCapital_157" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_158" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_134" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_158" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_156" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_134" xlink:to="loc_us-gaap_CommonStockValue_156" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_155" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_134" xlink:to="loc_us-gaap_PreferredStockValue_155" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_159" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_134" xlink:to="loc_us-gaap_StockholdersEquity_159" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_160" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_160" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent_148" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent_148" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_130" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_129" xlink:to="loc_us-gaap_AssetsAbstract_130" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaap_DeferredCosts_141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_130" xlink:to="loc_us-gaap_DeferredCosts_141" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent_140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_130" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent_140" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_130" xlink:to="loc_us-gaap_AssetsCurrentAbstract_131" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_131" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_137" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_131" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_138" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_139" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_131" xlink:to="loc_us-gaap_AssetsCurrent_139" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_142" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_130" xlink:to="loc_us-gaap_Assets_142" use="optional" order="42" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_188" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_184" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_StatementTable_184" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_185" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_us-gaap_StatementClassOfStockAxis_185" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_186" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_185" xlink:to="loc_us-gaap_ClassOfStockDomain_186" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_186_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_185" xlink:to="loc_us-gaap_ClassOfStockDomain_186_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_187" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_186" xlink:to="loc_us-gaap_CommonClassAMember_187" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonClassaSubjectToRedemptionMember" xlink:label="loc_ses_CommonClassaSubjectToRedemptionMember_189" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_186" xlink:to="loc_ses_CommonClassaSubjectToRedemptionMember_189" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_190" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_186" xlink:to="loc_us-gaap_CommonClassBMember_190" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262686" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_dei_LegalEntityAxis_1262686" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262687" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262686" xlink:to="loc_dei_EntityDomain_1262687" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262687_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262686" xlink:to="loc_dei_EntityDomain_1262687_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1269080" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_srt_RestatementAxis_1269080" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1269082" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_1269080" xlink:to="loc_srt_RestatementDomain_1269082" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1269082_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_1269080" xlink:to="loc_srt_RestatementDomain_1269082_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_198" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_198" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_191" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_191" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_202" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_202" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_195" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_195" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_196" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_196" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_197" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_CommonStockSharesIssued_197" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_199" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_199" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_192" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_192" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_193" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_PreferredStockSharesIssued_193" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_194" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_194" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_201" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_201" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_200" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_200" use="optional" order="25" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_231" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_227" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_StatementTable_227" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_228" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_227" xlink:to="loc_us-gaap_StatementClassOfStockAxis_228" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_229" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_228" xlink:to="loc_us-gaap_ClassOfStockDomain_229" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_229_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_228" xlink:to="loc_us-gaap_ClassOfStockDomain_229_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_230" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_229" xlink:to="loc_us-gaap_CommonClassAMember_230" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_234" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_229" xlink:to="loc_us-gaap_CommonClassBMember_234" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262696" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_227" xlink:to="loc_dei_LegalEntityAxis_1262696" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262697" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262696" xlink:to="loc_dei_EntityDomain_1262697" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262697_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262696" xlink:to="loc_dei_EntityDomain_1262697_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_239" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_239" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaap_GainLossOnInvestments_238" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_GainLossOnInvestments_238" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xlink:label="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_240" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_240" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsWarrantsIssuance" xlink:label="loc_ses_OfferingCostsWarrantsIssuance_241" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_ses_OfferingCostsWarrantsIssuance_241" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_235" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_235" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_1264259" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_1264259" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1264261" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1264261" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_236" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_236" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_242" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_NetIncomeLoss_242" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_237" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_CostsAndExpenses_237" use="optional" order="20" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_274" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_271" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_274" xlink:to="loc_us-gaap_StatementTable_271" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_272" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_271" xlink:to="loc_us-gaap_StatementClassOfStockAxis_272" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_278" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_272" xlink:to="loc_us-gaap_ClassOfStockDomain_278" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_278_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_272" xlink:to="loc_us-gaap_ClassOfStockDomain_278_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_276" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_278" xlink:to="loc_us-gaap_CommonClassAMember_276" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_277" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_278" xlink:to="loc_us-gaap_CommonClassBMember_277" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_273" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_271" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_273" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_282" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_273" xlink:to="loc_us-gaap_EquityComponentDomain_282" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_282_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_273" xlink:to="loc_us-gaap_EquityComponentDomain_282_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_280" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_282" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_280" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_281" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_282" xlink:to="loc_us-gaap_RetainedEarningsMember_281" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_279" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_282" xlink:to="loc_us-gaap_CommonStockMember_279" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262727" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_271" xlink:to="loc_dei_LegalEntityAxis_1262727" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262728" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262727" xlink:to="loc_dei_EntityDomain_1262728" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262728_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262727" xlink:to="loc_dei_EntityDomain_1262728_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_274" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_287" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_287" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_288" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_NetIncomeLoss_288" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_283" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_StockholdersEquity_283" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_284" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_SharesIssued_284" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockSubjectToPossibleRedemptionValue" xlink:label="loc_ses_CommonStockSubjectToPossibleRedemptionValue_285" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_ses_CommonStockSubjectToPossibleRedemptionValue_285" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_286" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_286" use="optional" order="22" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262739" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_351" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_351" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_352" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_352" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_349" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_349" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsReceivedFromInitialPublicOfferingGross" xlink:label="loc_ses_ProceedsReceivedFromInitialPublicOfferingGross_350" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_ses_ProceedsReceivedFromInitialPublicOfferingGross_350" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_353" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_353" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_354" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_354" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsReceivedFromNotePayableToRelatedParty" xlink:label="loc_ses_ProceedsReceivedFromNotePayableToRelatedParty_1353276" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_ses_ProceedsReceivedFromNotePayableToRelatedParty_1353276" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsPaid" xlink:label="loc_ses_OfferingCostsPaid_1353280" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_ses_OfferingCostsPaid_1353280" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_333" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_333" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_348" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_333" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_348" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="loc_ses_PaymentsForInvestmentOfCashInTrustAccount_347" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_333" xlink:to="loc_ses_PaymentsForInvestmentOfCashInTrustAccount_347" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_330" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_330" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_346" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_330" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_346" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_336" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_330" xlink:to="loc_us-gaap_ProfitLoss_336" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_330" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_337" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_us-gaap_InvestmentIncomeInterest_337" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_338" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_338" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsWarrantsIssuance" xlink:label="loc_ses_OfferingCostsWarrantsIssuance_340" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_ses_OfferingCostsWarrantsIssuance_340" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_344" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_344" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_343" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" xlink:to="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_343" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_341" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_341" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_342" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_342" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_IncreaseDecreaseInAccruedExpensesRealtedParties" xlink:label="loc_ses_IncreaseDecreaseInAccruedExpensesRealtedParties_345" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" xlink:to="loc_ses_IncreaseDecreaseInAccruedExpensesRealtedParties_345" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xlink:label="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_339" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_339" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" xlink:label="loc_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares_1353273" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares_1353273" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_356" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_356" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" xlink:label="loc_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote_361" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" xlink:to="loc_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote_361" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Underwritingcommissiondeferred" xlink:label="loc_ses_Underwritingcommissiondeferred_362" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" xlink:to="loc_ses_Underwritingcommissiondeferred_362" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredOfferingCostsIncludedInAccountsPayable" xlink:label="loc_ses_DeferredOfferingCostsIncludedInAccountsPayable_359" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" xlink:to="loc_ses_DeferredOfferingCostsIncludedInAccountsPayable_359" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xlink:label="loc_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses_360" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" xlink:to="loc_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses_360" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262736" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_StatementTable_1262736" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262741" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262736" xlink:to="loc_dei_LegalEntityAxis_1262741" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262742" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262741" xlink:to="loc_dei_EntityDomain_1262742" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262742_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262741" xlink:to="loc_dei_EntityDomain_1262742_default" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1262737" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262736" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1262737" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1262738" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1262737" xlink:to="loc_us-gaap_ClassOfStockDomain_1262738" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1262738_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1262737" xlink:to="loc_us-gaap_ClassOfStockDomain_1262738_default" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_355" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_355" use="optional" order="41" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1263540" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_370" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263540" xlink:to="loc_us-gaap_NatureOfOperations_370" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1263537" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1263540" xlink:to="loc_us-gaap_StatementTable_1263537" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263541" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1263537" xlink:to="loc_dei_LegalEntityAxis_1263541" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263542" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1263541" xlink:to="loc_dei_EntityDomain_1263542" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263542_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1263541" xlink:to="loc_dei_EntityDomain_1263542_default" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1263304" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1263301" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1263304" xlink:to="loc_us-gaap_StatementTable_1263301" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1263302" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1263301" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1263302" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1263303" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1263302" xlink:to="loc_us-gaap_ClassOfStockDomain_1263303" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1263303_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1263302" xlink:to="loc_us-gaap_ClassOfStockDomain_1263303_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263305" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1263301" xlink:to="loc_dei_LegalEntityAxis_1263305" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263306" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1263305" xlink:to="loc_dei_EntityDomain_1263306" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263306_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1263305" xlink:to="loc_dei_EntityDomain_1263306_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_376" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263304" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_376" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1263214" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InitialPublicOfferingTextBlock" xlink:label="loc_ses_InitialPublicOfferingTextBlock_382" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263214" xlink:to="loc_ses_InitialPublicOfferingTextBlock_382" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1263211" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1263214" xlink:to="loc_us-gaap_StatementTable_1263211" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1263212" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1263211" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1263212" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1263213" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1263212" xlink:to="loc_us-gaap_ClassOfStockDomain_1263213" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1263213_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1263212" xlink:to="loc_us-gaap_ClassOfStockDomain_1263213_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263215" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1263211" xlink:to="loc_dei_LegalEntityAxis_1263215" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263217" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1263215" xlink:to="loc_dei_EntityDomain_1263217" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263217_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1263215" xlink:to="loc_dei_EntityDomain_1263217_default" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262895" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementTextBlock" xlink:label="loc_ses_PrivatePlacementTextBlock_388" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262895" xlink:to="loc_ses_PrivatePlacementTextBlock_388" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262887" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262895" xlink:to="loc_us-gaap_StatementTable_1262887" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262888" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262887" xlink:to="loc_dei_LegalEntityAxis_1262888" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262889" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262888" xlink:to="loc_dei_EntityDomain_1262889" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262889_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262888" xlink:to="loc_dei_EntityDomain_1262889_default" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262997" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_394" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262997" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_394" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262993" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262997" xlink:to="loc_us-gaap_StatementTable_1262993" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262994" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262993" xlink:to="loc_dei_LegalEntityAxis_1262994" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262995" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262994" xlink:to="loc_dei_EntityDomain_1262995" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262995_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262994" xlink:to="loc_dei_EntityDomain_1262995_default" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262829" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262825" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262829" xlink:to="loc_us-gaap_StatementTable_1262825" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262826" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262825" xlink:to="loc_dei_LegalEntityAxis_1262826" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262827" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262826" xlink:to="loc_dei_EntityDomain_1262827" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262827_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262826" xlink:to="loc_dei_EntityDomain_1262827_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_400" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262829" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_400" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262776" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_406" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262776" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_406" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262770" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262776" xlink:to="loc_us-gaap_StatementTable_1262770" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262771" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262770" xlink:to="loc_dei_LegalEntityAxis_1262771" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262772" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262771" xlink:to="loc_dei_EntityDomain_1262772" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262772_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262771" xlink:to="loc_dei_EntityDomain_1262772_default" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262705" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TemporaryEquityDisclosureTextBlock" xlink:label="loc_ses_TemporaryEquityDisclosureTextBlock_412" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262705" xlink:to="loc_ses_TemporaryEquityDisclosureTextBlock_412" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262699" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262705" xlink:to="loc_us-gaap_StatementTable_1262699" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262700" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262699" xlink:to="loc_dei_LegalEntityAxis_1262700" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262701" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262700" xlink:to="loc_dei_EntityDomain_1262701" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262701_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262700" xlink:to="loc_dei_EntityDomain_1262701_default" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262588" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_418" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262588" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_418" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262584" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262588" xlink:to="loc_us-gaap_StatementTable_1262584" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262585" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262584" xlink:to="loc_dei_LegalEntityAxis_1262585" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262586" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262585" xlink:to="loc_dei_EntityDomain_1262586" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262586_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262585" xlink:to="loc_dei_EntityDomain_1262586_default" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262461" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262457" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262461" xlink:to="loc_us-gaap_StatementTable_1262457" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262458" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262457" xlink:to="loc_dei_LegalEntityAxis_1262458" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262459" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262458" xlink:to="loc_dei_EntityDomain_1262459" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262459_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262458" xlink:to="loc_dei_EntityDomain_1262459_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_424" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262461" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_424" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262455" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262445" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262455" xlink:to="loc_us-gaap_StatementTable_1262445" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262447" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262445" xlink:to="loc_dei_LegalEntityAxis_1262447" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262448" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262447" xlink:to="loc_dei_EntityDomain_1262448" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262448_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262447" xlink:to="loc_dei_EntityDomain_1262448_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_430" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262455" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_430" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1263312" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_453" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_453" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_ses_EmergingGrowthCompanyPolicyTextBlock_454" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_ses_EmergingGrowthCompanyPolicyTextBlock_454" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_460" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_460" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Derivativewarrantliabilitiespolicytextblock" xlink:label="loc_ses_Derivativewarrantliabilitiespolicytextblock_461" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_ses_Derivativewarrantliabilitiespolicytextblock_461" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_455" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_UseOfEstimates_455" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_457" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_457" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_458" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_458" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_459" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_459" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" xlink:label="loc_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock_462" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock_462" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_456" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_456" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_466" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_466" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1263309" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_StatementTable_1263309" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263313" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1263309" xlink:to="loc_dei_LegalEntityAxis_1263313" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263315" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1263313" xlink:to="loc_dei_EntityDomain_1263315" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263315_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1263313" xlink:to="loc_dei_EntityDomain_1263315_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1263310" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1263309" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1263310" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1263311" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1263310" xlink:to="loc_us-gaap_ClassOfStockDomain_1263311" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1263311_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1263310" xlink:to="loc_us-gaap_ClassOfStockDomain_1263311_default" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_451" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_451" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Commonstocksubjecttopossibleredemptionpolicytextblock" xlink:label="loc_ses_Commonstocksubjecttopossibleredemptionpolicytextblock_463" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_ses_Commonstocksubjecttopossibleredemptionpolicytextblock_463" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_464" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_464" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_465" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_465" use="optional" order="22" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1265560" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1265559" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1265560" xlink:to="loc_us-gaap_StatementTable_1265559" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1265561" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1265559" xlink:to="loc_dei_LegalEntityAxis_1265561" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1265562" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1265561" xlink:to="loc_dei_EntityDomain_1265562" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1265562_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1265561" xlink:to="loc_dei_EntityDomain_1265562_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_474" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1265560" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_474" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262712" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262706" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262712" xlink:to="loc_us-gaap_StatementTable_1262706" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262708" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262706" xlink:to="loc_dei_LegalEntityAxis_1262708" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262710" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262708" xlink:to="loc_dei_EntityDomain_1262710" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262710_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262708" xlink:to="loc_dei_EntityDomain_1262710_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_480" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262712" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_480" use="optional" order="5" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262515" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_488" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262515" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_488" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_489" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262515" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_489" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262511" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262515" xlink:to="loc_us-gaap_StatementTable_1262511" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262512" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262511" xlink:to="loc_dei_LegalEntityAxis_1262512" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262513" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262512" xlink:to="loc_dei_EntityDomain_1262513" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262513_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262512" xlink:to="loc_dei_EntityDomain_1262513_default" use="optional" order="6" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_580" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_580" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_581" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_580" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_581" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_581_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_580" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_581_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_582" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_581" xlink:to="loc_us-gaap_WarrantMember_582" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementWarrantsMember" xlink:label="loc_ses_PrivatePlacementWarrantsMember_602" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantMember_582" xlink:to="loc_ses_PrivatePlacementWarrantsMember_602" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WorkingCapitalLoansWarrantMember" xlink:label="loc_ses_WorkingCapitalLoansWarrantMember_603" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WarrantMember_582" xlink:to="loc_ses_WorkingCapitalLoansWarrantMember_603" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_576" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_576" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_577" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_576" xlink:to="loc_us-gaap_RelatedPartyDomain_577" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_577_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_576" xlink:to="loc_us-gaap_RelatedPartyDomain_577_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SponsorMember" xlink:label="loc_ses_SponsorMember_597" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_577" xlink:to="loc_ses_SponsorMember_597" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_578" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_578" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_579" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_578" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_579" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_579_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_578" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_579_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_599" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_579" xlink:to="loc_us-gaap_PrivatePlacementMember_599" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_598" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_579" xlink:to="loc_us-gaap_IPOMember_598" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_589" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_srt_StatementScenarioAxis_589" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_590" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_589" xlink:to="loc_srt_ScenarioUnspecifiedDomain_590" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_590_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_589" xlink:to="loc_srt_ScenarioUnspecifiedDomain_590_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_587" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_587" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_588" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_587" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_588" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_588_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_587" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_588_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_583" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_StatementClassOfStockAxis_583" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_584" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_583" xlink:to="loc_us-gaap_ClassOfStockDomain_584" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_584_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_583" xlink:to="loc_us-gaap_ClassOfStockDomain_584_default" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_585" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_TypeOfArrangementAxis_585" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_586" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_585" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_586" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_586_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_585" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_586_default" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_591" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_591" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_592" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_591" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_592" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_592_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_591" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_592_default" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_593" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_593" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_594" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_593" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_594" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_594_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_593" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_594_default" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262807" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_dei_LegalEntityAxis_1262807" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262808" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262807" xlink:to="loc_dei_EntityDomain_1262808" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262808_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262807" xlink:to="loc_dei_EntityDomain_1262808_default" use="optional" order="37" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_IvanhoeCapitalAcquisitionCorpMember" xlink:label="loc_ses_IvanhoeCapitalAcquisitionCorpMember_1262809" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1262808" xlink:to="loc_ses_IvanhoeCapitalAcquisitionCorpMember_1262809" use="optional" order="38" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_613" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_613" use="optional" order="39" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_612" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_612" use="optional" order="40" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredOfferingCostsNoncurrent" xlink:label="loc_ses_DeferredOfferingCostsNoncurrent_634" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_DeferredOfferingCostsNoncurrent_634" use="optional" order="41" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SaleOfStockOtherOfferingCosts" xlink:label="loc_ses_SaleOfStockOtherOfferingCosts_635" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_SaleOfStockOtherOfferingCosts_635" use="optional" order="42" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_629" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_629" use="optional" order="43" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_633" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_633" use="optional" order="44" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_646" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_646" use="optional" order="45" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent_647" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_DueToRelatedPartiesNoncurrent_647" use="optional" order="46" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" xlink:label="loc_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital_648" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital_648" use="optional" order="47" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_628" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_628" use="optional" order="48" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_632" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_632" use="optional" order="49" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="loc_ses_PaymentsForInvestmentOfCashInTrustAccount_636" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_PaymentsForInvestmentOfCashInTrustAccount_636" use="optional" order="50" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xlink:label="loc_ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_637" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_637" use="optional" order="51" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xlink:label="loc_ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_638" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_638" use="optional" order="52" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_630" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_630" use="optional" order="53" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionLimitPercentageWithoutPriorConsent" xlink:label="loc_ses_RedemptionLimitPercentageWithoutPriorConsent_640" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_RedemptionLimitPercentageWithoutPriorConsent_640" use="optional" order="54" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_631" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_631" use="optional" order="55" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:label="loc_ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_639" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_639" use="optional" order="56" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Monthstocompleteacquisition" xlink:label="loc_ses_Monthstocompleteacquisition_642" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_Monthstocompleteacquisition_642" use="optional" order="57" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumAllowedDissolutionExpenses" xlink:label="loc_ses_MaximumAllowedDissolutionExpenses_643" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_MaximumAllowedDissolutionExpenses_643" use="optional" order="58" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OperatingBankAccounts" xlink:label="loc_ses_OperatingBankAccounts_644" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_OperatingBankAccounts_644" use="optional" order="59" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WorkingCapital" xlink:label="loc_ses_WorkingCapital_645" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_WorkingCapital_645" use="optional" order="60" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:label="loc_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_641" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_641" use="optional" order="61" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_654" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_654" use="optional" order="62" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_675" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_680" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_680" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_671" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_StatementTable_671" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_672" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_us-gaap_StatementClassOfStockAxis_672" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_673" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_672" xlink:to="loc_us-gaap_ClassOfStockDomain_673" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_673_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_672" xlink:to="loc_us-gaap_ClassOfStockDomain_673_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_674" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_673" xlink:to="loc_us-gaap_CommonClassAMember_674" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonClassaSubjectToRedemptionMember" xlink:label="loc_ses_CommonClassaSubjectToRedemptionMember_676" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_673" xlink:to="loc_ses_CommonClassaSubjectToRedemptionMember_676" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1264060" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1264060" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1264061" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1264060" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1264061" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1264061_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1264060" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1264061_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1264076" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1264076" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1264079" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1264076" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1264079" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1264079_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1264076" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1264079_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263327" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_dei_LegalEntityAxis_1263327" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263328" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1263327" xlink:to="loc_dei_EntityDomain_1263328" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263328_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1263327" xlink:to="loc_dei_EntityDomain_1263328_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1264033" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_srt_RangeAxis_1264033" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1264034" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1264033" xlink:to="loc_srt_RangeMember_1264034" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1264034_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1264033" xlink:to="loc_srt_RangeMember_1264034_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1264057" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1264057" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1264058" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1264057" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1264058" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1264058_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1264057" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1264058_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_677" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_677" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_678" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_678" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_679" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_679" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_681" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_681" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaap_CashFDICInsuredAmount_1263330" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_CashFDICInsuredAmount_1263330" use="optional" order="27" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_824" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_825" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_824" xlink:to="loc_us-gaap_EarningsPerShareAbstract_825" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_826" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_825" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_826" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_830" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_826" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_830" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_833" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_825" xlink:to="loc_us-gaap_EarningsPerShareBasic_833" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_827" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_825" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_827" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_831" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_827" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_831" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_820" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_824" xlink:to="loc_us-gaap_StatementTable_820" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_821" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_820" xlink:to="loc_us-gaap_StatementClassOfStockAxis_821" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_822" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_821" xlink:to="loc_us-gaap_ClassOfStockDomain_822" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_822_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_821" xlink:to="loc_us-gaap_ClassOfStockDomain_822_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_823" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_822" xlink:to="loc_us-gaap_CommonClassAMember_823" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_829" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_822" xlink:to="loc_us-gaap_CommonClassBMember_829" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263803" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_820" xlink:to="loc_dei_LegalEntityAxis_1263803" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263804" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1263803" xlink:to="loc_dei_EntityDomain_1263804" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263804_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1263803" xlink:to="loc_dei_EntityDomain_1263804_default" use="optional" order="15" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_857" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_857" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_860" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_857" xlink:to="loc_us-gaap_StatementClassOfStockAxis_860" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_861" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_860" xlink:to="loc_us-gaap_ClassOfStockDomain_861" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_861_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_860" xlink:to="loc_us-gaap_ClassOfStockDomain_861_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_865" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_861" xlink:to="loc_us-gaap_CommonClassAMember_865" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_858" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_857" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_858" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_859" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_858" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_859" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_859_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_858" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_859_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_863" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_859" xlink:to="loc_us-gaap_IPOMember_863" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_864" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_859" xlink:to="loc_us-gaap_OverAllotmentOptionMember_864" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263223" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_857" xlink:to="loc_dei_LegalEntityAxis_1263223" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263224" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1263223" xlink:to="loc_dei_EntityDomain_1263224" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263224_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1263223" xlink:to="loc_dei_EntityDomain_1263224_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_IvanhoeCapitalAcquisitionCorpMember" xlink:label="loc_ses_IvanhoeCapitalAcquisitionCorpMember_1263227" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_1263224" xlink:to="loc_ses_IvanhoeCapitalAcquisitionCorpMember_1263227" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_869" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_869" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredUnderwritingCommissions" xlink:label="loc_ses_DeferredUnderwritingCommissions_870" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_ses_DeferredUnderwritingCommissions_870" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_NumberOfSharesIssuedPerUnit" xlink:label="loc_ses_NumberOfSharesIssuedPerUnit_871" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_ses_NumberOfSharesIssuedPerUnit_871" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_NumberOfWarrantsIssuedPerUnit" xlink:label="loc_ses_NumberOfWarrantsIssuedPerUnit_872" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_ses_NumberOfWarrantsIssuedPerUnit_872" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_867" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_867" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_866" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_866" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_868" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_868" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_874" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_874" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_873" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_873" use="optional" order="23" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_890" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_890" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_891" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_890" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_891" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_892" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_891" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_892" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_892_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_891" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_892_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_894" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_892" xlink:to="loc_us-gaap_PrivatePlacementMember_894" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262896" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_890" xlink:to="loc_dei_LegalEntityAxis_1262896" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262897" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262896" xlink:to="loc_dei_EntityDomain_1262897" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262897_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262896" xlink:to="loc_dei_EntityDomain_1262897_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_896" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" xlink:to="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_896" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_895" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_895" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_900" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_900" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_899" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_899" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsFromSaleOfUnits" xlink:label="loc_ses_ProceedsFromSaleOfUnits_897" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" xlink:to="loc_ses_ProceedsFromSaleOfUnits_897" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_941" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_935" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_935" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_936" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_935" xlink:to="loc_us-gaap_RelatedPartyDomain_936" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_936_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_935" xlink:to="loc_us-gaap_RelatedPartyDomain_936_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SponsorMember" xlink:label="loc_ses_SponsorMember_943" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_936" xlink:to="loc_ses_SponsorMember_943" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_933" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_933" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_934" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_933" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_934" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_934_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_933" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_934_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FounderSharesMember" xlink:label="loc_ses_FounderSharesMember_942" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_934" xlink:to="loc_ses_FounderSharesMember_942" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_937" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_srt_RangeAxis_937" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_938" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_937" xlink:to="loc_srt_RangeMember_938" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_938_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_937" xlink:to="loc_srt_RangeMember_938_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_945" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_938" xlink:to="loc_srt_MinimumMember_945" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_944" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_938" xlink:to="loc_srt_MaximumMember_944" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_939" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_us-gaap_StatementClassOfStockAxis_939" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_940" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_939" xlink:to="loc_us-gaap_ClassOfStockDomain_940" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_940_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_939" xlink:to="loc_us-gaap_ClassOfStockDomain_940_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_946" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_940" xlink:to="loc_us-gaap_CommonClassAMember_946" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_947" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_940" xlink:to="loc_us-gaap_CommonClassBMember_947" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263041" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_dei_LegalEntityAxis_1263041" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263043" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1263041" xlink:to="loc_dei_EntityDomain_1263043" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263043_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1263041" xlink:to="loc_dei_EntityDomain_1263043_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1263484" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1263484" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1263485" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1263484" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1263485" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1263485_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1263484" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1263485_default" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_948" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_948" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsShares" xlink:label="loc_us-gaap_CommonStockDividendsShares_951" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_us-gaap_CommonStockDividendsShares_951" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_AggregateNumberOfSharesOwned" xlink:label="loc_ses_AggregateNumberOfSharesOwned_952" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_AggregateNumberOfSharesOwned_952" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" xlink:label="loc_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares_954" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares_954" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:label="loc_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination_955" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination_955" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_949" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_949" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_AggregateOfSponsorSharesSurrendered" xlink:label="loc_ses_AggregateOfSponsorSharesSurrendered_950" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_AggregateOfSponsorSharesSurrendered_950" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_NumberOfSharesSubjectToForfeiture" xlink:label="loc_ses_NumberOfSharesSubjectToForfeiture_953" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_NumberOfSharesSubjectToForfeiture_953" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:label="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_956" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_956" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_957" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_957" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_958" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_958" use="optional" order="36" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1006" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_998" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_998" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_999" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_998" xlink:to="loc_us-gaap_RelatedPartyDomain_999" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_999_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_998" xlink:to="loc_us-gaap_RelatedPartyDomain_999_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SponsorMember" xlink:label="loc_ses_SponsorMember_1009" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_999" xlink:to="loc_ses_SponsorMember_1009" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_1010" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_999" xlink:to="loc_srt_ChiefExecutiveOfficerMember_1010" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1000" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1000" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1001" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1000" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1001" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1001_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1000" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1001_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WorkingCapitalLoansWarrantMember" xlink:label="loc_ses_WorkingCapitalLoansWarrantMember_1011" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1001" xlink:to="loc_ses_WorkingCapitalLoansWarrantMember_1011" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_996" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_996" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_997" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_996" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_997" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_997_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_996" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_997_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_AdministrativeSupportAgreementMember" xlink:label="loc_ses_AdministrativeSupportAgreementMember_1007" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_997" xlink:to="loc_ses_AdministrativeSupportAgreementMember_1007" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RelatedPartyLoansMember" xlink:label="loc_ses_RelatedPartyLoansMember_1008" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_997" xlink:to="loc_ses_RelatedPartyLoansMember_1008" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1004" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1004" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1005" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1004" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1005" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1005_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1004" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1005_default" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_1013" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_1005" xlink:to="loc_us-gaap_ConvertibleDebtMember_1013" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262999" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_dei_LegalEntityAxis_1262999" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263000" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262999" xlink:to="loc_dei_EntityDomain_1263000" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263000_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262999" xlink:to="loc_dei_EntityDomain_1263000_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1002" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1002" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1003" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1002" xlink:to="loc_us-gaap_ClassOfStockDomain_1003" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1003_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1002" xlink:to="loc_us-gaap_ClassOfStockDomain_1003_default" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1012" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1003" xlink:to="loc_us-gaap_CommonClassAMember_1012" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConverstionPricePerWarrants" xlink:label="loc_ses_ConverstionPricePerWarrants_1023" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_ses_ConverstionPricePerWarrants_1023" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_1024" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_SharePrice_1024" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1025" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1025" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_1026" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_1026" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:label="loc_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_1014" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_1014" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_1015" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_1015" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:label="loc_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_1017" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_1017" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1018" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1018" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1022" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1022" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumLoansConvertibleIntoWarrants" xlink:label="loc_ses_MaximumLoansConvertibleIntoWarrants_1019" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_ses_MaximumLoansConvertibleIntoWarrants_1019" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_1020" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_1020" use="optional" order="37" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262834" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262830" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_us-gaap_StatementTable_1262830" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262831" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_dei_LegalEntityAxis_1262831" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262832" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262831" xlink:to="loc_dei_EntityDomain_1262832" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262832_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262831" xlink:to="loc_dei_EntityDomain_1262832_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_LeasesArrangementTypeAxis" xlink:label="loc_ses_LeasesArrangementTypeAxis_1264587" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_ses_LeasesArrangementTypeAxis_1264587" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_LeasesArrangementTypeDomain" xlink:label="loc_ses_LeasesArrangementTypeDomain_1264588" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ses_LeasesArrangementTypeAxis_1264587" xlink:to="loc_ses_LeasesArrangementTypeDomain_1264588" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_LeasesArrangementTypeDomain" xlink:label="loc_ses_LeasesArrangementTypeDomain_1264588_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ses_LeasesArrangementTypeAxis_1264587" xlink:to="loc_ses_LeasesArrangementTypeDomain_1264588_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_1264527" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_us-gaap_CreditFacilityAxis_1264527" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_1264529" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1264527" xlink:to="loc_us-gaap_CreditFacilityDomain_1264529" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_1264529_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1264527" xlink:to="loc_us-gaap_CreditFacilityDomain_1264529_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1264581" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_srt_RangeAxis_1264581" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1264582" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1264581" xlink:to="loc_srt_RangeMember_1264582" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1264582_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1264581" xlink:to="loc_srt_RangeMember_1264582_default" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1264486" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1264486" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1264487" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1264486" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1264487" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1264487_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1264486" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1264487_default" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1264490" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_srt_StatementGeographicalAxis_1264490" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1264491" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1264490" xlink:to="loc_srt_SegmentGeographicalDomain_1264491" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1264491_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1264490" xlink:to="loc_srt_SegmentGeographicalDomain_1264491_default" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnderwriterCashDiscount" xlink:label="loc_ses_UnderwriterCashDiscount_1042" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_UnderwriterCashDiscount_1042" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredOfferingCostsNoncurrent" xlink:label="loc_ses_DeferredOfferingCostsNoncurrent_1044" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_DeferredOfferingCostsNoncurrent_1044" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredFeePerUnit" xlink:label="loc_ses_DeferredFeePerUnit_1043" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_DeferredFeePerUnit_1043" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:label="loc_ses_MaximumNumberOfDemandsForRegistrationOfSecurities_1038" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_MaximumNumberOfDemandsForRegistrationOfSecurities_1038" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_1039" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_1039" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueMeasurementOptionTerm" xlink:label="loc_ses_FairValueMeasurementOptionTerm_1040" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_FairValueMeasurementOptionTerm_1040" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnderwritingCashDiscountPerUnit" xlink:label="loc_ses_UnderwritingCashDiscountPerUnit_1041" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_UnderwritingCashDiscountPerUnit_1041" use="optional" order="26" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="loc_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_1104" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_1104" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" xlink:label="loc_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination_1098" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination_1098" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PercentageOfGrossProceedsOnTotalEquityProceeds" xlink:label="loc_ses_PercentageOfGrossProceedsOnTotalEquityProceeds_1099" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_PercentageOfGrossProceedsOnTotalEquityProceeds_1099" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1080" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1080" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1081" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1080" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1081" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1082" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1081" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1082" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1082_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1081" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1082_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PublicWarrantsMember" xlink:label="loc_ses_PublicWarrantsMember_1088" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1082" xlink:to="loc_ses_PublicWarrantsMember_1088" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementWarrantsMember" xlink:label="loc_ses_PrivatePlacementWarrantsMember_1087" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1082" xlink:to="loc_ses_PrivatePlacementWarrantsMember_1087" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1084" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1080" xlink:to="loc_srt_StatementScenarioAxis_1084" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1085" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_1084" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1085" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1085_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_1084" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1085_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_1090" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1085" xlink:to="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_1090" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_1089" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1085" xlink:to="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_1089" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262777" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1080" xlink:to="loc_dei_LegalEntityAxis_1262777" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262778" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262777" xlink:to="loc_dei_EntityDomain_1262778" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262778_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262777" xlink:to="loc_dei_EntityDomain_1262778_default" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1263451" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1080" xlink:to="loc_srt_RangeAxis_1263451" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1263452" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1263451" xlink:to="loc_srt_RangeMember_1263452" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1263452_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1263451" xlink:to="loc_srt_RangeMember_1263452_default" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" xlink:label="loc_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_1102" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_1102" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SharePricetriggerUsedToMeasureDilutionOfWarrant" xlink:label="loc_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant_1103" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant_1103" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1096" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1096" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:label="loc_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_1105" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_1105" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xlink:label="loc_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_1100" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_1100" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" xlink:label="loc_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_1101" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_1101" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xlink:label="loc_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_1094" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_1094" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xlink:label="loc_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_1095" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_1095" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1097" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1097" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1091" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1091" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" xlink:label="loc_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination_1092" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination_1092" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_1106" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_1106" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" xlink:label="loc_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering_1093" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering_1093" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionPeriod" xlink:label="loc_ses_RedemptionPeriod_1108" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_RedemptionPeriod_1108" use="optional" order="34" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" xlink:label="loc_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported_1109" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported_1109" use="optional" order="35" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MultiplierUsedInCalculatingWarrantExercisePrice" xlink:label="loc_ses_MultiplierUsedInCalculatingWarrantExercisePrice_1110" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_MultiplierUsedInCalculatingWarrantExercisePrice_1110" use="optional" order="36" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_1107" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_1107" use="optional" order="37" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1134" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1136" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1136" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1137" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1137" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockNumberOfVotesPerShare" xlink:label="loc_ses_CommonStockNumberOfVotesPerShare_1138" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_ses_CommonStockNumberOfVotesPerShare_1138" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1139" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1139" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsFromIssuanceOfTemporaryEquity" xlink:label="loc_ses_ProceedsFromIssuanceOfTemporaryEquity_1140" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_ses_ProceedsFromIssuanceOfTemporaryEquity_1140" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1130" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1130" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1131" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1130" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1131" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1132" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1131" xlink:to="loc_us-gaap_ClassOfStockDomain_1132" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1132_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1131" xlink:to="loc_us-gaap_ClassOfStockDomain_1132_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1133" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1132" xlink:to="loc_us-gaap_CommonClassAMember_1133" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonClassaSubjectToRedemptionMember" xlink:label="loc_ses_CommonClassaSubjectToRedemptionMember_1135" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1132" xlink:to="loc_ses_CommonClassaSubjectToRedemptionMember_1135" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262713" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1130" xlink:to="loc_dei_LegalEntityAxis_1262713" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262714" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262713" xlink:to="loc_dei_EntityDomain_1262714" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262714_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262713" xlink:to="loc_dei_EntityDomain_1262714_default" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TemporaryEquityFairValueOfWarrantsAtIssuance" xlink:label="loc_ses_TemporaryEquityFairValueOfWarrantsAtIssuance_1141" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_ses_TemporaryEquityFairValueOfWarrantsAtIssuance_1141" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TemporaryEquityIssuanceCosts" xlink:label="loc_ses_TemporaryEquityIssuanceCosts_1142" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_ses_TemporaryEquityIssuanceCosts_1142" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_1143" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_1143" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1144" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1144" use="optional" order="18" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262606" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1156" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262606" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1156" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1153" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262606" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1153" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262601" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1262606" xlink:to="loc_us-gaap_StatementTable_1262601" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262602" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1262601" xlink:to="loc_dei_LegalEntityAxis_1262602" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262603" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262602" xlink:to="loc_dei_EntityDomain_1262603" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262603_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262602" xlink:to="loc_dei_EntityDomain_1262603_default" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1154" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262606" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1154" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1155" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1262606" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1155" use="optional" order="8" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_1178" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1174" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_1178" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1174" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1175" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1174" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1175" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1176" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1175" xlink:to="loc_us-gaap_ClassOfStockDomain_1176" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1176_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1175" xlink:to="loc_us-gaap_ClassOfStockDomain_1176_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1177" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1176" xlink:to="loc_us-gaap_CommonClassAMember_1177" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_1180" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1176" xlink:to="loc_us-gaap_CommonClassBMember_1180" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262679" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1174" xlink:to="loc_dei_LegalEntityAxis_1262679" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262680" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262679" xlink:to="loc_dei_EntityDomain_1262680" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262680_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262679" xlink:to="loc_dei_EntityDomain_1262680_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1263570" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1174" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_1263570" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1263571" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1263570" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1263571" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1263571_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1263570" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1263571_default" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1181" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1178" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1181" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1182" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1178" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1182" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_1184" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1178" xlink:to="loc_us-gaap_CommonStockSharesIssued_1184" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1185" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1178" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1185" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockNumberOfVotesPerShare" xlink:label="loc_ses_CommonStockNumberOfVotesPerShare_1183" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_1178" xlink:to="loc_ses_CommonStockNumberOfVotesPerShare_1183" use="optional" order="17" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1216" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1216" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1210" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1210" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1210" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1210" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1219" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1219" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1220" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1220" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1263456" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1263456" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1214" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1214" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1215" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1214" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1215" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1215_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1214" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1215_default" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PublicWarrantsMember" xlink:label="loc_ses_PublicWarrantsMember_1222" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1215" xlink:to="loc_ses_PublicWarrantsMember_1222" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementWarrantsMember" xlink:label="loc_ses_PrivatePlacementWarrantsMember_1223" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1215" xlink:to="loc_ses_PrivatePlacementWarrantsMember_1223" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InvestmentClassAxis" xlink:label="loc_ses_InvestmentClassAxis_1263457" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_ses_InvestmentClassAxis_1263457" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InvestmentClassDomain" xlink:label="loc_ses_InvestmentClassDomain_1263458" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ses_InvestmentClassAxis_1263457" xlink:to="loc_ses_InvestmentClassDomain_1263458" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InvestmentClassDomain" xlink:label="loc_ses_InvestmentClassDomain_1263458_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ses_InvestmentClassAxis_1263457" xlink:to="loc_ses_InvestmentClassDomain_1263458_default" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1212" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1212" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1213" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1212" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1213" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1213_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1212" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1213_default" use="optional" order="18" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1221" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1213" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1221" use="optional" order="19" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_1263460" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_1263460" use="optional" order="20" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1263461" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_1263460" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1263461" use="optional" order="21" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1263461_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_1263460" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1263461_default" use="optional" order="22" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262532" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_dei_LegalEntityAxis_1262532" use="optional" order="23" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262533" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262532" xlink:to="loc_dei_EntityDomain_1262533" use="optional" order="24" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262533_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262532" xlink:to="loc_dei_EntityDomain_1262533_default" use="optional" order="25" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_1264247" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_us-gaap_InvestmentTypeAxis_1264247" use="optional" order="26" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_1264248" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_1264247" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_1264248" use="optional" order="27" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_1264248_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_1264247" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_1264248_default" use="optional" order="28" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_1217" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1216" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_1217" use="optional" order="29" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1264242" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1217" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1264242" use="optional" order="30" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_1224" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1264242" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_1224" use="optional" order="31" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1218" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1216" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1218" use="optional" order="32" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_1225" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1218" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_1225" use="optional" order="33" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1226" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1218" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1226" use="optional" order="34" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1247" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_1247" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1241" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1241" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1242" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1241" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1242" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1243" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1242" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1243" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1243_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1242" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1243_default" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1245" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1243" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1245" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262547" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1241" xlink:to="loc_dei_LegalEntityAxis_1262547" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262548" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262547" xlink:to="loc_dei_EntityDomain_1262548" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262548_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262547" xlink:to="loc_dei_EntityDomain_1262548_default" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_1248" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" xlink:to="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_1248" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_1249" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" xlink:to="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_1249" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1250" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1250" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_1246" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_1246" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1273" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1268" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1273" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1268" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262557" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1268" xlink:to="loc_dei_LegalEntityAxis_1262557" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262559" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262557" xlink:to="loc_dei_EntityDomain_1262559" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262559_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262557" xlink:to="loc_dei_EntityDomain_1262559_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1271" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1268" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1271" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1272" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1271" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1272" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1272_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1271" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1272_default" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1278" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1272" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1278" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1269" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1268" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1269" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1270" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1269" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1270" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1270_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1269" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1270_default" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1263277" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1270" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1263277" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1274" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1270" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1274" use="optional" order="13" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1275" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1270" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1275" use="optional" order="14" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_1276" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1270" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_1276" use="optional" order="15" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1277" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1270" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1277" use="optional" order="16" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_1279" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1273" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_1279" use="optional" order="17" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="loc_us-gaap_DebtInstrumentMeasurementInput_1280" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1273" xlink:to="loc_us-gaap_DebtInstrumentMeasurementInput_1280" use="optional" order="18" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1299" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1296" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1299" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1296" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1297" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1296" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1297" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1298" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1297" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1298" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1298_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1297" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1298_default" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1301" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1298" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1301" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262575" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1296" xlink:to="loc_dei_LegalEntityAxis_1262575" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262576" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262575" xlink:to="loc_dei_EntityDomain_1262576" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262576_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262575" xlink:to="loc_dei_EntityDomain_1262576_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1299" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1305" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1305" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1302" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1302" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1303" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1303" use="optional" order="12" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1304" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1304" use="optional" order="13" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1324" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1325" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1324" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1325" use="optional" order="1" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xlink:label="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_1329" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1325" xlink:to="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_1329" use="optional" order="2" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1327" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1325" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1327" use="optional" order="3" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueOfConvertibleDebtWithRelatedParties" xlink:label="loc_ses_FairValueOfConvertibleDebtWithRelatedParties_1328" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1325" xlink:to="loc_ses_FairValueOfConvertibleDebtWithRelatedParties_1328" use="optional" order="4" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1321" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1324" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1321" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="5" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1322" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1321" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1322" use="optional" order="6" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1323" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1322" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1323" use="optional" order="7" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1323_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1322" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1323_default" use="optional" order="8" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1326" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1323" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1326" use="optional" order="9" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262578" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1321" xlink:to="loc_dei_LegalEntityAxis_1262578" use="optional" order="10" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262580" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_1262578" xlink:to="loc_dei_EntityDomain_1262580" use="optional" order="11" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262580_default" />
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_1262578" xlink:to="loc_dei_EntityDomain_1262580_default" use="optional" order="12" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>ses-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 01-April-2022 [02:40:47] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract" xml:lang="en-US">Cover [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationTable" xml:lang="en-US">Document Information [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xml:lang="en-US">Class of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockDomain" xml:lang="en-US">Class of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonClassAMember" xml:lang="en-US">Common Class A [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonClassAMember" xml:lang="en-US">Class A Ordinary shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonClassBMember" xml:lang="en-US">Common Class B [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonClassBMember" xml:lang="en-US">Class B Ordinary share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantMember" xml:lang="en-US">Warrant [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WarrantMember" xml:lang="en-US">Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentInformationLineItems" xml:lang="en-US">Document Information [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFilerCategory" xml:lang="en-US">Entity Filer Category</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntitySmallBusiness" xml:lang="en-US">Entity Small Business</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityEmergingGrowthCompany" xml:lang="en-US">Entity Emerging Growth Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityExTransitionPeriod" xml:lang="en-US">Entity Ex Transition Period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentAnnualReport" xml:lang="en-US">Document Annual Report</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentTransitionReport" xml:lang="en-US">Document Transition Report</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityFileNumber" xml:lang="en-US">Entity File Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityTaxIdentificationNumber" xml:lang="en-US">Entity Tax Identification Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_Security12bTitle" xml:lang="en-US">Title of 12(b) Security</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_TradingSymbol" xml:lang="en-US">Trading Symbol</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_SecurityExchangeName" xml:lang="en-US">Security Exchange Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressAddressLine1" xml:lang="en-US">Entity Address, Address Line One</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressCityOrTown" xml:lang="en-US">Entity Address, City or Town</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressStateOrProvince" xml:lang="en-US">Entity Address, State or Province</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityAddressPostalZipCode" xml:lang="en-US">Entity Address, Postal Zip Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CityAreaCode" xml:lang="en-US">City Area Code</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LocalPhoneNumber" xml:lang="en-US">Local Phone Number</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xml:lang="en-US">Entity Well-known Seasoned Issuer</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityVoluntaryFilers" xml:lang="en-US">Entity Voluntary Filers</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCurrentReportingStatus" xml:lang="en-US">Entity Current Reporting Status</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInteractiveDataCurrent" xml:lang="en-US">Entity Interactive Data Current</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityShellCompany" xml:lang="en-US">Entity Shell Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityPublicFloat" xml:lang="en-US">Entity Public Float</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xml:lang="en-US">Entity Common Stock, Shares Outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorName" xml:lang="en-US">Auditor Name</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorFirmId" xml:lang="en-US">Auditor Firm ID</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AuditorLocation" xml:lang="en-US">Auditor Location</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementTable" xml:lang="en-US">Statement [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonClassaSubjectToRedemptionMember" xlink:label="loc_ses_CommonClassaSubjectToRedemptionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_CommonClassaSubjectToRedemptionMember" xml:lang="en-US">Class A Common Stock Subject to Redemption</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_CommonClassaSubjectToRedemptionMember" xml:lang="en-US">Class A Common Stock Subject to Redemption</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_CommonClassaSubjectToRedemptionMember" xlink:to="lab_ses_CommonClassaSubjectToRedemptionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_CommonClassaSubjectToRedemptionMember" xml:lang="en-US">Classification of common stock representing ownership interest in a corporation that is subject to redemption.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementLineItems" xml:lang="en-US">Statement [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US">Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders' Deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Liabilities" xml:lang="en-US">Total liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and Contingencies</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xml:lang="en-US">Commitments and Contingencies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesNoncurrent" xml:lang="en-US">Notes Payable, Related Parties, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesNoncurrent" xml:lang="en-US">Convertible note - related party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesNoncurrent" xml:lang="en-US">Fair Value of convertible note - related party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesNoncurrent" xml:lang="en-US">Convertible note - related party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesNoncurrent" xml:lang="en-US">Fair Value of convertible note - related party, end of period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesNoncurrent" xml:lang="en-US">Fair Value at January 1, 2021</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:to="lab_us-gaap_NotesPayableRelatedPartiesNoncurrent" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredUnderwritingFeePayableNoncurrent" xlink:label="loc_ses_DeferredUnderwritingFeePayableNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_DeferredUnderwritingFeePayableNoncurrent" xml:lang="en-US">Deferred Underwriting Fee Payable, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_DeferredUnderwritingFeePayableNoncurrent" xml:lang="en-US">Deferred underwriting commissions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_DeferredUnderwritingFeePayableNoncurrent" xlink:to="lab_ses_DeferredUnderwritingFeePayableNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_DeferredUnderwritingFeePayableNoncurrent" xml:lang="en-US">The carrying value as of balance sheet date of underwriting fee payable deferred, classified as noncurrent.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xml:lang="en-US">Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xml:lang="en-US">Derivative warrant liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:to="lab_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xml:lang="en-US">Liabilities, Current [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesCurrent" xml:lang="en-US">Total current liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xml:lang="en-US">Notes Payable, Related Parties, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xml:lang="en-US">Note payable - related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued Liabilities, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xml:lang="en-US">Accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent" xml:lang="en-US">Due to Related Parties, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DueToRelatedPartiesCurrent" xml:lang="en-US">Due to related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts Payable, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsPayableCurrent" xml:lang="en-US">Accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xml:lang="en-US">Class A ordinary shares subject to possible redemption, $0.0001 par value; 27,600,000 and -0- shares issued and outstanding at $10.00 per share as of September 30, 2021 and December 31, 2020, respectively</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xml:lang="en-US">Class A ordinary shares subject to possible redemption</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xml:lang="en-US">Shareholders' Deficit:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional Paid in Capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xml:lang="en-US">Additional paid-in capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xml:lang="en-US">Accumulated deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Common Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockValue" xml:lang="en-US">Ordinary shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockValue" xml:lang="en-US">Preferred Stock, Value, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockValue" xml:lang="en-US">Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Stockholders' Equity Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Total shareholders' deficit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Balance at the beginning</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_StockholdersEquity" xml:lang="en-US">Balance at the end</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Liabilities and Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xml:lang="en-US">Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent" xml:lang="en-US">Accrued liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">Assets [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsAbstract" xml:lang="en-US">Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaap_DeferredCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DeferredCosts" xml:lang="en-US">Deferred Costs, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DeferredCosts" xml:lang="en-US">Deferred offering costs associated with Initial Public Offering</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCosts" xlink:to="lab_us-gaap_DeferredCosts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsHeldInTrustNoncurrent" xml:lang="en-US">Assets Held-in-trust, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AssetsHeldInTrustNoncurrent" xml:lang="en-US">Investments held in Trust Account</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="lab_us-gaap_AssetsHeldInTrustNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Assets, Current [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xml:lang="en-US">Current assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US">Cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid Expense, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xml:lang="en-US">Prepaid expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Assets, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_AssetsCurrent" xml:lang="en-US">Total current assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Assets</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_Assets" xml:lang="en-US">Total Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RestatementAxis" xml:lang="en-US">Revision of Prior Period [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RestatementDomain" xml:lang="en-US">Revision of Prior Period [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xml:lang="en-US">Common stock, shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred stock, par value, (per share)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xml:lang="en-US">Preferred stock, par value, (per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Shares Issued, Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xml:lang="en-US">Purchase price, per unit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">stock price per share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xml:lang="en-US">Common shares, par value (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common stock, shares authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xml:lang="en-US">Common shares, shares authorized (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common Stock, Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common stock, shares issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CommonStockSharesIssued" xml:lang="en-US">Common shares, shares issued (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xml:lang="en-US">Temporary equity, par value, (per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred stock, shares authorized</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xml:lang="en-US">Preferred shares, shares authorized</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred Stock, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred stock, shares issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xml:lang="en-US">Preferred shares, shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred Stock, Shares Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred stock, shares outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xml:lang="en-US">Preferred shares, shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xml:lang="en-US">Temporary Equity, Shares Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xml:lang="en-US">Temporary equity, shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xml:lang="en-US">Temporary Equity, Shares Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xml:lang="en-US">Temporary equity, shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeStatementAbstract" xml:lang="en-US">Income Statement [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Fair Value Adjustment of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Change in fair value of derivative warrant liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xml:lang="en-US">Change in fair value of derivative warrant liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaap_GainLossOnInvestments" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GainLossOnInvestments" xml:lang="en-US">Gain (Loss) on Investments</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_GainLossOnInvestments" xml:lang="en-US">Income from investments held in Trust Account</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xlink:label="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xml:lang="en-US">Fair Value Adjustment Of Convertible Debt With Related Parties</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xml:lang="en-US">Change in fair value of convertible note - related party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xml:lang="en-US">Change in fair value of convertible note &#8211; related party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xml:lang="en-US">Change in fair value of convertible note - related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xlink:to="lab_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xml:lang="en-US">Amount of expense (income) related to adjustment to fair value of Convertible debt with related parties.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsWarrantsIssuance" xlink:label="loc_ses_OfferingCostsWarrantsIssuance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_OfferingCostsWarrantsIssuance" xml:lang="en-US">Offering Costs Warrants Issuance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ses_OfferingCostsWarrantsIssuance" xml:lang="en-US">Offering costs - derivative warrant liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_OfferingCostsWarrantsIssuance" xml:lang="en-US">Offering costs - derivative warrant liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_OfferingCostsWarrantsIssuance" xlink:to="lab_ses_OfferingCostsWarrantsIssuance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_OfferingCostsWarrantsIssuance" xml:lang="en-US">Represents the amount of offering costs incurred during issuance of warrants.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and Administrative Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xml:lang="en-US">General and administrative expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Earnings Per Share, Basic and Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xml:lang="en-US">Net loss per share, basic and diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xml:lang="en-US">Weighted-average shares outstanding, basic and diluted</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xml:lang="en-US">Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xml:lang="en-US">General and administrative expenses - related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net Income (Loss) Attributable to Parent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net income (loss)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NetIncomeLoss" xml:lang="en-US">Net income (loss)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CostsAndExpenses" xml:lang="en-US">Costs and Expenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_us-gaap_CostsAndExpenses" xml:lang="en-US">Total operating expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Shares issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Number of shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharesIssued" xml:lang="en-US">Shares, Issued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_SharesIssued" xml:lang="en-US">Balance at the beginning (in shares)</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_SharesIssued" xml:lang="en-US">Balance at the end (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockSubjectToPossibleRedemptionValue" xlink:label="loc_ses_CommonStockSubjectToPossibleRedemptionValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_CommonStockSubjectToPossibleRedemptionValue" xml:lang="en-US">Common Stock Subject To Possible Redemption, Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ses_CommonStockSubjectToPossibleRedemptionValue" xml:lang="en-US">Accretion of Class A ordinary shares subject to redemption</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_CommonStockSubjectToPossibleRedemptionValue" xlink:to="lab_ses_CommonStockSubjectToPossibleRedemptionValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_CommonStockSubjectToPossibleRedemptionValue" xml:lang="en-US">Equity impact of the value of common stock subject to possible redemption.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Issuance of Class B common stock to Sponsors</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xml:lang="en-US">Aggregate purchase price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xml:lang="en-US">Equity Components [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EquityComponentDomain" xml:lang="en-US">Equity Component [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Retained Earnings [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RetainedEarningsMember" xml:lang="en-US">Accumulated Deficit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockMember" xml:lang="en-US">Common Stock [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xml:lang="en-US">Proceeds from Issuance of Private Placement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xml:lang="en-US">Proceeds received from private placement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US">Payments of Stock Issuance Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US">Offering costs paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xml:lang="en-US">Offering cost</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xml:lang="en-US">Proceeds from (Repayments of) Related Party Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xml:lang="en-US">Payment of note payable to related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsReceivedFromInitialPublicOfferingGross" xlink:label="loc_ses_ProceedsReceivedFromInitialPublicOfferingGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ProceedsReceivedFromInitialPublicOfferingGross" xml:lang="en-US">Proceeds received from initial public offering, gross</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ProceedsReceivedFromInitialPublicOfferingGross" xml:lang="en-US">Proceeds received from Initial Public Offering, gross</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ProceedsReceivedFromInitialPublicOfferingGross" xlink:to="lab_ses_ProceedsReceivedFromInitialPublicOfferingGross" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ProceedsReceivedFromInitialPublicOfferingGross" xml:lang="en-US">Proceeds received from initial public offering, gross</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xml:lang="en-US">Proceeds from Related Party Debt</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xml:lang="en-US">Proceeds from convertible note to related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRelatedPartyDebt" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xml:lang="en-US">Net cash provided by financing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsReceivedFromNotePayableToRelatedParty" xlink:label="loc_ses_ProceedsReceivedFromNotePayableToRelatedParty" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ProceedsReceivedFromNotePayableToRelatedParty" xml:lang="en-US">Proceeds Received From Note Payable To Related Party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ProceedsReceivedFromNotePayableToRelatedParty" xlink:to="lab_ses_ProceedsReceivedFromNotePayableToRelatedParty" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ProceedsReceivedFromNotePayableToRelatedParty" xml:lang="en-US">Proceeds received from note payable to related party.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsPaid" xlink:label="loc_ses_OfferingCostsPaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_OfferingCostsPaid" xml:lang="en-US">Offering Costs Paid</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ses_OfferingCostsPaid" xml:lang="en-US">Offering Costs Paid</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_OfferingCostsPaid" xlink:to="lab_ses_OfferingCostsPaid" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_OfferingCostsPaid" xml:lang="en-US">Offering costs paid.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xml:lang="en-US">Net cash used in investing activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="loc_ses_PaymentsForInvestmentOfCashInTrustAccount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_PaymentsForInvestmentOfCashInTrustAccount" xml:lang="en-US">Payments for investment of cash in Trust Account</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ses_PaymentsForInvestmentOfCashInTrustAccount" xml:lang="en-US">Cash deposited in Trust Account</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_PaymentsForInvestmentOfCashInTrustAccount" xlink:to="lab_ses_PaymentsForInvestmentOfCashInTrustAccount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_PaymentsForInvestmentOfCashInTrustAccount" xml:lang="en-US">The amount of cash outflow for investment of cash in trust account.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xml:lang="en-US">Net cash used in operating activities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProfitLoss" xml:lang="en-US">Net loss</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xml:lang="en-US">Investment Income, Interest</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xml:lang="en-US">Income from investments held in Trust Account</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xml:lang="en-US">Accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xml:lang="en-US">Increase (Decrease) in Due to Related Parties, Current</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xml:lang="en-US">Due to related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:to="lab_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xml:lang="en-US">Prepaid expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xml:lang="en-US">Accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_IncreaseDecreaseInAccruedExpensesRealtedParties" xlink:label="loc_ses_IncreaseDecreaseInAccruedExpensesRealtedParties" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_IncreaseDecreaseInAccruedExpensesRealtedParties" xml:lang="en-US">Increase Decrease in accrued expenses realted parties</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_IncreaseDecreaseInAccruedExpensesRealtedParties" xml:lang="en-US">Accrued liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_IncreaseDecreaseInAccruedExpensesRealtedParties" xlink:to="lab_ses_IncreaseDecreaseInAccruedExpensesRealtedParties" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_IncreaseDecreaseInAccruedExpensesRealtedParties" xml:lang="en-US">Increase Decrease in accrued expenses realted parties</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" xlink:label="loc_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" xml:lang="en-US">General And Adminstartive Expenses Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" xml:lang="en-US">General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" xlink:to="lab_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" xml:lang="en-US">General and adminstartive expenses paid by sponsor in exchange for issuance of class B ordinary shares.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Cash - end of the period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xml:lang="en-US">Cash - beginning of the period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xml:lang="en-US">Supplemental disclosure of noncash financing activities:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" xlink:label="loc_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" xml:lang="en-US">Deferred Offering Costs Paid by Sponsor Under Promissory Note</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" xml:lang="en-US">Deferred offering costs paid by Sponsor under promissory note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" xlink:to="lab_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" xml:lang="en-US">Amount of deferred offering costs paid by Sponsor under promissory note in noncash investing and financing activities.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Underwritingcommissiondeferred" xlink:label="loc_ses_Underwritingcommissiondeferred" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_Underwritingcommissiondeferred" xml:lang="en-US">UnderwritingCommissionDeferred</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_Underwritingcommissiondeferred" xml:lang="en-US">Deferred underwriting commissions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_Underwritingcommissiondeferred" xlink:to="lab_ses_Underwritingcommissiondeferred" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_Underwritingcommissiondeferred" xml:lang="en-US">The amount of deferred underwriter commission during a noncash or partial noncash transaction.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredOfferingCostsIncludedInAccountsPayable" xlink:label="loc_ses_DeferredOfferingCostsIncludedInAccountsPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_DeferredOfferingCostsIncludedInAccountsPayable" xml:lang="en-US">Deferred Offering Costs included in Accounts Payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_DeferredOfferingCostsIncludedInAccountsPayable" xml:lang="en-US">Deferred offering costs included in accounts payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_DeferredOfferingCostsIncludedInAccountsPayable" xlink:to="lab_ses_DeferredOfferingCostsIncludedInAccountsPayable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_DeferredOfferingCostsIncludedInAccountsPayable" xml:lang="en-US">Amount of deferred offering costs included in accounts payable in noncash investing and financing activities.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xlink:label="loc_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xml:lang="en-US">OfferingCostsIncludedInAccountsPayableAccruedExpenses</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xml:lang="en-US">Offering costs included in accrued expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xlink:to="lab_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xml:lang="en-US">The amount of offering costs included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NatureOfOperations" xml:lang="en-US">Nature of Operations [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NatureOfOperations" xml:lang="en-US">Description of Organization and Business Operations</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xml:lang="en-US">Accounting Policies [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InitialPublicOfferingAbstract" xlink:label="loc_ses_InitialPublicOfferingAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_InitialPublicOfferingAbstract" xml:lang="en-US">Initial Public Offering.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_InitialPublicOfferingAbstract" xlink:to="lab_ses_InitialPublicOfferingAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_InitialPublicOfferingAbstract" xml:lang="en-US">No definition available.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InitialPublicOfferingTextBlock" xlink:label="loc_ses_InitialPublicOfferingTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_InitialPublicOfferingTextBlock" xml:lang="en-US">Initial Public Offering [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_InitialPublicOfferingTextBlock" xml:lang="en-US">Initial Public Offering</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_InitialPublicOfferingTextBlock" xlink:to="lab_ses_InitialPublicOfferingTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_InitialPublicOfferingTextBlock" xml:lang="en-US">The entire disclosure on information about initial public offering.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementAbstract" xlink:label="loc_ses_PrivatePlacementAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_PrivatePlacementAbstract" xml:lang="en-US">Private Placement.</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_PrivatePlacementAbstract" xlink:to="lab_ses_PrivatePlacementAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_PrivatePlacementAbstract" xml:lang="en-US">No definition available.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementTextBlock" xlink:label="loc_ses_PrivatePlacementTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_PrivatePlacementTextBlock" xml:lang="en-US">Private Placement [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_PrivatePlacementTextBlock" xml:lang="en-US">Private Placement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_PrivatePlacementTextBlock" xlink:to="lab_ses_PrivatePlacementTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_PrivatePlacementTextBlock" xml:lang="en-US">The entire disclosure on information about private placement.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xml:lang="en-US">Related Party Transactions [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US">Related Party Transactions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US">Commitments and Contingencies</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xml:lang="en-US">Derivative Warrant Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="lab_us-gaap_TemporaryEquityDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TemporaryEquityDisclosureTextBlock" xlink:label="loc_ses_TemporaryEquityDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_TemporaryEquityDisclosureTextBlock" xml:lang="en-US">Temporary Equity Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_TemporaryEquityDisclosureTextBlock" xml:lang="en-US">Class A Ordinary Shares Subject to Possible Redemption</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_TemporaryEquityDisclosureTextBlock" xlink:to="lab_ses_TemporaryEquityDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_TemporaryEquityDisclosureTextBlock" xml:lang="en-US">The entire disclosure for temporary equity.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xml:lang="en-US">Stockholders' Equity Note [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US">Shareholders' Equity (Deficit)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xml:lang="en-US">Fair Value Disclosures [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xml:lang="en-US">Fair Value Measurements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xml:lang="en-US">Subsequent Events [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events [Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xml:lang="en-US">Subsequent Events</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xml:lang="en-US">Principles of Consolidation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_ses_EmergingGrowthCompanyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_EmergingGrowthCompanyPolicyTextBlock" xml:lang="en-US">Emerging Growth Company [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_EmergingGrowthCompanyPolicyTextBlock" xml:lang="en-US">Emerging Growth Company</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_EmergingGrowthCompanyPolicyTextBlock" xlink:to="lab_ses_EmergingGrowthCompanyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_EmergingGrowthCompanyPolicyTextBlock" xml:lang="en-US">Represents the accounting policy on Emerging Growth Company.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xml:lang="en-US">Fair Value Measurements</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Derivativewarrantliabilitiespolicytextblock" xlink:label="loc_ses_Derivativewarrantliabilitiespolicytextblock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_Derivativewarrantliabilitiespolicytextblock" xml:lang="en-US">DerivativeWarrantLiabilitiesPolicyTextBlock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_Derivativewarrantliabilitiespolicytextblock" xml:lang="en-US">Derivative Warrant Liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_Derivativewarrantliabilitiespolicytextblock" xlink:to="lab_ses_Derivativewarrantliabilitiespolicytextblock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_Derivativewarrantliabilitiespolicytextblock" xml:lang="en-US">No definition available.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UseOfEstimates" xml:lang="en-US">Use of Estimates</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xml:lang="en-US">Concentration of Credit Risk</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xml:lang="en-US">Investments Held in Trust Account</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xml:lang="en-US">Fair Value of Financial Instruments</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" xlink:label="loc_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" xml:lang="en-US">OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" xml:lang="en-US">Offering Costs Associated with the Initial Public Offering</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" xlink:to="lab_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" xml:lang="en-US">Represents the accounting policy on offering costs associated with initial public offering.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xml:lang="en-US">Cash and Cash Equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xml:lang="en-US">Recent Issued Accounting Standards</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xml:lang="en-US">Basis of Presentation</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Commonstocksubjecttopossibleredemptionpolicytextblock" xlink:label="loc_ses_Commonstocksubjecttopossibleredemptionpolicytextblock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_Commonstocksubjecttopossibleredemptionpolicytextblock" xml:lang="en-US">CommonStockSubjectToPossibleRedemptionPolicyTextBlock</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_Commonstocksubjecttopossibleredemptionpolicytextblock" xml:lang="en-US">Class A Ordinary Shares Subject to Possible Redemption</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_Commonstocksubjecttopossibleredemptionpolicytextblock" xlink:to="lab_ses_Commonstocksubjecttopossibleredemptionpolicytextblock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_Commonstocksubjecttopossibleredemptionpolicytextblock" xml:lang="en-US">Represents the accounting policy on common stock subject to possible redemption.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xml:lang="en-US">Income Taxes</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xml:lang="en-US">Net Income (Loss) Per Ordinary Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xml:lang="en-US">Schedule of basic and diluted net income (loss) per common share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xml:lang="en-US">Temporary Equity [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xml:lang="en-US">Schedule of reconciliation of Class A ordinary share subject to possible redemption reflected on the condensed balance sheet</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xml:lang="en-US">Schedule of company's financial assets and liabilities that are measured at fair value on a recurring basis</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xml:lang="en-US">Schedule of quantitative information regarding and derivative warrant liabilities measured Level 3 fair value measurements inputs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xml:lang="en-US">Class of Warrant or Right [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xml:lang="en-US">Class of Warrant or Right [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementWarrantsMember" xlink:label="loc_ses_PrivatePlacementWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_PrivatePlacementWarrantsMember" xml:lang="en-US">Private Placement Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_PrivatePlacementWarrantsMember" xlink:to="lab_ses_PrivatePlacementWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_PrivatePlacementWarrantsMember" xml:lang="en-US">Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WorkingCapitalLoansWarrantMember" xlink:label="loc_ses_WorkingCapitalLoansWarrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_WorkingCapitalLoansWarrantMember" xml:lang="en-US">Working capital loans warrant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_WorkingCapitalLoansWarrantMember" xlink:to="lab_ses_WorkingCapitalLoansWarrantMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_WorkingCapitalLoansWarrantMember" xml:lang="en-US">Working capital loans warrant.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xml:lang="en-US">Related Party [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyDomain" xml:lang="en-US">Related Party [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SponsorMember" xlink:label="loc_ses_SponsorMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_SponsorMember" xml:lang="en-US">Sponsor</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_SponsorMember" xlink:to="lab_ses_SponsorMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_SponsorMember" xml:lang="en-US">This member stands for sponsor.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xml:lang="en-US">Sale of Stock [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xml:lang="en-US">Sale of Stock [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PrivatePlacementMember" xml:lang="en-US">Private Placement [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_IPOMember" xml:lang="en-US">IPO [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementScenarioAxis" xml:lang="en-US">Scenario [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xml:lang="en-US">Scenario [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_UnitsIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Units Issued During Period, Shares, New Issues</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ses_UnitsIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Numbers of units issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="lab_ses_UnitsIssuedDuringPeriodSharesNewIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_UnitsIssuedDuringPeriodSharesNewIssues" xml:lang="en-US">Number of new units issued during the period.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredOfferingCostsNoncurrent" xlink:label="loc_ses_DeferredOfferingCostsNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_DeferredOfferingCostsNoncurrent" xml:lang="en-US">Deferred underwriting fee payable</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_DeferredOfferingCostsNoncurrent" xml:lang="en-US">Deferred underwriting commissions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ses_DeferredOfferingCostsNoncurrent" xml:lang="en-US">Deferred underwriting fee payable</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_DeferredOfferingCostsNoncurrent" xlink:to="lab_ses_DeferredOfferingCostsNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_DeferredOfferingCostsNoncurrent" xml:lang="en-US">The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SaleOfStockOtherOfferingCosts" xlink:label="loc_ses_SaleOfStockOtherOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_SaleOfStockOtherOfferingCosts" xml:lang="en-US">Sale of Stock, Other Offering Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_SaleOfStockOtherOfferingCosts" xml:lang="en-US">Other offering costs</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_SaleOfStockOtherOfferingCosts" xlink:to="lab_ses_SaleOfStockOtherOfferingCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_SaleOfStockOtherOfferingCosts" xml:lang="en-US">Represents the amount of other offering costs incurred.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xml:lang="en-US">Number of warrants to purchase shares issued</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xml:lang="en-US">Sale of Stock, Price Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xml:lang="en-US">Sale of stock, price per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DueToRelatedPartiesNoncurrent" xml:lang="en-US">Due to Related Parties, Noncurrent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DueToRelatedPartiesNoncurrent" xml:lang="en-US">Amount borrowed</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesNoncurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesNoncurrent" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" xlink:label="loc_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" xml:lang="en-US">Maximum Borrowing Capacity Of Related Party Drawn Under Working Capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" xml:lang="en-US">Maximum borrowing capacity of working capital loan</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" xlink:to="lab_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" xml:lang="en-US">Amount of maximum borrowing capacity of related party was drawn under the Working Capital Loan.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xlink:label="loc_ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xml:lang="en-US">Condition for future business combination use of proceeds percentage</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xlink:to="lab_ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xml:lang="en-US">The threshold percentage of the assets held in the trust account funded by proceeds from the offering which must be used for purposes of consummating a business combination.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xlink:label="loc_ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xml:lang="en-US">Condition for future business combination threshold Percentage Ownership</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xlink:to="lab_ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xml:lang="en-US">The threshold percentage of voting interest to be acquired in a future business combination as specified for the use of proceeds from the offering.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xml:lang="en-US">Class of Warrant or Right, Price of Warrants or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xml:lang="en-US">Price of warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xml:lang="en-US">Price of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:to="lab_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xml:lang="en-US">Price per share or per unit of warrants or rights outstanding.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionLimitPercentageWithoutPriorConsent" xlink:label="loc_ses_RedemptionLimitPercentageWithoutPriorConsent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_RedemptionLimitPercentageWithoutPriorConsent" xml:lang="en-US">Redemption Limit Percentage Without Prior Consent</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_RedemptionLimitPercentageWithoutPriorConsent" xml:lang="en-US">Redemption limit percentage without prior consent</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_RedemptionLimitPercentageWithoutPriorConsent" xlink:to="lab_ses_RedemptionLimitPercentageWithoutPriorConsent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_RedemptionLimitPercentageWithoutPriorConsent" xml:lang="en-US">The limit on the percentage of shares which may be redeemed with out prior consent of the reporting entity.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Aggregate purchase price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xml:lang="en-US">Proceeds From Issuance Of Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:label="loc_ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xml:lang="en-US">Condition for future business combination threshold Net Tangible Assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:to="lab_ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xml:lang="en-US">The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Monthstocompleteacquisition" xlink:label="loc_ses_Monthstocompleteacquisition" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_Monthstocompleteacquisition" xml:lang="en-US">Months to complete acquisition</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_Monthstocompleteacquisition" xlink:to="lab_ses_Monthstocompleteacquisition" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_Monthstocompleteacquisition" xml:lang="en-US">Represents the anticipated business timeline in months for completing a business combination.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumAllowedDissolutionExpenses" xlink:label="loc_ses_MaximumAllowedDissolutionExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_MaximumAllowedDissolutionExpenses" xml:lang="en-US">Maximum Allowed Dissolution Expenses</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_MaximumAllowedDissolutionExpenses" xlink:to="lab_ses_MaximumAllowedDissolutionExpenses" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_MaximumAllowedDissolutionExpenses" xml:lang="en-US">The maximum amount permitted to be paid for dissolution expenses if a business combination is not completed within the specified period.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OperatingBankAccounts" xlink:label="loc_ses_OperatingBankAccounts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_OperatingBankAccounts" xml:lang="en-US">Operating Bank Accounts</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_OperatingBankAccounts" xml:lang="en-US">Operating bank accounts</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_OperatingBankAccounts" xlink:to="lab_ses_OperatingBankAccounts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_OperatingBankAccounts" xml:lang="en-US">Amount of operating bank accounts.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WorkingCapital" xlink:label="loc_ses_WorkingCapital" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_WorkingCapital" xml:lang="en-US">Working Capital</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_WorkingCapital" xml:lang="en-US">Working capital</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_WorkingCapital" xlink:to="lab_ses_WorkingCapital" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_WorkingCapital" xml:lang="en-US">Amount of working capital.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:label="loc_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xml:lang="en-US">Percentage Obligation To Redeem Public Shares If Entity Does Not Complete A Business Combination</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xml:lang="en-US">Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:to="lab_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xml:lang="en-US">Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xml:lang="en-US">Notes Payable, Related Parties</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xml:lang="en-US">Convertible note - related party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xml:lang="en-US">Outstanding balance of related party note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xml:lang="en-US">Related Party Transaction [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xml:lang="en-US">Related Party Transaction [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xml:lang="en-US">Business Acquisition [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xml:lang="en-US">Subsequent Event Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xml:lang="en-US">Subsequent Event Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_IvanhoeCapitalAcquisitionCorpMember" xlink:label="loc_ses_IvanhoeCapitalAcquisitionCorpMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_IvanhoeCapitalAcquisitionCorpMember" xml:lang="en-US">Ivanhoe Capital Acquisition Corp [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_IvanhoeCapitalAcquisitionCorpMember" xml:lang="en-US">Ivanhoe Capital Acquisition Corp [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_IvanhoeCapitalAcquisitionCorpMember" xlink:to="lab_ses_IvanhoeCapitalAcquisitionCorpMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_IvanhoeCapitalAcquisitionCorpMember" xml:lang="en-US">Ivanhoe Capital Acquisition Corp [Member]</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xml:lang="en-US">Balance Sheet Location [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xml:lang="en-US">Balance Sheet Location [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xml:lang="en-US">Long-term Debt, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xml:lang="en-US">Long-term Debt, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xml:lang="en-US">Cash Equivalents, at Carrying Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xml:lang="en-US">Cash equivalents</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xml:lang="en-US">Unrecognized Tax Benefits</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xml:lang="en-US">Unrecognized tax benefits accrued for interest and penalties</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xml:lang="en-US">Anti-dilutive securities attributable to warrants (in shares)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaap_CashFDICInsuredAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xml:lang="en-US">Cash, FDIC Insured Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xml:lang="en-US">Cash that is insured with federal insurance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFDICInsuredAmount" xlink:to="lab_us-gaap_CashFDICInsuredAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis" xml:lang="en-US">Statistical Measurement [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeMember" xml:lang="en-US">Statistical Measurement [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">Earnings Per Share [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xml:lang="en-US">Basic and diluted net income (loss) per ordinary share:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xml:lang="en-US">Numerator:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xml:lang="en-US">Allocation of net income (loss)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Earnings Per Share, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_EarningsPerShareBasic" xml:lang="en-US">Basic net income (loss) per ordinary share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xml:lang="en-US">Denominator:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xml:lang="en-US">Basic weighted average ordinary shares outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xml:lang="en-US">Over-Allotment Option [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredUnderwritingCommissions" xlink:label="loc_ses_DeferredUnderwritingCommissions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_DeferredUnderwritingCommissions" xml:lang="en-US">Deferred Underwriting Commissions</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_DeferredUnderwritingCommissions" xml:lang="en-US">Deferred underwriting commissions</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_DeferredUnderwritingCommissions" xlink:to="lab_ses_DeferredUnderwritingCommissions" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_DeferredUnderwritingCommissions" xml:lang="en-US">Amount of unrecognized fee revenue received from underwriting that is deferred.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_NumberOfSharesIssuedPerUnit" xlink:label="loc_ses_NumberOfSharesIssuedPerUnit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_NumberOfSharesIssuedPerUnit" xml:lang="en-US">Number of Shares Issued Per Unit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_NumberOfSharesIssuedPerUnit" xml:lang="en-US">Number of shares in a unit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_NumberOfSharesIssuedPerUnit" xlink:to="lab_ses_NumberOfSharesIssuedPerUnit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_NumberOfSharesIssuedPerUnit" xml:lang="en-US">Represents the number of shares in a unit.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_NumberOfWarrantsIssuedPerUnit" xlink:label="loc_ses_NumberOfWarrantsIssuedPerUnit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_NumberOfWarrantsIssuedPerUnit" xml:lang="en-US">Number of Warrants Issued Per Unit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_NumberOfWarrantsIssuedPerUnit" xml:lang="en-US">Number of warrants in a unit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_NumberOfWarrantsIssuedPerUnit" xlink:to="lab_ses_NumberOfWarrantsIssuedPerUnit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_NumberOfWarrantsIssuedPerUnit" xml:lang="en-US">Represents the number of warrants in a unit.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xml:lang="en-US">Proceeds from Issuance or Sale of Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xml:lang="en-US">Gross proceeds</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="lab_us-gaap_ProceedsFromIssuanceOrSaleOfEquity" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Exercise price of warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xml:lang="en-US">Exercise price of warrant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xml:lang="en-US">Number of shares issuable per warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xml:lang="en-US">Number of shares per warrant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsFromSaleOfUnits" xlink:label="loc_ses_ProceedsFromSaleOfUnits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ProceedsFromSaleOfUnits" xml:lang="en-US">Proceeds From Sale Of Units</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ProceedsFromSaleOfUnits" xml:lang="en-US">Proceeds from sale of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ProceedsFromSaleOfUnits" xlink:to="lab_ses_ProceedsFromSaleOfUnits" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ProceedsFromSaleOfUnits" xml:lang="en-US">This represents Proceeds from Sale of Units.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FounderSharesMember" xlink:label="loc_ses_FounderSharesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_FounderSharesMember" xml:lang="en-US">Founder Shares</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_FounderSharesMember" xlink:to="lab_ses_FounderSharesMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_FounderSharesMember" xml:lang="en-US">The member represents Founder shares.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xml:lang="en-US">Related Party Transaction [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsShares" xlink:label="loc_us-gaap_CommonStockDividendsShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CommonStockDividendsShares" xml:lang="en-US">Common Stock Dividends, Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_CommonStockDividendsShares" xml:lang="en-US">Share dividend</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsShares" xlink:to="lab_us-gaap_CommonStockDividendsShares" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_AggregateNumberOfSharesOwned" xlink:label="loc_ses_AggregateNumberOfSharesOwned" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_AggregateNumberOfSharesOwned" xml:lang="en-US">Aggregate Number Of Shares Owned</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_AggregateNumberOfSharesOwned" xml:lang="en-US">Aggregate number of shares owned</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_AggregateNumberOfSharesOwned" xlink:to="lab_ses_AggregateNumberOfSharesOwned" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_AggregateNumberOfSharesOwned" xml:lang="en-US">The number of shares owned by the founders after the impact of the stock dividend.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" xlink:label="loc_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" xml:lang="en-US">Common Stock Shares Subject To Forfeiture AsPercent Of Issued And Outstanding Shares</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" xml:lang="en-US">Common stock, shares subject to forfeiture, as a percent of issued and outstanding shares (as a percent)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" xlink:to="lab_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" xml:lang="en-US">Number of shares of the company that are subject to forfeiture represented as a percentage of issued and outstanding stock as a result of partial exercise of over-allotment option.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:label="loc_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xml:lang="en-US">Percentage Of Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xml:lang="en-US">Percentage of assign or sale of shares or warrants, after the completion of the initial business combination</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:to="lab_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xml:lang="en-US">Percentage of assign or sell any shares or warrants after completion of initial business combination.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_AggregateOfSponsorSharesSurrendered" xlink:label="loc_ses_AggregateOfSponsorSharesSurrendered" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_AggregateOfSponsorSharesSurrendered" xml:lang="en-US">Aggregate Of Sponsor Shares Surrendered</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_AggregateOfSponsorSharesSurrendered" xml:lang="en-US">Number of shares surrender</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_AggregateOfSponsorSharesSurrendered" xlink:to="lab_ses_AggregateOfSponsorSharesSurrendered" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_AggregateOfSponsorSharesSurrendered" xml:lang="en-US">Represents the number of common stock shares subject aggregate of sponsor surrendered.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_NumberOfSharesSubjectToForfeiture" xlink:label="loc_ses_NumberOfSharesSubjectToForfeiture" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_NumberOfSharesSubjectToForfeiture" xml:lang="en-US">Number Of Shares Subject To Forfeiture</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_NumberOfSharesSubjectToForfeiture" xml:lang="en-US">Shares subject to forfeiture</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_NumberOfSharesSubjectToForfeiture" xlink:to="lab_ses_NumberOfSharesSubjectToForfeiture" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_NumberOfSharesSubjectToForfeiture" xml:lang="en-US">The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:label="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xml:lang="en-US">Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Stock Price Trigger</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xml:lang="en-US">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:to="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xml:lang="en-US">The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xml:lang="en-US">Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Trading Days</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xml:lang="en-US">Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:to="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xml:lang="en-US">When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xml:lang="en-US">Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Consecutive Trading Days</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xml:lang="en-US">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:to="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xml:lang="en-US">When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember" xml:lang="en-US">Minimum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember" xml:lang="en-US">Maximum [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xml:lang="en-US">Chief Executive Officer [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_AdministrativeSupportAgreementMember" xlink:label="loc_ses_AdministrativeSupportAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_AdministrativeSupportAgreementMember" xml:lang="en-US">Administrative Support Agreement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_AdministrativeSupportAgreementMember" xlink:to="lab_ses_AdministrativeSupportAgreementMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_AdministrativeSupportAgreementMember" xml:lang="en-US">This member stands for Administrative Support Agreement.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RelatedPartyLoansMember" xlink:label="loc_ses_RelatedPartyLoansMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_RelatedPartyLoansMember" xml:lang="en-US">Related Party Loans [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_RelatedPartyLoansMember" xlink:to="lab_ses_RelatedPartyLoansMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_RelatedPartyLoansMember" xml:lang="en-US">This member stands for related party loans.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xml:lang="en-US">Short-term Debt, Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xml:lang="en-US">Short-term Debt, Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ConvertibleDebtMember" xml:lang="en-US">Convertible Debt [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConverstionPricePerWarrants" xlink:label="loc_ses_ConverstionPricePerWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ConverstionPricePerWarrants" xml:lang="en-US">Converstion Price Per Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ConverstionPricePerWarrants" xml:lang="en-US">Conversion price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ConverstionPricePerWarrants" xlink:to="lab_ses_ConverstionPricePerWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ConverstionPricePerWarrants" xml:lang="en-US">This elements represents conversion price per warrants.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_SharePrice" xml:lang="en-US">Share Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_SharePrice" xml:lang="en-US">Ordinary share price, per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:label="loc_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xml:lang="en-US">Maximum Borrowing Capacity of Related Party Promissory Note</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xml:lang="en-US">Maximum borrowing capacity of related party promissory note</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:to="lab_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xml:lang="en-US">Amount of maximum borrowing capacity of related party promissory note.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:label="loc_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party Per Month</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xml:lang="en-US">Expenses per month</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:to="lab_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xml:lang="en-US">The contractual monthly amount to be paid for support services.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xml:lang="en-US">Expenses incurred and paid</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumLoansConvertibleIntoWarrants" xlink:label="loc_ses_MaximumLoansConvertibleIntoWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_MaximumLoansConvertibleIntoWarrants" xml:lang="en-US">maximum Loans Convertible Into Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_MaximumLoansConvertibleIntoWarrants" xml:lang="en-US">Loan conversion agreement warrant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_MaximumLoansConvertibleIntoWarrants" xlink:to="lab_ses_MaximumLoansConvertibleIntoWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_MaximumLoansConvertibleIntoWarrants" xml:lang="en-US">The maximum amount which a potential loan could have repaid through issuance of warrants.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnderwriterCashDiscount" xlink:label="loc_ses_UnderwriterCashDiscount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_UnderwriterCashDiscount" xml:lang="en-US">Underwriter cash discount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_UnderwriterCashDiscount" xml:lang="en-US">Underwriter cash discount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_UnderwriterCashDiscount" xlink:to="lab_ses_UnderwriterCashDiscount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_UnderwriterCashDiscount" xml:lang="en-US">Represents the cash underwriting discount per unit.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredFeePerUnit" xlink:label="loc_ses_DeferredFeePerUnit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_DeferredFeePerUnit" xml:lang="en-US">Deferred Fee Per Unit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_DeferredFeePerUnit" xml:lang="en-US">Deferred fee per unit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_DeferredFeePerUnit" xlink:to="lab_ses_DeferredFeePerUnit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_DeferredFeePerUnit" xml:lang="en-US">Represents the deferred fee per unit.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:label="loc_ses_MaximumNumberOfDemandsForRegistrationOfSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_MaximumNumberOfDemandsForRegistrationOfSecurities" xml:lang="en-US">Maximum Number Of Demands For Registration Of Securities</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_MaximumNumberOfDemandsForRegistrationOfSecurities" xml:lang="en-US">Maximum number of demands for registration of securities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:to="lab_ses_MaximumNumberOfDemandsForRegistrationOfSecurities" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_MaximumNumberOfDemandsForRegistrationOfSecurities" xml:lang="en-US">Represents the maximum number of demands for registration of securities.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueMeasurementOptionTerm" xlink:label="loc_ses_FairValueMeasurementOptionTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_FairValueMeasurementOptionTerm" xml:lang="en-US">Fair Value Measurement Option Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ses_FairValueMeasurementOptionTerm" xml:lang="en-US">Granted the underwriters</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_FairValueMeasurementOptionTerm" xlink:to="lab_ses_FairValueMeasurementOptionTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_FairValueMeasurementOptionTerm" xml:lang="en-US">The term of fair value measurement option</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnderwritingCashDiscountPerUnit" xlink:label="loc_ses_UnderwritingCashDiscountPerUnit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_UnderwritingCashDiscountPerUnit" xml:lang="en-US">Underwriting cash discount per unit</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_UnderwritingCashDiscountPerUnit" xml:lang="en-US">Underwriting cash discount per unit</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_UnderwritingCashDiscountPerUnit" xlink:to="lab_ses_UnderwritingCashDiscountPerUnit" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_UnderwritingCashDiscountPerUnit" xml:lang="en-US">Represents the cash underwriting discount per unit.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_LeasesArrangementTypeAxis" xlink:label="loc_ses_LeasesArrangementTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_LeasesArrangementTypeAxis" xml:lang="en-US">Leases Arrangement Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_LeasesArrangementTypeAxis" xlink:to="lab_ses_LeasesArrangementTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_LeasesArrangementTypeAxis" xml:lang="en-US">Leases arrangement type.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_LeasesArrangementTypeDomain" xlink:label="loc_ses_LeasesArrangementTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_LeasesArrangementTypeDomain" xml:lang="en-US">Leases Arrangement Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_LeasesArrangementTypeDomain" xlink:to="lab_ses_LeasesArrangementTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_LeasesArrangementTypeDomain" xml:lang="en-US">Leases arrangement type.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CreditFacilityAxis" xml:lang="en-US">Credit Facility [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CreditFacilityDomain" xml:lang="en-US">Credit Facility [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_StatementGeographicalAxis" xml:lang="en-US">Geographical [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_SegmentGeographicalDomain" xml:lang="en-US">Geographical [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xml:lang="en-US">Class of Warrant or Right [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PublicWarrantsMember" xlink:label="loc_ses_PublicWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_PublicWarrantsMember" xml:lang="en-US">Public Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_PublicWarrantsMember" xlink:to="lab_ses_PublicWarrantsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_PublicWarrantsMember" xml:lang="en-US">Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xml:lang="en-US">Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:to="lab_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xml:lang="en-US">This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $10.00.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xml:lang="en-US">Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:to="lab_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xml:lang="en-US">This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xml:lang="en-US">Class of Warrant or Right [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="loc_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xml:lang="en-US">Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xml:lang="en-US">Redemption price per public warrant (in dollars per share)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:to="lab_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xml:lang="en-US">Redemption price per share or per unit of warrants or rights outstanding.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" xlink:label="loc_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" xml:lang="en-US">Threshold Issue Price For Capital Raising Purposes In Connection With Closing Of Business Combination</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" xml:lang="en-US">Threshold issue price per share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" xlink:to="lab_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" xml:lang="en-US">Represents the information pertaining to threshold issue price for capital raising purposes in connection with the closure of a business combination.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PercentageOfGrossProceedsOnTotalEquityProceeds" xlink:label="loc_ses_PercentageOfGrossProceedsOnTotalEquityProceeds" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_PercentageOfGrossProceedsOnTotalEquityProceeds" xml:lang="en-US">Percentage Of Gross Proceeds On Total Equity Proceeds</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_PercentageOfGrossProceedsOnTotalEquityProceeds" xml:lang="en-US">Percentage of gross proceeds on total equity proceeds</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_PercentageOfGrossProceedsOnTotalEquityProceeds" xlink:to="lab_ses_PercentageOfGrossProceedsOnTotalEquityProceeds" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_PercentageOfGrossProceedsOnTotalEquityProceeds" xml:lang="en-US">Represents the percentage of gross proceeds on total equity proceeds.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" xlink:label="loc_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" xml:lang="en-US">Class of Warrant or Right, Adjustment of Redemption Price of Warrants or Rights, Percent, Based On Market Value And Newly Issued Price 1</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" xml:lang="en-US">Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" xlink:to="lab_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" xml:lang="en-US">Percentage of adjustment of redemption price of stock based on market value and newly issued price.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SharePricetriggerUsedToMeasureDilutionOfWarrant" xlink:label="loc_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant" xml:lang="en-US">Share PriceTrigger Used To Measure Dilution Of Warrant</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant" xml:lang="en-US">Share price trigger used to measure dilution of warrant</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant" xlink:to="lab_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant" xml:lang="en-US">The cutoff price used to measure whether dilution of the warrant has occurred. Shares issued below this price will cause the exercise price of the warrant to be adjusted.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:label="loc_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xml:lang="en-US">Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xml:lang="en-US">Minimum threshold written notice period for redemption of public warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:to="lab_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xml:lang="en-US">The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xlink:label="loc_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xml:lang="en-US">Threshold Number Of Specified Trading Days Determining Volume Weighted Average Trading Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xml:lang="en-US">Threshold trading days determining volume weighted average price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xlink:to="lab_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xml:lang="en-US">The threshold number of specified trading period determining volume weighted average trading price , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" xlink:label="loc_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" xml:lang="en-US">Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" xml:lang="en-US">Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" xlink:to="lab_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" xml:lang="en-US">Percentage of adjustment of exercise price of warrants based on market value and newly issued price.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xlink:label="loc_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xml:lang="en-US">Maximum Period After Business Combination In Which To File Registration Statement</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xml:lang="en-US">Maximum period after business combination in which to file registration statement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xlink:to="lab_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xml:lang="en-US">The period of time after completion of a business combination in which the reporting entity is required to file a registration statement with the SEC.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xlink:label="loc_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xml:lang="en-US">Period Of Time Within Which Registration Statement Is Expected To Become Effective</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xml:lang="en-US">Period of time within which registration statement is expected to become effective</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xlink:to="lab_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xml:lang="en-US">The period of time after filing within which the registration statement filed with the SEC is expected to become effective.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xml:lang="en-US">Warrants and Rights Outstanding, Term</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xml:lang="en-US">Public Warrants expiration term</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xml:lang="en-US">Warrants outstanding</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" xlink:label="loc_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" xml:lang="en-US">Warrants And Rights Outstanding Exercisable Term After Business Combination</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" xml:lang="en-US">Public Warrants exercisable term after the completion of a business combination</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" xlink:to="lab_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" xml:lang="en-US">The warrants exercisable term after the completion of a business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xml:lang="en-US">Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xml:lang="en-US">Threshold trading days for redemption of public warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:to="lab_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xml:lang="en-US">Threshold number of specified trading days for stock price trigger considered for redemption of warrants.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" xlink:label="loc_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" xml:lang="en-US">Warrants And Rights Outstanding Exercisable Term From Closing Of Public Offering</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" xml:lang="en-US">Public Warrants exercisable term from the closing of the initial public offering</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" xlink:to="lab_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" xml:lang="en-US">The warrants exercisable term from the closing of the public offering, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionPeriod" xlink:label="loc_ses_RedemptionPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_RedemptionPeriod" xml:lang="en-US">Redemption Period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_RedemptionPeriod" xml:lang="en-US">Redemption period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_RedemptionPeriod" xlink:to="lab_ses_RedemptionPeriod" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_RedemptionPeriod" xml:lang="en-US">Redemption period.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" xlink:label="loc_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" xml:lang="en-US">Common Stock, Trading Days On Which Fair Market Value Of Shares Is Reported</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" xml:lang="en-US">Number of trading days on which fair market value of shares is reported</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" xlink:to="lab_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" xml:lang="en-US">The number of trading days on which fair market value of shares is reported.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MultiplierUsedInCalculatingWarrantExercisePrice" xlink:label="loc_ses_MultiplierUsedInCalculatingWarrantExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_MultiplierUsedInCalculatingWarrantExercisePrice" xml:lang="en-US">Multiplier Used In Calculating Warrant Exercise Price</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_MultiplierUsedInCalculatingWarrantExercisePrice" xml:lang="en-US">Multiplier used in calculating warrant exercise price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_MultiplierUsedInCalculatingWarrantExercisePrice" xlink:to="lab_ses_MultiplierUsedInCalculatingWarrantExercisePrice" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_MultiplierUsedInCalculatingWarrantExercisePrice" xml:lang="en-US">Multiplier used in calculating warrant exercise price.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xml:lang="en-US">Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xml:lang="en-US">Threshold consecutive trading days for redemption of public warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:to="lab_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xml:lang="en-US">Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xml:lang="en-US">Temporary Equity [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockNumberOfVotesPerShare" xlink:label="loc_ses_CommonStockNumberOfVotesPerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_CommonStockNumberOfVotesPerShare" xml:lang="en-US">Common Stock, Number Of Votes Per Share</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_CommonStockNumberOfVotesPerShare" xml:lang="en-US">Common Stock, Number Of Votes Per Share</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_CommonStockNumberOfVotesPerShare" xlink:to="lab_ses_CommonStockNumberOfVotesPerShare" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_CommonStockNumberOfVotesPerShare" xml:lang="en-US">The number of votes that each common share is entitled.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsFromIssuanceOfTemporaryEquity" xlink:label="loc_ses_ProceedsFromIssuanceOfTemporaryEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_ProceedsFromIssuanceOfTemporaryEquity" xml:lang="en-US">Proceeds from Issuance of Temporary Equity</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_ProceedsFromIssuanceOfTemporaryEquity" xml:lang="en-US">Gross proceeds from Initial Public Offering</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_ProceedsFromIssuanceOfTemporaryEquity" xlink:to="lab_ses_ProceedsFromIssuanceOfTemporaryEquity" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_ProceedsFromIssuanceOfTemporaryEquity" xml:lang="en-US">The cash inflow from issuance of temporary equity.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TemporaryEquityFairValueOfWarrantsAtIssuance" xlink:label="loc_ses_TemporaryEquityFairValueOfWarrantsAtIssuance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_TemporaryEquityFairValueOfWarrantsAtIssuance" xml:lang="en-US">Temporary Equity , Fair Value of Warrants At Issuance</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_TemporaryEquityFairValueOfWarrantsAtIssuance" xml:lang="en-US">Fair value of Public Warrants at issuance</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_TemporaryEquityFairValueOfWarrantsAtIssuance" xlink:to="lab_ses_TemporaryEquityFairValueOfWarrantsAtIssuance" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_TemporaryEquityFairValueOfWarrantsAtIssuance" xml:lang="en-US">Amount of fair value of warrants at issuance.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TemporaryEquityIssuanceCosts" xlink:label="loc_ses_TemporaryEquityIssuanceCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_TemporaryEquityIssuanceCosts" xml:lang="en-US">Temporary Equity, Issuance Costs</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_TemporaryEquityIssuanceCosts" xml:lang="en-US">Offering costs allocated to Class A ordinary shares subject to possible redemption</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_TemporaryEquityIssuanceCosts" xlink:to="lab_ses_TemporaryEquityIssuanceCosts" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_TemporaryEquityIssuanceCosts" xml:lang="en-US">Amount of issuance costs related to temporary equity.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xml:lang="en-US">Accretion on Class A ordinary shares subject to possible redemption amount</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xml:lang="en-US">Schedule of Stock by Class [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_ClassOfStockLineItems" xml:lang="en-US">Class of Stock [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Level 3</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xml:lang="en-US">Level 3</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xml:lang="en-US">Level 2</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xml:lang="en-US">Assets:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosureAbstract" xml:lang="en-US">Investments, Fair Value Disclosure [Abstract]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosureAbstract" xml:lang="en-US">Short-term investments:</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xml:lang="en-US">Investments, Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xml:lang="en-US">Investments held in Trust Account</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InvestmentClassAxis" xlink:label="loc_ses_InvestmentClassAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_InvestmentClassAxis" xml:lang="en-US">Investment Class [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_InvestmentClassAxis" xlink:to="lab_ses_InvestmentClassAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_InvestmentClassAxis" xml:lang="en-US">Investment class.</label>
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InvestmentClassDomain" xlink:label="loc_ses_InvestmentClassDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_InvestmentClassDomain" xml:lang="en-US">Investment Class [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_InvestmentClassDomain" xlink:to="lab_ses_InvestmentClassDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_InvestmentClassDomain" xml:lang="en-US">Investment class.</label>
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xml:lang="en-US">Measurement Frequency [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xml:lang="en-US">Measurement Frequency [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xml:lang="en-US">Fair Value, Recurring [Member]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xml:lang="en-US">Cash and Cash Equivalents [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xml:lang="en-US">Cash and Cash Equivalents [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentTypeAxis" xml:lang="en-US">Investment Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xml:lang="en-US">Investments [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xml:lang="en-US">Fair value liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xml:lang="en-US">Fair Value, Assets, Level 1 to Level 2 Transfers, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xml:lang="en-US">Fair value assets level 1 to level 2 transfers</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:to="lab_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xml:lang="en-US">Fair Value, Assets, Level 2 to Level 1 Transfers, Amount</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xml:lang="en-US">Fair value assets level 2 to level 1 transfers</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:to="lab_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xml:lang="en-US">Fair value assets transferred into (out of) level 3</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xml:lang="en-US">Assets, Fair Value Disclosure</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xml:lang="en-US">Fair value assets</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xml:lang="en-US">Derivative Liability, Measurement Input</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xml:lang="en-US">Fair value measurements inputs at their measurement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="lab_us-gaap_DerivativeLiabilityMeasurementInput" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="loc_us-gaap_DebtInstrumentMeasurementInput" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_DebtInstrumentMeasurementInput" xml:lang="en-US">Debt Instrument, Measurement Input</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_DebtInstrumentMeasurementInput" xml:lang="en-US">Fair value measurements inputs used by the estimated fair value of warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMeasurementInput" xlink:to="lab_us-gaap_DebtInstrumentMeasurementInput" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xml:lang="en-US">Measurement Input Type [Axis]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xml:lang="en-US">Measurement Input Type [Domain]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xml:lang="en-US">Expected dividends</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xml:lang="en-US">Measurement Input, Expected Term [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xml:lang="en-US">Option term (in years)</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xml:lang="en-US">Measurement Input, Share Price [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xml:lang="en-US">Stock price</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xml:lang="en-US">Measurement Input, Price Volatility [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xml:lang="en-US">Volatility</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xml:lang="en-US">Risk-free interest rate</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xml:lang="en-US">Change in fair value of derivative warrant liabilities</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Derivative warrant liabilities ending of the period</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xml:lang="en-US">Derivative warrant liabilities beginning of the period</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xml:lang="en-US">Issuance of Public and Private Warrants</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xml:lang="en-US">Transfer of Public Warrants to Level 1 measurement</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueOfConvertibleDebtWithRelatedParties" xlink:label="loc_ses_FairValueOfConvertibleDebtWithRelatedParties" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ses_FairValueOfConvertibleDebtWithRelatedParties" xml:lang="en-US">Fair Value Of Convertible Debt With Related Parties</label>
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ses_FairValueOfConvertibleDebtWithRelatedParties" xml:lang="en-US">Initial fair value of convertible note - related party</label>
<labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ses_FairValueOfConvertibleDebtWithRelatedParties" xlink:to="lab_ses_FairValueOfConvertibleDebtWithRelatedParties" />
<label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_ses_FairValueOfConvertibleDebtWithRelatedParties" xml:lang="en-US">Represents the amount of fair value of Convertible debt with related parties.</label>
</labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>ses-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 01-April-2022 [02:40:47] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CoverPage" roleURI="http://www.ivanhoecapitalacquisition.com/role/CoverPage" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedBalanceSheets" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedStatementsOfOperations" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CondensedConsolidatedStatementOfCashFlows" roleURI="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#DescriptionOfOrganizationAndBusinessOperations" roleURI="http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#InitialPublicOffering" roleURI="http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#PrivatePlacement" roleURI="http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#RelatedPartyTransactions" roleURI="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CommitmentsAndContingencies" roleURI="http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#DerivativeWarrantLiabilities" roleURI="http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ClassAOrdinarySharesSubjectToPossibleRedemption" roleURI="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ShareholdersEquityDeficit" roleURI="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurements" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SubsequentEvents" roleURI="http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ClassAOrdinarySharesSubjectToPossibleRedemptionTables" roleURI="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsTables" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#DescriptionOfOrganizationAndBusinessOperationsDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SummaryOfSignificantAccountingPoliciesDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#InitialPublicOfferingDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#PrivatePlacementDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#RelatedPartyTransactionsFounderSharesDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#RelatedPartyTransactionsAdditionalInformationDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#CommitmentsAndContingenciesAdditionalInformationDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#DerivativeWarrantLiabilitiesAdditionalInformationDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ClassAOrdinarySharesSubjectToPossibleRedemptionDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ShareholdersEquityDeficitPreferredStockSharesDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#ShareholdersEquityDeficitCommonStockDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsAdditionalInformationDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails" />
<roleRef xlink:type="simple" xlink:href="ses-20211231.xsd#FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails" roleURI="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails" />
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CoverPage">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_1264905" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="loc_dei_DocumentInformationTable_1353661" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1264905" xlink:to="loc_dei_DocumentInformationTable_1353661" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1353663" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1353661" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1353663" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1353666" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1353663" xlink:to="loc_us-gaap_ClassOfStockDomain_1353666" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1353667" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1353666" xlink:to="loc_us-gaap_CommonClassAMember_1353667" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_1353668" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1353666" xlink:to="loc_us-gaap_CommonClassBMember_1353668" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_1353705" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1353666" xlink:to="loc_us-gaap_WarrantMember_1353705" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="loc_dei_DocumentInformationLineItems_1353671" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_1353661" xlink:to="loc_dei_DocumentInformationLineItems_1353671" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_1264906" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentType_1264906" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_1264914" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_AmendmentFlag_1264914" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_dei_DocumentAnnualReport_1353675" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentAnnualReport_1353675" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_dei_DocumentTransitionReport_1353676" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentTransitionReport_1353676" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_1353680" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityFileNumber_1353680" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_1353677" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentPeriodEndDate_1353677" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_1353678" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentFiscalYearFocus_1353678" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_1353679" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_DocumentFiscalPeriodFocus_1353679" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_1353697" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_CurrentFiscalYearEndDate_1353697" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_1264907" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityRegistrantName_1264907" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_1264912" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityCentralIndexKey_1264912" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1353681" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1353681" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_1353682" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityTaxIdentificationNumber_1353682" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_1353689" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityAddressAddressLine1_1353689" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_1353690" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityAddressCityOrTown_1353690" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_1353691" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityAddressStateOrProvince_1353691" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_1353692" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityAddressPostalZipCode_1353692" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_1353693" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_CityAreaCode_1353693" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_1353694" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_LocalPhoneNumber_1353694" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_1264908" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityFilerCategory_1264908" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_1353683" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_Security12bTitle_1353683" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_1353684" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_TradingSymbol_1353684" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_1353685" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_SecurityExchangeName_1353685" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_1353698" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_1353698" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_1353699" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityVoluntaryFilers_1353699" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_1353700" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityCurrentReportingStatus_1353700" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_dei_EntityInteractiveDataCurrent_1353701" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityInteractiveDataCurrent_1353701" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_dei_EntitySmallBusiness_1264909" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntitySmallBusiness_1264909" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_1264910" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityEmergingGrowthCompany_1264910" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_dei_EntityExTransitionPeriod_1265088" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityExTransitionPeriod_1265088" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_dei_EntityShellCompany_1353702" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityShellCompany_1353702" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_1353703" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityPublicFloat_1353703" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_1353704" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_1353704" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="loc_dei_AuditorName_1364829" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_AuditorName_1364829" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="loc_dei_AuditorFirmId_1364830" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_AuditorFirmId_1364830" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="loc_dei_AuditorLocation_1364831" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_1353671" xlink:to="loc_dei_AuditorLocation_1364831" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/label" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_124" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_125" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_124" xlink:to="loc_us-gaap_StatementTable_125" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_126" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_125" xlink:to="loc_us-gaap_StatementClassOfStockAxis_126" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_127" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_126" xlink:to="loc_us-gaap_ClassOfStockDomain_127" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_128" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_127" xlink:to="loc_us-gaap_CommonClassAMember_128" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonClassaSubjectToRedemptionMember" xlink:label="loc_ses_CommonClassaSubjectToRedemptionMember_135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_127" xlink:to="loc_ses_CommonClassaSubjectToRedemptionMember_135" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_127" xlink:to="loc_us-gaap_CommonClassBMember_136" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262682" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_125" xlink:to="loc_dei_LegalEntityAxis_1262682" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262683" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262682" xlink:to="loc_dei_EntityDomain_1262683" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1269076" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_125" xlink:to="loc_srt_RestatementAxis_1269076" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1269077" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_1269076" xlink:to="loc_srt_RestatementDomain_1269077" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_129" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_125" xlink:to="loc_us-gaap_StatementLineItems_129" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_129" xlink:to="loc_us-gaap_AssetsAbstract_130" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_130" xlink:to="loc_us-gaap_AssetsCurrentAbstract_131" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_131" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_137" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_131" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_138" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_131" xlink:to="loc_us-gaap_AssetsCurrent_139" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="loc_us-gaap_AssetsHeldInTrustNoncurrent_140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_130" xlink:to="loc_us-gaap_AssetsHeldInTrustNoncurrent_140" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCosts" xlink:label="loc_us-gaap_DeferredCosts_141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_130" xlink:to="loc_us-gaap_DeferredCosts_141" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_130" xlink:to="loc_us-gaap_Assets_142" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_129" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_133" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_143" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_133" xlink:to="loc_us-gaap_AccountsPayableCurrent_143" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_144" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_133" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_144" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_145" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_133" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_145" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_146" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_133" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_146" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_147" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_133" xlink:to="loc_us-gaap_LiabilitiesCurrent_147" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent_148" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent_148" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_149" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_149" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredUnderwritingFeePayableNoncurrent" xlink:label="loc_ses_DeferredUnderwritingFeePayableNoncurrent_150" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_ses_DeferredUnderwritingFeePayableNoncurrent_150" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_151" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_151" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_152" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_Liabilities_152" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_CommitmentsAndContingencies_153" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_154" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_154" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_134" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_StockholdersEquityAbstract_134" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_155" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_134" xlink:to="loc_us-gaap_PreferredStockValue_155" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_156" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_134" xlink:to="loc_us-gaap_CommonStockValue_156" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_157" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_134" xlink:to="loc_us-gaap_AdditionalPaidInCapital_157" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_158" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_134" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_158" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_159" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_134" xlink:to="loc_us-gaap_StockholdersEquity_159" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_160" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_132" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_160" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_183" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_184" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_183" xlink:to="loc_us-gaap_StatementTable_184" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_185" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_us-gaap_StatementClassOfStockAxis_185" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_186" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_185" xlink:to="loc_us-gaap_ClassOfStockDomain_186" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonClassaSubjectToRedemptionMember" xlink:label="loc_ses_CommonClassaSubjectToRedemptionMember_189" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_186" xlink:to="loc_ses_CommonClassaSubjectToRedemptionMember_189" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_187" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_186" xlink:to="loc_us-gaap_CommonClassAMember_187" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_190" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_186" xlink:to="loc_us-gaap_CommonClassBMember_190" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262686" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_dei_LegalEntityAxis_1262686" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262687" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262686" xlink:to="loc_dei_EntityDomain_1262687" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis" xlink:label="loc_srt_RestatementAxis_1269080" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_srt_RestatementAxis_1269080" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain" xlink:label="loc_srt_RestatementDomain_1269082" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_1269080" xlink:to="loc_srt_RestatementDomain_1269082" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_188" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_184" xlink:to="loc_us-gaap_StatementLineItems_188" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_191" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_191" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_192" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_192" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_193" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_PreferredStockSharesIssued_193" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_194" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_194" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_195" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_195" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_196" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_196" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_197" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_CommonStockSharesIssued_197" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_198" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_198" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_199" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_199" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_200" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_200" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_201" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_201" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_202" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_188" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_202" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_226" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_227" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_226" xlink:to="loc_us-gaap_StatementTable_227" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_228" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_227" xlink:to="loc_us-gaap_StatementClassOfStockAxis_228" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_229" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_228" xlink:to="loc_us-gaap_ClassOfStockDomain_229" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_230" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_229" xlink:to="loc_us-gaap_CommonClassAMember_230" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_234" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_229" xlink:to="loc_us-gaap_CommonClassBMember_234" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262696" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_227" xlink:to="loc_dei_LegalEntityAxis_1262696" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262697" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262696" xlink:to="loc_dei_EntityDomain_1262697" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_231" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_227" xlink:to="loc_us-gaap_StatementLineItems_231" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_235" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_235" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_236" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_236" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaap_CostsAndExpenses_237" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_CostsAndExpenses_237" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments" xlink:label="loc_us-gaap_GainLossOnInvestments_238" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_GainLossOnInvestments_238" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_239" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_239" use="optional" order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xlink:label="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_240" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_240" use="optional" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsWarrantsIssuance" xlink:label="loc_ses_OfferingCostsWarrantsIssuance_241" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_232" xlink:to="loc_ses_OfferingCostsWarrantsIssuance_241" use="optional" order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_242" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_NetIncomeLoss_242" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_1264259" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_1264259" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1264261" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_231" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1264261" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_270" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_271" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_270" xlink:to="loc_us-gaap_StatementTable_271" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_272" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_271" xlink:to="loc_us-gaap_StatementClassOfStockAxis_272" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_278" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_272" xlink:to="loc_us-gaap_ClassOfStockDomain_278" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_278" xlink:to="loc_us-gaap_CommonClassAMember_276" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_277" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_278" xlink:to="loc_us-gaap_CommonClassBMember_277" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_273" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_271" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_273" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_282" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_273" xlink:to="loc_us-gaap_EquityComponentDomain_282" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_279" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_282" xlink:to="loc_us-gaap_CommonStockMember_279" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_280" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_282" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_280" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_281" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_282" xlink:to="loc_us-gaap_RetainedEarningsMember_281" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262727" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_271" xlink:to="loc_dei_LegalEntityAxis_1262727" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262728" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262727" xlink:to="loc_dei_EntityDomain_1262728" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_274" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_271" xlink:to="loc_us-gaap_StatementLineItems_274" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_274" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_283" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_StockholdersEquity_283" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_284" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_SharesIssued_284" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockSubjectToPossibleRedemptionValue" xlink:label="loc_ses_CommonStockSubjectToPossibleRedemptionValue_285" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_ses_CommonStockSubjectToPossibleRedemptionValue_285" use="optional" order="17" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_286" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_286" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_287" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_287" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_288" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_NetIncomeLoss_288" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_289" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_StockholdersEquity_289" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_290" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_275" xlink:to="loc_us-gaap_SharesIssued_290" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_329" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262736" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_329" xlink:to="loc_us-gaap_StatementTable_1262736" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262741" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262736" xlink:to="loc_dei_LegalEntityAxis_1262741" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262742" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262741" xlink:to="loc_dei_EntityDomain_1262742" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1262737" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262736" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1262737" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1262738" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1262737" xlink:to="loc_us-gaap_ClassOfStockDomain_1262738" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262739" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262736" xlink:to="loc_us-gaap_StatementLineItems_1262739" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_330" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_330" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaap_ProfitLoss_336" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_330" xlink:to="loc_us-gaap_ProfitLoss_336" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_330" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares" xlink:label="loc_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares_1353273" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares_1353273" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_337" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_us-gaap_InvestmentIncomeInterest_337" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_338" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_338" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xlink:label="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_339" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_339" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsWarrantsIssuance" xlink:label="loc_ses_OfferingCostsWarrantsIssuance_340" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_ses_OfferingCostsWarrantsIssuance_340" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_331" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_341" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_341" use="optional" order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_342" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_342" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_343" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" xlink:to="loc_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent_343" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_344" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_344" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_IncreaseDecreaseInAccruedExpensesRealtedParties" xlink:label="loc_ses_IncreaseDecreaseInAccruedExpensesRealtedParties_345" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_332" xlink:to="loc_ses_IncreaseDecreaseInAccruedExpensesRealtedParties_345" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_346" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_330" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_346" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_333" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_333" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="loc_ses_PaymentsForInvestmentOfCashInTrustAccount_347" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_333" xlink:to="loc_ses_PaymentsForInvestmentOfCashInTrustAccount_347" use="optional" order="23" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_348" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_333" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_348" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_349" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_349" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsReceivedFromInitialPublicOfferingGross" xlink:label="loc_ses_ProceedsReceivedFromInitialPublicOfferingGross_350" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_ses_ProceedsReceivedFromInitialPublicOfferingGross_350" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_351" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_351" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_352" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_352" use="optional" order="29" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsReceivedFromNotePayableToRelatedParty" xlink:label="loc_ses_ProceedsReceivedFromNotePayableToRelatedParty_1353276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_ses_ProceedsReceivedFromNotePayableToRelatedParty_1353276" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsPaid" xlink:label="loc_ses_OfferingCostsPaid_1353280" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_ses_OfferingCostsPaid_1353280" use="optional" order="31" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_353" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_353" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_354" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_334" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_354" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_355" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_355" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_356" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_356" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_357" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_357" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262739" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredOfferingCostsIncludedInAccountsPayable" xlink:label="loc_ses_DeferredOfferingCostsIncludedInAccountsPayable_359" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" xlink:to="loc_ses_DeferredOfferingCostsIncludedInAccountsPayable_359" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses" xlink:label="loc_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses_360" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" xlink:to="loc_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses_360" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote" xlink:label="loc_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote_361" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" xlink:to="loc_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote_361" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Underwritingcommissiondeferred" xlink:label="loc_ses_Underwritingcommissiondeferred_362" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_335" xlink:to="loc_ses_Underwritingcommissiondeferred_362" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_369" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1263537" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_369" xlink:to="loc_us-gaap_StatementTable_1263537" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263541" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1263537" xlink:to="loc_dei_LegalEntityAxis_1263541" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263542" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1263541" xlink:to="loc_dei_EntityDomain_1263542" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1263540" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1263537" xlink:to="loc_us-gaap_StatementLineItems_1263540" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaap_NatureOfOperations_370" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263540" xlink:to="loc_us-gaap_NatureOfOperations_370" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_375" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1263301" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_375" xlink:to="loc_us-gaap_StatementTable_1263301" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1263302" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1263301" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1263302" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1263303" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1263302" xlink:to="loc_us-gaap_ClassOfStockDomain_1263303" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263305" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1263301" xlink:to="loc_dei_LegalEntityAxis_1263305" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263306" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1263305" xlink:to="loc_dei_EntityDomain_1263306" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1263304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1263301" xlink:to="loc_us-gaap_StatementLineItems_1263304" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_376" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263304" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_376" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering">
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InitialPublicOfferingAbstract" xlink:label="loc_ses_InitialPublicOfferingAbstract_381" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1263211" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ses_InitialPublicOfferingAbstract_381" xlink:to="loc_us-gaap_StatementTable_1263211" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1263212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1263211" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1263212" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1263213" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1263212" xlink:to="loc_us-gaap_ClassOfStockDomain_1263213" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263215" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1263211" xlink:to="loc_dei_LegalEntityAxis_1263215" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1263215" xlink:to="loc_dei_EntityDomain_1263217" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1263214" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1263211" xlink:to="loc_us-gaap_StatementLineItems_1263214" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InitialPublicOfferingTextBlock" xlink:label="loc_ses_InitialPublicOfferingTextBlock_382" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263214" xlink:to="loc_ses_InitialPublicOfferingTextBlock_382" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement">
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementAbstract" xlink:label="loc_ses_PrivatePlacementAbstract_387" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262887" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ses_PrivatePlacementAbstract_387" xlink:to="loc_us-gaap_StatementTable_1262887" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262888" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262887" xlink:to="loc_dei_LegalEntityAxis_1262888" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262889" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262888" xlink:to="loc_dei_EntityDomain_1262889" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262895" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262887" xlink:to="loc_us-gaap_StatementLineItems_1262895" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementTextBlock" xlink:label="loc_ses_PrivatePlacementTextBlock_388" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262895" xlink:to="loc_ses_PrivatePlacementTextBlock_388" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_393" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262993" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_393" xlink:to="loc_us-gaap_StatementTable_1262993" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262994" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262993" xlink:to="loc_dei_LegalEntityAxis_1262994" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262995" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262994" xlink:to="loc_dei_EntityDomain_1262995" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262997" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262993" xlink:to="loc_us-gaap_StatementLineItems_1262997" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_394" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262997" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_394" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_399" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262825" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_399" xlink:to="loc_us-gaap_StatementTable_1262825" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262826" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262825" xlink:to="loc_dei_LegalEntityAxis_1262826" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262827" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262826" xlink:to="loc_dei_EntityDomain_1262827" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262829" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262825" xlink:to="loc_us-gaap_StatementLineItems_1262829" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_400" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262829" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_400" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_405" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262770" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_405" xlink:to="loc_us-gaap_StatementTable_1262770" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262771" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262770" xlink:to="loc_dei_LegalEntityAxis_1262771" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262772" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262771" xlink:to="loc_dei_EntityDomain_1262772" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262776" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262770" xlink:to="loc_us-gaap_StatementLineItems_1262776" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_406" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262776" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_406" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_411" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262699" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_411" xlink:to="loc_us-gaap_StatementTable_1262699" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262700" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262699" xlink:to="loc_dei_LegalEntityAxis_1262700" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262701" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262700" xlink:to="loc_dei_EntityDomain_1262701" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262705" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262699" xlink:to="loc_us-gaap_StatementLineItems_1262705" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TemporaryEquityDisclosureTextBlock" xlink:label="loc_ses_TemporaryEquityDisclosureTextBlock_412" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262705" xlink:to="loc_ses_TemporaryEquityDisclosureTextBlock_412" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_417" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262584" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_417" xlink:to="loc_us-gaap_StatementTable_1262584" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262585" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262584" xlink:to="loc_dei_LegalEntityAxis_1262585" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262586" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262585" xlink:to="loc_dei_EntityDomain_1262586" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262588" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262584" xlink:to="loc_us-gaap_StatementLineItems_1262588" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_418" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262588" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_418" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_423" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262457" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_423" xlink:to="loc_us-gaap_StatementTable_1262457" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262458" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262457" xlink:to="loc_dei_LegalEntityAxis_1262458" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262459" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262458" xlink:to="loc_dei_EntityDomain_1262459" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262461" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262457" xlink:to="loc_us-gaap_StatementLineItems_1262461" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_424" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262461" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_424" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaap_SubsequentEventsAbstract_429" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262445" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_429" xlink:to="loc_us-gaap_StatementTable_1262445" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262447" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262445" xlink:to="loc_dei_LegalEntityAxis_1262447" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262448" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262447" xlink:to="loc_dei_EntityDomain_1262448" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262455" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262445" xlink:to="loc_us-gaap_StatementLineItems_1262455" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_430" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262455" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_430" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_450" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1263309" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_450" xlink:to="loc_us-gaap_StatementTable_1263309" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263313" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1263309" xlink:to="loc_dei_LegalEntityAxis_1263313" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263315" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1263313" xlink:to="loc_dei_EntityDomain_1263315" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1263310" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1263309" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1263310" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1263311" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1263310" xlink:to="loc_us-gaap_ClassOfStockDomain_1263311" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1263312" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1263309" xlink:to="loc_us-gaap_StatementLineItems_1263312" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_451" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_451" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaap_UseOfEstimates_455" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_UseOfEstimates_455" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_456" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_456" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_457" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_457" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_460" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_460" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_453" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_453" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_EmergingGrowthCompanyPolicyTextBlock" xlink:label="loc_ses_EmergingGrowthCompanyPolicyTextBlock_454" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_ses_EmergingGrowthCompanyPolicyTextBlock_454" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_458" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_458" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_459" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_459" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Derivativewarrantliabilitiespolicytextblock" xlink:label="loc_ses_Derivativewarrantliabilitiespolicytextblock_461" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_ses_Derivativewarrantliabilitiespolicytextblock_461" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock" xlink:label="loc_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock_462" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock_462" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Commonstocksubjecttopossibleredemptionpolicytextblock" xlink:label="loc_ses_Commonstocksubjecttopossibleredemptionpolicytextblock_463" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_ses_Commonstocksubjecttopossibleredemptionpolicytextblock_463" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_464" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_464" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_465" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_465" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_466" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1263312" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_466" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_472" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1265559" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_472" xlink:to="loc_us-gaap_StatementTable_1265559" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1265561" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1265559" xlink:to="loc_dei_LegalEntityAxis_1265561" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1265562" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1265561" xlink:to="loc_dei_EntityDomain_1265562" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1265560" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1265559" xlink:to="loc_us-gaap_StatementLineItems_1265560" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_474" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1265560" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_474" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_479" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262706" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_479" xlink:to="loc_us-gaap_StatementTable_1262706" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262708" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262706" xlink:to="loc_dei_LegalEntityAxis_1262708" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262710" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262708" xlink:to="loc_dei_EntityDomain_1262710" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262712" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262706" xlink:to="loc_us-gaap_StatementLineItems_1262712" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_480" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262712" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_480" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_487" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262511" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_487" xlink:to="loc_us-gaap_StatementTable_1262511" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262512" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262511" xlink:to="loc_dei_LegalEntityAxis_1262512" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262513" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262512" xlink:to="loc_dei_EntityDomain_1262513" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262515" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262511" xlink:to="loc_us-gaap_StatementLineItems_1262515" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_488" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262515" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_488" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_489" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262515" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_489" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_574" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_574" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_576" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_576" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_577" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_576" xlink:to="loc_us-gaap_RelatedPartyDomain_577" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SponsorMember" xlink:label="loc_ses_SponsorMember_597" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_577" xlink:to="loc_ses_SponsorMember_597" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_578" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_578" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_579" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_578" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_579" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_598" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_579" xlink:to="loc_us-gaap_IPOMember_598" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_599" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_579" xlink:to="loc_us-gaap_PrivatePlacementMember_599" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_580" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_580" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_581" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_580" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_581" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaap_WarrantMember_582" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_581" xlink:to="loc_us-gaap_WarrantMember_582" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementWarrantsMember" xlink:label="loc_ses_PrivatePlacementWarrantsMember_602" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantMember_582" xlink:to="loc_ses_PrivatePlacementWarrantsMember_602" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WorkingCapitalLoansWarrantMember" xlink:label="loc_ses_WorkingCapitalLoansWarrantMember_603" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantMember_582" xlink:to="loc_ses_WorkingCapitalLoansWarrantMember_603" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_583" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_StatementClassOfStockAxis_583" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_584" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_583" xlink:to="loc_us-gaap_ClassOfStockDomain_584" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaap_TypeOfArrangementAxis_585" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_TypeOfArrangementAxis_585" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_586" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_585" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_586" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_587" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_587" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_588" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_587" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_588" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_589" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_srt_StatementScenarioAxis_589" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_590" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_589" xlink:to="loc_srt_ScenarioUnspecifiedDomain_590" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_591" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_591" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_592" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_591" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_592" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_593" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_593" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_594" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_593" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_594" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262807" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_dei_LegalEntityAxis_1262807" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262808" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262807" xlink:to="loc_dei_EntityDomain_1262808" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_IvanhoeCapitalAcquisitionCorpMember" xlink:label="loc_ses_IvanhoeCapitalAcquisitionCorpMember_1262809" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1262808" xlink:to="loc_ses_IvanhoeCapitalAcquisitionCorpMember_1262809" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_575" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_612" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_612" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredOfferingCostsNoncurrent" xlink:label="loc_ses_DeferredOfferingCostsNoncurrent_634" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_DeferredOfferingCostsNoncurrent_634" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_613" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_613" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SaleOfStockOtherOfferingCosts" xlink:label="loc_ses_SaleOfStockOtherOfferingCosts_635" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_SaleOfStockOtherOfferingCosts_635" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_628" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_628" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_629" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_629" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_630" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_630" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_631" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_631" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_632" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_632" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_633" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_633" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PaymentsForInvestmentOfCashInTrustAccount" xlink:label="loc_ses_PaymentsForInvestmentOfCashInTrustAccount_636" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_PaymentsForInvestmentOfCashInTrustAccount_636" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage" xlink:label="loc_ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_637" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage_637" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership" xlink:label="loc_ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_638" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership_638" use="optional" order="42" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets" xlink:label="loc_ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_639" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets_639" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionLimitPercentageWithoutPriorConsent" xlink:label="loc_ses_RedemptionLimitPercentageWithoutPriorConsent_640" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_RedemptionLimitPercentageWithoutPriorConsent_640" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination" xlink:label="loc_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_641" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_641" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_Monthstocompleteacquisition" xlink:label="loc_ses_Monthstocompleteacquisition_642" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_Monthstocompleteacquisition_642" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumAllowedDissolutionExpenses" xlink:label="loc_ses_MaximumAllowedDissolutionExpenses_643" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_MaximumAllowedDissolutionExpenses_643" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_OperatingBankAccounts" xlink:label="loc_ses_OperatingBankAccounts_644" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_OperatingBankAccounts_644" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WorkingCapital" xlink:label="loc_ses_WorkingCapital_645" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_WorkingCapital_645" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_646" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_646" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent_647" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_DueToRelatedPartiesNoncurrent_647" use="optional" order="51" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital" xlink:label="loc_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital_648" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital_648" use="optional" order="52" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_654" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_595" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_654" use="optional" order="53" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_670" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_671" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_670" xlink:to="loc_us-gaap_StatementTable_671" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_672" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_us-gaap_StatementClassOfStockAxis_672" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_673" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_672" xlink:to="loc_us-gaap_ClassOfStockDomain_673" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_674" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_673" xlink:to="loc_us-gaap_CommonClassAMember_674" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonClassaSubjectToRedemptionMember" xlink:label="loc_ses_CommonClassaSubjectToRedemptionMember_676" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_673" xlink:to="loc_ses_CommonClassaSubjectToRedemptionMember_676" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263327" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_dei_LegalEntityAxis_1263327" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263328" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1263327" xlink:to="loc_dei_EntityDomain_1263328" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1264033" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_srt_RangeAxis_1264033" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1264034" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1264033" xlink:to="loc_srt_RangeMember_1264034" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1264057" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1264057" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1264058" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1264057" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1264058" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1264060" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1264060" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1264061" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1264060" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1264061" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1264076" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1264076" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1264079" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1264076" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1264079" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_675" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_671" xlink:to="loc_us-gaap_StatementLineItems_675" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaap_CashFDICInsuredAmount_1263330" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_CashFDICInsuredAmount_1263330" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_677" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_677" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_678" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_678" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_679" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_679" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_680" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_680" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_681" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_675" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_681" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_819" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_820" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_819" xlink:to="loc_us-gaap_StatementTable_820" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_821" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_820" xlink:to="loc_us-gaap_StatementClassOfStockAxis_821" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_822" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_821" xlink:to="loc_us-gaap_ClassOfStockDomain_822" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_823" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_822" xlink:to="loc_us-gaap_CommonClassAMember_823" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_829" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_822" xlink:to="loc_us-gaap_CommonClassBMember_829" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263803" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_820" xlink:to="loc_dei_LegalEntityAxis_1263803" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263804" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1263803" xlink:to="loc_dei_EntityDomain_1263804" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_824" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_820" xlink:to="loc_us-gaap_StatementLineItems_824" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_825" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_824" xlink:to="loc_us-gaap_EarningsPerShareAbstract_825" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_826" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_825" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_826" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_830" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_826" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_830" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_827" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_825" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_827" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_831" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_827" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_831" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_833" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_825" xlink:to="loc_us-gaap_EarningsPerShareBasic_833" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails">
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InitialPublicOfferingAbstract" xlink:label="loc_ses_InitialPublicOfferingAbstract_856" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_857" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ses_InitialPublicOfferingAbstract_856" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_857" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_858" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_857" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_858" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_859" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_858" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_859" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="loc_us-gaap_IPOMember_863" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_859" xlink:to="loc_us-gaap_IPOMember_863" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="loc_us-gaap_OverAllotmentOptionMember_864" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_859" xlink:to="loc_us-gaap_OverAllotmentOptionMember_864" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_860" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_857" xlink:to="loc_us-gaap_StatementClassOfStockAxis_860" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_861" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_860" xlink:to="loc_us-gaap_ClassOfStockDomain_861" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_865" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_861" xlink:to="loc_us-gaap_CommonClassAMember_865" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263223" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_857" xlink:to="loc_dei_LegalEntityAxis_1263223" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263224" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1263223" xlink:to="loc_dei_EntityDomain_1263224" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_IvanhoeCapitalAcquisitionCorpMember" xlink:label="loc_ses_IvanhoeCapitalAcquisitionCorpMember_1263227" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1263224" xlink:to="loc_ses_IvanhoeCapitalAcquisitionCorpMember_1263227" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_857" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_866" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_866" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_867" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_867" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_868" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_868" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_869" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_869" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredUnderwritingCommissions" xlink:label="loc_ses_DeferredUnderwritingCommissions_870" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_ses_DeferredUnderwritingCommissions_870" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_NumberOfSharesIssuedPerUnit" xlink:label="loc_ses_NumberOfSharesIssuedPerUnit_871" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_ses_NumberOfSharesIssuedPerUnit_871" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_NumberOfWarrantsIssuedPerUnit" xlink:label="loc_ses_NumberOfWarrantsIssuedPerUnit_872" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_ses_NumberOfWarrantsIssuedPerUnit_872" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_873" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_873" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_874" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_862" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_874" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails">
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementAbstract" xlink:label="loc_ses_PrivatePlacementAbstract_889" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_890" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ses_PrivatePlacementAbstract_889" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_890" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_891" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_890" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_891" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_892" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_891" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_892" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="loc_us-gaap_PrivatePlacementMember_894" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_892" xlink:to="loc_us-gaap_PrivatePlacementMember_894" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262896" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_890" xlink:to="loc_dei_LegalEntityAxis_1262896" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262897" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262896" xlink:to="loc_dei_EntityDomain_1262897" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_890" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_895" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_895" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_896" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" xlink:to="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_896" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsFromSaleOfUnits" xlink:label="loc_ses_ProceedsFromSaleOfUnits_897" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" xlink:to="loc_ses_ProceedsFromSaleOfUnits_897" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_899" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_899" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_900" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_893" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_900" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_931" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_931" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_933" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_933" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_934" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_933" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_934" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FounderSharesMember" xlink:label="loc_ses_FounderSharesMember_942" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_934" xlink:to="loc_ses_FounderSharesMember_942" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_935" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_935" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_936" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_935" xlink:to="loc_us-gaap_RelatedPartyDomain_936" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SponsorMember" xlink:label="loc_ses_SponsorMember_943" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_936" xlink:to="loc_ses_SponsorMember_943" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_937" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_srt_RangeAxis_937" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_938" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_937" xlink:to="loc_srt_RangeMember_938" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_944" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_938" xlink:to="loc_srt_MaximumMember_944" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_945" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_938" xlink:to="loc_srt_MinimumMember_945" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_939" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_us-gaap_StatementClassOfStockAxis_939" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_940" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_939" xlink:to="loc_us-gaap_ClassOfStockDomain_940" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_946" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_940" xlink:to="loc_us-gaap_CommonClassAMember_946" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_947" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_940" xlink:to="loc_us-gaap_CommonClassBMember_947" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1263041" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_dei_LegalEntityAxis_1263041" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263043" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1263041" xlink:to="loc_dei_EntityDomain_1263043" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1263484" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1263484" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1263485" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1263484" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1263485" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_941" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_932" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_941" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_948" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_948" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_949" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_949" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_AggregateOfSponsorSharesSurrendered" xlink:label="loc_ses_AggregateOfSponsorSharesSurrendered_950" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_AggregateOfSponsorSharesSurrendered_950" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsShares" xlink:label="loc_us-gaap_CommonStockDividendsShares_951" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_us-gaap_CommonStockDividendsShares_951" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_AggregateNumberOfSharesOwned" xlink:label="loc_ses_AggregateNumberOfSharesOwned_952" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_AggregateNumberOfSharesOwned_952" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_NumberOfSharesSubjectToForfeiture" xlink:label="loc_ses_NumberOfSharesSubjectToForfeiture_953" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_NumberOfSharesSubjectToForfeiture_953" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares" xlink:label="loc_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares_954" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares_954" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination" xlink:label="loc_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination_955" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination_955" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger" xlink:label="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_956" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger_956" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays" xlink:label="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_957" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays_957" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays" xlink:label="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_958" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_941" xlink:to="loc_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays_958" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_994" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_994" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_996" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_996" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_997" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_996" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_997" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_AdministrativeSupportAgreementMember" xlink:label="loc_ses_AdministrativeSupportAgreementMember_1007" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_997" xlink:to="loc_ses_AdministrativeSupportAgreementMember_1007" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RelatedPartyLoansMember" xlink:label="loc_ses_RelatedPartyLoansMember_1008" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_997" xlink:to="loc_ses_RelatedPartyLoansMember_1008" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_998" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_998" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_999" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_998" xlink:to="loc_us-gaap_RelatedPartyDomain_999" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SponsorMember" xlink:label="loc_ses_SponsorMember_1009" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_999" xlink:to="loc_ses_SponsorMember_1009" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_1010" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_999" xlink:to="loc_srt_ChiefExecutiveOfficerMember_1010" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1000" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1000" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1001" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1000" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1001" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WorkingCapitalLoansWarrantMember" xlink:label="loc_ses_WorkingCapitalLoansWarrantMember_1011" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1001" xlink:to="loc_ses_WorkingCapitalLoansWarrantMember_1011" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1002" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1002" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1003" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1002" xlink:to="loc_us-gaap_ClassOfStockDomain_1003" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1012" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1003" xlink:to="loc_us-gaap_CommonClassAMember_1012" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_1004" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_1004" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_1005" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_1004" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_1005" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_1013" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_1005" xlink:to="loc_us-gaap_ConvertibleDebtMember_1013" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262999" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_dei_LegalEntityAxis_1262999" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1263000" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262999" xlink:to="loc_dei_EntityDomain_1263000" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_1006" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_995" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_1006" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote" xlink:label="loc_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_1014" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote_1014" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_1015" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent_1015" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth" xlink:label="loc_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_1017" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth_1017" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1018" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1018" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumLoansConvertibleIntoWarrants" xlink:label="loc_ses_MaximumLoansConvertibleIntoWarrants_1019" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_ses_MaximumLoansConvertibleIntoWarrants_1019" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights" xlink:label="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_1020" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights_1020" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1022" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1022" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ConverstionPricePerWarrants" xlink:label="loc_ses_ConverstionPricePerWarrants_1023" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_ses_ConverstionPricePerWarrants_1023" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_1024" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_SharePrice_1024" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1025" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1025" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaap_DueToRelatedPartiesCurrent_1026" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_1006" xlink:to="loc_us-gaap_DueToRelatedPartiesCurrent_1026" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1037" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262830" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1037" xlink:to="loc_us-gaap_StatementTable_1262830" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262831" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_dei_LegalEntityAxis_1262831" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262832" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262831" xlink:to="loc_dei_EntityDomain_1262832" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1264486" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1264486" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1264487" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1264486" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1264487" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_1264490" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_srt_StatementGeographicalAxis_1264490" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_1264491" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1264490" xlink:to="loc_srt_SegmentGeographicalDomain_1264491" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_LeasesArrangementTypeAxis" xlink:label="loc_ses_LeasesArrangementTypeAxis_1264587" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_ses_LeasesArrangementTypeAxis_1264587" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_LeasesArrangementTypeDomain" xlink:label="loc_ses_LeasesArrangementTypeDomain_1264588" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ses_LeasesArrangementTypeAxis_1264587" xlink:to="loc_ses_LeasesArrangementTypeDomain_1264588" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_1264527" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_us-gaap_CreditFacilityAxis_1264527" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_1264529" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1264527" xlink:to="loc_us-gaap_CreditFacilityDomain_1264529" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1264581" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_srt_RangeAxis_1264581" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1264582" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1264581" xlink:to="loc_srt_RangeMember_1264582" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262834" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262830" xlink:to="loc_us-gaap_StatementLineItems_1262834" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumNumberOfDemandsForRegistrationOfSecurities" xlink:label="loc_ses_MaximumNumberOfDemandsForRegistrationOfSecurities_1038" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_MaximumNumberOfDemandsForRegistrationOfSecurities_1038" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_1039" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_UnitsIssuedDuringPeriodSharesNewIssues_1039" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueMeasurementOptionTerm" xlink:label="loc_ses_FairValueMeasurementOptionTerm_1040" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_FairValueMeasurementOptionTerm_1040" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnderwritingCashDiscountPerUnit" xlink:label="loc_ses_UnderwritingCashDiscountPerUnit_1041" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_UnderwritingCashDiscountPerUnit_1041" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_UnderwriterCashDiscount" xlink:label="loc_ses_UnderwriterCashDiscount_1042" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_UnderwriterCashDiscount_1042" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredFeePerUnit" xlink:label="loc_ses_DeferredFeePerUnit_1043" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_DeferredFeePerUnit_1043" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_DeferredOfferingCostsNoncurrent" xlink:label="loc_ses_DeferredOfferingCostsNoncurrent_1044" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262834" xlink:to="loc_ses_DeferredOfferingCostsNoncurrent_1044" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1079" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1080" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1079" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1080" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1081" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1080" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1081" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1082" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1081" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1082" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementWarrantsMember" xlink:label="loc_ses_PrivatePlacementWarrantsMember_1087" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1082" xlink:to="loc_ses_PrivatePlacementWarrantsMember_1087" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PublicWarrantsMember" xlink:label="loc_ses_PublicWarrantsMember_1088" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1082" xlink:to="loc_ses_PublicWarrantsMember_1088" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srt_StatementScenarioAxis_1084" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1080" xlink:to="loc_srt_StatementScenarioAxis_1084" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srt_ScenarioUnspecifiedDomain_1085" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_1084" xlink:to="loc_srt_ScenarioUnspecifiedDomain_1085" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member" xlink:label="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_1089" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1085" xlink:to="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member_1089" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member" xlink:label="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_1090" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_1085" xlink:to="loc_ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member_1090" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262777" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1080" xlink:to="loc_dei_LegalEntityAxis_1262777" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262778" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262777" xlink:to="loc_dei_EntityDomain_1262778" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_1263451" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1080" xlink:to="loc_srt_RangeAxis_1263451" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_1263452" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1263451" xlink:to="loc_srt_RangeMember_1263452" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1080" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1091" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_1091" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination" xlink:label="loc_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination_1092" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination_1092" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering" xlink:label="loc_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering_1093" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering_1093" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement" xlink:label="loc_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_1094" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement_1094" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective" xlink:label="loc_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_1095" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective_1095" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1096" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1096" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1097" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_1097" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination" xlink:label="loc_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination_1098" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination_1098" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PercentageOfGrossProceedsOnTotalEquityProceeds" xlink:label="loc_ses_PercentageOfGrossProceedsOnTotalEquityProceeds_1099" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_PercentageOfGrossProceedsOnTotalEquityProceeds_1099" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice" xlink:label="loc_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_1100" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice_1100" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" xlink:label="loc_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_1101" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_1101" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" xlink:label="loc_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_1102" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_1102" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_SharePricetriggerUsedToMeasureDilutionOfWarrant" xlink:label="loc_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant_1103" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant_1103" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights" xlink:label="loc_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_1104" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights_1104" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants" xlink:label="loc_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_1105" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants_1105" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays" xlink:label="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_1106" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays_1106" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays" xlink:label="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_1107" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays_1107" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_RedemptionPeriod" xlink:label="loc_ses_RedemptionPeriod_1108" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_RedemptionPeriod_1108" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported" xlink:label="loc_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported_1109" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported_1109" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_MultiplierUsedInCalculatingWarrantExercisePrice" xlink:label="loc_ses_MultiplierUsedInCalculatingWarrantExercisePrice_1110" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_1086" xlink:to="loc_ses_MultiplierUsedInCalculatingWarrantExercisePrice_1110" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_1129" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_1130" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_1129" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_1130" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1131" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1130" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1131" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1132" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1131" xlink:to="loc_us-gaap_ClassOfStockDomain_1132" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1133" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1132" xlink:to="loc_us-gaap_CommonClassAMember_1133" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonClassaSubjectToRedemptionMember" xlink:label="loc_ses_CommonClassaSubjectToRedemptionMember_1135" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1132" xlink:to="loc_ses_CommonClassaSubjectToRedemptionMember_1135" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262713" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1130" xlink:to="loc_dei_LegalEntityAxis_1262713" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262714" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262713" xlink:to="loc_dei_EntityDomain_1262714" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="loc_us-gaap_TemporaryEquityLineItems_1134" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_1130" xlink:to="loc_us-gaap_TemporaryEquityLineItems_1134" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1136" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1136" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1137" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1137" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockNumberOfVotesPerShare" xlink:label="loc_ses_CommonStockNumberOfVotesPerShare_1138" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_ses_CommonStockNumberOfVotesPerShare_1138" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1139" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1139" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_ProceedsFromIssuanceOfTemporaryEquity" xlink:label="loc_ses_ProceedsFromIssuanceOfTemporaryEquity_1140" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_ses_ProceedsFromIssuanceOfTemporaryEquity_1140" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TemporaryEquityFairValueOfWarrantsAtIssuance" xlink:label="loc_ses_TemporaryEquityFairValueOfWarrantsAtIssuance_1141" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_ses_TemporaryEquityFairValueOfWarrantsAtIssuance_1141" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_TemporaryEquityIssuanceCosts" xlink:label="loc_ses_TemporaryEquityIssuanceCosts_1142" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_ses_TemporaryEquityIssuanceCosts_1142" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_1143" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_1143" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1144" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_1134" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1144" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1152" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_1262601" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1152" xlink:to="loc_us-gaap_StatementTable_1262601" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262602" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262601" xlink:to="loc_dei_LegalEntityAxis_1262602" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262603" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262602" xlink:to="loc_dei_EntityDomain_1262603" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_1262606" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1262601" xlink:to="loc_us-gaap_StatementLineItems_1262606" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1153" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262606" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1153" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1154" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262606" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1154" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_1155" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262606" xlink:to="loc_us-gaap_PreferredStockSharesIssued_1155" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1156" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1262606" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1156" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1173" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1174" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1173" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1174" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1175" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1174" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1175" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_1176" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1175" xlink:to="loc_us-gaap_ClassOfStockDomain_1176" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember" xlink:label="loc_us-gaap_CommonClassAMember_1177" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1176" xlink:to="loc_us-gaap_CommonClassAMember_1177" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaap_CommonClassBMember_1180" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1176" xlink:to="loc_us-gaap_CommonClassBMember_1180" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262679" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1174" xlink:to="loc_dei_LegalEntityAxis_1262679" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262680" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262679" xlink:to="loc_dei_EntityDomain_1262680" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_1263570" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1174" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_1263570" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1263571" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_1263570" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1263571" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_1178" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1174" xlink:to="loc_us-gaap_ClassOfStockLineItems_1178" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1181" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1178" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1181" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1182" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1178" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1182" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_CommonStockNumberOfVotesPerShare" xlink:label="loc_ses_CommonStockNumberOfVotesPerShare_1183" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1178" xlink:to="loc_ses_CommonStockNumberOfVotesPerShare_1183" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_1184" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1178" xlink:to="loc_us-gaap_CommonStockSharesIssued_1184" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_1185" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_1178" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_1185" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1208" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1208" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1210" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1210" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1210" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1219" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1219" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_1263456" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_1263456" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1220" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1211" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1220" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1212" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1212" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1213" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1212" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1213" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1221" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1213" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1221" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1214" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1214" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1215" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1214" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1215" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PublicWarrantsMember" xlink:label="loc_ses_PublicWarrantsMember_1222" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1215" xlink:to="loc_ses_PublicWarrantsMember_1222" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_PrivatePlacementWarrantsMember" xlink:label="loc_ses_PrivatePlacementWarrantsMember_1223" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1215" xlink:to="loc_ses_PrivatePlacementWarrantsMember_1223" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262532" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_dei_LegalEntityAxis_1262532" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262533" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262532" xlink:to="loc_dei_EntityDomain_1262533" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InvestmentClassAxis" xlink:label="loc_ses_InvestmentClassAxis_1263457" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_ses_InvestmentClassAxis_1263457" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_InvestmentClassDomain" xlink:label="loc_ses_InvestmentClassDomain_1263458" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ses_InvestmentClassAxis_1263457" xlink:to="loc_ses_InvestmentClassDomain_1263458" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_1263460" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_1263460" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1263461" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_1263460" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_1263461" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="loc_us-gaap_InvestmentTypeAxis_1264247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_us-gaap_InvestmentTypeAxis_1264247" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_1264248" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_1264247" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_1264248" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1216" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1209" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1216" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_1217" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1216" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_1217" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1264242" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_1217" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1264242" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_1224" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosureAbstract_1264242" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_1224" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1218" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1216" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1218" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares" xlink:label="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_1225" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1218" xlink:to="loc_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_1225" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1226" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_1218" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1226" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1240" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1241" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1240" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1241" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1242" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1241" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1242" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_1243" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_1242" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_1243" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1245" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_1243" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1245" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262547" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1241" xlink:to="loc_dei_LegalEntityAxis_1262547" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262548" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262547" xlink:to="loc_dei_EntityDomain_1262548" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1241" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_1246" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_1246" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_1247" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_1247" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_1248" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" xlink:to="loc_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount_1248" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount" xlink:label="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_1249" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" xlink:to="loc_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount_1249" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1250" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1244" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1250" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1267" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1268" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1267" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1268" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1269" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1268" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1269" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1270" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1269" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1270" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_1274" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1270" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_1274" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_1275" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1270" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_1275" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_1276" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1270" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_1276" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1277" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1270" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_1277" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1263277" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_1270" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_1263277" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1271" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1268" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1271" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1272" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1271" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1272" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1278" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1272" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1278" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262557" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1268" xlink:to="loc_dei_LegalEntityAxis_1262557" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262559" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262557" xlink:to="loc_dei_EntityDomain_1262559" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1273" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1268" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1273" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_1279" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1273" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_1279" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="loc_us-gaap_DebtInstrumentMeasurementInput_1280" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1273" xlink:to="loc_us-gaap_DebtInstrumentMeasurementInput_1280" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1295" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1296" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1295" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1296" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1297" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1296" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1297" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1298" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1297" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1298" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1301" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1298" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1301" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262575" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1296" xlink:to="loc_dei_LegalEntityAxis_1262575" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262576" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262575" xlink:to="loc_dei_EntityDomain_1262576" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1299" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1296" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1299" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1299" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1302" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1302" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1303" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_1303" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1304" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1304" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1305" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1305" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1306" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1300" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1306" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
<presentationLink xlink:type="extended" xlink:role="http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails">
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1320" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1321" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1320" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1321" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1322" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1321" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1322" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1323" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1322" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1323" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1326" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1323" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1326" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_1262578" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1321" xlink:to="loc_dei_LegalEntityAxis_1262578" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_1262580" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1262578" xlink:to="loc_dei_EntityDomain_1262580" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1324" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_1321" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1324" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1325" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_1324" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1325" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/label" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1327" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1325" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1327" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueOfConvertibleDebtWithRelatedParties" xlink:label="loc_ses_FairValueOfConvertibleDebtWithRelatedParties_1328" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1325" xlink:to="loc_ses_FairValueOfConvertibleDebtWithRelatedParties_1328" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
<loc xlink:type="locator" xlink:href="ses-20211231.xsd#ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties" xlink:label="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_1329" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1325" xlink:to="loc_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties_1329" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
<loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1330" />
<presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_1325" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesNoncurrent_1330" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g251271g11x83.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g251271g11x83.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1F&4&AO=&]S:&]P(#,N,  X0DE-! 0
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M4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M"G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@
M  EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN=$]U
M='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O
M;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M        1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M     %)S;'15;G1&(U!X;$!D8           "G9E8W1O<D1A=&%B;V]L 0
M  !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M            5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C
M0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T
M0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O
M<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))
M30/M       0 [_^-0 "  $#O_XU  (  3A"24T$)@      #@
M   _@   .$))300-       $    >#A"24T$&0      !    !XX0DE- _,
M      D           $ .$))32<0       *  $          3A"24T#]0
M    2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R
M 0!:    !@       0 U     0 M    !@       3A"24T#^       <
M_____________________________P/H     /______________________
M______\#Z     #_____________________________ ^@     ________
M_____________________P/H   X0DE-! @      !     !   "0    D
M    .$))300>       $     #A"24T$&@     #-0    8
M :@   /O          $                          0             #
M[P   :@                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   :@     4F=H=&QO;F<   /O    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   #[P    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
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MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
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M_P#1_P!A08+9:]U74-FTDMW<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MI3A35%5D<G64M,)#96AS=X.3IK/#Q-+_Q  = 0$  @,! 0$!
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M<@P?'8&X.>V=M78KC^44GQ=O 8_7Q&P(D&3+ID; 2;X9)0 L:T!!=U-6WSE
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MKS-K3<K&CT)#XN^!6'/38MDDT=L&44T7Q2#@K+:0H@KD) 43!Y3$F<LNASS
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M<D)[MKOQN#M9<=HW(L5NL:Q:WRKMB[+X)+G;A--8XWB=3FVW^.!MS3$2P@,
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M9<V570/L#GOJ[,<,/D&2/QY$<CXL61'F7<V 1S8X8HC",1@6.>V$JW250="
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MOS.G#\VFM=_;A[$ MNWM+/$%@X==NV]Y9'$5I3B&0MV2U8?K?::J2N\*6LR
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M;H0WNE*U$[J5$),*4 <JQ-Q]N["NJKF)EV,2ZN\O4QBGLX]W7%A6N1H:1&^
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M:/,6]NMFUN'&-UMI8=%R&VV7%H2WO()(S0'M(]H^5D/:$R7',8Q2WQ+ =O\
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ME*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2NH:?!CN1DB7&
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M0K$3_P"K"R_ZT/CYX-4?Z']!_P#Q$_\ Y,:'SOZ?EQ3.B_B^C)\WP^=?I_\
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MC^7',Y5/B!%Z)RJ?#Y55/J2J7Z??[/GU8?Q0G$>/HPM#.G\E+G.)_E)[M3/
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M2PIU-W8NA>[<);<;W5LDAQM2'DMN)5O).Z5)0(((W@03T"UEH!T09J^6(T\
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M7KQQ\ZIKS+EA=-J"5V]PA2B0$EAP%13.\$@@$D 21F1QB,^I](6Y05I6%HD
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M+<B) N' #(WC$'U6%?A$8 L!K&L%Q[#U*/M."S3=VZ#(]E*[-:W%A,$R6$R
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M4A1^%^E%'_'YM6[1P:.+'#)2AUX$<Z"TM4Q%LQR_8D:?X)Y"N^"'&C<^KQP
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MTT[9^0Y]C>#XU88#F5OB$T65QRVC*JDOIWQDIXT&863CDC(<<Q;,YV&$FO\
M#+ NGXY81RSXX*Z0T89A'HI6F]]VQNTMCU3GDN/MM:XU5X/LM,S&O3<O&I,Z
MX*Z!M"',H^1W^35=C3UMG9_&\B8]:4$3&Z6.HQR^942Q$L9JE5/-NV/VAL9Q
MG()E#C3\T-62SV.-996;,9O6T68)!Q:)?V.!EH;7(1WE):1[20VECY -EH&Q
M&4BQX8IE=+8]2J_EO:>[3F/X?<9:_&HP94[<3.ZC"L=B;59-;N9C>%B >'$R
M:R;E,(R6.6%L(\>HGU]2@B1J^>8$<I4<K%*J-EV@^TC0RLP@V$NDA#9N)F"0
MKJ7L_G]Z'%<>B8S57V$8N^OI;,#KYV9RI,RJB9%',P%46NG,FC)-FU\<#/CY
M%-/E6T'9PSW>[<>;G5WNC05F%4]?-Q:MQO#AT=C%O8$FQV[PO*+\MK>S+(D6
MU%"R&^MZ2.V!61&A^#7LD22R!%&BE;8:4II2FE*:4KY$?2U[Q;M8;VVL_H\2
MW+SG&J0.-X$8%31Y3<U=>$LC%*XIRBAPY@0,><KGD*YK$5[U5SN57E<[;:5
MDS\N?V552MW09]?JS&??E'A7FJG:.W^\OQT;H+].<9&J_P#..K]DCDH^(^LB
MH!G.5#PGW&#45[1_: 3^S-N=_P"EG&2_=Q9)]_U>W4]BCD1X_834^*O\'_\
MYJ5.T;O\O/&]&Z*K\^<Y(U/^<$^S^#3L4=??4PH_N@.N[]YJ/Y1N_P BK_/H
MW0^;^;G(U3ZOY9+S]?M\M.Q1R/OJOM2!.4YF#IURCW>-0_*/W_\ 9O1NBO\
MNWR)/SV":=BCD1X_9-6F.?N)^0J;\H_?[^[/N@OT9ODB_FL5U'8HXA0\3_\
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M'*)$934A:P20HB0 J,MX R-Z,SGUI^H#T_''Y1UC_P  (WL\O]4>LG;*@ 9
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MW?FU =()(2 5&3,F3$3P)) &9)T I &8 !)DGF8 SGHD9:5/^H$57^N0L?\
MB^B_XQZ=LOI[J5LEV2O1(0.RUOEC&\\?>B9F)<<B741*,N( JF2$N*T]>KW3
M1W4MXO \5"HB =WE3NJJ(J\U4XI0@Q%//GWU[+ZI2FE*:4II2N)P1N7E4Z\<
M>:_Q_@]G72E4RWH*;(*NPH[RMAW%-;0SU]I560!3(%A!DC<*3#FQ)#2!DQI
MGN&8)F/&5KE1[515TI509% QC1L9W6,:C6M151K6HB(B(WR3CNIQPB<<=.B)
MPI4?5Q=.B]/_ "E^CSYY^OS3S147KI2H^KB_M?=[55?D\<=5Y]WU^WV:4J=K
M&M3A.>.47V>SR3R\OF^;2E3Z4II2FE*:4KQQ[8'HF:[M7[Z9#O1)WFF8<6^K
M,?K5H@XD"V%&;0U$>K:1)K[J&YZR$ AE:L=O<5RLY5&\K=+BDB!'NJ08RR\0
M#YTK6/\ 4!ZGV=H^Q3_>^BJJ?7\8^=6[9?3W5.\>GQCW @?"GZ@15?ZY"Q7Z
M=OHJ_GR-=.V7T]U1)X9=V5/U >H7S[1]@O\ O?1/TY$NI#R^,'X5.].HGQ5]
MM1_4!ZA%_P#A'6''N_%]$_1D2:%Y<Y0.D33>.@R[B?MI^H$5'^N.L4_WOXGZ
M<A70/JX@'X4WCW^)^HBHKZ FJ7R[1]BG^]_%7_M'J.V7T]U1X ]\_414?U F
MIXX7M'6*^_\ G?QNO_\ 46G;+Z>ZHGEEW5*OH"*GGIVCK!/][Z+^?XQ:=LOI
M[JF>>?>3]M%] 14K_P",?8_7M]$7_M$FI+ZCH /C2>67<3]M/U BH_UR%E_P
M!BI]B?&+_-J>W5_2CXU.]_:I]WWT_4"*G_7(6?\ P!C+_P!HM.W5_2CXU!,\
M .X#\]%] 15+Y]I"Q7Z=OHO^,>J]LOI[J Q^<CY$5#]0'JE\^TA9+_O?QO\
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M.=0%JS\1PYZY?74%[>/:T7A?QT9"B^[U&B3I[^M2G//L3VZCL$DZD#3*?O\
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M7A53GC2E5Y$X_3_'\WS:4JPMR/Z7(_S9/AG_ $KIT_3KP/I)_F<MNNU6Q/\
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MK55$>P@D2PJH97%C&8]S6N$Y>X1R+CND.VK";A%\^^KM[5"F76&$@!VZ996
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MKO4A/(V6TOC^&Q1J+NN$Y7([OIKEG9E)65_N51&F6L_F)/'3ABWBG,@$:$"
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M$8U7*%/ ,BH-4B#*SY"Z<1X]>7//B??W4\^?/U5X:^DOL<_-F.-"RN]KS7&
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M)U^>1%>M'H)2*[TLW8JY<JK^,;)$\_/^=KG/*\>SE/N\_/6CB1_%D?[KL/\
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M>>;+9'H]R;0D2'(D$1@QQADQB*)(PP\IQX7>Z,:K57O.U!Q.]G+ ;^!_LG#
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M@>( _P!VPTS[[Z?=UGA50PSP?M1W.WH]^]8#3AG\*F_D6#TGO"\?D\(J^?\
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9_P#+:GYNFE*GTI32E-*4TI32E-*4TI7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g251271g41v83.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g251271g41v83.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1;<4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %L"^6"0X0DE-! 0      %H< 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  (<G(U,#<U-34< @4 ,4UI8W)O<V]F="!7;W)D("T@5V]R;6AO;&4@+2!3
M+3%?5T,@1')A9G0@,BXQ,2XR,E\X0DE-!"4      ! @D1^A;OUAC0]PK_]=
MTB-#.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F       .
M             #^    X0DE- _(       H  /_______P  .$))300-
M   $    >#A"24T$&0      !    !XX0DE- _,       D           $
M.$))32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8
M!@       0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M     0 M    !@       3A"24T#^       <   ____________________
M_________P/H     /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H   X0DE-! @      !     !   "0    D      .$))300>       $
M     #A"24T$&@     #-0    8              8    /O          $
M                         0             #[P   8
M         0                         0     0       &YU;&P    "
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   8      4F=H=&QO
M;F<   /O    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90
M !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O
M<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N
M9P          0G1O;6QO;F<   &      %)G:'1L;VYG   #[P    -U<FQ4
M15A4     0       &YU;&Q415A4     0       $US9V5415A4     0
M    !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0
M  AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI
M8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53
M;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0
M !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M        "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_
M\        #A"24T$$0       0$ .$))3004       $    !#A"24T$#
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M 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MLBQV02\>D=S-?L^UW\O<U)O1<MI).5>^6N!#L@Q+V^EO]M =N0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MTI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI76J/2F8>1
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M-28R#<3, J^2AT["]FC)V5P]79N7""JZ$>N0I3(I(+E(=0I3)W6BE))<2HY
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M(KHL';U@,8R[1-_9'+*2;.*\R;KN64V':@U7.**H%JFS7O+2M24P@J2J1NJ
M,:\!VGAZN3QCIKPZWML&?PG",4O';O:=C9W%K"YP^Z;OL*=5U:G6RRT%(>O%
M-N!=HTTZZBY@EM2D@D9ZR?Z0;$6&[G7ZI?Z=ER!BYIU4X]Y>'E!E6U/@).Z
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M_<<JUU'T9^&X:-O=.HV='E:QG<\MXJS0WI<C)L[2K!W/'#X'<DZ0GYF>/)R
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M \\"(<\ASP/'(<CP/S#I2N74 ^ >(\<_@\/G^O\ EX<J5Q%4@#QR'/S<E 1
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MY.2;APFP8*N8^5DL=3LN=(K45%$UEFS4XIN&JD#=SGF>9RR@?MY3I-6]_?\
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MP53V>,W?UNK"'^\D_C5'3Y+/A!_BJVH_-4_I*?&;L%^$^&?E5?X*>SOFT/\
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MFF8@ 8I Z0-QJ*FNU>!AG*X.EXN/5<E;&9@N=DU.L#0W(&:@J=(QP;F 1 R
M&!(P>9!TI76K78-=8KE:*CE7)3*F*X58M%%RF72*@N8%C(BH!ED2$15,!N5$
MBE3/R0 *"E1><Q=1[).5JPS$ T=RM2E$YJ#6$RR"+:6;MNYLY%9FW419OWD>
MWY3BUWZ#E2-$QS,3(F,8PS)](CS4K((  >   !Y^'AJ*572E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E/Y?M^6E*IU!Y\^ >_P!WGQ^4-*4Y#YP^CZ?J
M^?\ !I2G(?. ?7X?ETI5?XM*4TI5.0XYY\..>?HTI50'GRTI01 //^7\N=*5
M0# /@ AS_(?X]*4$0#S'^_\ M:4IU!\_G_+\'X=*572E-*4TI32E-*5CC)E]
M6Q_#LY-O!KV!P]D"L4F*+]I&B'Z76<'6,Z>%,D %*@)03Z1,<QP#D Y'5T(*
MS (''/T?/6G?WK=A;FX=2I2 I*(3$RHP-2,N[.L*EW*38@(CBQYP4>G]F$%X
MCP ^]N'@(#QY\@(#SP/@&4VZIC>'H.?=\W,9\:X;ZJ+*,FKB1PAJ3G!_Z0Y<
MR!W4-N5F@ZN<6/? _3X7&!\NLI.H.6_VOCS\X 'S^&I%LHC[-(SC.??N\]5.
MU-EG]:?$9?\ 1>W?CAR,^:JCN5F_=BMWR!BE_9G!#]L<Q 'Q;  %#IZA'YA#
MZ=3XJ<_+3EV'U\JGZJ;'_-/'3['<.O>I/JG42!-4]I6<X']:M[\D2\A\,8'Q
MZBB8 #A#YBB'N^4/GP'.J^+F8WT^N/2??,1-/JIL=>JN(X9-9]WE^8\LHSH;
M<K.%ZP^*I\/2 <#\,H ?]20_'_Y?GG@P!R/'CJ/%U<%)/G(,\HB3YJ':BP !
M+=S'^BWZ3Y<=N1[ZY#N4FP$X?%:[ 2DYY^&4$(B/4!? .[#SR @/ _,;YM2;
M=0^W2>[.I^JBQWB.K?@3!(1GID "3/(<LSJ*XAN4FQ.8OQ6O0Z0 ?V80/ \G
M$GA]@ ?, -X@'@(!SSX:>+JUWA!XP??]U5^JJQ_S3_H0/:H?LXY15?:5F^0Y
MQ8[X^28?Y\8/R,4QN.>PXY#H'Q\A$2\> Z&W/!0.4Y ^\]G"I.U-B/\ HW])
MS",_0HCU]FN5 W*3G'(8L>#P3JX&XP7(\ )N!'NX (]/AX>9@\/#SGQ8S!6D
M>OU3/IB*#:BQG^+>TG+<G2="I/TP=!G0=RLWSP&*WGVIC#_/C!#QQT?]XYYX
M,/S^7E[M0;<C[=)SC0^KL[?<OJIL<_K;\\H3)Y1"B/7EQI[2DW\G]:QV/4(\
M#\,8+R*H*0@/V ?,?E![^@!\Q$-1XNK[H>WV5)VHL1$MOR1,$(D<(R41P[->
M0R%W*39Q('Q6O"]8 /(W&"X+Y@/5RW#WE$>.>>!#SU8VQ'VXUC0\IJ!M38$@
M=6^-[B$HR[Y(&?OPJ@;E9LW2'Q5O $P#QS<H(!#@@F\>&X\#QY>'VWT<ZCQ=
M43(CW%0-J;&8ZI_CF>K].2I[LN\35?:3G/D@.+G?)A.''PQ@A$O2 &\?TN7C
MD!  Y^81'W#J.H5]T/0:D[46,#ZT^9TCJX[9*E#+MCOC.@;E)P1 /BL>>)C%
MY&XP0  @?H 1#NXCP/VP?,'F/D SXNK[H>OW^DZ30;4V)(!;>2#Q.Y '/)1/
M[NRJ!N5G.H.<6O.!.4GA<(,?$3"3J']+!P7PZA'GP 2^7B&GBYSE208F"#/=
MW_L\SZJ;&8ZI[6#]B(UC4C6.,4'<K-@4#?%:['D2@ ?#*!Y#J()^1X;B'AT\
M#]8>&@MSQ6!' @]G[<NST/JIL()ZNXD$"(;SU/W9CN]';4=RDYX\8M=CP/3P
M-Q@^!'I*;Y(@AXA\KCW^(#IXN<_+&7&#S]53]5%C*OK;^1UA'+^JHGAZXR(B
MAMRDV7K$<6.S=(@7@MQ@^1Y,4O(<M@\A/SX\<@4?#WB\7,QOIUCCZ>ZH^JFP
M$_6WLN$"?;V^WD8J3<P_(\B4'V-WK-M)SD'"&=EM,*Z%L:<EV\2DY%NFBFHL
M1!1R151),Q5!3*($ 3CQJ%,%*2K>!C4#4?L[>?9G6>VVAL[I]MAM+@6XH)!4
M! )/9,^_#.MJA,8$RF$?$>.1\/I'ZO$ X\ \.>?=SK!7/GZ/;\U8(C\N2KF.
MDKD\AF#6@LW\Q&(KI/UU[0LZBI \.W-ZG(S%L8)253[JV:D>@Y1!5%5R!"@H
M!,I;&24DE9 )&H$B=> C@<_975&=HGEV[^*.VS*,(:>NK="TO.+OUKMW_%4'
MQ8,]6HW%R.J;0ETK1O)4YN@D#M7SS6V96Q'L=,,WPS1H.4BW)H5"2A'PN8EJ
MEWIHI+%4?HK*3; R2L,$F04SJ'-V9$C& &5$$R(W2I)U"HX \#WQ5E[6X>T&
MPXQ=-/&[%E<6SAM47%F\5VK:>N:5<RXA9NV2@VA?R)4O=2":M*>?6Y2)R$A7
MIJ+C2M[J9=HX9 YE79ZE9XJL@M%$:.5$EDUW,APJBJ4BXK@*2'6"(G5GJ3Y4
M&8ZOL'EI4H\)X>S*36JC;!K=#[]E=VS"4XN5MK:#ERX<,Q&WPZ6 TXI"DK<?
MS2K=7O"$R!O+]:VX:L((RIE(2U [KY912S1HQC8'E=1C%$$5%WW+T$%DUU73
M<K<(]5\J8JAE%"%3354))84",T[IB%3DH<QSSRCOX9U96VF'(1<DVN(ARQ\8
M.(,^+M];9)ME-I6I]/7;JDK+B.K-NMXJ!*MT &,]-5NW1(J B)5"E.7J#@>#
M% P (?4(?6(CY^>L)R)'+*NWI5O $:$ CN,QSX1QX\*]&HJU-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*5Q,/!1$/, '2E?,O.&\;(V+,EY+K!4*.UA*U2;7,TE%1H[L;VT
MS%;H;ZW+MY"5AK$@%8DFJS)8ZM9FZ^U3?0R .V%B4<.TVJ.1* 0"9$\HTDCY
MC2/GBH\XWG9)BX[#\VZE*@>L7&:>L[I89>@.8&7@CGF:C%PD8:@L<H6&=914
MLG+S)R7ALO/M47K2-:O:^T;N#NPD-@J4)/D^?TF/7 BH3,2=<\@-.7'Y_-67
M<L[D,ITK-4A3JE76EJK]=B,=3,K7VU,LSV1D8JV/+*E89<;ZQ>GK=2)7(^$(
M_0:3D2J64)WA$CQL<2&&H3*09B51V1$^GW,2)<8X1[3E[#Z:LK??_%))QKF:
MQ;9(1L^@*G.+H+S]<<S3?X>PDG/U%-M#(+ YE&KF-C2GG9-D<[2OK.02<&<]
MU>G;B@@2(4-#NYQIR[3\XRJ:M$/Z0MI:4JS&P>,912Q6Z/BIAH1I9ZU-Q,)7
MYW'L[D5K,2K]DNBD>1BH6O2)9>L)BF\3?E:,4GHIOB/"1N&2) CGQY1$ZZ=Y
MI[_35H<>D+7-3W;ZNT)2?F8F-IYGKZ0D&=>C/64PM0U9A:3CA5DEJ]"IQ]T*
M>,E5Y%\V6?-3(+&(W.W=.K!O3>4!W',Y$Y#/D)XB?/2IP^W\P2%UG,?1-#?6
M>R,7D+'PJ5>LL4]833Z2MS&D/VZDFY:LV3 T-./T0=&36D$S-$W)Q.DY0,U%
MU:@G>, =LS[*B0(D@><">[UU-#;L_7N+<W7&N5E:-G,+4V2>V9G.N$5H^(R!
M%H3JDI27BS4R N%H,(EH\?.TE$"+Q\S&+I$2[P :J$R4@_;$ ><^WC%"2.'O
M.?JG7LUJUVK>$RK-U;UJ+:Q5T&8KE(?0Q8^;@82"+)6!O=Y"5%[=9"8=1Q2M
MFE1<(MHX8TCE1^=%N5TLHY4!M(02).7E%)R.0''Z8G/S3.7[S'K[_P!_&H07
MTAE)F*5&3D7"NXJ?LK*15A8A^]AI"29$;8*L.;D)EQ$-Y)HM(Q9&< X@3&;.
MT&Z\F)NEZFW RI9ZL\Q',2?MDIC.,_*F/9P @Y@@CL(/ 'AWS4GQON]E<F9N
MQWCJ*KC)C5K##Y7&4F7LE'#/OIK&H4YNN9*KMG:LA6HQ:0GGG<E)-1V:2:)H
MJIF;=)!7@H@$[P,< DIX\9J"<QVS/?KR]5;\E^U#Z0Y\ X\_'R\?RZI4U72E
M-*4TI32E16W4JM7N-3B+3&$E&"3DCM-$ZSAN)'"93D*H15JL@L4>A0Y1 %.D
MQ3"4Q3 /&I2HI,I,'G6-QIMY.XZA+B)!W5I"A(T,'*1PK'0;<L.!_2>G]L)O
MZ*S8<B/S\2/CX  #SSY:MUKLSUBHY?MX5K_!]C]Z,<_XI/T4]G+#8]7-/2'J
M$3#S*S0\F$P&ZOZ(^(]0 ;D?(0 0T+CAU4?5EW<J?!UC]Z6_/^*3V=G8*J.W
M/#H_TGI^(E$>):;#D2B(@(\2/F F$>0]XZD.N#,+/OG08?8C2T8_))^BN(;<
M<-@)OYSTQZN.H!E9O@> $H?_ *CSX%$0#Q\ U/7._=GT#Z*?!]C]Z6_Y)'T4
M]G'#8\\T](>H.#<RLV//@4OC^J/ _)*4/+G@//YHZYW[L\>7'7A[^:GP?8D1
MXI;P>'5(CV54=N6'!YYIZ0B(<"/K6<\0YYX'F2'D.0 >!Y#D.=5ZQW@ZKU99
M1PCWRTI\'V.OBEO^23W\J>SEASGGX()\^'CZUFO'@W5_5#C[81-Y>8\^?CJW
M7._=GGH->>8-/@^Q^]+?\DCZ*H.W'#@_TH)AX 'A*S7D4!  _HCY !A\/+QU
M/7._=GT#Z*?!]C]Z6_Y)'T4#;CAP X^""?''3P,K-\<<"40#]4O#DOR?H#Z1
MYU7K'."R/?+T:]\4^#['[T8_)I^C]W"GLXX<\/YSTP$.?$)6:]_3SYR(^ ](
M<@/(#^ .'6.<5D^^7H&5/@ZQ^]+?E_%)^CUZU7V<\.>'\YZ?)>>!];38" B;
MJ$?"1 /$WB/AYZD.N#19]7T4^#['[TM_R2/HH7;GATH!TT](!+]J(2LV'3X#
MY?JE\XB/UC] :=:X=5J/>:?!UC]Z6_Y)/T>XRTJGLXX;Y*/P/2^3Y?JK->'(
M"4>!]8\^(#QXB/@' <:CK'."R#SI\'V/WI;\OXI&G+2N0[<\."/C3TQX >.9
M6;'IZN.H0YD?,W <B/S![M ZZ!&^3Z/?S:=E#A]B=;2W/>TCZ*I[.>'0XZ:@
MF @/("$K-^?(&Y_HE[S !A_[H.?/4EUPZJ/J^BGP?8_>EO\ DD?15/9QPYQ^
MP]/GJZ@-ZUF^0-R)NH/U2\^H1-S\X^/.G6N1&^??MUH,/L1I:6^7_P )/T57
MV<\.< 'P/3Z0X\/6TWQR "'(_JEXCP/'/S"(>_4!QSBLD\].VGP=8_>C'/\
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MMI4[<J=ZD. NK)* M+*$E(!3E(2%9UG!!$J"1$B (%3*4A0$>1 I0 I0Y]_
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M::DDIN0VH4-P:^LZ\@TM;Z)L/8NHS'+IC:W+Z 9S8R51>NO5+=[&6!3X(R+
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MU+!4%P%2YSDB0!'#F(G20,JMED/7[G./2:B[*R[&K'C5A.3CR @(V.C'%Q/
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M9GRQC;%4;A#($,^R1;(BJ,I9]+12K./<3*L<FDZ=)(MBJ*HI#)I&.5,W4!2
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MNP[EZE(+/U>Z-"L6J[9N<X&!9'V/DZZ3Q$'4G4>^E('+GKVYFMP0(4  H!X
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MJW0-T%(TW<LHGCIVU\B]'M_M0G;C"/$G\3<NW<393B*'57"^LL0^E5^;U*Y
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M@@ZSQ],9FN+VIVC7CW1[C.,;$79O7G+52&W+9*Q>,("CXSU;0^NLW3;/6@)
MWPH @'=3/QLV"SF8O:7J25;<V)_&OWKH,@(.UI%Q$G@A:N!=O)WK,**:C=TH
MB=DNZZ522"B)"B(JG*;DKPLEA6\E(5'ULI G?(,3()^Q!SD$:U\T=#UUM-]7
M&&HL7+UVW=><3C*7E7"[86A;(><NDK(1UB%%OJE'R@Z4@2":_3,0""<H&,3I
MXY'J(00$W2N  8G67@1$A #DW@/AP/0 'X3+=T&H$Y]^0/GT(UTK[F24J(@_
M:IS)D_8S!)@'/*<L]= 3.<8E3^,6FAR7I"R18E#H#CDKMB " "?Y(_9%.#!R
M <G$0'M1[,2//J9GT<X[S/+B3N8;_E]L)(/C#9\\C3ED3K,>>OKHG]H7ZM5K
MTVN>E*:4II2FE*:4II2FE*:4II2FE*:4II2G ?-]'X/FTI32E-*4TI32E-*4
MTI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*5P4\"B/\ 'QY^
M'GR >_R'P'R]^E*^,F1\[;B(.?S?&LK;>WS:)MD I$3,37R5^MU6KO,O5N!<
MP#DLKBYY,0MD;4]X^.661<7>(F(A!]9$DDSE;IHY!U>0C.#O$R,R/1KQD'EP
MI63ZCF7*ZN;L'Q2=QO%MHUJA(IA)0\7%%=J-9 8VW.Y:SVJ<D\6P;.S5I5PW
MAFBLM"3%7?5]ZW105A5ROC M&ZDH6 84-%9Z'@!SRRGB=:C.=,OG]_8>RK[.
M9@W5MKE:H>%I?:5-EN,DZ[!W>2EVJ;<:HC17,C'PCZKIPR;X*V>=23%U9TY8
MO043D*N E*!:P.8T$SS)C+N])U%36,'N[S.\K8:CDNOUM6/IEEHUP"KT:0K5
MPFR7":@+74( C/OE?361AY^;EDKB2LR#X!9&K;9L^,W6!PJJC<H R*A(R([>
M8XQV:Z&3G3W]FGS_ +:F\CN7W'QI8VSR%-9,&$N\NL89,D!:WT/1H"&S$RH;
M2U6U@P!>2F7K>!2>V-0L4NP;+Q[A$R8"U34>:)2@Y%7=H)TY]_$B>%*EE:S;
MD."P=BC(5UF9E#UGN'M$;>),*[,& ,=K7"]H1@%BW4<K-QT #%O DC55T".F
M[(K,JBP=1CFJ0G.#D-)X^LSZ^_C4"8SB>R3[^CZ:O5TR=FFP85S)(XV"=B9]
M2[GB\<7E1BT>E81SVV4YA&N$:W)-TG[QDK$RT@Y$PQZS5!HBY%9P50@F(2 2
M 2 #,GEKZ\AZ:GWT]_GK [S<YN]J\M<+-9L;R47$.8?&T5#5>4@%G[&FN"2U
MV@[I=)!:(49NI)"P34"T]6-SRB#=A!R,"_5Z!<&*K8H1 &])G/2(S&4G6/;G
M49SPCU\??TUZ)G>%N1I=5O\ ,6&D)OK4A:JXM5Z6SHED?)1U:D\:Q%G4CSSK
M5U%H2(2D^$M$14C^GI!-\BZ;*-%^S9MB3U:)2 L0!F9Y#6-,^1T[\A-91M64
M<GHX1E;:_GKG25Y#<36(N3EF$8#^;JN,)JW0B,]ZM;NX:2)W.*@W3XJ;TT8X
M!!-(RP\B4>*PD*B00$R3, JT@3F<S.F@/=40>?$^CW]'=D<=QVZ/<36)^#JT
M?5)7(U*F;/(!2LG76L2<%)WJJ)R\2P[JX;PL?&IQ,A#M'4S(MY8\"X5L$=&L
MG*<6DDNZ?EMN(@>4$J^V@R)Y]OF]6IGZ3^[O''V"N^+W<9WDVD+87=//$$6-
M8("Q/%:G;5Z;7P;7"I1J=G1C&G;S=G:-&$H[;I.&3B/.Z4%8Z[!D#%\5*I2D
MF$DD1RS]<"//K3/W]_?MJ>8MW.9VR XHTZ%2JIJ1*R6+8R=<-HFUI2+[XP;+
M;X*3E819PL9LRCZRW@HN3=H2*+E=)-\=N\4:B":AA2 #)\H'("#Z<\LO;3WX
M]OOZ//\ 2(H\@/U_WOV_Y<>&J4KEI2FE*:4K7G<_Q\5+[Q$H^N88 $.//O)O
M 1$0$ XY$.GY74 #Y (@'OQ]^VN$VA(&&N$_YUK_ +W#WCG7YF-^6\13!TK
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MCR9))C(9Y&(SBN V;5M>O";1>T2<):Q=0<%TED/E W5*2U(:"F@I:4A2DH)
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M\U8.OQ_^C<)_OF[_ .!U7UIFG[BL:?OF6C_-+J/(_K>JG7X__1N$_P!\W?\
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MG]Q[#L/:LW+9]IIVY1/B^Z'&E;A0M3_6."4G?CR:QEN(V$YG?9WLKRK#6I:
MOEKD)N-DI&U0D8Z8DFI#O2R,C'R#II(J&9'='+^IC1]VB28"EUJ=!#W9O& T
M)"]Y W2 @P#'W6@&AS($#NK@]M>B+:9_:W$'K#Q2YM,8OWKQBX?O[2W<93=O
M*6L/,ON-.*+(6?\ )T.2D #RLJV4W:9>LNTK#&$\#0$97+3*+U3LI:>M,.A/
M1B1(8R2*@1\8\(5FNLJ]=+"DL]2.*#5)(IFW:+*"3#;-"Y><=G=2"2!)23IJ
M09$Y:?;:#**[STB;27_1SLSLOLE9LV5_<+PT(N+O$+47=NE-FMM!ZMIQ75K6
MMQU9"G L!H)&[)FK]M7RG8MX6W;-&'+ P@:K.1\*6%CIFLQ:<-$*MIY!4[-5
MU%-3BW;N$'C!07O<TDT5FJQ>DB)R"!:O-IMG6G "08403)&H.ZK(D9@B.4UM
M]'V/WG23L7M/LW=M6EA=,VILV'[!D6MLOQQM9;WF&H;:*'FD!S<R+1R!,@ZF
M;>-@V9F6>*N\MBE;AJ_0+;&6.2DV%IA)=T^"O2J+YLT8QL8[<2*1Y!=LFD)I
M)DQ*W;J*BL0JQ0;FV7[QDM*2@*E2"""E0R*8RRB!KJ3P/.O.MB^B+:=K:W#7
M,1-C:VF#XC;W;S[.(VERXZ+.X0MM+;%NMUU/7.(0E1>0@)0I16 H[M2K=]O;
MO,+GR<JU:J= /$XUFBQK1U:*FPL$K*N6R"*KA=9W(=:\>W,JLH5LE&J-U0)P
MJ+DZAQZ:VUL@LI65N@K$D(7N 1E&0,C(F"-W,",JY#I)Z4L6M=KKC#K+#<'-
MO@5T&6UXAAK-Y<7"TH2M:BXZ2MA!4LALL]6YNC>"Q( V.W$42V[X-K&(\I4Y
M*/A;-&D=S3NKR$DC'1;KMRJQ$FDSD)%<C9N=!=B5=BH].DF9JJ+<RA#"!AQ,
M.(M7W6G 2F8D))5G!!\G/0\3KQTCNNVF$8ETK]'^SF/X6ABTO&@Y=N8>Z\6&
M7-XFV>#3CRRA 2XU+*G5)06Y!(*A4&V68"O6V.NY:W Y%*Q L50Y@L55(*<C
MIU212C6YY5RX?.XE\M&DZU&Z#5HF1XJJ0#NSJ)) !4U9N'47"D,M@@E0\I0W
M=9$!)$Q&9)TX:Q7%]%VQV*["6>T6V&-=3O6^%7*;;#[2[9NU.BW0IY3CRK9;
MC*0I24I;&^7(*E 1D=>,1>D$OWQZ14[.4K'8PMOGV4/*M(*JLXN;9,I9\FT,
MNRL)3>M7;Q(5"N%0DG"R3PY#%*1N"I3IYW+)L- )+F\$$DE1()2D1Y.20()$
M@#2=)GIFS?3'BYVMMKJYPK!!;8C>M6SR+/#6V;QENX7U6^U=@E]QV%[SG6J4
M'" !N2(SWZ0/:%DW(N4&F5:(M#2T?.1$1#OXJ5L45 .XM]')*(D.W/./VK)R
MS<(]!NANX%P5P"P&;\")PP6ERAMOJU)4"E1,A*B3.F0F#Q)TCS5V[IAZ-L>Q
MO'FL>P<VURU<6]O;7%M<7MM:N6[K&\D+;-RXVRXAP'>4EIQ2DJ$=63)$S14M
M&P'91T2+6(M5ZNMM,0(YRH:6JD*YL+ YC=J*"A6T@BT91H*&3(8K60=K@4%#
MI)B*L$(O+J1*4-H!,RDJ .>NF:M8S C+6N30<0Z'>B]27DV]_BV*X@4!E97<
M6%H;II:E3N[B5]6TTDK3O*2Z\J 2A"C4-]'[NZME]R0ZQ%:JS46S6Q1\M,1<
MO4:RQK2K)Y'I]Y6;R#:+[!DZ:*-Q5!%RHB5TFY*0BCA7MP +W=LA#8=22-W@
MI1,QI$F3^P@5QO0[TD8CC&-O[.8C98:E%Y;75RQ<6%BU9+0ME(=<2^FW"&UH
M4A.XA:D%P+* 2J:UNR#Z/3-BV:9>!B7%7=P%@LCQ]'V%W:85JNC&2#Y1UWA[
M"JNR39G+9-8Q%46D:L"BZ9@0,H0P#K(B\;ZN5!8*0D*$9 ITCG)/,1(G45TC
M&>AO:=S:>YM;=RP>L[Z^6\U?/8C:M.)9?=4Z2Y;+7XRIQH*.\EMIP*(&Z9)C
M;'?3N G]O$#B[ E2BX"P"G0X=[(6.Y0[.RBHWBCJP30C:.D1<L.]*J1:SEPX
M<IKB5)5)--,#"8Y->U82]OOJ*A]</DA6Z?*,R2,S]D"((RURBO0NE?;&]V*L
M\!V0P^ULKM2<'MW'[[$K1F^0M+)59M]2U<!;?6;]JI2U.I6L!0E*2)K9O8+N
M%E,\8KDUY^!AX"3H\JUA%S5YD6-A7K5PV[XU<-F +%;LUBD25*Y104! IP(<
MA$2B)B8KQI++IW23O9P2209/'4<)@F9.<YUWKHBVR>VNV=?5>6MM9W&$/M6+
MOBS09M76U(*DO(;!W6R(!<2V$H$DH"1D-VV$Y"2IETHR8CI!9 Q@<I,7K9V=
M 2@0.%2-WACI^)3!RH5,?#@"B(=)=8A0 E) GE$DCN([(,@Y@<AZDQ=VUPI2
M&;EAXI,+ZEUITH.62PE2B#PTB/,!<0,7J$1'I#P 1$2]0!\ORY5*4/,O/!R\
M ?P+X_9H!.@S\V7;D(,9GAG '8,TZ#@"9\T\)T,YY=F>E3K&(E#(M+Y\!&RQ
M/ @)>!$':' #]EY'[4XCP)_ I0X/P((E \YY9:SR]&L"<SQ$[N'&+^S'_P P
MW!B(E0] @'M,3.>7UX*7Y)  1#@ 'Z?+Q#Z.>?K#Z]4KT^NKNR?S>_G\/E[A
M#Z?HX_;TJ,^?#EQY\?1SJH-R (^?''''(@ >?CQSQ[^  0\   \>-* 1[3E$
MF.STYS[*"W((\^_CCGCZ?#\ <^'T\_..E/FT[/6>>7+2N*C1)4ATSE Y5"B1
M0I@Y*<I@Z3%,7R,!@\! >? 1#R'@%#F"#!!$$$2",\B) .9/L(-6F"J\!5XU
M&&KD1&P,2W%4R$9$,6\>Q1,NH958R35J1-$AE53'44,!>3G.8QA$PB.I))S)
M)/,F:P6UK;V;(M[1AJV8224,L-I9:222HD-MA*!O+)4J )423G5X! H!\D1+
M\_'AR/S\<^'_ -]16<@Y9QJ>.IUT(^>N_2III2FE*:4II2J#X (_, Z4JRLO
M"9E@^9&/ ?KZ%M*Q(_C7>YOV*J]Z5EII2FE*:4II2FE*:4IP >0<:4II2FE*
M:4II2FE*:4II2FE*< 'D'&E*:4II2H@]#FZPGAR'J*8^;_MR+]WX0U$]_H]_
M?6M1?^7,_P"K/_[QBI?J:VZ:4II2NI9/M2"3G@!\_GX\O >0$//S#Q^;2E?.
M:[XDVO625D</P^+)]LI6%XV&NV1:' )MVT K*OX>\*1-TM@.4I6;-*BR82<T
MX52FCQ:BR,D]=,'O8JED2,Y@C0'D>64<?;4 S/88J#V8-BT$^:68KMQ:BPM#
MR/,DK47)S\@E,IX^F(.X75:U.'3U-S,3QGDG NE&%Q=N&S](&3KNYB((*!8%
M9,29,#EDJ0,^61[AD!4Z>^O&LL$6V/6**I,RYDZ.9DT='A()JXG7J*1EV$FW
MLYHJ?C4WA$9./@9N=:S;8UB;NXF*?2K1^U40"004<P0OB%<QKZ1]-(]_?U<N
M%0UE%[%*Y;92K1 1C1U&MY"[R]FC;;84TH=6LOH2F##I3B,V#_L7)YUM"(P$
M.LO%.RQZT8JV.X8=W)/ED1*CG$23F!RUTI[^SW\W=68Y>XX2Q8UQW;Z74I2Z
MGNI\AMZ>XH:C"3%9I/N9#)=_>'5F9V+9 @X?,W\DX2%P9X1V0[%NW!3]+A4)
M)DC[6)!/;'G,P,\^7&1RCMF/,"=3EP]-8QKLCL/=QE6ND;*55@VC%X2PQC1W
M,SC,S-6;41R17FLY J/1371@E72=IB8B3:N6-0(!I!HWCD$C+!8E>AX@<!H#
MEGV>^M =/G^BO;D.?V63V66#2YA6[;9;&QL"4NZ5EGDE48U-E5TV3N0F(T9$
MU>]:.(&52@T95DQ6DFZ$F5FJL@1R4# 5@$B0$QKR4,H'(Z:<N%//[?W>BO$[
MQ/LK8VR(3?S$>Y6C(V6HC*EJ6:>D45'$'9!G9Q"91*\7DI$@2ZC-DZ9SJZT,
MJLV8,TVRCE)(HBM1&9\_'NGWBE<*2GL@@W![Q",8N!:2L'4K4RF):3E@0=,+
M(6^-H./C(-_).7S)!FUD+<88QO%-XULQ=.54NT1:*&;P=\#RB<X/HY$3Q',^
MBFGKU_;[BI12\=;*#6A+'52/59.TDD&MC3@4[3,RCIT9.EL46K4JCF5<$?0Z
MU$FHX"U_MG$8YKRK4_J]1FD50L[[D:F.[+V1K2NZMS6US$+RIV.-@UZLJ_NN
M6,>L;1,.)!V9E)T>%EG-N-,2TM+/78PZ4/CD\?!BLJN5%!I'M&2#5-3IU!*E
M DF8CW\W;PI\TCYB*C3]UL@C;O.7J?<0$--R;^&L19^4GI)-G+/9QU&9-*^B
M8H9)8L><7]0C[%*&/%QO6>.4>+=LW!P<HA1&Z02,\HT,P9X@T_9S]^_]]2R-
MI^S2V9#A:Y#.:K*7II*NK1&Q4+9)<?64HTL3C)BK]TDPD"14\ZA9NU.)YN5Y
MWY6$">,5(C1!X"1AWP(((  R@ 0K,1RGCI/;4^@^\SER]49UO0 " <> ?-QX
M^'[0>_G_ .^JU%5TI32E-*5KONAY^*EY_MU#>'B >#@X^(AY (_)'GP'JX\!
MX'2N#VA,8:L\GF#Z%BOR!>E>^,LUSQ^"0SAL;!7U!:E8@]-$DLYGBR;X7W8$
M[#OPM"MB-N\#UB@"@MQ[-0X&YC#BF%JGR][(*&J2,C/'4\N/"*^$O"&^'#B6
M$=6+OX"-BKJBR'/%1?%QP7/7;H"$N]66]P*5*D[\)D9Y%V,,$)#:?E-MN,.8
MN%%),XQQK:=ZB@E$IMT5I%PP75,#E- DKW96,,PYYDR"#/E43%/2[,/-AK-V
M))&<&20#VYZY0(X#/F^BAI+G1YC[6VTC9==RI32\24M*46R&]ZX4TM8WPCQH
M-^+J9E77@%)(RJ:[,(/8PSR5(NL'35@F<B)1K\T<E>3+=Y;QA@+ZQ4K21XV.
M14Y0$R3@Q^V?%:'6)R!!/S2Z5=%$NA(1(G<!29SS5FK+*>&>?*N4Z,++HH:Q
MJX7LI=75WC*6GRR,64HK0Q" \;,%FW1&X2)A;NZ5^5N@BOECNM+EX=RF0PLH
M6@T\-P?EK/8!)B(Q!7Q_@[Z@[#[9L1H5L#4S'P!0#])NUYUNL%'B[8&Z 4B9
M(GB#)T)![] ,AI\_](0VE.W.,&_1B)NSB;PP\(2Z5"VZ]8LQ9[J84WN;@"6@
MH[P(U(KZS9CB,'2.VC":V\^1DXZX(0,:DS?1"JA+P$DHQ3-(H-T2M':JJ9FI
M61ID'C0Z!7)4NLP.A)K0;ZX/O>+ [F<SD,XG,2)F".S.!7T3M+;[)O[";*GI
M.>>8Q!-I;AIZV4I.*^,EN;AMN6'SNAH-BY2ML + ,AP(J[XHA\.L-IF6R[+W
MLA(SSR"F@/(O%U#7LU@+'@5%%_UMV9FSU./%4T.FV100[905F74L?J&KA=5<
M(\9T)!)^U '#@ )R)R\F,XK:V>MMFV.CS:$]&3CSUTNSN@;A94<37>BW!0W<
MI"6P'4ME26>K0EL+.\C))GX_[4$,P&W*8Z3J9+46;1NL2:T@;UD7LX).21&S
M!.@M\@K48XKXK@K\!**P%+R*PEYY-]39865%&[ND)$CRI (X'.1QS&N4BOFS
MH]3M*-N,$&'_  DF[3BMLJ_24O@BU3=-JO\ QS>&0+0<2KK2)6==[=GZ9;L(
M#8 XS,JXRY.V.(R&Y%@I:6M)5< R,?LT :J68A8V0*DZ49 B1<K%5N][N8IE
M0!0"FUHVZKOJ@6P"C, J3.<F8@C+B!GF3EPKW7I#L^A]>TT[2W5[;8VM31OV
M\)+W5$A.ZV<0+=M<I0HM)0#U2VWBD()(D53TA+*4:[:,5-,$D4+AQHZ2+)%I
MXO3,AA0CBC7UG1VJ@BO#BX!R=918IDQD#%5=G*J8H"LB"ZX7B>MYG*3O#+4@
M'.<M -()JG3(S<M;"X C9-#GU-MN#K1AV\I LRRCQ,NN-[Q5;;P4'"HI!<*2
ML S.(O1=)7<[S*J5F2>FPTK6!2G/A 5<8 \J<%4S%;"Z,#;D(H'82AD/DE;B
MW%SP )@;+?[ODJ'\;O)( ' Y3,ZZ1RF9DFNO= 2,64O:%-^A?U,*L?X7XZ%H
MLE/RL'=<<*4E(MBX7BA0 2$E<:5D+#59]'"&X%B:DSDQ(6Q";65K$385G*E
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M\/(E!I$IV*PU]]BQ2<8R-CG/6*:\(UD6@*'G9^08O6L8$D^,0BCE2^^QO90
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MF<P=)L58X]'/BK)#/(L;G!*>?0\@:2@(:R32#B%A7Y'76T<MDVL P=.E& B
M-!?/792'*1<PJ+I)K:V%KO5(+9:(!$+@"5:F3)/+3CF!QCRW <$Z%, QAK&6
M-J47CK#RG[2VO;UE5M:.!0+3C:6[1EQQ30R07G5@*2%05C>K?-/>7M<*F8I<
MTTTWCP'*Z_//=TBE^0# H"(E( A]C'@>4^3%*"*6L+=XQ#2M1EK&D\>P]I&>
M@KUT=)FP0D_5/A6I!(?U!)C+=X#*..9G*:P;G;).Q_</3R4^]YDKA&[1_P"L
MHJ4B7IF<Q$2'9J)&79*JPJR/"B*@IKHK-ETER 4#D4,0HCE:;NF5;R&MXJ!!
M"H(B9,PI,Y@1K!RYSU7:['.BS;3#AAF+;36!0V[U[-PQ<]7<,.ID!QHJ:=05
M%)*5)6E:%).:9 (B.W>7V';:6LV%*S9$2LO8%&Q).Q6-\1[)J-&:PG;,$"LX
M1HR:LR',HH8C9J51P8Q3J+G B0DE\7;V2D>2F#"1 G(&!).O'(#3+.>-V+N>
MB;8=N[&%[46ES<7BD%^\O;EI3Q;024,I#+#+:$)*B3NMIWE:_8B=FS;R-KO0
M7]>NGB'0/DNJ(B B7Q'B,X 1Y_[ G//5T@)>281;/?YM0B<^.4=HT)]49\>]
MGI,V$.1VHPLC,_QY(&]KJ.)B<^4UJ'N&:; -QTY'66U9Q80-E8-RQZDS5Y)!
MJXD6"*CI1%H_3?UY^U7*B94W8N2ID7(02I=N)?DJ;#)O&$J2ELE)T"@2!G&0
MG(G03GF8XFO-]M&^A_;BZ9OL1VJ9LKYI"6C=X=<LI<>93)2T\FXMGFU[F00X
M$(6 3*B,JS=B7-NRK"5(B*!1LP55K"1AUG JNW:KM\^?.E&AW3]^Y&) #N7!
MD4NU.F5$H$  3*4$2"AB<9NG5E:VS)G['01ED"<@3.4\^ KM6SFU71?LKA3&
M#81M'AC=HRI;DN7*E/.NNP''7G"@!3BH3, #[%(R"0G)X[R-KAA$1S53O%$Q
M>.U7'Y!AY'DPQQO$0$/D=12CX<IF#@-0;:XX-J.AT SC,Y$<O7V5SJNDW8+(
M':C"P-R/X]1$G7)*"((DDG49'6:^?UDQ)Z-NUY'?WYWF\&:<C-*3<G5&,XBA
M6GCM=R9=RF4BU</)MVCA83**(MI4A0ZS FHD00$-I*[U* CJI(3N;Q&<'4Y*
M.<\>,]]>/W^S_0AB&..8RYM.VVEZY5=/X:W>M)LGG"K>4%)-FIY+;BH4MMM]
M(' @FM^&6[W:G'1S2,8YCIC9DR2;-&K=$ZI2(-FO9IH())!&]()I)D*0A01Z
MA*4HE. CU!I^+7"I.XHGMU'9G)YC.,Y\_KC/2/L PRVPSM+A+;+2$--MH>A*
M4-I"4)2D(3(2D )E,P!))!-1R[[DMG61J7.T>VY;ILE7[''+1TDU%RX35,FL
MW^2JB=.. [=TT5*1RT722(9NX22,')0[ ]D,7#:DK2V0I&8G($B8X\@9YCO)
MK4Q3;GHVQK#;S"\1VBPNXM+UEQE]LOD%2%B%0HI)"A 6A8\I#B$J[]3<)4[T
M>6#;TGD&#SHA8YY@5;U&%HEV[IG"&<]2*CAFWCJZP[9R5#M&Z:[LSD4DU5#%
MZ5C$6+L.JO'4[BF0 HY[B8.4Y$E1R,3GF#$:$'SK9?#.AG9/%1C-KM6S>W;(
M6+,7UTVZU:EQ)!4A-O:MJ6ZE)*4NKD %28WB%#=]3>3M>,D<OQU4\0$1'D5U
MC#X"W$.0&,-X\D#Q,F;CQ-R @0R6H;6X&75*F#IV'.9]@^FO5#TG;!9QM1A@
M@F)=6F!)G(H 2#/9I64L+;L-N5ERUC*O0.7*K)S,Q<Z['1<>U5647?/7<DLB
MV:I%%CTE4656$J8 9("CT@)B@HH9>%V[R1O%!@ 'N R[,M))C/E7*X'TA;%W
M^-898VFT6'7%W=7;#+##;BU+=<6X$(2DA!22I1 UF>'/]!"?VA?JU@KZ$KGI
M2FE*:4II2FE*:4II2FE*:4II2FE*>6E*QY-%OS.86<U:-J[]B[:MBKC.2\E'
M.47+?MRF*D1E$R":B1B'3,!S'(;JZB]/ <C.7&?1/SBN.N/A)+Q59MV3C:DI
M"_&'7VEA0F(ZMEY*ANG^KGSX>#UCF'[G<>C]/PHGPY__ .9T\GF?[(_Q5AZS
M'9_R7"XYF\NOU/YJKZQS#[Z[C[\9Y\?^;0:>3P)_L@?^(TZS'?O;"OSR[_4J
M#(YA]U=Q[^&T3X?\VATRYGT#Z:=9COWMA7YY=_J54]8YA^YS'OXT3_\ DSIE
MS/H'TTZS'?O;"OSR[_4JKZQS!]SN/OQGG_\ )K3R>9] _P 5.LQW[VPK\\N_
MU*J>L<P_<YCW\:)__)G3+F?0/IJ.LQ[[TPO\\N?U.GK',/W.8]_&B?\ \F=3
M"/NE?V1_CJ>LQW[VPK\\NOU*GK',/W.8]_&B?_R9TA'W2O[(_P =.LQW[VPK
M\\N_U*J^L<P^^NX]_&B?'_FT&AW>!5YT@?\ B-.LQW[VPK\\N_U*GK','W.X
M^_&>?_R:U&7,^@?33K,=^]L*_/+O]2JGK',/W.8]_&B?_P F=/)YGT#_ !4Z
MS'?O;"OSR[_4JKZQS!]SN/OQGG_\FM,N9] ^FG68[][85^>7?ZE3UCF#[G<?
M?C//_P"36F7,^@?33K,=^]<*_/+K]3JGK',/W.8]_&B?_P F=3">)5_9!_\
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1]:URTI32E-*4TI32E-*5_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g251271g49h79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g251271g49h79.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1DZ4&AO=&]S:&]P(#,N,  X0DE-! 0
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M4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M"G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@
M  EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN=$]U
M='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O
M;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M        1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M     %)S;'15;G1&(U!X;$!DX           "G9E8W1O<D1A=&%B;V]L 0
M  !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M            5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C
M0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T
M0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O
M<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))
M30/M       0 [_^-0 "  $#O_XU  (  3A"24T$)@      #@
M   _@   .$))300-       $    >#A"24T$&0      !    !XX0DE- _,
M      D           $ .$))32<0       *  $          3A"24T#]0
M    2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R
M 0!:    !@       0 U     0 M    !@       3A"24T#^       <
M_____________________________P/H     /______________________
M______\#Z     #_____________________________ ^@     ________
M_____________________P/H   X0DE-! @      !     !   "0    D
M    .$))300>       $     #A"24T$&@     #-0    8
M 9@   /K          $                          0             #
MZP   9@                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   9@     4F=H=&QO;F<   /K    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   #ZP    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
M   $    !#A"24T$#      .K@    $   "@    00   >   'G@   .D@ 8
M  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(
M# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,
M# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ 00"@ P$B
M  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*
M"P$  04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"!0<&" 4#
M##,!  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q
M8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75
MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
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MO:RPMV@6AU=DD?X3[/\ ^#)'*ZU.T7X$CP
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M-41E<W2CM,+#Q,7A\4-D<G>D2%.ELK/_Q  = 0$!  (# 0$!
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MB/\ \-HGB3WQ\@%2,0< W&9F #XW*/YOHJCS0?;?SS+[>_O*.WS]WT14C%F
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MB0+G,R8OG?E*^YK@9;$+;KXJ4A2F+78<@FZ#N!WZIO -O:38!#P\=O?^%?\
MDU3Q[R?::\$EC=E8%E($V:P[4J$ CF&M;I:X.<#KOMF<[[IL5A<7-^\XES0<
M@!28WX0!R B++I9K^N*_ 4:(C1%%EJS7C"DRZD#:;:QAY9)%!PHR<(O3J%1<
ME$Z"FZ#94G*H4!,7UM]@\-?C6^OY0?V/?9UMRINUOGOML_86VZ.'H8JKL_$X
M?:%2LS#XEH?0JDX;!UF<-5AXF$/,A>MV/N+O7M_!-VCLC8V(QN#?4J4FUZ3J
M(::E(@5&P^HUTM)$R(O9-O\ 5,X,^R#%?M>2_,M>2_2\_)S_ +3]C_W3:_\
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MSR4_-5O_ /U<Q9[JN%)\A7E'ZIC!WV0(O]K2?YCJ?I=_DZ?VG[&_NNUO\/\
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M]WO\5*I^U_[/OZP4A_V':/SPY2?J5LZAN(T-S]J5A-@__P B7\>GZ&OY1_\
M9OB^_P#EC=__ !6/<A^U_P"SW3>"G_<=H#__ $$?!*7A:SKXEH;@=O=*00__
M #(=#^1I^4>;?FWQ?^V=W_\ %5/SO_9]_6"G_<=H?\.E'A9SN._\H;GK[Y2%
M#\$@.L?T,_RCL_S;8O\ VSN_I_[55'VO_9[_ %AI_P!PV@?CAU3^I6SK]83G
M[4K"_CD@UE^AK^4A_9OB_P#;&[_^*I^>#[/M-X*7^S\>/_TQ50\+6=1  /1'
M( 'AO*P90^3_ +XCOI^AI^4A_9OB_';.[P^.U5!]KWV>C+;]*?\ J&/_ .&2
M?J6,Z>RA.1#V#YT@QW^WYRZZ?H:_E(?V;XO_ &QN]_BJ?G?^S[^L%/\ N.T/
M^&1^I8SM]83G]TX/^,M/T-?RD/[-\7_MC=[_ !5/SO\ V??U@I_W':'_  Z0
M.%?.X;_RB..OOE(,?FW?#M]K0_D:?E'G_P!6^+'=MG8 _P#^LLOSO_9Y_6"G
M_<-H_P"Y6_W"3CRX8XI]@B[C#+0SY[/]\;(JKM7':-@9()=KS-%UTPW43,'*
M(E'J(@ AK^F_Y$OV6[]?95N'O1L;?W8=386T,?O/]^P6'?BL%B^UP8V=AJ)J
MBI@L1B6-_74ZC.%[P8:"+9_.'VR;R[%WGV[L[%[#QHQV&H;-^[U:C:52B&51
M7>[A#:M.F\@M<#)%_>M7/*=<!N4N-+'[2,QGG:QT"4A4E#$Q\^=J(8SN2VYS
ME&?&,;>>6TD &*BV>J*24>F4 YHTA]UP^UZ504W>TT$$W,21W?/I*_'W D6,
M$9?#X+F1Y#_AASCPL<6?$72,W4&:J$H;$T8E%R2[=1:NV)!O=60'>UZ?23\W
M2[00$B@G;+F71343[PBDH80#97>U[60XF"9!-Q('N^<K%H FU]>L&QSY=+QG
M9?34(?RSMA]T$[^^_;:XRS5FW4NI7V!>U6[5V'M5<DP1+(0<^P;2<8]!NNFY
M0[RS=IJHK=DX1263YR#RJ)D,'4-4$@R+$(1-BFDO5,20EC>VQ2 I<=:&=>CJ
M@^L!VL2VEV]9='[.+KSA\8I'*<6Y7$J3&/4."+A7E3124, %%)(CK/63US2+
MSK$>&:93KA\X8;E%U8\AB?$T_%5Q@];U$75:K[QI%1LH!GCY&+ [<Y$6CH7:
MCI=$OT+G<&7,0IU!.*7 FY$YCYQH;Y\LE('*_/7SSUMRT6?E\8X&A'4#<IBB
M8X8O*+$%3KED?0<$DZK4+!M#N4RQ$@HW[5DSB62*BZ16QRILT$S*)=F0#&TO
MI/+ST\853K4B<>S%GA+@ZCJT]M<%#O"U^QKI,59>+@Y@PMWQ8Z1.(KMF,B=(
MR3@$CE36$AB& 1*;9<2//P182PX]PV[N3.\V*F4)Y>H5B5ZRM$I#PBUCC8]!
M3L >(R3E SY!N@J<$4W(* 1$QQ(0Y-P#23!$F-8)\K=UQK%\D6,<TG!$1'J0
M;RKXZC8NMV F6%HMRU@V;:$L3I=[R7]9JJ"9&#Y=R=^!9Y0B)CKF<E*X$Y3@
M$OG)R \ (B=;1FD3X762+B;"X'(4E"HACK7%W?0($/$&,:]/D3*/;2).R'GL
M+INLH=Q(["[4144,8XD,(C>)T1)'LEMN1T3YIJ5G G#17EY^#JF*L6Q8RE;<
MQEC91-;@D ?52R/7#EPPDDT4/H\-*OH]RH**O,U56:*"4H&1]47.,>T;$D#2
M38]/!,T\2XBPT?'S?$H42D*8T1:HD;408J,4K!6;9P5ZAV<.)#-!01="1T0P
M)"4JHE4 =Q =),S)GGJI B-(B.BP5:PQ@#',A /J?CC'-1D&;N1/6WD)!0T8
MX;.[ V:LY48I5JBFH165:Q[%L[,W']<)-6Y%1,5,@:$DYDGO2 ,@ G\XI= <
M3SJYNJ[67%BD(AM .[$Y81ZS]Y"LG9Y!K%K/E4S&58M7IE':+8QA337$RQ2@
M<.8)D(DQRFW*>^-54UYG"N$+"UF&$]C?'TPTLE@4L\VVDZ_"O4IBS)H)HJS3
MTCANH#F6(V;)I*NS@9QV")2*&$A-@H)&1.4>"+SS>$\%V)_ STWC;'DO)U2!
MD*W6Y%W 0SA:#KC]HO&R$-'JB@/=8E=H[<,UV9!!MV;E5,2 *Q^8'.%@XB;Y
MGI?ORNB9E*P5PKA#*N*1BS%",*JO'N#*1-9A$6BZU6D%E8AX)R-BE7"'D4U5
M8UZ G317(*S57H!M.(\S[,B^DB_F"BF1Q5J'+65G<GD+79"VP;%W",; X;,7
M,Q$L'@HN'T<W>* ==F@Y$[=9P@0R8*@HB=0H@8FDF"-#GUA$W&&),-QUD/<8
MJB49K;#/YB:-/LXB*2ES24RU28SLF+U)(%P=2+,$VLDYYN== 2)+F,02ET+G
M$07$CD28Z(F@IB#AJ5@H<CC&V*%8"E2,J, FXKM<4CJ](H+.7TOYM!9L9)FX
M2<).GCPB @/:IJKF 1*8^K+N9N#Y'Y(O3*X&X<KM/)Y!G\6XNL5D?M8\4[3(
MUN!>23EM&"1Q''+(*-Q54[CR)'04 VZ %(!#%*4 "!S@" 2 =)4(!S$I[1V,
M,4Q%ND,AQ5(I4==Y5(R<E<&4+$MK ]143(<Y7$NB@1XJ55$B9U!,L(J)E(8Y
MC% HZ2<O7)5.Y">AW,DO$-9-@XD&C=J[=-$G2*CA%J^%T#-<Z1#B<J;HS)X"
M)Q#E.+58 '<@ZB+)]X;[*CVZ.R/18>U)LD/+S;*^M]#]40-Z^WJCOX:(J.^L
M^3M.]M>S$G: ?O"7)V>XEY^;GY>3F 2\V_+N AON Z(@SQH43E%TV Z8%,<H
MK)@8@'$"D$Y><!*!S"!2B.P"(@ ;Z(O$SFXM^@FY:R#)PV6 #HN47**B*I!6
M%N4Q#E.)3%,N H%, CNJ I_3AMHB]HO68#L+ML ]H*.PKI /:AR[I;<_\T#G
M)N3Z8.8O3U@W(JCNFQ!(4[A @J&$B8'63*)S@;D$I $P"8P']42EW'F]7;?I
MHB0';4P@4'+<1,4YR@"R8B)$Q %#@ &W$I!$ .8.A1$ ,("(:(D[XSY>?O3;
MD[(5^;MTN7L $ %;FY]NR 1 !4WY $0#?<0T17$UT51."2R2@IF IP34(<2&
M$H& IP*(\IA*8I@ =A$I@';80'1%=T1&B(T1&B(T1&B(T10CG_;T'CM_#T]Q
M[_E=%:*'IS'Q$^Y3-HJKHJ$#<.8-P\0]O3Q^;1%KOQ'9/QU3\59)2M5NJL8N
MUIDNLO%2T]&L'2Z+ADL1),6[AP1QRNMCD2$J1^T$! @&$! +3>T5:;34%,E[
M8,@%IXK.SM!B.HU67!5+'/93<_A!(@6)&DY=Z^>0.)/"#LIBP-QQG7>T(9,R
MY;)'.E!1[7D,0#BX1*4RH"(@ D$0*;?V  =TQM+#D&M7[0F\]H#(,?Z-Q:#!
MO!L(LN)5[9P<UE M!'"21<$YQEX#F%VNX$LF8V?82K\5%Y$ILU)NI^=31:LK
M%$N'KIPL_.8$T6B3@5SJG'FV(1+Z*8!.F E,&NNQU6E4Q+W4W M=$9 D_P .
MG@%NHT*E.DT<+R/:<7182=8D1)BUENK:)-K'UF?D5U"E;LH63=K'W#8J*#)9
M50=S<I>B93"/,8H!MU$->=WAK_==@[;Q/ ^I]WV3M&MV;&ESW]GA*S^!C6@N
M+G1#0 220N9@Z9K8O#4AG4KT6"2 !Q5&B23D!,E?&?Y1"=+-Q.,UJG(0,NX:
MR%@<*HJ2#<Q2 HA' 0B@MW113%3E.<HGYB@*8ARCXZ_BU^2ONQM?#[:^T'$;
M2V/M; ,VA6PKZ3Z^!Q5'C#<1C2> U:(#G,#@?9)F;2OK_>!SZ>%P5-E;#&HT
MN#@:K0V[AK(!;?T "N?>-KS<H^X5IM(0%9*Q5FF9'1V[A1ZZ3 SI,-TBIN1(
M40W$!5,40(7F$0Y0$0^K-YMUGUMA;5-!NTG5ON&)X ,.X22P@0#3<YQF &-D
MD9 KSF#Q%<8NB*AP7"U\$4Z],.OD<SR$QI>^OV5\!TI&/IC(CAF^9.")QE?1
M4,V=)+E3,95VH4ARIG,)#&((&+N/4.H!KP'_ ).#8VTMEXS[3W[2P6-P=2I2
MV.RF,;A:V$=4 KXIU0M968PD-): 8\]/)?;, *.[X#V/DXX^R6F/:IR'0XF9
MO<1?.5TI*H0VW*8!WZAM[0\=_FZZ_J@OP=5Z(C1$:(C1$:(C1$:(C1$:(C1$
M:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$@@ AL.B*T*"8JE6Y2\Y2F(4PE 3 0P
M@)B@8?6 #"4HB&^PB4!$.@:(L&;I:&Q?_$;OK_PYJ/X]$7BF*5#SMEJML>K2
MY)2GC+GB$F<U)L8M09MD1B]\[1+1TC'S0$0( LRR;=T5DN)G#8$UC"?1%%]^
MP_*6^PR3MK8VT= 6 ],=6&/5AC/)-1[1)127ASQ$F$DU;,6KM<4$95)W&R*B
MJ"!BLG#)5852@8((T116EPIKLP0%C:F3=S&0=BC(A92NF=<KVS&H??W\DW=3
M"[-V(-JB_C$2(-F9DX^P+D*H#A 7"N1(.FG/6]_,RGKER^?GJ%ZYWA?D)_&]
M.HLG>%)%_6HZW1BTW)QAUT5F=MK-CK:_<&#>3:*,56+>;;J-!<OY!(H1Y4A0
M*F<G8@X";6.DZ)ZOW$?OO*<3?AHKZ+Y,IW**M;222(E5NY'"+(<D*[8*F[('
MHIF(YE'BTVNB8@I'>**"=,QC"IIQ&9M/<+?PTF4644PW92M:U')6]HY;Q^,$
M<;V![*1+U[,2H-E6;I*;9/DYMNFT=K.&@&<IO4)(%2*FY52*;'"3GU,_'ZHL
M#D_A>B<G2LM+R-KG62TO78RM/$$4VAF\G#QRMAD"14R7LDQ=Q99V2A)M!%N+
M-RFO7$6IW:K20?H+T.(@0TP9N)/=/+UR@L,GPOR;23>33.Z(IS!IV:DH^3<P
MKQRJS93;>PE'O#/SXG&O)F+4G$DHR3<,SIA'QZ$>]9NTBI A)'+S/T ^*)T5
M+ \W6:_<XU.WMO.EKKS>$0>-:\BC'0P-I:SRJ8-HA=\Z248?RR':BRYT@!%
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M\>?PNBTQKKHTPX=,D(5(&L&VE2.907*S9("R")D78]@542G!9 H%#F >R$@
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MP(X-_E^B:(CS1:1_HP'[5?C!#[ZF_P![1%5YGM/UX;_WOQWXE T14^:;0/\
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MY]C#6O?]F\B_4VZI.ZYH " 5S/@/*<3AS->A@5V3WV7-ONGZP"40   Q1W,
M:?T?D[4?B=YV'E\,U0S>GV0*M.\DDLPMKVS:8D>7+FHM,S\Q0!Q/CNFIN(';
M 4#@KLF'^N-Q$4QW#8   W 0YO!_1^1L>9OW6CK\KP8&;SR/US!())-+#YSE
M9A.5Y/*Z46N: $0!U/@ )K"&QV^PG!0 2  %P AS)[F 0V /: CI^H&<^9M;
M.PC/OY=50S>@F#6IP0Z_!AX!! :(+0?:$DR($0<Y%(M<T;J!WF>V[-82[*-P
M$3E4(5,@;K].8HB8H[B4 +L("8>D'89>U?63 ^<^[P0,WHO-9GX21[&'_$"
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M@]GUVZ[("ME$C)% H.UJ3/%D( @0!T%^G\+*J\^\G/PINWN.%2TV=80^*RP
M5.F1M_N[.C$<UEZM)P4C*5-.>&(EI9G)N%Y \H]04D)%XLHI*.7PJ;#!4> 1
M.>?.>D1"Q+02#R\HY$91X+()^3YX7FX8R\TU&:@%L/VJX6NDNX.]W-@^9O\
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M^<OA%RJH)CJG*9R*?.81.(%*8P;COK!Q))L0>7.V7CZZDX #< W$P%$! Q
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MBB*: 'SU> 442DSFY:7"@(=A)()HB(&IY 'D;D7)N4I@ #@"YR+[$3"E3/\
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M>17/GN\E[-C(+(%-3(<!35!@FHV']AO8E[%97M.95<4R 0XJ\Z12&6@I4_\
MFSG&?6^GQMG>ROWND!Q=K1CGQM_^9>=;RI_E&P[P8F>;US=V6,0I:5!B8BHL
MT.3H:H$ IB++"8 ,<Q ,F81$Z8$!:&C3RX#,\^1YQ<<YMUR4&+HG*M0S(CM&
M VSL7@^[N5UYY5#RBY%W@(9ZO!TP3 4>2F0O*F;N!51ZK4TIO54534'G$2[
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M)9XHHX,81,<XB8VL7O+XXM!$:>777N0 "P6V6L%528P%VW]O@'3<=$50=?\
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M=EG$E&0^\J"#A + C'-6KQ+O+=TB<Y6JC@%DU@$97%_&,LPI-S8V \9T'<F
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MUR03PX?2]0=")'QUZC0I-XY >O=XYKF&Q#910Q#  CS^J8.H;F$1,(E >;<
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M$S=2/.5<IQ%<I2I&(90#@!4P$#'W XB(G[##D]FV!^V8MF<^1R.M\HZKYO\
MM-#7[RXJG4@TWX'#->'G]6&=DYSN(F> &(<X"+D:E?/!1J;P@AG!JA$W.S/'
MK>R)K0,0\;&1K!IQ%ZX.T9(RQ2D=NT$72+<&H+*-T5SE23!=<K@X)=CQ533D
M\/X3.<QF2)MTC.9.B^3MF[/W _G*QM''8VI4;BN/"X:H.SP@Q-.J7"FVO$NI
MM>!V9XA)]F7"4WN*_/>8:_F>4KL/892LQ%7.Q&%;L2%0+)$59I+'?O53D4&4
M075671*@LHLQ*0ATRH@85>:TJ; P$M!D$R=,Q[M9O;,"%QM^MZ=X,+O'7PF'
MQ=;!X; NIC#4Z3&4Q6' TNJO=P%U=CW\7"'ES!!AC7%Q.Q^1G>/\H<--$N?$
M*_?5R6<M"/6#Z*24&9-*G!9L4&$<N5QWAN_023>K,SF1;(E4,HD#<@$<'P;Q
MMJN;3$MM(T$VTDZQW ]R];M:KLK;>YNS-H[UUJN#KU*/'0J4&N=B'5BWL_U;
M.%[G-J-AY8YS6M,$%@,EOX>=XLQU@C*5RP-(R%HM4=!JN9=6QL1"33=I()F9
MINH8A3-ACVHJ.W*)44G*3@Y'"2KHR9.T/'\;JH#P PNB!:X%@.N7*<QS7&W>
M?L;9.[&V-H[KUJ^,Q]+"O?7?BZ?]);5;!IA^'![,,IAQ+0.,/]H\1@$P'PN9
M]S1/9I@H&2LDU:8NSO'I9]B].*Z;1JFS>.3O&IR=EYO2:+)IK*IH*)H+@0$#
M)**&3+K*JQ@:8!  ,:1R@D "?*;R("\MN5O3O)B]XL-AZN,Q&.HXRK4^\TZK
MBYK&!KGE[#^*G1EH::8/9D6+.*"'WFNG<)*6;7'I%;['%2+V6(\M<3 ,R/:Z
MD_<K@HLBX?IMR+QH..8!?I,D'8H\QSF*U,IRI5O:\#;-)$1,R>I%^\7&G*_9
M[QX#<(;R.&*VAC</7?7;4Q]#"4F5<"*I/$YCJH<U]#BD%XITJMS)CB=PY7C)
MRS=:!\'M,QO+.:Q3%ZJS?LW\&<4#O&R!@:QS)M(D,LHE'M&:2"I$&KD 5[P!
MU3*;@=3"DT$.<X<<O,S,ATQ$2.X]]NF_[0-O;0V2-D[.V17=@=G' 4WL?A2U
MKJK6P*+6U@.,,92CV0X%W%[1=!3_ ,;VJ/S%PLSC[B,D7:< PDG#7TC5 S9\
MZ0C!:*1LBR,1LL59^1TH=BD+=HL=T9,R6QA.?8YO ]O9B)D<,P!,&W=I>.N8
M/:;&QU'>'<O$5-[:U08.A6=1&++G"K5%(4W,JT^%KFOJ,>XL!+/:>#< N);_
M  KQ6 8-Y;9_%L]8;9D*,@95=DVLC((F228$(H8OF=JT5!-4SI5-LDLY(N=V
MD!DO5:]J805 ]Q;/#P3<--C>;Y:S?6($KB;DT-UL*_:&+V%B,3CMJT<-B'4Z
M>,:*-9M-H<6G#TVGA<'N#6N=((81#6N*U?QYQ-9V=9?AW*E@EY8DW9FS%_3R
MI;Q1&3Y^BW<L648!.RCC((%*DFX3!-9(C=/O"IDR'UM-*F0X%H B0;\7B";Y
MSE,D=X\9LK?3>=^W\*]V+KU_O.,ITJFS^%OW<,=58PTZ- -#*):'0'- ,-':
M%P"VNXQ*]PYN[+"/LA6:>K=Y6C4P=%JL<E*NY"+!P";=Q,MEDRHIK(@+E-JL
M,@=RLB4X"15-LW*IKH]IPD- +0/9))YC*#$&Y/@,S;W'V@X3=&IC<-5VKB\5
M@MI.ICM#@Z+*]2K1#VM#\2TN#6O #@VIVY>YA) X6M!\.:+HWQ%PX45+AXDE
MDZA-2RS)6S( 9V]1(JBY=.U#JNDA[C)/WA2D75[!%=N9N5-(Q!(B".5)O:57
M]H!( MH+Y"9D=_, 7E:MX]HMW>W0V9_-&NYN!Q-=U-V*:!4J-XF%]2]4/+*M
M5T%U1H]AU,\!;[,4\&65KAD>)R+5,H/7-HJ,?!"X7F)U7M"LF;M%=I(1CMV<
MIE5D5V?;.P.?G60[-=05B@J)@5Z;61V8AQ@ #,DYB=)@9G6T1?'[.]O;0VS0
MVO@=N578S9]+"%U7$8F_94ZC:C*U-]3\18ZG+B;O$EP/X0F9ANH<)?PX-/1*
MY6B5E&<F1U5(F89@U@3RB0G.F1I+=BS=2 MU0'NK=ZW:D$Z1 !9X(\XJG:EA
M):!#8=!DP (M<<S:3G81?@;O8'<3^<E+[AM''5L0VLRIL^AB:?988U@ \AF(
MAKW%CI[-KZ=*3'"Y]RHXXB.(?-T)FFRQL799RGQ]8F!;0D0R 6C5=D@F!$GC
MI$$2%E4)4ISO#%= Y1$C]=,FX'4,8QE/@ X 2[.),=^@GP@B++JM[=[=Y<-O
M%C:-/&8K 4L'BG4\/AV%K6N:P!@>\<)[9M8%\%Q<WVW 2'.*V<SN?%&0L-8Q
MN.=7\I3[4^A$7D86OH%7E5'CQ@"[U (Q9)1-5BLJ"+L2.5FAD%3II'<D$ZIM
M:Z8<Q[VL +0?VB;6TB=9YY:F)]EO.=A;8W>V-M#>:KB-GXZIAFU*(PC"ZMQO
MHA]1HH'C+Z1=[9,MAT,+FR2,959:F8JX7+I;^'5Z_L4IWYH>4F9ADD::8.SN
M6K-=PZBQ34(T2CF*IS(IIB*.QS.3&6*93;)P+JK!4 X8(: 9!-Q?BB9 [XZQ
M.C U]G[#W)VCM#=.I5Q6([6F*^(JL'WBC4+^S[2IAGLAG!3L"TO:6U"X22(C
M3@RSCEFU94/4K)/RELKLM&2<C)&EE.]>:'#4!71>HK<@F236=JIMS-Q*HB8Q
MT#I)I&;I*I*S&=F8;!D<-HO>;6TRCQ%EU'V>;S;=QVW3@L9B\1CL'6H5ZM45
M7%YP[J8#F56.L6-+B&EK3%P0 X2OKC\G@!!QM;Q( !M;Q'H  /2+: 4!V3)T
M IN@ (@ ]    -^HQ APG,B_J3YFYU7W;]E<_P D[2D0?Y0 /.>PIY^)*Z$:
MXZ_44:(H[M,X_K<HQE&U6L-G048.6"B5<2C%W#98SENX(==.2E(L 1.0ARE4
M2,KZX 4Q2@8#"18+X6)/[$64Q^2/JOX[;^/5CN\PI.E_(_&(5 Y5D1W$<0Y2
M$1#Q\W501Z> =;9M\^X>P>G32+3;S$^6:3I?R/QB%:#)SSF,?X'LH@<P !C!
M&U,#& /I>82VO<W*/4-QZ#UTB>7F!\2DQS\B?@%5\*3T#<XX@RB!]M@.,=5.
M8"B;F$I3>ENX%W -P 0 =@WW'KJ(3'/R)^"K'*;\0W'$.43>'^UU5W]O7?TK
M !\??JQW>821U\C]$!E)]L'^I!E$-O8,=5A_[6"'7Y?ETCN\Q]4GH?(_1(.5
M)$!Z8@RE[-_]+JIUV]^]K$=ODT@]/,?5)'7R/T2AE-_]B'*(;^/^EU6Z_P#2
ML?\ /XP#9!Z>8^J2.OD?HD^%-]OTQ#E'?;;8(ZJ]?M>EG4?C$-]2-/F/CDDC
MKY'Z)1RI(;?[$.4AV_\ %U5Z_$/\MG@.K!Z>8^J2.OD?HD^%61'QP_E(/DCJ
MI^EH:D1_$'X),\_$$?%*.4WX '^I!E$VW3I&U7?;X][8 "'Q?>VU8CEY@_ H
M#.A\00J?A3D0'?X(,H@'LVCJKN&_RVSEW]_WO9I&MO,?"921U\C]$H95D0'<
M,093*/7U@CJG[?$?V6]/CV#42>_R*#94D#>&(<H#U$1$8ZJB.XCOX^E@_']K
MH&K$\O$@?%)'7R/T0&5)(=BCB'*&PB.^T;5?$=_8%K]OAT#?W]-]([O,?5)[
M_(CXA'PJ2(>&'\I;AM_M=5/ /9OZ6>'VMQ]NI&GS'QR2;3?R,^6:/A3?F#8V
M'\H]=PV&.JH]!Z#O_+7MX>S8>GS:L'IYCZI(Y'R/T5)<I/R@)0P_E+EZ  !'
M578 #P  &VAL >P/9UZZB3//Q!'Q5093D##ZV'\H@'CN,=5>HAMMT+:]OO;=
M.NK!Z>8^J2.1\C]$I<J2!1Z8AREOX<_FZJ_A]+.;XO#K[??I%XMYB//))Z'R
M/T58Y8D@';X),I?N?5OQVP-2(_B#\$D<CY'Z) RQ*#XXBRF']SZJ/_:S5@]/
M,?5)'7R/T2_"Q)_8BRI^Y]5_2W2.[S"2.OD?HCX5Y/[$>4_W/JWZ6:0>GF/J
MDCKY'Z(^%>3^Q'E/]SZM^EFD'IYCZI(Z^1^B7X5Y+[$>4P^6.JWXK8.D'IYC
MZI(Y'R/T1\*\E]B3*7[G5?\ 2O2#T\Q]4D=?(_1'PKR7V),I?N=5_P!*](/3
MS'U21U\C]$GPKR7V(\IC_<^K?CM@:0>GF/JDCKY'Z('*\F'AB/*8_)'U;\=L
M#2(Y>8/P*3//R(^(2?"S)?8CRGO[O-]5W_RM]FHDCKY'Z)?A8D_L193_ '/J
MOZ6ZL3R\P/B4D=?(_1 Y8D_L194'^Y]5_';0U(C^(/P21U\C]$GPLR7LQ'E,
M?DCZK^ENB2.OD?HCX6)/[$.5/W/JGZ6Z*I0RO)B&_P $>4P^(8^K;_>M@A]_
M5B>7F!\2I/?Y'Z)AY"L5DR!$Q-=C,87^-7-;ZC)JOIEK76\>U9Q$^QD7BRZK
M6QO%PY6[<_*";94QC;%V#?<)$?Q!^"3.GF",HYCR[ELML/N'YAT57)2P)@67
M\IAL4VPW7% &W #;F'%U6*82AOX"7E -]M^NWMUR6F11L3':"VD0<N9F_.5B
M#+G=S1:>4>=M,OCRY9\@+'#D*7E$QMAW Q@ 1,83!]+MX  ==NGLV'6WPS.E
MKWDB;QUF;6$++U>_GS61,(%$X 0=S;\I>@!MRCL/-N/TH[#MT /M:'(^1F\Y
M1 &8.N6NJGCZL1KR\\\K*T)M]RJ@8 #<QMA'8WTPD 0 -M]MMQZ!N ;![=9
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MQ!5"V7=]1V6*JICZ5G6CQ^PEJJEV8/3L"]Z6CGR:B)%^;NQWJR2J;M-OMVA
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MK:Z3LGC:U3]DMS)H[19M[0T0CUVT2HN@5R_B$4T (NHLGL@JX'=9)L=5,&Z
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M.Y37FVU0@L94T]TEWJM>9MY"3 \>E),7!01:."K\R15O4(L8X$*01"L87S!
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M=#DD82R2R40P0&403D4P8NW)2IBHD*QVYB*%35.@FW$NXD,4,*3@PO9!LXW
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M-9Y4:Q)'CXNJRH2D: 0K=U('2=NVNR"[E99ND0 1%0R" K  \YA3%4>VHYK
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M.I(WZU/(EK',ZO(O4DW#8C<%3I M)"@^4:FA&*C5!59L +HK\C0J1@$SH=#
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MH!NUK5HBIZ-LS9])33UD];,VC=L_*9^^<R"Q"M5FITB..4I%CE=@H)$^8%
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MPG(A?)^S]V]S6;Q@4]X&XE]#%]IA]EBEV;75Z54U&41CB7TJ[>-H9V3*;'.
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M*?ZW%8S,1*F/9)<Y2@ '[)/G W(721S'F$6<+F#$X;"-JA@$@FY!%N\*)>8
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M$&5?6(51CVY(MH2*.Y;G0,5_WMZN@J80*X2(5N)>U!3G#;72;VG&_C<T.<3
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MPCSU5_Z]C?G)_!T21S'F%5Y]K/\ 7T;_ .C_ (.B2.8\PD\^5<!W[]&@/O\
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M4QY'PCYX@-B1'LE&(H/"$YU*'4YF0UW&.(D$@YR1'O!L9R&9A!B+$WN;1I:
M=/XW3K8<'?',G?L!@[9Y*B:O6<2\.=>J$E2+U6V[?"=@I<%#-<H,K/!/\A04
M6_++/FK\7:[&%O:4TP7[BV,Q-R+)1SZ9:ZW$YSCTSRM;E,YB8(%H$&00;<B-
M+3?O%E])+8JA&Z)%3@HJ1(A5%"EY"G.4H 8Y2;CR%,8!$I=QY0$ W';?7'62
MO:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1$:(C1%"6?OV#QO]
MGN/?\KHK10_,?$*:.<?<'W_W]%5S2O!3*Y5X^4.@%#%F"W([[["'F6X@/AX&
M^@#L(?*(ZY-*": M^-V=_EU$#4]25#J>@CO$E<OQ$I1Y1V* B(;#U$ $?8(!
M[Q\ 'H'B.HWV2228N>HB9B=,O155PI0'H&P[!N [>\1VV]NW7K\>V^_MR#VN
M!M.=X%CY#GGXZP+\AYS:UM//ETN%*)>4!V$NQ@ 1+TY@ -P =A'80';??V^(
M;=< #).ACW*?N]_?EWKS*$]<-@+L(" AX\HB4H]-QWW'<?$=O?X!O5<[>O73
MGEFK(IDY1 W4=QY2[CN7IL B "'CN8-@]GO\-#8 GH+:$]<M5#&O3WZ?(J@$
MCEV,.V_-X[;<P<NY0  ]NWB(B;W[>S1%96 .R'F$0'DVV$1#<=^H@.P &P;#
MMT$0#I[M;&N!;RU&DQKJ3E))'@;IWKIQPU[%XQ790\ X*,&!MOU#_3B='<0W
M^/H/MWW]^I5O2!M_E'>,^M/FL"?;'4>!SY6]674K7$6:-$7#/CU61;YXFW#K
MZ&R1JM?6<**=KV144V"IE3'#NQDQ3*0%!4Y3F* %-S&*!3]GS\-^ 0+\1(N,
MYB<P>XP8-QR7SA]ISFLWEQ3ZH!HMP.$<\EI(%/LG<9B#+0T.+@,P#K9?/A1[
MSP=?#@U5B:5.,9->Q)$@;$[<NUZV:>5>&3;O&\2#APLR36=&1%J*[%=)$ZJ:
M@I-2M]UNQ/;EA)> (/L@.'*TD SX2=,U\I[.VG]GPWEFCLS%4Z[L8!AL55=4
M=@W8EU5X8\4@\OI->]S>&*3@"0Z "9B7C$J&4%\XRK]:)L<C%281XT]=HF\>
MMBLR,D$Q0:@@D -G";M)P=9(Y$EQ-LN83D/V@YTBTTQ!  $'ORTF/W$RNC^T
M+ ;:=O-7J5,/BZM'$]B-FN8'U6]F&!K:=,@?JW->UP<T@0;\1!XEMS?9&GT_
MAGQ_#<3,1+3D^I'MT&\,D/9V09)L*ZK0Z<CWEL9D9I'&;M'CP5'*:O*8IU'*
MIC(&T-#NT)8X !TN(RF#EIFUQS'DO>[5K[.V=N9LK#;Y8>OBL4^A293H- ;C
M#4I@EH;6XVFEPT^!KJLDAK8(+C P&,'^-;5@'+$/PY0<I6KFM"+#)1SU\HI.
M'<KI%3;F3EG+@[06RS<';5DH20;"DH514S855QY,W\8J4W5""V\1S%I(.N41
M(SO (7#V)6V1C=U=NX?='"5\'M%^&/;4JCR[%OJ$@-(JO<6.8^F'BFTN86'C
M]F""S5KA&I>54\[P;UC%3\8RA57Z]R<R#61;-21IV;I!PV>D,4HN7#IPJFBW
M+R+=D[.DY.4$D#F+MJ\)ID$B>$\,#,F3F<XMERT7B-PMF[<;O/A7TZ.*P]/#
MU*IV@Y]-P8*+J;Z=1CRZSGN<[@;^(!XXG$!O$IIS-<^$0^9G2-FI<[,2[:51
M9VB>@G1F$"$@W5*DX5<QZ$CO*]B/5^JV!(5Q*<A%G!B"JKA3%7AL6QH2#)!U
M-L]-?@O1[Q;1W!=O%4;C=G8JM697%+&XC#.-/#"I3/ [BIMJQ6X"T->:989!
M:*C@V5X>.6"M<X..)NH,9.2Q=Z+,R1/F9%=Q%MG#H3+,E!;HI)*$*YC"MBLU
M5F::0$0,5)0%>V12QPY$.!(#^,@]8UU)CW =ZP^TO#8[%'9&(P#*U;8HP-,8
M=M!I?18ZIPFF[@ [0]I0[(ASF</LP#Q<0$EXC;L:%PFRH\1,2_/4W,FX/&PL
MFBJM)JQ<@+4(QNR:J+,EVCM1\#IRR_7:+AJF<%R\A0V"5.+M3P&"!!(O89SG
M .?T,+N=@LI[-W$K'>S#U#@'UJCJ5"NPOJ5*%3@[)M&F74N&L2"ZE+VN8"'6
M(('FX6K%@&3=6^-P]5YFJY)=0,D2+)9'YY1^];)E.*)(MV7O39+D<BU.Y0!!
M%83<@@5R0@E"50]W!Q.)8'#B   ,'(DF(SUC6Q6&Y&,W6K/VC1W>P.*P.V:N
M$J]A]ZK&N][?:+&X=X<\,!>&<;0#(%G$B5I3C.AYK4S?"E:P]F0M;&UH/)B1
M<I+@F@DUD$5)1T]?J"#)RV% QC'V7.DY3,D5$3@HF)N07-:USID.: !-Q$<[
M9Y03U7YQLC9>\?\ .3#AF&QC,=2Q['5ZCPX-9V=4.K/?5>&TW4FW=8N:YL%G
M$" =X^+JQ\-\?:8AIDFK3%JNR<<B*Z5:>A$O(^*%<YT$9=^9XF1114#+JMD%
M8P'*:6^YD"N$A1X] 58D.#6: B^H(@6MK[1,B_-?I6_N,W0I8ZA2VS@L3CMI
M-IL#A@:@H/HT0X.#*[N,E[K%S6NIM<&V @\36[Q H-KIPRTAY@-@^#'K.7$T
MO"Q:+E)XDV;HG1[)ZU(0SAXHQD0!61.*ZYCJG2<J%%,$UU*P.%5W$6\4  W@
M@2#I/+3D!)7%WK%/:.Y6RZNZM.L-DLQ)&)PM%CQ5:&M(#:[ 7/>ZG4X34]HD
M2QQ,/$XW@9B;E7H?(\K=4)"%Q@$0+APG/M%$F"[MNBLK).VZ3LZ*HI)11#IO
M.Q3,FN ID$5%$0(&5>(:+%_$(X3U',3U MK>TK1]F5#'X3#;8K[1;5PVQA0+
MGMQ5,BB][&%U:HUM0 PW#AP?P@RW)KG0%:PU=N$;X;6R=3I4_$33U^#2K3TL
MY6/">='(JEYF<0+J25C55SG[-J[<+*IE(9,Q$&"A3=I2*SJ?XO9@D\($VN1>
M!>]M389E8;O[2W!_G(T8#9N,H8BK5%/ XO$'CPW;N<6S3PP=B>R<[VN"HYSF
M@P8HF"-?>)JCY=6SQ95W,39)526F"+5%W$H/'K96*V($4A'*LT^R059I)]@X
M1(*2B3MNY45$%04/K92+11$$2!!F"1K87@DQ$@:P8(7E]]-F[??O1CG/PV+K
MNKXIS\ ^@QU5KZ,--)M,TQ <P-:UXD%M5CIDB3N1FV:QS7,+XRA^)"%E+3=E
M8=L=%G$F3;3R,HW9%(^64E4GB*#5-,3I-7:A@>D7=;*]S4,D)"Z&![WO[-T-
MXN0(D G($WF;3K&1!7Z#O)B-CX/=W8M#?&CB,;M/[NQS&88M9B^V8P-DUVU&
MLIM EM0^WQNX>*F2SA.*BEJG>N%>[0O#1$/X*106;>>8%9T(V1PJ"[=Q) $@
MHMSO%GD<F<R1FZBA5$B*M""D<!3"F656&H="UKB !/(ZR,Y(S(OJN/AS@-I;
MD[2P^YM"KAZ['L=B<*]_]*=8.K#B<0*SGT>)S.R #FTWL:T.:V8-X&JIDMEE
MIS)F83D15&<1(H6A:2:NVK%RJJ IQS0P.NQ3.^!^4%2GY@41 BA#&YW)$ELJ
MY'!^R<B!,$7SO8@CO%N<1YO[,\%MAFWJE8T<32P-+#UVXUU:F]E(EPX6-(>
MUU3C,_B'".*_$0#]@_D[@ ,:V\ .4X^EV^Y>0.GFQH4!]10X" ["!1V#<"AL
M8P>'3XK\;8M[&7*Y.6AO?P7WS]E1!V/M @@_^<-+C_(,RN1&H@Q"EOB@X+>'
MKB\K/H]FNAL; X;)*)PMH9J'BK?75%0.!58>>:<CI(A#G%0S%R+B.7. "X:*
M\I0#2Q[F&6^1R/\ 'UD%^HD V*T&\GAY+^P\ O$AF&TQ5X:7G$V0,>LX2K.G
MB'<;;#/VEH:218J>:)%%B\ &)3BE,,%$4ESIG*LP:&,F YU:O: 2 ' DF,B(
M$:S*Q:P-F,C'G>?#)=AA_9,V_P!PG7_6#76E9KQS%WKT%9:M4I%=ZG-W(TN6
M 00BI-VU<#!M"OI'O<BU:+1\6"38Y3)#)N6@.CCV37ME0$@$4/9!XA:U1;7)
M4^2C)9S)M5<?HM^P82R\>[+?9U:"247E&<0\C(P(PZ)W"Z4B]15>)[)-R <Y
M!U0TD2!9)CW)I0N>,7,T4'50I3Q.5GT&LDLG7:RV;^>P+8:E S(-7R3=FO)/
M(9[=8PR@/FS(5Q,LHF<J::IRCQ:SXW]]QY)ZA.:D\35%N$XXAD0?M3NYB/B:
MP*[1<BT^=U$5R1>E*@H1,&KV(7L'8R#$QU5$FK-9^4YTN8"28^"3Z^:R9N)3
M'Q)ES$'8V]--I*O8I>9/7%BPB:D=;@HC]V+TRX'%BVM9THE1P5 1,=8CE(BC
M/F<%O"2;7,3;EU18=OQ28EL .XYNC8)1%-92/G2! %>L8QNN^A8E-654(X6:
MJ,'[BQQ!$A:F>BHB][15$B2+@4KPN%XC73S3Y9K%SG$?3:M,UNM5^%7<PAZV
MO999XS00BV%:KB$;77L<FU:&3306?/\ THB46K #LFZ(@NFHN1444E<?#._R
M]=R+,M^)ZCRD5!SM<AKC8(69F:I )R;"%12:(25N/%D;-US/I!JH"L<66:*2
M14B'*ENJ1!5<Y#!H;$CDBSCKB*QRA(A#HJS+]^6(93BY&<68R+2+>0S^>1=O
M'*ZS=NV2"/C7 J]JJ4R:PI(&+SJ%#1%%)N)C&#="VW>!J;I;L(1-R%D3A6K,
MTM*D3L )5V=DD4CNVRPR%<58(J@,@T[55-4RB29DS*Y<)EH_THB_-%)\#Q'8
MZG8&Y6!BI-NF=$9(R$X*$.NJ=1LJYD&(J18%, O2IO(I^BH4X-UDB(E<+)IM
MUD53BT@P1!F/73JBQC/B9HCEPDFLSL+0CZWQE,B%E6<:LE*R,LQ@'S!RS[K)
MK'6CEC6*.:BZ A@3<*F$^Z)04+ "<A,"?!%8H'%3C.]^:TD!G85U(PT9,KMY
MN,*@G$A*1#.=:1TBY;N722;U6+D&;LADA6:&!=%+O0.#BB @@D&Q&8152'$?
M7E)ZM0L+%2:Y)J2$9"2ET5(EE%U1"/L+Y:V(&*B].^9**UQZR;H&*S6.L8IE
MQ01,D92?.;]WKZHL8'%'6R3QV+NN6IE -E+,D_LBK!NLU9#6K@VIZT@L@U<+
M*E@W;UT"B#T!%<I.BS%,H'.2Q:>L=>:)X1?$CC&8JSVVLWLEYO9I X(U<,"M
M7[YJ9*/72<QZ:[A-LNBHE*,A #.DU4SJ&0622<)G2 YI:8<(/@BIK'$)3KM+
MUF-JL=9Y!K:"E.TFS1)6D0V(K56-O1%RLZ=)+#VD5),RB+5NN5)XL+=0>8AS
M%B);!Q&4&LQ:4O-HV&.BG4R6%8R+B,1(C("*YFJDFR1[\+Q>*07 I%W)6H*I
M N@<S?D5((D3:6XH:E"N7"MH@[7 09(^)<IS#F)!RDF[E!L8H1[U)DX<*-G+
MHM;=#' 3O .A53*J9L<2@<GH>M/AUT7CM7%A2H%5J@C#V-1=I:ZW7;BF]CA9
M$IJ=A?/&I'<NH4[D%E@;,'CUJVC^]E<I)E*=PW.H0HL_*?>!\T3N)Q#4EU5&
M]PCF=C=Q:EI85-Z4L6F1U$NGJ::Y7[U-1R5%2-1:J)N%UV*KPX%,*1$C.2*(
M@1>&(XE:/9FCT]986>9=L8M[*O$"0PHHL6;=GWMF\?.CKF03:R13=FU%J9TY
M Z:X+MD3(J%"AI-XMSD=W-%:0XGJ B"B<JPMT:Z8=B:PI.*XXY*R@N2 .B\F
M5$U#@DR7)9HA9!1'O"QD'0J'02!NY!&\#KVR_?EZGHB\BG$[5PM$%!H5^T*I
M3D6[>MBC&@E*KKF6JWF5-E&F5%-PVF&EH0>%=*/VX-"-U2N4B*;E+CX_'Z*3
M<#G/N7O:<4^*'@MEDW%@2BW0..SG7$$Y1B2*LG<1'R*"ZYS@N@I&OYR.:/3*
MMR(IJ*G4(JHW066(Y=?J1\E5/D-*MYR)CIAH1PDUE&35^W3=HF;.BH.T2+I
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M&G4(=(:XW:Z"YHTB ,-PPXXQU@EI.K2V5:7-6FR)MVKT[&>8)1+-FT/VI&Z
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M'J/$7C8!Z=/1:S]-O#_\?V!^+W:Y VFT?YIW,7'*.6NJ_-_T2MOG_E=L>/\
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MCZHA_<&._(:(@<18N'^E_4?D\PQW7Y=V^B(^"'%OV/J@']P8W\;<=$0&(L7
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M]AWW#F$!';KT#XQ\=]$5P V#;I]H-@^;1$NB(T1&B(T1&B)-@]P?,&B*D$R
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M]$2IW*IK2*4.E98)2765<((Q1)9@>156: )G:*;(K@7!U6H (N$RIB=$ $5
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ML^2<SL<BRDW<<S,+VB["N2DC7)%B(,'L(BL1FH@+]00*JJ" )(IF*K#4:6.
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M'%BU(JZ2:?0U@%SSHXM<WAX7%S8O+29/3EXDZ#DD7F<@;$<XR.F7QYKEC9N
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>E+S>KZVP;_3>_P"T'VPW\=$5[1$:(C1$:(C1%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g251271g68u75.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g251271g68u75.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1404&AO=&]S:&]P(#,N,  X0DE-! 0
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M4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M"G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@
M  EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN=$]U
M='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O
M;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M        1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M     %)S;'15;G1&(U!X;$!D@           "G9E8W1O<D1A=&%B;V]L 0
M  !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M            5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C
M0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T
M0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O
M<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))
M30/M       0 [_^-0 "  $#O_XU  (  3A"24T$)@      #@
M   _@   .$))300-       $    >#A"24T$&0      !    !XX0DE- _,
M      D           $ .$))32<0       *  $          3A"24T#]0
M    2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R
M 0!:    !@       0 U     0 M    !@       3A"24T#^       <
M_____________________________P/H     /______________________
M______\#Z     #_____________________________ ^@     ________
M_____________________P/H   X0DE-! @      !     !   "0    D
M    .$))300>       $     #A"24T$&@     #-0    8
M :<   /O          $                          0             #
M[P   :<                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   :<     4F=H=&QO;F<   /O    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   #[P    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
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MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
M A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H(
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0'_P  1" #X DX# 1$  A$! Q$!_\0 'P !  $#!0$!
M          @!!@<"! 4)"@,+_\0 ;A    8" 0$% @@$"PX1!PT  0(#! 4&
M  <1" D2$R$Q%$$5%B)187&1L8&AP? *%Q@9&B,R4E97E24F)R@V-T)&6'5W
ML[35)#,U.$=(9866E[;1U-;AY/%3<H*2Q,7&-$-$155B8V9VAY.DM?_$ !T!
M 0 " @,! 0             ! @,$!08'" G_Q !5$0 ! P," P0'! 8%" @#
M"0 !  (#! 41!B$2,4$'$U%A%")Q@9&Q\#*AP=$50E*2X?$((V)RU!87&"0S
M4U:5-#=#1G6"L](ED\0F8X.%E**CI,+_V@ , P$  A$#$0 _ /8[UC=>VANB
M2'K,AN"5?J25LE6[*%K-?;ED)UQ'^U((2LXHU,JD",5$H+'7665.07*B?LC7
MQ%S\!DCC=(<-Z#)\@H<>$$\\>[KA2DUUL:F;8I=<V#K^=96:H6J-1E82:CU0
M5;.VJQ?,/WZ2Z*@&0<MU2E6;N$U45B$43,7*$$$@\PI7/3UB@ZM&.)JQRT=!
MP[/PO:Y25>-V#!KXZR;=$%W3E1-%,5EU4T4P,<!444(0@&.8 &$5NJ;0URD1
MZHK>JDD2-;Q[M^92PQ1 9-I44_@U=T)G8> D_P#%3]D.KW"K^(GX8F\0G>(K
MV171<)IK(*IK(JID5252.51-5)0I3IJ)J$$2&(<ABF(8IA Q1 P<@.$7UPB8
M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(O.9^B-F#(.GK2,A[*V!^;;+IM[;X"7M?LH
M5MR<6XN.YXOLX*#XG@B?N=_Y7=Y#G-FF^V3T#3G\_=^*H\D 8&<YV./=S_C[
M%WK:%CF$=I74J,>S;,4 UQ2U ;LT$FR *+5R.564!%$A$P.JJ<ZJIP*!E%#G
M.<1,8PCKN.23SR2K-S@<0P>N/'W+=;@H;C8]+=UENG#++*OX:113GRS)HDZT
M/*M9-('/P#)Q,F0Q5&Q5&ZC=T()N2(G60<)%,B:%*A^ET9W)%>NO5]@P\U(4
MY2:?13R:K[U56S2%MC(6*L(7?PGX#)M8M*(]JJ )""L>Y6 [LZYDA.H48^OS
M]WUL%+E2,>ZWU WB(V056>5&IQ<2UE%B)F<.#1;1FQ!VJFKXJ??6!(R@D,"G
M=$W=$3<<B0_B/F%E=,.Z0 ^L?M$1X_!SQ[_K'UPI6O")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81
M,(F$3")A%YU_T1S_ *VW1WT[?>!^#XLNA_(&;5+]I_\ =_%8Y.GO_!=[&D?Z
MS.I?\&M'_P"3,9FLX .<!R!('LRKC< ^("RAR'SY"E,(K$V=_4#:/[V'_P :
MEA0>7O;\PKZ+Z!]0?=A2JX1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A%@GJ9W./3QHC9FZO@(;,7759<V(T"#T(X90&Z
MS='V4'XH.@:]_P ?GQ1;K<=WCN>?(9(F=Y(QA=PASL9QGGG&V1UQU76]8:A;
MI33-ZU&ZF-8+1125AI1)W1FX'-:&"3@?PY+N?"5Y\_V1XAR']*VKQY>?Z9A/
M3Y^?BG\WOX_!G(FVC?$KL;^MP C YG[8) Z[+Y7']+>,_P#<MP\1^F!D;9Q_
MT#&??NJC^B.VX?[5M;\&RR#^/XJ!Y_1QC]&^$V?8PCW8R4_TN(O^"Y/^;M_P
M2J;]$=H '/ZEI7U_C,(/_P )!C]&#K4#_P"61_\ Z*?Z7$7_  7)_P W;_@E
MI_9'C?\ N6UO^,LG_57'Z-&?]KMX\/\ %/\ 2XB_X+D_YNW_  2!^B/6_OZ6
MUN?HV6G_ -5,C]&>$P \V'\#A5/]+B/D-%2'_P#.&?>/0D_9'B ^G2TL/_[E
MD_)5!R1;0><V/_(3^*D_TN(NFBI/^<-'_P!$4#]$=H_W+2WX-EE'_P"%,&VM
M SW_ /\ L(_%/]+B/KHJ3_G#?\"%J_9';?C_ %K:O/ ^0[,( _9\4Q^_SP+9
MQ<IQ[!&3M[0['W*?]+B+_@N3_F[?\$M(?HCU#W]+*X_^;LM/\M4#\&2;7_\
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MCZ<\!F>F_P"D1?WPO-NV#_JRUG_X-+_ZL2_/:  $0#GU]?K\_+[OPYV,[$N
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MY8G!['M/?G):X!PR",@9"G40O=*!?F#Y^?/W^N8%Z4M6$3")A$PB81,(J"/
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M:F=..].M-R-M9V6OH5=LVM-H]IDT$5ENZFV%"(:HHJ&8MEF+HCH5P%VLFJ0
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MJKJ%T_7M'7,D]%42KRU3F8=O5'[6*?-EZ83PX5OXZ\<^1]D(G\E=(K4HJ%
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M+*1<3+3<\N[,BU<LXYJP^$';QT\>N$TP$$TT!.<2YG;2LDI8WM+&/<[!<]V
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M3ZFATO\ H:_6:LKJ22MM4MWIH*>.O@C:9"YC8ZB62/O(VNDA+F.:]C7$N:<
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M#>%P(=Q0XZ?83JSL?0AV@%7NS'>-GUB^H\I&].S+;\5(K[3E6YT9 KIHA'+
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M86/C%*3Z^OKV*1>L555:+4C*QCR&[L&R3)&R#1DP>()HI DEX[%@F@U9'43
MBGLB;9J9N!@25;(*$.D4BX_;]2L]UI$E7ZA*0L+./EH[V>5G(KX8;,4$'R*S
MQ9JV[Q?!DQ:%63C) .^:.>G2>D34.@0@D430Z.9UC)Q\C7;-7ZXTB3IN4:XT
M86-_7IQZ->85=):R,Y.?<I+GK\4@]+7W4>@R<"LY25D?']F(4Q%)V6K@4_20
MU0KE5Z2MTZ,@RO5PX6>!%MF;('*A>\(%,L"/?$OGP!@+WAX$1*#R'M;\PLR%
M] ^H/NPI5<(F$3")A$PB81,(F$3")A$PB81,(M(G* \#_P!GGZ<#Z>?Y^[DB
M=\O "(@ #^?Y_;Z816_*6VKPDA#1,S8(6*D["X<-8!A(R;)D\FW35'VARVB6
M[E=-:0<(-^5E46A%5") *AB@4!')P<9P<>.-D7A [2*M1-P[2[JBA91RS;>*
M>PO(@SV78P;96PQVO$GU?;*R$BNV9$!U*(-T"H++I@Y$WLX&*8Y0'D(\B*/G
MC&^-MB?=Y=<^&0L)&9' >6^? 9\\? <U%.OZAU-)WA*K3.S:U7FJU @G[R24
M< XCHFRO4:V60(26+,#&/7C1S(2A5&1'8HHBT545;I-B"9-G8GF.6X).3UQS
MZ<_XH6XYGS&-]O>>OLZ^1*K;M(:CKE86?);63>VIPG83-*\U?U620BE(*NQL
MX@WEY")EW2#E6;6=+,(Y2,,H0K@"(F[SA%PD%FN.<C !VQX#(\#R^XD^*.;P
MC.>?ECIU^"]B/9!6F*I'9?:BMDX5Z,17FFR)23-&L'4H[28L[U95W:Z+%BDL
MZ<%00(=50J"1S F0QN.Z41S1F_VK_(X^X>*RMY#V#Y*?<IU,ZBA71VTE8W#=
M-&!1L*\D:"FS0R#1U6G=O:,EY<C$T>G-.ZXQ<RC2%,N$HY2(5-%J999%,^)3
M^*^:'4_J%PX9-2SLBW<N70,G[=]6[ Q7J[@\NT@6X7(CF/3^*9'DN_8L6)YW
MV$KQ5V@+<RB9A.!1D?7Y<UFF LM>M4>65K,Y$6&+.HJ@22@Y)G*QYUT#=Q=$
MCQBNX;F41/R14A5!,F;Y)P*;RPI7-X1,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB818DV]O+3VB(%&R[BV'5->0CE<6K-[9YAI%_"#K
MN]\S6/074!S(+D3#Q%$F:*YR$^6<I2\"-F1OD/"QI>? #/E_!<)?=2V'3-*R
MLO\ =J&TTTC^[BDK9V0][)MZD+7'CE> 02V-KB <D86UU)O[26^XAW-:=V53
M]BQL>HFC)*5::922T8HL!S()RC-NJ+N/,L":AD"O4$?& AQ2[W</Q+XWQG#V
M.;GQ&%2PZHT]JBGDJM/7B@N\,1:V9U#4QS.A<X$M;-&UW>0N< 2T2M82.6<'
M%F]172OI;JE@X.!V[!RLHWK4BK+UU[!V*9K<I#2*R!FRKMD_AWC90JBC<ZB!
MA5!4.X=0@%#O><Q3/A)=&6[C&" 1]$8]WBM'5FB=/ZVI::DU!2S5#*.8U%)+
M!53TE133.:6&2*:G>QS7%A+2=_5<1U.='3ETH:(Z5(*9@M+U$*^G9'Z4E999
M_(OYNP6)\@58K=>6FY)=P]>"@#EP*"8J BF+A8R:93*'')EFDF(,CLXV Z#V
M#HJZ2T-IK1%-44NG+?Z)Z;(R6MJ))IJJKK)8PX,?45$[WRR%O>/+6Y#07O(&
M7$F27[3SQP(#]8^7X_S^O,2[=GX^'XK",+U&:9L.T=CZ6A[:B\V1J>#:V._U
MPK"2(O PSULQ=MGBCM5J1DY*JA(LE"ILW"ZG"H ).\ @%S$YK6O+<-D)X3XD
M;'Z/X%=;IM6Z?K+W=]/07!DEXL5.RKNE'W<H?302,CD;(7E@8\<,L9(C<XCB
M (SE;K2&^M2=15,'8.GK4G;ZC\*/X0TL@R?,4RR<:9,KQL*$DU:. ,B*B8=_
MPA(;O )3"'GB2-\3N!XX78XL>7X^Y9--ZHL>KK=^EM/UK;A0=_)3=^R.6,":
M(@2,+96,?EN0<\/"0002-UF, 1#GU'D?7GW_ %AP'(<>?/I]64\_PW_/W+L'
MN^7B/K;P0#(#Y<#R ^G(\\^GD &]_'EQR'D/'H/#Z^OBHV^&/=G8>?EY<CA.
M$N>0$P>GER !Y^0!Y^?GSQ\_G].%.1X_7T"JF,B(@7@?_1]  />;@?KXY\QX
M'CGSPGU]?!4Y1$1$0$!'@./W(>@  \ (>H<?:'O'&1XI[O/IM]_-:5#MR$$1
M I0*43"/= ?DE+Y^?F(CP'T\\!Z\AD'Y[?RQ]#GT4' !]F3MGX@;GE[UUHZ,
MT=T&;^WM;.K75:#K8.S*;L"3AIF=E)>UN8>N; CV3=!^K'5Z>,FP;/VS11L5
MNX9(*-6PD24:"FHF0P;<DM0R-L3SAKFY P.+A.1@GGOOX;%>0:;TYV8ZHU+7
MZ[L8-UO%NNLU-4U$D]:ZGH[JR*(2.BI*GAC9,V-T7"]C2QI:TM +01V<  !Z
M  ?4'&:J]@5<(F$3")A$PB@_U>H.6YJ+/(IV0"PKQ^Y*^3?2\=1(A=,B1B2-
MQDJS-QUCA2II'<$;S+)C)M6S91Z5ZB"9@ 2*6-!<D?4JIO$W4>_(Y@(Q<KV*
MDWTU&N@69I']H82TF5.0D6JO>[Z#UXF5RX3$JBQ2G,( 17?A$PBL39O]0-H_
MO8?_ !J6%!Y>]OS"OHOH'U!]V%*KA$PB81,(F$3")A$PB81,(N)FIZ&KD<[E
MY^48P\6Q1.X>2,DZ09,FJ) $QU%W+@Z:292@'(B8P811V'J"FKJ;P]%:TL&R
M6)E!0^/,VNEKW7*2P#P)T9:Q-_C-/M +R8K^IU*>C5O(J+T_(F"<>)QY<S[Q
MT]Y"+>N:AU+6<Q?A?:],UXP5*45F&O*6:=F$>?,Z:-FNCQ9F<0_<^/\ %%$?
M+O%2 1X!D#H#[<CY'Z\^K?W>S\<_@JDZ=O;>36C<F\[.<_\ IA5+V6LH'  Y
M$H-Z1%UA-(HFX$H$ HE#Y/>]1R>+P#1[@?GDGPW)"+Z&Z5=-.>Z,I%6V>-_9
MFL&S=E2QC#Y<][VRV*<\C[N.[Y!P   !D!Q'A\!^ 18KO_9Y]+.Q9RAST_0'
M1%=?3J]ABF;&SV-NU?R"C4S9(98QY-9VZ0;B(*)(HNFP'4 !6%5(/#RW&[&,
MC!VW:T_?C*@@'QYYYX^O'W+Q9]K0V09=H)U&-&B146S:S1;=ND7D2I((UN'3
M23 3"8W=*0I2@)A$1#@1YYS>CSW4>YQC)/O_  _COA8B=W9YY(&V-B#C\!G^
M*Q;3HG3I=0P[]VEK]SLIPV.9)M>):=:12[5*RS25G4=C"+HJ$EXZ'3K!X)LY
M60]K9/)A2+1D)1-!$MB7%Q(W Y8;UQON1SQ@<_+'((<>K@>W?._AX_+/18&V
MLU@&<W $KQ(M$%Z14W4PC#.5',>G-N(PBCP4U%3J* LLB+5R\34/XB+M==-8
MB"Q5$$K,.QR02>?+?D.73)^MU!QDXY9V^O<O;_V/U?:6SLO]3U=^==-C8XS:
M4&^4:F*1R1I*W"TL7!VYSD4(58J2YS)&,0Y . &$I@#@>/G_ -J_VCY!9FCU
M0.F /N4T9GI/UY/S<%-2IGKI2 K"=:9LE6-=7:K@WJDG36TI)F7A55I1ZVAI
M9V5%%ZJLQ!4Q0%H+8#-S8E*MN+Z*M;PR3E*/F+4W)-.".;DFDK"%1N9FMB8V
MB-)+HFA3$;$CI>-9"W")+'BJT3.S>"Y15.)B;?7UXK/.H]6Q6H:RI5(62F)*
M--*/Y-#X649B# 'QDS?!L8VCV;!C'1+4$^&D>T:I(-Q.J*9"@IW"$64\(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB814$0 !$1X /,1'
M"+HH[636])VKMKIU38;\U/KC=>OF\[:Z;KW=C-=QKN\QQI%@0_PD[<,'E>:N
M1>-/9@93/ 2;0RH)E K;Q"<A1O=&R5QB<^)PX7.C!+VD#.0!S VWP<9.X7S9
MVXV:WWR^:3;%JFQVC45K94UUOM&HV/-HND+I8P>]>Z":C#S)$6<%2,21AP;P
MXRHR:!ZC!==)O:/$J6IM<Z&W5JBF*NK'L/I\>&;T^SS+5O+LHV7@'#%T\:1[
MA@=H\60/$/#M717AG1"IJB<F9)8OZ^F)>9(W. #7XX@T[D$XSN,;D$[XVQD=
M-TOJTNT+VP>@6&T:7U)8K>7UESTK*6T%94PQSQPSTKHI)8H98RR0@TTG=OX^
M,8(RH_OK!UFT"L] >VFG67M*5G.J]XE2Y*(F%?;ZW5F$LZ1AVCM",<+G:S,B
MV9/SNU'SY'VLTHBDY*Y(0O='*!"\U$?<1 0^N3@ N .^^01T]N_0D+JTE9VA
MVNB[+;]%VB7N>IUS(+9-!5N[VDH8II!3,E9$\NCJ)V1/,@DD9WG?!CSDA3;Z
M6MH;8Z=>I3KLT1MW?FQMNZ]U!JA'9#*UV8YY:V0RYF2+UTX@T%E'14' HRWA
M_!Z9@8*.&;-4B21 4YP3,9)%3R1QM:Z1[68Q@'[0(=C&=P-\Y\^17H^BKW>]
M):P[3=,:@U1>+[:-/V07J*NJSW]?3N=&R1[Z5KB0U_#4 "$%D1D8,,:S=0BU
M)U+[^K'45T9W6O[=W[-4+?\ L)K"2\=N#:NOKFQN->=3K.&=.DJ!3Y-Z[H8$
M]L< DC,-6;@JZ:*C-5043D'8DBC=%,W@C+HQD%K"PC+20[)W=N#X\.^>:\YL
M6L=3T6K.SVX4U_U546O5=U9#40:AOEHKXJZEDGB@>66FVS2R6P%SW!K:AL;P
M>'NR0UP'8QHT #M7NTL > XT-5#!QQ_!RBCY\?A'YA\A\\U)!_JE)C.>-X^+
MCC'7IX8\//U337_7EVP\M],49SUVIK:",XSX9&>HVW77II;?>U>GKL<92UZB
M=OH>P6+J6F*3(VJ-31%_4:_-F67?S3)9T8K9JZ.I'M8MJ]<""+5:235%1,P%
M4+L21B2M =@@1Y .3DM&PP-SN>0SR\.7ENG=3WS2?]'V6MT^^6EJZO651;9:
MZ$L[V@I:EKS+40N>!'%)Q4\<#7R$-8Z;BR#PJ9?0Y<.JB-W=;($;'LBVZ#E=
M'2-EFE]M[WTGM:[U2Z!&/EH:QPI=?7JPS<? SCEN9LDT,R$&:G>]I!(R"2RV
M*H;#W8=PAL@D:&\,;F-<WB'$UV2<G&=QR&=_#T3LSN&MXM2UM,:N[W#2M1IN
M6MJ'7W4^G;Y<*&O[A[Z:KIOT5<JJIAIJN0%G=F+,1^T&X"N'L>F/4)NIK8.H
M/:/4EL2XUFKWG85 AM73+Y>0B5U#!&+*3DJ_<./&<+LC+E1BVIDU$F:1#BF8
M@J'**N[IF(V1-:XX=Q  '8D 9YD8SS)!R#C(!6QV MU5J*.KU5>M87>XT5'<
M[O:Z:R54CY(7'^K=Z5/+([O'%G&UL,9;B'#@,9+73)[3_=#/4VDZQ#)V[:=/
MM&R]BUVFU1UJ61@(*R2+YP<ZKF+7L]G50A:W'/&X=Q>7=N$_9!,14/(A\UZ2
M,O>7886L&7%^X&01GA_6]F.?+DO0>V744=BTW10-K[W;ZV\7>CM]#)8YJ6DJ
MI97.)= ZMK2VEI(I&N#73O<"P;@Y&1UL]$.[M_15RZ_]*W'8VQ)J+UCT^V:^
M4\M^V)7=FW"G65&%7(G[/?:@^D(=T9(SDJX)QSP4VSELCRF@X(J0VS41L(I7
MAK/7>&.X&NC#AQ [M)S^MC( 7C_9QJ;54%R[5=.7"[W6I@LFEJZZV_\ 2MUI
M;U<;?6LIG-'!=*%\M-)P\8>!#*YK'-82 \N B#7[YU?U[H]T/UO+=7FV)B0<
M]0C/7)-=R<HX7KSB"6GIM)VK,K&<F/..'"\4J0R<F@NDE'KD0;BD9$ALSEL)
MFDI^Y:W^JSQ!HR3G;& "!RY.Z>8"Z%1W;7U-V?Z6[27Z^OE1([5D=G;:)JES
MZ1]*^KJV2.J'%Q])D>Z)P+9F'NXG<#2"QN)Y=36SMC[8[0AUHBT]4UJZ4=54
M?1T+L"LR-<FVU<;W&R/HME*NG#MR]408222+IRZ;GCWBBH*-HA9LV;BLJJ8,
M$(;' V00ME<]Y:06GB:,X.3C(QT((WY^?J&L;Q>+]VJRZ6K=:UVA[%;=-T]U
MI)J*J;1MN-6^"*>1\CY7,CF9')*Z,Q/>0YD+FL:7DE9#[!)87&B^H9=67+/J
MK=2-G5-.D(*1)HZM?KJAI4J7=*"19$PF>%3[I>Z"O= H<<!2X9XX\_L<O  G
M'UG?KR&.2_HP.XM+ZK>ZI%8]VL:\NJ1D"H)I:3-0&?JB<DR[  <>!L,#OBSC
MU],IA$PB81,(F$5L3=+JEE>1LA8*_%33N'%4T8I*,T7I61UO#\51!)P4Z)53
M^$3A7N"H02_(,7D>2*XTDDT$TT42$222(5---,I2)ID('!2$(0"D(4H< !2E
M      X#"+'NU+D]H5,E[2P;0[M:+(W4,E/S9J[$$04<II+KNY1-A*.$_"2.
M8R+=K'NW3U<$VB"0J*@8I%$@.LJPG=5V-4U@G&RUS4F6-;82UN,V59RU/BH:
M8N36W>% N!@D&[:7!*O+(%DE9ERW.DNWC1.40*,[@>.?N_FI,S%E2N.E5;4@
MW6:-['3XV=1;.! 5VR4JV9/DVZPAP J)%7 AC%#NF,43%^28N$/+WM^868R^
M@?4'W84JN$3")A$PB81,(F$3")A%CC:&QHO6=:/.OT'$F^=NVT-6ZY'>&:8M
M5EDC>!$U^)24,4IG;Y<>3JJ"5LR:)N'SM1-JW64)(&?(#<GH!XE%B>K::F+M
M(LK_ +\7:V2R)J)OX#72#A9UKG70"0 029QJQ4T+59D"";VZV3350XN3JI0S
M2,9D(0TEPY-V'CU=YYZ#P PBDTF@BB4J:21$TR !2)D(4I"%#C@I"E "E H!
MP   <!E47UPB81,(J" "'GZ>N$73WU"]BKTN=2FX;MNR]V?:3.UWR12DI=M!
M3D4UB4ED6C=F0K1!Q#.52$\)JF)@464$3B8>>!XS.VHD: T8P-MQOCVY52T$
MYR<^[I[EAC]CP]%H^0V_=(_5980/K_M>]_T\A[N./+)])D//'NR-O<?O^Y1P
M#Q^X>WPW^AG"K^QXNBX!Y"X;K /0 ^,T&(<?AKHC^'\GED&H>?#X>WW_ %\
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MLCIKDNG_ &OU2[#V0[>[.KVQ&NP;1$,7TS'(5\$#(UMNU._%+V)=5-1<RPJ
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M&3"-/:GP2,19@?O;Q%2+J>305C9-LV1@*T]D(?V-)$OPJVA3NC*)G>@0'KG
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M$\-CF:V8PAO X@/!+>*#._>S^ZJ(;J7ZD[CKK7]@W'J_J7>KRC@E<W['Z;^
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M4)[#-0QER("#EFX71/\ *25\,V26N'#D8XL8S[<;_!%Y+Q[>;M" ,8 MNN@
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M-2!*RL3=ZO/K"F2.*DL1ZS(<HI%DNP-@3X[#&-LD[Y\O#&P&RH7$[;#KG?\
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MQ]GO^CC/Z42,.8/=[]]U7@'G]?=]>U5_8V>KA]>IC8'N]*A7@]!^AU]0!\W
M<>8!E?2?[ Y8W.??R_$#WIP#S^[\E+'HG[&6C=%>^8C>E>W1;+N_BH"P5\L#
M,5V(CF:R5@:$:JN#.F:YUBJ-P)WB% G=.;D#< '(T?,7M+2  3Q;>*D, .=]
MEW)/ZM7)=)ZA*0L9((2*K=601>,6CE-ZJT*0K4[HJJ)@<';%33! ZG>,D!"
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MX4W/^7?^ZX14^)!/X5W7CYOAX>/L]E_%A%7XD$_A3<_Y=_[KA$^)!/X4W/\
MEW_NN$7R6IB**2BRUNN::*13**'/8 (FFF4.\8YC&:@4I"% 3"(B % !$1
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<PB81,(F$3")A$PB81,(F$3")A$PB81,(F$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g251271g84e14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g251271g84e14.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1P"4&AO=&]S:&]P(#,N,  X0DE-! 0
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M4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M"G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@
M  EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN=$]U
M='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O
M;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M        1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M     %)S;'15;G1&(U!X;$!D            "G9E8W1O<D1A=&%B;V]L 0
M  !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M            5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C
M0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T
M0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O
M<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))
M30/M       0 [_^-0 "  $#O_XU  (  3A"24T$)@      #@
M   _@   .$))300-       $    >#A"24T$&0      !    !XX0DE- _,
M      D           $ .$))32<0       *  $          3A"24T#]0
M    2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R
M 0!:    !@       0 U     0 M    !@       3A"24T#^       <
M_____________________________P/H     /______________________
M______\#Z     #_____________________________ ^@     ________
M_____________________P/H   X0DE-! @      !     !   "0    D
M    .$))300>       $     #A"24T$&@     #-0    8
M ;(   /-          $                          0             #
MS0   ;(                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   ;(     4F=H=&QO;F<   /-    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG   #S0    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
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MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
M A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R
M@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9V
MAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]5225?J&?C=-P;\_
M+<68^,PV6N +B&MY]K?<DI,7-&A('Q*SV=7O@;^GY(,2[:UI _D^]U3G/_>V
M,_XOU*_TMC]0ZST_!N;5DML<]S \%E3GC:26_2:T_NJK_P YNC?Z.[_MA_\
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M9+;BULC9LM?[KI_4_H[OM.RWT_W%
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MX31$1DAB9F=TEZ+'\4-ULK2VQ%-E@H6'DJ.DI;7"_\0 '0$!  (# 0$! 0
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M4G2R;%ZOFL[!9TT(H8J#A5D.-7(M%5TNE11MWEQV)S&3[93CJ%2NN%VW+>W
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M]8F$P"0,7=/ ]1NKY/RNHW/NTIRCEY8$=T"/=$?)7Q+9=PQ.>SVZ8Y( ](F
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MI32E-*4TI32E-*4TI32E-*4TI32E-*5%K-OZ]^TO[HM__-+;-*X>I_?/A_\
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M^\PB _"(Q^GVW/*#^,5V?_,M_DAG?W^JK'R,^38?\&;/_/N!\[XJ@>D)W?\
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MVS/K%1]IGR;?BQ9_RC__ &BG\D)W?A_NR3GWV40/Y6&@\K?E#!__ ,BNR?\
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M/J7546C)DV*)UW"ZJL68A4TR 81ZNKD.0*43](ED<!<%$@#A3A_)_!5E\GQ
M[NO?DBI^VQY3C 3QQQ0I9("4IUB]DDP!CM3C.>Z),16'L0Y%VGYS6FV>,X3&
M%@>P I>LFI\>0$>Z*DL8Y2/$&KZ";'<LU%"'*+I! 42'Z2"5(3$3&3P!P8D
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MT_'QGI![IZFKN4QGB]-N993&N."$(053J&I%6*!4RB?J,8!B^R*0A2@)C=!
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M;.;^E<OCC+*;)Q0ZS\6*EB+%),DRR);<E#F=F8D?'DA?G8'D>Q.=RHT]6=W
MYP0*H82@L>"RD#T228[Q&1ZNGK]1G-9%</L^;E?;++X;"P0 6YY"KEP 1!.\
M]TR*X;X-FN5LAYM6R32'$#+PM_;Q!$V\W9HBO/8=\V8(L@9F1FG;47;4Z:"2
MZ!F(N%"BH=(R(&('5+;B4( (',%$SDS,8)$C&QV^43.DZI;L6X8="D+MU+ *
M4+6"#N92E1G?<A)Z $9DAD+*-M]'QM1Q-5&C:/N-\<]O#)NI$[E>O1;LY%9J
M2  079O'K)B9\+&-2(HV[4H%6.9(A!*:@ =<4=DG/HX^0SW#<^.YK19MTZQJ
M-POF4AH<JBI*?24/N00DC!4,F4X)RGI7E8'S[;M^.#LY8LL3&(I]U)6PCV]@
M@BO4(1TC/&>&9&<,W+IZZ:"F\8BVD 2=."N&:YSI$2.44QDI#2DJ$J'<8W&Q
M$1/JB=\U:[M&M(N[2X25N,ER2E03V@"=Y$!)F2< 2?"H\;+=D.7*9GZ(O-T=
MP$-#8Z>OUW(0ELAYI_+O#,UV;=FFVB'#Q5JQ7%SVKD9,C$YVY#($2%8Y2A+K
MB2F ,D#QWW]6W0GW5NZGJML]:%M':+6Z$P%HY>03CFD1&\ 015UYC]*-D"E9
MFL=.KE'JSVB5"TNX!^E*IRA;%-%AWXMI!V@^2>H-HLRJK=062:L>Z!,H$,Y$
M_4)2 T"D*,@JV ZG?N/M.!X#-5M-!:>M4+=<6'7$H6D-E 0@* 4F0I!)C8^E
MG?)R/1WU[;[[N%<8WSMCE2-<1LY2X%J\KU@GHF!5B"O$PE&2S5W+NVC%R*P/
M3HO4DU2N"G0(<B:@&X*;6E'HJ&02)[^A /K&,;GK$UCTJ_9LNWM'@J4NDI=;
M0ISF*2$Y2,A, R23F)C:LI4E:T^CRV8.IBQ)L;9<I6T^L&<(V?&>5^)D[,DS
M:LV1I!J) 68M6T<H^>J,S=DX?KK)ME1(<C@\$)=<Q,1$^(GJ<1[-@#WUB>Y=
M9U,);(;:">4J5 <)3)DC/+S$PD'V]"?)VI;S+9NT6R+A>_P\/7;%/4>Q^I+-
M4T7[5JBV>,31#U-XS>O7YDG30KY!TS<HNR@H)#IF2ZA ^BVP@!:5$P<A68@B
M!@#$[^O'2FHZ6SIR6;MI2E\KR L.K3,)@X(0$[B"",Q @S42,)^C[S;$Y]KA
M)]_58V$HUIBY^0G&%JAW[QXRB)!N_0!A#M'*DPFN_P"Q32Z'S-FF@!E!.?Y/
MR[J=3& 9,B"-I$;G S)W.T=*Z=SK-JNR64I<4MY!;"5-E*9(@JYR2DYC;O,
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MII2FE*:4II2FE*:4II2FE*:4II2FE*BUFW]>_:7]T6__ )I;9I7#U/[Y\/\
M\,O/Z.N:E+I7<II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:
M4II2J&\A^@?R:4J#.U[^>*WYC[\WT7\6"<8A^/CG4GIX#Z2?IKDZ9^OZQ_&A
M_P!!LJG/J*ZU!$ #D?(-*5QZB^_Y_(?I]WN\?H\?+2E<M*4TI5 $!#D!Y_C_
M !Y]WEYZ4K0E]4P_L/>XW^J;!OY[:%I0[&=NM82^I2_V+G_^/^4O[G7M*@1
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M<<Z8Q_,."<>X=%E8]9LU04C6C%1!+MVR9P:J(G.!DQ54*<TK;0$A2?1V[IG
MP9S.8)[^\5N:MIMHQ9+=;;#2VN52#,E><),@ \V^-NIZUV]P>TK!;S<K*-76
MY6F4HUUM*,K+4V29NW<[%/)UXFN^CT'[55Q%ME7JK@ZD?ZV.T[ 7"0+IF;D$
MQK)<7RB&YY4@S(Z8G(DB!OG.<X-18ZA<"Q1%DXXEI*&PZE3<*"0!)287!W(
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ME?L7/]<!E/\ N=>THG8>H?-6_/<" #BVQ"(<]/J\W/\ ^\6Y?#P'G]5Y>7B
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MM*A6Q]1^:L)?4I7[%S_7 93_ +G7M*A/W(^N^:WY;@O#%=D'V!ZNY\P\/6*
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M5#.!,=!0.S0J%.\@ 2("=XZ"(@@G>=\?)6O9OZMY@"BW;4A+?*TZ7"ETI"
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M;'U&L(_4I9@_D7/'CX[@,I\>''^PKWO^G[_LY'PTHG('JZUOTW ASBRQ^_\
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M2HCYWW!6'$]HC8*+A8N20>PZ<D=9\LZ(J10[E='LRE0X*) *D!@$?E<CP(^
M 'XM_NC/[IKB7R+\7Z9PYH_#VCZO;WVALZJNXU!^[;>0XY=W=N6TI84EOD 8
M!!^ZDF<17LODZ\FFG<9Z3=ZA>:A>6KEO>JM4MVZ&5)4D--N!1+F9E1&(VVK"
M/UZUS^U.OC_RE]_#X_AU^?OU?7'7XD\,?E>I?IUZ#]H31/PWJ7\C;?GI]>M<
M_M3K_P"Z7VGZOKCK\2>&/RK4OTJ?:$T3\-ZE_(6_YZ?7K7/[4Z_^Z7VGZOKC
MK\2>&/RK4OTJ?:$T3\-ZE_(6_P">GUZUS^U.O_NE]I^KZXZ_$GAC\JU+]*GV
MA-$_#>I?R%O^>GUZUS^U.O\ [I?:?J^N.OQ)X8_*M2_2I]H31/PWJ7\A;_GI
M]>M<_M3K_P"Z7VGZOKCK\2>&/RK4OTJ?:$T3\-ZE_(6_YZ?7K7/[4Z_^Z7VG
MZOKCK\2>&/RK4OTJ?:$T3\-ZE_(6_P">GUZUS^U.O_NE]I^KZXZ_$GAC\JU+
M]*GVA-$_#>I?R%O^>GUZUS^U.O\ [I?:?J^N.OQ)X8_*M2_2I]H31/PWJ7\A
M;_GI]>M<_M3K_P"Z7VGZOKCK\2>&/RK4OTJ?:$T3\-ZE_(6_YZ?7K7/[4Z_^
MZ7VGZOKCK\2>&/RK4OTJ?:$T3\-ZE_(6_P">GUZUS^U.O_NE]I^KZXZ_$GAC
M\JU+]*GVA-$_#>I?R%O^>GUZUS^U.O\ [I?:?J^N.OQ)X8_*M2_2I]H31/PW
MJ7\A;_GI]>M<_M3K_P"Z7VGZOKCK\2>&/RK4OTJ?:$T3\-ZE_(6_YZ?7K7/[
M4Z_^Z7VGZOKCK\2>&/RK4OTJ?:$T3\-ZE_(6_P">GUZUS^U.O_NE]I^KZXZ_
M$GAC\JU+]*GVA-$_#>I?R%O^>GUZUS^U.O\ [I?:?J^N.OQ)X8_*M2_2I]H3
M1/PWJ7\A;_GI]>M=!_\ !2O!]+A^/Y-0?[OKCO\ $GA@_P#ZO4?I6*?:$T,?
M[]:F?4S;#YZF]B>XOK_1(*V2#9!DYE4G!U&S8QSH)BBZ60*!!4^R#R"8"(F$
M?'P#PU_0/R,\=W_E*\G/#O&FIV5MI][K+5TX]:6:W5VS1M[RXM0&U/$N$*2R
M%$*)@G%?G_C'0F>&N(M0T6W?<N&;);:4NN@)<7SM-N>D$^C(YCM\M8BS;^O?
MM+^Z+?\ \TMLUZC7GNI_?/A_^&7G]'7-2C,8"AR//'S!SJ"0-_[-P/I_/7<K
M'BV7,8MEEF[B]5E!=NJH@NBK*M2*)*I&$BB9RF4 2F(<!*8!\0$!UY?<>6SR
M1VEP_:7/E&X08N;9YVWN&'=;LD.LO,.*:=;<2792MMQ"D*!V4"#D5]*WP;Q6
MZVVZWP]JRVW4)<;<39/*2M"QS)4DA,$*3D$8(,BN'QPXL^W^J_V8:?X36+[>
MGD<_?+X-_GVR_K:O]A/%WXN:Q^0O_H4^.'%GV_U7^S#3_":?;T\CG[Y?!O\
M/ME_6T^PGB[\7-8_(7_T*H&8L6"(A\/JM](R[3C^Z:?;T\CG[Y?!O\^V7];4
M_83Q=^+FL?D3WZ-5^.'%GV_U7^S#3_":?;T\CG[Y?!O\^V7];4?83Q=^+FL?
MD+_Z%/CAQ;]OU5#Z9AG_  *CI]O3R.?OE\&_S[9?UM/L)XN_%S6/R%_]"J?'
M%BSR^,"J<^[URS_PFGV]/(Y^^7P;_/ME_6T^PGB[\7-8_(7_ -"@YAQ8 <_#
M^J_>F&G^$T^WIY'/WR^#?Y]LOZVGV$\7?BYK'Y"_^C5?CAQ9]O\ 5?[,-/\
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MQ;U$ZZ[8JK6^/G21EVRIT'*!%$(HY3+-UB'172 1.DJ0R9RE.4P!4_W$_D/
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MXG/VL>(O;;6I/M_OKV#\T5(\K'DX_&O2AN8YG-NI/Q7M)KB&.[KX_P"AY_\
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M%>DCUK=.,[PUB?[-ZI\7ET$?"O2'F4O %2_5'.)"ASVG'(F 0#V<@//NT/\
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ME,.$\CG*%08,!4X/KK\K+KTDNY5NW<JFB*RF"0F#D:NDHD7ARS1Y5,6P=10
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M+>S,TT/-6Y%\VD'JJL-"1D(UBW[EK*RI!69%8+N3E%5 X+2"_6WZA,H>M*D
MM,1C>191"[]DC*2*+MRPCE7:";UZW8"@#Y=HU.<J[E%F+EL#I5%,Z: KH]J8
MHJ$ZE*](!YXX\A_C[OX?HYTI5=*4TI6$L$CS WS[MV:P_!DFPAI2K'S;^O?M
M+^Z+?_S2VS2N'J?WSX?_ (9>?T=<U*%3GI$0#R*8?_='CD.!Y^;V<\"(#X:5
MW*_%CEWTC^[RO9,O,)&SS!&-99 M$+'I_ JLN"'8,%1=M2 X.X!052HJ(KF4
M< F86RA1.8JI#(EWTP )[A\V/EKC.:+ISBEK+:E*4HJ5"I/,I4DB<$$^R3FL
M;QGI.]Y,@8J8V-@MVJZ"(E:T6L<"56/?OS])E7"8 J)FA%$2AP!T4W!>HBA2
MD/:8Z#Y^H\3W=(WJGP)IOI#LE"1@%2I^ZY@8S(S$&>A@U2.])YO(D)1@R-98
M]8KY0I%$D*+5^\J=J@=R<6A#KI%,<!2,9,ASI"9,O')14 -"?#QS'J[AUG&W
MA5O@3385+1](_MU$#((GV)QW@SFO@?TH.\L6[-<;-%E*\9-'9CA1:R *=[1D
M%#JI "O4*9S,# W Q2G.1)0!*4QTRFF1C Q\N(_U^.T2:+T+32">QCTIPX3&
MP (]AW\<&*^RGI/=Y0DCU#V./#OS%D\$P4:KF!87JW9**(=*P\(*%*)4.T[,
MX*@3K(F54HZCFQL)SN!U\-I'3IX5/P%IR@2$)$R,K(B3X@[CIMZXKE_)/-Y/
M<VCCX2,!,[8HOA,%$J_=3F<R#IB95,X+B<$C W(FF0Q"* J1<W0"92G/!SO&
M_A[?9^?'6J_ .GY]%.5<T=J? P3$$?3ZB1R:>D[WEN5G"1;''*"DS8/>@M&K
M B4[Z:;Q J'$RY0[%4JQ&R(@(G!V8PJE(BF=74ST]^TGVQ/OFI^ -.C[A!/,
M5?KI]41L>IVGIDUQ;>D[WC+'1ZK(S,!W31L(I4.L"H)7CA9ITID%P '5,DW#
MLOE 0'93)"<"F*?4R(B-^L#PV C;UYZU"M#TX9#8.YCM#.8 ]1$9QGQBOFMZ
M4#>405!^$D:0I?5Z8==&J_:!ZR551.!B@N/@KV)@:G 1+UD()Q3*LF88)D[
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M5"%/)1LA3?8@(+(=4DN! [0!)*S$"M;N/8#<&UW&Q!46-L2R6E;D%)MXZ0?
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M#LD;(F^22,S(W.,F>+3.5-V5J=VG&"Q[F!2FE4P%H!G!#%&5\W,@($D)(/4
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M@ -W<6 H$7,S(!%7'=RI"9P0@%E84"F-^D@S$"9ZA.3T@C<Q$\[R;-OM:/Q
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MCHR+)5W,@NYBR!W?LQ%1X02-CF,!0YECE()WR 8.<>(3@]8Y@#M6QPNPUI_
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M@C:;WW&Y)M&SO#&(,78X6;NW3AE),W-HE&"$@F=)CW==V+=FKVK3MWCR0%1
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M96(Q8'WSYPM&9JK7[0O'SM=N,^W@W4-'0C%FNP3E#]V0=1SMJAWL?51CIKJ
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MFEJ*Q391#MQ'I!(,WSYNCV34B+=-^HS?&1[(2)I$6*!3\%%(;4@@=%2-S,D
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M[&Q_-4Y1$ XY]H\?A_CXZ5UJ<AR <^(\!Q[?$!$.0\_'@=*4$P!Y^[G[WO\
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MZ27/2/W*B@%1 PEO8Q?F62S_ #DPK7;+88BP*,?@8]B6+R09=P(U112CF_=
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M&*>NC2-)AV2:#UB5)(C) JD8Q65%R,6Z27(HDD"H#VR;T!,(]0P(2H@E/,0
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MM;.Q_'&%X>W6VWT#*(Y'O\' 2S:"@'$ _J8H-7)")FD4VL@H=Q) LH)6*CE
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MJWEZ!66%6.W731.DL602CDDTG@D3=]HR=.>I8BJ8$,H<#EX+ $$;I,D*V49
M))).<^..[KAX XF>U>^OM%=L+&U3J%I<NA_2K-%FIM83RJ"VV"D.$)6I2%J
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M,HFNB@H<6JJJKHQC+$ R22?2(F,-$I2L*.=YC]B!),R-X[XQ [P*[_'6OO:
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M(XRQI&L[Q8FD(Y=U>GQ\59F99EZ#9!P:?;$3>R1TEEDA=@]4,15(%#%*ETE
M+%"()',!B"8)G?()',(Q\HP(KBZ#QW<.<26[KVDZ0EO4;M-NXJTL66;UM#[B
M4A0N4CM7%))!4IT*"H)@&"G]/NU'Y4Y:0 H>,8RX-\GP K@>>./$.H>!'I#@
M>.!Y 0XU?KM]?KZJ_6?#F%W)_P"*1MG 4=O#N_-M.0/(./ . X#W:5]95=*5
M9T2/-RMX>YG6_P ;=_I6BR/[^OC_ ,7:#W)>_/5XZ5O500Y 0]X"'X=*5US-
MB&\1X$1#@1Z?,OEQ^JYX /+@?>/F/.E,]#'JWIW8GF AR/F(E >?+[P>7D
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MJ-2AHU9.T,95JBLXCV**;%JY:N&Q57:;+LBO6ZAS&3(;K.,+@%*_2S,@RK:
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M [Q.<=.O4YVKB\8:#<6'!RM+X;MG6FF'FG+BW86I;[S 4HO*4M12XZX5E"U
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MH>? =(@ >!>/#B0XWG*9Z?%D^O>@X2\K8.;#B01B!=K(\,BZ(/N\*!M4]*6
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M3PEY6CO8<2'N'G:X$[P/.P!/7OZS5?K5/2E\\_ C/?/@("-C4,("'D(&&:Y
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M?6IHH2;P )*.4I'*(&!&U6*.R'TI8\=5&S&8"ATE*.08\Q2@ % .DHVH0*
M0@<  !P0H?[$-3S($D%!/JSZI)P/#;PK0/ _E8W\PX@)W)^$TDG$9F^R8ZC)
M[Z!LA]*7TB0*/F0"B %$OQA,"@)0\.D0&U>)>/#CRX$??H%I.Y0.[$_34?83
MY6>FG\0 =1\)) \,>>';ZS5"[(?2E /R:+F0@ (^60(\/'CCD.+47V?)\^.
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M?_53["/*O^#^(._&I 9.YQ>]>M!V0^E*, @-'S(8!XZ@-?V/!N! 0YYM8]7
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MLTF<=V/7U^FN5IOZ_J_\9J_T*SJ=&E=6FE*:4II2FE*:4II2FE*:4II2N"@
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M @VK,XFHW=MF<DU@YZ"*Z,=4U<USV,;\Y"^T_,&2:CE5_$TWT@K[+T[!X_W
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M9=J=4UEA[Z.7TD/QRQN75L]Y)L,W3<R[0W]37<Y\E(J%D,45/'2<#N4"9HS
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MZ+IC;;VHZI=LV-DTZ^Q:M.7-PM+;*%W-RXU;LA2U!/.ZZA G)JP&V<L3*O\
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M\=LF%:KUB7K4]*LY!JBN^J:8$.X45$9F>FW3_7TKU]O_ *%C=WB)W@!>[W[
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M(/%E(Q3U$>T3^:I7POH;-U438Z](S>?J-?@K>4\*WE.S6B<O@6>69XVV@VG
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MTI32E-*4TI32E4Z2^X/P!I2JZ4II2G >X-*4X#W!I2G >7'A[M*4X#W!I2G
M>[2E. ]W\0\OP:4JG >X/P:4JO >[Y_O^_2E4X#W!^#^/N#\&E*<![@\/+P\
MM*572E-*4TI32E-*4TI32E-*500 ?, 'Z0 =*4Z2^X/P!I2JZ4IP'N^;[WNT
MI5. XXX#CW<>&E*KP'NTI3@/<&E*IP'N#\&E*<![@\/+PTI5> ]P:4IP'N#^
M/_S'\.E*IP'N#\&E*<![@_!I2J\ /F ?Q#C\GA]&E*:4II2FE*:4J)&X&9B(
M+,>U"0FY2/AX]#(UZ*L^E'K9@S2,MB>V$2*HY=JHHD%0_P D@&. F-P4O)A
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M&OTZI\:N+OZ8U"'_ )W5[^&0#2#W'W&GGUE^[+7\H:_3JOQJXNY\,CT/D?\
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M_JJ?6%;,>./K9L-_O&@^?P]TYTJ/@C2?P7IWY%;?U55^L+V9?M9\.?O'A/\
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M@(CSMEPV/A]HT)[P_P""ZFGP3I7X,TX^NRMC\[5?0=A&S ?_ !9L.?O'A?\
M%=-J?!.D_@O3?R&UGW]E-<?K!ME_[6;#@?\ ,>$_A:CI3X)TK\&:?^16W]77
M NPG9B(_SLV' \/91X0/=_P72 =Q-/@G2OP9I_Y%;?U=#;"MF0"(?6SX<X_J
M'A/$!#Q ?T+Y#Y#\VH@#( ![P!(I\$Z5^#-/_(K;^JK-^,,-8LPU%/83%5"K
M%!B)!WWY[&U>*:Q#-T\[,B7>5D&B::9UA3(4@J&*)A*' CQX:G)WS]?K].:V
@V6&+9'96[#-NWS*5V;#2&D<RC*CR-I2F3ZM@!L *_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129908112760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 28, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SES AI Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001819142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-1567584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">35 Cabot Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woburn<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">298-8750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">WithumSmith+Brown, PC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SES<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303,989,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,881,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SES WS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129905081560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 117,282<span></span>
</td>
<td class="nump">$ 161,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">608,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">726,186<span></span>
</td>
<td class="nump">161,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Investments held in Trust Account</a></td>
<td class="nump">276,057,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred offering costs associated with Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">413,039<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">276,784,152<span></span>
</td>
<td class="nump">574,310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">89,017<span></span>
</td>
<td class="nump">13,785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="nump">20,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">795,586<span></span>
</td>
<td class="nump">68,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Note payable - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">905,135<span></span>
</td>
<td class="nump">582,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent', window );">Accrued liabilities</a></td>
<td class="nump">4,888,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Convertible note - related party</a></td>
<td class="nump">1,152,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_DeferredUnderwritingFeePayableNoncurrent', window );">Deferred underwriting commissions</a></td>
<td class="nump">9,660,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Derivative warrant liabilities</a></td>
<td class="nump">25,324,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">41,931,234<span></span>
</td>
<td class="nump">582,131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(41,147,772)<span></span>
</td>
<td class="num">(32,821)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' deficit</a></td>
<td class="num">(41,147,082)<span></span>
</td>
<td class="num">(7,821)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit</a></td>
<td class="nump">276,784,152<span></span>
</td>
<td class="nump">574,310<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A ordinary shares subject to possible redemption, $0.0001 par value; 27,600,000 and -0- shares issued and outstanding at $10.00 per share as of September 30, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">276,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares</a></td>
<td class="nump">$ 690<span></span>
</td>
<td class="nump">$ 690<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_DeferredUnderwritingFeePayableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting fee payable deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_DeferredUnderwritingFeePayableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907226600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value, (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Temporary equity, par value, (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Temporary equity, shares issued</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Purchase price, per unit</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129909062648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">$ 32,821<span></span>
</td>
<td class="nump">$ 7,238,072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty', window );">General and administrative expenses - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="num">(32,821)<span></span>
</td>
<td class="num">(7,358,072)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Income from investments held in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,176,530)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties', window );">Change in fair value of convertible note - related party</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(207,986)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_OfferingCostsWarrantsIssuance', window );">Offering costs - derivative warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(855,043)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (32,821)<span></span>
</td>
<td class="num">$ (11,539,665)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average shares outstanding, basic and diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,843,836<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share, basic and diluted</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average shares outstanding, basic and diluted</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">6,875,342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of Convertible debt with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_OfferingCostsWarrantsIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering costs incurred during issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_OfferingCostsWarrantsIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907243048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Common Class A [Member] </div>
<div>Common Stock [Member]</div>
</th>
<th class="th">
<div>Common Class B [Member] </div>
<div>Common Stock [Member]</div>
</th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Jul. 07, 2020</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the beginning (in shares) at Jul. 07, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Class B common stock to Sponsors</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">24,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(32,821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32,821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2020</a></td>
<td class="num">(7,821)<span></span>
</td>
<td class="nump">24,310<span></span>
</td>
<td class="num">(32,821)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 690<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_CommonStockSubjectToPossibleRedemptionValue', window );">Accretion of Class A ordinary shares subject to redemption</a></td>
<td class="num">(29,599,596)<span></span>
</td>
<td class="num">(24,310)<span></span>
</td>
<td class="num">(29,575,286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Class B common stock to Sponsors</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(11,539,665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,539,665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the end at Dec. 31, 2021</a></td>
<td class="num">$ (41,147,082)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (41,147,772)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 690<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at the end (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_CommonStockSubjectToPossibleRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_CommonStockSubjectToPossibleRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907963384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Operating Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (32,821)<span></span>
</td>
<td class="num">$ (11,539,665)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares', window );">General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Income from investments held in Trust Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(57,966)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,176,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties', window );">Change in fair value of convertible note &#8211; related party</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">207,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_OfferingCostsWarrantsIssuance', window );">Offering costs - derivative warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">855,043<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Increase (Decrease) in Operating Capital [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(608,904)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">75,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">6,213<span></span>
</td>
<td class="nump">684,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_IncreaseDecreaseInAccruedExpensesRealtedParties', window );">Accrued liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,888,889<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(1,608)<span></span>
</td>
<td class="num">(2,297,949)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Investing Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_PaymentsForInvestmentOfCashInTrustAccount', window );">Cash deposited in Trust Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(276,000,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(276,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Financing Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Payment of note payable to related party</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ProceedsReceivedFromInitialPublicOfferingGross', window );">Proceeds received from Initial Public Offering, gross</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">276,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds received from private placement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,520,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering costs paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,710,734)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ProceedsReceivedFromNotePayableToRelatedParty', window );">Proceeds Received From Note Payable To Related Party</a></td>
<td class="nump">408,341<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_OfferingCostsPaid', window );">Offering Costs Paid</a></td>
<td class="num">(245,462)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from convertible note to related party</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">944,694<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">162,879<span></span>
</td>
<td class="nump">278,253,960<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">161,271<span></span>
</td>
<td class="num">(43,989)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash - beginning of the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">161,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash - end of the period</a></td>
<td class="nump">161,271<span></span>
</td>
<td class="nump">117,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of noncash financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_DeferredOfferingCostsIncludedInAccountsPayable', window );">Deferred offering costs included in accounts payable</a></td>
<td class="nump">13,785<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses', window );">Offering costs included in accrued expenses</a></td>
<td class="nump">62,133<span></span>
</td>
<td class="nump">42,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote', window );">Deferred offering costs paid by Sponsor under promissory note</a></td>
<td class="nump">91,659<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_Underwritingcommissiondeferred', window );">Deferred underwriting commissions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,660,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_DeferredOfferingCostsIncludedInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred offering costs included in accounts payable in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_DeferredOfferingCostsIncludedInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred offering costs paid by Sponsor under promissory note in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of Convertible debt with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General and adminstartive expenses paid by sponsor in exchange for issuance of class B ordinary shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_IncreaseDecreaseInAccruedExpensesRealtedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease in accrued expenses realted parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_IncreaseDecreaseInAccruedExpensesRealtedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of offering costs included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_OfferingCostsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offering costs paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_OfferingCostsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_OfferingCostsWarrantsIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of offering costs incurred during issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_OfferingCostsWarrantsIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ProceedsReceivedFromInitialPublicOfferingGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds received from initial public offering, gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ProceedsReceivedFromInitialPublicOfferingGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ProceedsReceivedFromNotePayableToRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds received from note payable to related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ProceedsReceivedFromNotePayableToRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_Underwritingcommissiondeferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred underwriter commission during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_Underwritingcommissiondeferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129906504536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of Organization and Business Operations</a></td>
<td class="text"><div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 1&#8212;Description of Organization and Business Operations </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SES AI Corporation, formerly known as Ivanhoe Capital Acquisition Corp. prior to February&#160;3, 2022 (the &#8220;Company&#8221;), is a blank check company incorporated as a Cayman Islands exempted company on July&#160;8, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (&#8220;Business Combination&#8221;). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June&#160;28, 2021, the Company formed a wholly owned subsidiary, Wormhole Merger Sub Pte. Ltd., a Singapore private company limited by shares (&#8220;Amalgamation Sub&#8221;). </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Business Operations </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2021, the Company had not yet commenced operations. All activity for the period from July&#160;8, 2020 (inception) through December&#160;31, 2021 relates to the Company&#8217;s formation and the initial public offering (the &#8220;Initial Public Offering&#8221;), which is described below, and since the closing of the Initial Public Offering, the search for a prospective Business Combination, including activities in connection with the proposed acquisition of SES Holdings Pte. Ltd., a Singapore private company limited by shares (&#8220;SES&#8221;). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> income in the form of interest income on its investments held in the trust account from the proceeds of its Initial Public Offering. The Company incurs expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a business combination. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s sponsor is Ivanhoe Capital Sponsor LLC, a Cayman Islands limited liability company (&#8220;Sponsor&#8221;). The registration statement for the Company&#8217;s Initial Public Offering was declared effective on January&#160;6, 2021. On January&#160;11, 2021, the Company consummated its Initial Public Offering of 27,600,000 units (the &#8220;Units&#8221; and, with respect to the Class&#160;A ordinary shares included in the Units being offered, the &#8220;Public Shares&#8221;), including 3,600,000 additional Units to cover over-allotments (the &#8220;Over-Allotment Units&#8221;), at $10.00 per Unit, generating gross proceeds of $276.0&#160;million, and incurring offering costs of approximately $15.8&#160;million, of which approximately $9.7&#160;million was for deferred underwriting commissions (Note 6). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (&#8220;Private Placement&#8221;) of 5,013,333 warrants (each, a &#8220;Private Placement Warrant&#8221; and collectively, the &#8220;Private Placement Warrants&#8221;), at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $7.5&#160;million (Note 4). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the closing of the Initial Public Offering and the Private Placement, $276.0&#160;million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (&#8220;Trust Account&#8221;) with Continental Stock Transfer&#160;&amp; Trust Company acting as trustee and invested in United States &#8220;government securities&#8221; within the meaning of Section&#160;2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2a-7</div> promulgated under the Investment Company Act of 1940, as amended, or the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i)&#160;the completion of a Business Combination and (ii)&#160;the distribution of the Trust Account as described below. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company&#8217;s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the amount of any deferred underwriting discount held in Trust) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will provide its holders of the Public Shares (the &#8220;Public Shareholders&#8221;) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i)&#160;in connection with a shareholder meeting called to approve the Business Combination or (ii)&#160;by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480 &#8220;Distinguishing Liabilities from Equity&#8221; (&#8220;ASC 480&#8221;). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which will be adopted by the Company upon the consummation of the Initial Public Offering (the &#8220;Amended and Restated Memorandum and Articles of Association&#8221;), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares prior to the Initial Public Offering (the &#8220;Initial Shareholders&#8221;) have agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company has agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Company&#8217;s Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a &#8220;group&#8221; (as defined under Section&#160;13 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class&#160;A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s Sponsor, executive officers, directors and director nominees agreed not to propose an amendment to the Company&#8217;s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company&#8217;s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class&#160;A ordinary shares in conjunction with any such amendment. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or January&#160;11, 2023 (the &#8220;Combination Period&#8221;), the Company will (i)&#160;cease all operations except for the purpose of winding up, (ii)&#160;as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">per-share</div> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders&#8217; rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in each case to the Company&#8217;s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div>  <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the redemption of 100% of the Company&#8217;s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company&#8217;s taxes payable (less up to $100,000 of interest to pay dissolution expenses). The Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company&#8217;s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii)&#160;the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#8217;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company&#8217;s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. </div> <div style="margin-top: 10pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Business Combination </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;3, 2022, we consummated the previously announced business combination (the &#8220;Business Combination&#8221;) pursuant to that certain Business Combination Agreement dated July&#160;12, 2021 (the &#8220;Business Combination Agreement&#8221;), by and among Ivanhoe, Wormhole Amalgamation Sub Pte. Ltd., a Singapore private company limited by shares and our direct wholly-owned subsidiary (&#8220;Amalgamation Sub&#8221;), and SES Holdings Pte. Ltd. (&#8220;SES&#8221;), a Singapore private company limited by shares. In connection with the closing of the Business Combination (the &#8220;Closing&#8221;), a business combination between the Company, Amalgamation Sub and SES was effectuated through the merger of Amalgamation Sub with and into SES, with SES continuing as the surviving company. On the Closing Date, we changed our name from Ivanhoe Capital Acquisition Corp. to &#8220;SES AI Corporation&#8221;. </div> <div style="margin-top: 10pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Risks and Uncertainties </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management continues to evaluate the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#8217;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div> <div style="margin-top: 10pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Liquidity and Capital Resources </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company successfully consummated its Business Combination on February&#160;3, 2022. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As indicated in the accompanying financial statements, as of December&#160;31, 2021, we had approximately $100,000 in our operating bank account and working deficit of approximately $200,000. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our liquidity needs to date have been satisfied through a contribution of $25,000 from Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of $500,000 from the Sponsor pursuant to the Note, and the proceeds from the consummation of the Private Placement not held in the Trust Account. We repaid the Note in full on January&#160;15, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, provide us Working Capital Loans. On April&#160;9, 2021, we issued an unsecured convertible promissory note (the &#8220;Convertible Note&#8221;) to our Chief Executive Officer, pursuant to which we may borrow up to $1,500,000 for ongoing expenses reasonably related to our business and the consummation of the Business Combination. The Convertible Note does not bear any interest. All unpaid principal under the Convertible Note will be due and payable in full on the earlier of (i)&#160;January&#160;11, 2023 and (ii)&#160;the effective date of the Business Combination (such earlier date, the &#8220;Maturity Date&#8221;). As of December&#160;31, 2021, $945,000 was drawn on the convertible note&#8212;related party, presented at its fair value of approximately $1.2&#160;million on the accompanying consolidated balance sheets. Subsequently, the loan was repaid in full with cash at the closing of our business combination on February&#160;3, 2022. There were no amounts outstanding under the Convertible Note as of December&#160;31, 2020. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the foregoing, management believes that we will have sufficient working capital and borrowing capacity from our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors to meet our needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, we expect to be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129909914440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 2&#8212;Summary of Significant Accounting Policies </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (&#8220;SEC&#8221;). </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Principles of Consolidation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of the Company include its wholly-owned subsidiary, Wormhole Merger Sub Pte. Ltd., which was incorporated in Singapore on June&#160;28, 2021, in connection with the planned business combination. All inter-company accounts and transactions are eliminated in consolidation. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging Growth Company </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December&#160;31, 2021 and 2020 held outside of the Trust Account. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of December&#160;31, 2021 and 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div>  <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Investments Held in Trust Account </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section&#160;2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, &#8220;Fair Value Measurements&#8221; approximates the carrying amounts represented in the balance sheet. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has elected the fair value option to account for its Convertible Note with its Sponsor as defined and more fully described in Note 5. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value are recorded as change in the fair value of Convertible Note&#8212;related party on the consolidated statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management&#8217;s and, if applicable, an independent third-party valuation firm&#8217;s own assumption about the assumptions a market participant would use in pricing the asset or liability. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level&#160;1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level&#160;2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level&#160;3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Derivative Warrant Liabilities </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-assessed</div> at the end of each reporting period. Derivative warrant liabilities are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The warrants issued in connection with the Initial Public Offering (the &#8220;Public Warrants&#8221;) and the Private Placement Warrants (as defined in Note 4) (collectively, the &#8220;Warrant&#8221;) are recognized as derivative liabilities in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40.</div> Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised, and any change in fair value is recognized in the Company&#8217;s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Offering Costs Associated with the Initial Public Offering </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> expenses in the statement of operations. Offering costs associated with the Class&#160;A ordinary shares are charged against their carrying value upon the completion of the Initial Public Offering. Deferred underwriting commissions are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Class&#160;A Ordinary Shares Subject to Possible Redemption </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for its Class&#160;A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Class&#160;A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class&#160;A ordinary shares (including Class&#160;A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) are classified as temporary equity. At all other times, Class&#160;A ordinary shares are classified as shareholders&#8217; equity. The Company&#8217;s Class&#160;A ordinary shares feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of December&#160;31, 2021, 27,600,000 Class&#160;A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders&#8217; equity (deficit) section of the Company&#8217;s consolidated balance sheets. As of December&#160;31, 2020, there were no Class&#160;A ordinary shares subject to possible redemption. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class&#160;A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital (to the extent available) and accumulated deficit. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the Cayman Islands is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December&#160;31, 2021 and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company&#8217;s tax provision was zero for the period presented. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Net Income (Loss) per Ordinary Shares </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary shares and Class&#160;B ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding for the respective period.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 14,213,333 Class&#160;A ordinary share in the calculation of diluted income (loss) per ordinary share, because their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per share ordinary for the year ended December&#160;31, 2021 and for the period from July&#160;8, 2020 (inception) through the year ended December&#160;31, 2020. Accretion associated with the redeemable Class&#160;A ordinary shares is excluded from earnings per ordinary share as the redemption value approximates fair value. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per ordinary share for each class of ordinary shares: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">
<tr>
<td style="width:58%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:4%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:3%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:3%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:4%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">For the Period From<br/> July</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">8, 2020 (Inception)</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Through December&#160;31,<br/> 2020</div></div> </td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For&#160;the&#160;Year&#160;Ended&#160;December&#160;31,<br/> 2021</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per ordinary share:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net loss</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;(9,186,727</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;(2,352,938</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(32,821</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average ordinary shares outstanding</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,843,836</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,875,342</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per ordinary share</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.01</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table>  <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Adopted Accounting Standards </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2020-06,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt-Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</div></div>, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. The Company early adopted the ASU on January&#160;21, 2021 (inception). Adoption of the ASU did not impact the Company&#8217;s financial position, results of operations or cash flows. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Issued Accounting Standards </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying consolidated financial statements. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907135112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_InitialPublicOfferingTextBlock', window );">Initial Public Offering</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 3&#8212;Initial Public Offering </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On January&#160;11, 2021, the Company consummated its Initial Public Offering of 27,600,000 Units, including 3,600,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $276.0&#160;million, and incurring offering costs of approximately $15.8&#160;million, of which approximately $9.7&#160;million was for deferred underwriting commissions. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Unit consists of one Class&#160;A ordinary share and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">one</div>-third</div> of one redeemable warrant (&#8220;Public Warrant&#8221;). Each whole Public Warrant will entitle the holder to purchase one Class&#160;A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7). </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_InitialPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on information about initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_InitialPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907126600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_PrivatePlacementTextBlock', window );">Private Placement</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 4 &#8211; Private Placement </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 5,013,333 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $7.5&#160;million.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each whole Private Placement Warrant is exercisable for one whole Class&#160;A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-redeemable</div> for cash and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Sponsor and the Company&#8217;s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_PrivatePlacementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure on information about private placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_PrivatePlacementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129906427032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 5 &#8211; Related Party Transactions </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Founder Shares </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;22, 2020, the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 8,625,000 Class&#160;B ordinary shares (the &#8220;Founder Shares&#8221;). On December&#160;16, 2020, the Sponsor surrendered 2,875,000 Founder Shares to the Company for cancellation for no consideration. On January&#160;6, 2021, the Company effected a share capitalization of 1,150,000 shares, resulting in an aggregate of 6,900,000 Founder Shares outstanding. All shares and associated amounts have been retroactively restated to reflect the share surrender and share capitalization. The holders of the Founder Shares have agreed to forfeit up to an aggregate of 900,000 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional units was not exercised in full by the underwriters, so that the Founder Shares would represent 20% of the Company&#8217;s issued and outstanding shares after the Initial Public Offering. On January&#160;11, 2021, the underwriter fully exercised its over-allotment option; thus, these Founder Shares are no longer subject to forfeiture. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (i)&#160;(v) with respect to 20% of such shares, until consummation of the initial Business Combination, (w)&#160;with respect to 20% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $12.00 for any 20 trading days within a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period following the consummation of the initial Business Combination (a &#8220;Requisite Trading Period&#8221;), (x) with respect to 20% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $14.00 for the Requisite Trading Period, (y)&#160;with respect to 20% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $16.00 for the Requisite Trading Period, and (z)&#160;with respect to the remaining 20% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $18.00 for the Requisite Trading Period, and (ii)&#160;the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the initial Business Combination that results in all of the shareholders having the right to exchange their Class&#160;A ordinary shares for cash, securities or other property; provided that in the event that the per share value of the cash, securities or other property to be received by the shareholders in such liquidation, merger, capital stock exchange or other similar transaction (the &#8220;Per Share Transaction Value&#8221;) is less than $18.00, then the Founder Shares will be released from these transfer restrictions to the Initial Shareholders on a pro rata basis as follows: (a)&#160;to the extent not previously released, all Founder Shares that are subject to release upon achievement of any share price performance requirements that are less than the Per Share Transaction Value will be released, and (b)&#160;the number of Founder Shares that would be released upon the achievement of the next share price performance requirement that is higher than the Per Share Transaction Value (the &#8220;Release Threshold&#8221;), multiplied by a fraction, the numerator of which equals (x) 2, minus (y)&#160;the amount by which the Release Threshold exceeds the Per Share Transaction Value, and the denominator of which equals 2, will be released. Any Founder Shares not released pursuant to the preceding sentence will be forfeited and cancelled. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Related Party Loans </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;22, 2020, the Sponsor agreed to loan the Company up to $600,000 pursuant to a promissory note (the &#8220;Note&#8221;), which was later amended on December&#160;1, 2020. The Note is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-interest</div> bearing, unsecured and due upon the closing of the Initial Public Offering. The Company borrowed $500,000 under the Note. On January&#160;15, 2021, the Company repaid the Note in full. Subsequent to the repayment, the facility was no longer available to the Company. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company&#8217;s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (&#8220;Working Capital Loans&#8221;). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lenders&#8217; discretion, up to $1.5&#160;million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&#160;9, 2021, the Company issued an unsecured convertible promissory note (the &#8220;Convertible Note&#8221;) to the Company&#8217;s Chief Executive Officer, pursuant to which the Company may borrow up to $1,500,000 for ongoing expenses reasonably related to the business of the Company and the consummation of the Business Combination. The Convertible Note does not bear any interest. All unpaid principal under the Convertible Note will be due and payable in full on the earlier of (i)&#160;January&#160;11, 2023 and (ii)&#160;the effective date of the Business Combination (such earlier date, the &#8220;Maturity Date&#8221;). The Chief Executive Officer will have the option, at any time on or prior to the Maturity Date, to convert any amounts outstanding under the Convertible Note into warrants to purchase the Company&#8217;s Class&#160;A ordinary shares, par value $0.0001 per share, at a conversion price of $1.50 per warrant, with each warrant entitling the holder to purchase one Class&#160;A ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to the private placement warrants sold concurrently with the Company&#8217;s initial public offering. As of December&#160;31, 2021, $945,000 was drawn on the convertible note&#8212;related party, presented at its fair value of approximately $1.2&#160;million on the accompanying consolidated balance sheets. Subsequently, the loan was repaid in full with cash at the closing of our business combination on February&#160;3, 2022. There were no amounts outstanding under the Convertible Note as of December&#160;31, 2020. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Administrative Support Agreement </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Commencing on the date that the Company&#8217;s securities were first listed on the NYSE through the earlier of consummation of the initial Business Combination and the liquidation, the Company agreed to pay the Sponsor $10,000 per month for office space, utilities, secretarial and administrative support services provided to members of the management team. Administrative expenses were included within general and administrative expenses&#8212;related party in the consolidated statements of operations. For the year ended December&#160;31, 2021, the Company incurred $120,000 in administrative expenses. As of December&#160;31, 2021, $10,000 has been included in due to related party on the consolidated balance sheets. There were no administrative expenses incurred for the period from July&#160;8, 2020 (inception) through December&#160;31, 2020. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">out-of-pocket</div></div> expenses incurred in connection with activities on the Company&#8217;s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company&#8217;s audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers or directors, or the Company&#8217;s or their affiliates. Any such payments prior to an initial Business Combination will be made from funds held outside the Trust Account. As of December&#160;31, 2021, approximately $10,000 is included in due to related party on the accompanying consolidated balance sheets. There were no balances outstanding as of December&#160;31, 2020. </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129906490168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 6&#8212;Commitments and Contingencies </div></div> <div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Registration Rights </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any Class&#160;A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The holders of these securities were entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Underwriting Agreement </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company granted the underwriters a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">45-day</div> option from the date of the Initial Public Offering prospectus to purchase up to 3,600,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On January&#160;11, 2021, the underwriter fully exercised its over-allotment option. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters were entitled to an underwriting discount of $0.20 per unit, or approximately $5.5&#160;million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $9.7&#160;million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129906487144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Warrant Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Warrant Liabilities</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 7&#8212;Derivative Warrant Liabilities </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2021, the Company had 9,200,000 Public Warrants and 5,013,333 Private Warrants outstanding. There were no warrants outstanding as of December&#160;31, 2020.</div> <div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the Class&#160;A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class&#160;A ordinary shares is available throughout the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-day</div> redemption period. </div> <div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of warrants when the price per Class&#160;A ordinary share equals or exceeds $10.00: </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once the warrants become exercisable, the Company may redeem the outstanding warrants: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">in whole and not in part; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">at $0.10 per warrant upon a minimum of 30 days&#8217; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class&#160;A ordinary shares to be determined by reference to an agreed table based on the redemption date and the &#8220;fair market value&#8221; of Class&#160;A ordinary shares; and </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">if, and only if, the closing price of Class&#160;A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">30-trading</div> day period ending three trading days before the Company sends the notice of redemption to the warrant holders. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The &#8220;fair market value&#8221; of Class&#160;A ordinary shares for the above purpose shall mean the volume-weighted average price of the Class&#160;A ordinary shares for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class&#160;A ordinary shares per warrant (subject to adjustment). </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#8217;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129910111768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Class A Ordinary Shares Subject to Possible Redemption<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_TemporaryEquityDisclosureTextBlock', window );">Class A Ordinary Shares Subject to Possible Redemption</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 8 &#8211; Class&#160;A Ordinary Shares Subject to Possible Redemption&#160;&#160;&#160;&#160; </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s Class&#160;A ordinary shares feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of future events. The Company is authorized to issue 200,000,000 shares of Class&#160;A ordinary shares with a par value of $0.0001 per share. Holders of the Company&#8217;s Class&#160;A ordinary shares are entitled to one vote for each ordinary share. As of December&#160;31, 2021, there were 27,600,000 shares of Class&#160;A ordinary shares outstanding, which were all subject to possible redemption and are classified outside of permanent equity in the consolidated balance sheet. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Class&#160;A ordinary shares subject to possible redemption reflected on the consolidated balance sheet is reconciled on the following table: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr>
<td style="width:82%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:4%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross proceeds from Initial Public Offering</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">276,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of Public Warrants at issuance</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,628,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering costs allocated to Class&#160;A ordinary shares subject to possible redemption</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,971,596</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion on Class&#160;A ordinary shares subject to possible redemption amount</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,599,596</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class&#160;A ordinary shares subject to possible redemption</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;276,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_TemporaryEquityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_TemporaryEquityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129988911480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity (Deficit)</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 9&#8212;Shareholders&#8217; Equity (Deficit) </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preference Shares-</div></div></div></div> The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share. As of December&#160;31, 2021 and 2020, there were no preference shares issued or outstanding. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;A Ordinary Shares- </div></div></div></div>The Company is authorized to issue 200,000,000 Class&#160;A ordinary shares with a par value of $0.0001 per share. Holders of the Company&#8217;s Class&#160;A ordinary shares are entitled to one vote for each share. At December&#160;31, 2021, there were 27,600,000 Class&#160;A ordinary shares issued and outstanding. All issued and outstanding Class&#160;A ordinary shares are subject to possible redemption and have been classified as temporary equity (See Note 8). As of December&#160;31, 2020, there were no Class&#160;A ordinary shares issued and outstanding. </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">&#160;B Ordinary Shares-</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div>The Company is authorized to issue 20,000,000 Class&#160;B ordinary shares with a par value of $0.0001 per share. As of December&#160;31, 2021 and 2020, there were 6,900,000 Class&#160;B ordinary shares issued and outstanding. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class&#160;A ordinary shares and holders of Class&#160;B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In a vote to continue the company in jurisdiction outside the Cayman Islands (which required the approval of at least two thirds of the votes of all ordinary shares), holders of the Founder Shares will have <span style="-sec-ix-hidden:hidden42197942">ten</span> votes for every Founder Share and holders of the Class&#160;A ordinary shares will have one vote for every Class&#160;A ordinary share. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Class&#160;B ordinary shares will automatically convert into Class&#160;A ordinary shares at the time of the consummation of the initial Business Combination on a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis, subject to adjustment for share <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sub-divisions,</div> share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class&#160;A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class&#160;A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class&#160;A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class&#160;A ordinary shares by Public Shareholders), including the total number of Class&#160;A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class&#160;A ordinary shares or equity-linked securities exercisable for or convertible into Class&#160;A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of working capital loans; provided that such conversion of Founder Shares will never occur on a less than <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">one-for-one</div></div> basis. </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129998879720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 9&#8212;Fair Value Measurements </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents information about the Company&#8217;s assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:73%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/> Active Markets<br/> (Level 1)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments held in Trust Account</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;276,057,966</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities - Public Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,100,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities - Private Placement Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;9,224,530</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible note &#8211; related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,152,680</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr> </table>  <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&#160;31, 2020, there were no assets or liabilities that are measured at fair value on a recurring basis. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level&#160;3 measurement to a Level&#160;1 fair value measurement in February 2021, when the Public Warrants were separately listed and traded. There were no other transfers to/from Levels 1, 2, and 3 during the year ended December&#160;31, 2021. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level&#160;1 assets include investments in money market funds that invest solely in U.S. government securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The fair value of the Public Warrants as of December&#160;31, 2021 was measured utilizing the Level&#160;1 input of the observable listed trading price for such warrants. </div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Level&#160;3 instruments are comprised of derivative warrant liabilities measured at fair value using a Monte Carlo simulation and Black-Scholes Option Pricing Model. The estimated fair value of the Private Placement Warrants and the Public Warrants, prior to being separately listed and traded, was determined using Level&#160;3 inputs. The estimated fair value of warrants that may be issued upon conversion of the Convertible Note was determined using Level&#160;3 inputs. Inherent in a Monte Carlo simulation and Black-Scholes Option Pricing model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Black-Scholes analysis relies upon appropriate inputs derived from the Monte Carlo simulation of the public warrants; namely, the underlying stock price and the implied volatility from the traded Public Warrant price. The Company estimates the volatility of its ordinary shares warrants based on implied volatility from the Company&#8217;s traded warrants and from historical volatility of select peer company&#8217;s ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">zero-coupon</div> yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides quantitative information regarding Level&#160;3 fair value measurements inputs used in the valuation of the derivative warrant liabilities at their measurement dates: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:75%"/>
<td style="vertical-align:bottom;width:22%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;December&#160;31,&#160;2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Option term (in years)</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.09</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock price</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.95</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.2</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.26</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividends</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The change in the fair value of the derivative warrant liabilities measured using Level&#160;3 inputs for the year ended December&#160;31, 2021 is summarized as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities at January&#160;1, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Public and Private Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,148,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfer of Public Warrants to Level&#160;1 measurement</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,628,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of derivative warrant liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,176,530</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities at December&#160;31, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,696,530</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides quantitative information regarding Level&#160;3 fair value measurements inputs used by the estimated fair value of warrants that may be issued upon conversion of the Convertible Note at their measurement dates: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:75%"/>
<td style="vertical-align:bottom;width:22%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;December&#160;31,&#160;2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Option term (in years)</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock price</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.84</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72.1</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.06</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividends</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The change in the fair value of the convertible note &#8211; related party measured with Level&#160;3 inputs for year ended December&#160;31, 2021 is summarized as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:85%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value at January&#160;1, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Initial fair value of convertible note - related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">944,694</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of convertible note - related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">207,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value of convertible note - related party, December&#160;31, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;1,152,680</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129910204856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Note 10 - Subsequent Events </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company evaluated subsequent events and transactions that occurred up to the date consolidated financial statements were issued. Based on this evaluation, other than as noted in Note 1, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129908202136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (&#8220;SEC&#8221;). </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December&#160;31, 2021 and 2020 held outside of the Trust Account. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of December&#160;31, 2021 and 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level&#160;1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level&#160;2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div> </td> </tr> </table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top;text-align:left;">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: left; line-height: normal;">Level&#160;3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div> </td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Principles of Consolidation </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of the Company include its wholly-owned subsidiary, Wormhole Merger Sub Pte. Ltd., which was incorporated in Singapore on June&#160;28, 2021, in connection with the planned business combination. All inter-company accounts and transactions are eliminated in consolidation. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Emerging Growth Company </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-emerging</div> growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Investments Held in Trust Account</a></td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Investments Held in Trust Account </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section&#160;2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#8217;s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#8217;s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, &#8220;Fair Value Measurements&#8221; approximates the carrying amounts represented in the balance sheet. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has elected the fair value option to account for its Convertible Note with its Sponsor as defined and more fully described in Note 5. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value are recorded as change in the fair value of Convertible Note&#8212;related party on the consolidated statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management&#8217;s and, if applicable, an independent third-party valuation firm&#8217;s own assumption about the assumptions a market participant would use in pricing the asset or liability. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_Derivativewarrantliabilitiespolicytextblock', window );">Derivative Warrant Liabilities</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Derivative Warrant Liabilities </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#8220;Derivatives and Hedging&#8221; (&#8220;ASC 815&#8221;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">re-assessed</div> at the end of each reporting period. Derivative warrant liabilities are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The warrants issued in connection with the Initial Public Offering (the &#8220;Public Warrants&#8221;) and the Private Placement Warrants (as defined in Note 4) (collectively, the &#8220;Warrant&#8221;) are recognized as derivative liabilities in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40.</div> Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised, and any change in fair value is recognized in the Company&#8217;s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock', window );">Offering Costs Associated with the Initial Public Offering</a></td>
<td class="text"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Offering Costs Associated with the Initial Public Offering </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-operating</div> expenses in the statement of operations. Offering costs associated with the Class&#160;A ordinary shares are charged against their carrying value upon the completion of the Initial Public Offering. Deferred underwriting commissions are classified as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-current</div> liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_Commonstocksubjecttopossibleredemptionpolicytextblock', window );">Class A Ordinary Shares Subject to Possible Redemption</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Class&#160;A Ordinary Shares Subject to Possible Redemption </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for its Class&#160;A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 &#8220;Distinguishing Liabilities from Equity.&#8221; Class&#160;A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class&#160;A ordinary shares (including Class&#160;A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control) are classified as temporary equity. At all other times, Class&#160;A ordinary shares are classified as shareholders&#8217; equity. The Company&#8217;s Class&#160;A ordinary shares feature certain redemption rights that are considered to be outside of the Company&#8217;s control and subject to the occurrence of uncertain future events. Accordingly, as of December&#160;31, 2021, 27,600,000 Class&#160;A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders&#8217; equity (deficit) section of the Company&#8217;s consolidated balance sheets. As of December&#160;31, 2020, there were no Class&#160;A ordinary shares subject to possible redemption. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class&#160;A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">paid-in</div> capital (to the extent available) and accumulated deficit. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company complies with the accounting and reporting requirements of ASC Topic 740, &#8220;Income Taxes&#8221; (&#8220;ASC 740&#8221;) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">more-likely-than-not</div> to be sustained upon examination by taxing authorities. The Company&#8217;s management determined that the Cayman Islands is the Company&#8217;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December&#160;31, 2021 and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company&#8217;s tax provision was zero for the period presented. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Ordinary Share</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Net Income (Loss) per Ordinary Shares </div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary shares and Class&#160;B ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding for the respective period.</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 14,213,333 Class&#160;A ordinary share in the calculation of diluted income (loss) per ordinary share, because their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per share ordinary for the year ended December&#160;31, 2021 and for the period from July&#160;8, 2020 (inception) through the year ended December&#160;31, 2020. Accretion associated with the redeemable Class&#160;A ordinary shares is excluded from earnings per ordinary share as the redemption value approximates fair value. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per ordinary share for each class of ordinary shares: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">
<tr>
<td style="width:58%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:4%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:3%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:3%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:4%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">For the Period From<br/> July</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">8, 2020 (Inception)</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Through December&#160;31,<br/> 2020</div></div> </td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For&#160;the&#160;Year&#160;Ended&#160;December&#160;31,<br/> 2021</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per ordinary share:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net loss</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;(9,186,727</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;(2,352,938</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(32,821</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average ordinary shares outstanding</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,843,836</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,875,342</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per ordinary share</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.01</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Issued Accounting Standards</a></td>
<td class="text"><div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recently Adopted Accounting Standards </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2020, the FASB issued ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No.&#160;2020-06,</div> <div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Debt-Debt with Conversion and Other Options (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">470-20)</div> and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-40):</div> Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</div></div>, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. The Company early adopted the ASU on January&#160;21, 2021 (inception). Adoption of the ASU did not impact the Company&#8217;s financial position, results of operations or cash flows. </div> <div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Recent Issued Accounting Standards </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#8217;s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying consolidated financial statements. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_Commonstocksubjecttopossibleredemptionpolicytextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the accounting policy on common stock subject to possible redemption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_Commonstocksubjecttopossibleredemptionpolicytextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_Derivativewarrantliabilitiespolicytextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_Derivativewarrantliabilitiespolicytextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the accounting policy on Emerging Growth Company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the accounting policy on offering costs associated with initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129909030744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of basic and diluted net income (loss) per common share</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per ordinary share for each class of ordinary shares: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">
<tr>
<td style="width:58%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:4%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:3%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:3%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:4%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">For the Period From<br/> July</div></div> <div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">8, 2020 (Inception)</div></div> <div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &quot;Times New Roman&quot;; text-align: center; line-height: normal;"><div style="font-weight:bold;display:inline;">Through December&#160;31,<br/> 2020</div></div> </td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For&#160;the&#160;Year&#160;Ended&#160;December&#160;31,<br/> 2021</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;A</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Class&#160;B</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per ordinary share:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Numerator:</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Allocation of net loss</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;(9,186,727</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;(2,352,938</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(32,821</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Denominator:</div></div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted weighted average ordinary shares outstanding</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">26,843,836</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,875,342</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">6,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Basic and diluted net loss per ordinary share</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.34</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(0.01</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129910945288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Class A Ordinary Shares Subject to Possible Redemption (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of reconciliation of Class A ordinary share subject to possible redemption reflected on the condensed balance sheet</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Class&#160;A ordinary shares subject to possible redemption reflected on the consolidated balance sheet is reconciled on the following table: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr>
<td style="width:82%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:4%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Gross proceeds from Initial Public Offering</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">276,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Less:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair value of Public Warrants at issuance</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,628,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Offering costs allocated to Class&#160;A ordinary shares subject to possible redemption</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,971,596</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Plus:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Accretion on Class&#160;A ordinary shares subject to possible redemption amount</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">29,599,596</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Class&#160;A ordinary shares subject to possible redemption</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;276,000,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907117176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of company's financial assets and liabilities that are measured at fair value on a recurring basis</a></td>
<td class="text"><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:73%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td style="vertical-align:bottom;width:2%"> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td>
<td> <div style="line-height: 0pt;">&#160;</div> </td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Description</div></div> </td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted Prices in<br/> Active Markets<br/> (Level 1)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Assets:</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Investments held in Trust Account</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;276,057,966</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;"><div style="font-weight:bold;display:inline;">Liabilities:</div></div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities - Public Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">16,100,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities - Private Placement Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;9,224,530</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Convertible note &#8211; related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1,152,680</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr> </table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of quantitative information regarding and derivative warrant liabilities measured Level 3 fair value measurements inputs</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides quantitative information regarding Level&#160;3 fair value measurements inputs used in the valuation of the derivative warrant liabilities at their measurement dates: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:75%"/>
<td style="vertical-align:bottom;width:22%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;December&#160;31,&#160;2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Option term (in years)</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">5.09</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock price</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">9.95</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">24.2</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.26</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividends</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The change in the fair value of the derivative warrant liabilities measured using Level&#160;3 inputs for the year ended December&#160;31, 2021 is summarized as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:83%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities at January&#160;1, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Issuance of Public and Private Warrants</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">22,148,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Transfer of Public Warrants to Level&#160;1 measurement</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">(14,628,000</td>
<td style="white-space:nowrap;vertical-align:bottom">)&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of derivative warrant liabilities</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">3,176,530</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Derivative warrant liabilities at December&#160;31, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">10,696,530</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides quantitative information regarding Level&#160;3 fair value measurements inputs used by the estimated fair value of warrants that may be issued upon conversion of the Convertible Note at their measurement dates: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:75%"/>
<td style="vertical-align:bottom;width:22%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;&#160;</td>
<td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">As&#160;of&#160;December&#160;31,&#160;2021</div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.5pt;">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Option term (in years)</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.09</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Stock price</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">1.84</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Volatility</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">72.1</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Risk-free interest rate</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.06</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Expected dividends</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">0.00</td>
<td style="white-space:nowrap;vertical-align:bottom">%&#160;</td> </tr> </table> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The change in the fair value of the convertible note &#8211; related party measured with Level&#160;3 inputs for year ended December&#160;31, 2021 is summarized as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto">
<tr style="font-size: 0px;">
<td style="width:85%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value at January&#160;1, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#8212;&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Initial fair value of convertible note - related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">944,694</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Change in fair value of convertible note - related party</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">207,986</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &quot;Times New Roman&quot;; line-height: normal;">Fair Value of convertible note - related party, December&#160;31, 2021</div> </td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right;">&#160;1,152,680</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td> </tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td style="vertical-align:bottom"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;">&#160;</div> </td>
<td>&#160;</td> </tr> </table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129900934376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 11, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 22, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>Month </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_UnitsIssuedDuringPeriodSharesNewIssues', window );">Numbers of units issued | shares</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_DeferredOfferingCostsNoncurrent', window );">Deferred underwriting commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_PaymentsForInvestmentOfCashInTrustAccount', window );">Payments for investment of cash in Trust Account</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 276,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage', window );">Condition for future business combination use of proceeds percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership', window );">Condition for future business combination threshold Percentage Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets', window );">Condition for future business combination threshold Net Tangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_RedemptionLimitPercentageWithoutPriorConsent', window );">Redemption limit percentage without prior consent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination', window );">Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_Monthstocompleteacquisition', window );">Months to complete acquisition | Month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_MaximumAllowedDissolutionExpenses', window );">Maximum Allowed Dissolution Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_OperatingBankAccounts', window );">Operating bank accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_WorkingCapital', window );">Working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Convertible note - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=ses_IvanhoeCapitalAcquisitionCorpMember', window );">Ivanhoe Capital Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ses_WorkingCapitalLoansWarrantMember', window );">Working capital loans warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital', window );">Maximum borrowing capacity of working capital loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_UnitsIssuedDuringPeriodSharesNewIssues', window );">Numbers of units issued | shares</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_DeferredOfferingCostsNoncurrent', window );">Deferred underwriting commissions</a></td>
<td class="nump">$ 9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share | $ / shares</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_SaleOfStockOtherOfferingCosts', window );">Other offering costs</a></td>
<td class="nump">$ 15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from Issuance Initial Public Offering</a></td>
<td class="nump">$ 276,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Convertible note - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 945,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,013,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,013,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds From Issuance Of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ses_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesNoncurrent', window );">Amount borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The threshold percentage of voting interest to be acquired in a future business combination as specified for the use of proceeds from the offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The threshold percentage of the assets held in the trust account funded by proceeds from the offering which must be used for purposes of consummating a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_DeferredOfferingCostsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_DeferredOfferingCostsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_MaximumAllowedDissolutionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount permitted to be paid for dissolution expenses if a business combination is not completed within the specified period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_MaximumAllowedDissolutionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum borrowing capacity of related party was drawn under the Working Capital Loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_Monthstocompleteacquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the anticipated business timeline in months for completing a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_Monthstocompleteacquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:positiveIntegerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_OperatingBankAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating bank accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_OperatingBankAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_PaymentsForInvestmentOfCashInTrustAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash outflow for investment of cash in trust account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_PaymentsForInvestmentOfCashInTrustAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_RedemptionLimitPercentageWithoutPriorConsent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The limit on the percentage of shares which may be redeemed with out prior consent of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_RedemptionLimitPercentageWithoutPriorConsent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_SaleOfStockOtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of other offering costs incurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_SaleOfStockOtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of working capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ses_IvanhoeCapitalAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ses_IvanhoeCapitalAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ses_WorkingCapitalLoansWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ses_WorkingCapitalLoansWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ses_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ses_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ses_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ses_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129909295112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash that is insured with federal insurance</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits accrued for interest and penalties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities attributable to warrants (in shares)</a></td>
<td class="nump">14,213,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary Equity, Shares Outstanding</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129908205608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Net income (loss) per share (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Allocation of net income (loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (9,186,727)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average ordinary shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">26,843,836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per ordinary share</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Allocation of net income (loss)</a></td>
<td class="num">$ (32,821)<span></span>
</td>
<td class="num">$ (2,352,938)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average ordinary shares outstanding</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">6,875,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per ordinary share</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129902305992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 11, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_UnitsIssuedDuringPeriodSharesNewIssues', window );">Numbers of units issued</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,710,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_UnitsIssuedDuringPeriodSharesNewIssues', window );">Numbers of units issued</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares Issued, Price Per Share</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Gross proceeds</a></td>
<td class="nump">$ 276,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Offering cost</a></td>
<td class="nump">15,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_DeferredUnderwritingCommissions', window );">Deferred underwriting commissions</a></td>
<td class="nump">$ 9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_NumberOfWarrantsIssuedPerUnit', window );">Number of warrants in a unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares issuable per warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_NumberOfSharesIssuedPerUnit', window );">Number of shares in a unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Common Class A [Member] | Ivanhoe Capital Acquisition Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_UnitsIssuedDuringPeriodSharesNewIssues', window );">Numbers of units issued</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_DeferredUnderwritingCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized fee revenue received from underwriting that is deferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_DeferredUnderwritingCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_NumberOfSharesIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares in a unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_NumberOfSharesIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_NumberOfWarrantsIssuedPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of warrants in a unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_NumberOfWarrantsIssuedPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ses_IvanhoeCapitalAcquisitionCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ses_IvanhoeCapitalAcquisitionCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129908041576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant</a></td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares issued | shares</a></td>
<td class="nump">5,013,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrants</a></td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ProceedsFromSaleOfUnits', window );">Proceeds from sale of warrants | $</a></td>
<td class="nump">$ 7.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per warrant | shares</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrant</a></td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ProceedsFromSaleOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This represents Proceeds from Sale of Units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ProceedsFromSaleOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129901109400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Founder Shares (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 06, 2021</div></th>
<th class="th"><div>Dec. 16, 2020</div></th>
<th class="th"><div>Jul. 22, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 11, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ses_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_FounderSharesMember', window );">Founder Shares | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination', window );">Percentage of assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger', window );">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_FounderSharesMember', window );">Founder Shares | Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination', window );">Percentage of assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_FounderSharesMember', window );">Founder Shares | Maximum [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger', window );">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_FounderSharesMember', window );">Founder Shares | Minimum [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger', window );">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_FounderSharesMember', window );">Founder Shares | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination', window );">Percentage of assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_FounderSharesMember', window );">Founder Shares | Sponsor | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination', window );">Percentage of assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger', window );">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays', window );">Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_FounderSharesMember', window );">Founder Shares | Sponsor | Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_AggregateOfSponsorSharesSurrendered', window );">Number of shares surrender</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsShares', window );">Share dividend</a></td>
<td class="nump">1,150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_AggregateNumberOfSharesOwned', window );">Aggregate number of shares owned</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_NumberOfSharesSubjectToForfeiture', window );">Shares subject to forfeiture</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares', window );">Common stock, shares subject to forfeiture, as a percent of issued and outstanding shares (as a percent)</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_FounderSharesMember', window );">Founder Shares | Sponsor | Minimum [Member] | Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger', window );">Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_AggregateNumberOfSharesOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders after the impact of the stock dividend.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_AggregateNumberOfSharesOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_AggregateOfSponsorSharesSurrendered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of common stock shares subject aggregate of sponsor surrendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_AggregateOfSponsorSharesSurrendered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of the company that are subject to forfeiture represented as a percentage of issued and outstanding stock as a result of partial exercise of over-allotment option.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_NumberOfSharesSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_NumberOfSharesSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of assign or sell any shares or warrants after completion of initial business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ses_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ses_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ses_FounderSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ses_FounderSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907706984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 09, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 22, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Outstanding balance of related party note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Ordinary share price, per share</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Fair Value of convertible note - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,152,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote', window );">Maximum borrowing capacity of related party promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">945,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Fair Value of convertible note - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member] | Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">stock price per share</a></td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ConverstionPricePerWarrants', window );">Conversion price</a></td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer [Member] | Convertible Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote', window );">Maximum borrowing capacity of related party promissory note</a></td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_AdministrativeSupportAgreementMember', window );">Administrative Support Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth', window );">Expenses per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses incurred and paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_AdministrativeSupportAgreementMember', window );">Administrative Support Agreement | Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses incurred and paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_RelatedPartyLoansMember', window );">Related Party Loans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote', window );">Maximum borrowing capacity of related party promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent', window );">Outstanding balance of related party note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_MaximumLoansConvertibleIntoWarrants', window );">Loan conversion agreement warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=ses_RelatedPartyLoansMember', window );">Related Party Loans [Member] | Working capital loans warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights', window );">Price of warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ConverstionPricePerWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This elements represents conversion price per warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ConverstionPricePerWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum borrowing capacity of related party promissory note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_MaximumLoansConvertibleIntoWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount which a potential loan could have repaid through issuance of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_MaximumLoansConvertibleIntoWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The contractual monthly amount to be paid for support services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ses_AdministrativeSupportAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ses_AdministrativeSupportAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ses_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ses_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=ses_RelatedPartyLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=ses_RelatedPartyLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ses_WorkingCapitalLoansWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ses_WorkingCapitalLoansWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129909014328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 11, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Day </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_MaximumNumberOfDemandsForRegistrationOfSecurities', window );">Maximum number of demands for registration of securities | Day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_UnitsIssuedDuringPeriodSharesNewIssues', window );">Numbers of units issued | shares</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="nump">3,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_FairValueMeasurementOptionTerm', window );">Granted the underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_UnderwritingCashDiscountPerUnit', window );">Underwriting cash discount per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_UnderwriterCashDiscount', window );">Underwriter cash discount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_DeferredFeePerUnit', window );">Deferred fee per unit | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_DeferredOfferingCostsNoncurrent', window );">Deferred underwriting fee payable | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_DeferredFeePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred fee per unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_DeferredFeePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_DeferredOfferingCostsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_DeferredOfferingCostsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_FairValueMeasurementOptionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The term of fair value measurement option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_FairValueMeasurementOptionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_MaximumNumberOfDemandsForRegistrationOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum number of demands for registration of securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_MaximumNumberOfDemandsForRegistrationOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_UnderwriterCashDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the cash underwriting discount per unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_UnderwriterCashDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_UnderwritingCashDiscountPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the cash underwriting discount per unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_UnderwritingCashDiscountPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new units issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129900968488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Warrant Liabilities - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Day </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination', window );">Public Warrants exercisable term after the completion of a business combination</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering', window );">Public Warrants exercisable term from the closing of the initial public offering</a></td>
<td class="text">12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement', window );">Maximum period after business combination in which to file registration statement</a></td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective', window );">Period of time within which registration statement is expected to become effective</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Public Warrants expiration term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination', window );">Threshold issue price per share</a></td>
<td class="nump">$ 9.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_PercentageOfGrossProceedsOnTotalEquityProceeds', window );">Percentage of gross proceeds on total equity proceeds</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice', window );">Threshold trading days determining volume weighted average price</a></td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice', window );">Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)</a></td>
<td class="nump">115.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1', window );">Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)</a></td>
<td class="nump">180.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant', window );">Share price trigger used to measure dilution of warrant</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants', window );">Minimum threshold written notice period for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported', window );">Number of trading days on which fair market value of shares is reported | Day</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_MultiplierUsedInCalculatingWarrantExercisePrice', window );">Multiplier used in calculating warrant exercise price</a></td>
<td class="nump">0.361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member', window );">Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant', window );">Share price trigger used to measure dilution of warrant</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants', window );">Minimum threshold written notice period for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays', window );">Threshold trading days for redemption of public warrants | Day</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for redemption of public warrants | Day</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_RedemptionPeriod', window );">Redemption period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member', window );">Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant', window );">Share price trigger used to measure dilution of warrant</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights', window );">Redemption price per public warrant (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants', window );">Minimum threshold written notice period for redemption of public warrants</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays', window );">Threshold trading days for redemption of public warrants | Day</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days for redemption of public warrants | Day</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ses_PrivatePlacementWarrantsMember', window );">Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding | shares</a></td>
<td class="nump">5,013,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ses_PublicWarrantsMember', window );">Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding | shares</a></td>
<td class="nump">9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of adjustment of exercise price of warrants based on market value and newly issued price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of adjustment of redemption price of stock based on market value and newly issued price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days for stock price trigger considered for redemption of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redemption price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of trading days on which fair market value of shares is reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period of time after completion of a business combination in which the reporting entity is required to file a registration statement with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_MultiplierUsedInCalculatingWarrantExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Multiplier used in calculating warrant exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_MultiplierUsedInCalculatingWarrantExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_PercentageOfGrossProceedsOnTotalEquityProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross proceeds on total equity proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_PercentageOfGrossProceedsOnTotalEquityProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The period of time after filing within which the registration statement filed with the SEC is expected to become effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_RedemptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redemption period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_RedemptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_SharePricetriggerUsedToMeasureDilutionOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cutoff price used to measure whether dilution of the warrant has occurred. Shares issued below this price will cause the exercise price of the warrant to be adjusted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_SharePricetriggerUsedToMeasureDilutionOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the information pertaining to threshold issue price for capital raising purposes in connection with the closure of a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The threshold number of specified trading period determining volume weighted average trading price , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The warrants exercisable term from the closing of the public offering, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The warrants exercisable term after the completion of a business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ses_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ses_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ses_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ses_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907904808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Class A Ordinary Shares Subject to Possible Redemption (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Day </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_CommonStockNumberOfVotesPerShare', window );">Common Stock, Number Of Votes Per Share | Day</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized | shares</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_CommonStockNumberOfVotesPerShare', window );">Common Stock, Number Of Votes Per Share | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember', window );">Class A Common Stock Subject to Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Temporary equity, shares outstanding | shares</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_ProceedsFromIssuanceOfTemporaryEquity', window );">Gross proceeds from Initial Public Offering</a></td>
<td class="nump">$ 276,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_TemporaryEquityFairValueOfWarrantsAtIssuance', window );">Fair value of Public Warrants at issuance</a></td>
<td class="num">(14,628,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_TemporaryEquityIssuanceCosts', window );">Offering costs allocated to Class A ordinary shares subject to possible redemption</a></td>
<td class="num">(14,971,596)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Accretion on Class A ordinary shares subject to possible redemption amount</a></td>
<td class="nump">29,599,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A ordinary shares subject to possible redemption</a></td>
<td class="nump">$ 276,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_CommonStockNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of votes that each common share is entitled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_CommonStockNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_ProceedsFromIssuanceOfTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_ProceedsFromIssuanceOfTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_TemporaryEquityFairValueOfWarrantsAtIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of fair value of warrants at issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_TemporaryEquityFairValueOfWarrantsAtIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_TemporaryEquityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuance costs related to temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_TemporaryEquityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ses_CommonClassaSubjectToRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907548056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity (Deficit) - Preferred Stock Shares (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value, (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129900926488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity (Deficit) - Common stock  (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Day </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_CommonStockNumberOfVotesPerShare', window );">Common Stock, Number Of Votes Per Share | Day</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_CommonStockNumberOfVotesPerShare', window );">Common Stock, Number Of Votes Per Share | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">27,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common shares, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares, shares issued (in shares)</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_CommonStockNumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of votes that each common share is entitled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_CommonStockNumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129909244712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Company's financial assets and liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Derivative warrant liabilities</a></td>
<td class="nump">$ 25,324,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Convertible note - related party</a></td>
<td class="nump">1,152,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Short-term investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments held in Trust Account</a></td>
<td class="nump">276,057,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Convertible note - related party</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Derivative warrant liabilities</a></td>
<td class="nump">16,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Derivative warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Short-term investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments held in Trust Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Convertible note - related party</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring [Member] | Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Derivative warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring [Member] | Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Derivative warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Convertible note - related party</a></td>
<td class="nump">1,152,680<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosureAbstract', window );"><strong>Short-term investments:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments held in Trust Account</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Convertible note - related party</a></td>
<td class="nump">1,152,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Derivative warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Private Placement Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares', window );">Derivative warrant liabilities</a></td>
<td class="nump">$ 9,224,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109262807&amp;loc=d3e22047-110879<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ses_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ses_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ses_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ses_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907197896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount', window );">Fair value assets level 1 to level 2 transfers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount', window );">Fair value assets level 2 to level 1 transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Fair value assets transferred into (out of) level 3</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Fair value liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907906264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Level 3 Fair Value Measurements Inputs (Details) - Level 3<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>yr</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Option term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements inputs at their measurement</a></td>
<td class="nump">5.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Fair value measurements inputs used by the estimated fair value of warrants</a></td>
<td class="nump">0.09<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock price</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements inputs at their measurement</a></td>
<td class="nump">9.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Fair value measurements inputs used by the estimated fair value of warrants</a></td>
<td class="nump">1.84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements inputs at their measurement</a></td>
<td class="nump">24.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Fair value measurements inputs used by the estimated fair value of warrants</a></td>
<td class="nump">72.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements inputs at their measurement</a></td>
<td class="nump">1.26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Fair value measurements inputs used by the estimated fair value of warrants</a></td>
<td class="nump">0.06<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Expected dividends</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Fair value measurements inputs at their measurement</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Fair value measurements inputs used by the estimated fair value of warrants</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129909284152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details) - Level 3<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities beginning of the period</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Issuance of Public and Private Warrants</a></td>
<td class="nump">22,148,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Transfer of Public Warrants to Level 1 measurement</a></td>
<td class="num">(14,628,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of derivative warrant liabilities</a></td>
<td class="nump">3,176,530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Derivative warrant liabilities ending of the period</a></td>
<td class="nump">$ 10,696,530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140129907282440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Change in the Fair Value of the Convertible note - related party (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties', window );">Change in fair value of convertible note - related party</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 207,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Fair Value of convertible note - related party, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,152,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Fair Value at January 1, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_FairValueOfConvertibleDebtWithRelatedParties', window );">Initial fair value of convertible note - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">944,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties', window );">Change in fair value of convertible note - related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Fair Value of convertible note - related party, end of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,152,680<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of Convertible debt with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ses_FairValueOfConvertibleDebtWithRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of fair value of Convertible debt with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ses_FairValueOfConvertibleDebtWithRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ses_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>d251271d10k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:ses="http://www.ivanhoecapitalacquisition.com/20211231"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ses-20211231.xsd" xlink:type="simple"/>
    <context id="PAsOn12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P07_08_2020To12_31_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
        </entity>
        <period>
            <startDate>2020-07-08</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_11_2021To01_11_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
        </entity>
        <period>
            <startDate>2021-01-11</startDate>
            <endDate>2021-01-11</endDate>
        </period>
    </context>
    <context id="PAsOn04_09_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
        </entity>
        <period>
            <instant>2021-04-09</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2021">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="PAsOn07_07_2020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
        </entity>
        <period>
            <instant>2020-07-07</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ses:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">ses:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">ses:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_IvanhoeCapitalAcquisitionCorpMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ses:IvanhoeCapitalAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_WorkingCapitalLoansWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ses:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ses:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">ses:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">ses:RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ses:CommonClassaSubjectToRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-08</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P07_08_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-08</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P07_08_2020To12_31_2020_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:AdministrativeSupportAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-08</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P07_08_2020To12_31_2020_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-08</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P07_08_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-08</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-08</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P07_08_2020To12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-08</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-11</startDate>
            <endDate>2021-01-11</endDate>
        </period>
    </context>
    <context id="P01_11_2021To01_11_2021_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-11</startDate>
            <endDate>2021-01-11</endDate>
        </period>
    </context>
    <context id="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-11</instant>
        </period>
    </context>
    <context id="PAsOn01_11_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ses:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-11</instant>
        </period>
    </context>
    <context id="PAsOn01_11_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis_IvanhoeCapitalAcquisitionCorpMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ses:IvanhoeCapitalAcquisitionCorpMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-11</instant>
        </period>
    </context>
    <context id="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ses:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-22</startDate>
            <endDate>2020-07-22</endDate>
        </period>
    </context>
    <context id="P07_22_2020To07_22_2020_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ses:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-22</startDate>
            <endDate>2020-07-22</endDate>
        </period>
    </context>
    <context id="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ses:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-22</startDate>
            <endDate>2020-07-22</endDate>
        </period>
    </context>
    <context id="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-22</startDate>
            <endDate>2020-07-22</endDate>
        </period>
    </context>
    <context id="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-22</startDate>
            <endDate>2020-07-22</endDate>
        </period>
    </context>
    <context id="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MinimumMembersrtRangeAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ses:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-22</startDate>
            <endDate>2020-07-22</endDate>
        </period>
    </context>
    <context id="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-22</startDate>
            <endDate>2020-07-22</endDate>
        </period>
    </context>
    <context id="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-22</startDate>
            <endDate>2020-07-22</endDate>
        </period>
    </context>
    <context id="P07_22_2020To07_22_2020_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ses:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-22</startDate>
            <endDate>2020-07-22</endDate>
        </period>
    </context>
    <context id="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-22</instant>
        </period>
    </context>
    <context id="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis_WorkingCapitalLoansWarrantMemberusgaapClassOfWarrantOrRightAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ses:WorkingCapitalLoansWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:RelatedPartyLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-22</instant>
        </period>
    </context>
    <context id="PAsOn07_22_2020_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ses:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-22</instant>
        </period>
    </context>
    <context id="P12_16_2020To12_16_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ses:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-16</startDate>
            <endDate>2020-12-16</endDate>
        </period>
    </context>
    <context id="P01_06_2021To01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ses:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-06</startDate>
            <endDate>2021-01-06</endDate>
        </period>
    </context>
    <context id="PAsOn01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">ses:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ses:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-06</instant>
        </period>
    </context>
    <context id="PAsOn04_09_2021_ChiefExecutiveOfficerMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-09</instant>
        </period>
    </context>
    <context id="PAsOn04_09_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-09</instant>
        </period>
    </context>
    <context id="P04_09_2021To04_09_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-09</startDate>
            <endDate>2021-04-09</endDate>
        </period>
    </context>
    <context id="PAsOn03_28_2022_CommonClassAMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-28</instant>
        </period>
    </context>
    <context id="PAsOn03_28_2022_CommonClassBMemberusgaapStatementClassOfStockAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-28</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="PAsOn07_07_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-07</instant>
        </period>
    </context>
    <context id="PAsOn07_07_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-07</instant>
        </period>
    </context>
    <context id="PAsOn07_07_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-07</instant>
        </period>
    </context>
    <context id="PAsOn07_07_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819142</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-07</instant>
        </period>
    </context>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_shares">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_Day">
        <measure>utr:Day</measure>
    </unit>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_Year">
        <measure>utr:Year</measure>
    </unit>
    <unit id="Unit_USD_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_vote">
        <measure>ses:vote</measure>
    </unit>
    <unit id="Unit_Month">
        <measure>utr:Month</measure>
    </unit>
    <unit id="Unit_Y">
        <measure>utr:Y</measure>
    </unit>
    <ses:CommonStockNumberOfVotesPerShare
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      id="hidden42197942"
      unitRef="Unit_Day">10</ses:CommonStockNumberOfVotesPerShare>
    <dei:AmendmentFlag contextRef="P01_01_2021To12_31_2021">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="P01_01_2021To12_31_2021">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="P01_01_2021To12_31_2021">0001819142</dei:EntityCentralIndexKey>
    <dei:EntityAddressStateOrProvince contextRef="P01_01_2021To12_31_2021" id="hidden42198043">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityWellKnownSeasonedIssuer contextRef="P01_01_2021To12_31_2021" id="hidden42198049">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="P01_01_2021To12_31_2021" id="hidden42198051">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="P01_01_2021To12_31_2021" id="hidden42198053">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="P01_01_2021To12_31_2021" id="hidden42198055">Yes</dei:EntityInteractiveDataCurrent>
    <dei:DocumentType contextRef="P01_01_2021To12_31_2021">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="P01_01_2021To12_31_2021">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="P01_01_2021To12_31_2021">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="P01_01_2021To12_31_2021">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="P01_01_2021To12_31_2021">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="P01_01_2021To12_31_2021">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="P01_01_2021To12_31_2021">001-39845</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="P01_01_2021To12_31_2021">SES AI Corporation</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="P01_01_2021To12_31_2021">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="P01_01_2021To12_31_2021">95-1567584</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="P01_01_2021To12_31_2021">35 Cabot Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="P01_01_2021To12_31_2021">Woburn</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="P01_01_2021To12_31_2021">01801</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P01_01_2021To12_31_2021">339</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P01_01_2021To12_31_2021">298-8750</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis">Class A common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis">SES</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementClassOfStockAxis">Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementClassOfStockAxis">SES WS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="P01_01_2021To12_31_2021_WarrantMemberusgaapStatementClassOfStockAxis">NYSE</dei:SecurityExchangeName>
    <dei:EntityFilerCategory contextRef="P01_01_2021To12_31_2021">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="P01_01_2021To12_31_2021">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="P01_01_2021To12_31_2021">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="P01_01_2021To12_31_2021">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="P01_01_2021To12_31_2021">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="PAsOn06_30_2021"
      decimals="-5"
      unitRef="Unit_USD">280600000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="PAsOn03_28_2022_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">303989794</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="PAsOn03_28_2022_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">43881251</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorName contextRef="P01_01_2021To12_31_2021">WithumSmith+Brown, PC</dei:AuditorName>
    <dei:AuditorLocation contextRef="P01_01_2021To12_31_2021">New York, New York</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="P01_01_2021To12_31_2021">100</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">117282</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">161271</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">608904</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">726186</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">161271</us-gaap:AssetsCurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">276057966</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:DeferredCosts
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">413039</us-gaap:DeferredCosts>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">276784152</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">574310</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">89017</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">13785</us-gaap:AccountsPayableCurrent>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">20532</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">795586</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">68346</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">500000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">905135</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">582131</us-gaap:LiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">4888889</us-gaap:AccountsPayableAndAccruedLiabilitiesNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">1152680</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <ses:DeferredUnderwritingFeePayableNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">9660000</ses:DeferredUnderwritingFeePayableNoncurrent>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">25324530</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">41931234</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">582131</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="PAsOn12_31_2021"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="PAsOn12_31_2020"
      unitRef="Unit_USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">27600000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">27600000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">276000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2020"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_31_2020"
      decimals="INF"
      unitRef="Unit_shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn12_31_2020"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2020"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockValue
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6900000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6900000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">690</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">690</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">24310</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">-41147772</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">-32821</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">-41147082</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">-7821</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">276784152</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">574310</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">7238072</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">32821</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">120000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:CostsAndExpenses
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">7358072</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">32821</us-gaap:CostsAndExpenses>
    <us-gaap:GainLossOnInvestments
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">57966</us-gaap:GainLossOnInvestments>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">3176530</us-gaap:FairValueAdjustmentOfWarrants>
    <ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">207986</ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties>
    <ses:OfferingCostsWarrantsIssuance
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">855043</ses:OfferingCostsWarrantsIssuance>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">-11539665</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">-32821</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">26843836</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.34</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6875342</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6000000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.34</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:SharesIssued
      contextRef="PAsOn07_07_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn07_07_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="PAsOn07_07_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn07_07_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn07_07_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn07_07_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn07_07_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">6900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">690</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P07_08_2020To12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">24310</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="P07_08_2020To12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-32821</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">-32821</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">6900000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">690</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2020_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">24310</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2020_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-32821</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">-7821</us-gaap:StockholdersEquity>
    <ses:CommonStockSubjectToPossibleRedemptionValue
      contextRef="P01_01_2021To12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">24310</ses:CommonStockSubjectToPossibleRedemptionValue>
    <ses:CommonStockSubjectToPossibleRedemptionValue
      contextRef="P01_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">29575286</ses:CommonStockSubjectToPossibleRedemptionValue>
    <ses:CommonStockSubjectToPossibleRedemptionValue
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">29599596</ses:CommonStockSubjectToPossibleRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2021To12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-11539665</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">-11539665</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="INF"
      unitRef="Unit_shares">6900000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_CommonStockMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">690</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_AdditionalPaidInCapitalMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021_RetainedEarningsMemberusgaapStatementEquityComponentsAxis"
      decimals="0"
      unitRef="Unit_USD">-41147772</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">-41147082</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">-11539665</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">-32821</us-gaap:ProfitLoss>
    <ses:GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</ses:GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares>
    <ses:GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">25000</ses:GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares>
    <us-gaap:InvestmentIncomeInterest
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">57966</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">3176530</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:FairValueAdjustmentOfWarrants>
    <ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">207986</ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties>
    <ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties>
    <ses:OfferingCostsWarrantsIssuance
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">855043</ses:OfferingCostsWarrantsIssuance>
    <ses:OfferingCostsWarrantsIssuance
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</ses:OfferingCostsWarrantsIssuance>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">608904</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">75232</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">20532</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">684374</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">6213</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <ses:IncreaseDecreaseInAccruedExpensesRealtedParties
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">4888889</ses:IncreaseDecreaseInAccruedExpensesRealtedParties>
    <ses:IncreaseDecreaseInAccruedExpensesRealtedParties
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</ses:IncreaseDecreaseInAccruedExpensesRealtedParties>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">-2297949</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">-1608</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <ses:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">276000000</ses:PaymentsForInvestmentOfCashInTrustAccount>
    <ses:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</ses:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">-276000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">-500000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <ses:ProceedsReceivedFromInitialPublicOfferingGross
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">276000000</ses:ProceedsReceivedFromInitialPublicOfferingGross>
    <ses:ProceedsReceivedFromInitialPublicOfferingGross
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</ses:ProceedsReceivedFromInitialPublicOfferingGross>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">7520000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">5710734</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <ses:ProceedsReceivedFromNotePayableToRelatedParty
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</ses:ProceedsReceivedFromNotePayableToRelatedParty>
    <ses:ProceedsReceivedFromNotePayableToRelatedParty
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">408341</ses:ProceedsReceivedFromNotePayableToRelatedParty>
    <ses:OfferingCostsPaid
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</ses:OfferingCostsPaid>
    <ses:OfferingCostsPaid
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">245462</ses:OfferingCostsPaid>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">944694</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">278253960</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">162879</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">-43989</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">161271</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">161271</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="PAsOn07_07_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">117282</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">161271</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <ses:DeferredOfferingCostsIncludedInAccountsPayable
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</ses:DeferredOfferingCostsIncludedInAccountsPayable>
    <ses:DeferredOfferingCostsIncludedInAccountsPayable
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">13785</ses:DeferredOfferingCostsIncludedInAccountsPayable>
    <ses:OfferingCostsIncludedInAccountsPayableAccruedExpenses
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">42867</ses:OfferingCostsIncludedInAccountsPayableAccruedExpenses>
    <ses:OfferingCostsIncludedInAccountsPayableAccruedExpenses
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">62133</ses:OfferingCostsIncludedInAccountsPayableAccruedExpenses>
    <ses:DeferredOfferingCostsPaidBySponsorUnderPromissoryNote
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</ses:DeferredOfferingCostsPaidBySponsorUnderPromissoryNote>
    <ses:DeferredOfferingCostsPaidBySponsorUnderPromissoryNote
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">91659</ses:DeferredOfferingCostsPaidBySponsorUnderPromissoryNote>
    <ses:Underwritingcommissiondeferred
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">9660000</ses:Underwritingcommissiondeferred>
    <ses:Underwritingcommissiondeferred
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</ses:Underwritingcommissiondeferred>
    <us-gaap:NatureOfOperations contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 1&#x2014;Description of Organization and Business Operations &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;SES AI Corporation, formerly known as Ivanhoe Capital Acquisition Corp. prior to February&#160;3, 2022 (the &#x201c;Company&#x201d;), is a blank check company incorporated as a Cayman Islands exempted company on July&#160;8, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (&#x201c;Business Combination&#x201d;). &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;On June&#160;28, 2021, the Company formed a wholly owned subsidiary, Wormhole Merger Sub Pte. Ltd., a Singapore private company limited by shares (&#x201c;Amalgamation Sub&#x201d;). &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Business Operations &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As of December&#160;31, 2021, the Company had not yet commenced operations. All activity for the period from July&#160;8, 2020 (inception) through December&#160;31, 2021 relates to the Company&#x2019;s formation and the initial public offering (the &#x201c;Initial Public Offering&#x201d;), which is described below, and since the closing of the Initial Public Offering, the search for a prospective Business Combination, including activities in connection with the proposed acquisition of SES Holdings Pte. Ltd., a Singapore private company limited by shares (&#x201c;SES&#x201d;). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-operating&lt;/div&gt; income in the form of interest income on its investments held in the trust account from the proceeds of its Initial Public Offering. The Company incurs expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a business combination. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s sponsor is Ivanhoe Capital Sponsor LLC, a Cayman Islands limited liability company (&#x201c;Sponsor&#x201d;). The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on January&#160;6, 2021. On January&#160;11, 2021, the Company consummated its Initial Public Offering of 27,600,000 units (the &#x201c;Units&#x201d; and, with respect to the Class&#160;A ordinary shares included in the Units being offered, the &#x201c;Public Shares&#x201d;), including 3,600,000 additional Units to cover over-allotments (the &#x201c;Over-Allotment Units&#x201d;), at $10.00 per Unit, generating gross proceeds of $276.0&#160;million, and incurring offering costs of approximately $15.8&#160;million, of which approximately $9.7&#160;million was for deferred underwriting commissions (Note 6). &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (&#x201c;Private Placement&#x201d;) of 5,013,333 warrants (each, a &#x201c;Private Placement Warrant&#x201d; and collectively, the &#x201c;Private Placement Warrants&#x201d;), at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $7.5&#160;million (Note 4). &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Upon the closing of the Initial Public Offering and the Private Placement, $276.0&#160;million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (&#x201c;Trust Account&#x201d;) with Continental Stock Transfer&#160;&amp;amp; Trust Company acting as trustee and invested in United States &#x201c;government securities&#x201d; within the meaning of Section&#160;2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;2a-7&lt;/div&gt; promulgated under the Investment Company Act of 1940, as amended, or the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i)&#160;the completion of a Business Combination and (ii)&#160;the distribution of the Trust Account as described below. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company&#x2019;s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the amount of any deferred underwriting discount held in Trust) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company will provide its holders of the Public Shares (the &#x201c;Public Shareholders&#x201d;) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i)&#160;in connection with a shareholder meeting called to approve the Business Combination or (ii)&#160;by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;per-share&lt;/div&gt; amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing Liabilities from Equity&#x201d; (&#x201c;ASC 480&#x201d;). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which will be adopted by the Company upon the consummation of the Initial Public Offering (the &#x201c;Amended and Restated Memorandum and Articles of Association&#x201d;), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares prior to the Initial Public Offering (the &#x201c;Initial Shareholders&#x201d;) have agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company has agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Notwithstanding the foregoing, the Company&#x2019;s Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a &#x201c;group&#x201d; (as defined under Section&#160;13 of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class&#160;A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s Sponsor, executive officers, directors and director nominees agreed not to propose an amendment to the Company&#x2019;s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company&#x2019;s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class&#160;A ordinary shares in conjunction with any such amendment. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or January&#160;11, 2023 (the &#x201c;Combination Period&#x201d;), the Company will (i)&#160;cease all operations except for the purpose of winding up, (ii)&#160;as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;per-share&lt;/div&gt; price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders&#x2019; rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in each case to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;  &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In connection with the redemption of 100% of the Company&#x2019;s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company&#x2019;s taxes payable (less up to $100,000 of interest to pay dissolution expenses). The Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company&#x2019;s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii)&#160;the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#x2019;s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company&#x2019;s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. &lt;/div&gt; &lt;div style="margin-top: 10pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Business Combination &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;On February&#160;3, 2022, we consummated the previously announced business combination (the &#x201c;Business Combination&#x201d;) pursuant to that certain Business Combination Agreement dated July&#160;12, 2021 (the &#x201c;Business Combination Agreement&#x201d;), by and among Ivanhoe, Wormhole Amalgamation Sub Pte. Ltd., a Singapore private company limited by shares and our direct wholly-owned subsidiary (&#x201c;Amalgamation Sub&#x201d;), and SES Holdings Pte. Ltd. (&#x201c;SES&#x201d;), a Singapore private company limited by shares. In connection with the closing of the Business Combination (the &#x201c;Closing&#x201d;), a business combination between the Company, Amalgamation Sub and SES was effectuated through the merger of Amalgamation Sub with and into SES, with SES continuing as the surviving company. On the Closing Date, we changed our name from Ivanhoe Capital Acquisition Corp. to &#x201c;SES AI Corporation&#x201d;. &lt;/div&gt; &lt;div style="margin-top: 10pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Risks and Uncertainties &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Management continues to evaluate the impact of the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;COVID-19&lt;/div&gt; pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company&#x2019;s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these consolidated financial statements. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. &lt;/div&gt; &lt;div style="margin-top: 10pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liquidity and Capital Resources &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company successfully consummated its Business Combination on February&#160;3, 2022. &lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As indicated in the accompanying financial statements, as of December&#160;31, 2021, we had approximately $100,000 in our operating bank account and working deficit of approximately $200,000. &lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Our liquidity needs to date have been satisfied through a contribution of $25,000 from Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of $500,000 from the Sponsor pursuant to the Note, and the proceeds from the consummation of the Private Placement not held in the Trust Account. We repaid the Note in full on January&#160;15, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, provide us Working Capital Loans. On April&#160;9, 2021, we issued an unsecured convertible promissory note (the &#x201c;Convertible Note&#x201d;) to our Chief Executive Officer, pursuant to which we may borrow up to $1,500,000 for ongoing expenses reasonably related to our business and the consummation of the Business Combination. The Convertible Note does not bear any interest. All unpaid principal under the Convertible Note will be due and payable in full on the earlier of (i)&#160;January&#160;11, 2023 and (ii)&#160;the effective date of the Business Combination (such earlier date, the &#x201c;Maturity Date&#x201d;). As of December&#160;31, 2021, $945,000 was drawn on the convertible note&#x2014;related party, presented at its fair value of approximately $1.2&#160;million on the accompanying consolidated balance sheets. Subsequently, the loan was repaid in full with cash at the closing of our business combination on February&#160;3, 2022. There were no amounts outstanding under the Convertible Note as of December&#160;31, 2020. &lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Based on the foregoing, management believes that we will have sufficient working capital and borrowing capacity from our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors to meet our needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, we expect to be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt; </us-gaap:NatureOfOperations>
    <ses:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">27600000</ses:UnitsIssuedDuringPeriodSharesNewIssues>
    <ses:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="P01_11_2021To01_11_2021"
      decimals="0"
      unitRef="Unit_shares">3600000</ses:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">276000000.0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <ses:SaleOfStockOtherOfferingCosts
      contextRef="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">15800000</ses:SaleOfStockOtherOfferingCosts>
    <ses:DeferredOfferingCostsNoncurrent
      contextRef="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">9700000</ses:DeferredOfferingCostsNoncurrent>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_shares">5013333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <ses:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">1.50</ses:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="P07_08_2020To12_31_2020_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="-5"
      unitRef="Unit_USD">7500000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <ses:PaymentsForInvestmentOfCashInTrustAccount
      contextRef="P01_01_2021To12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">276000000.0</ses:PaymentsForInvestmentOfCashInTrustAccount>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="PAsOn12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">10.00</us-gaap:SharesIssuedPricePerShare>
    <ses:ConditionForFutureBusinessCombinationUseOfProceedsPercentage
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_pure">80</ses:ConditionForFutureBusinessCombinationUseOfProceedsPercentage>
    <ses:ConditionForFutureBusinessCombinationThresholdPercentageOwnership
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_pure">50</ses:ConditionForFutureBusinessCombinationThresholdPercentageOwnership>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="PAsOn12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">10.00</us-gaap:SharesIssuedPricePerShare>
    <ses:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">5000001</ses:ConditionForFutureBusinessCombinationThresholdNetTangibleAssets>
    <ses:RedemptionLimitPercentageWithoutPriorConsent
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_pure">20</ses:RedemptionLimitPercentageWithoutPriorConsent>
    <ses:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">1</ses:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <ses:Monthstocompleteacquisition
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_Month">24</ses:Monthstocompleteacquisition>
    <ses:MaximumAllowedDissolutionExpenses
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">100000</ses:MaximumAllowedDissolutionExpenses>
    <ses:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">1</ses:PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination>
    <ses:MaximumAllowedDissolutionExpenses
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">100000</ses:MaximumAllowedDissolutionExpenses>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="PAsOn12_31_2021_IvanhoeCapitalAcquisitionCorpMemberdeiLegalEntityAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="PAsOn12_31_2021_IvanhoeCapitalAcquisitionCorpMemberdeiLegalEntityAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="P01_01_2021To12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="2"
      unitRef="Unit_shares">10.00</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <ses:OperatingBankAccounts
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">100000</ses:OperatingBankAccounts>
    <ses:WorkingCapital
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">200000</ses:WorkingCapital>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P07_22_2020To07_22_2020_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="PAsOn07_22_2020_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">500000</us-gaap:DueToRelatedPartiesNoncurrent>
    <ses:MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital
      contextRef="PAsOn12_31_2021_WorkingCapitalLoansWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_USD">1500000</ses:MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="PAsOn12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">945000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P01_01_2021To12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">1200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 2&#x2014;Summary of Significant Accounting Policies &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Basis of Presentation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (&#x201c;SEC&#x201d;). &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Principles of Consolidation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The consolidated financial statements of the Company include its wholly-owned subsidiary, Wormhole Merger Sub Pte. Ltd., which was incorporated in Singapore on June&#160;28, 2021, in connection with the planned business combination. All inter-company accounts and transactions are eliminated in consolidation. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Emerging Growth Company &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-emerging&lt;/div&gt; growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Use of Estimates &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The preparation of consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Cash and Cash Equivalents &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December&#160;31, 2021 and 2020 held outside of the Trust Account. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Concentration of Credit Risk &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of December&#160;31, 2021 and 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;  &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Investments Held in Trust Account &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section&#160;2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#x2019;s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#x2019;s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair Value of Financial Instruments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, &#x201c;Fair Value Measurements&#x201d; approximates the carrying amounts represented in the balance sheet. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company has elected the fair value option to account for its Convertible Note with its Sponsor as defined and more fully described in Note 5. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value are recorded as change in the fair value of Convertible Note&#x2014;related party on the consolidated statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management&#x2019;s and, if applicable, an independent third-party valuation firm&#x2019;s own assumption about the assumptions a market participant would use in pricing the asset or liability. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair Value Measurements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: &lt;/div&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Level&#160;1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Level&#160;2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Level&#160;3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Derivative Warrant Liabilities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;re-assessed&lt;/div&gt; at the end of each reporting period. Derivative warrant liabilities are classified as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The warrants issued in connection with the Initial Public Offering (the &#x201c;Public Warrants&#x201d;) and the Private Placement Warrants (as defined in Note 4) (collectively, the &#x201c;Warrant&#x201d;) are recognized as derivative liabilities in accordance with ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;815-40.&lt;/div&gt; Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised, and any change in fair value is recognized in the Company&#x2019;s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Offering Costs Associated with the Initial Public Offering &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-operating&lt;/div&gt; expenses in the statement of operations. Offering costs associated with the Class&#160;A ordinary shares are charged against their carrying value upon the completion of the Initial Public Offering. Deferred underwriting commissions are classified as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Class&#160;A Ordinary Shares Subject to Possible Redemption &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company accounts for its Class&#160;A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Class&#160;A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class&#160;A ordinary shares (including Class&#160;A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) are classified as temporary equity. At all other times, Class&#160;A ordinary shares are classified as shareholders&#x2019; equity. The Company&#x2019;s Class&#160;A ordinary shares feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events. Accordingly, as of December&#160;31, 2021, 27,600,000 Class&#160;A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders&#x2019; equity (deficit) section of the Company&#x2019;s consolidated balance sheets. As of December&#160;31, 2020, there were no Class&#160;A ordinary shares subject to possible redemption. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class&#160;A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;paid-in&lt;/div&gt; capital (to the extent available) and accumulated deficit. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Income Taxes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company complies with the accounting and reporting requirements of ASC Topic 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;more-likely-than-not&lt;/div&gt; to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December&#160;31, 2021 and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company&#x2019;s tax provision was zero for the period presented. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net Income (Loss) per Ordinary Shares &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary shares and Class&#160;B ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding for the respective period.&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 14,213,333 Class&#160;A ordinary share in the calculation of diluted income (loss) per ordinary share, because their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per share ordinary for the year ended December&#160;31, 2021 and for the period from July&#160;8, 2020 (inception) through the year ended December&#160;31, 2020. Accretion associated with the redeemable Class&#160;A ordinary shares is excluded from earnings per ordinary share as the redemption value approximates fair value. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per ordinary share for each class of ordinary shares: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:58%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For the Period From&lt;br/&gt; July&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8, 2020 (Inception)&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Through December&#160;31,&lt;br/&gt; 2020&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For&#160;the&#160;Year&#160;Ended&#160;December&#160;31,&lt;br/&gt; 2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;A&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;B&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;A&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;B&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Basic and diluted net loss per ordinary share:&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Numerator:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Allocation of net loss&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;(9,186,727&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;(2,352,938&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(32,821&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Denominator:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Basic and diluted weighted average ordinary shares outstanding&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;26,843,836&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,875,342&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,000,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Basic and diluted net loss per ordinary share&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.34&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.34&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.01&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Recently Adopted Accounting Standards &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In August 2020, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No.&#160;2020-06,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Debt-Debt with Conversion and Other Options (Subtopic &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;470-20)&lt;/div&gt; and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;815-40):&lt;/div&gt; Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/div&gt;&lt;/div&gt;, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. The Company early adopted the ASU on January&#160;21, 2021 (inception). Adoption of the ASU did not impact the Company&#x2019;s financial position, results of operations or cash flows. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Recent Issued Accounting Standards &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying consolidated financial statements. &lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Basis of Presentation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and pursuant to the rules and regulations of the U.S. Securities and Exchanges Commission (&#x201c;SEC&#x201d;). &lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Principles of Consolidation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The consolidated financial statements of the Company include its wholly-owned subsidiary, Wormhole Merger Sub Pte. Ltd., which was incorporated in Singapore on June&#160;28, 2021, in connection with the planned business combination. All inter-company accounts and transactions are eliminated in consolidation. &lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <ses:EmergingGrowthCompanyPolicyTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Emerging Growth Company &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-emerging&lt;/div&gt; growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s consolidated financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. &lt;/div&gt;</ses:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Use of Estimates &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The preparation of consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. &lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Cash and Cash Equivalents &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December&#160;31, 2021 and 2020 held outside of the Trust Account. &lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Concentration of Credit Risk &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. As of December&#160;31, 2021 and 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:MarketableSecuritiesPolicy contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Investments Held in Trust Account &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section&#160;2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company&#x2019;s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company&#x2019;s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying consolidated statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. &lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair Value of Financial Instruments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, &#x201c;Fair Value Measurements&#x201d; approximates the carrying amounts represented in the balance sheet. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company has elected the fair value option to account for its Convertible Note with its Sponsor as defined and more fully described in Note 5. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value are recorded as change in the fair value of Convertible Note&#x2014;related party on the consolidated statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management&#x2019;s and, if applicable, an independent third-party valuation firm&#x2019;s own assumption about the assumptions a market participant would use in pricing the asset or liability. &lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Fair Value Measurements &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: &lt;/div&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Level&#160;1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Level&#160;2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;Level&#160;3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. &lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <ses:Derivativewarrantliabilitiespolicytextblock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Derivative Warrant Liabilities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d; (&#x201c;ASC 815&#x201d;). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;re-assessed&lt;/div&gt; at the end of each reporting period. Derivative warrant liabilities are classified as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The warrants issued in connection with the Initial Public Offering (the &#x201c;Public Warrants&#x201d;) and the Private Placement Warrants (as defined in Note 4) (collectively, the &#x201c;Warrant&#x201d;) are recognized as derivative liabilities in accordance with ASC &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;815-40.&lt;/div&gt; Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the carrying value of the instruments to fair value at each reporting period until they are exercised, and any change in fair value is recognized in the Company&#x2019;s statement of operations. The fair value of the Public Warrants issued in connection with the Initial Public Offering and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;</ses:Derivativewarrantliabilitiespolicytextblock>
    <ses:Offeringcostsassociatedwithinitialpublicofferingpolicytextblock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Offering Costs Associated with the Initial Public Offering &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred and presented as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-operating&lt;/div&gt; expenses in the statement of operations. Offering costs associated with the Class&#160;A ordinary shares are charged against their carrying value upon the completion of the Initial Public Offering. Deferred underwriting commissions are classified as &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-current&lt;/div&gt; liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. &lt;/div&gt;</ses:Offeringcostsassociatedwithinitialpublicofferingpolicytextblock>
    <ses:Commonstocksubjecttopossibleredemptionpolicytextblock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Class&#160;A Ordinary Shares Subject to Possible Redemption &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company accounts for its Class&#160;A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 &#x201c;Distinguishing Liabilities from Equity.&#x201d; Class&#160;A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class&#160;A ordinary shares (including Class&#160;A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control) are classified as temporary equity. At all other times, Class&#160;A ordinary shares are classified as shareholders&#x2019; equity. The Company&#x2019;s Class&#160;A ordinary shares feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of uncertain future events. Accordingly, as of December&#160;31, 2021, 27,600,000 Class&#160;A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders&#x2019; equity (deficit) section of the Company&#x2019;s consolidated balance sheets. As of December&#160;31, 2020, there were no Class&#160;A ordinary shares subject to possible redemption. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class&#160;A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;paid-in&lt;/div&gt; capital (to the extent available) and accumulated deficit. &lt;/div&gt;</ses:Commonstocksubjecttopossibleredemptionpolicytextblock>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">27600000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2020_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Income Taxes &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company complies with the accounting and reporting requirements of ASC Topic 740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;) which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;more-likely-than-not&lt;/div&gt; to be sustained upon examination by taxing authorities. The Company&#x2019;s management determined that the Cayman Islands is the Company&#x2019;s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December&#160;31, 2021 and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company is considered an exempted Cayman Islands Company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company&#x2019;s tax provision was zero for the period presented. &lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="PAsOn12_31_2020"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;"&gt;Net Income (Loss) per Ordinary Shares &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary shares and Class&#160;B ordinary shares. Income and losses are shared pro rata between the two classes of ordinary shares. Net income (loss) per ordinary share is calculated by dividing the net income (loss) by the weighted average ordinary shares outstanding for the respective period.&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and the Private Placement to purchase an aggregate of 14,213,333 Class&#160;A ordinary share in the calculation of diluted income (loss) per ordinary share, because their exercise is contingent upon future events. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per share ordinary for the year ended December&#160;31, 2021 and for the period from July&#160;8, 2020 (inception) through the year ended December&#160;31, 2020. Accretion associated with the redeemable Class&#160;A ordinary shares is excluded from earnings per ordinary share as the redemption value approximates fair value. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per ordinary share for each class of ordinary shares: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:58%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For the Period From&lt;br/&gt; July&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8, 2020 (Inception)&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Through December&#160;31,&lt;br/&gt; 2020&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For&#160;the&#160;Year&#160;Ended&#160;December&#160;31,&lt;br/&gt; 2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;A&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;B&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;A&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;B&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Basic and diluted net loss per ordinary share:&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Numerator:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Allocation of net loss&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;(9,186,727&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;(2,352,938&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(32,821&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Denominator:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Basic and diluted weighted average ordinary shares outstanding&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;26,843,836&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,875,342&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,000,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Basic and diluted net loss per ordinary share&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.34&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.34&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.01&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">14213333</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table reflects presents a reconciliation of the numerator and denominator used to compute basic and diluted net income (loss) per ordinary share for each class of ordinary shares: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:58%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For the Period From&lt;br/&gt; July&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8, 2020 (Inception)&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; text-align: center; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Through December&#160;31,&lt;br/&gt; 2020&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;For&#160;the&#160;Year&#160;Ended&#160;December&#160;31,&lt;br/&gt; 2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;A&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;B&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;A&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Class&#160;B&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Basic and diluted net loss per ordinary share:&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Numerator:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Allocation of net loss&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;(9,186,727&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;(2,352,938&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(32,821&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Denominator:&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Basic and diluted weighted average ordinary shares outstanding&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;26,843,836&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,875,342&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;6,000,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Basic and diluted net loss per ordinary share&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.34&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.34&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(0.01&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">-9186727</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">-2352938</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P07_08_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">-32821</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">26843836</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">6875342</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P07_08_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">6000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="P01_01_2021To12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="P07_08_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD_per_Share">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="P07_08_2020To12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Recently Adopted Accounting Standards &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In August 2020, the FASB issued ASU &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;No.&#160;2020-06,&lt;/div&gt; &lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Debt-Debt with Conversion and Other Options (Subtopic &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;470-20)&lt;/div&gt; and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;815-40):&lt;/div&gt; Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/div&gt;&lt;/div&gt;, which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. The Company early adopted the ASU on January&#160;21, 2021 (inception). Adoption of the ASU did not impact the Company&#x2019;s financial position, results of operations or cash flows. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Recent Issued Accounting Standards &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying consolidated financial statements. &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <ses:InitialPublicOfferingTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 3&#x2014;Initial Public Offering &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;On January&#160;11, 2021, the Company consummated its Initial Public Offering of 27,600,000 Units, including 3,600,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of $276.0&#160;million, and incurring offering costs of approximately $15.8&#160;million, of which approximately $9.7&#160;million was for deferred underwriting commissions. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Each Unit consists of one Class&#160;A ordinary share and &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;one&lt;/div&gt;-third&lt;/div&gt; of one redeemable warrant (&#x201c;Public Warrant&#x201d;). Each whole Public Warrant will entitle the holder to purchase one Class&#160;A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7). &lt;/div&gt;</ses:InitialPublicOfferingTextBlock>
    <ses:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">27600000</ses:UnitsIssuedDuringPeriodSharesNewIssues>
    <ses:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="P01_11_2021To01_11_2021_OverAllotmentOptionMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">3600000</ses:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">10.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">276000000.0</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">15800000</us-gaap:PaymentsOfStockIssuanceCosts>
    <ses:DeferredUnderwritingCommissions
      contextRef="PAsOn01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">9700000</ses:DeferredUnderwritingCommissions>
    <ses:NumberOfSharesIssuedPerUnit
      contextRef="P01_01_2021To12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1</ses:NumberOfSharesIssuedPerUnit>
    <ses:NumberOfWarrantsIssuedPerUnit
      contextRef="P01_01_2021To12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1</ses:NumberOfWarrantsIssuedPerUnit>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="PAsOn12_31_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn01_11_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_IPOMemberusgaapSubsidiarySaleOfStockAxis_IvanhoeCapitalAcquisitionCorpMemberdeiLegalEntityAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ses:PrivatePlacementTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 4 &#x2013; Private Placement &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 5,013,333 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $7.5&#160;million.&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Each whole Private Placement Warrant is exercisable for one whole Class&#160;A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-redeemable&lt;/div&gt; for cash and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Sponsor and the Company&#x2019;s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination. &lt;/div&gt; </ses:PrivatePlacementTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">5013333</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <ses:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">1.50</ses:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <ses:ProceedsFromSaleOfUnits
      contextRef="P01_01_2021To12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="-5"
      unitRef="Unit_USD">7500000</ses:ProceedsFromSaleOfUnits>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="0"
      unitRef="Unit_shares">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 5 &#x2013; Related Party Transactions &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Founder Shares &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;On July&#160;22, 2020, the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 8,625,000 Class&#160;B ordinary shares (the &#x201c;Founder Shares&#x201d;). On December&#160;16, 2020, the Sponsor surrendered 2,875,000 Founder Shares to the Company for cancellation for no consideration. On January&#160;6, 2021, the Company effected a share capitalization of 1,150,000 shares, resulting in an aggregate of 6,900,000 Founder Shares outstanding. All shares and associated amounts have been retroactively restated to reflect the share surrender and share capitalization. The holders of the Founder Shares have agreed to forfeit up to an aggregate of 900,000 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional units was not exercised in full by the underwriters, so that the Founder Shares would represent 20% of the Company&#x2019;s issued and outstanding shares after the Initial Public Offering. On January&#160;11, 2021, the underwriter fully exercised its over-allotment option; thus, these Founder Shares are no longer subject to forfeiture. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (i)&#160;(v) with respect to 20% of such shares, until consummation of the initial Business Combination, (w)&#160;with respect to 20% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $12.00 for any 20 trading days within a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;30-trading&lt;/div&gt; day period following the consummation of the initial Business Combination (a &#x201c;Requisite Trading Period&#x201d;), (x) with respect to 20% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $14.00 for the Requisite Trading Period, (y)&#160;with respect to 20% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $16.00 for the Requisite Trading Period, and (z)&#160;with respect to the remaining 20% of such shares, until the closing price of Class&#160;A ordinary shares equals or exceeds $18.00 for the Requisite Trading Period, and (ii)&#160;the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the initial Business Combination that results in all of the shareholders having the right to exchange their Class&#160;A ordinary shares for cash, securities or other property; provided that in the event that the per share value of the cash, securities or other property to be received by the shareholders in such liquidation, merger, capital stock exchange or other similar transaction (the &#x201c;Per Share Transaction Value&#x201d;) is less than $18.00, then the Founder Shares will be released from these transfer restrictions to the Initial Shareholders on a pro rata basis as follows: (a)&#160;to the extent not previously released, all Founder Shares that are subject to release upon achievement of any share price performance requirements that are less than the Per Share Transaction Value will be released, and (b)&#160;the number of Founder Shares that would be released upon the achievement of the next share price performance requirement that is higher than the Per Share Transaction Value (the &#x201c;Release Threshold&#x201d;), multiplied by a fraction, the numerator of which equals (x) 2, minus (y)&#160;the amount by which the Release Threshold exceeds the Per Share Transaction Value, and the denominator of which equals 2, will be released. Any Founder Shares not released pursuant to the preceding sentence will be forfeited and cancelled. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Related Party Loans &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;On July&#160;22, 2020, the Sponsor agreed to loan the Company up to $600,000 pursuant to a promissory note (the &#x201c;Note&#x201d;), which was later amended on December&#160;1, 2020. The Note is &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;non-interest&lt;/div&gt; bearing, unsecured and due upon the closing of the Initial Public Offering. The Company borrowed $500,000 under the Note. On January&#160;15, 2021, the Company repaid the Note in full. Subsequent to the repayment, the facility was no longer available to the Company. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company&#x2019;s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lenders&#x2019; discretion, up to $1.5&#160;million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans.&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;On April&#160;9, 2021, the Company issued an unsecured convertible promissory note (the &#x201c;Convertible Note&#x201d;) to the Company&#x2019;s Chief Executive Officer, pursuant to which the Company may borrow up to $1,500,000 for ongoing expenses reasonably related to the business of the Company and the consummation of the Business Combination. The Convertible Note does not bear any interest. All unpaid principal under the Convertible Note will be due and payable in full on the earlier of (i)&#160;January&#160;11, 2023 and (ii)&#160;the effective date of the Business Combination (such earlier date, the &#x201c;Maturity Date&#x201d;). The Chief Executive Officer will have the option, at any time on or prior to the Maturity Date, to convert any amounts outstanding under the Convertible Note into warrants to purchase the Company&#x2019;s Class&#160;A ordinary shares, par value $0.0001 per share, at a conversion price of $1.50 per warrant, with each warrant entitling the holder to purchase one Class&#160;A ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to the private placement warrants sold concurrently with the Company&#x2019;s initial public offering. As of December&#160;31, 2021, $945,000 was drawn on the convertible note&#x2014;related party, presented at its fair value of approximately $1.2&#160;million on the accompanying consolidated balance sheets. Subsequently, the loan was repaid in full with cash at the closing of our business combination on February&#160;3, 2022. There were no amounts outstanding under the Convertible Note as of December&#160;31, 2020. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Administrative Support Agreement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Commencing on the date that the Company&#x2019;s securities were first listed on the NYSE through the earlier of consummation of the initial Business Combination and the liquidation, the Company agreed to pay the Sponsor $10,000 per month for office space, utilities, secretarial and administrative support services provided to members of the management team. Administrative expenses were included within general and administrative expenses&#x2014;related party in the consolidated statements of operations. For the year ended December&#160;31, 2021, the Company incurred $120,000 in administrative expenses. As of December&#160;31, 2021, $10,000 has been included in due to related party on the consolidated balance sheets. There were no administrative expenses incurred for the period from July&#160;8, 2020 (inception) through December&#160;31, 2020. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In addition, the Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;out-of-pocket&lt;/div&gt;&lt;/div&gt; expenses incurred in connection with activities on the Company&#x2019;s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company&#x2019;s audit committee will review on a quarterly basis all payments that were made to the Sponsor, officers or directors, or the Company&#x2019;s or their affiliates. Any such payments prior to an initial Business Combination will be made from funds held outside the Trust Account. As of December&#160;31, 2021, approximately $10,000 is included in due to related party on the accompanying consolidated balance sheets. There were no balances outstanding as of December&#160;31, 2020. &lt;/div&gt; </us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_shares">8625000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <ses:AggregateOfSponsorSharesSurrendered
      contextRef="P12_16_2020To12_16_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_shares">2875000</ses:AggregateOfSponsorSharesSurrendered>
    <us-gaap:CommonStockDividendsShares
      contextRef="P01_06_2021To01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_shares">1150000</us-gaap:CommonStockDividendsShares>
    <ses:AggregateNumberOfSharesOwned
      contextRef="PAsOn01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_shares">6900000</ses:AggregateNumberOfSharesOwned>
    <ses:NumberOfSharesSubjectToForfeiture
      contextRef="PAsOn01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_shares">900000</ses:NumberOfSharesSubjectToForfeiture>
    <ses:CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares
      contextRef="PAsOn01_06_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="2"
      unitRef="Unit_pure">0.20</ses:CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares>
    <ses:NumberOfSharesSubjectToForfeiture
      contextRef="PAsOn01_11_2021_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_shares">0</ses:NumberOfSharesSubjectToForfeiture>
    <ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination
      contextRef="P07_22_2020To07_22_2020_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="2"
      unitRef="Unit_pure">0.20</ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination>
    <ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination
      contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="2"
      unitRef="Unit_pure">0.20</ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination>
    <ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
      contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">12.00</ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger>
    <ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">P20D</ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays>
    <ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays contextRef="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis">P30D</ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays>
    <ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination
      contextRef="P07_22_2020To07_22_2020_CommonClassBMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis"
      decimals="2"
      unitRef="Unit_pure">0.20</ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination>
    <ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
      contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">14.00</ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger>
    <ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination
      contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis"
      decimals="2"
      unitRef="Unit_pure">0.20</ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination>
    <ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
      contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MinimumMembersrtRangeAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">16.00</ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger>
    <ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination
      contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis"
      decimals="2"
      unitRef="Unit_pure">0.20</ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination>
    <ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
      contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MaximumMembersrtRangeAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">18.00</ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger>
    <ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger
      contextRef="P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis_MinimumMembersrtRangeAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">18.00</ses:TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger>
    <ses:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis"
      decimals="0"
      unitRef="Unit_USD">600000</ses:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis"
      decimals="0"
      unitRef="Unit_USD">500000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <ses:MaximumLoansConvertibleIntoWarrants
      contextRef="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis"
      decimals="-5"
      unitRef="Unit_USD">1500000</ses:MaximumLoansConvertibleIntoWarrants>
    <ses:ClassOfWarrantOrRightPriceOfWarrantsOrRights
      contextRef="PAsOn07_22_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis_WorkingCapitalLoansWarrantMemberusgaapClassOfWarrantOrRightAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">1.50</ses:ClassOfWarrantOrRightPriceOfWarrantsOrRights>
    <ses:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="PAsOn04_09_2021_ChiefExecutiveOfficerMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">1500000</ses:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn04_09_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis"
      decimals="4"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <ses:ConverstionPricePerWarrants
      contextRef="P04_09_2021To04_09_2021_CommonClassAMemberusgaapStatementClassOfStockAxis_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">1.50</ses:ConverstionPricePerWarrants>
    <us-gaap:SharePrice
      contextRef="PAsOn04_09_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">11.50</us-gaap:SharePrice>
    <ses:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote
      contextRef="PAsOn12_31_2021_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis"
      decimals="0"
      unitRef="Unit_USD">945000</ses:MaximumBorrowingCapacityOfRelatedPartyPromissoryNote>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent
      contextRef="PAsOn12_31_2021_ConvertibleDebtMemberusgaapShortTermDebtTypeAxis"
      decimals="-5"
      unitRef="Unit_USD">1200000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="PAsOn12_31_2020_RelatedPartyLoansMemberusgaapRelatedPartyTransactionAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <ses:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth
      contextRef="P07_08_2020To12_31_2020_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis"
      decimals="0"
      unitRef="Unit_USD">10000</ses:RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="P01_01_2021To12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis"
      decimals="0"
      unitRef="Unit_USD">120000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:DueToRelatedPartiesCurrent
      contextRef="PAsOn12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis"
      decimals="0"
      unitRef="Unit_USD">10000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="P07_08_2020To12_31_2020_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="P01_01_2021To12_31_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis"
      decimals="0"
      unitRef="Unit_USD">10000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 6&#x2014;Commitments and Contingencies &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top: 6pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Registration Rights &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any Class&#160;A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the effective date of the Initial Public Offering. The holders of these securities were entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. &lt;/div&gt; &lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Underwriting Agreement &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company granted the underwriters a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;45-day&lt;/div&gt; option from the date of the Initial Public Offering prospectus to purchase up to 3,600,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On January&#160;11, 2021, the underwriter fully exercised its over-allotment option. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The underwriters were entitled to an underwriting discount of $0.20 per unit, or approximately $5.5&#160;million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $9.7&#160;million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. &lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ses:MaximumNumberOfDemandsForRegistrationOfSecurities
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_Day">3</ses:MaximumNumberOfDemandsForRegistrationOfSecurities>
    <ses:FairValueMeasurementOptionTerm contextRef="P07_08_2020To12_31_2020">P45D</ses:FairValueMeasurementOptionTerm>
    <ses:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="P07_08_2020To12_31_2020"
      decimals="0"
      unitRef="Unit_shares">3600000</ses:UnitsIssuedDuringPeriodSharesNewIssues>
    <ses:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="P01_11_2021To01_11_2021"
      decimals="0"
      unitRef="Unit_shares">3600000</ses:UnitsIssuedDuringPeriodSharesNewIssues>
    <ses:UnderwritingCashDiscountPerUnit
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.20</ses:UnderwritingCashDiscountPerUnit>
    <ses:UnderwriterCashDiscount
      contextRef="P01_01_2021To12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">5500000</ses:UnderwriterCashDiscount>
    <ses:DeferredFeePerUnit
      contextRef="PAsOn12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.35</ses:DeferredFeePerUnit>
    <ses:DeferredOfferingCostsNoncurrent
      contextRef="PAsOn12_31_2021"
      decimals="-5"
      unitRef="Unit_USD">9700000</ses:DeferredOfferingCostsNoncurrent>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 7&#x2014;Derivative Warrant Liabilities &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As of December&#160;31, 2021, the Company had 9,200,000 Public Warrants and 5,013,333 Private Warrants outstanding. There were no warrants outstanding as of December&#160;31, 2020.&lt;/div&gt; &lt;div style="margin-top: 0px; margin-bottom: 0px; font-size: 8pt;"&gt;&#160;&lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the Class&#160;A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class&#160;A ordinary shares is available throughout the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;30-day&lt;/div&gt; redemption period. &lt;/div&gt; &lt;div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Redemption of warrants when the price per Class&#160;A ordinary share equals or exceeds $10.00: &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Once the warrants become exercisable, the Company may redeem the outstanding warrants: &lt;/div&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;in whole and not in part; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;at $0.10 per warrant upon a minimum of 30 days&#x2019; prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of Class&#160;A ordinary shares to be determined by reference to an agreed table based on the redemption date and the &#x201c;fair market value&#x201d; of Class&#160;A ordinary shares; and &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:5%"&gt;&#160;&lt;/td&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left;"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-family: &amp;quot;Times New Roman&amp;quot;; font-size: 10pt; text-align: left; line-height: normal;"&gt;if, and only if, the closing price of Class&#160;A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within the &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;30-trading&lt;/div&gt; day period ending three trading days before the Company sends the notice of redemption to the warrant holders. &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The &#x201c;fair market value&#x201d; of Class&#160;A ordinary shares for the above purpose shall mean the volume-weighted average price of the Class&#160;A ordinary shares for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class&#160;A ordinary shares per warrant (subject to adjustment). &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company&#x2019;s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. &lt;/div&gt; </us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn12_31_2021_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">9200000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn12_31_2021_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="INF"
      unitRef="Unit_shares">5013333</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="PAsOn12_31_2020"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <ses:WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination contextRef="P01_01_2021To12_31_2021">P30D</ses:WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination>
    <ses:WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering contextRef="P01_01_2021To12_31_2021">P12D</ses:WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering>
    <ses:MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement contextRef="P01_01_2021To12_31_2021">P15D</ses:MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement>
    <ses:PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective contextRef="P01_01_2021To12_31_2021">P60D</ses:PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="PAsOn12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="PAsOn12_31_2021">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <ses:ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">9.20</ses:ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination>
    <ses:PercentageOfGrossProceedsOnTotalEquityProceeds
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">0.60</ses:PercentageOfGrossProceedsOnTotalEquityProceeds>
    <ses:ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice contextRef="P01_01_2021To12_31_2021">P10D</ses:ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice>
    <ses:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">1.15</ses:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice>
    <ses:ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1
      contextRef="P01_01_2021To12_31_2021"
      decimals="2"
      unitRef="Unit_pure">1.80</ses:ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1>
    <ses:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants contextRef="P01_01_2021To12_31_2021">P30D</ses:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <ses:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.01</ses:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <ses:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis">P30D</ses:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <ses:SharePricetriggerUsedToMeasureDilutionOfWarrant
      contextRef="PAsOn12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">18.00</ses:SharePricetriggerUsedToMeasureDilutionOfWarrant>
    <ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
      contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis"
      decimals="0"
      unitRef="Unit_Day">20</ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays
      contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis"
      decimals="0"
      unitRef="Unit_Day">30</ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <ses:RedemptionPeriod contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00MembersrtStatementScenarioAxis">P30D</ses:RedemptionPeriod>
    <ses:SharePricetriggerUsedToMeasureDilutionOfWarrant
      contextRef="PAsOn12_31_2021"
      decimals="2"
      unitRef="Unit_USD_per_Share">10.00</ses:SharePricetriggerUsedToMeasureDilutionOfWarrant>
    <ses:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
      contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">0.10</ses:ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights>
    <ses:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis">P30D</ses:ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants>
    <ses:SharePricetriggerUsedToMeasureDilutionOfWarrant
      contextRef="PAsOn12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis"
      decimals="2"
      unitRef="Unit_USD_per_Share">10.00</ses:SharePricetriggerUsedToMeasureDilutionOfWarrant>
    <ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays
      contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis"
      decimals="0"
      unitRef="Unit_Day">20</ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays>
    <ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays
      contextRef="P01_01_2021To12_31_2021_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00MembersrtStatementScenarioAxis"
      decimals="0"
      unitRef="Unit_Day">30</ses:ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays>
    <ses:CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_Day">10</ses:CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported>
    <ses:MultiplierUsedInCalculatingWarrantExercisePrice
      contextRef="PAsOn12_31_2021"
      decimals="3"
      unitRef="Unit_pure">0.361</ses:MultiplierUsedInCalculatingWarrantExercisePrice>
    <ses:TemporaryEquityDisclosureTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 8 &#x2013; Class&#160;A Ordinary Shares Subject to Possible Redemption&#160;&#160;&#160;&#160; &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company&#x2019;s Class&#160;A ordinary shares feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence of future events. The Company is authorized to issue 200,000,000 shares of Class&#160;A ordinary shares with a par value of $0.0001 per share. Holders of the Company&#x2019;s Class&#160;A ordinary shares are entitled to one vote for each ordinary share. As of December&#160;31, 2021, there were 27,600,000 shares of Class&#160;A ordinary shares outstanding, which were all subject to possible redemption and are classified outside of permanent equity in the consolidated balance sheet. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Class&#160;A ordinary shares subject to possible redemption reflected on the consolidated balance sheet is reconciled on the following table: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:82%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Gross proceeds from Initial Public Offering&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;276,000,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less:&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value of Public Warrants at issuance&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(14,628,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Offering costs allocated to Class&#160;A ordinary shares subject to possible redemption&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(14,971,596&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Plus:&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accretion on Class&#160;A ordinary shares subject to possible redemption amount&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;29,599,596&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Class&#160;A ordinary shares subject to possible redemption&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;276,000,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </ses:TemporaryEquityDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <ses:CommonStockNumberOfVotesPerShare
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_vote">1</ses:CommonStockNumberOfVotesPerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">27600000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Class&#160;A ordinary shares subject to possible redemption reflected on the consolidated balance sheet is reconciled on the following table: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:82%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Gross proceeds from Initial Public Offering&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;276,000,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Less:&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair value of Public Warrants at issuance&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(14,628,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Offering costs allocated to Class&#160;A ordinary shares subject to possible redemption&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(14,971,596&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Plus:&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Accretion on Class&#160;A ordinary shares subject to possible redemption amount&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;29,599,596&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Class&#160;A ordinary shares subject to possible redemption&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;276,000,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:TemporaryEquityTableTextBlock>
    <ses:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="P01_01_2021To12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">276000000</ses:ProceedsFromIssuanceOfTemporaryEquity>
    <ses:TemporaryEquityFairValueOfWarrantsAtIssuance
      contextRef="P01_01_2021To12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">-14628000</ses:TemporaryEquityFairValueOfWarrantsAtIssuance>
    <ses:TemporaryEquityIssuanceCosts
      contextRef="P01_01_2021To12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">-14971596</ses:TemporaryEquityIssuanceCosts>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="P01_01_2021To12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">29599596</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis"
      decimals="0"
      unitRef="Unit_USD">276000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 9&#x2014;Shareholders&#x2019; Equity (Deficit) &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Preference Shares-&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share. As of December&#160;31, 2021 and 2020, there were no preference shares issued or outstanding. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Class&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;A Ordinary Shares- &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;The Company is authorized to issue 200,000,000 Class&#160;A ordinary shares with a par value of $0.0001 per share. Holders of the Company&#x2019;s Class&#160;A ordinary shares are entitled to one vote for each share. At December&#160;31, 2021, there were 27,600,000 Class&#160;A ordinary shares issued and outstanding. All issued and outstanding Class&#160;A ordinary shares are subject to possible redemption and have been classified as temporary equity (See Note 8). As of December&#160;31, 2020, there were no Class&#160;A ordinary shares issued and outstanding. &lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Class&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;B Ordinary Shares-&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;The Company is authorized to issue 20,000,000 Class&#160;B ordinary shares with a par value of $0.0001 per share. As of December&#160;31, 2021 and 2020, there were 6,900,000 Class&#160;B ordinary shares issued and outstanding. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class&#160;A ordinary shares and holders of Class&#160;B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;In a vote to continue the company in jurisdiction outside the Cayman Islands (which required the approval of at least two thirds of the votes of all ordinary shares), holders of the Founder Shares will have &lt;span style="-sec-ix-hidden:hidden42197942"&gt;ten&lt;/span&gt; votes for every Founder Share and holders of the Class&#160;A ordinary shares will have one vote for every Class&#160;A ordinary share. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Class&#160;B ordinary shares will automatically convert into Class&#160;A ordinary shares at the time of the consummation of the initial Business Combination on a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-for-one&lt;/div&gt;&lt;/div&gt; basis, subject to adjustment for share &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;sub-divisions,&lt;/div&gt; share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class&#160;A ordinary shares or equity-linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class&#160;A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class&#160;A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class&#160;A ordinary shares by Public Shareholders), including the total number of Class&#160;A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class&#160;A ordinary shares or equity-linked securities exercisable for or convertible into Class&#160;A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of working capital loans; provided that such conversion of Founder Shares will never occur on a less than &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;one-for-one&lt;/div&gt;&lt;/div&gt; basis. &lt;/div&gt; </us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="PAsOn12_31_2020"
      decimals="INF"
      unitRef="Unit_shares">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2020"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="PAsOn12_31_2020"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2021"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="PAsOn12_31_2020"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <ses:CommonStockNumberOfVotesPerShare
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_vote">1</ses:CommonStockNumberOfVotesPerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">27600000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">27600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_USD_per_Share">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2021_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6900000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="PAsOn12_31_2020_CommonClassBMemberusgaapStatementClassOfStockAxis"
      decimals="INF"
      unitRef="Unit_shares">6900000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 9&#x2014;Fair Value Measurements &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table presents information about the Company&#x2019;s assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2021 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:73%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Description&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Quoted Prices in&lt;br/&gt; Active Markets&lt;br/&gt; (Level 1)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;br/&gt; (Level 2)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;br/&gt; (Level 3)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Assets:&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Investments held in Trust Account&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;276,057,966&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Derivative warrant liabilities - Public Warrants&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;16,100,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Derivative warrant liabilities - Private Placement Warrants&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;9,224,530&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Convertible note &#x2013; related party&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,152,680&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;  &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;As of December&#160;31, 2020, there were no assets or liabilities that are measured at fair value on a recurring basis. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level&#160;3 measurement to a Level&#160;1 fair value measurement in February 2021, when the Public Warrants were separately listed and traded. There were no other transfers to/from Levels 1, 2, and 3 during the year ended December&#160;31, 2021. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Level&#160;1 assets include investments in money market funds that invest solely in U.S. government securities. The Company uses inputs such as actual trade data, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The fair value of the Public Warrants as of December&#160;31, 2021 was measured utilizing the Level&#160;1 input of the observable listed trading price for such warrants. &lt;/div&gt; &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;Level&#160;3 instruments are comprised of derivative warrant liabilities measured at fair value using a Monte Carlo simulation and Black-Scholes Option Pricing Model. The estimated fair value of the Private Placement Warrants and the Public Warrants, prior to being separately listed and traded, was determined using Level&#160;3 inputs. The estimated fair value of warrants that may be issued upon conversion of the Convertible Note was determined using Level&#160;3 inputs. Inherent in a Monte Carlo simulation and Black-Scholes Option Pricing model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Black-Scholes analysis relies upon appropriate inputs derived from the Monte Carlo simulation of the public warrants; namely, the underlying stock price and the implied volatility from the traded Public Warrant price. The Company estimates the volatility of its ordinary shares warrants based on implied volatility from the Company&#x2019;s traded warrants and from historical volatility of select peer company&#x2019;s ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"&gt;zero-coupon&lt;/div&gt; yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. &lt;/div&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table provides quantitative information regarding Level&#160;3 fair value measurements inputs used in the valuation of the derivative warrant liabilities at their measurement dates: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:75%"/&gt;
&lt;td style="vertical-align:bottom;width:22%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&#160;of&#160;December&#160;31,&#160;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Option term (in years)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.09&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock price&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.95&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Volatility&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;24.2&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Risk-free interest rate&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.26&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividends&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The change in the fair value of the derivative warrant liabilities measured using Level&#160;3 inputs for the year ended December&#160;31, 2021 is summarized as follows: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:83%"/&gt;
&lt;td style="vertical-align:bottom;width:5%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Derivative warrant liabilities at January&#160;1, 2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of Public and Private Warrants&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;22,148,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Transfer of Public Warrants to Level&#160;1 measurement&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(14,628,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in fair value of derivative warrant liabilities&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,176,530&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Derivative warrant liabilities at December&#160;31, 2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,696,530&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table provides quantitative information regarding Level&#160;3 fair value measurements inputs used by the estimated fair value of warrants that may be issued upon conversion of the Convertible Note at their measurement dates: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:75%"/&gt;
&lt;td style="vertical-align:bottom;width:22%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&#160;of&#160;December&#160;31,&#160;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Option term (in years)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.09&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock price&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.84&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Volatility&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;72.1&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Risk-free interest rate&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.06&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividends&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The change in the fair value of the convertible note &#x2013; related party measured with Level&#160;3 inputs for year ended December&#160;31, 2021 is summarized as follows: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:85%"/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair Value at January&#160;1, 2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Initial fair value of convertible note - related party&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;944,694&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in fair value of convertible note - related party&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;207,986&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair Value of convertible note - related party, December&#160;31, 2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;1,152,680&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:73%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt; &lt;div style="line-height: 0pt;"&gt;&#160;&lt;/div&gt; &lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; font-size: 8pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Description&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Quoted Prices in&lt;br/&gt; Active Markets&lt;br/&gt; (Level 1)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Observable&lt;br/&gt; Inputs&lt;br/&gt; (Level 2)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Significant&lt;br/&gt; Other&lt;br/&gt; Unobservable&lt;br/&gt; Inputs&lt;br/&gt; (Level 3)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Assets:&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Investments held in Trust Account&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;276,057,966&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Liabilities:&lt;/div&gt;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Derivative warrant liabilities - Public Warrants&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;16,100,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Derivative warrant liabilities - Private Placement Warrants&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;9,224,530&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Convertible note &#x2013; related party&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1,152,680&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">276057966</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_USD">16100000</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis"
      decimals="0"
      unitRef="Unit_USD">9224530</us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent
      contextRef="PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent
      contextRef="PAsOn12_31_2021_FairValueInputsLevel2MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">1152680</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="PAsOn12_31_2020_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="PAsOn12_31_2020_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount>
    <us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount
      contextRef="PAsOn12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:FairValueAssetsLevel2ToLevel1TransfersAmount>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="P01_01_2021To12_31_2021"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table provides quantitative information regarding Level&#160;3 fair value measurements inputs used in the valuation of the derivative warrant liabilities at their measurement dates: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:75%"/&gt;
&lt;td style="vertical-align:bottom;width:22%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&#160;of&#160;December&#160;31,&#160;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Option term (in years)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;5.09&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock price&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;9.95&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Volatility&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;24.2&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Risk-free interest rate&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.26&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividends&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The change in the fair value of the derivative warrant liabilities measured using Level&#160;3 inputs for the year ended December&#160;31, 2021 is summarized as follows: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:83%"/&gt;
&lt;td style="vertical-align:bottom;width:5%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Derivative warrant liabilities at January&#160;1, 2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Issuance of Public and Private Warrants&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;22,148,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Transfer of Public Warrants to Level&#160;1 measurement&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;(14,628,000&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;)&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in fair value of derivative warrant liabilities&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;3,176,530&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Derivative warrant liabilities at December&#160;31, 2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;10,696,530&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The following table provides quantitative information regarding Level&#160;3 fair value measurements inputs used by the estimated fair value of warrants that may be issued upon conversion of the Convertible Note at their measurement dates: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:75%"/&gt;
&lt;td style="vertical-align:bottom;width:22%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;As&#160;of&#160;December&#160;31,&#160;2021&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.5pt;"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Option term (in years)&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.09&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Stock price&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;1.84&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Volatility&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;72.1&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Risk-free interest rate&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.06&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Expected dividends&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;0.00&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;%&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The change in the fair value of the convertible note &#x2013; related party measured with Level&#160;3 inputs for year ended December&#160;31, 2021 is summarized as follows: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:68%;border:0;margin:0 auto"&gt;
&lt;tr style="font-size: 0px;"&gt;
&lt;td style="width:85%"/&gt;
&lt;td style="vertical-align:bottom;width:4%"/&gt;
&lt;td/&gt;
&lt;td/&gt;
&lt;td/&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair Value at January&#160;1, 2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#x2014;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Initial fair value of convertible note - related party&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;944,694&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Change in fair value of convertible note - related party&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;207,986&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"&gt;
&lt;td style="vertical-align:top"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;; line-height: normal;"&gt;Fair Value of convertible note - related party, December&#160;31, 2021&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;$&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom;text-align:right;"&gt;&#160;1,152,680&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:bottom"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;
&lt;tr style="font-size:1px"&gt;
&lt;td style="vertical-align:bottom"/&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt; &lt;div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"&gt;&#160;&lt;/div&gt; &lt;/td&gt;
&lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt; </us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis"
      decimals="INF"
      unitRef="Unit_Y">5.09</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">9.95</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis"
      decimals="1"
      unitRef="Unit_pure">24.2</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">1.26</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.00</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="0"
      unitRef="Unit_USD">22148000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="0"
      unitRef="Unit_USD">-14628000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="0"
      unitRef="Unit_USD">3176530</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="0"
      unitRef="Unit_USD">10696530</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis"
      decimals="INF"
      unitRef="Unit_Y">0.09</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">1.84</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputPriceVolatilityMemberusgaapMeasurementInputTypeAxis"
      decimals="1"
      unitRef="Unit_pure">72.1</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputRiskFreeInterestRateMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.06</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedDividendRateMemberusgaapMeasurementInputTypeAxis"
      decimals="2"
      unitRef="Unit_pure">0.00</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent
      contextRef="PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="0"
      unitRef="Unit_USD">0</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <ses:FairValueOfConvertibleDebtWithRelatedParties
      contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="0"
      unitRef="Unit_USD">944694</ses:FairValueOfConvertibleDebtWithRelatedParties>
    <ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties
      contextRef="P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="0"
      unitRef="Unit_USD">207986</ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent
      contextRef="PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis"
      decimals="0"
      unitRef="Unit_USD">1152680</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:SubsequentEventsTextBlock contextRef="P01_01_2021To12_31_2021">&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &amp;quot;Times New Roman&amp;quot;;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note 10 - Subsequent Events &lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"&gt;The Company evaluated subsequent events and transactions that occurred up to the date consolidated financial statements were issued. Based on this evaluation, other than as noted in Note 1, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated financial statements. &lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>56
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M?TO1UJY-$[A_O%4?YP\/#S-GB@]%_!"%>G71ZK5(R!<LB_6=V/S!RP?J&KU
MQ"K_2S;%O;[?(D&FM$C*8'"01&GQG[V4B=@+Z#D' F@90-\$N(=:\,H KVF
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MG(5<FAO@]X40>GMB&MA]L[[\#U!+ P04    " !(BW]4UB4JFOL%  #Q%@
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M3GMC.C)Y*!BYV#O.^BZE%[@4.V;]QCO]QM;B_ARS99R D[B\0-M*_W.ZE$I
MN_C+4NS8:?'2L?J@21")"O;.E@DW(J+3,0\*"P='3C"081J,/+,3\!ZD8WL^
ME1RI')IL4N5.P81Z-ZJ)N_%R/$IZ]F\A%I-3+A(EMX-/(^*@_L>>UZE_ YT_
MHFY/Q>$6M+$=M1]SQ;<AA/9VRE>S1MQ!QCKZTZ-("]38CM2'>)FT&6ST6A>S
MQXZ'J7?LM2Z=-R*8]L F;L$=V]%]&]I3>G9AVQWI3P\ X1:XL1VY9SE MU"Q
M#ENF8W@Z=G>XB]P8(,D?]06O!6Y\)G*76<3%1H!#*O1.TUCJ0=?LG"XX0PNQ
MY%(+S]B.SW/H!VNFYV*T84*P,Q+* -F  *Y'^Y1IL1B/STCL4_N/#8UJ3#&A
M[G%*=REM*4U:0"=V0)_I:#6S ,LB!!FFH\BSL$=GNSQ][KJ6!0OY[0 .5I*+
M-1],D E3?H"@0YO;#D&PM5$N5DSP59Y TLJ?$&1Q',;*-@R3O?G:#OXP>4)-
M@/<XDGH7Z,0?G"M(;JP+%*U94O*/"%_ &_W7$"%6JE4NXG]Y]!'J.N,("D@#
MC8X(G#ZE@H5YUKDCW1;1D[RD;0_$WAZF413K8R9DL)ZC+V$^#%D10T8; ]EM
M#J1_FB%M;R#VW@!H6Z9EC6Y1'22C [IH?^EB[ 9!<#QWF4@I'$KZJJAM#.2<
ML5\>Y)5-Y6Z#J%5V.@<D$VG0KW';28B]D]0:'XZ,"8S<:(J>!.0:$^]H42?G
MHES^S4.EAZKG'(!=-Y\O/.)I45]%0(X:*\IHN?$881R2#:2V*9FT;8O8VU;'
MSKH(;?7?]B R^L'0TG848N\H5G4;[W:[1(^W:-L@Z(D&T7A+-PJ(]D+EX;?]
ME&@SP7:;T&(SM6/S_S_$T!:DJ1VDMR;EAQY%LK6JV":ZV)EG1'(27/@-E.LZ
MN'0NM\+,"(Z80A^PEH,*+FI:..G"V1<M>*%XNH2WU*GOBRKF.0^;M\TUT 7H
M) M>70 FQHF/=EN"/JM;!G:Z=]USXKZG\MW=4?'8PM+B/75_;.W0%I^I'9_/
MJ)U&POY5E#]VCC#I!%&MW7#O/E)?!O_&Q%N<293P5^!RK@(0(NK[U?I!Y45U
M1;G,E<K3:KGB#-R@">#WUQQ&_>9!WWKN;KDG_P%02P,$%     @ 2(M_5.X*
M:47# P  21   !@   !X;"]W;W)K<VAE971S+W-H965T,RYX;6RMF%%SFS@0
MQ[^*AKF'=B87$'9LIV-[QK%]T\ZTB2?D>L\*R$870%02<=M/WQ40,#'(.*T?
M; EV5[^5M/I'F>ZY>)(AI0I]CZ-$SJQ0J?2#;4L_I#&1ESRE";S9<A$3!5VQ
MLV4J* ERISBR7<<9V3%AB36?YL\V8C[EF8I80C<"R2R.B?AQ0R.^GUG8>GEP
MSW:AT@_L^30E.^I1]6^Z$="SJR@!BVDB&4^0H-N9M< ?EF[ND%M\970O#]I(
MI_+(^9/N? IFEJ.):$1]I4,0^'FF2QI%.A)P?"N#6M68VO&P_1+]GSQY2.:1
M2+KDT7\L4.',FE@HH%N21>J>[S_2,J$K'<_GD<R_T;ZP'8TMY&=2\;AT!H*8
M)<4O^5Y.Q($#'G8XN*6#V]=A4#H,\D0+LCRM%5%D/A5\CX2VAFBZD<]-[@W9
ML$0OHZ<$O&7@I^;+N]O5^M9;KQ"TO+O/GU:+!^C<+#XO;I=KY'U<KQ\\]&Y#
M!$U42!7S2?0>_8W^0C:2(3R54UL!AXYF^^68-\68;L>8*^I?H@&^0*[CXA;W
M97]WI^EN0_;5%+C5%+AYO&%'O UL'"H$#1#,MO]T@5(BT#.),GJ!WJ54%'F^
M;\NS"#S) ^N">9X[EX[C0%+/A_F<-&MP#RKNP7G<Q7H@DJF0"_:3!FW(1<S1
M 0MV\L\KYM-V#>AA!3U\$S23,FL''AZ!O$8U630@KRK(JS=!PC$H%4D"ENS:
M2*].DIHL&J2CBG1D)LV$'\(IAE+!?-BO>KMF"5-M>$6D<6-%VT<?5Z./C:,O
M(R(E6J ECV,XDCT]6<C+'O^',QHICNYI0.-4']>&,IU4@TV,@SU *"Y :A#]
MEC'UXYPZG?2KTY-F#?#K"ORZ)_BZ!/>*[71GWD[71YO%'8_:2O78L&-=L5.K
M@G/F9)^LTS)B#]X6RR[@ QG#?ZP0RE =E5 R&FV:D+708+/2O-3+G8 UUY/;
MIJ#-V+488+,:'-;@!0*]1EQ CR@XQ;[J(D$;F))\Y[7.R:!?B9RV:_+7NH#-
MPE#RGR-E^/C@=QVG5<UZF3;):[' 9K5H)3?4R;$(=-5);[G M5Y@LV"TPI[0
MM3)D'^)CRR[B6F-P'Y&Y>54TIIJI%06;)>5W:Z:GK)RV:_+7PH+-RO*6FFE1
ME8Z2Z6'9_'N[5A?7K"YG5HQ[K!>CZS;D'H9-XEI>7+.\O*5LRI ]L$\;%MCV
MP3U/7[*_$+%CB401W8*G<SF& T,4]]:BHWB:7_T>N8*+9-X,X:Y/A3: ]UO.
MU4M'WR:K_Q[,?P%02P,$%     @ 2(M_5(1CW7H@!   < X  !@   !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6RU5UN/VC@4_BL6VH=6*I,X(1<J!HE;=T?:
MN6B@[4.U#R8Q8-6Q6=O ]-_O<9))Z)"DL]WM"['-N7SGZN/12:JO>D>I04\9
M%_JZMS-F_]YQ=+*C&=%7<D\%_+.1*B,&MFKKZ+VB),V9,NYXKALZ&6&B-Q[E
M9P]J/)('PYF@#PKI0Y81]6U*N3Q=]W#O^>"1;7?&'CCCT9YLZ9*:C_L'!3NG
MDI*RC K-I$"*;JY[$_Q^AH>6(:?XQ.A)GZV1-64MY5>[N4FO>ZY%1#E-C!5!
MX'.D,\JYE00X_BZ%]BJ=EO%\_2S]0VX\&+,FFLXD_\Q2L[ONQ3V4T@TY</,H
M3W_0TJ# RDLDU_DO.A6T 1 G!VUD5C(#@HR)XDN>2D><,8"<9@:O9/!>,H0M
M#'[)X.>&%LARL^;$D/%(R1-2EAJDV47NFYP;K&'"AG%I%/S+@,^,9_=W\\7=
M<C%'L%K>_WDSGZQ@LUS!YW9QMUJB^P_H_F'Q.%G=  'JHX_+.7KSV]N18T"]
M%>(DI:IIH<IK416B6RG,3J.%2&G:P#_KYL=>AP '[*Z,]YZ-GWJ=$N<TN4(^
M?H<\UW.; +V>'7? \:M8^+F\08N\WZF@BG!$1(I("L%FVBABTQS1)ZA;3763
MUPNA42[45NUQ['NQ!70\-^62*O+\V(V\BNX[S(,*\^"_8H:<49030U.T)\I\
M:W)TH20\0X>A$;EN,[B@ A=T@EM) ]"@Y5E$8MOIQ> "0;_)C0UDD1^T^S&L
MH(8YI]\"]4Z*&N>-2&1&T9M%@?<M^C)96[<FYJ^.-(LJ55&G5TKI&R4SQ,21
M:@-MV6BTHSR% [12T';0)$GD09BF8$47/@BB81@V.R"N4,6=J&8[(K;4ZM\0
MIM"1\ -%<@,M6;%CD5 GHA01!G%&UHPSPYHC&5_ <U\$\9*B[^,H#/R6?!M6
M-@Q_RH9$@IN586M.D9"&OJ(BIL,?6G%)T??<:!BW! *[]97@=IIQO]F TR$/
M$ZF-+=]_'X-20Q?\!I)^' 3NP&_!?W:EX4[\=S#]L+*$N-2Z^:["%PVQL>";
MZ# .?$CXH 6H5P/UNO-%9AF,,C-.M$83].669FNJNFH<UW<)]G]U0\'U)8"[
M;P'K<>MI!!J1WA%%W]GABB7YO9 R?C M-WXA=WCN7??*'[1XMF[\N+OS?\['
M-YKV"10>C*,%*(U@D-4&,(%37HOPLN-[83SP8[^MSNJ6C\/7AW_ZJO#7/1Y'
MOSS\=>O&W;W[9\,_+>6^"+][48.-9*U94K=KW-VO_[<LF>++9ARZ[G<33&E*
M V$<!?[@Y?S@G,WT&57;_*FC47XI%^-]=5H]IR;Y(\*IR8NWV"U16R8TXG0#
MK.Y5!"FMBN=-L3%RG[\0UM+ >R-?[N!)2)4E@/\W$BZM<F,55(_,\3]02P,$
M%     @ 2(M_5/OG#NI !   ]@\  !@   !X;"]W;W)K<VAE971S+W-H965T
M-2YX;6R]5VMOVS84_2N$,: )L$2BGG;A&' D>7'7.&GD;!B*?: E.N9"B2Y)
MQ^V_'R4KLJV7DQ48$,2D=,_EX>'1)3G<,OXL5AA+\#VAJ;CJK:1<?]0T$:UP
M@L0E6^-4O5DRGB"INOQ)$VN.49R#$JH9NNYH"2)I;S3,G]WST9!M)"4ION=
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M!BVDN.=@(EH]HE=?%%SP\C6ZV3%)-2_OT+E9^EQSIM ?YRNE)>3"GQX TP;
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M2\GH?$4F>6R^^D.&)LH(<LI2K*3<#17IV.RAM FM;<XQRJ/IY$;D?G1NS[J
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M=!$W[KQ U+HQ'3O5V3(\5U\-FALMEX Q5I)&[[9BU0-S*[JJ+0=IQ]Y:L39
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MK_G/E=&P1AJ ]XL:1AA^T ;=YZ5O_@502P,$%     @ 2(M_5/F8>B?5%
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M]/L9;R"IQZ/L:&>'[A8VA@B;&.6OJ'80XT#5J47%W(3)90&1P2#'J5UK*J(
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M)BAJ!Z!XH>A)#1N78)S)J]]02P,$%     @ 2(M_5&+F*1*$ P  " @  !D
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MCY#P6="K#RT+T/G.T"W7+=C!\(Y<_0=02P,$%     @ 2(M_5.9^F?Q-!0
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M50F=@5'D ><Y= G*1\Y:U_LF"Y3AMA-:T1]& >2:K -3=!'RI8+727O?JM1
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M#L_'99J:_\'3V_-9N(TRGC=CS:'CT?MW&;@TS].";!MG:&F)6Q4_:WX"T04
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MQ($7-'F,#<0$DMH"8N->GD)99YH0)TJ7'/DUPB($8A?[2\^.A&TLG<Q]'\>
M<2,U\=G(ME$AR==8JNX/[O(2XV[9?T/QIJI-.S_H N0K<G!WV?,9\)SOB.A
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MY!F\@6<9X&N#<&';3I@GP+W0O2"4W/NS'XY^PD@@)XP7L4T]4",(;%7USG%
MWP%9MB%(!D#%'E8K&6&U,L)42FCPQ(8V\@9T",K['N4"-MRO$KCYJ5'^((.S
MG(!EI NY># \&!MXRL!8T4E,>% OE0P.H"0G4/43!./S0J+NP?9:0B/VR!/[
MT*M0@I _N8^#.K".:;[2UO=!I8EY_EG3 O[6 ^E1T[?H=G&T/=-Z0V/_S];Y
M]C@?A^:W^WCU7 NW4_SI-=8<FBW>GR;@QG$>-V2[.$);2SR0<=GP#8@N./!Y
M;?F[39N08+Y3RU]02P,$%     @ 2(M_5',!7Q<*%@  :D8  !D   !X;"]W
M;W)K<VAE971S+W-H965T,3@N>&ULM3QK<]NVEM_S*SC>.SOV#"U+\K-YS3AN
MTJ;3VWCJ]';V(T1"$FXH@B5 R^JOW_, 0)"BZ"2[]T-3220.#L[[!;_>ZOJ+
M64MIDZ=-49HW1VMKJY=G9R9;RXTP$UW)$IXL=;T1%K[6JS-3U5+DM&A3G,VG
MTZNSC5#ET=O7]-M]_?:U;FRA2GE?)Z;9;$2]>R<+O7US-#OR/_RN5FN+/YR]
M?5V)E7R0]H_JOH9O9P%*KC:R-$J722V7;XYN9R_?S:YQ ;WQ+R6W)OJ<X%$6
M6G_!+Q_S-T=3Q$@6,K,(0L#_'N6=+ J$!'C\Y8 >A3UQ8?S90_] AX?#+(21
M=[KX4^5V_>;HYBC)Y5(TA?U=;W^6[D"7""_3A:%_DRV_>_G#49(UQNJ-6PP8
M;%3)_Q=/CA#1@IOI@05SMV!.>/-&A.6/PHJWKVN]36I\&Z#A!SHJK0;D5(E<
M>; U/%6PSKY]8&XD>ID\J%6IEBH3I4UNLTPWI57E*KG7A<J4-,FQ_W3R^LS"
MU@C@+'/;O.-MY@>VF<V3?^K2KDWROLQEW@5P!C@'Q.<>\7?S48@_RFR2G,_2
M9#Z=ST;@G0="G!.\BP/PW@FC#)+AOI9&EE:@T P==!0,*M%+4XE,OCFJ$%#]
M*(^&82>?UQ*$,M.;2I0[I'2F2P,DSH65>;)4I2@S)8K$P/L2%,&:9"T>9;*0
MLDP >"5J>$^5!*3.X6T)PF/7]-TQKZH5 *D*8-]*EK(61;'#Y[*RO-8"$G^4
M"K\]X#Z$YNU&UB 'R?%__]?-?#Y]]=/M[3U]G+TZ2429)U53FP;EQ&J"4#>X
M SZIY:HIZ'P$B<!/'B;)@\R:6EGE7GO_E*U%N8)O=WJS48:4W&_W\/[.[S9)
M1EA[$5A[,<K:/XQ$7-X;JS9XQ"&NCD(8YFH?+#&4^<(,AH?/LQ1X "^A>55V
MQ_Q#<@,A_VH4[$4DO&,A0:K,KE\9,  EF$P$@!S8B"\RD0$-I*\P8&8K9H-=
M"YN(Y1+L(#-+5KI&?,0&Q83X!.]+RTL+)1:J:%F5*Y,5VC2U= ="P<*=#ZWA
M7?#(7@*>I<($#(YMX"<X,)A3 RN: K<&K.MD6>L-P-$F.N4D^6@31;L54A@+
M*X71I5B ?%<:Y&E12#XY(N"7>80D4P,/CLCE"BF5)D8!$LPZ<%R27LA4G34;
M0!74R]%2/BE#]/N.DZ;)=JVR=<Q!7*-RZ909)8$T"+17 24\ZJFC">N-5]U2
MBCJQLMXD>2-1%G0I$?F-!G8M&XM<0_%2(%X 4#XRM3^5 6-ZTT2F/[(>K4R!
M%2F:/)@,\Q4G1>X0>23B!R]XG< ?ET+5R:,HFH#'5M0U;A^)$EB-!DC58K$1
M.[!^$$$L_DW"K#TUA.%S@(VID:2JY'@%=UQ(,+$HEX]"%0+%@A2$;"8<$N3%
MDB$^+'\1=>#M86D<,5.7P4Q=CIJI.V'6A!M]> _J#P1"2@[9JU%0P_;J('PR
M7,[$!&D$@A7 SC68BE,2,%4^PGF9M>QF4$W4"CA; &<LFO<=<[.6*%?D[D$6
MP37 BC4ZK:8&AAD0&& =,#)#1&2+R*2#R5KD2:GW7D)FPR[@_^5F =SQ,0 =
M#3Y,D[4$WD$$BN?PXO6YAEC*AS6C[+H*[+H:9Y<&BU#:UM;?@08KF_RNS)<A
MCHU".\"QD2V2#T'G5&ELW3!GR$!5VL(71<X^*$M$652<&#01-&/8-<(F(3!L
M_TAJF&[DK42D[;@SV$RVGF384K**$+>#I4-UE4^91'[#[A]DC@$(< X,M+(:
MHLZ/)?@5"ESN= U>B0^:Z4=X$=2Z4. 4$8E_S"^GZ70Z!3_Q#//3SD%!V$"$
MT&)7$-%(V A\%7@'#'.\(0MG0Q"165[(0H&][#A@M&D.GG9B')M.I!U!-FBW
M/.!1:;L.TG8]*FT?T&#^BPSF/\'3@5W?'#(-HX"&!>T ].1#:Z;AY)#L # ,
M+H@F$%MFSL=NR5PN,+;()&19.;JQQ(#"DH\M.59 8U )Q0]!]$J#UI6<L+?Z
MNY1$#"T+" O:9GQ-9,Z2VRW&OI"P? %H$&=9R$> +S9$'9L6>_++$PZFP'"!
MY5>0)L&;;*!.P</4L1]:PW<!]FGG732<3V/(^K>3 5568%.2QK ;Y*W03;9
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M7' GN2'U.83A<>NX#KU"*N[\=(Q\C5W0_<YY5+=")U_KPB=TKBR-G=J6+A'
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M]>41%Q[]%V 1_3&1A;96;^CC6@J(&? %>+[4VOHON$'X\S)O_Q=02P,$%
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M\&X2!987S+'9Q.@M&.]-:'X12@W11$XH?RDK9^A44)R;G4MF+<SAQF1"T:W
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M90?0^U123G7'+M!\!)W]!5!+ P04    " !(BW]46JIC%*P&  !O'   &0
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MN?F;4@+MGKX!KJ\X:*4]T&^$MN\8+_X%4$L#!!0    ( $B+?U3CO<ME.0,
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MBT.*?]SB' G:&>#[C5+V:>$.:"?3V7]02P,$%     @ 2(M_5&T3"6W5 P
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M]-:U-C_<[7[]=-5?-F>:GCB@%<V8TH>X^_!+SB2S!^H5%UF?.2"U'Q+O=>>
MU)Y'NCWOFW;.91FLW]9)&L>]KUC?&<2[^SCF2M]S%'K(K*Y])*T=COBO+&GM
M7J2/>_7:4LFU<;6?%MW&O</<$C]0<62I1#$<--(;!-IT1''Q*AJ*9_8JLN=*
M7VSLXTE?5D&8#OK[@7/UW#"WF^KZN_@74$L#!!0    ( $B+?U0CH'3'T@(
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M"^#WA1#Z_L1\XRJ_RT[^!5!+ P04    " !(BW]4'_0%L;<$  #/%0  &0
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M'K2;@,\SI>R^XTZ'YM_#_"]02P,$%     @ 2(M_5+NCFUA7!@  \AL  !D
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MQX1 ('7&)(ID8,L#^??H;WEL%0HWZ,KBNV.KH!J\7BCHU2D8#5AOU&]04)T
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MAN,/KXV$:CM5.T%9N<N^E&A:AQOFIKF#L@"SGTF)VXGM'_WG(OX+4$L#!!0
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M7.*E$91=@/-S*<U+Q]YCRFOHY"]02P,$%     @ 2(M_5$)/@)[J @  = <
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M5]:ME+>^;J%F6M3'+QC'KR\?_@-02P,$%     @ 2(M_5+>]PDN! 0  *1<
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M2=8/K9=__9^X79-:E<W!GW4_XV=?4$L! A0#%     @ 2(M_5 =!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " !(BW]4>*N+P>T    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " !(BW]4F5R<(Q &  "<)P  $P
M        @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( $B+
M?U1,\9T_P@8  +\>   8              " @0P(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " !(BW]4UB4JFOL%  #Q%@  &
M        @($$#P  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%
M  @ 2(M_5.X*:47# P  21   !@              ("!-14  'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( $B+?U2$8]UZ( 0  ' .   8
M              " @2X9  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M% ,4    " !(BW]4^^<.ZD $  #V#P  &               @(&$'0  >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ 2(M_5"--J.'F!@
M.1P  !@              ("!^B$  'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;%!+ 0(4 Q0    ( $B+?U1LKBTD%A,  &HZ   8              " @18I
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !(BW]4^9AZ
M)]44  #'/0  &               @(%B/   >&PO=V]R:W-H965T<R]S:&5E
M=#@N>&UL4$L! A0#%     @ 2(M_5,MBFZ^A @  GP4  !@
M ("!;5$  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( $B+
M?U1BYBD2A ,   @(   9              " @414  !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL4$L! A0#%     @ 2(M_5 M&Z4_2"0  *1H  !D
M         ("!_U<  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M    " !(BW]4YH?K75,$  !3"@  &0              @($(8@  >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( $B+?U3F?IG\304  )T,
M   9              " @9)F  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
M4$L! A0#%     @ 2(M_5+PHE8*: P  ]0@  !D              ("!%FP
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !(BW]47Z*/
M S\#  !@!P  &0              @('G;P  >&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;%!+ 0(4 Q0    ( $B+?U3"M";92@<  &@5   9
M  " @5US  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @
M2(M_5(-KD$9X @  7P4  !D              ("!WGH  'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6Q02P$"% ,4    " !(BW]4<P%?%PH6  !J1@  &0
M            @(&-?0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4
M Q0    ( $B+?U0=UW*$%P,  +X&   9              " @<Z3  !X;"]W
M;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ 2(M_5*GBL;3" @
M@ 8  !D              ("!')<  'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6Q02P$"% ,4    " !(BW]4OI*G%JP$   0#0  &0              @($5
MF@  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( $B+?U1:
MJF,4K 8  &\<   9              " @?B>  !X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L! A0#%     @ 2(M_5..]RV4Y P  K@@  !D
M     ("!VZ4  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $B+?U0?] 6QMP0  ,\5   9              "
M@2FY  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ 2(M_
M5-@ 1$OR @  20@  !D              ("!%[X  'AL+W=O<FMS:&5E=',O
M<VAE970R.2YX;6Q02P$"% ,4    " !(BW]4NZ.;6%<&  #R&P  &0
M        @(% P0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0
M   ( $B+?U0]I]"&U0,  -8,   9              " @<['  !X;"]W;W)K
M<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ 2(M_5  V'\I' @  .@8
M !D              ("!VLL  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q0
M2P$"% ,4    " !(BW]4]X*@@#P#  ")#   &0              @(%8S@
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( $B+?U2"8:$<
M. 0  ",7   9              " @<O1  !X;"]W;W)K<VAE971S+W-H965T
M,S0N>&UL4$L! A0#%     @ 2(M_5$!./&6_ @  4 @  !D
M ("!.M8  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !(
MBW]4YG_7+$@#  "2#@  &0              @($PV0  >&PO=V]R:W-H965T
M<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( $B+?U1"3X">Z@(  '0'   9
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !(BW]4M[W"2X$!   I%P
M&@              @ %&ZP  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " !(BW]48]:*%)L!  "4%P  $P              @ '_[
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     +@ N 'D,  #+[@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>101</ContextCount>
  <ElementCount>233</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>33</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>1001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007 - Disclosure - Description of Organization and Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations</Role>
      <ShortName>Description of Organization and Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1009 - Disclosure - Initial Public Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering</Role>
      <ShortName>Initial Public Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>1010 - Disclosure - Private Placement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement</Role>
      <ShortName>Private Placement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>1011 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>1012 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>1013 - Disclosure - Derivative Warrant Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities</Role>
      <ShortName>Derivative Warrant Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>1014 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption</Role>
      <ShortName>Class A Ordinary Shares Subject to Possible Redemption</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>1015 - Disclosure - Shareholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit</Role>
      <ShortName>Shareholders' Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>1016 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>1017 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>1018 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>1019 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>1020 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables</Role>
      <ShortName>Class A Ordinary Shares Subject to Possible Redemption (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>1021 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>1022 - Disclosure - Description of Organization and Business Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails</Role>
      <ShortName>Description of Organization and Business Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>1023 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>1024 - Disclosure - Summary of Significant Accounting Policies - Net income (loss) per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Net income (loss) per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>1025 - Disclosure - Initial Public Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails</Role>
      <ShortName>Initial Public Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>1026 - Disclosure - Private Placement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails</Role>
      <ShortName>Private Placement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>1027 - Disclosure - Related Party Transactions - Founder Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails</Role>
      <ShortName>Related Party Transactions - Founder Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>1028 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>1029 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>1030 - Disclosure - Derivative Warrant Liabilities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails</Role>
      <ShortName>Derivative Warrant Liabilities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>1031 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails</Role>
      <ShortName>Class A Ordinary Shares Subject to Possible Redemption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>1032 - Disclosure - Shareholders' Equity (Deficit) - Preferred Stock Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails</Role>
      <ShortName>Shareholders' Equity (Deficit) - Preferred Stock Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>1033 - Disclosure - Shareholders' Equity (Deficit) - Common stock  (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails</Role>
      <ShortName>Shareholders' Equity (Deficit) - Common stock  (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>1034 - Disclosure - Fair Value Measurements - Company's financial assets and liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Company's financial assets and liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>1035 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>1036 - Disclosure - Fair Value Measurements - Level 3 Fair Value Measurements Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails</Role>
      <ShortName>Fair Value Measurements - Level 3 Fair Value Measurements Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>1037 - Disclosure - Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="d251271d10k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>1038 - Disclosure - Fair Value Measurements - Change in the Fair Value of the Convertible note - related party (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails</Role>
      <ShortName>Fair Value Measurements - Change in the Fair Value of the Convertible note - related party (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="d251271d10k.htm">d251271d10k.htm</File>
    <File>d251271dex311.htm</File>
    <File>d251271dex312.htm</File>
    <File>d251271dex321.htm</File>
    <File>d251271dex322.htm</File>
    <File>d251271dex42.htm</File>
    <File>ses-20211231.xsd</File>
    <File>ses-20211231_cal.xml</File>
    <File>ses-20211231_def.xml</File>
    <File>ses-20211231_lab.xml</File>
    <File>ses-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g251271g11x83.jpg</File>
    <File>g251271g41v83.jpg</File>
    <File>g251271g49h79.jpg</File>
    <File>g251271g68u75.jpg</File>
    <File>g251271g84e14.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="291">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>62
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d251271d10k.htm": {
   "axisCustom": 0,
   "axisStandard": 13,
   "contextCount": 101,
   "dts": {
    "calculationLink": {
     "local": [
      "ses-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ses-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d251271d10k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ses-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ses-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ses-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 374,
   "entityCount": 1,
   "hidden": {
    "http://www.ivanhoecapitalacquisition.com/20211231": 1,
    "http://xbrl.sec.gov/dei/2021q4": 8,
    "total": 9
   },
   "keyCustom": 78,
   "keyStandard": 155,
   "memberCustom": 11,
   "memberStandard": 22,
   "nsprefix": "ses",
   "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "1001 - Document - Cover Page",
     "role": "http://www.ivanhoecapitalacquisition.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ses:PrivatePlacementTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1010 - Disclosure - Private Placement",
     "role": "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement",
     "shortName": "Private Placement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ses:PrivatePlacementTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1011 - Disclosure - Related Party Transactions",
     "role": "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1012 - Disclosure - Commitments and Contingencies",
     "role": "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1013 - Disclosure - Derivative Warrant Liabilities",
     "role": "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities",
     "shortName": "Derivative Warrant Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ses:TemporaryEquityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1014 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption",
     "role": "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption",
     "shortName": "Class A Ordinary Shares Subject to Possible Redemption",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ses:TemporaryEquityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1015 - Disclosure - Shareholders' Equity (Deficit)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit",
     "shortName": "Shareholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1016 - Disclosure - Fair Value Measurements",
     "role": "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1017 - Disclosure - Subsequent Events",
     "role": "http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1018 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1019 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ses:TemporaryEquityDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1020 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Tables)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables",
     "shortName": "Class A Ordinary Shares Subject to Possible Redemption (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ses:TemporaryEquityDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1021 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_11_2021To01_11_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ses:UnitsIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1022 - Disclosure - Description of Organization and Business Operations (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
     "shortName": "Description of Organization and Business Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": "0",
      "lang": null,
      "name": "ses:ConditionForFutureBusinessCombinationUseOfProceedsPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashFDICInsuredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1023 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashFDICInsuredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P07_08_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1024 - Disclosure - Summary of Significant Accounting Policies - Net income (loss) per share (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails",
     "shortName": "Summary of Significant Accounting Policies - Net income (loss) per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P07_08_2020To12_31_2020_CommonClassAMemberusgaapStatementClassOfStockAxis",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_11_2021To01_11_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ses:UnitsIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1025 - Disclosure - Initial Public Offering (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
     "shortName": "Initial Public Offering (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ses:InitialPublicOfferingTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_11_2021To01_11_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1026 - Disclosure - Private Placement (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails",
     "shortName": "Private Placement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ses:PrivatePlacementTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021_PrivatePlacementMemberusgaapSubsidiarySaleOfStockAxis",
      "decimals": "-5",
      "lang": null,
      "name": "ses:ProceedsFromSaleOfUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P07_08_2020To12_31_2020",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1027 - Disclosure - Related Party Transactions - Founder Shares (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails",
     "shortName": "Related Party Transactions - Founder Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P07_22_2020To07_22_2020_CommonClassAMemberusgaapStatementClassOfStockAxis_FounderSharesMemberusgaapRelatedPartyTransactionAxis",
      "decimals": "2",
      "lang": null,
      "name": "ses:PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_pure",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2020",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1028 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn04_09_2021",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ses:MaximumNumberOfDemandsForRegistrationOfSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Day",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1029 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ses:MaximumNumberOfDemandsForRegistrationOfSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Day",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD_per_Share",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2020",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1030 - Disclosure - Derivative Warrant Liabilities - Additional Information (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
     "shortName": "Derivative Warrant Liabilities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2020",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1031 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
     "shortName": "Class A Ordinary Shares Subject to Possible Redemption (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ses:TemporaryEquityDisclosureTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021_CommonClassaSubjectToRedemptionMemberusgaapStatementClassOfStockAxis",
      "decimals": "0",
      "lang": null,
      "name": "ses:ProceedsFromIssuanceOfTemporaryEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1032 - Disclosure - Shareholders' Equity (Deficit) - Preferred Stock Shares (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails",
     "shortName": "Shareholders' Equity (Deficit) - Preferred Stock Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021_CommonClassAMemberusgaapStatementClassOfStockAxis",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "Unit_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1033 - Disclosure - Shareholders' Equity (Deficit) - Common stock  (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails",
     "shortName": "Shareholders' Equity (Deficit) - Common stock  (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1034 - Disclosure - Fair Value Measurements - Company's financial assets and liabilities (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails",
     "shortName": "Fair Value Measurements - Company's financial assets and liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021_FairValueInputsLevel1MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1035 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Y",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1036 - Disclosure - Fair Value Measurements - Level 3 Fair Value Measurements Inputs (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
     "shortName": "Fair Value Measurements - Level 3 Fair Value Measurements Inputs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputExpectedTermMemberusgaapMeasurementInputTypeAxis",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_Y",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1037 - Disclosure - Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails",
     "shortName": "Fair Value Measurements - Change in the Fair Value of the Warrant Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn12_31_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P07_08_2020To12_31_2020",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ses:FairValueAdjustmentOfConvertibleDebtWithRelatedParties",
      "reportCount": 1,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1038 - Disclosure - Fair Value Measurements - Change in the Fair Value of the Convertible note - related party (Details)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails",
     "shortName": "Fair Value Measurements - Change in the Fair Value of the Convertible note - related party (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis",
      "decimals": "0",
      "lang": null,
      "name": "ses:FairValueOfConvertibleDebtWithRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P07_08_2020To12_31_2020",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P07_08_2020To12_31_2020",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn07_07_2020",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)",
     "role": "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "PAsOn07_07_2020",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P07_08_2020To12_31_2020",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS",
     "role": "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P07_08_2020To12_31_2020",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Unit_USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1007 - Disclosure - Description of Organization and Business Operations",
     "role": "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations",
     "shortName": "Description of Organization and Business Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1008 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ses:InitialPublicOfferingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "1009 - Disclosure - Initial Public Offering",
     "role": "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering",
     "shortName": "Initial Public Offering",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d251271d10k.htm",
      "contextRef": "P01_01_2021To12_31_2021",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ses:InitialPublicOfferingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 33,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r384",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption",
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables",
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies",
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities",
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption",
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables",
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies",
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities",
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ses_AdministrativeSupportAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Administrative Support Agreement.",
        "label": "Administrative Support Agreement"
       }
      }
     },
     "localname": "AdministrativeSupportAgreementMember",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_AggregateNumberOfSharesOwned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares owned by the founders after the impact of the stock dividend.",
        "label": "Aggregate Number Of Shares Owned",
        "terseLabel": "Aggregate number of shares owned"
       }
      }
     },
     "localname": "AggregateNumberOfSharesOwned",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ses_AggregateOfSponsorSharesSurrendered": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of common stock shares subject aggregate of sponsor surrendered.",
        "label": "Aggregate Of Sponsor Shares Surrendered",
        "terseLabel": "Number of shares surrender"
       }
      }
     },
     "localname": "AggregateOfSponsorSharesSurrendered",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ses_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of adjustment of exercise price of warrants based on market value and newly issued price.",
        "label": "Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Market Value And Newly Issued Price",
        "terseLabel": "Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ses_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of adjustment of redemption price of stock based on market value and newly issued price.",
        "label": "Class of Warrant or Right, Adjustment of Redemption Price of Warrants or Rights, Percent, Based On Market Value And Newly Issued Price 1",
        "terseLabel": "Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ses_ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum threshold period during which a written notice is required for redemption of warrants, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Class Of Warrant Or Right, Minimum Threshold Written Notice Period For Redemption Of Warrants",
        "terseLabel": "Minimum threshold written notice period for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightMinimumThresholdWrittenNoticePeriodForRedemptionOfWarrants",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ses_ClassOfWarrantOrRightPriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Price of Warrants or Rights",
        "terseLabel": "Price of warrant",
        "verboseLabel": "Price of warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightPriceOfWarrantsOrRights",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified consecutive trading days for stock price trigger considered for redemption of warrants.",
        "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ses_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days for stock price trigger considered for redemption of warrants.",
        "label": "Class Of Warrant Or Right, Redemption Of Warrants Or Rights, , Threshold Trading Days",
        "terseLabel": "Threshold trading days for redemption of public warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ses_ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption price per share or per unit of warrants or rights outstanding.",
        "label": "Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights",
        "terseLabel": "Redemption price per public warrant (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ses_CommonClassaSubjectToRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation that is subject to redemption.",
        "label": "Class A Common Stock Subject to Redemption",
        "terseLabel": "Class A Common Stock Subject to Redemption"
       }
      }
     },
     "localname": "CommonClassaSubjectToRedemptionMember",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_CommonStockNumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of votes that each common share is entitled.",
        "label": "Common Stock, Number Of Votes Per Share",
        "terseLabel": "Common Stock, Number Of Votes Per Share"
       }
      }
     },
     "localname": "CommonStockNumberOfVotesPerShare",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ses_CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of the company that are subject to forfeiture represented as a percentage of issued and outstanding stock as a result of partial exercise of over-allotment option.",
        "label": "Common Stock Shares Subject To Forfeiture AsPercent Of Issued And Outstanding Shares",
        "terseLabel": "Common stock, shares subject to forfeiture, as a percent of issued and outstanding shares (as a percent)"
       }
      }
     },
     "localname": "CommonStockSharesSubjectToForfeitureAspercentOfIssuedAndOutstandingShares",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ses_CommonStockSubjectToPossibleRedemptionValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of common stock subject to possible redemption.",
        "label": "Common Stock Subject To Possible Redemption, Value",
        "negatedLabel": "Accretion of Class A ordinary shares subject to redemption"
       }
      }
     },
     "localname": "CommonStockSubjectToPossibleRedemptionValue",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of trading days on which fair market value of shares is reported.",
        "label": "Common Stock, Trading Days On Which Fair Market Value Of Shares Is Reported",
        "terseLabel": "Number of trading days on which fair market value of shares is reported"
       }
      }
     },
     "localname": "CommonStockTradingDaysOnWhichFairMarketValueOfSharesIsReported",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ses_Commonstocksubjecttopossibleredemptionpolicytextblock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the accounting policy on common stock subject to possible redemption.",
        "label": "CommonStockSubjectToPossibleRedemptionPolicyTextBlock",
        "terseLabel": "Class A Ordinary Shares Subject to Possible Redemption"
       }
      }
     },
     "localname": "Commonstocksubjecttopossibleredemptionpolicytextblock",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ses_ConditionForFutureBusinessCombinationThresholdNetTangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The threshold net tangible assets which the reporting entity must maintain in order to proceed with a business combination utilizing the proceeds of the offering.",
        "label": "Condition for future business combination threshold Net Tangible Assets"
       }
      }
     },
     "localname": "ConditionForFutureBusinessCombinationThresholdNetTangibleAssets",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_ConditionForFutureBusinessCombinationThresholdPercentageOwnership": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The threshold percentage of voting interest to be acquired in a future business combination as specified for the use of proceeds from the offering.",
        "label": "Condition for future business combination threshold Percentage Ownership"
       }
      }
     },
     "localname": "ConditionForFutureBusinessCombinationThresholdPercentageOwnership",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ses_ConditionForFutureBusinessCombinationUseOfProceedsPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The threshold percentage of the assets held in the trust account funded by proceeds from the offering which must be used for purposes of consummating a business combination.",
        "label": "Condition for future business combination use of proceeds percentage"
       }
      }
     },
     "localname": "ConditionForFutureBusinessCombinationUseOfProceedsPercentage",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ses_ConverstionPricePerWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This elements represents conversion price per warrants.",
        "label": "Converstion Price Per Warrants",
        "terseLabel": "Conversion price"
       }
      }
     },
     "localname": "ConverstionPricePerWarrants",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ses_DeferredFeePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the deferred fee per unit.",
        "label": "Deferred Fee Per Unit",
        "terseLabel": "Deferred fee per unit"
       }
      }
     },
     "localname": "DeferredFeePerUnit",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ses_DeferredOfferingCostsIncludedInAccountsPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred offering costs included in accounts payable in noncash investing and financing activities.",
        "label": "Deferred Offering Costs included in Accounts Payable",
        "terseLabel": "Deferred offering costs included in accounts payable"
       }
      }
     },
     "localname": "DeferredOfferingCostsIncludedInAccountsPayable",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_DeferredOfferingCostsNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of balance sheet date of underwriting fees payable or deferred, classified as noncurrent.",
        "label": "Deferred underwriting fee payable",
        "terseLabel": "Deferred underwriting commissions",
        "verboseLabel": "Deferred underwriting fee payable"
       }
      }
     },
     "localname": "DeferredOfferingCostsNoncurrent",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_DeferredOfferingCostsPaidBySponsorUnderPromissoryNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred offering costs paid by Sponsor under promissory note in noncash investing and financing activities.",
        "label": "Deferred Offering Costs Paid by Sponsor Under Promissory Note",
        "terseLabel": "Deferred offering costs paid by Sponsor under promissory note"
       }
      }
     },
     "localname": "DeferredOfferingCostsPaidBySponsorUnderPromissoryNote",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_DeferredUnderwritingCommissions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized fee revenue received from underwriting that is deferred.",
        "label": "Deferred Underwriting Commissions",
        "terseLabel": "Deferred underwriting commissions"
       }
      }
     },
     "localname": "DeferredUnderwritingCommissions",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_DeferredUnderwritingFeePayableNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 15.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of balance sheet date of underwriting fee payable deferred, classified as noncurrent.",
        "label": "Deferred Underwriting Fee Payable, Noncurrent",
        "terseLabel": "Deferred underwriting commissions"
       }
      }
     },
     "localname": "DeferredUnderwritingFeePayableNoncurrent",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_Derivativewarrantliabilitiespolicytextblock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "DerivativeWarrantLiabilitiesPolicyTextBlock",
        "terseLabel": "Derivative Warrant Liabilities"
       }
      }
     },
     "localname": "Derivativewarrantliabilitiespolicytextblock",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ses_EmergingGrowthCompanyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the accounting policy on Emerging Growth Company.",
        "label": "Emerging Growth Company [Policy Text Block]",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ses_FairValueAdjustmentOfConvertibleDebtWithRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of Convertible debt with related parties.",
        "label": "Fair Value Adjustment Of Convertible Debt With Related Parties",
        "negatedLabel": "Change in fair value of convertible note - related party",
        "terseLabel": "Change in fair value of convertible note \u2013 related party",
        "verboseLabel": "Change in fair value of convertible note - related party"
       }
      }
     },
     "localname": "FairValueAdjustmentOfConvertibleDebtWithRelatedParties",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_FairValueMeasurementOptionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The term of fair value measurement option",
        "label": "Fair Value Measurement Option Term",
        "verboseLabel": "Granted the underwriters"
       }
      }
     },
     "localname": "FairValueMeasurementOptionTerm",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ses_FairValueOfConvertibleDebtWithRelatedParties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of fair value of Convertible debt with related parties.",
        "label": "Fair Value Of Convertible Debt With Related Parties",
        "terseLabel": "Initial fair value of convertible note - related party"
       }
      }
     },
     "localname": "FairValueOfConvertibleDebtWithRelatedParties",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_FounderSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represents Founder shares.",
        "label": "Founder Shares"
       }
      }
     },
     "localname": "FounderSharesMember",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares": {
     "auth_ref": [],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and adminstartive expenses paid by sponsor in exchange for issuance of class B ordinary shares.",
        "label": "General And Adminstartive Expenses Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares",
        "verboseLabel": "General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares"
       }
      }
     },
     "localname": "GeneralAndAdminstartiveExpensesPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_IncreaseDecreaseInAccruedExpensesRealtedParties": {
     "auth_ref": [],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease in accrued expenses realted parties",
        "label": "Increase Decrease in accrued expenses realted parties",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedExpensesRealtedParties",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_InitialPublicOfferingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Initial Public Offering."
       }
      }
     },
     "localname": "InitialPublicOfferingAbstract",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "xbrltype": "stringItemType"
    },
    "ses_InitialPublicOfferingTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure on information about initial public offering.",
        "label": "Initial Public Offering [Text Block]",
        "terseLabel": "Initial Public Offering"
       }
      }
     },
     "localname": "InitialPublicOfferingTextBlock",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ses_InvestmentClassAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment class.",
        "label": "Investment Class [Axis]"
       }
      }
     },
     "localname": "InvestmentClassAxis",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ses_InvestmentClassDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment class.",
        "label": "Investment Class [Domain]"
       }
      }
     },
     "localname": "InvestmentClassDomain",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_IvanhoeCapitalAcquisitionCorpMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ivanhoe Capital Acquisition Corp [Member]",
        "label": "Ivanhoe Capital Acquisition Corp [Member]",
        "terseLabel": "Ivanhoe Capital Acquisition Corp [Member]"
       }
      }
     },
     "localname": "IvanhoeCapitalAcquisitionCorpMember",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_LeasesArrangementTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases arrangement type.",
        "label": "Leases Arrangement Type [Axis]"
       }
      }
     },
     "localname": "LeasesArrangementTypeAxis",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ses_LeasesArrangementTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases arrangement type.",
        "label": "Leases Arrangement Type [Domain]"
       }
      }
     },
     "localname": "LeasesArrangementTypeDomain",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_MaximumAllowedDissolutionExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount permitted to be paid for dissolution expenses if a business combination is not completed within the specified period.",
        "label": "Maximum Allowed Dissolution Expenses"
       }
      }
     },
     "localname": "MaximumAllowedDissolutionExpenses",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of maximum borrowing capacity of related party was drawn under the Working Capital Loan.",
        "label": "Maximum Borrowing Capacity Of Related Party Drawn Under Working Capital",
        "terseLabel": "Maximum borrowing capacity of working capital loan"
       }
      }
     },
     "localname": "MaximumBorrowingCapacityOfRelatedPartyDrawnUnderWorkingCapital",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of maximum borrowing capacity of related party promissory note.",
        "label": "Maximum Borrowing Capacity of Related Party Promissory Note",
        "terseLabel": "Maximum borrowing capacity of related party promissory note"
       }
      }
     },
     "localname": "MaximumBorrowingCapacityOfRelatedPartyPromissoryNote",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_MaximumLoansConvertibleIntoWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount which a potential loan could have repaid through issuance of warrants.",
        "label": "maximum Loans Convertible Into Warrants",
        "terseLabel": "Loan conversion agreement warrant"
       }
      }
     },
     "localname": "MaximumLoansConvertibleIntoWarrants",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_MaximumNumberOfDemandsForRegistrationOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum number of demands for registration of securities.",
        "label": "Maximum Number Of Demands For Registration Of Securities",
        "terseLabel": "Maximum number of demands for registration of securities"
       }
      }
     },
     "localname": "MaximumNumberOfDemandsForRegistrationOfSecurities",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ses_MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after completion of a business combination in which the reporting entity is required to file a registration statement with the SEC.",
        "label": "Maximum Period After Business Combination In Which To File Registration Statement",
        "terseLabel": "Maximum period after business combination in which to file registration statement"
       }
      }
     },
     "localname": "MaximumPeriodAfterBusinessCombinationInWhichToFileRegistrationStatement",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ses_Monthstocompleteacquisition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the anticipated business timeline in months for completing a business combination.",
        "label": "Months to complete acquisition"
       }
      }
     },
     "localname": "Monthstocompleteacquisition",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "positiveIntegerItemType"
    },
    "ses_MultiplierUsedInCalculatingWarrantExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Multiplier used in calculating warrant exercise price.",
        "label": "Multiplier Used In Calculating Warrant Exercise Price",
        "terseLabel": "Multiplier used in calculating warrant exercise price"
       }
      }
     },
     "localname": "MultiplierUsedInCalculatingWarrantExercisePrice",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ses_NumberOfSharesIssuedPerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of shares in a unit.",
        "label": "Number of Shares Issued Per Unit",
        "terseLabel": "Number of shares in a unit"
       }
      }
     },
     "localname": "NumberOfSharesIssuedPerUnit",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ses_NumberOfSharesSubjectToForfeiture": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares owned by the founders subject to forfeiture if the underwriter overallotment option is not exercised in the proposed public offering.",
        "label": "Number Of Shares Subject To Forfeiture",
        "terseLabel": "Shares subject to forfeiture"
       }
      }
     },
     "localname": "NumberOfSharesSubjectToForfeiture",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ses_NumberOfWarrantsIssuedPerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of warrants in a unit.",
        "label": "Number of Warrants Issued Per Unit",
        "terseLabel": "Number of warrants in a unit"
       }
      }
     },
     "localname": "NumberOfWarrantsIssuedPerUnit",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ses_OfferingCostsIncludedInAccountsPayableAccruedExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of offering costs included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.",
        "label": "OfferingCostsIncludedInAccountsPayableAccruedExpenses",
        "terseLabel": "Offering costs included in accrued expenses"
       }
      }
     },
     "localname": "OfferingCostsIncludedInAccountsPayableAccruedExpenses",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_OfferingCostsPaid": {
     "auth_ref": [],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering costs paid.",
        "label": "Offering Costs Paid",
        "negatedLabel": "Offering Costs Paid"
       }
      }
     },
     "localname": "OfferingCostsPaid",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_OfferingCostsWarrantsIssuance": {
     "auth_ref": [],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of offering costs incurred during issuance of warrants.",
        "label": "Offering Costs Warrants Issuance",
        "negatedLabel": "Offering costs - derivative warrant liabilities",
        "terseLabel": "Offering costs - derivative warrant liabilities"
       }
      }
     },
     "localname": "OfferingCostsWarrantsIssuance",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_Offeringcostsassociatedwithinitialpublicofferingpolicytextblock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the accounting policy on offering costs associated with initial public offering.",
        "label": "OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock",
        "terseLabel": "Offering Costs Associated with the Initial Public Offering"
       }
      }
     },
     "localname": "Offeringcostsassociatedwithinitialpublicofferingpolicytextblock",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ses_OperatingBankAccounts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating bank accounts.",
        "label": "Operating Bank Accounts",
        "terseLabel": "Operating bank accounts"
       }
      }
     },
     "localname": "OperatingBankAccounts",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_PaymentsForInvestmentOfCashInTrustAccount": {
     "auth_ref": [],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash outflow for investment of cash in trust account.",
        "label": "Payments for investment of cash in Trust Account",
        "negatedLabel": "Cash deposited in Trust Account"
       }
      }
     },
     "localname": "PaymentsForInvestmentOfCashInTrustAccount",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of shares which the reporting entity is obligated to redeem if a business combination is not consummated using the offering proceeds within a specified period.",
        "label": "Percentage Obligation To Redeem Public Shares If Entity Does Not Complete A Business Combination",
        "terseLabel": "Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)"
       }
      }
     },
     "localname": "PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ses_PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of assign or sell any shares or warrants after completion of initial business combination.",
        "label": "Percentage Of Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination",
        "terseLabel": "Percentage of assign or sale of shares or warrants, after the completion of the initial business combination"
       }
      }
     },
     "localname": "PercentageOfAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombination",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ses_PercentageOfGrossProceedsOnTotalEquityProceeds": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of gross proceeds on total equity proceeds.",
        "label": "Percentage Of Gross Proceeds On Total Equity Proceeds",
        "terseLabel": "Percentage of gross proceeds on total equity proceeds"
       }
      }
     },
     "localname": "PercentageOfGrossProceedsOnTotalEquityProceeds",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ses_PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The period of time after filing within which the registration statement filed with the SEC is expected to become effective.",
        "label": "Period Of Time Within Which Registration Statement Is Expected To Become Effective",
        "terseLabel": "Period of time within which registration statement is expected to become effective"
       }
      }
     },
     "localname": "PeriodOfTimeWithinWhichRegistrationStatementIsExpectedToBecomeEffective",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ses_PrivatePlacementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "Private Placement."
       }
      }
     },
     "localname": "PrivatePlacementAbstract",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "xbrltype": "stringItemType"
    },
    "ses_PrivatePlacementTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure on information about private placement.",
        "label": "Private Placement [Text Block]",
        "terseLabel": "Private Placement"
       }
      }
     },
     "localname": "PrivatePlacementTextBlock",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ses_PrivatePlacementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a redeemable warrant (Private Placement Warrant) that entitles the holder to purchase shares of common stock if the underwriter's option is exercised in full.",
        "label": "Private Placement Warrants"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsMember",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_ProceedsFromIssuanceOfTemporaryEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of temporary equity.",
        "label": "Proceeds from Issuance of Temporary Equity",
        "terseLabel": "Gross proceeds from Initial Public Offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfTemporaryEquity",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_ProceedsFromSaleOfUnits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents Proceeds from Sale of Units.",
        "label": "Proceeds From Sale Of Units",
        "terseLabel": "Proceeds from sale of warrants"
       }
      }
     },
     "localname": "ProceedsFromSaleOfUnits",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_ProceedsReceivedFromInitialPublicOfferingGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds received from initial public offering, gross",
        "label": "Proceeds received from initial public offering, gross",
        "terseLabel": "Proceeds received from Initial Public Offering, gross"
       }
      }
     },
     "localname": "ProceedsReceivedFromInitialPublicOfferingGross",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_ProceedsReceivedFromNotePayableToRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds received from note payable to related party.",
        "label": "Proceeds Received From Note Payable To Related Party"
       }
      }
     },
     "localname": "ProceedsReceivedFromNotePayableToRelatedParty",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_PublicWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents a redeemable warrant (Public Warrant) that entitles the holder to purchase shares of common stock subject to adjustment.",
        "label": "Public Warrants"
       }
      }
     },
     "localname": "PublicWarrantsMember",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_RedemptionLimitPercentageWithoutPriorConsent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The limit on the percentage of shares which may be redeemed with out prior consent of the reporting entity.",
        "label": "Redemption Limit Percentage Without Prior Consent",
        "terseLabel": "Redemption limit percentage without prior consent"
       }
      }
     },
     "localname": "RedemptionLimitPercentageWithoutPriorConsent",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $10.00.",
        "label": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00"
       }
      }
     },
     "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds10.00Member",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the scenario, where redemption of warrants when the price per share of class a common stock equals or exceeds $18.00.",
        "label": "Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00"
       }
      }
     },
     "localname": "RedemptionOfWarrantsWhenPricePerShareOfClassCommonStockEqualsOrExceeds18.00Member",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_RedemptionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redemption period.",
        "label": "Redemption Period",
        "terseLabel": "Redemption period"
       }
      }
     },
     "localname": "RedemptionPeriod",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ses_RelatedPartyLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for related party loans.",
        "label": "Related Party Loans [Member]"
       }
      }
     },
     "localname": "RelatedPartyLoansMember",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The contractual monthly amount to be paid for support services.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party Per Month",
        "terseLabel": "Expenses per month"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_SaleOfStockOtherOfferingCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of other offering costs incurred.",
        "label": "Sale of Stock, Other Offering Costs",
        "terseLabel": "Other offering costs"
       }
      }
     },
     "localname": "SaleOfStockOtherOfferingCosts",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_SharePricetriggerUsedToMeasureDilutionOfWarrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cutoff price used to measure whether dilution of the warrant has occurred. Shares issued below this price will cause the exercise price of the warrant to be adjusted.",
        "label": "Share PriceTrigger Used To Measure Dilution Of Warrant",
        "terseLabel": "Share price trigger used to measure dilution of warrant"
       }
      }
     },
     "localname": "SharePricetriggerUsedToMeasureDilutionOfWarrant",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ses_SponsorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for sponsor.",
        "label": "Sponsor"
       }
      }
     },
     "localname": "SponsorMember",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ses_TemporaryEquityDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for temporary equity.",
        "label": "Temporary Equity Disclosure [Text Block]",
        "terseLabel": "Class A Ordinary Shares Subject to Possible Redemption"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureTextBlock",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ses_TemporaryEquityFairValueOfWarrantsAtIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fair value of warrants at issuance.",
        "label": "Temporary Equity , Fair Value of Warrants At Issuance",
        "terseLabel": "Fair value of Public Warrants at issuance"
       }
      }
     },
     "localname": "TemporaryEquityFairValueOfWarrantsAtIssuance",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_TemporaryEquityIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuance costs related to temporary equity.",
        "label": "Temporary Equity, Issuance Costs",
        "terseLabel": "Offering costs allocated to Class A ordinary shares subject to possible redemption"
       }
      }
     },
     "localname": "TemporaryEquityIssuanceCosts",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to threshold issue price for capital raising purposes in connection with the closure of a business combination.",
        "label": "Threshold Issue Price For Capital Raising Purposes In Connection With Closing Of Business Combination",
        "terseLabel": "Threshold issue price per share"
       }
      }
     },
     "localname": "ThresholdIssuePriceForCapitalRaisingPurposesInConnectionWithClosingOfBusinessCombination",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ses_ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The threshold number of specified trading period determining volume weighted average trading price , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Threshold Number Of Specified Trading Days Determining Volume Weighted Average Trading Price",
        "terseLabel": "Threshold trading days determining volume weighted average price"
       }
      }
     },
     "localname": "ThresholdNumberOfSpecifiedTradingDaysDeterminingVolumeWeightedAverageTradingPrice",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The share price threshold that must be achieved in order to waive the restriction on transfer of shares during a restricted period after a business combination.",
        "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Stock Price Trigger",
        "terseLabel": "Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share)"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationStockPriceTrigger",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of consecutive trading days used to observe the share price.",
        "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdConsecutiveTradingDays",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ses_TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "When determining the condition for transfer of shares without restriction after a business combination, the number of days in which the share price must exceed the specified amount.",
        "label": "Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination, Threshold Trading Days",
        "terseLabel": "Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination"
       }
      }
     },
     "localname": "TransferAssignOrSellAnySharesOrWarrantsAfterCompletionOfInitialBusinessCombinationThresholdTradingDays",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ses_UnderwriterCashDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the cash underwriting discount per unit.",
        "label": "Underwriter cash discount",
        "terseLabel": "Underwriter cash discount"
       }
      }
     },
     "localname": "UnderwriterCashDiscount",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_UnderwritingCashDiscountPerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the cash underwriting discount per unit.",
        "label": "Underwriting cash discount per unit",
        "terseLabel": "Underwriting cash discount per unit"
       }
      }
     },
     "localname": "UnderwritingCashDiscountPerUnit",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ses_Underwritingcommissiondeferred": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of deferred underwriter commission during a noncash or partial noncash transaction.",
        "label": "UnderwritingCommissionDeferred",
        "terseLabel": "Deferred underwriting commissions"
       }
      }
     },
     "localname": "Underwritingcommissiondeferred",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_UnitsIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new units issued during the period.",
        "label": "Units Issued During Period, Shares, New Issues",
        "verboseLabel": "Numbers of units issued"
       }
      }
     },
     "localname": "UnitsIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ses_WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The warrants exercisable term from the closing of the public offering, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Warrants And Rights Outstanding Exercisable Term From Closing Of Public Offering",
        "terseLabel": "Public Warrants exercisable term from the closing of the initial public offering"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingExercisableTermFromClosingOfPublicOffering",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ses_WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The warrants exercisable term after the completion of a business combination, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Warrants And Rights Outstanding Exercisable Term After Business Combination",
        "terseLabel": "Public Warrants exercisable term after the completion of a business combination"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingExercisabletErmAfterBusinessCombination",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ses_WorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of working capital.",
        "label": "Working Capital",
        "terseLabel": "Working capital"
       }
      }
     },
     "localname": "WorkingCapital",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ses_WorkingCapitalLoansWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Working capital loans warrant.",
        "label": "Working capital loans warrant"
       }
      }
     },
     "localname": "WorkingCapitalLoansWarrantMember",
     "nsuri": "http://www.ivanhoecapitalacquisition.com/20211231",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r161",
      "r182",
      "r219",
      "r222",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r340",
      "r342",
      "r379",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r161",
      "r182",
      "r219",
      "r222",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r340",
      "r342",
      "r379",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r161",
      "r182",
      "r208",
      "r219",
      "r222",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r340",
      "r342",
      "r379",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r161",
      "r182",
      "r208",
      "r219",
      "r222",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r340",
      "r342",
      "r379",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r1",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r75",
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r82",
      "r95",
      "r127",
      "r128",
      "r227",
      "r238",
      "r255",
      "r256",
      "r257",
      "r258",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r1",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r75",
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r82",
      "r95",
      "r127",
      "r128",
      "r227",
      "r238",
      "r255",
      "r256",
      "r257",
      "r258",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r76",
      "r82",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r120",
      "r121",
      "r206",
      "r207",
      "r341",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r120",
      "r121",
      "r206",
      "r207",
      "r341",
      "r368",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r76",
      "r82",
      "r142",
      "r220",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 13.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due after one year (or beyond the operating cycle if longer), including liabilities for compensation costs, fringe benefits other than pension and postretirement obligations, rent, contractual rights and obligations, and statutory obligations.",
        "label": "Accounts Payable and Accrued Liabilities, Noncurrent",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r24",
      "r293"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 11.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r16",
      "r227",
      "r293"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r67",
      "r68",
      "r69",
      "r224",
      "r225",
      "r226",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Anti-dilutive securities attributable to warrants (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r64",
      "r112",
      "r114",
      "r118",
      "r125",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r156",
      "r157",
      "r243",
      "r248",
      "r274",
      "r291",
      "r293",
      "r324",
      "r333"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r7",
      "r35",
      "r64",
      "r125",
      "r145",
      "r146",
      "r147",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r156",
      "r157",
      "r243",
      "r248",
      "r274",
      "r291",
      "r293"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 17.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "verboseLabel": "Fair value assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 20.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.",
        "label": "Assets Held-in-trust, Noncurrent",
        "verboseLabel": "Investments held in Trust Account"
       }
      }
     },
     "localname": "AssetsHeldInTrustNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r218",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r218",
      "r221",
      "r239",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r21",
      "r57"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 18.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r52",
      "r57",
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash - end of the period",
        "periodStartLabel": "Cash - beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r52",
      "r275"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFDICInsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, FDIC Insured Amount",
        "verboseLabel": "Cash that is insured with federal insurance"
       }
      }
     },
     "localname": "CashFDICInsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of noncash financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r62",
      "r64",
      "r85",
      "r86",
      "r87",
      "r90",
      "r92",
      "r98",
      "r99",
      "r100",
      "r125",
      "r145",
      "r150",
      "r151",
      "r152",
      "r156",
      "r157",
      "r180",
      "r181",
      "r185",
      "r189",
      "r274",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r204",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrants",
        "verboseLabel": "Exercise price of warrant"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Number of shares issuable per warrant",
        "verboseLabel": "Number of shares per warrant"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Number of warrants to purchase shares issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r204",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r32",
      "r141",
      "r326",
      "r336"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r143",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Class A Ordinary shares"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Class B Ordinary share"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockDividendsShares": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits.",
        "label": "Common Stock Dividends, Shares",
        "terseLabel": "Share dividend"
       }
      }
     },
     "localname": "CommonStockDividendsShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r67",
      "r68",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "stock price per share",
        "verboseLabel": "Common shares, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "verboseLabel": "Common shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "verboseLabel": "Common shares, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r15",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r15",
      "r293"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Ordinary shares"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r104",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r60",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.",
        "label": "Debt Instrument, Measurement Input",
        "terseLabel": "Fair value measurements inputs used by the estimated fair value of warrants"
       }
      }
     },
     "localname": "DebtInstrumentMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DeferredCosts": {
     "auth_ref": [
      "r11",
      "r323",
      "r332"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 21.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.",
        "label": "Deferred Costs, Noncurrent",
        "terseLabel": "Deferred offering costs associated with Initial Public Offering"
       }
      }
     },
     "localname": "DeferredCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r254",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Warrant Liabilities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure derivative liability.",
        "label": "Derivative Liability, Measurement Input",
        "terseLabel": "Fair value measurements inputs at their measurement"
       }
      }
     },
     "localname": "DerivativeLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r24",
      "r65",
      "r148",
      "r150",
      "r151",
      "r155",
      "r156",
      "r157",
      "r286"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Related Parties, Current",
        "terseLabel": "Due to related party"
       }
      }
     },
     "localname": "DueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r30",
      "r65",
      "r148",
      "r150",
      "r151",
      "r155",
      "r156",
      "r157",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.",
        "label": "Due to Related Parties, Noncurrent",
        "terseLabel": "Amount borrowed"
       }
      }
     },
     "localname": "DueToRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Basic and diluted net income (loss) per ordinary share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r43",
      "r72",
      "r73",
      "r75",
      "r76",
      "r77",
      "r83",
      "r85",
      "r90",
      "r91",
      "r92",
      "r95",
      "r96",
      "r257",
      "r258",
      "r328",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income (loss) per ordinary share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share, basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r93",
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income (Loss) Per Ordinary Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r39",
      "r40",
      "r41",
      "r67",
      "r68",
      "r69",
      "r71",
      "r78",
      "r81",
      "r97",
      "r126",
      "r196",
      "r203",
      "r224",
      "r225",
      "r226",
      "r237",
      "r238",
      "r256",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r343",
      "r344",
      "r345",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r55",
      "r174"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "negatedLabel": "Change in fair value of derivative warrant liabilities",
        "terseLabel": "Change in fair value of derivative warrant liabilities"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of quantitative information regarding and derivative warrant liabilities measured Level 3 fair value measurements inputs"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.",
        "label": "Fair Value, Assets, Level 1 to Level 2 Transfers, Amount",
        "terseLabel": "Fair value assets level 1 to level 2 transfers"
       }
      }
     },
     "localname": "FairValueAssetsLevel1ToLevel2TransfersAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount": {
     "auth_ref": [
      "r262"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.",
        "label": "Fair Value, Assets, Level 2 to Level 1 Transfers, Amount",
        "terseLabel": "Fair value assets level 2 to level 1 transfers"
       }
      }
     },
     "localname": "FairValueAssetsLevel2ToLevel1TransfersAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of company's financial assets and liabilities that are measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r164",
      "r170",
      "r171",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r217",
      "r261",
      "r298",
      "r299",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r260",
      "r261",
      "r264",
      "r265",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r164",
      "r209",
      "r210",
      "r215",
      "r217",
      "r261",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r164",
      "r170",
      "r171",
      "r209",
      "r210",
      "r215",
      "r217",
      "r261",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r164",
      "r170",
      "r171",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r217",
      "r261",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r266",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net",
        "verboseLabel": "Fair value assets transferred into (out of) level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value of derivative warrant liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Issuance of Public and Private Warrants"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "terseLabel": "Transfer of Public Warrants to Level 1 measurement"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Derivative warrant liabilities ending of the period",
        "periodStartLabel": "Derivative warrant liabilities beginning of the period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r164",
      "r170",
      "r171",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r217",
      "r298",
      "r299",
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheWarrantLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r269",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r131",
      "r132",
      "r134",
      "r135",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r131",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r47",
      "r55",
      "r124"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "verboseLabel": "Income from investments held in Trust Account"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r38",
      "r229",
      "r230",
      "r233",
      "r234",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDueToRelatedPartiesCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.",
        "label": "Increase (Decrease) in Due to Related Parties, Current",
        "terseLabel": "Due to related party"
       }
      }
     },
     "localname": "IncreaseDecreaseInDueToRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r46",
      "r111"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedLabel": "Income from investments held in Trust Account"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "verboseLabel": "Investments held in Trust Account"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Fair Value Disclosure [Abstract]",
        "verboseLabel": "Short-term investments:"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r26",
      "r64",
      "r115",
      "r125",
      "r145",
      "r146",
      "r147",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r156",
      "r157",
      "r244",
      "r248",
      "r249",
      "r274",
      "r291",
      "r292"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r20",
      "r64",
      "r125",
      "r274",
      "r293",
      "r325",
      "r335"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders' Deficit"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r28",
      "r64",
      "r125",
      "r145",
      "r146",
      "r147",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r156",
      "r157",
      "r244",
      "r248",
      "r249",
      "r274",
      "r291",
      "r292",
      "r293"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Fair value liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r29",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Investments Held in Trust Account"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "verboseLabel": "Expected dividends"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "verboseLabel": "Option term (in years)"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "verboseLabel": "Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "verboseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]",
        "verboseLabel": "Stock price"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsLevel3FairValueMeasurementsInputsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r101",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "verboseLabel": "Description of Organization and Business Operations"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 21.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r52",
      "r53",
      "r56"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r36",
      "r37",
      "r41",
      "r42",
      "r56",
      "r64",
      "r70",
      "r72",
      "r73",
      "r75",
      "r76",
      "r80",
      "r81",
      "r88",
      "r112",
      "r113",
      "r116",
      "r117",
      "r119",
      "r125",
      "r145",
      "r146",
      "r147",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r156",
      "r157",
      "r258",
      "r274",
      "r327",
      "r338"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r72",
      "r73",
      "r75",
      "r76",
      "r83",
      "r84",
      "r89",
      "r92",
      "r112",
      "r113",
      "r116",
      "r117",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Allocation of net income (loss)"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "Recent Issued Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": {
     "auth_ref": [
      "r23",
      "r65",
      "r287"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 12.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Notes Payable, Related Parties, Current",
        "terseLabel": "Note payable - related party"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r65",
      "r286",
      "r337"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), due to related parties.",
        "label": "Notes Payable, Related Parties",
        "terseLabel": "Outstanding balance of related party note",
        "verboseLabel": "Convertible note - related party"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r30",
      "r65",
      "r286"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 14.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Fair Value of convertible note - related party",
        "documentation": "The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).",
        "label": "Notes Payable, Related Parties, Noncurrent",
        "periodEndLabel": "Fair Value of convertible note - related party, end of period",
        "periodStartLabel": "Fair Value at January 1, 2021",
        "terseLabel": "Convertible note - related party",
        "verboseLabel": "Convertible note - related party"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsChangeInTheFairValueOfTheConvertibleNoteRelatedPartyDetails",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Offering costs paid",
        "terseLabel": "Offering cost"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r14",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value, (per share)",
        "verboseLabel": "Preferred stock, par value, (per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized",
        "verboseLabel": "Preferred shares, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r14",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "verboseLabel": "Preferred shares, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding",
        "verboseLabel": "Preferred shares, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r14",
      "r293"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r4",
      "r6",
      "r129",
      "r130"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 19.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Proceeds received from private placement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Aggregate purchase price",
        "terseLabel": "Proceeds From Issuance Of Warrants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Gross proceeds"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from Related Party Debt",
        "verboseLabel": "Proceeds from convertible note to related party"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.",
        "label": "Proceeds from (Repayments of) Related Party Debt",
        "terseLabel": "Payment of note payable to related party"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r36",
      "r37",
      "r41",
      "r51",
      "r64",
      "r70",
      "r80",
      "r81",
      "r112",
      "r113",
      "r116",
      "r117",
      "r119",
      "r125",
      "r145",
      "r146",
      "r147",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r156",
      "r157",
      "r242",
      "r246",
      "r247",
      "r250",
      "r251",
      "r258",
      "r274",
      "r329"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r22",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r10",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r216",
      "r285",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r216",
      "r285",
      "r286",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r285"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "verboseLabel": "Expenses incurred and paid"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.",
        "label": "Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party",
        "verboseLabel": "General and administrative expenses - related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r216",
      "r285",
      "r288",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r283",
      "r284",
      "r286",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r17",
      "r203",
      "r227",
      "r293",
      "r334",
      "r347",
      "r352"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r67",
      "r68",
      "r69",
      "r71",
      "r78",
      "r81",
      "r126",
      "r224",
      "r225",
      "r226",
      "r237",
      "r238",
      "r256",
      "r343",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of basic and diluted net income (loss) per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r33",
      "r62",
      "r98",
      "r99",
      "r176",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r189",
      "r194",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Ordinary share price, per share"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance at the end (in shares)",
        "periodStartLabel": "Balance at the beginning (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "definitionGuidance": "Purchase price, per unit",
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 16.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.",
        "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Fair Value of Shares",
        "terseLabel": "Derivative warrant liabilities"
       }
      }
     },
     "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsCompanysFinancialAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r62",
      "r64",
      "r85",
      "r86",
      "r87",
      "r90",
      "r92",
      "r98",
      "r99",
      "r100",
      "r125",
      "r145",
      "r150",
      "r151",
      "r152",
      "r156",
      "r157",
      "r180",
      "r181",
      "r185",
      "r189",
      "r196",
      "r274",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r34",
      "r39",
      "r40",
      "r41",
      "r67",
      "r68",
      "r69",
      "r71",
      "r78",
      "r81",
      "r97",
      "r126",
      "r196",
      "r203",
      "r224",
      "r225",
      "r226",
      "r237",
      "r238",
      "r256",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r343",
      "r344",
      "r345",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption",
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables",
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies",
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r67",
      "r68",
      "r69",
      "r97",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemption",
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables",
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingencies",
      "http://www.ivanhoecapitalacquisition.com/role/CommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementOfCashFlows",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations",
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilities",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperations",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurements",
      "http://www.ivanhoecapitalacquisition.com/role/FairValueMeasurementsTables",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOffering",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacement",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactions",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitPreferredStockSharesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPolicies",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r14",
      "r15",
      "r196",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Shares issues",
        "verboseLabel": "Number of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r14",
      "r15",
      "r196",
      "r203"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Class B common stock to Sponsors",
        "verboseLabel": "Aggregate purchase price"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/RelatedPartyTransactionsFounderSharesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r15",
      "r18",
      "r19",
      "r64",
      "r123",
      "r125",
      "r274",
      "r293"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at the end",
        "periodStartLabel": "Balance at the beginning",
        "totalLabel": "Total shareholders' deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfChangesInStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' Deficit:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r63",
      "r181",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r203",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r282",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r282",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r294",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails",
      "http://www.ivanhoecapitalacquisition.com/role/ShareholdersEquityDeficitCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails",
      "http://www.ivanhoecapitalacquisition.com/role/InitialPublicOfferingDetails",
      "http://www.ivanhoecapitalacquisition.com/role/PrivatePlacementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "terseLabel": "Accretion on Class A ordinary shares subject to possible redemption amount"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r8",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r145",
      "r150",
      "r151",
      "r152",
      "r156",
      "r157"
     ],
     "calculation": {
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "terseLabel": "Class A ordinary shares subject to possible redemption, $0.0001 par value; 27,600,000 and -0- shares issued and outstanding at $10.00 per share as of September 30, 2021 and December 31, 2020, respectively",
        "verboseLabel": "Class A ordinary shares subject to possible redemption"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r8",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Temporary equity, par value, (per share)"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Temporary equity, shares issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "verboseLabel": "Temporary equity, shares outstanding"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionDetails",
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r8",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of Class A ordinary share subject to possible redemption reflected on the condensed balance sheet"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/ClassAOrdinarySharesSubjectToPossibleRedemptionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r228",
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits accrued for interest and penalties"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r102",
      "r103",
      "r105",
      "r106",
      "r107",
      "r108",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CoverPage",
      "http://www.ivanhoecapitalacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Public Warrants expiration term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/DerivativeWarrantLiabilitiesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "verboseLabel": "Weighted-average shares outstanding, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/CondensedConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r83",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted average ordinary shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ivanhoecapitalacquisition.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.23)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r381": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r382": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r383": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r384": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r385": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r386": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r387": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r388": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r389": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r390": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r391": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(b))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>63
<FILENAME>0001193125-22-092102-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-092102-xbrl.zip
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MQ2E<\%1F$H;7)DR1BI -\U3E:,O,$@9/H/BHKW"S]:KS&C$"?3KM !CN,_&
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M@2]'26ZGH\4L'O1QDKJA/=J$A7G+Y%S'MGC*CJ)\ELDLSU"Z3OX2-HH6.4O
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M@DCR=RZ#<Y ?Q$4242Z]U3)TX):_Y?Z6^UO^Y&_YN+Q@+9-8TB( L@4! #'
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MR"([G_KEHBO#X!/:Y+61O"<#<IH AF"1FDJ?#/)06=NY\=4>[Q_!,U3' 7C
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M5%N>(IX,S#2%,3Y30$RB6ZX50WWY7'GU07(%BX]A"@5-?DZ3?*A)SE!1DDH
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MHC12X.@H@6;_N==6^C( ] I1L/9>&>U'5-+Z@&1EX@#HB'Z%3>7F.TT"2@Y
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MF%66IH4\EK&9*-+->JHPRE;C,VF]G/)+)KU*3CBF,0B:, Q\27*)%FNR@^E
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M+()'/1@IZP]T$I/DO1@CY]WXLWIJ(J[-&Z12.0:&30Q'F>5)Y(YIHKUT6NA
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M)ZNY2=V4+DEB+;]\ADA]W)'!)90MV'+<,6+.GK9=8C1<_Z4;%$V<%X,]+/9
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M7U:+F)S'$I.X$4(*;FAJE24;*?H#*U!U1M4P 3C@;+K8>ZE"F9_.+A"]?SZ
M+@CUR([W!&@9D2Q@AM&6R2T&R1*)(:H;1@. 47J0<(G<V%$$#V]KK_K@+Z-C
M=Q]P3@F>ANX1%M+(KOO[GYQ-\(LC81Z3_99PH>_&QM\7 UPND4:<P23K?MAO
MDI*,:A<F6U",Z%Q<^*56-ED"1NH)[($;TWJX5VUAKBJ<=RE^&-0$R0R63).@
MAP-S+FH68I3MTZAN:60Z;!S'G<J#%J%GY1.\&F1=<S'9Q_</IC:F-]B:&.Z6
M@S'%9D7-6&@JMTSMQO]D_<*A\%[$-*\+F$"FW#B*D-3$/,?2(+YA180VH.;#
M9!E@X-.MJ?=;@^',4M]C7Z>L ;ZIC12G"F^M2AIU.0;@25?0Y2>)9\\JF#W:
MQLQ=IOH:M6.F1H@3Z6W+^7&F(UGW%60$Q,P);5^)#G(^CC[(%%."TDYFE[X3
MB,$=8*FH=@%;#?T/KGRTQ3Y(<MG ).P=RDD ="0,L1GE)%0Y !>]WST%9U2W
MU<^W(\ L'^TH4L"ELCYJ?NDM8R3<7LLWY*$ML6V$DH$K=S"BB3Q'H3BT1][-
MY*)\S_:S AVF[K>;4E=ZY.3AY4Z.H?P7&A.<C34NF$2EPUWSG4@[EZ(I:DFZ
MN+--*<_GOS0'EZ>_$FABU;(7&D_KR8_?T7PZ\A!R9V ^SN\%$H#!307] ZH.
M-/QD,MNH#2/F#A1V&&P XAY\4R+4G-J5QZ%Y>D[.@'07/?A8>!8\#UB\X^Q'
M*,/'7<J^<(4W.^X8WX\0[3$(]C9D$,CB+*<FLK0@QEB=*W1%W5PN7@*,6VY%
MN[%]XPC!V#@V7,Y[%&U3&J:I)V4_9&)-/<A-8=&NY#Z@4#7V+8MEHW7K'$UA
MRR)S= )=]078P(*>0-BCD9MZ6X9*"^#P>YAO$FA_!/UR"(MOB%8JV\GI;LJ0
MP! 1RRC0L:;.7SI[6(:(ZX/<- >W:#HII-4?%GAO]B73QC/,"Q:%=;0,$<SK
M0&HE9PHVL_E_+//_'1P 7D(/O[MV(2WSK/PKOW85/IVG0=^+A /W\ ZFI_UY
M'!#J%W,!A$TRV;3__NZ%IE8G10<6ACEX#)OW"":?IU'F],7%ZP+&_5;W>IG-
M280DNR8)L6YL97P=6)#H?:4.JMH]I#>[ W. :+8.:R-OFE(,%AP71YG&L!HE
M3^5 +[8!:^N&<$9S@A>?NI07^0!CO!^5%QV$FY/-.PD[U!F+>'<4[/I0+D(8
M4*Y,?\!<_\FEO#PO0!T9A#UX1@4*F&#V?85]_K37KN.R=<Q]:EPTR7.!A7:"
M&(=KL_&2#'K\9A +Z5!+T+#J9"X:QT '3J)*@B+JF[IEB[6G% V2_GV),0=&
M"L-KXU5$PZF0R*SA;^E[$!=[B@(E[7K5//Q 1T7D=[3_G(F1TM#EXD5]XE8'
ML04;.:<,641+)PR4-]R7'Z]OZ,RKC-/D';E!,(3=0GAX5;0B]7K(K-#R,JR5
M,UA<ETIJ:\"2!<9\\DE8'4/LGU+5;6D4N.6$G%VA>T7"ULO@,CJBM6SU0Y02
M4P8E*QL5PF'.H5NKAQ=G$R7YPRC4*&FI.94,=?^L_)8GE.S244U:VJY^$)M'
MLI;2@R*(K6T<O)M)=_N,XK82QF7EX32UVA]W_ZGD\K, KNO8P#H6&\(!+"$4
M*$C6TL0]=GHU>-+$G*#G#-F7'A+%+[$S,!,KLC YJW6DLW:O'5.N]#E)[SE<
MN532Y0#T85U6-A<DDREZ*@ATK(3$%87A,*DDF8)-AR+I:%!S3S6>E%8RKL;.
MRQW;OI-QT4=EH'$M.P/HVWWT7?58K)B8>]!9%RL.?J2 5^AUZJP32CAG;=7F
M@%?KSN!/37O]GV6:(CQW"!0^7TB66)Q13HLX,Y5,4$+7"-5,ZL>*LRN84*6@
ML0H<PP"DG9JQMQFBVK89I)"&K#DQG!?!^+RQY]: ?$8^/D/DX]<S\O'#1CX^
MI&-P?GF^NJT_URPA*H#*4RXF96""6D:=LS/?RQ'"0@V ?>5579Q'AC@*1G*2
MG4:F2IVD)M#-L7;B0EIX,QT:9%+A@Y,%;Z3W(C@C.&RKYP"6HR7N[N&N!NG9
MMKXLJ4MK!9CQXA<1>++,77].&CQX; )H/%;F??!#$K'7.[SJ)C83%[&'PA_Z
MUC<5QSV.((9@4[0;*4W>#"M(;9 .A,'QS2(@YE,%+J(?F8.6CO^J.9E4]91W
MM7R ;' "E;B\\S!H0@G?R;<M(WL;-SBO XLY;6C]\3G9(0XM8EG;2A:>T"?W
M&K*((>\6D Y9:W\_WP<[1W"W0I-&BQ$%C:N1^R;K#.E !WIAF&H6X2W/ST=:
M3C)SSPRE](3QVR 9IC6@AIEZMJIBV[$"X)[F:"-[YYP<;$QNB96-:O>N[UFY
MM"YE_S5;^E#$(/5U^?>>4T;;\JIW3&(RQ8J.D*)H#AN5P("S;8SX&LK\U=PQ
MU>7%2GO:,Y<::)"2E:RB&B^C-$;IQ,XIF!I4!*O6\3#D*0DW,I?"R.3/9],@
MUN$1&G&FQO/-W173:2.[N K'&ZXG[T($EIG,K3ZR'?G;.*BT?#:3#8'Y]^E4
MZ>D6B(CC29XJC18(ZSO;"RIU$8YBN6;<D)(#2Q99K\8S P^@92ZR)JH=!>TN
M'.+!D5FU4?>%\TO!2;'N$@TCK=R]!&)%6W9:CBT2V=M9C\($ %T]8<IL.5B>
M.1JY#V61>I8<SDD7].QB&%##3"%]+7VF""=70C[:DQ_'+7EZT"8.%J-O'QRC
MEIHH]N3B;V8VCE^87NP02Y?=#E"(9<8+:P62I9'0Y+)I6*UUP'9&CT-;W"2&
MK:5'0V)1TZJ(G93#3G"8+08^=KH%[GFIZ,E/4<B<;8H4P)DH8!XSY*S?(\(4
M%-LG#10PD=!^%H?MMU;9B@J\9QI9!RQBMLN!VU%>S960;\!SW$ $GC^NIE()
MV<HN C&57U@+;)PR2BA*736^O,;<<_G5P!LT/)AHZ!L!^HVN%@\^@;IZD=VI
M%U;2"+JZM)T;'4=J!4KZH;>O/:[/QL67%K[3LAQBF)\&B\WGU@<)!'YM4S%9
M(7XZ1HB?FXS7CNR.-J6/]T87.6R2&G8Z5)T#EQ9V<=4&=0 B7Z/3C=82K).Y
M!1JX9FYIR$-*N[QIJZ>/83>1_P,'8%.B[HNN-1J/MM@?$*/VIKVJ&\NSE*2'
MFSS0C?^"%M,;*0?6 IXR:H=_ZFAX[EMJ&;UK(=IS+\6,<REI_0AP3!LR13+6
M%[NF[X+"')M6GY..4_7CQ<9+T)/\MH95Q_<4 G'Z(,(#V/D&IX=0@!1'96,1
M934ZF#E7-=@# J>>6F^".C=<%[ %I;#ZM#:O951RS?)<5F#NFFSYQDL93AS7
MDI=$E,!%DT^0!_*/9-T;QLP(LJ(47]\\ZLV]#S/5$J[ !XB%D7-#;J00M2[;
M=;^7X 8UN%.3:(0@8'A)YCN%<%8GU17 3*;2>9?1[Z64F;A_Y_TN5\-Y@>55
M=BIXZ$D2T_(Q7?*RBI]-/%AWDCLRU??(.4PAI1(^U[GQTZW E&=#<CIO1Y^>
MXNA;:7["T#E5K(C[I?=3)8MZ,.WLL$7A4J0_Y4I9:5,9EI4P>+Q2%@SGU_R*
MNHY)2BQY[A%PXKHWS-Q8P)FU]K%QN'?X(&)EJ&"S$3E)_5H<I[+NM"1Y$VED
M9#%*DD[.Y_4I;AH9-]'67)''6W(L>Z0%N-WRC;L=5%NO3&:$A\AH-@,-3+.G
M<)\9YM&/OO:998_1809Q*5[O\>8X+I%<JM Q8=F2GR!66O"-_ORFI5 N6 S$
MX3A\]R$80:/Q-^$T/MD&5*7OF8% MV-NDZ(1V;8<<6L7O!_<9% 2_VO7->N2
MVZJCIY7BN1=1 XYU7(R."BO0)^SO0CK-4/''BA@&)(5/YQ:F<E;447 (DL'.
M8@+@9<0(<9!PI'4S(.?.*C//*KF0$732H[='>2?#7 PH \F*?/7%5U_A_Z]Q
M..P48V)#D?'EI=>/-/2TX^B4T"1A3#+&1M\SI/ ?9+Q[BZB!!;UXU^?Q_")[
M\WV<L<D8_7=!VK5O<E)7H$Y#<0UG#. T;:C> PE4!^G>K:J+(Q]57 /NP!A>
M:7J)_D1SCF1OQH8=UX"KB0F>L0L9OY];)T)!SJAR%)6!6?84XIN 6!RG0))J
M%9//X@BX.L+MK!"'=/R@ 8F/GIE?[5FBC'XUHXQFE-&S79ZO1KA-=T0.Z56U
M#X&)5.']7H@K$LVJ4E(+^VY]<GX\8G6.!NR3;!-CS5J.WN)-6"3"[@F28L<@
M,/!YP#'IA;F476ORS4[N,1">H$F%-97BJ]+IEE0')'^/VC JL_A_9%U.M-+*
M_"'.U@'CAEQ_)X<12 TF^#M];2PFQASUJ-? 1J'EW -J"''F75/\R>\ZI7FM
MM2GID_7'3-#NG?5)D:]WA"41B7Q;9.)UBE)P\O0IBI]SP;*1F(U,.>=Z\G6[
M*Y6+GMT)1MI5IXON#7T\\RVP:M4GY^AZFA'8VF"P3)KV3:Q0TP"4D-A<L)8.
M \M_"NNV+Z-8&-]>0>:[A=U?7']^]B,VF/<^F.J5O\KDT\).07?R.8X&%0;-
M5TBF%JS#ZM+LRE4IZR<%$VD%)5([_ZJ\D$9,L<.E,P"EC1?X4["DI!CL#'-Y
M3$1E:R9?+IKX %-WTW=^R9$7G&1C#L!L'(5+*)3:U9 J%DF6E5OI6&3*9 $3
M-J:E86YY6458C6/+3[4A5Q$R%5)U?-%%?VM2-Y^58]-4:@4E<18!D]82J4P(
MNDB/X=#IZEI.]!!8LIT9R$7%+X+0!CECI.R%EDF794)J/(4U^;Y4JWT<F94G
M3QW$5!3\QW7!79EB"C;7-)H%TSG2/!4*EGC/9!]2^XKPW=$&LG:.UG3RE/Z>
M6SZU'SI 5:\MU[8QA5H()RRMX!-H(\3<"4QRRWZ?1/ Y&>*6X2.<\<GQ78;9
MLHW!.(,G(("\?:I';'0V=KS[9  ]>:ULW-7?+/>2G14\**7M^Q2O\B9_=5=T
M:J12L33LF7?XY %$GJ&,9;VM^L!X[544Z_"\'BZU'S/5YS0-KLNVL=K!KO@'
M,-PJO;.G>YLFBJ1N!]E:[O?JT)FL!X[ZC70OP8)U4F",;%>RZNCCZT5WH@%E
M6GF!D+,(T7K-+7CL%YE^32@[).*U%"2KM<:* TR\[+ [S06((#S!M$?'CO;2
MIH%#\'K'QM&[<"VKNMLJ)3NVE$8YH:VS?JFJN:&C0/>%9ZV<9G2W'BG5V=-G
M<[*+19>$_89N+-]>K+BD;L1#XA+>WWHIQO.P%B+A%[T@84SKNK&V0AP*FY@\
M6SN47Z#]';B.85I<6N^599T)V;ABBT,X\9K)EY;<=SD2+Y/E8M4#N'%&J);*
M!8D!K:+AIO^64<YM:1H/8\K_.*F1^E^5=V<FF?>';^2I./1MUZOU-$9%ZZ:4
MOPG_2?(0G8Y*1;,MY)7_A*I#N97M)*"?Y(,_MW3^F!!F<@1L '-I-N^GIDS^
MQ 4D)1_>,@T!%XB-T.\9J\T_O*-P\:HW>,XY$I2H&N_;;F_AYQF(IC$#8YJ
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M+SBQY X7#"D_=/1K^U?\4_:^_R+O$!T.YYX@%;R!>W+=E!O[X&9P4O_Z7]W
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M>PG0.\P'HX!LW4EHE-O\-L9;YBQ(4E'U-N039,/[\:RK$;B_@P%8L(-@>J-
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MG*^JY\81;VBO3L(B31[&%?-+1^AU;-4@4Q9:R*)GZQLRR)/+%SZEJ2ZN3BH
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M_36HDN,RU4+D)$PXN$@A>@ XSV70%&675V>BZGVZ@*6+F:["YOK0Q!0(SW)
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MV*%G5P35ICW**RB.7S58:5S/9C@CI@8&>X2!SD"-52C$4Z&%0Q<$C:OZ]'O
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MS^F_FIGHC80IZILZ\IAB(PL9,WN3-H=5'5@O;O4).V4IB ]Y@QN%BCL"C*\
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M2Z"U=)0A#HL G98@F@EK:>Q@1) (;/RB-CQ;^Q6 0?F,"=%L/46A)\ .6%R
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M L+3M>/XM9T<%?\-"UI-HLQW?_EQ;T]*_OES\8A8!.P4/OW7)C?.V$=)^^#
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M8(%(]PB5<V'R\($B"'@ZF)A]'36.6-2-I"G]F2=KGTYE+_&K4K/B4<(SA93
MQ#2,DY:M<: ^YQ]F2Q!;E><T1CIWQ^;+ *'>Y5C$O1M]<(.16>H5QD)B5Y1$
M01\JH+]%#]*'LO<+]ZDH3H,97\4\^I;=2ML%W4A/ =(,IW4D=*IM/3@G:1T1
M[WA4%1,8@#>""HGLP[?7<MI,OJ.K'IB?]GVT'A0Z0E9RD!;5 E^#'QH^$D8
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MCQ K<3N;"H.=U+2&M$?S."VCLSAK3(\FV=\]X & V,YH>?E=J(_(2&7WP:O
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M]D$[%%9)*LM0^+4\P^^L1)]B S+K&AA(LP;GLSOC/8MFX7>HTEX14;3+/-"
M7V,3]5LB?BT40GO8$AIX\?ZCR<'^X>3P\/"":E.I]NF?@XN^?X)Z.49=P[K*
M5JJFE> ,G!KEK!<^#:J0J0BH1_LR)Y>;\U00.!%*$TX[F"\P7?UW\@WV_OFV
M34Z*Z[Q%^\;FE@WD?5#2^S; )!_$Q)@EV3,7% 5+E:J1@1B5GST3)!"EI0OR
MBA_A2K%\Y*+OK"Y3$)Z/DH+PO;UBH1,4DS'2J=P%9?\FCXZ:4RPUX]X?*EM'
MA2IBY.CDCZNW27\K=GD+XCMW]IXHR\RMES)-ZQW\'SXY+UP!.Q[4]Q2F?2_,
M+0^N+V3]Z,>]G8.]AQIPS8,XM!^PWM$^(1*PK["*TWG6[\]S"<)?YU@YMO'P
M;UYP0[8YRC4?L^N-'\= Z\@?>[QA^/[Y4',,G-T5\;=4OITXYWR'?:4?ZYAB
M@&59$);R,OZ3$%8LP 0YS%6;CUI]E9^/CH[9&<7#$&=5P8^"EVO5/;@]=6:!
M;[A.55(M<>D17>,(.5Z_ Q/XB:$&91I SVI:1G6"%[BJ9L6* /T%0X,:)FL>
MC3<;=)>HN4!XL\SV%3 :"#+\&%T]SEO%)<*JB]2JY9O;6)('JL"\KL)=EG6>
MEXYW)FG"V# "^K,%'(Y#N\#EU,3;]Y-F%<WQ1N3O754<MX@;ZX'9><"4A&HG
M9X[#J1R&8D7&\*%XY1IL.-L%%$!N5':"FY4@K:5SGXJ+CP4((1_U26FU/-0G
M#A(-P2_V0RU]5];1E>LA\&-VGC.LI:BB$P2WC([0*3H=I(F\^6-S(>ZT2DS>
M7;"1KWRN"IBK:3!7! 0:Q?Y<A5D8I*B.#O<.'\0/'SQZB&"K^!4?S*DJDRL?
MY,G.WS5C,K8B#,S1K^^?GR#CWYW8V&@?_=HL5R#3RCIZ[X/!GN"?FE5%8X5]
M<["W?Q"D"_5#; Y/JE8J1G:NK#4U$78493=%\V9"T!B?K3'C\E=!H!!M*K&O
M*+?E(S-1%=='XY?%Q+:5<H#ZP>>E="BU=DG(0T8>9HX7^I'-'.::0N1G*2."
M604$7\M\-F*S^BF35N,J 8]*K.8!R@O^(,Q0E#'X[P];GT:9.POMB85$L)58
M47EFV_#0K&Z4K)\?5Q'L:@Y0;?.=3M'*Q\$*FK-8<E3T5PF[>F/CAEA[9UJ%
M9O6U)$YT[442=3DZ@O@2M\1>A):H4S45[IM2^\/L8]F(^:(MPTB/+=BQ<.L,
M6])C?<[MU><<C/4Y8WW.\+8\LDW'6$0@/$,252?80H;I\8"E\9>IR<&&8[\:
M1"PI/I&XK$%!>#;(GC:@,X57P?("JW;;]<M]5>]Z@0_D&H2-5R]TB'HC.E23
MK=2K)8,F:JL"J0X9!(LX$AFT_[-1'F5/ TV]< MR0_09#)900(DC,*^!6(M%
M:0-0,1S@JA:X!,M\A &,:EVA.:RPD]@(3E&<(N.^ZSYHQZ"@]H23,CR$1WN/
M)D1?8%DL/,XHG R35SP*+P7J8V[8KX5[;E )M@THSPAZ623)SNL227$^XL><
MU"7Z%Q\,05Y(\*]JX+'1<5G4DJ*B[0$3H6L3)(/)H;<[,_A^#5;)'CU^<?3^
MN<?DCO@:<8WT';3"L#@P!GBK182/83>M5IE-=I%-U-H,L@%XA2A=YD  _/J1
M>(IL]O8) ?W&9JO@@;R25MGCM(^%T_ZAT%R<R>S(9C >P8VRC 2;1F'C8"\L
M'8$[CZFD'WWJNX&'$$T'8\Y3K9PBA\9E2K3;LEM?O'IO9RRXGV#CDY1XU%99
ML3;A\RFX6IG@0&,+?;S"#<!(O)(>@S?-<7B86T.;'BULE79= -NA9&=12E&;
M"-*\B#*0$J:\C%Q" ]7@<<>L&=,17&!9[7^]:;5_1;;5__Y?_\X4ZC.392O<
MS?GI?_RP]P/]6YY+_Y8A3(DDB)ZO 3&R#V >? /B*RPF?L,.EGG&JPK^K/]E
M?PH^]P?Z!&O&>#9/2BERT-5G19K(=;#_$U#5GP\>[Q_\N/]_]@]^Z-@_,'I*
M',SB3(T"F-&??O*L!#(2PJ6Y7I0Q#+OPVOUXM!M:AG4B'R8/^X*Q=^V?*XJK
M#.WJ"#]K1XU,"37>DUC+/U!YIS4G8U#^_0-C!?+OEU8S5]$1J8!W7-F(; V[
MO98]K!_\3XG_@^<P^*Q9!O($/K]>_+2,/^N$B5RXO>8I"FE$%2Q:1J:CFC:6
M"].%#$$7?VBR:X $WS^8[APHQ@]KG5?*YD9A%U29PA'FF8'6MN(2:*>PR2X\
MQUJ25O*/Z A0:8XR_9[(],/[)M.?CB+]5D7Z:VN'GS@[G#!&K3^ U4XOXSK^
M-F3X;58_7N@ ^=)Z:@1R,"35!(E,B:BGK(I6*RZNT]^.\KPA?EORU1A1>B9D
MUG 9<LV!GT2%(. '(%O"+MR#C$#F,RL3]*=Z!X<L88CE:7-A^X\OR-B.VN%N
M:8=']TT[/!NUP^WBO)%1*=5I"9KX%AU/@%.E-(>*KBE^%30L..WBO(-1C7S%
M@OQ6Y!<5$8]"]VX)W<?W3NB.898[P'R B13NT2UF)FG*#F/$E0O.;Q&8\Y7D
M CD<[I10-##'MU1%),G6_;\.S.(?-JU4-2M3<C40(]!;<KT8#V6ZBOW8ORL2
M]=%6\!?'4N[2'4)"S)D.^[OS!0IE;B>\W3QI9DS 9S.NKNS95EODDI1]<Q;G
MB\+8U(B7QYOY2[%R2^$(.P5HA;J>X3X8RK\:^%QS$7U2+,D>[)Y&]\4KYL/(
MW#4T&N\?QCO[CQ\8OW'AZE_R. E>XI*.?AAP-_)XL#$]8Q=I\K4[H,T7FQ#=
ML=_!-<,<L.8CVV[IY$MV@Q"D>V7+F\C/]UV['#%AV_KD<U#;M"=A#Z34=Q%F
MKP>3U^ F]ST%2Y]P6R%A^&S-,-P!42;A'\GO*553Y]N_="+[5_AVN2,O=DWI
M1CAYN=N?R[[=*!&=VX>6T/R@CST1\\(4)0\J76X1I;#,F@@=3C2:1'M4$DX!
MR0043D0@C@@(<96"[CH1JEXNW@B%4Q\'<7N+=,L,XI*B$1S-AA]A*+5+U;9;
M8FR!!N9'/_?CD&F_%^S:M"82UF##$:.P<&D4./Z4"C1-@KG;M.K9'EP4YY _
M2A,L2/L;*?U-,!%4F*PER;3-!W#PXXJ6("V:*EO;VCC9W/]@*0D_?+#%&Z^Q
M_.#J1=+>SC]$&FG?SK_LRT4FL*Q^A_2;[;/*@2ZKRTY>O:!VFR8W\KV/O&91
M>VRWVJRMX52;AN%>>+AG)QACH695^S)&?L1N'[\BJ>[?! R-(;RHZ$GW'\P.
M4HUBFH6]4FFKA4QK&V2_5RV@ "E5A3U282A715)/6Q0CZ7?'NEF:7#3]WE,O
M*S&^MP;YEUN81(1M*"((.>5S5PGE9_1:<62MDR')UI#N0P$<) U9YU2*6(10
M>Q.MJL/_K)HE3!;"&$UDW^'U<FJ54CA=J@50*3>[$WYPJETM$9E?TOJ]E$U*
MGR$0@.Y;4FIO;):"UJ <(4V."(/\B==FZN(6A>^A^AZI_:'2[13V0XRD(SF5
M;55<SH<]W_"PF+DJJ?!=MW0"<\$5_*XHRRY2,A0;&VN3[\SA?'0XUB;?S]KD
MF]F%-QO6>&>%G96HSL)[HY:RC7&\1_?"Q>(_V*J5N] S=4L'^LC+MH)61)/3
M*:72-O55V+7->7!J/Y8ZW4=[C]0&.HG+:0R&WL[[SYE9<P5OR[TAG5JM$+<&
MSPDUP%<8KA/@8'RE>A-<6 LC0S5R">\4F\VVOIR#(<Z.T,H@S[&,P14JR0MQ
M&DNZE"R\'!6B=A^N!;]@Z5ET@0[\<\M$AZW&0P^JQ<&[[<>H_&/W9%<P"2[Y
MX>QD5I+H7H'U.DM-Q]!"4^1OVRCC)U^MC)^,698ORK*$*@/$DYN5=L)"KGF\
M?=[EP?[#;SOO<3-"=B51%^DH(!EG<CK&U(V#AUJ;6JEKU8H?< SC-"-D@J9D
M0COR%N*TI#C'/*/.&W0Z0$I5,=OAZOPJJ(:-("LH(TLA+6./KC65,@J(;UE
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M*.RZ_3=YH'O4ZP;LT1?X$4?8/PF[!2=(GR+CW'O2MT=$,,?1.Q%;3O3BHGS
M\2'  LJD%VZH_&;M+HY1.+-$;I;3./4? O?M/WOV["*ITEL*%[5J4[:S$:^B
M[K>GSN718_L)8QVX5P>N+PHZ-KBK:4.%^$"%Y'75J@^\N!?X/>J6IW\]\GOW
MM3I5S[ZNN66[IHGK;>VZ9<22H':COUT#1%\EHH\OW,HQZ11-[$8GBW[%[EM<
M S<'NKRZ0)GWC=97Y:KI)EX>G]](.O>?X"2 NI_M.C7]+,+6^"QXS;'5B1,:
MD7O-P#>0\F_RX^(<_EL5HL#$"/+$VQJ\-'WIC_)2?#]\_QPUR2(^XT)P>I?8
MNA4X)E%99-;X#1_Z,A5N07S_HLGG!IX07O("[/#<:M$Z\>P3.X8?=Z/77>W=
MGFQTE'0N=9[_38R!W^//H0\)SP;O+*(900@\7!QX,MM..*?G[&FHO85X;EF!
MB&M603]1-<]N6E$BGY)_(=>U5ZR#00.?%A.8A3@_!1>930-*2/^]0)R)]M>H
MZP4O?T<NE,>%3"/ V0ZU_B_Q>9RF;'S!;<]C, ) W7C0:JVY?][ %D9@+WH@
MC#&/6X\\-@B/81KTBZ+G)OV3,#&&1/(5R<8M85N^;>'HU3-=*!OAJJT$XX8J
MHF$1>>&M?3Y/CYP$T;77&K-GVWN2TA/)_X3G>XX7#<*WT=U87GIN@!.=[.'L
M*6F9''(&B.<#+A Y"*D"OV 4(,WI])!0HTL\/^LT+D$<'$9GXACAQ?"BI_1\
M?*,35(<B'7Z<A-^,K_W9P/,(GZO)*_ !8DQ&KL!S0LKSY PE6!*]2V=EL?-^
M56/<Y!AQ*TE$'X=?T7DVC"BCM5J5"-(R,][)G<@9)_0[^'<,DR?XF1^QIR&8
MVK@RT=NWQZTE0V>RBA+$G7GU[OF1B([?$=%ET032XV2V*!!9!YPGF.1BB9^!
M+WX70E6_^>WDU=%+*[3>OGW.C_Q-A50HD.RP1RET U(HJ*$;%$/JG9X4VXFA
M;N7:8."E:Y]U;[X@V,)RIW5L1,'[C_?- W+*?7=91<I3%2E\AKS;CRWMF]YG
M;U)#X6EKKC">\=8%"T$*8'35D %H;WXL-S]I1T.<Q(S5NOQ@*D-FX@E'*RL*
MB?Q:+/**&N,$DC%X_IX\_S$%1#DT$($A09CX+]^_4GA@ 85]6YR#S*P00RQO
MYB!A.'1$HQ#F.S(&,6*5GF)4F\:]B)V%1&*W';HQ.FDPX)-X6348('KYIAL-
MX<A%Y:.X^L^A"+!GM1WM'QR"A06.NWV4K.'>,_>HBN>/1A6,Y.^11.=Q;^D#
M1*_ U.F4'?\R$/25R6LMO$9O<C'M*$*#L6%^!1BG>.KR3^=PA1-_H\2[ 8G7
M3OL-Q(SNV1Q\2]_R)1E/5_@[I,1L^NGG+6WI5KGM)318Z\ZMU%<PO/.0I7E(
MB:DV\*VZ/C/9ZK2N\?K4:LJ?RZ)9@0$>2RJ!$EWLM)_ ^S#HSY<(:N!)4V&3
M.$42Y;J72*12:Z">,G1E47Q"M,+<F7MOXRE:]$4I.40=Y;X,Z= I[S"DLLTG
MPWMA,&?H,'@=YO+=^\^>Z7?O3\(9I_4XBTN<\<BQ06&^ 31+#9(?E.X[DV"8
M?0+;(%L27SL1Q%%:!;T)V@XN *3Y":NT_3SWY,)/D5@.8U].T/Q88E93GMK:
M,=T\;DOE=(,)$K&01,!>.Z';NO_8$*Q].X'P]&!46J/2&I76%RFM=H/"A:H+
M+_,T3VQA-BQ4KQ+5;=0XK\VT)%A^T EP?D_HCPXLGP,JX4O#BI[CLIB;JBK8
MA#9%D_5Y\YBH1M!OD>:>0CN">V<$F>N>Y"+35EE9E^[/@GE.-[Q*7K+IR0=>
MO)F$'5R<$O9PS\5[[N(#_$KV,&SLYDT.WD_=,!"*ZGM\IO->V^M&Q&!G/4*Z
MG;GE6"U6QQ1EGL;ANSSO&%_GR>K>QPS.V(;Z'!IM?X5.9]-A>4YO&0[RL^85
M,7;,P*2 X7$=C9NIH*QFIMIF8MTS36*KUU7KEZ>FOQ9F5#I7*Z2Z+307!HCL
MM5<OI7K>@3<0KO?!XV@-%A ! +5V&5XS-28G&L#3G&BUIK8VS*%6^UD3CX:$
MQTT%82F'=!6.7,N]4F.9*_*Z-"#E<M-HW5@&4@-,O=H=VE1K >FA2FXQ;5(L
MX>G[2FOY>Q_FGZ_>F4G9L7'&9JNVZ=5[C\[%@BP%F$Q:NQA>(S6$#Z,'O$B_
M-B#.P0Q\^G#"#$NVN//*>1)>%#L.1H,.OXS!UUS[3V%HGJ9A)@4=DRU=Y9J8
M>.VKA?9CO EZATDTCLYK[>&U?9Y\6Y#+_+N6/%%M*[I=Z"%,.,[WH'-<]G]\
MN"MEGQOV$Q>"33J[8$$Y!@SO<188SR\J#:3?*NMYD:4%#FHJJ444QD>6WP 3
MU@,GE4XA'?^!,F!,<((T%,?G%9T>WHS\G;(C?SG^+[L+^=,M&Q1&.<%//_XO
M*HY;K;*U,">L8"1UC-KEU!0K*E5%7'U/HZ".@W5+$P_CGCEG3IF_"6[$*^D^
M4 M&L/SCV<QDAC)4QALQO/.TC)>57$O4;B) N.07$^Z6V6#H#%.E<WB0[1;F
MPC,]U=YF/4YG4M/G;P_9[(</)U(99C?8@^XD/GD85GK;PYX;=SC^^>&Y.O[T
MHB.0IKE1B:HL)2ISEVS!@0A#[I&,2N%D A=H@Y25%AB<%V66].XBXGQ!%[QV
M-@D^%.8[;Y:F1-^=RA;MLW+D5_"$=B42'0FPB!?!>OJ6^ @5U@W(KG;-.U=)
M_&[^$?T"M@ \%.0-4@C"E_:)N2>XCL$#KGS,;W:.FZP20*U@+QW!<<HHT/ZP
MO9E@('^'HU;'T<G1B5[_&Y)S\,#WGCVDDM!S#,1K^,UK*/@9/C[Z+Q2XN+"$
M]-?:?0=[#WN/"QRWA(DIF$57J01A)R!M('74<)'W3"H\/AB#R>XL,]@:T#:'
M^_=?OTTL)'FV9-:A'[:LX@36<-&R4F" 5/CN5*<7?Q)+JG^77X!J>'>PB2^J
M[?NVP(F?1.&WA__GZNM2HZ\O3+WAJL]MZT_',M!OP8^D7OQ7N[8=?S"4Z62N
M7GJ-;J1]!94)K58%^H#)8 T"B>*P6FFB5GD8X/="^*C0WG4M-:_Q@NN+A#J6
MN9HHDS#I&2@UK%7(!)OB\<%^HM3EKLDQ<<.NBJQ1RT:8==OC.C.+=):A]?FZ
M#$M1F4)S8#4H OCS.^M'.$/>MP+48:%F"N*TLJ-L]6VTPH3M3X2!&GT(O%L&
M#:M<)N<(_ANTAXASAD$!Y-.2&V?V+G0%P*C!D8 YD$Y+-ZJD3,_$0B748\)I
M[DY!;WU&=PJP_#?/B7</JZ,J^E3+MTOOI%865T'BU^/:"<$/J>)S^BBX>EE,
MD:OL6F@(03[)+*F%RD0(SA#A0(F%A/9WVS2>?9)J6"]L6QH-W,+8N9#N2=^V
MPF5O%0*Z#JR^HUA'KY%6C!QR=0OQ+]8O["DQ?K(;/2?]::/)>,>&70X#UH2@
M)/=PQ5J[]92V.6R&]K;%[=?DM$")W8=H@4IMMIQ*F?+ )B9>2Z)4=+>A>$F1
M!UQ;!JMB7M/^#WZI:O1$.4+:_3 O2<AQXU?N!9W(\?L%^/DG2,/K)_VHON_Y
MD<LIOF[ )/9* 6W%,4:4FT]F8\BY5\9]9=C9MZN=2>WU@H;6=1"%[M_=D[:8
MM7-OA>P8C[X!.T)Q7;:P'^"JJS<=7ML,5:^6M.^4/@TO3K,AXO7SB[>B" /M
M(+[_A'['32*1EC].CJS$@Y]4X&%0IQ7$-GS#K,A!1BTY0H4L02E,[O](X<*,
M@@ZTI;UJ#K[3D^-XL.PTH11\\7;PNS<%^$CYTZE]9_N[MVH:T4#(R>L7KRCP
M8=LJ=J;$4E\UU+5^/8&0+#[?F<7EM/!C-S*]%??,I+)T.!1K>+4+/'_<#2<M
M2 A:H8HP)NDI?'RO[&6Y+5W)-%->M37=__\NS)\I)I9_ANFIL!EE.Q&,([I=
MZ;MY-XX"=JPR&:M,OJ3*1."PAM6FS?R_BR^M-7OZ@'K+2UA9^F\*2TIBA8FY
M2&&"8CW#DHU!9ICHP6]')R^/_O&WZ,7;H_]^:-6EW.BI3-6'T:HI5XBS$7O/
MTM1L9;CR#3F5*2O&.3$$/X@$_,!SA"P.@C47]FSUY:0[T4FG >EY&1N00JKZ
M;)Q OT)^][]">I7 H^49F8/AH07ZK.<)N0&'<>6Z<9DFC @A6ZEO*J+"@FB(
MUT-^+)7MK+@]T^5G*,Z>S\L87)E&G!J.I>]&1W9ZPJF<%[.F8N2*U")ID(N5
MI*>PFO_#-A5L'@?18M/X!K<6ZBSXHQL79O'//?W3&A,GT1*#*9G9HJ=2J7><
M86>M+*W=R+:Z]C"5_UYE,[ONAZF_Y.QV8C\&E;H:V+9@(.#".W@)@?_8>ZHN
M:S4087%SID,;\/*I8@&5-'76VF6Q'W^8#FUQJ>15<!.1)]3Z!I_QFZFQ=80"
M!?CADTZ5DSJ5;YTA 1/UML&@L+M84XK/T9%^&T^KB[Y\518)+*B7V!8'&G8
MK+_]/8N;'/$VZ"8=-07[XCKVAC]1PGH7#M1'>&&JW6"2*/S(B%9SE(#,'H\]
M+M9&?I]C1@W7?9[BGW)^8:4R:G=(KOI0+I4O/*GZ+8_/,(B2SHU6L%5.=A[]
M\[_>/G05ZOOA.YSI"L.16C8O6F':P82>ZF-,1\1)03*O:#("".-FF8L>]+%
M28$)].,B6]/^!,?05<G!(][%517/%B 5:LG3]Z!4O8WS_UD4S79%<?#17V4=
MPVA=25QH)^M^F:B@5.NX)=A!6L:(#-AD),[EK :U12S=1F/Y!HRK$&YRBY@$
M7WA=Y;M:F_%LTGEC:&AM,*W>I9]A!$O!IXC%;<.-]N'UR?LWT7+Y$42&Y^&R
M\PV_X\;Y%6N$UHI.16(-S:F2"^Y.Z(R!(EBFLR)'D5APR<=0?D8&/RVI%F*@
MPH]ZH6.1F2X:[94F]4U&T.S1YYOZ(%9P_<R/Y5RY"34K=N9L^LJ.H2;H#*<)
M; /8?>O*M?)H_\KCB:N5<8AR:0F75OX4XX<T4UMO2.5PK^2T4VCBRC_GI 8A
MM=.LW,?@2__;H#$D[9BS%H*DK9LX*68,-/)[G)Y31(N_^4'_GGI=?(8/S:6D
MR2I2+T7CMGDKO^ R5,>LH&'-7\*/I_DD.HDS4_E=.>_B\A/7<&'PBVXC9X5J
M/SOM2[[E+Z@!^]U#V9<\ZH[Q(Z[O.?R3!R7M]=YH?ONOX_:9LBH<?GOSD-K6
M:%HZO6MMH+>?8;T7T1%L^T),EW:JJWT'.2EXB.P[_R][[]K5-I(NC/X5+2;]
M+MA'.)8O7#HS?0XAI#O=26"'3/<[GV8)N\":R))'%PC__CR7JE*5+!D;VV 3
M[35[)MARJ>JIYW[]Z^3KUR+\HOHS>--T:#F_WK8N9;VR5@NFO%_UX0J[AR;S
M44KJX2T6#[X+R"("$V\$#YZ$^3@*)(YUN%T$J1XLW2GDQBAB 1A^%P;4@N:M
M H.> LL9Q]1 07?-F_B9LD9P23\1/*B4_9T""YI#,1G%$:NZMW#9,2IVXSQ2
MT3=++2D#<BLB)I0:S'WU(M2_9FHJ30;3<V<P'3893-N=P;0$LCP2,Q=3U9\&
MCREN).TIBJFI'KO4E@8T+N#_.C,%[6QS<'?!U"N4^G495A5SOI^7%?QS(F7^
M((Q3RD*53;^51P8,AJL@DC/"[]!=!NN344 .4QO&/F;DLG..DG0%V.A*.-D3
MPPLYI&:'4\KVK!4309JADZ>.\>K[N197 O\Z!\4!=&@RU3/,!1ICHS?2-M^)
MT*>H/_Q/RWD2=)C3SGY"?, [T( HNEP5=4,?_3MG%T$I_9;OC"@ULJI1G,#K
MT76E?T/0#Y%6L3VPP']%J/SA*JI> +Y7Q&OE5\,?UDI2V0A0G,2#;]P9F?UV
M8U"7L ;$&?IC_T8Z\U LD6?/7%4:5&!/@<H7T$]R;MV;YE?8[04W/.!"'$ 5
MV4X<,-1J!8%*$N&I8'5O8%97&1 Z'8'!)+1'7U4B<+^=6+97)&>4!DTZ%VSP
M?.99J= L431G'>Z^I#"2V]2EH&QP&Z"C.1X(064)KO%NL,9DD=!-' ^=:Y\R
M[R-9-C3&!G<);UT^C\IOC''=>Z7/DLYZ1;HDO#>* 0<F&(O1.O@5AUR0JZ19
MJCJY8X8=[BXAB)0VR$Y?8YO8G"B*B[>C2PU58'JUX>U#?1AV@<XZJ>^359!'
M@/# &GYHJK^Z!R!H^)L(_):^T?A+2#N4$,5GQSG=H.+'Y 3@.FJR):*4JZ],
MXK'Y]0-<6G,58M-4+@5,AZB1+5^V<@!_T)0UGD8J]A.D@#+EFV]5GQ54%D1I
MGM#^^:P<V;(%D^SV7RSMZ@797:'YQW@2QO="TF@:CX5^DU'H_$.B7*CU-T0[
M#7]7H8_.^2T#7_--;79+)LNA ,;DL8\7GPY /\#F-K:\0%\$N1[Q;O'Q'*23
M?P,7!GAGL]B"I;+@L1FKKC0KMD0XB6_'QCAL&E]?HU2!)4!UR@>!' (2!M^
M.XV0M2)C%Q3M(]L\H-9KK "5]V3BKNN(6ZJZC/.;$4@O"DHAUR9U+;C&CP9
M%T!1KC-&#=Z)X<W)'9KW5R#>KP.F88(RL%\32C\R;B94A%VXU$"Z "<C3J"[
MUAFWQ+%&*:$PX!J'M^RZNI<<=9KUF0P#]2*+3\@1$"6\QX;4>-/9#WLU?PE%
M7J R^+)Z>0[F;K#T. P&]Y@2DN:R:2P#>]J.T'()E6%: 3VZDB +<4&ZUT!J
MNOXW$4FF!+QBX./!,ME#H'KU4E"RQ$QL_N8JYB;UX'2FQ83;C@32/W*K#&.Q
M&?:4E5%L@E_A6V1=:N9&:Y%N1?X([VB['1)%-^-?L;*#.YG_R.Z%\SS1]IL
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MRGAV=>],0ISZA+GWMS$S!VS'CO\&/,+L&_@Y%<.H-;#)L0%)RM@WWBJ;K52
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MC8;4Y[0(Z!G1.QG.H\(V)$'-UF2:K&Y3I>)_Q7KP$$8&B0V-_6^2E%.A-_O
MN2C&/R2UF4A)IF9QB[6 TJ#,D'01_%Q+G8&J(RT5&1#T.89&=0_<_)KN#E0G
M5L6!F\ENJK8&4'/N(0; $=ZAH*:SV(]90DS",$BL.S3;+G+K!RQ ID3G^"Z2
MS<A4@IOLFLQ*AD+1M4*,S5EU/M<8!D':GI$78%3XPE=CU($&27!5]'Y6\6$[
M.OS,'4T?SI# /N7W5@:$U??4#ELW0F%&DJLL8-H,]K]9VBLRHFNNU?2YHKXH
M^/J9C &['.(-*WM%'9GUS4(%96_D.%LU1FM@]D8G?LV-^HD1Z5\5F;?$WHO+
M300V%M?F;95JEZ(JAXR2<@IH4#5N3C9*K9-^_CUUNX*=L8-@4&1-N[)7D>I$
MSOW.93<1N<?4VB4-LA*4YP#<'_3,^$Y-(W2N<^YV/R-O%C8! C9(1\I?8U;G
M51_/)<TZQ<0W_)ZD3I"E4]MM,FPW-X6Q=]QDV&YWANV:PQ=;UL[]A(2*ELP5
M@OGYO$LE'["NGS9* I&)VUDGY0S>^K1=.?F+A!>Z#FK>H:HT[!=+*S&5_)SD
MJ<R&J_),1=B\"^LLJ ].ANW7;^0LC:)O4@SRY,;7TVO'-"_65*II=X-!C-Y2
MFKJ!FZ)_%:61+'R5W.?7H)R4S9NO\TCJZE?W+)N4NL[Y>6C7R%&P; *7J\S!
MC Q2[G4YR6'# V-'/(*')?!M(.X*<T>I!/!K ,[T60">J%FK23AJ6BAYBF@^
M7F@^3#G1<9A67PWYC6B"K) = _D)<7U->Y#7O/BAL(E-*G,BE<5CBGJKIPPJ
M9>GU/5ZV"*\+JWZQUP:I]0/8>N&!LWS@*[< )Z"/"B!R2?Z%'\'G_F0XWE6U
M@.3 !C\BO09L/\$GJ]^9US[9[]IM]L^^<WV4<S+(=$-4#?(R@F P@/P=8J@M
M_BO6)I,@Y5F&F)G-@Y.F^RNTL!>Z>O4<#,I<I-))HP&&#AD"XT*OH,9/V/*!
M/:UT>NYTA &=@C6 =BF S.Z7\!1IAU#AE[;XJ57)C9N=LY3;-6JY*4)%0:B@
M*.P&?O@!AX7VVH>XIR]ZBVN8Y+#_1VM[O;Q/[#LQ#=!GU"(VSLBOT%VJC?7'
MJ#"EZ4Q3&DSUFPJ;N6(7V@&=.C>RO;'U)+6'4_9U5EY'^\RE"F0WKZX[.#>L
M^T8> _P86&31&+E"BRJ4!\,E7RQ=XDM3FRS>S-I)*H?9Z8.G8I G078OA^M:
M/T9.:A6\FVT*BQZ%[&N),'G$CZ33F +U_A#=OS2]"Y>1D^MPA%%$T3G 'NRD
M?#X#3PRUIM2DIWP7-XD_EB)D/AQ4RHJJ!M)=&6M"#==Q[5*Z2JAAH?.QT,^V
MIZZR5U[#66=RUH6<G2IKS\$J4_S?@LO2E'7Y725C7>A%S/P6VULP/:Q1AMXJ
M6&2-L5FPR0$ZDH?4.)V:HJM'=("#S#ZX"[FUH@>%.:&J@J\N?2C)QY0A6+D
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M2RR<(RPYH12T34"B;H-$VX5$YS23H,&B!HN6N;&5CQ7X'$?[9Y1?:V#@!]T
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M)3%\*<7PL_):C>^UDE'?N&W=T%T70T'E4S9:D,ZK%!B:&3JN'Z0(FV&?A+D
M"'52_% .(#G7>5F"E,1U)!5MJ73#;JZ#[V@@*#6,>(>IS4DK7#DX],H:+NDW
MX,.PX\PETH + \;D\N!95G-26#IEKAH@W7PPO8"NJ=4C$P&K#[45@Z8,=E3F
MW?2&$?E1YA)OY'I)\\%(FE/3"Y:M'?R;KA/)[E5'^CIWLU%"I&^+O\Z1:UC5
MK[KJZ2L!:$E>4,//(+T/>S5;0<3'E\\GMHMM KK FSO*IUILHRR3J?7BX@J"
MC&T LC.6:XNTP$B6"A1*X,9^+D#NT-B1S#*S=[0=G.F$[^FMU,&?50W4IO-,
MSJ/'O0:Z+[A%X< .4 K5\C<EGD#[8:];M3Z$YM)0L+ZAW)J&#A2#@8(_'\IF
MGRGZC*U]P!_C(,L$, _MO<.4"]@ P#48EM\Z>R(MFQ_P?8RZ4CCU4]B<Z]R
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MJZ:PG01LOA:/2<?7,3LHZZ_HA<E3W)I_%6-"B;G;J2H'VC%F\PUD?9=,[G4
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M0Z[/)>Q<7AM'J&'*C*GS<$B,LNQ=9>ZDOE7N0*GPO<6J<Y%B%?SX2I9X[#U
M*DU3JN=K2M5MFE)M3[*"U9O*[$55[E5E71O=O5Q5-I>B3Z362?!^XU@7\B@,
M)/+C%V"#Z="?I/"I^I?^RL+-G=K&],6WI6Y53J_[D]V3V_ZZ _NO[2%8_.K!
M?S;+-LLNTX[]:)D1:JHYI"3R@M&V^I/L$?TK9Z\SM9KN<M_9V8P=KF$=?4:O
M]^ A)>OB/\WN^6"5X'_VRH\H;FJP1/F-].:D<0A8,)TZ6)(<2SM[9AL&W!:)
MC8%']55_=@0]^%'OCIM&K?GJ-I7]/1V8/X.%M0[P+L-R7RA&_THY+>_\;"T
M7Z<$^6&O['-.H9SXVKHQ&GKR=(R0G<V!2)]Q$__$F%-X#RL_ZR9T7N8S[H*5
MBN>\C#.& EK*].;=O^UM,D=I^$K#5QJ^L@5\1<.AX2Q;RUD8BYY?.(EGW,)%
M$@PD_KYJ\+?!WP7Q5Y46T(LWW5QK4&@SE2L.)#_O'M"#]HSO_XI)6+_YM\\I
M"C['F?.G2#/0[!I]9AN)^9.??!/9,V+0GW(*0<-,&F928B9K5"Z;,=E;/R9;
MIX;^;S 8^;'S6_XH;-F.N9"]U]YK+'98=G^[WMXCYV9N*F2./;??[S7#1"M
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MX5T $J*8]"R5?R;7E#89#X 2$64U)S=]9DQB>M2L_(17AU^T1 NX2)MV!)K
M=299E^5R \&)O-+IMN'S^UD,5RX_OWHBYP4R<R4M8]<0\5+=D+LEBXGW ILY
MEIN9WK/OW,9A'F4HL4J;LU\\8ZOXEMO9+UG)N6T-Z^&S YAV85_>T=3&0%X
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M\\^!#7,&0.5U :E$F$$W2(A*@6\]@-)TS&%,?H%I8JG>L[RYFOVB?X<S549
M:\H]8RT[=265[W$9DL"#4N#$<)J0.7<8W 1HG@-3HAWO+L%CX2;C_(8IRF0Y
M>TYP[3HR?6@2!Q@0(\>LC))> Q7.3&UT'[YSOXXRR'[*)Q+OU>W/QOQ)(FZ#
M.$]1)2H1027$%1&@)*E&)=)V?!5,!26!E:=77J?5=QWT/=,_T=<'Z@4<.<%
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MR86?1/OG>2:A*+E1R?-=?XC=8A-&'FOM\S+<TNNZ1T>>V^E[Y02F:H=1\1(
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M]DT560V<MAN3>MOB>V\,^2=2 +X&?O3?P/D89*,@'SN__0'&?,M=FZ/>:_\
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M1Y 0Z!Q@6++_1()GS9)C&39KK-"$$9Z0/GLOESX]][C3=OMM;RX/Y0PB/?3
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M^1FD>B$K4,U[&Q+C\TG7KD;F*X:_2N@LWXNZDUVCWU'M'BJV4#BUS)7!3)@
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M4-*J8P+R)H[ -KR'?S)MRT-HWYKD@F75"KLQYN.QKZ1 G:JFL-P&F3,$# +
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MR"M2MJMK"3#7B+UP]PYHXO' F-$SE65>3L"WZTS<"HFKCJ$$0DEDO.H>5/P
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M=NQZ%>.(%>A$'YDL2G,H@A1CB8E@)<Q:/".<PI'(A1DP+8<_(5XQX'&!FG>
M=H@3(:ZI\W-\S263P,^G.(9.:N!HI\PJK?/,2\?\U-XPYV0?5I1>=]Q-' :<
M:GS-K2SPY9B@3,DQKG0(Z336_^9^DE%5\H._Y01B=0[2:3%DP1(VU.D:E-V*
M2Q>^[4QF$=.Y98-DOQ!PJ&-7.F?@U8 =R;W,VJ#$)?P3$[S!HN)DD:);A'D!
ML(=Z]NWK^Y/9-2G' XJN7_(-A<UV>7:J;^S!]EF.:NS.+</D6D%AL% 1YQ1&
M5(! 5H@_U&5:;TTF_E*^3]'S\H@G&SB[<%A.$*.F^)6;Q_D,,5#"=-NO8X^2
MGN!L_(-7AT=NYZCM&DG=13.<.H*NLB.?AZ+W53;B%&6K4-:#%.ZG:9[H */Z
MU32)5+?SA[LBUZ@Q3$7R@L1PVSX%5V!7*M$RDBJ&374;<=4Z2C-!G0@+Q$=#
M<>1I9?\5!WLGIEDEH\@* L/R:")OP<?528E4(8(EO6&F!\(,1!(QHU![-[B'
MG'T!>R;',I8S^<DPY?3BN<C5E7"WKIWR!$L4T#LD"C#N4+9"J/0MLZO'2-W7
M *<&OW#U"U_LY7Y/]<E1+/"O8FC#Q*]C>E10-XW:PZ(SX H8QU:0_E?_NT7P
M^/=C!;G1!@%6H5%7 5*S2W_#>Z-((2A^X _QAPO<6*;V9MS3?++G![Q8'$;"
M'<<M?HX=2#AIY"%>KI],M9D]]TT9K]CTNZHH+RCN8DUWLRB;NTC$_HE,\)7'
MJ2LK,.VYNC-7^""61\\/U=W*+_WDRH]$NG_^/13W:C)9I]WNL">ZG-N(@^PS
MZO?!.<F&&E \!+>]* @G $+9?DD"!Q&<%Z8*!>RDD:$D6'1ES/6A==3 %<40
ME]+_RXUYJE*]28&^5?K2PJ_02C3PY1R6H]PMEL?L5- )/9A(%J>& B@GTE$3
MH4#.3BI?DBH8]XT @0C9,N%+S49Q(K]9_CI7=FVP&ZQH5[580Y&"[>Y71/A+
M!VXY'^2(^.)D0:K//'3Y2_WW \LYXSQ5RJ<J?.2Q,Z7GY!B:"(AW>@W9WPIQ
M'4 RIFPX!;BB)\_4GEK806B R5\#C /=4 ]$Q"'0^L* TAT&11LOY3R<TSC;
M4WVPJ(A44PMK_X\UETD]70*+E&T@*U&G[G8V1T7V.,50'9.#@IBQ/8^+>G@6
M8,9O*MQ3!QU]A,;C]Q(\?HO@PU1\9_HTI5!=#Y2.DR]?G0]_5F&^\>Y.@?FU
MA%!"?!T%E:N]/?_R[NS+_NGYQX\G%Y=G/ZM_S#Y3&0 R5MI^PU>!2+?S4)R5
M]S(CG$G13/E8*5\%8Y>E\!]&_Z:"?R7 ]I>(1O9U-#(;EO8TST[L.W3L6W/6
MBF2X@9U?SKYSMP%7=14&V7"I?0"7@Q'HL*$9SBN'\.J0\.A'1<+>?#CXRZZW
MMYE(,X4C%9B1SH</"QHXO44-G*^RM]YLSZ'4CF3J.FHII":1>@0O_HZJW*FY
M2N6!T3UX'83<'P4+05E= G7RA'7U+Z075JHE#5TL0!>=;:$+Q3LWAQ:$VI%$
M^2N!R7YS8B[7> ]4DXJAPY8DJM\T@8+J/Z35$\:R'0 6A0_PZ8?P?AFEI)R*
M5<;2E=)%00X%B?!.?VXKO9"H0&+H'**?3RA7/OQII^HG4EL]5M\2(LU%;L[<
MYR.#9ZZ=3AMJ4^KIH^A-)K#)C[Q6&Y\DQNO\C6::M-\XMKJU?P6X]JUTBJ55
M:T6[?[]*7O_R.4<#>UX]CO>N4-7(@VX BX!])_0$BC);M+'9(+MIM)26Z0%^
M4P%<XVNT6P&>T3]V.FND'*_](.F@2)J^WIU?.BV/HI&]N;%D4=R"-QLF]"C+
M)C^_?GUW=]=*Q:!U$]^^/DD&H^!6I*_%\,9/7H.2X[]NM>1_@N__[S >_*/R
M(>_(._9ZG=<X;,AK]P[ZQQW/ZW<Z!_W7P:T?[6. P.MTO.]ISV^-LO'?0*"(
M[R<[OSS41=-L-#<]]U*5TC[4>[[E.G_%R7@4@XSX))(;&KAP94RVH(S$L\MB
MVI YHPA4.MDB#^<9X3_)YOD<RWY]'OM2L:,?;_=23#(CG(%I"!0AV;6D9EE<
M2D[C !Z4.DAKIYS5/.UR.@*+^+U@"/;UR=]?X\]^<7;?@^A?? T-AFZWN]_I
M'QT<>WNN6I.UB2*@4/3/08B??1^,L-4-GG,<<$-V^,_O?E3T$^QS/\$]5!O\
MAD>T.IO((RK)WSL\[AZ\SL8=KW/D>;VA]V_QO;/O(?GO_%)-1O&#775-?E!#
M9D_ %):GY%.N"- :]6,I^ B[5*V&?N'N]KO'1[W^DN1;OA89'VXHF"BXV_(V
MEW2/NUX'I':[ZWD'AZ^'G>->K],?BN]=2;6G^$+J\$9>]P^:"&3#-Z26DP^Z
M?R%^.A^E='](2K$[YQXUDLZBD\X6TDF'Z>3M?>C?I4M21*>AB(8B#(KH;:/D
MZ)GZ7KG)^%\\,F>AQN(N4@Q-*1?9G1#1U)P%'L&*LWE".;SXJ^R-+6&"+?'5
M+\BZDY-['+A;^._YR+/7"*R&/$ODV?F?IZ'/(<>CD;JDO#%\:6P8J<MLK@:O
MQFMO(^OTVK-XYUP#&F9S4#:3IS64Q:9</$Z]P2MI&&C#0&TJ[?QM&\E4,F%"
M4J )/<^)\:#4X7^J27\QUF-NRFDL@X9R2I33W4K*Z3+E5$@1BI=\B#!8B,1S
M<H<-V2Y"?P'YTFVHI*$2FTIZ6TDEO8)**D(11"DT4]B@E\4HI==02D,I-J7T
MMY)2^DPI9\5LCAK7TB<?7B+#CL<J;%AR+.EY?/\;  ;%CAS+MU1$$"';$%M#
M;#:Q'6PEL1W,2VSV[7L'-?3V.^99?\8&D^E*".V@(;2&T&Q".]Q*0CM\)*'U
M:PCM2PS0 1'X#93&P%\)K1TVM%9#:P^E^&]!]6FWJ3Y=4?6IHQ.WI^M/'2Y
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MVIBJ>L.^MA0.0)_!,46:8BB)O6%#Q)U:"/@I;8,>1H &[(/FE^?)!# [Q8<
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MVEN]'UDI+,&W2=S&J_QC_W[?Z D;.8<1)"._!]9KHIU;PR%LA8QQ/T)6@U_
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M/KJ>>Q.1)6.XUC.&@(3SL8T@]?P;^. #,3Q8]AT&&VX;S6_P']IF#UZS]>V
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M)5;G+6V1+A7Z.6F/OJ#G8>3)Z8Y>_M 7AM7M>L]#RWV#%\![0P"6Y</'KN$
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M.1  (FL( /OA(%L$&ZL 8$A?VB8Z@)!^*JB\-.R9"3#-H_W3<7"!K;/F/#$
M<J/I-Q[!=G22UII!<+8_FDB6@@ )65)^QH5YC1WR0QVOR#-P[SR#"FBYPHN"
MP5MB.$QCO^2)?%94,P/^8G5&SD4SXL%HBJD6JP-Q91\*P$[O3\OW+3?L^'=H
MG]]$>-APL +0@PRB<^#HV/I07A?("\O+7;]EY[5-A$0C=ZEWZG?G+GNQZL:1
MV6@>F <Y&7" ?;PB8T=8W3YJH$4'8<@5:HH(0&PP8*5P\);6'XKN3@M)-&I!
M]I6(""3X7 B1T(P_W)Q3G%\2[Q\5".)"H"?$*ZV%,>)Z(E9</M]0P6BBV'Y%
MSF4F!G^R/YIVGV;PS+8/5\2V_X 3GH)/QSZP$>0QRTA2C76[\OSKV$?1Z6&Y
M]+7[@-X)F?R[B,R<12IBQLX"%?/2'2Q5W]Y5Q^J*,$6ZXXZZ*_S0<MRXG4?F
MUE$6\BI\*:>Y8"'C>U)RF\[<D(<>RVSB.^<4_N.B2")>XP%H,>@IO^W_L9Z'
MGPQ^@%(8+!FO"?AU0DC]&5&-%X)0@)_N0W+URE4\H<GFTKJ#6. K@86+D>;O
ML[!4"[9[=BO) ,B.M;O3/-Y-(*EP.UY9&RSNOO4BHTD8($6O#%S?/#TR;.LM
M,,@Q%M"_\+IGSQ5O2-7?X:1Z$3IUGH5@W4Z>!> 5FZ"!3'Z^BP9+\$:VK+T3
MR8$PNSH:/)$^QJ\LV2WN[>RP0=XZ(!6XW#8-K^R6V!E.WQJ>.T WHV$[/OHK
M_MB_WS>TDPJQXV+D Q !79\X1$ OLP7L[]EQV;.LZ9.F] HGCETPUGL?C1U'
M=KP<=11;N>YAPJH=1[_-1L>9\QBI&_&S%'+SRE(N_O4Y%N$+ZXD)M0_K>O0]
MRZ;*8U\DSM*,HPA_<7K &$#, W^P])UFV4F9?TY)CL#B')YBG0].<Q#V*62#
M84,P*O"!@!3P5^Z;,?"*+G'$-5SVH^#%PF^LN.#-H0?*JYW8%DR2><><<GC'
ML"N+&QC/>.+PVI$H;A*BT.*Y&)_! '+ UUM&SW)\1?0OUB "//U/!.^"O8#:
M.P"$#TM<:.>*(8!XO8HP!T.M45OB'P&-D6:(@9#"E!' A9D$[C!*2ZE)#8O3
M41'UBWZ@$BAZZ")-2SOBA_(HXI?6,WV*] J<)-\B1NRFJ]13Z8F[*M 3 MFD
M;$]LOHLA#7@:G?@+O.;)%XRA!<&Q,M38-W[W7L4+)A'HKZ%0$G$ZR7A$$<]Q
MI.CU@G O1$DHSS].>GAU&:,P,(?.VSD1Y:$/#^E[ SM!DLXK$%'0=X8KQ98<
MN^67A*X8*EX4(G\@C'CQZ, 32:XN"H&3 G;!K1YZP%Z=0"30LFA+/EBF>+,6
M6--O#:(><$!'!46<D&*1S&E\04^R>409!E*$3[+/U>)Q\6F-$Y_["\]454"4
M.5NKSUP]2>=FEN8*SIJW.G7::C6R5E>;; IX('/K)&>Q"_/K2I+PVL,A"-KX
MTF_-XM*8!:!42H]AKBFG[Y"R@7P*6%-LC^AQJ%0 1O]&WI0V.XB;##$>C=SK
MC:G9!K[/6@=E5&"P.E9^0&*G7Q?%IO0DJJ1PD!<E.FB.:+$X',?+3<P <DB2
M:H!^EQ<67[GO\'Q-6P6=&.T8]M@8I"SY'%A@?0?Y;D!*+L6T7ON"%C@BM (A
MOJ<6QLNP!B6;A86@U1)UP\RK^9' 19\M.-&LVAYX \&V )YUHJ?R@G..-'X<
M$) 3#A13IF/,.[(X4\8 )2U[P$J]@!_= G5$"GY43>&%76?(+FN2"QOO.* S
M-L&8CP+2KV(PQ4(2C"FTMB3:L[5:K+RA 8!B<^B+%X>C!+Y W99!IB,:_#JT
MWNC40^N';NG)C(6%6[M#O!@W+&65.GLZRMC(XY7F(EZ_%-'B_"52&( 0$B-U
M?"!GA 01-A)B\4VXB!V+J20* O9ZQ!&@!ZJ9R5D3K:>+/<5L]K#C)IXY79DM
M$7(#H5L4C$!.Q WA L_'= %4?8!7%G"^TGB/;//CV^@ 3ECP59P<U$XR@NY1
MQ0/C+3 ^>_!/;)(I;])5^_YSS,US[SOW;+1AF1O%*:/WY_%=#]X0EG=XVE "
MXP+.')X1.0'E#7V1&36H5E("U25M73F+M$?B0Y+TFFL7E,=N'T>QB!P+0)JP
MBM^7&0!)NF1 QA+L[8GFXTJK";FOLA7+HB-3V0 W(GR0[VG3:U;1Y?4(,R_@
M_]&FEHQI#-#8CA_KL4''VU^><KR1#X(I "P&Q&@P)_@GP,F>]8)V0J]0J,*1
M]C*2&6_&7"VD[]@: .H>6*^QUT.=GNT)OA!W:]-<8WQ*WA-1.,5Y:<IXX20Z
M WU@Y/?*8I2)&>@858G]-]('1RM!KDTBZEF %06?1,\,(2Q0'+#%!.CD 0&R
M&D)^.<4H+-L;AB/>-9WZTT=2YES6=;.VML([M<*OZ16VM16VDQ4FX4&E7X24
MSZ9X6# "CI3VX4>#Q$PD1V,2^*77JGDNN%G)CU-+O[\\UR*4+E8B#C+OL+UN
MQ E!25CM\CPIF4@2$0O=4=<]$[!$>A&L0N6+4SUC#T& .)G!Q]@3&^,CH2%I
M?-XCN9=SGY[%Q3%8*+>>*%]Q7AF>TU^1F])R,7KX1@W>NT[(V),]-;Z$CRO6
M(\:>[+[1CK.U,.*,,>L<Z0WL 4390/H\2Z2XXTO?**4U]G0=^2VA6=0IGP"2
M09C.G-:.AIA(RNL$2G60#_I<PR _>1F?F+&(KCSV.,@=Q%@W*6VJ:W(-I[ZE
MO&.D%Q$$&&Z9UY)B@@XU32TYVF76 [M/0UF5T-B&'7'VDZ\E=!<M6N?=A73D
MQNE[9NIA*54NLZM7RWE1V]*4(S*M@SR/^>CV<9\93,IW)$YB.>9L0U<-Y,*E
M?XH<":BP>T4N31\HV><B +?<QXVK]"*%U [;=(%P55&VRA9837@#< @7%'O_
M9'J\>/*RZ42QNCB'G$E['L(^J<JCG 3>ZSTQ3V!"Q=AD#V2"@Y$.>"2I+CJ9
M(VZC$Y?N 2,D4.@ !L7SZ.58+,>Q3L8@C ER."%)Q<$RYV&LF&J4)W%2CV V
M#^+#2P1?+/3B<-[!H1[.2S$(_6+%&+"\)38N5&]T5IN9N](&PD")A2P1D8<7
M@(SJ&Z#J$^(HPZ]8K[V+2?,+)L$GSNL_&6UO$6//&6%7ZL9N3>#&+DW&#KS$
MHBXTI\82IR2&]<4>XUPB\0-038I0L,D YTT9Z_5\YI7J-^!B&,\56:XF12IA
M!Z(DQX7SR[?F(7JB\U<O0OV<RAG8>."89)>"?*'SK&7-9%^>."[DLHE]J+H*
M39K(V.E8(5'L7TLTEY(TG"2B$R_LP;NCV_C5TBO5NT3_V=L%&"O 9\]EA"K'
M4%P()26^JKW6&&=500 Q!W9I_2HVN\9$VS!5@+(Q])OEN04C+N;$ZUCJ0&:=
M8$S!18YBC'HA"H 8QU=#O!G5U,$T$PIA),9*8;!2)LT4H^!7>#,(;4\]2"LG
MG F7Z'DSL>7#4>_",RTN*9";-'<9R"^OD.D@6_@>@XEK7!++<<1^BL,"7?2/
M<@@B*>45/["V-:]V_=5A;2@:FIKKWZ)\36 UZ*@.I-D&1_J&4>6 G$B/$<<T
M$]$+YE1B\E&F$NHH@C1Q4T/M-.')/-VE^V<I$=A4#<+5L&,SR9L@UT>L.NBN
M?("_+6#C3ICKI];+EF)/]X[*4)*_PU)8OT%/'**']4/$[<I)ID1#7$6)(^ZK
M]<-YCIZQ*.A5V!?8R6] :43KZ&';+"IWTHM-I5?>3I8:%UWNH@A')AE[AUS*
MI)>D Y8%!3H(,GK,/H,[#&5-+A(Q*%X!^ K0D$[9/$8LY:ZRS:R411U03;B6
M/4)7,9ON"E1'>I'/+C8'>)+-E*KG=\$"'4HUV56)8%,06,_#@Z8$A2BU1Q,5
MBK^TA*NL2\<7SY9#^8>IW2C/XB.ZQ/':6(<RXQT(J4[A@;V(^$WD?2=G"+JE
MBS0G+>HB38=LM:GUFE5KN@/+>28]J@L[=&*-#KW]>)(6IC]E]LNVCW14L:>,
MD\HQVPQ!!^]9?%J$0;BNQ\-7GQEQFIL9,9(9,%/OJG><5)%M<;$)C<#&YF:L
M.NWB.M]#E;99WJ&ID<LIBR2:2C!(YQ6,"91+/[7T^) $5!+*@GO9#S53PL):
M@_EY@$NK33MD>;TSQ8GS&:9U1.LJ2K$G.NN'SAC%/<L9!%-8=?+>C!6C);@Z
M:3LIM9F@SWX4SKL<]71,XN0W.=*2E^03 X13?A.=+;'FT@B<!1=I9:4^A$6!
MZR&;ME$6<."SC0,+XY)%C)U ")7V44*^\D/LFA/.Y"A1FRS<)W>><&2TGEYD
M*G<&#W=2QQ@WFXB%S#CFPWXY%95^@7-1_@F\,T=.Y?&>U%E34"6!B/+4ZYAD
M8MJO$R0:/:V"[&^5+"4S9F*]/7!LM$9E@D:BQR=+IDINO81$LU&R923XD-UX
MVY0[/B['+*F G#S%[)ML.2,[SFC-_K#7'Q=+VL+Y@A%@EMVK[B#!L$YR[PH1
MA4Z5YB5*.R54/ER%@R5"6(MHZ8$U.G4G03]LM3/(VE!L)\:2$" M2&:^*0,)
MC&0+OG+ <L.VQMS5+!#^"YP28@I2-PICFFR!>0TR#)!^C6F,=/J2">NQXT;&
MDM"LSD8*29&E@"Q%!Y&9H,^'/3-*?B$D %EZ#O:L!W!3$HW*15$-#9-HHE?0
MW3"^PI3I;[J^ J]BBL\G=H^KIN@KU!!X<3O.[CM%?]E:BZE@M"(-+B6FP[ =
MN:&X+Y@5)PW8,MI&$-<TC;SZ-I+ZTF5NN6./! ]CAFX_.0K< OLP+8PG84<R
M]OM'*@6'(9T2#!+LQ-!-"3M=$3:52T5R&Q)%24NO.)<4722D7I<Q%F8AQ?RA
M[\F '/?L1-W#5Q55E)^!YH>NA:"7'*/$)55:*B^&(GAR_?+)#O(= '%7X$YW
ML<4\;\C)WT]2+S-:CP<2WM62^E(ZU;C:9IF@HVIJ!TEZI^[_U3[65J*%RI,(
M^4%AA#Q]>2HU5-?!T&_N)F>1P M-YCBK/'(U\,7;2!UY6G2E,X^ILYRC"2PI
MFN2!)TA&\B@BJ0$/WF-<XC/)Z8E(-0$*\9FWLYK$#XLUI=2B2.V%F^1!]MYR
M4$D25)Y;$3 =88TY/^31]?B! $V;?*!2FBI:0O^OC)L481,Z6&1*#%5Q = E
MZ]2Z$_8<_WG7+*,IH65KDHGBB$(Y3.JVNE&%QK7T'"VVF+0P=KB<''XFPH3S
M1C/(3.Q-Y8A5Q_K=81<LAXG'T>_XCKE+:&>^J(ZY*QI9D6L2Y7AQE]]GM^/F
M-]TVC5<M(S=NI!1[:RS7A<.F.H0\A4UG8&5MIS-9F%;"4G-!U(XU11[<D33N
M;;9D.]YQ;TZ>D<1/'Z6L M1^4BTSM3[3V=[0LS>JY?B5KWH3<(OKO6R+Z[%-
MJ3E7.+]W;EXSW"F72;(E-[\P'=#.!6\J9LW7Z\O(Q99'$;X*X>I\RAR%NMHS
MMC#C]J"1Q$SNSTS*!;<$QT2<[.TR*4(:+/ @V=@2'RE]YZH)"&7I /M_42UD
M*?.I(Q<H@7 !+V<JH00V/EA45]EE-+[K/:PB.:I,'WT)LHW@I7=.\)U1^P]7
M4B_)K)7QL*])6PI5=TK:ID"UV>*D8L.!4^S&Z6P+3S X[_SK^F*O>:;R"RS4
M2K"[-R,-2% 0D3[S&;2>,?F2W5;LC>ICXC][B/+"O[$*].* K(6[T1G*CC_#
MQ1P%5"28*-0KLRI*TC>9DA?()<6-E^/>&UJ."*SS5_(I:"W!I:+2511*=*+:
M>TCXQG4LE@UG%3=5874SST*<9!83JXSC1S;9'KU<>@39!K'_BE1/:P+B,X7M
M9<?IV+GK12%WPL8U4<J2PN2Q*8^5H,$O9&:CLHP(IGC.G0B *75728NZ;@\&
M +P[P)C3:!_F_$3$ FUDW!DL:N0 IC]UK3#I7)R:*Y:'<Z;$ZJ))!2 ?<$#!
MQ.U&.ZKARV?+_:Y&&E<B(H4& $@XK2,-SERQM(#>J^=_IP"*P&X7X51]9O_D
M>R7FKJ),L%6PT97@6B=203BD69?:$('$(KY(;/T1]:$  !U0V:S2<62[$:UC
MU&P>LW^A0ZG087;RK=62;1.3G[])ZUMWFMW1[ O[%LW[!ZUT[/.;_LT$#1 G
M/K2C?.0D1J[< W%+;65+Z+W]U1">./W1D5TD\TN>4&<=>-8DH+Z(!*8HQ/MV
MQ)@^P=4"[5$1X<="4L$W6SF'\4(S3BB+VVHE>; YA9VC[;M0<I<X%?Y$_Q--
M[U:OI)JMB/H@9?)GC]2(@%2IDZ,%<YB5I^H=97/L*>OE%$RH$"==K*-]39$6
MK1DB,5)9O9 J6< >:Z!983HM.H01)C*/CEQXL6O7 "50LLQ8VG\!- W(3&F#
MB3=@6)QI@BA.H@2$H39'-/O*I?FBJ)]EIJ!GTH^3ZQ#XL0&/E9^PF_.^(WK&
M95R;T>'=I>N)93VPH(K)1\_WO=>)\S4^T^4L(D G#]\Z/9T0+GSKU:7!KU-(
MDF_I:PF LHO<(KJZ3BQRS6+:0]1RJ2@MX6*:@<##AVQU"K%UK8@QC_3*>M:E
M#SD)YS\*BRO-E).0IRI%+E$DH)N+W4L&*7][YEDJXFG+IA!:[K6B8O(HQQT6
MDRSV_.SXT=A5,C1$#T'ENRDXKT"^S"9;7D/WKZK5)EKYB<^]?"K5&/F 4 AN
M>==I,7'.,J+MVJ4"8P'!JUFG4!\6R%V:V8*DIXY/YR>NY!/-UB>%IS+", 04
MPO@Q-0U!:X Z&,91KJDZ0L^DX2RU,7!SOS6F+;"78UVDS-M':T#R*>@+@?8O
M'K#X3P0P4ZW/22EYI6QQHD%%1B2QL)A!M2C4G'8I%M&=R.YZP*(-;LN[*NR>
M=?CV'L@T/ HP0VS +AR(E3-_169NZ#F7)4RKQ+AKK,10^$PID2JK,BE0UEJQ
M/@K@82]"^C=>A18>TQH/*N.L*[4%Y)Z/2J;BIR1466E#/"E1;+2OIU!L,'0D
ML-P%W:1L\&B.6XWMY\FMXL)%[);ZAM))JIL.>KH&-'<,I^;P)]2FDR?^D2:$
MHK2KVC-%@2SI"%3J&$I=$$\L=+F1CS)TM2@[Y[3TWE1W6NENQ%_U\%YI47P7
M41!)'@P-6!]B,UG0J=%DV-"B+%YHJL622>/#P0]860#--R(;)N T<%FYD@WB
MT\G 1[+];-P+5,X2#/VH&T:<0.D"_H6.%0]:2[7#+50NMK+ZXJSN2UF)OI3E
M0Z6!?SH!=BXFA8-0!031/;R#&GJY8=+OZY8ZR(@ ZR8^#T"I6,KXZ9.SLY4.
M;I]I^G1+JFWW2-L^I<AH(--[I"F@33'G6QY)!O!O_/=<P"^$:XXH?F\9!PAT
M[IN>4,)Z4@X>2C7?W,!.XA(=HKKKR^D0F0: 6IJ-M$BQ*4/2PAV^%T/-N9\>
MZD Q8T17*PZA_Z/=OHT='62S9CQ?24<I4,RB@8R=3= 0+$AU!!OM!K8?'TVV
M^W(999W'@(3'+I.>JCST>D4$=9M@&,O !/+K(ZOQE.1ENC/(4"G:X 79*&,'
MKDNOGD5S/V4* Q-9DG/BY0]^+YH6#<:O6Y!:Q(XG<D/MJ0R66#<GMY?>P@Z=
MJ (37%RUIJY^4M.1&7HC+U%3AFW] PRGL"_!6)/:4DE-P=Q@H,?(NS8RTWJ;
M@&TLN;=0JWSB5:HTB7B"7:J'W<@@H)Q&6C3;!FY[INZS26^$?T;/0R!I/S0P
MC!A;7/?X432,LXI;C68KY</_9^?SO9Y#+,>$AN2.#ZWOV*+SQ:*J6\J5C:-G
M<3=,LK%?+!^3 )/QV^GB>TY%]H5>@H_N:4IH3<WU=H1V-7J9\T'HQ!.%R015
MK494VAI&1=A%K2W%C@OMM%F24R7I&A;@="#UI&QW@=3I'38.X\.S_$<+#F.O
M\V,@Y' BU:\9.RL/O"!";JBU1D@:Z"6-K7#AP@UD*3>W+V?O!:R3P<Z\3K:^
MU+,1T!&1.3"N)DOOH,^)@Y@^Y+F/LNT+'+]#X1]JQ>BY14MBMP!PNKP6[D 7
M3_BQB\Y>J]O'A.2A'."6K?F5+>CMU70FNN(&'6:FAUVCM?.XN].,*5"1B81C
M4(*6!-YRQ'/A_1[VIP#0IH2RAF]!W&B:)TVE,S0=GD6 GG+JE8J]>NA7THHI
M;(H9)MFZ@H*I['D3UGV5.24SRJA?-U4Q)H_4"";QE^K=^W:)C,OH;RI0<$0J
M/@NMB9:L=,AGM^A12YJQ>D/T-\99?U2M8*M>JIR+.8S+34?6F\/65(G)PO,'
M@0KWU)8D+8Q@&T6%XZY><IL.-X=3.W6XS>R+1XPW76M!57MX3](*3P,0!\0*
M(:3T/!X"(9,6!8[H4T=&[^80LW;*4L3TJ;<\S7YWP]0L,/)^LLN5&3&5'&4(
M(-7CRI3S<8HD+N$ =9O.0[MXN?H(IU&*&WL_PM:A>#W\_UW>ZCM!<<GP>.U<
MYBCGR$I9!8/IE7+T1PD-N%[IUY)Y8+YG2'G+=/ZQ&[R,3/ (G2ZF3N(<H^>D
M_Y?H6E$0AUR'7LCUGO&9=SG[)I_I!8D$F,[@I:EDET%(H<))@WRUWCVAWOT'
M'V@,W_4IW.SUB:-!XPF)#3T*IX22HZ,S1['T()<^M9@:AD20J$6\=RH0 >ZF
M-"N6!TE;3U;+A)U$&'NJ<A]OU4L!95.M6!OL2:?QDX@+]4?O"4=*:R=(FVYS
M,:]*\^:T<29)I1JB-A'O<M^X)AX33X(HS457M\7B5>:?]SA-4>5= 0>)XG!=
MP WONH[?C9ZY#ZJ$)47:A#W33F/AE*H$"!Q;5JA3F)C\<[)SL%JZ*6$BU1CI
M&'0QGHB)ZZJ 4!_)V*.I%US5SM$Z*L&DS*MXQ71EH+G,-<:7X%3<NH+?.TDJ
M/)X.@4<EUJ<Z Z6R*/ 3.7!=1R5,)D!)'Z^"DK&$WE9-0H-,3]PJQ^QAE1QM
MYY(=S)</M%X41"#DD85-#MX,K9@\%_\TZ S>"K!Q)B>H%?3;KHW_X) 5  ?"
MK7;1+%54G%/""94>P \:W-?OI%&,(*!:]* /7'J/:#L9KQ@K7D#D#KP84%:?
MM1SV?2%4=U<U;YF4WV36 *<24-Z-2':?U;_M,4DT&:1MA^= OQ@CH6RF963%
MCR3-+&N!R\SJ&4WSR1Y$:94&(2XND?./,34(4VSSVE7,')?!V#<K,%@N=TYE
MZ/A3S8@6S(AT4%-DAD!M(*S7PXN2D638:\&/-'=";"8-WA+QJS$,\J%H^]%:
M&!@^;HAX6\ :%7%@%0A!4TO3'_#-H(6Q/D:J$C5:1M,W,'E^S8^ND%7>5\+&
M@"D0"Q4*HC_PV@5-E0*M6HTJ%UF@LYA<L1-42"#WN+JX/J?'";M-FO)*:GV.
MBFI]RC)Z8[XP.B:%O-4_T"@65 0/JCPU;E!Z7"HBE9^KEPHCR.=Y4I3HFJ-/
MY;5J;IEZ\"H&_:Y[\F^S4:=83=ZE-G4\$[>I3=V5<PII3^?*A@ACEM2$0X3A
M4NYF6R:!OUK^=Q$B.!,O.9L$"Q7 %<C?*I*_4F!.+7^O-2WY=UF>E6ZRLS[=
M/O;<H.NE!\?I<=^Y9,4.Y0X,??+<PG>4D_.$<LLE?IP$.$R][R8ZN7D8/(U)
M"/NY(=N=YG$<-,H?QVZJ C+=G&B>'O% !&E*4 YU:M$N&AL"_<J(M3(IF?V_
M=!E>4;P3DCE)UI.,Z>16Y"<. ]D+4"\*0"^S\'K[QI]]D=]20%]T2:]?7TQ^
M"!RG31Y+-Z?'Q_J6S6>C[EK\"D?!G[\RG'T+DOJ_[+9*H EVW\@J9>^1<<=L
M48<651XC$__3Y2#I=RF'F7!IZ=3\.0G-#V77V']@IR_V*K*JPCX9BG;'=9JQ
M$VS$D00JC;83)^VZPK0?U?9D,H#G5=>G7%_IC*6D+P4;U,I#9&L+#;*D7W[<
MB@PPG!FDFZK*X]"\7;-9?5>P-C*+.[W8!KA.3( EB)\JVW^SRA^$HO$OA8J)
M,:5!<AT2:-35FF4]^8Y\Y:G&.3/8L\X*,F::VE,29,?QU 9.AN8ATZ=HCZC)
MU0EPO@H+C2JZ.4XY2NKHV.+H2F]-'*0 1A'S&B>'UZQ\WELJ2)WU:0]5M%MU
MG<"H,;KS<XI-46:'\=@X/?N*3#+VY ](( 9=WWG41XN266BI)C%RFLA;/"8R
MNZ*T><CST -FQ%@;F6'74B-XLKBC'K+CC!Q1'0ED_4U<^F>HW.$TAU:"B(>P
M!YE81AI1\\JXL^696BGGI Q9>PG(AD=5LT93EDC/D:51^&31[;O.?R(5]I$1
M.5CN,-*SQP"9^D $WB,V8HP##+IAK.:_O)"BHZ_A.:$%-;M>/AZ,*\H-24SR
MA%ZIX;@^.<;DF:9)TIC>S#+9$8:!DED.KZX6)C2L1S5548\=6DK&#&ERMC.T
M7#4H,**U$N04OA$C(511[37GE$<:JUA^Z<66RR2=[:Y:#EVEJ"YF;X%LP^%T
M9:R6,8L:N-(<$)O;LUKL6[#<!,.HDEA6$;I!3[;R31"/,K8MV4<#8WQ:^PS5
MQ&\4M>/HM4:7%-_=YZ \IED^#AP0. &UHO6%V NQ&%0CZ3[\CJW(WI0 I2FE
M(%+_*T6;)'#,)2'-FEY%ZJVNE?>U)QE/CO+$]0%YT*Z2#R7/:^1R[S!X'F*=
ML!4[HS062ISCK7+R$E>#=I-^_1K!4@;?%X%UF4T=",%NW*@!AY&,+$!C?G)[
M\BD'Z:<H)H= BU7SCWFB.\&OX\1#6.@PS!1=_O__W]_(A6)TQ6 PQ,8J[A-Y
M7O%W23SLD^67?>[<75S>[9UWOGQIW]Y??E0_E+L"LS3P2,CVL:%[X7@ML>-.
M\_$Y%.S[:+UXCBTOL]/NJZ-?DFV%=NXE![]\(BD)IRE=7 "B$8\7/@;TK./B
MYS3SGE/R]HE>6MB'KMSY- E?'67)VNL->K^!+'!/^D954.?#;X26,I_6U%G1
M* JS&SO($-5.0FZ[&7K2M>(1VON4N(@1G/"W3W_C&VO4KU%_I:C?2J&^Q'=.
MYJ3I!N/D2*S\RA1/;IXP>&,'8?);0E/YQ$3B70[7**4>?/#HK0GI%3]G9,DT
M48 >_HF$6DV6-5E6A"P/4F29IU8!0K-6"<I:.! \>4)ILC;.N:/L1/8"^Q1&
ME(8K-\+@1OVDM=GX7F_(_713QF!@QN0:&X^HMONLDG-I58Z9'"].ST+4#6'%
M:%(Y=5)OMO'I/KN5]9WO3TR@BQ\0[AH!^HM3.:#FB!)/74E(R4V9]M2^EU*M
M0O$$NO)_Y>0OQ]7J"P9X"$%.6F2L_,OY&1Z9VZDUY/L1*)*DO5)69>&Y^R)\
MR_&V)';&H][#1RKZM$+>;YS9G^/<*')J3%NV>B&HP %P06:$:J;)D*Q_I*O'
MVOJ?P/I/8&G(EH#&%\W06V.J8]RN#[U(=K+,5.*19_2%_20XW23RN54Z90_U
M #=-R?4H'HA\#G!2)@!WWS@7)9W4J)JL<WJE;"2>Z]).34;G.B$J(HRS*%6V
M,A*BET1HT"E'C%/?!L=PU Z)^2':HE.U)ZR0]X5TI3G:,<7'1B>I=F.Z025Z
MV0]/&Z3 9-WNV%54NMTOM!?CI;\#0),Y!\GX!K@9;DMZ.E")O@QF=N,,M?R#
MTJ&E!B*-0$%.Q7Q,.X!UMP.[OE%4D?<F6'SEFB_VT.,!_]D2W2<*2&I4E).D
MGA/W74K)G4QMEPM/+8 \0YE9J4EW>U45P9W$6%PI5S9N7A9#J=3YQ">D7]2%
M!\4U+?+*5*;^JH(OBO 471;T92@:AZ47F<OO)&<,4NU3PMS&O^I28R==(D^Q
MF,-=8Z?K#09<JJJ:'\IWR3N3=V1"\H%.6_KAYC2/06)=.(H!]>\=-E2N7CNI
MCA@-&=&:@U311HK?!=ER(#T"A*47Y#W)A/E2 <J,%$AG$.12J2Q'#G%J+IFE
M/X3?Q1P)CDQ1=GU>SH"3BF@Y^:D924ER>4!)-8Q.X]6,F(K++L% ZG.93 :5
M*E<FN4,E#!A?44\RSBU_@!F;S[+_#[9K$(-,Z$Z=>,Z^BE>3=#U*$AXF>C<=
MYJBS?12PBP&J;#69[)47'4,OK?]RE9>*$E"40E4?*S;$2YVQQ.FM$@5-M8";
M1, M/8FY GTBF\UT%O,XH3YC'K,Q=2)S@1MNU9G,E<M 'DTNGB(3N564B4S#
M723'I$D#0#%>%UOJVNR^(-[*-?^>O&Z9EOD6IBK' NF<)CFT8P"/%V&KGKJH
MWLLS)V09#^>>#G TM*D5#)O):%J*9PLU2)!L0C6U@MAK>AA>T69EGVBTH%5(
M09LC4'+GOI%9.+5Y&@!NZC<'5*M/Z<6YF6V)DE&VR%AIL'AQ*$<UX?^(_2Q-
MV71#OMO#OM;Q^!&5[#"ZZ Q>%$EG.6]!QG(D?+GK4MR]?DE2.QZR)'%1'V!#
M("[2G<=LE?1P5#I89K8-4FZPPZL:4.E3&K"/\PS5=&#6$C(V132,L\2>A[!%
M344K1)X+ 3_%#804/G?C1IBU4J1;_9,[=[&5*$ /?6E2YX7]RVX- &[9#*QV
M\TXYT5&GDXZB$YX*A2TPE6UQJ_IBW,6@7J</.*X\C'-CR^A=LY'B_AX)RN3Y
M21"#GY T\!/X/O&0HN-4.4BY:7[D!'TD<=T]3G&N2_)'[BN'Z:1+?,:.0520
MJJUQQZ&F<[LYS",Q"5.N%+3K?%%@W>^CBLJM2\@'@&\2SR3.2I>YD[AK2Z\C
MX2M=U/HV2$D=30'0BI)H\ILW4&Q6]MZC0>LQA+0'QAS:ZTK_/?&F>+*E;%M"
MK"WP!D)V/BOPULB7YT$9)!&6!,,6V<V\;[1##@9PY@,7&8\7.ZF'TA>\Q4 N
M(GY\7@58Z>,5N-7.2\"NM8WAE@Z9;@ %<%'N'G4.97"7#614UYB45[!\F&1Y
M=?6#.@>F+N94G63.2?E$(18B!$9+<C><9J< E9HVI+0/.1BK<-H0@W^F@NT3
M\[AH)M8\#"U=796#O&;VP(L1T=B1@RYWL39*UX!*&[]E1_N45* W9+[!)/-W
MYCG]QII/?Z+)/7,<^^JK6#2/OE:TH2&B=)0_/PO;X3%7K'J^,=N8T*4_#RG@
M@&P,CM*#1E8V40R/&R"*L._9,LG\Q0%X:#>&<6<T+:J ]A3&B1FM 3.\[!JH
M^9<:T"D+#X'Q7\8M2XM&TA?8'@7A%EM5(?ILP,@*1G[$H^=]E\!("U:NG5)Y
MZ.P*EDYSLIR"V')2LR?A:0NW8S!5?\]Q)6*KJ4X[4O90"\<P<6;O*F]V1*$"
MBH$3[YJME.2:*CX?K!]UY<BTU?14*@N06V^F"%GMJ(['A*0UJ.-Y%KG-O7%(
M1JSPGQPFE8CZQO+R(.#:.$RK"$>V8HP+4/122=D;&OE./*XUTRHXO4PR=W@1
M(2Y"<S<D'Q=V5Y0%X%$HBV/TMJ6JL(7"3Z,M^3BR#<]&CU59VT=VN^%L-EE8
MF.B"<#L[R.'-V"Z<"_1DD::9^,*$:['; 5XWL%[EZ!'.ODEU6Z<*(.*V6OX@
M?JAO3#FYE"=#=;.4BV&P[5.AD^S[/1AXKU9R;URW0]V! 42NP('O-#2">6;4
MQ3B>/ ?M .02>8>I15 N"Q#7?U?5%5QB)ZF%5 C*I9\D(F0?!/@&-4#FH:G
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M81W$7","S!R4JA%@Z0BP@/-?7I0Z__S?M>U?10:PO*CTPAA 8\71Z6VU]0]
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MT%,6\5J8^.1=#L>UPHA=C/FG(VD_W?P<8/:J"E 5^0&+R\=HZD7VMK*6+@N
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MK>HU>IXZP+0 JLU7  \GI%_L<9\SJ53ODDKZ=3<9+#61JLV7XZ>JU7^!59.
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M+\Z]8#\@0B[-:6^<U]U#"7IDKWC6%)QZG,-"<2YJGD1B7!:BR<0*O"*[5.J
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M->UT%;O@0MD%KZKUM:WIUG,[N_>C@.N&0F"ZEY<N@$I/0!DB_@;^4"_D5$_
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MZ!>B20O,.((HI37<TW6.;(%5:N.NT<Q;*,-+@+G5.@&#89(?H>$%R(G,?2!
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MW&+M_?-.>_^*_%IGP>'Q-S3!LYA8&WK.:.Q^='O=L3N\9,./[&KD7O;<J^Z
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M&36K213PG]IVH=[BSU3">Y.':>2:<_5^Z\.K%"<>"X\$U)<D6*#3%QWD7"D
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MCD3XM, :Q>!.5=9#';78%QZ[TR>O[8XI!<N@/7>_2-37+=XW^[\#GLMEZ_U
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MIH)A),/05YU'AX<#_JC#N!B_@Y^D&*\^4,MCHZ.^9#%8? #_"5!+ P04
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M?F^2IVF^--DT*>LY#+I*\DE2S32\ "9J5)K _\Q+^^E(+4P%'Y95/OJ '][
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M6L.*U$.^I!E_+B\E+:Q$ NA^+AHD3KFZ7>WW_-L&WEC@L<,/8&-+"N" 7,&
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M-=P4&]CDQ'WYF,R-0;B.O<P:F*3?8PBY](_;[&*:*JR,@R41Q.>T9%0Z4-J
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M]MK[[#EGKOUMYMLS +6^MIXV  \/'R\ +P  ^+;-$F'LAL*@O-U0GD I,0F
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M3_&^SSR$],>EHPXE/"Y3'(?TX^\!NWOX.9S1\9X! $&'YU2+ &8 WK>9;]L
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M_2:SEV^)IY1]J(O0\Q!5X'-TU1B2TR9^?%[-?[V'76A<N "GB]]TEXW32_C
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M[IO>]2'CQ.P\71OMDA"!6Z[TKPW$X*S*-?I@ R+A."'#>:$T95RT]F7U <I
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M-'93"CQ^-\#5%4#AZLODX4V'JO(I?V( R#.@SOR.2JQ()MB4;6:F38'9=KN
MLWG*R6QUW56*U(.W>E.]F*LF?,8@NNI).V6794?I%2O#JG=__L3?C&$DS&T4
M0*_9O)+0(K2R9PNT/$(G,<I _&SZTN*WX+[+\)3M'8MA<]-NFU:;>DQY*4.?
M"'%MJ6RV$>I;#<I8?C="T22NG.C/W\6VW?H'Z00J*:$-?15G+%$6V6W+JDNQ
MWX&8PTA^-0@E5BIEH)XN3A7S8,QP0['E?W288VOYZB^7P)Y[W3PL\5C#TIP9
MIH 86%=1J,>T%Q+Z#P8^"LEPPVMC%.24<7,TH[!I-J60;-43_CF3@C7RJ1&;
M%K:Z]0GN5!-A17M6W<6-.V%O8KKI'TVX6DVIEZ][1A/":3+P>F(&=7S^2DE0
M2?N_M_G_*Y8R6UN(& 03"(Q&YY\)U/V4LG%*W2ZV^88R>\4(LW"8\ZD[H-"4
M;IBEX)WX^8YIAJ52PIZNOP%/HIG8:(C^P_.PI.[]IIJ3) 8R<:CTF:"IT?Y<
M,Z%>[(;CZ6"AB=%I-5=JK<_XLIG/-J9^_(I!F8_UNW;Y6PY8A'XPV 6B'30S
M6WRCQA$^5CT70R)B0J/\*GFQ,R:C+M.]S(IHI&3XW+I3;?6F!/>5/>)):FOX
M3^U%"QG=1__ZL2M<8S:<F#?WY:C9M$!1'>26R"9Z_M0*<HK3E$2VZ7EO/EB$
M]3S9X^8:L8&\^:B?LV;-9>-_7"CB32\A^HK"<4EZ4K1^FQ]'E4TG([QHTO]P
M6ONE9]NQF('H>B7)2+OE9EC'GQJ.L]7O9KI<E^W^@X)NAX0$PB^$ET6K2L^,
M1%DGG_[!(%5>(1.81#(VO8P,;-KNB-7R]BM$HENV=]!C%[R&F>:N5CD#%)/<
M:MWMP#CCU"%-BLTO?1F4T"5S3,OOJZK?)-('TSN6,&:OYOND(./[IXXX"%1-
MB3?AQ.4U'I F+#"R[R5Q]\A.A_-ZXT3Y\2:IK*/"*7L/OEXRI7Q)*!+N;\V2
M@-H\QMLX]5%P*7=="9-^GV$065KY]C1 R A%44 Z#?^6'"!8DI_XY7[=RQ9I
M+:UQ_;=MXL59&J:)G(L*A:)*RD+*U]LKF@)").I;*>4(Y4A;HD];R*5-[P#T
M;<,9H^_I%Y0V$?H>WQ9WC]6L(.;!WK14@,]XNDDMA![-IAA9,#1U77MQH*NV
MOH$8WM -TKKW>D?A&:=/@/^]X<9%,\=-Z,O*D1KN6K")VG+;*T<N$;P3'<X"
MB:J\"39>-J5E6SYD68TZB0//_>1^AGPI"YV>[6I,)T%7^)1*V:+F1EIRW_D@
M'YEDMK@ #:*_ L;XQ'N^P.0&@\"J?<0.4>7[8%B>94W[HK_=AAPZ6;<9)\O2
M5*/AJO .4]GN9VB8?+,9TTB$$6]!].RC5>_$E54++$S6DCG1\K"W;6_$KXZ;
M4#-MMI?2LDH(EWSR/GDO;)5T^]U\R=-&C6K5\16(Y5-"*O#O+@#)$D6J+R/<
MU34=BE4AS'S&G#JMY&KPMON[(.>OBM51"AZ=R-C\JBODJM=H3"YMJ#F[XRQH
M0411IVCW(^%M]\4\FG;EON+'QK<,.Z?'!&B:Y8, (NIIYKX8^.JS?[PD UQ=
MUTXI%PM2 6W62-:%Z2-1_J&L#E6SG?@HAP^XK]W7$=J:V'['\BMKZ]YNRRC
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M+CX^;OY&COVV#U>O_? \P[S%S@=E!$'^2N-%9*RS]?P)22*2^90#+X3XK4G
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MPVX_$A[M(:69,FW3%"U79$*FPAKC8?9A%05%ED]&W./,GJ/UA+-J@_+D6A8
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M^K [I!*6]L\1X) %<*C4JQRTOHDO7.JRB1Z2<S5]Q'"('C)7E;&;76W5(2R
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MKJM3W,[J%I<6AU7U^J0#/[5VBJ5[A5NK$F+81!6A0GILY1\7MI+I732#$C3
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M;_@.E3^[=>=D-A5>/2OF5DW[J"E"Z&=]3A0/ S<I@5/=XTTGLD7KK?[A)=>
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M4#$2Q41+.M+LK3H_26ODPFWD"GHRO6?Y0*QJV)L[-N#,X(H4M=6/<,7I^,+
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MP1TVZ,5(:6Y_[#I4+HOLPNW*''2Z0MU(N*I#%4*H0B)K2ZTSQ%\@+>R/N(:
M-<%DDD.,;EJ53*D(R._"H,2)22,:WD;*A>RO$XF?EH;F:41FR7F6\F+%PU##
M6&^B6A=\R$86TAGU#$?Y31Q36*Q/Q997ERAK3YA3W8,^9#2*3M4FV28@S!VY
M0P**FQVXN7:^Q-!%))7T(BRW^,77"^2HH>?C('WX+'>4L^-%M"OH;K^R&U<Z
M*\EV#!*WS&U,-&#6Z6[&P>&YVI):;@I;LS$4A9.94D48)-=&%Y%&-R(;"^;"
M<%WR4W_@_H)>F%R 4#"1(\TTF#!-&<L[TT%1)4#OF&5>:07B.\^ #$8K^JJ)
M'^S,%_ +&:\D8;#QXOOS'8R5[TQ84R4RB<O$S"T[_*51-*>BUH[L]HM"F=D_
M50:5SG/B1M_2#;2.CP2JZ7>R/T)$XRG=L1-*I=@_"BJBW)0Q]>9'0=, _3_V
MV&+YKA3,UN@%JB $&2SZ)/->S\/9CBP*+AA\TN?10KQ>S;/?3_Z)AO'9<;<6
M%L5(W\\3X)=62)26-GMU0MS$#9B]F\3U0TO;O)]Q(\,,^Q0.D2.ED&#A>9IA
M\1RL5'TRE>\P(8Q_X*J1Z%54 +'<[05P #,L&A%0Z1*1/W3,1AYU-K=FF)W)
M1>X^E)V"LK7*V3X.PUW- $@M#A+3=]FWKXA<:G- UD>M<X<Q8E9/\IAB^?I@
M'JP*QH]6M);8&-(CD_>1G<8*<^@NE_M^JI$"[5(&+]OET^4\WY2)3[@7,+BC
ML\<JB)E+AW7 U3[6N^\FIN+<&?N9L,DS,Y"S_?I$I!(WPOI73**FM+-A!X1#
M,,^KW/+   RH*BQ*U9NX=JN76_[6?4KL>;F:_F7)I$'VR*''_?$]G:P%O5+8
M!TQP+MQ5M*?,0CT3:A%QK<,\=O+4\OL]:0=91,3WA7\DW7L#FI\;G#2'GB]N
M^4>=O/:K+,M &!+AN[>3WBM]ZO24<;A)!ZM[A1U\K1HZB PVO=3]CQ+#$X4]
MQ=32:^8E9#Q1VR7\!]3\0RIBB:DW^QTV,U5U<%;"3W'/7/M*TIB&6OYB\7";
M5D8-9W423DUW[3Y:6D+1'1U#4RJTQQ%LM?J#4T@X.\H#X:Z0&-I,Z%,C0UK/
M'535H$20\ 71)T[PJW4T<8.F D-=JBUA>.G93%J?0:?X=)3V*K^Y/BVDIEE4
MQV%.EVFX>QB@ODVK\0\6,O4"5Y<*6?OL9!&JJZM5@N3B>E);V)@<V-R2Q&N_
M%(:D*1,F!2?<?Q[>]A/&O@+E3H4UU3<Z#-?4[@7Y5!' *VNLSF(MCO/!['S@
M?))UI%4U=_M72E&X(H[E<Z40_+!AV(%[&&GPE:!^Q:+,%#4<P[MNE'[KI5*^
MP6::HP/-"+:%J)FNLNT5 V,$F= HJWPMD70] 3C)]@_19'FR5%UU';O<'5+E
M9BQB&KG7\P-<\^>FUUW5/"9SW#''S0]?!G%T-]U=*4.,4%@7E"2MKUQOD5L,
M,W?(7&-T_K ;F2EJ!'BJ+LHY'LX-#]];M+5HQZY"1EN/&;RI2FB92RJ[U=_5
MG1BR92,/Q#OH-N!-U-9XQ[.N]J1:8+N28?666Z"7DU-"PCF-$W;<DG"S?M]7
MK.>M-E9+VGC4/"I:_[7F,_!]UZ=C9A\F^VO+8I$.\@X[J<"$7K$>"8'@^M^)
M!.)CV'?WPB^-R,B)2RP5B8=J2:=,U+0.LHFE(H0)<<-H:N)$R>WESHZ0\;V6
M>=03SXONJB'U(L$9_3:'JU*K?\V&SDO^&G;V06_V2=,>!WOL7(H,4QA3XJ=#
MZ'C)=5"SB+;ZES! ":OJR4^4,PM>4X0#' Y)\J<\T1OU*C2%K1>9QR00!HZ/
M,T@Q#\3%+?IU:1L^?[DU=5?P=[:N"4$I#:NP&,9&C@A6*N\X7+]D6?"V(1Z,
M=Z1'&YJ0XKU?.F-'(KTW3I_)=T1PDFW]GF<DJD X5E=$[%?Y>U/C'$&7\HJ5
M@M$;1-2<=Z"VI4BSXN_A9%DEPQPEOSGB$'<1QD6XV\0)!<2,>:V\QM5S[VQV
M1NT\5HH\AG;&D>+*)+-D2PV+F#%'3/;FIA4J&+DX=4J%E41%!DO&1OF0QFJ:
M/:>M;)!U?O#?(^N$BF5 D622.B"IO C1"16.^=)5X18]8>3GQNB&<;PY#)N!
MA>+*B /&WFSH;2R! V7Z8I9E!,7A)4GES,]'-#5?RROG0Y8%1MMGCUQ/*\<6
M'Z->NE).W;P^9+ISU4Y;.3/]34J$;_WXKD96Q'DV/-,$MXK:TG;14MC%PHZ3
MB8Y>FFX#<=B11J:3S:9P)6,)K]Q!3J7_$"E2&.W''*.FI3*#4I26:KYXY-IF
M%<@A3C"BI\7J0(=X'SB5O+Z@L]E*7=.4S!2LV_%<IQE@JZVCA5L1*GL FKT9
MK4-<46DTL9)B0):1IF@[93F -ZGF#UK<;,K[DF*#4+)LM#S>Y%=#A]YC12TF
M/8%&D%JVNIKF5LVFR*Q.?-@=C3E(+[0;F"\2%"YYBT\P<ZCAINQ58<;L6828
M4?JUP^]L(^#@(,+L='UA5]MT,<7 [9YL\39CQ03"4QUL<X&KZV ?CQD<#Z%3
MPDS"TF69CC ,#S#O(U()]\?" ]])4_D)YMEB?O",_Z@]]!S7L/LP0!W3S$@E
M/#4Y7I<?AS?&KO@-4D&8]8=0#.IN;'W.D!AD?']&\29-0B-W6)[42Y\J2B4+
M1)Q^C+W_M6K,S_.<WK_#DSY_U%-!K&7QQV[A0YK\EH5]TX/ZER^Q,::*X=?C
MD#O'\ZTZ:9N;U54.L]!O#Z(JW9JJO?DL[B%>WQ>+$P-MN^08,S<$>>=O3#M9
M_O<L3_5".\6?@JWKWEE7M.,G5_B8.U"1[HO!&^[I$D/H7^D1FZ]+Q9S!D8MS
M3LR_5,U-&J5KECSIYR)1?V3$J(YG T$Z&N PUU< C3^B!YILXC\^D^7,W__J
M(I/L:>3:5QX&E:Q_"OC[*]5MA*%3+*JS=;/JT<H350]%K7U*+/-<KU:GMA6(
M=W!3=/R5LC>KA8JVL_.'A/3( _)58CB8I!:D<Y&BIHI,6/,0^(LBG!$I+YI7
M-.ZK-'5);Y%0\YS44L<0'MKTJ7S'UJ3.3ZP"K99+.9D(L9(XY/@!^F_2O'(+
M6#K:_,XF_XI%N$N2G?+ZGNUM+/!R?KHP6#O_GW]L>-PL21HY9I0QU(S1:6LQ
MI2*2,QJB]AN+(],:4_#ZBTH9#Y:#''-(.,45YPF[2WUPGB@Z$8[-IGRFC+P\
M:IMV:FN.YLKQU.%#_W UE)EV=Y5]2_<6QD%8X=&2:320T08D=- X@W4,VYF)
MHRWGD?K.DW1_J!^"9]87R3H]K*].4Y#G;5-UHO)I"]&Q*\CPR [J1UM&-W"Z
M$F(4C6HTRI180%#/7-0@#V5EH.4\*HYJ%4-5%][XQO1!)P*XWQ9,?/)^W;0V
M>AVU$2^J+C:)&)8%<?C;\ ]132+'DN9LCB0-3&Q 34\H;6(.Q6RPF[I).-E+
M=<!%%&,054'BC0SV3[^0I3WJ0\V].+X1I7^N4!#:T?-(\L2Z;L)I 1/9^"D-
MYO_@"0\5- SR?BRK!-,\ "E4(0L8([SMUI*1!V<E/2$FP9XU]5^D2K8CL,.&
M76#-!-DR5P,3&5:VRQ,LA;*U@@:3A0OEF9CE7PX*7%@/=4;8,B2,JOD/-":O
M>*NL[!5R]/^(H5P%EBAW4Z%ZFCF"3KYNZ)1Z5@*I"<<UVKL=(7R7E8B(QA ^
MA\O@6=BC,N?I.4L7[O08C]RQZ@(?IHA*S?(1$9-.$;O2]-G'9%&GU>^66L_#
M<G[>J[=%V9(-7ET9\BOR/S 3H:Z-N&'*$^\VT9.GW.T8 \>$!\,["!>KG$B^
MXD,R2=8NN6?+O08S/5E8I\>#;L&>#[) /X."%)N>TGX8;\I,FGQ>XYV_WO@O
M>VA[*)G]^N$/C6P#*'X=G49=W:/,)N)S$I=K%Y4BM9X=W$3D80B'8>-7&KIS
M.L22<0'6C=.+G>$1P,?K6_VRZ2'./0?2OQ'3F8GIUMSO^E3B2[A2;R(DG9'>
MT[7JM22J.<*Q>X3O:[^@MR(?P,$NRC!=3L[3@ZB0QD"VQ.\X'WM!*=QV=9J?
MU4F"C<[;W/SN:I?'!>Q+L/L<602<U<05[?1_WZ\QW+$_.'=C%N@^<"]]G/A%
MKTXPXIX#P(L[1%O!Y!65B^S7BI&T."B:A&S&)]K(1R"K'W\]P?WR4^&/;),%
M4X%REPS^#N^HDK2DSWLG>5E3YC.B$G+B=L&R1X7BB''$L.%'R-71NH1^[/D>
M]BRLYR2H=IF_\J.K&8&42!A[WD\L@%D[?TW&$4G\LIVKZ &YW DSPH:Z!5T?
MHZ%6[+=F5F?\7F*CDGS1]RMX/S&+),DE1)IQ1U5#N$>QJI#;'B$[MJQM$I.R
MXJ-!.[7+K/6ZRRW#\9+OR7NII<93ST(KM_#:D_XB&^W.0;^B/;<O<R,"7J15
MEATL"!=[L=A6F3TN'T$X6"?Z6&=BM_1'8OD!"&8CT7J<>]T,UGIDOP"EOOF$
MSXZA<?/]^2KV;?2Y3@,N/"!)%K&MMHP\S^N=%9K?CYS.#6I4[QFR]O^)L/^(
M5:/D@2]L!N&X^QDJ+4G#>\PV1/D6R*2TU953?55$/AZ(8%=-HA07R!*88LTF
M7WG$4)(ZQ=$(?'JR*C.NNUNC/60Z;R/%Z;7%?8^B93B?HL@H-DS0:#+_A6<0
MHXB7@-O]!2ND0;>MUYI)!>CBYMR7^QDEP\5".#K?^7>3H:%64(B+T5:#HF0N
M@X"P9R,3"(HS%@]%#3O;>7C0_WPG]& VH#;1\TQXHA)_+A.[LT9P2C+#(*K;
M\>5 SE0-!P%5.$!?$OT:LO\*0(6?<\U&=E$1G;2P3Y\EZ]=:PITJ"4"71&-%
MO=*IT4DR6968Q"/>MCN)VWMNU(\)Y:6XI]L;PLHV4U.;GZW._IL^'4UA>H32
M9>^,2.VVL)H>#OCG/QO7K']IA#A?Q$+J>R=BS4$RFJ[93R7G5V;-MCO)$??)
MMT[Z8ZI&Z%CEG6!2([W1Y7X8_O"UG<<[TU*(,LAKG#^7LQW\K/IV<*G*@_KZ
M?5EMP;KN6#J&I)OP]W&5&W&/D1VTY#,O3>!8_=:C&\3_-Y#1]D1A'295LRA@
M>HS2R*);6V.K>#JUO8(?BJXB@LD9H)%A.Y#VNTQ=9#;J].+O%*1*@P8"@IE8
M%AF<Z$P_VH95Z=D]*3H/BY_E;];W7XXVC-F>QCO"U_?AM'V\7L*@=&VR>T'7
MG&KLJ^RO7L+^2;'UQ49< .&+EF336+-9IJB9\?%0:&6T!HXR;EXR_"P(*SIS
M!$!!7]58E8(TS@=9OQ!,1\P 3L4WYJ..9*:HU*8]U1L-92(-HO_TXB#;:G@B
MJYG;FX-QIJBXZVRA4J%$HL[;J,NAHUG]&X",$*ZZVJYX!GI\5'$Z7SM2CBV@
M#*T0!RE(](0))(0T[<]>:5"X&/RV^;Q!?*#>]<D)OI_+RD(3F;PASOD4WUWE
M*W:#W6]9IL&P=]"_*%%;Z&!UG#NQ'Y_@RJW>#U3?T#XJ?/JVNIPS"%-IY:SH
M"^QBUY3SHZ34/'1=->,LC4J+6D!=]63+9;_6!UIB8>RWO0)T5C4<!F@SCC87
MUC>Z#J;AM>-? 7EMCC>(A'U/Y(R;Y1AMPD$+39>176%2!VSZESW3DGEE&XA+
M_+*<6*V+1E(MM?:T_X3!?NR;.,T$8SG*J-$_A1WK$UTC]3/<<H;$],.V.TB1
MV[WC/.3=K:K$LA*.DYJ=]F]M,&MS_9)A=KC>07!M*I7=HPMDEHCH(A]X/+D$
MR8[U_B6[E@&4 )B@L"7N.$PRO@><371)[2,FP2D64O@EBE< S'N 9GI$M)WW
MX/;>1>_[_L"4,"N8]*1XFK)V85.Q61T)B+SX3&@=-VT!<\\RD#-\!9#VBYE-
M1\DMZ32RH!;5&0!Y,-.VRYZK$Q:/KR8>V*^C < <U$;>\T4Y]] S!9+R\=95
M)==EX_Y6^;KM*,FI.]^>BX">H:G67WWL>8T=_SSG6TJ&64K2HP6SYXKH.]D]
M7.85YB?F"W3VN;)B7+NV4\>O@6%<"%<G> IG>B<+O'B55B_Q,+2%[H8JA#2R
MOB7LCWCHM9^#)=A+ZP5;QLP$\4F)4DN+(X:(B1!#2\.Z\P,BDO2]XT"^ER#5
M*,\5CG/CZY/PX@^"1,:C5$$^K>[I5ER_I%*9@?9^";RVL9^5=:TZY=:B;3CT
MI[0ZJ@Z8E+:.#N!0R[/@G:6SX32\]4)6F@7<BJ-);ET(*C&&YQE2@J"3$J[G
MZW;T&9>9:[=ZX(\H3TB"?.N)Z9$T[[N7E14A7C'0$25D5K<X\YWN"=4T.FV5
M8BA^-K?;G<@Q VDU9[0^\?ZS,2*8+)2W0+$@,9.W:Z^_$MW5:!6^N?*.%R]F
M*X71(^P2A%N*$K?4EJ>1*,D &AD@GIFO;7R"$Z0K)ULY8>[3>52J_WJ+!;:0
M&[M4&R-<+!X:M LC.,@FV3H/6[Q5RH?4/DI=T 7"DF$57(H@^F.>[ ]#^U+A
M8UXLBRE?^YQT?9G;O):&+8(2V7CC_D9Y;1'PV<_0[;A8$&6N:V#RZH87BHF=
M@5\!$_,;MK=Y435_&]8)EK]459W39/JLHW27?^*JXCDI@TT[>#A>9CG0?H['
M9$JERD>]&/AK(UDH)VO).G^N8Y,E@67HG)B["UW.>:O#TJ-:#CM&8B55"C:"
MP\SI:N''4'T9[Z-(S]I^BP]=0G+%N709Y!""?H:5-5"%':H8S&%ZN6K!O:/7
M.GA"-^*?G>FYM\HQ-2TN[ARCKF"3GRC6$M-[G9(/F$@CB4- 7DC?A2RVJZO;
M+==@?,6<GLJ'BYENJ7\7@A_)-6^YEX_IXW/?)REPJQH(<2F&W&%N]J!O?^Y,
M5$/,'(!@Z*QAK0TX3&KOB(N+0WW<&M9B8&_OT9J-B,&D6E?H8=T2QECC9A&R
M7/LH[J43P)4;0BBLXA8+(5?Z42!&%%8)PXG><DOYK*-KE%)5>TH<_I' $VK+
M51_)MZ.D4BLA!I_L^-XT&G>MT^W<ZD1GY"5EPVH0%(#AFU70_7CN2=IQ^@HP
MX*XE?=!;PAKYP:7Q"O B6>HY#[]&VZN%";*52T(M?C!0=,+*IK/S#N3!C <7
M(X4N>T?P&B)F.Y]B1R7R=%>;"HQ!O!NA7FF,3BE!!RLW/Q6I#L8%!3K@@[5H
M?3#30=[YI_D/#(NP"3<Q.IF!,\PZ-@[4?)-DK=TXH<V#*3")H8U=DL*TD5A.
M]A!23:-_)J67^Q/9GM9$+F'3&5OEWJ-I7EM'MJ-]:#97QUT^M78!_>"+TL==
M%)>[ 'TR3 HDC'Q,(<D*"VE8$/M*7;T>^J<O=#8[FQ$Z9#GJ'WBW>TR@)*6<
M'CQ6X]!VO S@J'9XR0#T%OQ1QZ9PW@?+G7VMT5!'UJTV *W%=56\]=.\-49D
M1&!@%5C&8B2P8%!%93/P-)#!&1QR;03#"/#D;Y91NZS>-CIRJ-T,,8\]+%\2
MK1LB9WKWU0-=I'R$$K6L8(3+%5O*7[-IF]&_A?^)J[$EYX^5V"V%1U,X1=+A
MGG<N?16SXU55TXHU,VF@C=V?"%E"*C!A+8_KE"'L\+L(HHWY7Z:3BKF\WXV)
M!.Y=]+#$7)FZF"^1\LMM'):D+GO\7O/'!BI>XK2TO*Z[+S![-]%NL;!?6I-Y
M1C2(<Q<G8I=;6:I%##?@I<=0=, [2K\J2M6K@6S% M6J]9("#Z=EH9I)-Z&L
MR=!>FT(.?-VPX=;>(&9G$\\B(OL\=[Z\E*S-W%(*"JM[RCM/*.J2I\+BDS(2
MN6;_T/)'*58BQQZ,ML8P O3A9>D#HJ,;[IS6W-/QS88RH5'(=0/<^ UL665P
M&QR$=B6 ^G/)&L?D--MLFH\O"YNXI*0^=L_E<X0&ZBXF?VY>4XH),:B-WCXT
MDW\P I;Q>;*5Q=/XB? TN5O7&/E:T"1TY4\OK#P[EPG;)O;=+QFUB Q#9%@^
M;<.'_?"+VU8QY5J?V%3Z[XJK)\;_:C$AU+.>(WF- !-$6==FL\>V>JJ?Q(%=
M%SWCJWL+TS.+;MPD2P ?],HP-F'$+0QOC!;AT H['V7B'HW<=MRLT*@'EHV;
M:AW6#-5I?]MS(JY[I.NB*,/19VI#*_<_EJ/M=<_IIM"DX.63TVQR1"0Y#+JU
M#P*P-:.%<!M71F[GF^9G%&TA\;K3AB]%Q,[4?8$\'UX!IH%Y\G 90SBIY?\-
M=\0*6R#AD?0BPH,+O];W %EM%NO/'DP.=5\_\#P*T>TS3'Y@#<I]G-S]1S*!
M7J!C.*K%>T(TZ#H^NX)P02[<&S8.)+=JT &9/.J0]B[C_[3-L,>#HM%]ER:Z
MFM>:]PZIZU^I<ZOQ]/4C),7M[*N2T63;DR=X8I/_2KBDG"1U27.L57'&IK_;
M7 XZS;TLNV\E><)OQV$[R/[)Z@I3+K.)'W %6A#K!> ED_F=\@:L+%0URLPZ
M%DW\,?-9(&<.GL,$QRKE^@2$/(@O)5E'TSE<]PSWVO]3_7R\ZE"8+%_QZ$9K
MCX.]\W:>EG'T4_?82=F _5PTUQL[)4"2FA&W*E3(IJQ2J)24L=+O&,/AV5K<
M&U^P ;X'BGR)_JA:W1!30B\3SUQUP3U-QT[]J75%Z>6_<2"5@MYU:PFPG8V<
M<L\=<N& Q3^)> )4W)1_9\=0\_]:V5C^5#>\NV;MDMZFP5%&+*#[^S>HTB%5
MDK\EGTZ[TJFURMBK.&)>_W!@8B_/^NLC:GNW*XNI_0WT!=)\>,<4V7S$M5:!
M1F?#XDY-56SWS@VJRFXUKFO#!71-476*V$2#+;<NSRL@K2JI$4]E%#4YC[7B
M?-OH=XI0_QZ*.)OFS:II#U<O@KKZ_3W*!MY"Z!R?C66P)(K$[2K"J:-;,VBM
MNUH'G+XLH+F@S6$5? )*:G\(:J4S2:XII_JD$QC8D-B0I&\XIM/T3N(J>'01
M?4V3V7:UH]I0XW/3%4R6:Q^-3N;KXMKD1"Z$-HGN,V8JL%D3/G+^JADU(.3G
M)0%WL^1W\PICW)3VLV#UFI)Q?=!P:&A&E7ZF^[R&[9G@=V/7PO-O11%X'QCS
MZ^/H'4Q'9[C\T/2G9F(5/__J"Z2L[V/=O8V/.CHR;*M#4CPJ@27Z%KR3OM?(
M)DR!V!O]3!UCC4N-4*Y1/4';C?IPNSQ34*/4KYS+GR)W+[O;]M+0OJTV?^4V
M-9XK]W7>"B9KM%;_26+4!XVGDNKP-TS%(9)<1\2>>>Z_&76@4'QJ4^Q4Z6%Q
MGZ#%BI)F?8P(HT%?AM%.B"&$=CM"MD SAVLA%5$5?NG#AU@Q]:-C;+&@N@4
M1OB\MT&X6Y'!\I#&D.=3P5Z(0/BV.)1'/X-&WN?\^F,()-B3X-K!MON3N9-)
M]?)J=VZQ.M7ZU*=1K:ZW0GR4#MLRP%I.&>U?L"$,!B;?5A127N)[R-,H2 L_
M7)7W#'MY@NFS>ZJJ-)+*;5J33B#+&?V?,D(7L566(H:=W5L+C*YW5$,@9<,4
MI10LB!W:]^L%Y?CM?Z[M&C0Y2E4PP+]6Z]7]D*=46S9ES.C61+V_MGKQNK<!
MB7I8"&74&IAC\PNT\N.1$7F)0I6A&O5XAC;.M&?F@P$A1+J\%9X,VE^XHX\Z
M9&C$=WBV#N;K:^MM\%PRZT*__RKC=U4CDM)4LDDD\\=&#++=)?N5@Z]!MX==
MM.J,F<0TCTM'A:Y66R%&PFEJ  7-\7[%M1\NO?5^;VA]3]07'G5CA8Q_/MTQ
MCJHTN!B!HSFKH'V6G.$PUM;/5'V'1A-MW?_M%.='D:O/'I8+_*S-U%1"*#1F
MH0IBS=D"VTQ>6D*S<Y65=J"BA=<CU-6_7!O'@,B/0+F+&Z4U+-NODTEEAU;4
MSJA(+>@1*43&H_2R<<UG03[OBQ7 G1^Z%7S^5K;NF57CX*LC!2;,H]735#W(
M6WC>G _JK^8[XJ+%O)1."BVYK^!5G\ORW;%N"EZ=E([%^?&<LJ,K[4@:15):
MZ?7\%3MS6!?W1>IV,=@[@V[5NLK_>(FI\69 J6]PX.F@"^1AK-!N5!WI,)H<
M42NK$7TWH]OH3E6.^173B>/63A0O+P2]?[&E&3RZS&6KS=RQ.>4W-1,BQR0&
M>#<A34$F=@EYI(<JU]*W+U;6AF;>)[$5Z^<;D]0,D9L)GEBV$Z^PAK,"BSY;
MI6;ZR-![?/[;\X.)*P'N>C3$V-5"I<J:B4MKSL#D8[7./_VF?605F?@CQ3_Q
M,C(_<O!3LU(*44R6&25_GE;H*W\76RLP5Y9RJU.UKY@\[C^<BXM#(*9*JV<]
MEC#FXO#YL_"^HS5&3YCM_8J:%]56?FJ\9LDE28R5MX+JPXS5[]!VG2K"_<<?
M=IU2BMT<2*T0^]7CEPE#<OG$8KKTU51'J$:I,%DLH85M&2LB_!+^J$M-FT.(
MZRM@\GFG-:<N5).\=F,S?6-"F9T#MN$0GU 8X.[%WD-$G-JCR<:658.IUNB&
M45RI.IZX[31?!%X=VP*-S"I7B.^'#9SY=AF-M@)%^.$7ZX.37$)6UCJ;8K-F
MC](?"TIV)$RL,-H4\B61[U+R&V<=&IJVPOD'&LWA)W3J)3)OLF2^T:YP4]#S
MXA#-NXC_=VTM%+=YN3R@2B-+2_^C19=D=:3L-=''QD0DBQ5!0)<B"R ;'->N
M=7U$J%ANX9@$8?1%>EGQN\4=FZ\4UL9NT<Y6["7[R6.["NKN\?ZRK()@]5FC
M=6UT1%=S5Z,@\C"N]=7(&9I,9$UJ\!0,-3G32<.#&8OJ&BUDDEP9&^+!<7K6
M5OAM [:37IX5>W%6-N8H"4S+W(OY\>YEG R/)EC]515>EMNJ,O]O2RVBIX7!
M0\'3Y6HKANJ^^?81=[6 /ILBJU:[=+@RB%P#-FS^AS+S& HZ<?OMO(,C!)9+
M#6,;EO,J0SY9U$JJ7]I[,)VH_)V8<%&9W6=MHZQL7GIW#X6_RM.X>HEZEYB)
M1-Q?;%V!&&#=Z^LHN:C;,U#<,P'"*5<\4<'VP3T0)[VXA]A.=N5%$+&KA.@C
M..740^3$ZX@ZC22R-[)$6S=""+B%JH@ =@;Q&*S2IUO!E*JE'D5B>[NS:@4,
MG'0R C.FW_96&-B5 A%%T7\-T2&1; #F6I$F>21**;RP8J SH$-D+G[8J%7;
MO;B"LL>.1NYEQ/#]U;@\G=K5])RT9:VX-3S$^TG*SRGE2!U<-@X$"EBJR,CE
M)\::BD0^,6 NF/S]'L55[<Z$I'07$]-2[&BOJZ)"CTM:"1W.R -TL2AX9U ;
M)QQNG2BXF!'I=-:6U;_LO^LZ^(0@F9$+20I>8'C B7N9Y ]9\T]0KT@>V?AB
M;#\J]C6OV2!67,VRZF;4HLW4+:$J'5=7]B1S\5B>7H+&[T=JN#JBBIU]*[]?
MCB,LH(*6H3Q Z+Y5W6@-M6+T^?>O]_20CF83:4I19-TP@@!,'A/UB$?VDXC!
M*NUN"A:!QN;WJDGW<RP,MV_YKV\370/W2^:QK[*B&W@5BM,T)KB0Y$@(?V6.
MH\=EQ>F);::++<';V*A/<2T\#_95HGG?AF7I[_\^[CN&-M205)J(8N"H/J/;
MJ^8Z=7NG9ESO*.,FJ<'HG?KK=!YHK@TM-XF-)W<'OAW]Q&;"0R/!CL=I0Q0,
MSO$3@6[05V[BG73+NO'+UVN@)B8F\H>OT%%3H8L@[")28?2"MC3JW:EE*"1R
M(ML<NI-T3T$\4%"YUX<VAP'B,1[05@PU3'U!']\TL7 <M:>"^\,A*B2ICIIN
M U/'A@K CFZ5<@UNZ31AZ4Q3/CDE<<9TH:;7/Q#<K.)INF$DP226=\<0S M'
M<'N9JB&^N1HG\H),4!4/4645C>^-:_];A=09U%0/\Q74PY^]LZSLYPP-G<MS
MA]&(*:9A\#F<WK?=X&28I(PP-JD]43@-0#P,BN[^Y^?7Q;S%V]"AL<12[_#?
M!^9AS"B\Q!A _4@*[Z/N]DI]$+CM)4J3R>(IJ827&%N266\VRKIV(ZA^:0 V
M*-/Q8Y;MSH=5<7EBMO3IO+M=*'J3@O[^6AX^8MY]Z%_6SW\9]T/G%2Z&,)FY
M67\*RCHY[[+R)A*2'9"N:U42[*'X%2!*L]J?$Y]'%>^1E40JJ>ES;?RD[3.<
MUB1!)<2?>J)2E7U-V\(RE]U3LJ8&]_7#]P*AJ.JT&PE@']E3UU56CH9%4]8W
M3JNT[VKA$<,^/1\5^'*+&/5Q<%>+D35C<0#G #3MN*IU]1M"5I$;=2HQGX8L
M OO26"LR.*!6  JQ=P@>TZVO9:^"I\=Y6?Y_S>]8?F"1_R)K+K6-'O<7#;[
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M5&Q]>>Q*_R76RI%]APM$\4#I9Y<)$K:Z1DI_ #C'B/HR[<#F07V?JW_^:L&
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M+%U 5Y[F>.I"</>P*269-I4-_'E[4;^AX'R/PFG>G"N6AP F:XV-@SK 4P=
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MG_-0EZM8X(]OG(=*G[^L..?<+J%M MT0PW6XJ'?/V<H]%/C???D6O18%K8>
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M8[^#GIQDMUC:_=$Z)BNVBVX<<6,(7M<]P5SBWO+E>AUN"^O?RR3'Y]MZ4JC
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MN"8K7D72EGUTB:/B!'I*O?#V0KV7'OIQ&A)Z_%MBPG^B>1'K64]M_PV#TQM
M,AM"F/LAKBY;7NQB]+VX9,6[GF*7EEZY=^3V'HSI?'%]&*IOF:J[S I#?0LG
MACJN"F! 9O674+RCD&BJ6P3-W^KBIZ'-F=\'"=8%%T!'[08;M<P15\GV%'9Y
MH ,S:5>42P1W>XS\3-=D]$H%B\JE&_N:6\&,V^&%RLBO'9O+.OOFZ69S.;Q>
MA4BA_$UA:\YY25WP2R8R=DR+U0 _#?T2/-%>Z9/\M2?9,O5E'>:6\;89]@;&
MP_/XFJ,HLP]BX5*Y%;@L;_TVE]7S$*408IR8BVX"V/)N)%8]E,5,QD#S\YK*
M6?48QJBG6LY+H<5+J]+/G0X\X?6I2_"K"$BWT&*2$]V@TXW>/T#]BU$X"_B.
MN\S]QHYN?]#' LH=[RPG/ 53R9PK^V3"9YNS% :.I[AXH:HDYN-L>\X6]$WB
M9X"DTTYV_H+(J/Z>>Z%C$"VT\<B=9,#]R'9%1SV:^:&H.G-F"6W3Q!NV9Z7(
M\P:D20XL40R;.)%J>$QC:S#@"<[QWYT].RW3.8(*H*GYENQ-GAEEV%,L22[G
M!,6Y>@<,?3+3HGOZSN7RFM8(];,3CJ">,B07ZM!'I$OKJAD)UXHLU[2R3="_
MS\("*Z2Q>RAJ)K*;'2E;9M-TT[>>\0X:S]/(F^RNA_^(3.-5>0-)P\7R.]7
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M'-;??C]HR*IHA$F''O(6^ORJ85KSK2*O?V* EJABKWRJ4C3U&]QH21@3XVB
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M;>,]*<^*K!$+,\J+71;W6R$AFT-E.3,.D-6+X[78=D 7\;!WA._W*\2KT""
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M<![]<QRB:[UX[6 J%+65^9M1U#;FZ;G#;M0P#JL5']L+0)6;\4^R$'=$]%I
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M')_(4&J7SSR)V<^*UGS$JQ;PN!^5>QLWI4>39 B" S-ZMS4I>^)1B$))U[[
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M)@9\]<=D>ZH@IXPK/,R>&I>= V9L*JG=Q#.V07',K-I06>)D9SRKX,.7K9,
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M,;%0N/*@T=R28RO^T6MRK9S%)F[>2",IV7BDO:W\JXJWP$<G6V.Y\B\)P!$
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MS%HQ6K.[?@^VX//;'8?Z2XVUL"F[LY'3"([0"L84*P\^YT)&KO\:J8$$3/T
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ML3^QH667&&K\K;5$5S#H<IP__*!P< '&)8NS>OHPB.4:^MMHA)EPRVE<9;:
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M_TF3NK.UO8VWO"4<+,G/BX@'+S\7'[\>(KC\ F)\0AR\@F("O-^4_"+Y=]:
M_Z(#H4!0["K_KSI^D?RS'8ADM+:$6_Y+EOPJ^]\.AC7H9RQ<W&&0\WRU!O&
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M$1Z*\YA=J675=CCT+0=?QB=V:+*-M4II9$!>(<-7>]\W<$4Q FM0.BJLR@#
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M4@"RSXBU,FIX4(&2-D6L:T_R9KV/I"LXB=_$_NWH=G0U]W*5Q:+:!.-\*J-
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MO+1'0KHB8@@,4&:;8:,@X._E]=-_Y22LD&*J&[TH4K;+N..Q?_>E*:2ISC[
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ML5D_0AO(DIT7"V9_VI5NM(PQ<4B\[^TOZO+T%'!,IJM:6/5V%"5^]W;'"</
M!C?QCH47K9>]ZB/(]TCN)V,M'*K#\R5B/:KVGBWZ=S3>6'3L3"JL^C JN8>H
M3L4Y*$_*V=AS1%G8. X_!1 M^ L.)NU*3';-_B1S&"]AU/_(M9:OUT/V_-__
M2+=?4^=?SY1_HO0[:1U:H!6]BOVMEKBVA )X7QY'F>7YJ=*5O-_K(V'OFZEU
M2;1Z%/&^6#93$/,FGYH6 0'!8"[@-9+Q^7\-*X+XX.=<+?K'8?CO'O/L!*@
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M?YUBX9=\W$4;5>V%KO,C(9E]:!V]((ED-\89&6B$(XJGO%V1==+JGB@:?KT
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M6>^:'A#O"$-\QH<>&/S1^SAHZ5J<.T,_U^!@[WJ4C&?;MZH[/"SC:Z&D0,H
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M;$GFZF?8(-8V:G@ XR^Z)UDA+G>XB6$)?XVKX03Q,IN%69'I^P/5$[(_IH[
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MQ@D5C>O_!3!*)R<"[IMJ83ME)DW7K)@?1;'@2(Q:)CFUKDK+:[G.U.2 "A;
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M8O,K>3W=BYG]P(O9B2L\QL\[[6TSY6:G-TQ:K?,/TWID0X50ZL:8YN8A[I%
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M&TLU3#:W-P9V:)C C)/!QGT3@4H*R'(ZI0ZOS1*V+S69GC/:W$GG8QFE\4$
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M/&296$$AG'$!GI#&"\.[DT!.YUF%7;K&T+9'SQ#QHD\3CR3HO2Z6RJ?M@[[
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M'7JLZXPZ\W0!S'J[%PA4VI16L:CU,*(?&>=*1@PDUA=8[3@)O\9/(84E<]N
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M>O7/DWG3Q+Z(46@*.>>#&!@QZ#@"];!89D<7E CD$SL];%#H"!TK:1NMZ<,
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M31)A!YB^6=MN"JK2J5!ZF"\SWGF&,O!Q[RPY8SEIA$CR0()EB#!^2=^*1%M
M^T@%#JJFI6J4+E0C/.K4P2@'7TB+.6<C$B?^TR'X:+R0L[C7J_0[^3!L,[6'
MF$93I?FWL=?Y+6^K 2I6!J:SJ%:+L+3.D>H>&>F\:]=)GG.^#2QTR&?P61Y^
MZ9JHJ4I>Y4M+M!;M7B\*1@5798F!.)%V99C#)MK"*AWDFT4Y7'6LP3@M">66
MAC5^(RZO"'0HH. J)P*;Q*E3_XNSP\6L79 IE"?DO81].@^F!,[6%Z<\5N\'
M<(IHA2?ZR;@=FQ3:^Q2WFI1-*&;GI2*QF>-BC*$@L%X;4I1E&;*P%K4ZCHY-
M2'KO@.+-%_XF29T![^.W6L-,(M$Y=08B%0=O=>AN3;OJL9K8LQOM2WSF">W(
M>;+Q;K%QRJ"HVNI+^EH.$NM54D2%<C^UKHZ1]1&=96,9OH%R; VN1N/6;T*2
MZC"3NY;PFBZF/I%TEGWD\UQP1QC'S*)Y[OU.FP/FXHZC8;=[GU/8[O"T5*UT
M1YI*EREMTL>>SW3W!!Y/MHY)@#)?(SEXU3/5$*618 :VU:-7@+4K=HS7.[N&
MYP L$9<N5]^? 9T+)QJ;10X;LO'%R.,Q!O-?4L**:4FU\IFU6G=[.L)NSL@%
M.2QB5P;WQ/C .W5L1$SU2Z@E9VY' J9'C25:PQ]A7#FTNJ-OOG$%Q5?(031P
MO?*:D9([;Z(W$!BY-%#)\?JDXSPI^27]&Z@XC=\XG,T'!)I"FF+?-UB6<9^)
M$"_'BGB[A:^Z<EWFM; 8S"X1A59\TVKA<JM0/>ZF6>TYSJF^A_B%&H=W^*:I
M:AF+IS*0J$&-6J7JU&"@44AAG&%U9FSPN?Q<A)Q4V;MFNE!70^/F<%@JC##1
M1_6*.C+/)O9NF6X.1;9+-]K)ZHX]N'3M;IJD7?;%HHVNC-/(T%:VPI<+"7^.
M.+G=X)2H4^ID 'W:]^#L%6#Y]&[PH3K)A:1*/$NU(+8E7OAZ,04[*C4UW<7V
MD*U85QYD,]H:"])([&8\7X04JK%86$D*N)P65S (  B]6P!H6V1X?/A N4/C
MKPX-NIV<1Z> ;_B#:6\^/&@7&)^B=]2#D]X8U56HJ_Z6R4&UPF )8H]4/8XX
M6Q;KV*AA8'<Z\&O1+54:T]Q/H."3JV-&HJP2T3F(];-#'3H-!IS#:BG88!4>
M(>$'Z@)H"TER\QY]^AI42&#5A]P=$"*^8HIJL;1(THUK-]FY>[9GV#GQL/&*
MGED;SG8;T]8I6B-Q+/&6S(I:0/A"L7-C":.27FHGK#B)%;GED,Q/X&:=HP55
M,# XLES74;TQ_IQC/ZAW3T_A*VA6&7L4&/13PD,.C,3>Q\_@JIE*@H> UB3F
M-[57Y%-=(NL1&:QP80\,H0H1_Z'@.<]-'7)7DUO<+!S5U-+OZ$S>;GRC:WCJ
M&YZ/36O(UYDNNAQN6'72)Z 1')&:+T$KUI)<:,GRK(Z@6/R.'"T&+1/DL.C$
M3NM=MF=L?4Z_)F:$!TTBIV*HW<-8(]-$MPL2>YL</[7!R>918P<,0E4'B>!]
M<T=A2"<#3GI=9/R6^X0Z9+"ZSL&.WB7HR.?J]H?3-.97Q;L2L(R>TR(4R"A2
M80<'XDV"157(3#I2)V)E\MCI)X25;]KK-,^CZA1\45%Y6B&V4JYWS$+R2-8R
MX4\A,L0]IB07I1M=RK(F(*,?.V?V59:9 0$OV8AH)[[A2F?D-,^@?S?TSN7Y
M91I>;=#<SV,DA ]8*]3KW_):1 5KQ"UT+$20MK,IT>.>R'P(W!:@7&D=N>ZA
M&V.S$B^($2:D,V/4D^UK2&:X;^3: UM75=]W?DQ3"<9"]831Y; 43A$ZNH)X
ME)-,3 2O15OW1B'ED63X%O%-XY R7G;%0I/HUA#KAGV+AY_04<&E9<B:H>"#
MY_+2M5\ZX9'SB#+(R7"$8A^L#X[6;&<V;&1Z!53+3<'2E)X-8ZADI/0W^1Q.
MH[-PG-[H*4B(2?X\&"A\Z?(^+0V:D&VATX#2RXUIXG$ITG/,+X96.&SIB>#+
M2 4K1=%[ /)^'_L<0H1D'=[W. !6[SFKG=/&E3OZ0]IC:AJ/97*$*O4,53LZ
M44]F4AAH"3JU#76[51HMJ18:!Q_;"(JW0(J$MD.U;-?O)$QNVD>YJM>%(%-G
M2!U+="4Z\COVM=][@5VT^($EU<1MJ&W8_$<,(HAHO")E]/S;F8C)B41'$JR.
M7&_F$'RP%\X>9 ?UM!M)(C8X#$7UVPTN5ET+/R\Z S>JA8,UX5AAA4+VBA&L
M@BHAYT+,FW4U9!-K)50E]$1>4X3>A)/S*7WX>#'+H&!Y=0%B'^R205P>./H[
MU!P(HJ':SKRW2RB]# YI2/7(- ,\"M?:UFHLVU,A=8+KF2:I4U?5?0X)?&]+
MQ1)9P)!*31%7!2.<DJLJHRXC@P<=FU(RNDZ7X[I?,F]''WVZ^7#&#F>:@D^U
MM!4K$3^[QNPU!N&4?DQ85K7KQT%M7#9L?"TE4Y$Y%W0XO+,(SL5V+%;I81PM
MN$W#T&"@)1P$GH]>8#<ME[V(*X6KMK5Q&:.[MU[!<&A3<.<0O=^@L=/L?)"S
ML8U"YV:2I:V]OGKJI_HH4,M?R$^$;^# MFET'A::76ET=IT<5Y8'\;;H+^%Z
MU*W\S+^I\W*F;<]>KI$)>X=D.8*\5X9P96G";:AP9: 5&AMLXQ,HIH&/%@C\
MK6)[KBN3K>_=0G)/:A-MM+V2>G-?_L7M1ZL3GL=U'M9&L^&IZ #2T9H6:I0:
M</B[4XUZ!+E0[P+"6W%8*EV%= 5M 67AE1<8'4K"BJ2JE!7]7 PCH&A2(F#M
M#(R"%[>H_&ZPA'QDD%*8*6+#;:.W/2PAK+N43166@S]MXQ)\[*OGV9U:F*O.
M7&THA<3.JP6GSHT&Q P+^/;N'./6@<A?Q?U_GPQ*7].4>Y3HZ_M,C"=,I7Q:
MOHM^!7P"#R3L&E\XKU1V'^O;_0^203;:^SLGM#^SD$_##/PU\J^ =+X_?U/4
MIR&V]R5.\_^TKNS_9#J%EVZO )6A##:9>?_Z^FK=F4;=+'9VH'OI0GR>B+9@
M.>F>BBSN*4TB72 Z902RD%(&\I%,FK<&K CQVT0@'W.8)U;[$/<$!IP[[F"=
M?GT3]&2QQ4BR9JD_7E@&%T*Y) U0:'GLW+"8#+NPL[5I@WPGP1)#C([5TV/7
MJ&CYM$'BM=V[TJZJ0'6CB K?9Z6A=MXKAXDBS*)N-/S>-\D;JGJJP< -"8;(
M@0)]$U;?<SA5;>(YC3:;L+803QCKEZ@(^5NXK=&<:!52FD9D^+:46A;7%&K4
MT%M.<^NHKOS9.F90*3@@7\WN]+)CM;.S8\R#0$9(*1(INWD8\*"JDX3STH04
MO([1:"FBFDB(8_;Q].?[89PMJ+B)R%*@I#H[7LC+-)Q1S^CN)N&9"<5/$YSF
M-(H8UW=?75V]J-H[?*49 O892]>O\>%Q4SZS*"G1PA<Z"&%?W_4 E:OX-7U8
M/JVS9WR:27T3Z<T'APCHDV"DEYZ.@)>-9C,7G+9$<&!.PA.Q]+$KN)C7/V<N
M/@\F=U(@I8W]?9,$0J;%[(WD2W.OL174&-J*=RQ)VN/E+W4#LC]F\BF_ZY=^
M1Q_+/[Z8?FY<7D'Y3<)GQ21*E2O Z+$]8YRE DD I9EKW:%;1K1^-31NQOS=
MNO6' @_NOY*TQA=9(O@7>X*%ZNZ[<TVO>&-QFB^MS5]L#8TZM=G8E-.J7%O$
M[O;3*6 V&@X^#ME5:P*JZ/AM<&G'>#/UF%E#@PWRXWFC54PE4(6C6ZKR<@F@
M4H&5*K0I,E>VG!D^E\K=V:6$B+4%'_)XG7PGRRE^0ZY;N?(K9'8QK*0[-V]V
MF]-@K7$>DS\]!7_=L81%!DT-20X.F)05Q>M0Z.]IJ-#<!UHZ=-NG!Q-#B1;D
MLDG8J[6V>#XLKGNC4?92R^(.@:#HB*(!3'1RD1%,*@8Q#L4I%9P5C-P*=B*G
M/$Q\9V3#3CHWQ5SQSC50QSK!9#2_I?,(IUJR-QPE3J(9!A^'%!2D0;ARF1-4
M3(-ZN[/3T8VRXC$4.?AY 3BT=BRH#L Y;#JS]TG+AHJ<R0Z WOD24M1 ?I)I
MXY0(5A+N\DY034U8[:T29UHDHLP/-)U22/*XJDC0D'@;7*\HX3>>\(8TP1*2
M^/KK_.;6[FXKG:5X)/CYN)(N!2-7%<Q$$T]35CHU':&J#_-;)LOHF=%&\RI"
M"7!CIS?3WDHECX!O!?2,M*@!L3[4FGN#+/1I]6T^ _PU"@9#R</U=TEYP=T>
M'IGU,N\6)8DJ$"-N$3/&O0/'A ]L6*LI<AM5A^]QWC%*WF>RAT)G_WX["TOH
M33)S!N0BK L5C&&5?=4)Z/0%I9WL@L:,(T@(2;*XA2(&T.-49[J:G0)I]&!Z
MRPE6O@R\:LJ.:>VU,_?"R>;^<+(8)X$@6>CMV0:/^^(&]XDE"CF;W0(1(2R5
MT<Z ,#G+$IY>S#M]Q6O-8#*,75 ./+Y"Z @2(XJ[HAXMG\WJ\YK 91=6B,UJ
MHILH#&>P+E'OC=4L[_@6A<9XY74'5H1E<"?!NR$C)M=1!LYS',:M=.5%M5)U
M-82=RY=,#NXDOO_2W6'WCG@&),N*63]N*P..$JLI\S5XB<S-%KP6[)IYOUR;
M1S<CJ5Q)3TO_'F^'+Q#O\,^WG)O%.7@34*BAQ!\G&69)$47;F7PMF^'NO&1!
MW#VO(@P&OF=?6F>'\AUS]WV!<O]PNWJL855%?2?]P5"LU!"WX0H^79AT510Q
M:OFQG,%;E1??)^VQJ%0A\[V*)#=<<#J4\9'-D=>9% Q+&P7-L. CNR;F1,VH
M^F;L.$S>S?9$W.T<9Y\IVF<V]MBAV6YN+W.4#&="4IJOH9QY3OZ9B,*X88&0
M\M@J(7.C]<9J1J7( O4F).UJH-F2"UN75U7;=+ZH^N?-MQ_WS*6P]WN3E%M$
MK>0*I "0$D0E%G/7[#(=G=:)S"<J1*M$9EK(OO@#^KFA2(LQR5DMX1!6J!,U
MZ681FR%L?RSEIK8+;MC$I0!)N!SR#>%,@Q<-;73W2UPMJ9RB@.87=1Z?<UV:
M1+,]7^YAB@$IV3U/PJ+M,6ML!#6G6F'!HL\SF+M\293= :E35<6;P2-4Y7W?
M-A)V%^1RW<"HP4"8)QF5=<\G?1[F(NARTO?ON0<_K7-BYY+=/!7X(C\;^)Q[
M,QF/6=$O]H^VV6Z;\4;3KVF%83?!VP.EX;"*:V]94$^*0R^<\7*H5,$BT]1\
MWTW>?FIZ034GW<T8SU9=M_/;UWVW7;/5G,V<P[:EIJ&2E:<,92-L70^@=:'-
M^AYNV+V6X^&N-"02G[&:#,SFM]\DJ-2@7:VSSD(%)BK\"K9CDDD,0_0++6%)
M^<&P0/Z1TZ5"+)JY37TU)\]">.K#G_9II2= /V?]U-PV9^,<[KS3YR.PVIJ,
M6DHQ'2]^(KP5'P $)% ?[]EK]4RJ<&_VAQJ6CNJ>N8XK@@1(N BT1JN_[U5&
MS<<CM'G,:B2-R\\IA4.W@;&4*6((JYA&@L4UG(G%ULRT2AF[(V0'8J,U$$VH
MG^!0_?K$&[PU#JZ=N=MTLH#&1R0EO3"9:! Z+G%8 BLV'=OEP@:CZB]?T_4Y
M7V0<43J+/%/M;@7B**^+S#ZR:0TV8>LMT<[^5C<M,87CVK,I>>"BVN"QWH!>
M%W;EU<(%:R)\O']42,H>2'UDX#"#AQSWPZG5SZEPKW=$I).UBTW^7B-Z323+
M*IV+%:Y (CK!NYH*: FPA*M6"@D4MT,H%*"R=^XS2OF52NL*#H]:WC-6$GY#
M-I&TW^=:ZHK7>G=@(S (,^US2SN9)SA#U(OR("#DN$Y+@MF1V+6%U#38W-C
M%)03#5#B6RVQXN#LPNK0=UOBK9/:'ZO.F1B<ZJ(BH5[43C&^6793IE^ME">6
M8%2WTL$O!5@&%LW!FP='D_D8=XU2#"(#4-HQNWCG0+&/NNQ!O\(:O!^6R"SL
MFO4\!S<7US'K^Z&<RIZ#[;BAQ:&$L!)<@<SMZ5^X_S@W8 G]-W['\7\YA^T?
MYFL''DZ6_\J7H3]I(%C[$M-:$]T^I3RJ*"(__G&CE$W.BH V*XHT O+-G3+\
MY.3-.[B1*2.;V;?"M:*[V\ OVM:;R7$5K!A7$>_MS&3,15M-P.''?VH_//A(
M6&1\/'0]>GF+SMR?_PHX\+CVS3]+N-*A;J+*OS;B$LD>KUOX8U]7[8[3TY7P
ME>QP^(\3<MX[^$^-*'\85)NHGM;1GZ\O;]DPX\WN=5TOMYO?13RO4?$>!" <
ME^G'OYR'??3U_IVJN202<>%._8?_W2L@6=1JXC?*_#_5_0N.LG$A^6SSMWVF
MYK_M2[T"B$0GO"\=V6_&ORY4YC5,O'7/N+\J_/2<.<]E,R.9%=]$_32/\7Q]
M>"OJ-\S],F7Q?2CJ%7!MHXGZ5/+)\E-\6?7PQ[N^K^*=+^!_KCR'=P_^,_(*
MH/HG\)Z&"<G?%Q+/MODTC\WD5%M()AY!KX#(^7]#Z/I?"#3N[4]7>9^>LQ;^
ML^]E?XG9./A'];^^>_Q7WWO^J?*_^NZ9<;FUHGN8_JGB+RLA%]XT'_FF_[)B
M\._(RW^13V]%_P.R)W<>X_M5E%< ;IE^0L!I&,[=>%W6Q/Q_H%5&\OC]*LWN
M/]&N^X_[WC3NKX"<F[]9](_E*WOQ/.NWL]23EWFYUF+WK42/^]]/M-_I'=!T
M3/@_S+[] SDQH_&H^SO^_['_DK\/_I6A1O($YLQ?.%=:GAGW6^UZKP#'SL?J
M2=W_VA'-)8NO?MOO\XP_EAG/U-0Y<\3MUV"RXYV3R7=9!YGN6Q:GZWM#R<N9
M]*@'A_& R0RN/Y2L(!:D",4 <7T7R20:%9--TN@+V>6X-?Y0WF9:0_'3,8VT
M9H+N)?X1)3@R/)'35,MN>;?_^_3TO^F24K%?:\'K,^L;I5@*>[F8UUY^DR';
MZ$E,V6QT)CY%O4X;J+>!.<9PG7#2+H#$"+7$[6M%B:Y-V<\C&8AX/+21DH\V
MN;ZO % 7SE5$8]W9S( DYAL3?>.8GJ(A(97L3>BV0XV]S$#4%K?I17+& Y3F
M\V B+AS7T1K !9ZFIO"[4+LDL8_/B^@6:2;!;:--UG3VXOI4C],C4(3F9A%Q
MGR\X5Y'L:D<UQW-7^X\-ON+W3L&05T"3=OO/W02X5E3_D+N0@X5GID^321M-
M-XL?E<:?^9V?,GZ^ J"U[R=VE!Y> 8L*P\,'0PZ!3]VO /27[1]OTV6CK9+E
M/JT1W&@E('JC7"\VO0*V46^F$_+7^?_88,M>%MO\C8B2RBV+RY=4^Z^HKX"?
MTW?35>E997N)%_DZ-:\ =VJ:\^9_%!U?2TK/2(CGU_KP_/'DD\/!#W[AV).%
M^TK/2S+L298/^)2BYU4V7Y&9UP/*K)-S$7X).[\\%=L\K;VY00U8C&C_^/FE
M1FF@#1)>U"'GSY J"<*^6K?,>Z8R*KJ\]/WK"];?P&QAD'R[,?M)4OSA0?=P
M>O[E_%W?7]THZ+[=$]!YFM=YJ/W(T(%W:_\]'UETX-TCM&>*:.2M;.2S>)O2
M]'V38?_TB"2Q"_7'<TF"*;\D\?M%\<>;J;*]^!]_#(J>,IZ7%P<^R4;14QL6
MV3SP%'[>_O4*D'C?NUM)*45ED'>;?#CAL%Y>\%/1Q>K6=L..!H'TE\^YYF,.
M".]FD^)MM6OAUT&'P\V" 7.Z0@;8R)VWV@-#^Z>TN+_\L">\W5Z=_UL2]WJ3
MXEUOG [.XP+-B&3@PC/#*Z!?Y!5@]/1"R2*.3PF/O";T,O')I.Q&V(WZ[:T&
M_]4KH+?R%2!$X_E^/&GAF7FT_$+]E^9>XN%VU8=7P)[%R1^J]*S\OR/K@])"
M\1:'[J'%\)BFLR?@+R7Y:$FO  7WA#9Q,?YY3F&M9QAEPN-)_&40Q*'_P<OH
MFORW_=>)[:_4(IL,;W'>+$VJ_Z1Y>UPN?DN#AE!E.)QI$/7KM^D)<%!W+_Y
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MU?[$&)4K^U!()MKT$=E&](4J40ZL3L.#Y9IZ6^/VSR^IU]5_ 5!+ P04
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MTC-^4@1.WZ^AWG]0A$_?N?^DG,K</3U&K23D/S;T3R?#__ZQ4U]@?_?HJ5X
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MLI;^B-'%Z8H?CCAF/7^T+ZL_A'_ H'3JLRLGV$!.GT='W'[A,!(@TGIM@G+
M%7[_W333G<_^^GT$Z[OR46.3$R>:OC_BE66313D!"2!&D<!TU][CR:]+"[Q(
M@!3O^ C4VDY CQ],?F!R>9/;].W7#82X;Y%#,!*P'*/_8^I'OAU90C_R2"V4
M_9X?X!AF1,>.K$R;Z ST+W(/2U%>4TP=]>B0W=8HH_/OZI3IWCE,HZZ.1@)M
MS?ZM+$=Z8J(K@>=16O:H'5L6??;<DU#W<ZN20A4I5/QN^=W<00*\"Q\%O''3
M+'P'WQX_NDT[NW:JSIHG][<?0;'R=_M#G754:5AOVEE;7QQ3^"V /P(2Z_,T
MT_A0Q/L*RGN+W&/M]$A D.#XB+[8YMQ1/",2N-GM9UGLSU76]1[G<-'!2^II
MO=%!:#^+[$FPCXS;LI=J=&_?\5992GLU:87=-(J*X))?JG]2T7;.LZ:Z5><U
M)##U9P11P0YN[2,@H@DFH^?RYD.-/?>_7-8U+(N*32PJBI/32\<WJY' _HD_
M6EO\F]10"]IFY!SO=F71@@1]]_*&.UC6[H *"1R?M_</RSO@G%PGK?>J1P(G
MV;'%I,<[>#&@JS=&P;5DEL))\OZ=T8)I@8+%"L87"?7-=M29%>(:;^JQ+V#Y
M^CVN,;7+C-O.J5CWN>(J&HS:],FB1UZX:,*&HT6JD>RJG,2%RW,A0XC&V.Y%
M:4IE-;\ MLEUQR_;(Q.]2E*LHR\-7EIPZ9)_UBLVNOSY/,5Z4(<8N/6M8"\;
M1D.#,8U/[=5T"AW^:&V=GA'*\^SE%J_+64A+IM]5LZG5(T@9U&$4!@K$=T!\
M:8 HD4<=K&A7,O:8OB;A=6HOQQU'3E.K9P^LJK@,2AEJ8L0*#6$- CH))$NX
M?K>-*8R6B[?%669Q$WV8]YI#21YD/GH1^* 9O;PF$Y%.)VL PDCH9KM[=,,Q
M(D2:W4EF5_2Z;]%KP$^+P*QXL3^95W32RP(?IQ7#ZMMC8UGM+K\XFXPQ9O#5
M@@<2\U0-^E)C+\9*5^[?>.:)J<NDQ\R9_H8YKS,M,F*E\,W&=3Z+C^6Q;E/W
MX[!9V7*-W[^\;> :[%4S&TOK/)P>FJZ@R,36*ET,C1EEGO(RC&_]/(>][S-;
MT$6W./:!5O 1SV-SK*[2BI#.*7(G#)$.X0#Q =L8,:\[)8QF65O/Z@+?R@7A
MD/;Z??E*M_ >"21["M=,=Z+J%1U?!\(3/,Y]K3QD:Y)IWI[9<>+S'$_*:)8E
MS14F5B)Z(V[MA6CFQ$@U"3@L1>?">Y\T<G(M)8H>8S5(3O,[,^QS4^K0MF^,
M!CSH<FI+6#)6GKM>E)Y4WGJ"%QW+R,V]5FSHW;"IB@A=4RFIH:T9E*2,4MUW
MO7#$?324>H(K0LFF&Y8'V.827<UO#RPCR*V?)@<2,*Q2 FBK\F@8@79L<TQI
M:3CQD(3S?&[KUPDZ%J[.$.)%RE#S*U]([NECXO4Z8.TW6KI@;1B!=3/#^[JD
M8OGMK!0%)2/H=>7"_$@IU>["XM>M;5!,;?90LA8O$V,YIA"TZVTD/@M',KA9
MS]?X]'6$YX5>BU6M? E?I-.?&%YGJ<"=\6GS9)W$-6$K2_*FX!2Z,5*\-3K+
M.,2J3/ZN)?K1_01XVU+,/=K[H0^+%46[*H-#UJUQTD+'LEI--5-TS0()WZBK
MKLN2E"5U7VY['RM)<Y<@8BV@9<3KU>60PUOMFK=F)@X^DZB.CS5E5X!).%7A
M(LJX#$*]@VK 5=A<LB!SMW+7YQ$^L:!=4 /TVUIF.AA8AED?5M(ZRE"52>-U
MV[5Q.!J@S3O8A^1_NKB;4^N2E[BP+#B,18I1-X3'NMY65TOW.>*=<GE7M!=9
M[P3[QB5YD_>M&CD2=O%V(A=GI6C,W"AZ PEZC=(%"VZ(=NYI,15\@LGO$'%V
MD*0:F[=:7HJZ[8W%@-[23+ES8:ZNU_B _$TIR5?34G$YKI0[\UE2\&T9RT8E
MU5[!$))(%:SXB* '*UQVY^H2$.ELX=#H\B^D/NG//CV;8::F:)L+3JEZ<2Q!
M<$6AIJR_UCIF;@W_W?GXF]'E#"H4I3/K,>/!Q355F0U7+%GTS19,&\]77&,9
M"RUG-6K78&-U&_&02Y<3?EZA%TJT:K3(9V9:FM4P)/>!,M,F=6VIN%/*0%YR
MIOH.=LFUO6SSR*>S,I![:J34D_')&N_GX4V7[UX@;7MVSU$S.<<(_\,%NO8Z
MW);@EN+(3C:(6\CTMK%&E"KXR>+L%'=QD@L&^-SF<E&.TB,:S?7Y5A&"65S6
MMW>O?3&FOO92V,=0XY76F$)M>5O7A"-%79;0IVC2])29O<KE2_M.@<D55=-T
M7]/P1D$O!>VIC*"QC+MV;X%$-@5O4HHO[&HSG3DV'-5-[VF2L:(/"[-NF!NI
M[1N:VF!Y]U0Y0;X..DM.X*Z^X*5N'^+?TIT3:LTT[&[S=*:1S)%2-Z=(E'MR
MI[[Z9O'N(S3K#[;/UZY-4;\<+U'/3$K'^F@IA]'\A>:51/8]#/6C6_//GL>Q
MTQ/SU,0I>!QQQ:P[<;F]?+4YVV!IZ\; 3F"=IGF-:5PJ^&Z0O)W:Y]38W.Y#
MJ@[/[>R@S ;&3NM+[NB$K_,*@!NK 33XFH8DB"0!WB=WDZ1"U.5998J2L^<Q
MC*4>I"_R&90D5[?&YG_@&,F\P^$5E2(F->CB0*;^P,7J2GRBCJYN>7]FX>?
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MT"8(:V(SE-S]HR&'OL.E;@V,B!DIYB@?1D8U ?F^EG&'^S$A%P0$J_U<99
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MA@+]':V1Y6"H8)<PW0 +66J8%#1-3=BA[?'S-@R8KB<U8_Y#B$6Y2Y?!'=W
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M[&(DM!['F\:>.J!>O6T VP&3[CFJ2O77?PK_IL?C>S?=M[7U^/HI(3('6KZ
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M,)T-BLE_8/=K]Z<(J?Z;^VN3\P&Q1"]]OP_$C1\ZSPM!&T^.?9M44*&H_CA
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MB!)II/*3%.Y_8I+'%,^TWID&&ZK**489Q*_0%3VD"[K.T;:(GU!@%RB\"T#
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ML^Z]U9&3R?M):#^LSX[QBS=XJ1N%R*&CG872D5;FG!E9!KF"_/'(J<!)['K
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M*+AA^ . ]MC[EW[2N]8>F7?:PL_52$AVHK$+G#+@1'FLK#TSO.3=ZS95JPP
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M::4H I+<EB2QBL7-;TM/5-2-DGS#KXJ?[@]"U'0B+-,0@@G5U2*D$@FN^J/
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MX3"B:.MV!2IH-A&Q,:);7(X6?..PQ=(G9MQKN R0M1J<&T<;1(7@9:Z.!KD
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M3U8=JHWG5\"AS L&#I"CG_A^BLLOYA5P&F!P]01[!;QM+ "3Y-  'X$#^Z^
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M>OY:,=CH=HG,4H(H.0@]9NWP>,]1=#^LC!#T#Z,28S1/5P0T"_C;&N!A_A&
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MG ,,X!81 ,CV*P]GC_@^F?<GN"L.3L/."]7LGNY=?NUS#V#&QST5"%0"VCT
MH%2W=DSK-3RF7&M:%15UB6G5EC@TF%2/"Q?CD5H^IUB&US$^0#9(2Z(TH*1
MP#K%+201A>'Y9L)0/3K;K<6$S\D%QA().1QN[3[NECU@A:2^=PG\W\[):,(,
M<%9\.@-> 0O/?U9B8+420OC<(<&H2'H>/+3#P2KM[R;$[11-,AF?6N$&)IUI
M0^*A.F@&J5_R49 .N.3 >A+_]\N+LU2ICOZ5IO76H#K:AR^+/3&J3?LK20.2
MN.Q*IR,AE#]6%6@.E+969Z.<@WAG5.O>8!=T&:FEA<")'[#7&PO>5V/3]\I.
MTE"7*J"&__)Q+TVE\%"_=\[(XZ[=DZXC+MXY6!GW=*-*3OK^+CY,GUPF0WA%
M5):4%?S-S;GE%J)DI3IE0XC 7)9N.T7 /SSE[,^.+@'K K%+S\37 "U&]PXH
MZY+3@Z[#MV]O0J7R%W/[I(SN"<G?,L5>!R%^-4W7,;DYM0Y:OL::L2!UK7$8
MU"Q@TY(3=OQ0SGH&7F->4L<.$N'! ,G2;<)&_0.,4+>1K"%$I)%%JS$0KS]^
M""?-#_+N;[^B!:<.3RM]O$D^I\ETEY.:<+#X>#]E\GE-#79CC1>\BQND94B;
M"F-D#<9V=13DMB&G$%RV=87$%.%<_>*310819"PD[02NJ!9C4:6N\,:$Y8?*
MB:[NN4XB8C"H*CIK=<8%^#%A+B:6#\JPR[0B.1@<S7A U$3J>!H^R'(57SWQ
MIS6.C9EP9,BD+;0<=EZ+J^EA%5A*M0[O'BALAUY1Q>";;2>[2P[.[W$!Z<Q"
M0CT^Z+5EAY0GJL1SZ/6W?N"M!,-Q@Y=<"#5YQS:=^R7".RMXQ$G+:[UU'>;@
M^G)(BTPM@]'YY;3/$KZX7S$_AXR'@*DUNR06S8R+V#@V>.)(#YQ1:*1.9$.M
M9VV66[B'9,8)Z*,,/0*L\#:Q%_&&Y4P-8YEL,"_"*Q\$0#\KDR8EKZ%-W+X3
MH=/*_%#%L3YI7-G39+T>2(CSLAP&4F\>!WV;(BFHCD%&A_Q H5 11-&+XA N
M[G"X4J%MLJP8+'M4GF+8D=_!HF4M>%W_H5-.>[?.QI=P1H_/+-TNPW("J?]6
M9E'K#6VH2CFB#=$T8\4PTJ?*]O+#;QM/Y2;< 1@"X4WJ/JS&XJ^ C[CQ5F/A
M%%/BG2,S6(P;2->^2>G?OX1)5<K!^TX\*CZ+Y?"#E-"J;E%^/) 6U=^_O[K#
M+]C5Y3?;3 [#C40;+4:ESU= FJGWZ4QT']G^X_AHA5:AC*EC.W>?/K&426*\
M;^HD/XBO\-G*U-9]I \HP$(;1]08?ZJ1;/8# _<W9WQT'K&PV>Z/-*I",%H2
M'+7,/B%A YZ1+$Z6Q,'):L2;? ]%<GW!Q-8MU\4,>J1,B99E9L)O-M]8Y[ZY
MP4(;Z6/TY'47!NI9E\:%BUT5-32)IJKU*M?ZOY5#9Y@>+(J!VN[A3B$99+3M
M$<9KJ0F#LFF$2.P&=T,7GP$;(](]HQ'95<<Y6C0LSBV')*VIY\>IC#<L>O6?
ML+_U+-&0OO6W/A_0]Q/=8KQ6D"CX$V%)EJV9J"!GF)VY+RC#+;6I(RLPO&L7
M/Z6%#$(;Y;\.N!R@4ZU?-:A,L2*S=-YU<>T#(D9?XYTD.6?U6][@B&WG$!0=
M3,4F1%JWSZNS<,E1],JFX7DS6Z=%"\ CF'-M7;S09LCL<RQTC8(Z:M=5Q?&*
MJ;;32J-"?W]0YY-BX8G9H;580)[<)VZH:?\F2])G]M.R#+\"NNH=)*MA"E<0
MY169G,QA!!'*P@PT D0-DX0W9*X(JK3 (UXDP7N;<U1%< VO:YR363@K5'X)
M^[7<8S*@4ON!Z)<0J=A(NI@ ,@_G,D'4KLKB-PO_[O*S87S3.5N,!"[ M]_4
MY>;\BD5W@OP@1W# 9+5R&)\L0#;W31FN^HA0KZD%Z?#G.I&(F1-$QZXOKB/O
MLSUHRAT^F",:8Q^?UGR02Q9J?P "/[ L=4Q_#.;FP($SVR*(C36[X61%M37
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MQV29CK=4!DA/QU'?U2>/GO$6JNDDBSCA'J %-MT%8@A0?LY?%,\0*,3C^RM
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M(1/9%1C>P'/$ =M2QS@J8/.(WB\2>F\&9.\XDH4T3@-\Y:!$%YBMC=@<8BZ
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M1@M6BR 4W;ZW71]<K?L';C;Z^R55RQX')BVH&Y:^%]&@B*5W_5/6,EK> '0
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M! N9VB%49/\N3?PF\R-L\L'L(/8A^SWER67,$97RWQ)AX)H;3XJ5NVOY=T3
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M':1AG? #UZOB\;'??9-%CM;25CW.Q+Z?G_%[(/F@#H,?TL4!O%"\;X@WQ(,
M2IC.Q('.Z+?HR% 5MHS]/,_[5Q.RI 6_:;5U;QA$Q%"GF?:1IYBBZ(-.I-"@
MC[\ P KNT]F4W-H4]U/#C$;C$S3 \\(";?3TO'WHD*H3G1XQ>G>'V!+Q)KZD
M@>G4_+<QSI08,"N\-NHW(!1#EF)>H)TD)J\*U"_T"(AI%19TJ7(P$1%&E[W,
MC6LS%'DZ+%X,:J>_JP@'E'S;%^HI("W<Z4=>VWE^&O+9IQ-_$*4[C2O^]X9+
M/*3WHJ;I4P^E0H(%1<2))0J+?&9(>.XPU8^5/$BD@#ICE(!\D7MVS0UT-CJG
MQ23#X]W(0 +Y\8-XH@YMH+O@X*^.:_DX#J&AA*&NBM_2LT/SK&BH5&U#75$/
MAEM-]31%;IC[Y"2B7A>&Z ;X5K1(DP;5D)6BT_ETM24"K/BW9V92G$6E.!38
M6^"M80JYG)2FD68V)+0)[=*\O,'\8A\Q)@L(/39H!$Q'*G1;.^Y%V"@4+-PJ
MW>R1!%RAD6$PW<_7&\4'$?(0GC8>O!+:K?BBHM&,%,L='@HSG V_ %=\F2L+
M3#L+O[BZ*0J!2FGJG%!Z2CJUH+MQW:R=D2 L"Y3G^+BN6OVS\5_3G-63JQD2
MX+$42>F0TF#8/0J"&I"6>-9OVU]-&[><.GFO2+XD><^Q.,FO7SA?\W=VOC(
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M].([WVG9EF"2RM=^!!4?O8_OK/]5NM4_RUY6C3K>#1'N/R"E/ZMN_VF$^-A
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M=]Y[VD5$NXZ9:[9$M[EM:LO!7M\B9QF-+;%W\'R$NGH6BQ&I5I4B78FK6$W
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M5ZW?8\&F3G#HU-S$-'I2HYT:%[+TM-9A!%WAX<P.[+>GVZ; WNH501N=(7$
M<@"QO1$IS59W3\=E7):;%#]4W ,,%+FCH"*1WSA7QRNNCP]4D A7?%Q,.OS[
M+XM/8%6=F^+I\0_AR=,!RFKTY-.6?D38^B41[U^WQ<XL:6DH,,?3_5M%O)CL
M=6KKY'TDBI56LP)W>7I[6=K5-@YVBGHJE :ZF;H<K]UKX>6ZNG"@+2^<+17E
MY@U_,0@/P.0TGKA4!QETS@ZTV06*SO05E-63<2L9F-:T7Z3'@U;4>69H._N*
M_?PFK!_(TS2)I-LU\E41&&F+')OEDOU&7;N?QZ&MW>G256H'96^G6,NQ"M-&
M>/$F^/5M1%6=I-J.QA&9X,+5IN6MU(UJ!)=\ZDOS^&.U-(VX4SB!E_0+>;M7
M->$D./+DX<>:4HEH^Y0D+L$ZXI;RS7-@1L]3EL$-]^Y!\\\U^2?WQT&J#9G1
M$:FV:U0DY. 0VD5M-=CA:TQ=2$]<@K&TFAD,]4A/F2!,Y 1AJ-P-M'S58>!?
M0.1"@7YUO<Y89'.;YW5<-E2G^*^#GO%G^^^!*[[[P:PIK@NIR$+N$' &"$-.
M"IM!/'I3(MPT&\LT#L?M$)U(NQJSO7)+&*[,NE6.&0Q$0K:N3_F3V(#K*N6G
M&U5*O2E31<@:GR>1H;>H=MZI"J[>1Z&A[U1,P8-G@[X7@U7;=3B20=J'M!I>
M?POJ.<]A8(2U57-XN,/DLQY*H3FB^+K7&?G8+(]BX<-IR_AT**U&>C[;X[P=
M_L5.?XR_G_BV*%3NFQ[T5W8D07<M-X91;8X#9P62S[M,7:(K0NEK>4ZJX:.:
M2SLTNS7&UKN?%=%)T]/PX&#U^1G?)W!<5./P]S\G@YCP3=C%PV@5*3A(%-EX
MA8YD"(Z9,MS3<:XBI-.;#@-(+2C<C;P8S9/;Y&?JRJ3%VW&3CC4]L'_>%A;?
M=VDSY.4*^="Z%NY+1"4"LI-1=.-_^9[_#*_.12IP/6RCN05;?8(Z5]J)='\>
MW"J*[HT,3:+GT#8D\\'> 7?#>+ BHX/E*3HC(SC@E5,"?H(&Q? ,A<K29F)7
M)K4\ZZ6^4J0.X%CE8%+(QT5I4JHC*G\ZP.ZND.(A\Z'DQZ,@-N&'#EJR:O,E
M(58UMZ@=?@<*(<36HLE:/U-9H]C*XKE;13EP.M1YIB1:):Z4'(X6_5P$[.@4
MSSS2?5Z'$*@7G7>/TM-6H7!%+<H@)5/'<B)P+55;TW#@N_G%Y)\)9<('<&)H
M0R)Y13,?:[?&VWFF"#=8;'ZL'%RRI0<SRBL*"_OO2\MU,*SML-O:D#8I*! 3
MDN!2)Q;%']O&;=@<OL7()RI5F#-,?]7]_.*;61@: Y:6JBG=4M)>+_U09G4[
M1"9H1;Z3FD1J=:#WGA+QK"+BI:P!RQ4YQ+("DF&S,37SPF:#)@W")_EOYLPR
MJ]:<5_2FA.$/A$S 7R#).3$8?.21Z0XR\KW6Y"Z:_=W4F'G+O*,84)' ;$KW
M%,SJY1J^=#Q,G<>9+S'1K2B/KCU+S#CZU^7J2?%&>G:-Z,YJ]\W)EY/KA/+I
MM?@XD34^Z(9=MCD&I6EM  @TS#=#A$A! X2Z#^*KTG#99=#KMC^3#>8L?I 6
M"^K"1*M45BFOT<D(;)VK/9N.[?IVHN$<M4RYL#KJK'!-]<_*%."/KQ!RBEI9
M5\!=-BU4!.S+Y<&=' PG L2Y^S FQIH^96AZ*XZPJ%K&B";?^%*.NIJA6RX5
M0OOU6#R&T@5/JFI:#8/Q DBQ?C15@?Q]052*VH/4S')B6!1%,^VB+(MC$KRB
MF2 _Z7GC]9@*)Y>1XH2I9Y'QFA$[(> :X6VTKX& 7)O*@)3.C_<9<1I8&,2E
MQ>V>A=W9@RN_2$%=BE.8WF,UF4G 1#AY_Z!<X[U50Z?.'F'CS#:OS9);JQ]7
M@K0DE$9>S40='JD* F"51^T"!D1#8-5%=#@/:WK?^]0+4AB\\WA\L0G6\9&Y
M0:V]$JJNVG&%TB)I904\E*R)TE,$EA D?G9*-\9PN/G64"1X-!EEBVE#!DH+
MW>P?I3-2:O_S%#D$8VZ?2C9^79SWN\4MQG:(59/$TLY'"'FZ&,?])^MUD8%'
M>$B]NF)L;L"D9?8K[@8DD@_U-QIS'>(3&0 (M77KU)G8$?>)B^/W7%#=W-F*
MP.^G=SQ6=44X,R@HC/5!$<%T@']H5F58Y"XTU4%GXA;:UJ'(G>RXSQX#M7(0
M:R%IG\U-1C)VI,)%*+XXWU/[^51CMM*W?JK&&Y) @+_O%>&H)&O7YATL67JA
MQU']%Z,@'-OA$S0UU(YM6)"X.((KD#3BZ)HLQ.@9K;MB+ODF_[?5MD6NU\G9
MQ>F.3GX9[_NA*7 = "OI; I\1GQ-'*0DM,+:*0\\A7=%R$@N0#!RG\KXI4+A
M-V$ ?6-VBK'E@0\0EMDE[8=ZZR>];LV9^HR0[W7L-#WL526 /#\(T^D!\ *L
M(U2$QDAL"_L\HQN]H,JNU8VZP\4F2$V<)</0*V?%^9[=)?FK*O:GYA%5L![=
M0D$!T5&'SF-V;I]=^G ICW,** T"6S&YUSA+WRW.[IZ8FO,%L,.&C]?#.H '
M3-#9"HVAH1$3#Z&WC1Z =%B?K:WGMI'*VV&NW$2N-9.D;B]5%2"U5$LKT<^;
M<P+6N$OU"4+* [%TDO%1ZSS#:F:IQVCN;)V)-O$B5F/Z11:OV'!S<DHK+4XX
MRL]$B?N% UU><T,2#A+9AU0459/!:GZ4AU.G<VU\WD(#B?4,S_5E+8U/!HHR
M.,ISZ&H#31YO=$R;FW"/1BI'=#SC)XB1QZ14=%!"UF;$AUFGIX?C=5_&X]BE
MP)\ ^\V(*8?]<5]5S]3,^!S5*&.@KH4(#6DIS4.P.NLPK(-YP]WC H-"WS[O
MRF^YH$VV"1FRLA'(H/WYLA&FN%1CTF+KTC3,J(&>?#44)KR<,[R'G(9KV/BP
M@N!<+MW>13_A177E03\D8GO->\YETD/9B&]2Y+D).;[9JJ6%P[KRH0"]+OH>
MN)!AA^'BLLO!#_*L;N)LNQ2>F'/D>;UNLPI!*?6 %JLO\'LE79\81(;"MEE\
MA36W=15 TZGDUI:.MRX]KG61;AG0<>2N@2<XZQ/ZDSL\J10+LD:"\.>UDD">
M7<9S5<?B*-5S3IGD8HM'?!K:]IKM%^[A4**K$UB[ /&PJKO"+;_GZ(7M@JWU
M/#JK-;_:W](%AB[("OKZR-L,,6V#.0$[OYL172UDX.(R80"6"G-8NGLL1P['
MR:RO;;L3!<,SL3JAG-*<5DZ4],]6KD@Y$#K5??/J@V8;QF):!A3\9=O29X&Z
M<!-@#A?-MUE#8SQ8T.313?OZIM!)4_O'Z*9O(F/B(/S2V%V:6G%-'DK=X,(H
ME(7OCL]=(:4B]O)!2^0O7\7VV0D1YPK9EI(NSY]4EVEV"J*^/R/5TDQ](2(Y
MZ^12.M<X<!\0BV+4^&3O&(S).@,,PCM#Q$1\6VH,4,K75!?GJTZA@LY.")%W
M)A=>4O]:60OI&4176(M82C]#C[F<$7#(H'&8A?'JEB=O?E+([F%I;-#8!LY6
MQ\5ML?0A7NUL 6%++0+GM,AS9;5EVMT/[L+C2-0AYE\<16)#TU$$VM-@H%#1
M:)$XG4V-'P#'M-SQ9S5;7VR%)F2<S<_GZVW-&G6K6ZL.D/4&GY<J]P-\!)H?
M'ED/W;S-68!<_ZR+RQZU0O!/^']!9K2F-CT%J,V84R= [.)6&,I2[.;7$_+9
ME<FUWJ>444H:17ENK(>2V.RE^X//$BT)_;2/\Z32A[^)/O\T..EY>DE":GH^
M(59&AW_99S_\1D04ZTR8AT916[\D=PO;F]4WRM,VKDQN87^ '#7&=IFJ6'ZM
M_JADS,1'F"P,@0C_EJ6VFA?H/^^SWH&?Z)"RP.$V%-"-X?B4 ]&PN%JI!N&[
M  ]X64]$,?RD9AY.GO'_#&Y7K QJ.3.1@&LW8X"@F(.[V6&((IH="TOM*&^\
M45FBFT,L)J7(@9BHI6&#<];(+VAQ1S=MPNV%I32M9B11,&;'S44*3[(294%)
M^G8!Z_3)J>()A?IZ.6:BEUU;1$)%U Q+V_2T74;7N1^>D?'AK?;J5L_G;\.;
M&05Q)7$#AW%,N'>K0\%U S,65:VROAZYNPRV:8,TP[129!%(SSGV(OE1NT6M
MPL0M?EZ]&]Q2S$S%(Y,J\O.-(Y@]ME?J0JKNW>&:"PAP FCE)Z@:NG=X//6D
MTX!]7_/^ ),6M[(N&^<&ZZ#\PZKK"TW[:Y'\=UX\+/F663),$G#EIHO%".^\
M#ZJTR.(N';]K:_*^9156/"N->P'N[T2A\@DV_6A(G/6]EVPX$ZF>3K]4J 8"
M2!/<Y(RZ)-D"BKK6E/W3F&2I;&B[:)%+?(.'9RDW9>":C3#Z/F[T?1/^U_5,
M7EOTQ,9*07A93)G<K2O4;/U%\KYD'"+* 88D.G(;6327-B(1'BXQIU9=BWMR
MVY26L[&:^[<43*D!>=KQ_H'!V2R,DR0Y=V:+].&=9M:>H'[$!@:)F3*M&50?
MY,A"#",W,[+8[;.4<5*%E+C!(Y];#W;^=V7*:#RRB.$U#WLM#SO589ZP=&)[
MX=;V+&"/"@J"LNHAIR&7.8$C4&'\E]+R,4^AI@.F3%)<]61DJ2TLDX\Z@MQ6
M>P]Y3T:F<PH B(,2#MT(>,S6P)%I+\GM7X3=BW4HZ@7-?J'I\>@(_G9YM=/0
M86_N^CIY/:#C)2R*#-R<]]FI^M:RI5Z"CD0ST*R[2V^V[UT-&.XULC;@M:SG
M:Y:O, >WS+)'^GVR1A73Y_#>'Z?679'-%G"V-OHQ!<C1R%#60JE$2O1PH%.U
M=8R.3H4[#D7+#76_$;[I_3:P]^=@Y/J=BJ-ME#6:#WL2AWVT@'/3J?(#]W\1
M]I9!<3Y1]^ ,#L'=F0!! \$=@@SN[NXVN$."N[N[N[LSN 1W=]= ""2P^;WO
M?VNW]LM^Z ]/=3^GS^U[N^N>JA9BQQF:3+,/]5.PO!E>)]M8M'9$;I?3-FNJ
M-B/7?^Y/K,TR%+C$HUH6-7M+MQH+*^>9A*?U>(1U";)+8-O@A+'0%JO089GV
M_<$#X>&\Z&;F*Z,-VS7]PR;N5W(2'R@"RV2MU=U<%/$BS(D7*[^&+UJ9YHWJ
M^W,5C9<B-64B<I]@9S#_&G+[0'! ZL/<19G97D7$B+5 E8:>%"W-9=,,GI%Q
M38"/K8PBY6<GHH8KQTD.]#.6XJIPR6:6#[E_![R(SXC5>J6LW:2NK&?E-#XQ
M#Z]I92;+UL?B-<3N59ZT!JM\-F;R$=YG 0('XGF'H^4YW?<G 8<,3+7@F&,M
M&?%4YC$),&3MY0R9>N,CC42^*'.%NAURASXE[I&X:RJK@NM?8[0BY6(M3'OJ
M43:@H)E/>)9Q_1V)Y+=?FK:74VX637@RK83&=Z)9U@OE+Z8MMHRL,58N^8Z=
M^7 M=?#+*"LH>@Q;K-M@+I&V<3%N&6!SL0\"2Z*5S.>[C9^X<=J2'[B/J2PJ
MN+3%W"59-=7%XE%% ^001VJ4CATC?#/28*V.Y8-W&,VD3V(/(!+S:R1J5WI^
M>OP(^#DV:A7&#;@7G47G+8OM-D)94=8L'.U#X>[VK(Z]5=VY*,"[EJ[3T*_W
M.],7I*C ']C_YFBP=^Q07[W8D'WKBGIXAMW][Y>)R:N=QKJ_&''O@+I_I4$Q
MI3N)8$+Z"%\W $7-Y713'-*[9@_H\B0*H=H>/; *,U('8J\R@47 P[]81<R,
MB<)\'!/ (]J=W\&D]"I7J%)8>8+.'QX1^8,]?NORZIW>LSE50&F)2-7N8(VG
M/3P2YQ*T*CF'(:G0$6/Y*J*E\4B9WYG(5%%J9'2!UOG[(D8:XO/6-.J;V25T
M"!.7IH3]0[3AX\M&BD)A<H=(7,-Q![2IN43'\-<$<V./36U8=X2TAMXBK>V3
M)O/7?)X677=,:F7":D7U4QO>/Z'15<]Z T"A(QP>_0*2D4GUFB5)ILO%\?84
M$?4D'TS!HL;L\.PC>ECM^M T;"G:^!Q*)*X@:Q:I'Y^0]K%8ZVKUWP&?IL?K
MJ.LP%6U9HH_9EEFG\+U0L<P&4J51ES"LFT,%C(W:9%:UUAJHDXK&QDMX=4RI
ML\$F]Z46G<5&6ZJ\$!%*:[LK;2[+#R+I%,W>X_6]FN,@(""[:?D=H*BWV$)U
MV#<>0[\6*M24_%'6[SOGD'T=DF%)!$MUC?=*H,WGRKB2&@:LS O<92[S9(AC
MC/)9[+HPU%&@T#F+?!F)%01#NL:-*-T!IX/4DT\_1!6<:*D-^CVC?\[>ZT5J
MKV(&/=.\5B=Z8ED-L7-*++R:J7&<WM:BJ571S-(_;KQOWY*L[,W(S$IDFR9'
MM:ET_ZS!$8":CIO!U8RH%;C/!L,C#(#A0\-@\RI#&\@N8_O^_69Y_.3K86YN
MO":#7$/2*)5KDQ-_.-LC^07=MO9594]LPP*/NRJ>ICN>25H:=?% T2:#<ZMS
M%7?E9W5#7CQT)R1&80 7 $ZXGC9OYDO.[TI)2I$3VCVA9M5?:*2 21/Q)G&+
M'\P3Q%FV,TW:H1%&@T\^%MS=M8/J"TLZ\S<H_67861-0*DMQ*BUL*<$H?2>^
MPM7\3+%J0]7P(*^]/?:K#\X9@=Z2\LHU 0<7NP7'!K)5<J$J-6LW*I[K>^"8
M_05NR]^1U5U$O&9'MD3,]=$"J R7Q90* XM0M2170Z$;&GQA^M+"#]4%WF8,
M_2"D3P'!T9>^PRUP.)ME  0+DX-T:H.G7+W4@5T%N+(&9D#PJ.UV+G>WVH%S
ML[Q]-O@H9QD?WZ.+,],"-[5:KRN]G=$;Z[,E2:/CO'I )#W(8HQT>D($E?2-
M5@XX,6ABR?J=LE''$/&P?S^S SF%6+U1 C3JE$;'YZKZ63*NA\\^_,AP8(NR
MVL5=DJ45;+$^;T%]8+HUTH!2+3HVRDC9./8D+'R\ML&1FC@9T1,Q-ORG^*$S
MFT]:\+M36P<?2UWB#L-<2<-KE7T=&7]8S<F?GI1CVTN"!KEFE;;$NTS70,UU
M8A.\]*^N6Z<,70]"XDT>=C,()VRE;#IQE63#@ @K'$ &>JM>:!E]JTH"?@..
M5:N$R*Q/<Z\C5UFH 48C#>GN+ZK;.6-)_.:,C,"^94;W3C%KB8H?',VC,@5$
M[-Z,X:6Q\LSCTI3-7UV1 =2V9CCR(FQ&2G&>;A+=TH'S(EFW9SG=O)8^@  <
MD#GO[_-"/@>$30.>X4W./=\DR_ZC4L>-1$>RUAY:69+9U9*].](,O"11Q9F[
M8>,3[KN(DDWX2BL01O!68P75A<U3-+J/OVM'+:915*PP[,V)J?E'Z&;_J=Q]
M#)P?X+S9:27)A7?_<FTPA<6ZV4>?3>@W%%:Z^TBX_ >3EPX&M7JU\(P/UR0C
MN48X452$*Z&DBW27]$(@G=JRG R@UKY\FSAW#JXE'PF+U0]!A^017LH1!&O5
M59PUW).T(O#0H-JB.IXRS+ TVE)U#1Z*U>J_#?BV9Q!T^B"KZS:6$CDSZ$XS
M;JI\ )NB2L2!)R/"];'KVWB';F%[Y>X1=,DZW)I\PT"Z(Q[ *@CO'Y!;!4(O
MM1S*H_II0!IP6#B-3Z*^I!4AA_4%SW72,^AS$J7NP6?:276CT8265K9FG<M,
M+ PLT>;;CSD>E+^@D4S9'FXZ)>L98*-*^/W;4YCI-*FD&?A:JL*0U@@6EXZO
M1'&[;5_BME'9)'&?<BFJ%RTY8'$P>CNZT@+ZY+9M+\N0+<+-"1=K2LI!R1?&
M%JZXSOG4CW4VGR@E\1*455!+;V?H$:0"L/*T$>LF/JI0HT8@ZO7L#!4&-"(F
M*7XQSRQL.7M-(: H+_N@(8"003>OV?%D=[AI'GDL$J3WHR;0>DWGHGT5&-X
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M)YG?QTYOY\SQ3S"H;)UKB>GB+BNMQ]1 271*A.?T5]GEDS.879^2+P3W2L4
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M5,D;1J"[WQ!?]U*)Q=_MK/VJ38D$=&@N:IJ7\!4.P6CXTXNN&J\O'*]N[QT
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MJFTRYKX#/%>T^\PU-?@HU,Z4-+#P,[?2IU HU&)$VD0Z/\@4Y9['L2![('D
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M2?%I9YA'*K;I4,Y0S*E8OVF]L)#>N<F)VM:5BUW-[G6&9:%PIRLA4OQ@^O'
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M<12^+/49UHQ\=_/2-8L41X-(E%R\J YL2E56Z)V !)Q)WLL@U9(3!AG?.,W
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MZ#!O*Z-*>>3( MZ(4,IJ1TY"F<^XV#CK'ORPA=9] .V!QS25_@P$'0&;(V.
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M%AO\K!WWIV?UGRSRAO)HQ/WTTWCR%/KSDG[99VYS)HBYJ$%)/.U;0 0EBL_
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M:].% ? [-ZIY__DTIO?_XU#J_Q]##89"'.HTE1&0!4/6"4>(G%H:O((Y$00
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MA&=:[:M(,(5K;=D;UC\ODX.>DC)FLXFX;48OI^>;=ZT-CIO#C <I)#^]Y-2
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MF'\X61+LY L6#2HB:;ROSZ4_VIJ"2?"0*#7",Z<$5E;NN.TR6BDEB5> 6CK
M2P[T=$ "Z2<4C;K]1L7U<ROOR!.@)NA.DQ95K07H6JZ5G+CL,;XF?WALTI)_
M2[.9(:AB?Y;LCM.CH^:HSK[7&\*.^K-5":>6R7?J>I^$$KG:T=;2;(&KXD&L
MF*<Z$'OR>RG,J2#I B?C8%4@YV9,4K]GS#GOLOF/F)0MZ2 5OQDB ?*=? _O
M-,+GYI6WN162L9$N&:[DS 3FK%-#O)K:*)MXSYC!$FRF:%4<R4Z%U(W/H$+
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MBN^+GO;VW=[7T6(IR,4+5J$6=?S6:S53R:$J%T\1I.9,W19[\IG!MO<K=U#
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M!EU8Y0&O:,2[^K?&"W(<WL07RX?,+;$XTR:;8%-]/?+,="K7P(FXSB&!>(*
MKJ=4*&=8_]9-(-V^<8WH2I>L^+S**9]A;&=8M3-&D]DP[ZW(\%WZPA5F0]F
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M!9*^W[E0<"ZRYR/<\R)/\3-/?2%U^R*/^8,/Z8*+!?^[F7]T_W<4X.[%LQ*
MR\H*40)%7-%^8_I.>?HXY2>%]^)JA+C^H A<7#E^IUS(/+AX1HRDL[]-P*_G
MQ?_YL@M;8'RWZ(5> &2I[[_?RJA_VNE[_NKY$U#@I_;?FY"'H*W_--U?TR^T
M\WKG]?]EA9_I]\  <'2#GCL8\CFLA9.;(]CU3^/2$L[S0\US9_[%D0!_\CB
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MUG[^SW23][_[^/-,?TOP2.KS2;J79";ZMX<CD/%DA"%(=1]Z]S1]6$71&LX
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MR$8C!762UNG.,?='"9"PSBGDF*-%LNVYA&2]UM 9H%67NC/2]Y'7B9K1^AE
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M]XL+&<)/"3MI0X6[HISOW)MUCBCJ(?#" 3)>+Q/ *,#*L@+F.@/QY_ )D[,
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M.6$]BN-B8CE0#_R VK%U'8.1_-#EIUX$)OPO;^TY/#%ZA;]61XHSC/^</69
MJ@/T7ED/0R;M8&D>VH?.'SM8P4_(K3&[)O8RREJJ7M%2E'3F"3RGJO-E0:.2
MP>>EDDI\[1N1&5%]#/ZLBPP^Z.01T=@UA)\74 )&!.U*C?\4S-[5:R0VO'FN
M#RF0-TH!81LHM8\7"2!G8;+JI1Z8(2FT40VG:VQ&3&-1O<&CY?'&W)TL:7#%
M$4)2*'QG2&)5L0/F8XY=>F'R+M=.0IF6?GJ\OZ(7/D4K%$/F'&O/#L!BD^*.
MQ+<N_5QZG_Y_>F@5-EO^2)E)5[-)AH O;8%[0SO^&0'/(^\F320"&F=T87E0
M'917W^9ZY(C>4VVORM)$BA9'-;.QP0*#) [.Q^WA]!9"1EAUCPHQD )XK^I!
M9/>:!PB2P/ABZ!,>WWS6'R'YWPSY!J!A8BPGSB5PWJ.HJJRYE@J<9L]F%7Y,
M$01VU$YWK0RW>CF$(A4D"N9M428BH4^;I8MD H*>MCWRBT4/><L92G:"OZ^
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M,8(IR* 8)\) F;P=%S45VZ/! $HZ:_AO>)_>T'W+R.XZ$B0K_E0)CQ6(4N!
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MQ$@-FU;>$$#69Q\7J4XU]S\VVSZPKBRN!<X=GQX3#8\VRUQ3*$P*2Z8R5*7
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MCU0)O!?7YQ;*)@.!>7!WI;-1<\8R07K2ESA?C6W[BS/UC%O/ZY<3\[754L*
M#$GUP>#B<J5,SR*@I0J#K\Y[^758WP*3VX#6?H'@PSM9+X"1TN!7(W62\ANG
M2+SR>2>X3$]L<ZP77&:)$F9GQZ-!_%;BKM(#0*1 &(;K9SM<@S#_3U]51]6E
M\PQ]8 L!RA\=2)>;SF*<$H\LU(#<!7-4$SX/[RQ=^U5FWW2O2O+S!)<?A4(#
M+T@5'B*+@TT'HM96Y9W28LA&(L.+H :442N1 ?#*_^V8C &'U'R]W"U6K$U_
MQ48JW6/(EKC,K?U@W3""_8FL G31DZ8:41KQAR[)@F:G+J!371]^DRJEJHJH
M3)-*>*HI?\6;3]4LS[%]5C&#KP-G]9!?-Z]=G(7$_&AU9U^BBXB.M",3OG::
MRH#>VKA36+DS$3=-HE0D]+"PYW<U#Y>5TF&Y;CO5CG7BI>?KQK*1(!;^%CW+
M1NK15AWU $HLOBMU@L9UUB@NX5%6E_2_-^L-$O[+4:IL$G_46/RJ5^G<3\F1
MW%/G+6F]"^ N<06[G@&M+S;?:UH:EY*-2R:%6DV8WDP.P_Y#.Z[]CA4RE<T$
M^N098JQL[/FFO?D5S=0_@)^$#I8M#"4N>WQ+& 1>#5X+R  LQ3S[4554W6Q8
MY#[P!N^*='QJ31J/PI@E-3K]<*HWA9C):4'X !I-JF)1'#V+'9T,A I&(1M)
M*R420Y 91>-?(@QF  !P)=;Y]M\U3145+$5P09<LY)=&7UP?AQ=SE_-6RXO-
MILJ5SR1>6?F6I)HL7ZRBI:& M52;Y A/NH(Z<HVYF:85O!H#A2\%CX@]G2TZ
MT<"66[]8MRX[_"FC^'7!<=07B^%%V]_H/SV35ZPB,!O?35\^1*-[DD1;@ABD
MYRDN$_O&;][37#$INP("!=Z(AQHO?<$<,$<<I'5P"W"'O$31E%%@VM<?C!F2
M57ZWKP'_DK3? &87/Q<>[I]_7_8X09,KE?25_*VK2Y\N-L:?A'VG<[AF(Y<P
MZ76(LVU2.?K*O6<W:2J]("M*F6ZP/MJPH3UC,)P' ?';QGYY-A0SK/<&[RS_
M%Y^<%$5348F'P5+L/[TAIKQ+2",U.1]"*V6\8!=SV6=KF7/1!:__ 0Q.K^_G
MBOP@0T&*'8S(AF%&B!2,B8T)!^$-T3 PQ<0DR2G3^>T%Y!;XT@51BCLTV*/3
M5GCIN(U6U7E?]'P7BEQ)FP%]]<A[T393IN1YIA J*'=-(?_LN='PE)BLI>\E
MAM):YXS$-+:E[T2PD6:23AB)<*KDIIU%IIAO'D.CZ7TL"X\X3!U> &^=/H_I
M,>GA;?<![!^NI+UZ;PY+EK,CU<UI&)8U;U\TN%@W;RA)R@<.?Z405*@6$;<1
M=$1+]N@<H&7UOBF?*Z0OX8N@O5)7]<&LH"A[UQMG)])N+Q5Q+G$H.@&$N1+$
ME=4HDE7 8,,1%I;"&B 2-KA_%/CW. ;\9 _KS>%1FOV4DZ.,W_WXYB_)!\+%
ML.B8(EOC5]([Q>X2*@H/\UCQ^%[4UBJ2_\LR"EQ-<-%<+-43V,I.$ENX:19*
MEX+4W:['!?*='I3EC<17^H0WH16#A$@,*[]?CR'HT)4C2KZ0U'^M;&:7*$(^
M=NQ+$(?MW@/QIU]J&B)G]_J,:K2M@YLQ28EJB*KL [#Z_I8I(48,L2JZ]%(K
MX*N3F77W$Y'U-JC[['<INLE2UNISEZ3C6KP9[Z6A*'=61N\8&P>;0R?@*W=2
MXBZHDK1/"^^TEB5XTD5",?TNUJFCO;( %>$34Z77J"^O2LKR:=*)YKL"$9.=
M"F5Y2.>LI@S(2;NK>03JQ2^G9+XW0.**U]8OQ1+Q(LC/M\/%CV9+J%M4L5PH
MV4[[Q1<VZ(C:%")PHN&=4P"WQL7 X\3O;NQVTW);E-AK]ZC-DI5L.FO*B>>H
M)G3Z1KWH%=WZW*(Z>@-CS8EQQ;^?-E?'QD)#6R7.NH1/5< 8I?7TC\<^VDL6
M7I[G\WG3B\A(*_;+X;$<9_TFRPYA=7%Q75Q(%BS4OYCCM%-&A20V& Q0PZ?G
ML8ZN90+%PU9+ETC,?]GDJB^N7RULV'^C2R<8@W M>R@R(RC21?Y1]=@V7#*9
MCT%$P^(:.>< O7DLC.1SE"[S@EDRK,>LA$]PV,H"&$:.N63#,VNS?<Q' *?7
MK30CSK!N6"J("=D,(#4*@>[!GS9T>7[O@;_K"- QR]JZJC]@S#J-T"W0O-0K
M0O@52X7^5M^+Q)Y\-EA/$.2T^3[Y+:=6Y?R*_)N/WG*;+PFYUY^>R=.4IS%+
M\\F1F1 Z3,LT!0PJ&PY)^%#MA_N>R#VXA-+=E[R^T?&1A^>@P#5&*\BSB9#2
M&RD^.&--D>Y>I[\ )'[-J/X9":2U76BR3<LHLA_H?0):$3FHL[?^5;)VLP+T
MC8BE<61+]4RUN>J&IVC3@8]O\P;*C-)&39=58<GD_SV+06N^2;CC&JTDFA#<
MT'NO=,S)B=EJ?)XR*L<&ML2PE!XZ6'VG!\FYDY,E3L)<>IB$R;FZ-L^BEB5E
M>VG'"T!_5)SQOA :EK3E:DC)E$P:T:M:1N)_MWROQ.VW!@>F_\!-UQ7PG6*R
MB(F9KDC_(ZKNT:5FE#J1^/QLLY,^NOG(D-0BW+;I^=00^L)"Z]+(J1TEW!*[
M@1%6=,K=/%# 0:,X.;GC@E@6G)M8][UM#2JB0&X$8\X.)DFP37G]26Y%<YV/
M8U5+K2').&IR41YH>ONG?9D3<>J^X,V4YB_/B#RRB&4RQK=1XS,G&L=;NP>S
MSN#(\EK\Y>?=TP\]DK&^>Y0,GG@[Z=U3-QP?1J>U+4?/;$C&([!AQFE'3+Y_
M6A>;UI:8^=73N-=LEB==BHLU+,Z^D0(%#_.20Z554B"K1#0WE2%#+.N%%T<-
MD:W !I%6Y$$[:)%$75M96>QMT FL*AVJS*XK\HU.U85I^-FC9 [3\^#LGF<X
MW>?<!+^J34:GEZ)P[:G>#UV,NSW*G+N9(L]#X$&Y)-[+4E^6ZQHUO&@'/D+I
M$Q4V35HYD\?L-]HCH8#XF// U:=XU:^>,[A+Z^R\>CG^V3O:HKR:2-ELU[8.
MY0'R AGM]?,A<*1L[6G&!_^_**_7WI_YM7^8U:1+<OQKT9I);GG)L5$ZA(^,
MTUW><96;8>^37(.6ZA B]C%?C'9F*&"(U=BSHXY;'22&4E=LF3O6%H@BTR'8
MXX*%%.'ND#>"CWX9#"N.W+-SC:-2R1420B3;O^ZD8=7 IDI*EX.>*QV&OB#+
M71;'5.:I %)DD( %\D[\*S\# ,Q*_ZJ R+[_=TR++>*_XNEUL \?GNZ'F/HT
MXN5M74@SQE*-30?/!1KX@G\F:HA<YAKTA:85#'26P(J3S*\AR^$]Q[M:-,F1
M.-$E:8",0QWWN^ZVWV%H*<3$.]4;&Y-UF20 8G#)/[;29?]WU/[_Z<"1ZW_U
M<Y<UJ,@D#]_^J6,0U:C3N))TD^J0GH(GOHDJ+>*[MIQ)#@JPYVA".ZN<-HP,
M@$$% \U=GK6KK*&#E4:VHW65('?U=Q\3..^%:ZNMGXIO%Y^HJG:H@9Y=XS\Y
MUE6&V1&K:ZU.JT;IC*PA3&R+.%,G.W.V)#N8#D>MB;&4\XFH. 4F^K0]E=DW
MJ=7AMI>$'7Y7O9 ?36WH=J)"L(7FR!$<%!5UPT/K-&%@4#3;P%IP76+Z5MO4
M6V:G-EZW=Z\<#IW*[7R%TG$Y/1X<;N(O-M&+A?K:LM'@*G&AB$=W;@U:$'\F
M)VB2=&0<_9[=:7%U]27NG*-X:5YE,PGHV\V_C-WC?4<=W#(Q,#P^P+'!AQ,;
M;=+H)]VO4^D82PY^+OJT0R5=1,\R36"@3IPPR[J]8,EF9D;L_3I)])R"R-%'
MT%%\1:DU7%OEJ9<$>=[*'\P@:NP4<DY/780,JIQMGFA#% 9.Q:X_E28>_VW=
M)$,@>QZ)GS=\IZU5FREH_[QJV.O<U.H0@!M'ZMU.G"V[K+#8HL%2TS3)5DS(
MVM*P;SVN61P3.V%ZAP+_Q8>G V%0%U72(V=_M)_;WX+H^*4ATOV*XJ:AA^0*
M!VH@K6[=T+8BO#ZFH:/V%Q=MN2'@_460H#<3S&W0[.SJLW4!H;3]K$5R8E,<
MQ-/59@S/4/6K;<I$Q'17:OW:\(:IU+9J(HU=FPDEVC;.W7F',[#,_*SBB@$S
M4,.S)A*+9%(5=52F+GUTYL#/Y3Q$8%_H8@8-(WJ]OC1 =^4YIV#6\Z0(PIO6
M8:+MTKE@V""U]Y:;-B;X/41O;@UG8*/@M>PZ;^#OM=3>O2O^/X!R_X(+X<%-
MKV6.W!_&%D+U]I>L@/ND>RC)+JO!,CFK 8W F>Q2%.TDU"^*(S7P!,9&E-_0
M9 K0%.^&'3VJQDSKYTTA217B_N*2D?>(:.:.@;"]QEKI56BK&_0O[20FALOB
MN*RYF,T^WR6U&2#6?5WNX+Q\[?3%3U-;8YSOIMSC?E@TD7$%?J-'OT/X#M-G
M!^5".#C5IX%7M]FPK$SLW:PW:DN$^>O+:7)F0./%+!(24ZX5:9<F#4?X,).D
MBNJ[63Y5*Y.AS/?K%'&Y(\!V$PX"C-L X-0C/UFM-JGO'X ":J38N"9X4;*2
MW!Y"B*@QK^H)5E0.ZB$ZYEQ6MJ_X[F@I]]P3@4WMRB8(GY&PMFQC5[!0[LB1
M!LW_ K5-+.G4,=SCX%NOGO192%4MHV3Q)!J/JW8?)9B9TV9GZ@']R;C*BT4K
M!+@?1*4W.H[I9[RH48]V[9/+1WE#IXDNIIO/K]<;];8:HCKM5(74 X17EUBA
M-+55&07%J0J^%A%9#[A$LSNLNWOR<)UC/)LK,IVL:JT1ZF;<4M6^>=7\:NMC
M_9?Z3C!F*8DL[@HR7W#K6#*$-N/@9&>\) Z .M@"0E6^TO,85QA;8A)WO[U,
MMZ3?I%KF53B:.\*.M26)&N- SOQ+NM, W)8",S+R[8E3HK+)271!6M;9CA&H
MBYF>B"R?@(*3\,"YE[W:^&K+VH8(;.?PI]CPYU(+;D>+4?[C)%;:0*Q0&0++
MFG*6N%"=!Z;4M"1K<(;BC"8AU\>O#=($C-ZWCZWO@:&^BYE*XJMUAN@Y+P;@
M'=_6><^"NITOJX?9%6U1,G B0").N+"A(!_WBPSA0=#V)F,;8]&;=0Y[N+MQ
M+9AF$ ;1I--P6Y:_5QD8>4[7VBD_D<]OGPU"X#W*3:4^8-*#S6&A<E/5TLKC
M5C(,NR5:^@/:-0,,A^9==29K!6::K4'.T04VYZUY2?S:#:/V%2M8H-75K+4[
M:M-I5TE0Q+)M*V?:)Y('WL9].U%XO@UV6,O'GYMP;3X8N>=1'I878(*^;1,>
M%85!%:F^3F;4QJ,R#7NH=7E*\U3^VH M-H0O6\BS-).)2)20.5:I,ZH V2YG
M?'S@&YV[LZ"<Y;A)$R+[>.8W3.G%H*I=E[<?ACJF[/RU:L6+K=.JNNKT/A[V
M&68;*C3VW<8/*D-G"2Y^@8GP[8>?MN%P/4<WDUOXO^FD[>9W./G(*;5O8(&T
MVJ>3XOI_=G%&^ ZV9EK%%!JL5X5'HS"L2!'K#2W ]8*J@);+G)5^=D3KA6S.
MJ6CCA+X+PGO70EC^%#_<]SQ=G/0=YMH[[5AG*;+S,_WM*LJZ['+S7I"@Y;$@
MY;,GM50V#J[QL&<"J],8 7B^KMW9S=J5@\DG:;$&8?LU;Q9"92,4<XP[)U"'
M,B]EO*96?).*1OP=KLG,4N)F_D,Y*8OWC,;>[E@3HNLJGNOM\"C/ZXD9NS,"
MS\],M@<Q^5!C51LG\-7,:KI>(JE=3?M9;MGR"\M&[6D".(DD6C9*AF)-N'S&
MSH_KCI^A@&;\7@SB>=B9<S-+7N?#*CCZ76M]^=6!JWC%:!.=8/_=C*>#J@LO
M!.RT$P:EZ_0LJ9&E"9.*[2DNYPU:;DP6VG<COKO]$MT=A%QV<W>>+V"]S"5E
MM^%=%-;:Q7' "=8[OKLS<T/HPL* H86_=N5QMC")_/]Z"I*<B"G)E*;8VOW?
MU&Z#+<9_'4?H<<QBD:"7AL+\M::$0'79_A];\Z#,!?&B]Z9R_?\W3ZO_2\0B
M88IB5J9\P(I?TORN$\7R?:*DPLSSI1#ZW?]C,.)KJKS&,=_JS^_&^>XK?^Y.
MG#P@(+91::HWM7G[[":69HQF7(TA&4M-Y^_<EGL: &8)02R0NWO!2N:(!#Q
M!JY0)>*_1G3^HX/Z_.E[4WR#>,<;@M?*RHWJI:TJQ!:B5\]MD+IFS;+(3JF
M?]D:Y8SRP<AAPL_#MXFJ=BZE]DHZPIDEVMMA5HW5(4>T1?MM1C!%E%,"FNQ_
M;[H8\-F[MQOZWB=>4@]YVO190B>7Q<.>9@+YC-RQFOXF'GB=L2":!YXT7_6T
M.F^U"#N H/\ ')Z4FYZE.WN$^YI)+DEEI DA7!/Z@W"T1L[+-Z.?S4UTEHVG
M44**T:K?RP12K'*U5E7HDAB:7&^[0_)LQG_,-PXG-%Q&M=R5GBQU[CCX]O0K
MK]#O9!J>9;.KL)<!.A+K> A>U+P5W:C"%.%<2V]LYQ* '_Q>SH.EMOT5[-Y9
M)J[EPM+VCX?.<8V*7\P+8V;;N>?)#C=-X1TR3G3U<9P40H&*>T6:KI83S);E
M*;="22 JU-<N2^+QY]Q.)%I'E[Q3HO6&^LW5W*S=RTP'ZZQ5OJ>VYVBCBCXH
MR6MU90Y7S)9+?4SF%%5@H-7#^,#7M8P0^0;^/GQOGTOZMT^[_K@>:$D5&><4
M=\Q64H+G?,WKU4TH.43FD S.;H3KXPPD"/$DOCM+&AY<%R>'1X5!1AE_B1!I
M](LT_%[(X<\KBXSM,9[#6>W6ALF&ALL>+6B0#+0N];PGH3TA(JN6Y6HY"<N'
MIG@#/:-\Z/,%7'Z*G"*&-P0!LO'?:GO'*,V:IDWT+J-+=]FVW65TV;9MN[IL
MV[9MV]5EV[9=?9YWWN\[<[#.G)E9,_\R5JX=&;EVQ-Y71EZ9<0!EFG8:HJ$3
M3[TD&YG9UQHN'5<UK=4F2 9(,(UC[" <AMV#3)^Y'+8'1YO:NB>$WK.1RJ &
M,>?]=F\]RKKD_YW+Y-=YY6;"VIS,FZ6<V2SL>WR5]*<T2FEDS_'1=+ZY)GW3
MAO%0L6G/?W!YA!UP?<(%G<B@2?/D7_.2W*K3T?RSJFX=%9+QKD%!;75BGFEJ
M/L*!\,I>EXOSG8GIV#W")E6YLL $IRHUS!!:V;<R#+=O=WY_%&]2*GS\*&OW
MP&@OZ\ ZF3=M@EO8M;?94O)".KE^;OAWLY <ZJR.?J&U#)($:^Q^!)86G+9!
MU0P*1X:H*DZ+JV*93&V=7891V61-2OE5)::F*QH"<;ER ]BXBP[>QM+%0@LX
M'E<M6'.*HP,U= W5Z[%4,HZ_ EQTU2#VBC"N^NQR9WB?-2.,'<F8S>1AQY6;
M(:F>;:L,;Z75XQ7\>W5SJY4);T] ;7=N;/1U246%T5$)(KWO&A2N!H\ZK)AU
M32C1,X82+]L3KM50D-)T5CZ^D)@J,#B:A9L)'VT5;W!4YL]L_,1+=M:Q3"22
ML#0!$3,4 !.'TUIQ.+J(D_N)&_?UJN'J)6>:ZGI]4NS\P3$%AC69)^E.OB$#
M_[R.M\'OC=2J\#K,.7@3.-HG1P@)R-&71Q3X_ L@P/+WU QZ08@VHMNRM/*I
M7^H88TE:<?[9I/K8(-*LRB?1.9L.QJ\J/PU[! '- H4D'/U'X582U"Z),[LQ
M9>"5Z;Q]4P.?V^G5YD;7Q?[R/:>W28K?'*%M"D^D8(6L/N5Y8!!U*G'>B::$
MX< JM @X@!4 Q7._U,CU,VJUV^#TN@:]0WQ4XDRRZLNDF)=R>;(^6]8E.CE\
MLRU!8<(6&Z_=VK),D3R@F*.5$#K4:Q.'R1KY%]0&Y_XYW\SHY?WGTO4[:,Y%
M[>-REXM7O5PII65989XUG;,*786)%N[+A.X*8Y-* IBF6Y1[%=;[:C(4:DT]
M%;(6L?<@??55F39^IQWF5&:$=B!%Q3B31!C:?'"*;6(S- WYQ0!-4"(R3N<V
M&,07Z3&&?=0 -!0I,E/TY]A):V,)U\I;9FO/QCI\@U6W4OY*\F6;]+/PZHY=
M"A4!JR$/3_CJ&NZ/3'*POGY,U9"TRZZ<E<P%B1NK&455WNR?11=2RH1$V?+G
MR>Y^-6B!96.G(X>UR1WA8.S3PM/XO%@P4-?0L&W.M@*@-Y4(,>I#@MU[XVXX
ML3\=4*)"#N.X;*+;J_%X5Z=$"A7/IF0<EM%6,K)_"G^XD'%?-:$J'\=V>LD/
M+"LT\*$/XXRB'-Z8>$4C.MTU]%IE9\ZJ3)DLZ[;!9]+N(=1>-CYC2; (LE O
M#L[\%BA;"@!<'B82$^ZZ*_3'H\ (Y? Z$11UQD 9??D!P!9=[D:\O[PK$XLN
M(Q)29M;1\G3.<:=\-934>$8RF"^<*MP;5K6&O^P-7 4]+#;2CDM"935=:N76
MQ;0L0I2L5M>M*@:Q%SQ&992,]V7(=2E<YJN1%91G.3\^,8/D=T$).H"'8*@-
M6,9>0?IM)P1ZNDNG7++]^"D+*=[<J-<5$7,B>#C4^",C;YE8KOC';-/P%!PC
M<O0^6(U,-0/_]7]5Q^[M*;LDW-PWT)L2F9H0Z+/-](A;4#=OP8^*8%IL0QF>
MJ!*>K%XDHI(H'PJNS.]\^#4+%*0ASSJ'D,K:+(1,O'\:5U%O;VCDG8HR#FIT
ME0<JU#DXOZ$KP66/,ADQ1BPLLS=\#R"HZL=C<K@C(X25BQV\>+B\4[@PZM5E
M1\[UXYDY,EA+4SG0GN!'^)5UIEA/13 C\,@#[KK4A)4'RD*I$2D(6!"0[O&7
MWYY^L&'\/P' OT@,)S$<#X?N]P,,C-TM.DXN4O,O\IK'Q07/0]G(G6S5*%E)
MT498X$\_F4.R$TSII8NRM)8B?$T%B=TD'9,$&?%OB$DRD^Z8_CAE@841PMWC
M$/#7=ALZ\!BT$WJX;/J8.(^^W^H4=-WRBJNWG4RF8<?N_@6<@WPT,C@A8='-
MA#V07+^6T=MS0,7SC,A"^OP%L'ZYT\_I(PB5XV#@YW_VEWMZ?:O<(I9NQ5SC
M:V/>C;B>>V;AA]HD[5T_!<9P(7;VN>QDW.36;53U%+U7-=^,<-^8C>]D*%T\
MKB0?$M2%&*N?(#LRC_$K,$7&&CNE.V<6"-Y)YTO"A#K#$A-S+32PH[_H^SEE
M95WSYA'4LIF:084=GNR]Y.:V>])!0/.%(+8>/TVY.-]!$ZQ! D%^(>;[^=3R
M$*_\3X$936EB"""BGEOOS#DB#_%Y:I-0>4W#NWIHQ@9717"YM29[+1A<<8#J
M&NT7MZ%2 [.8?@7</G9%'/V?@$KZ<S_;ETGE;>]M%ML,2E,>1&:'Q/,0_P!&
MSL3LAUR$G.%]G2HK_%EG%5Z1^U&K.A6+"FQ+-Q4Y'07&-D_E)4@*IJ3+>+^1
MY;3;75GM@^P0!,8Z%ZL57N[\[N'%Z^FR<VRO1FH3T)V2Y0I.W:&M"V[6)$]'
M\L817JT@-(F@2#U3H>&_ !FN /(;DC&]]E(7(2*C(DX&Q#' 47N_Q8XA%_!&
MFTVVXXIZ9ZTD;]DM X]?D,=U0V50CBM$@GJ#UF5A@/1QE?Q)_7?Z/CS(=N7F
MYTD06D*'UI7JV8Y3[\)[0K^]9\YU]]*>BFOI,(QYA''WG'A!=VI(4*8&LEC9
M'I2P_1(QN:\I2Y&R:6)@A6+<4D:,JEN,D7NAK:PCRV +#-;TVP[8O?9TY%6K
MA"6G-3I7Q1M.V742Z\@O<TNBEAD'UC\I)3DIQ5= CA8QSL#016:VN5 ,(TXM
MV^?,Q_)B5]+GIB;UR_O$I">L4J_X,D5:]HHM$+$1T#PIYT<EE;1AJFT@6B)7
M*;?/F;\\=3"S22$5>7RU/3S(VMZ^O07'CKX;34:OZVA^T]5RQ8R6EA:O3%N3
M#EGKAF7E&9W)VYZ-MPPW'B[B&-$4:8I^J'X QJ"+"\\ E*^SD6K%M?JI9LMS
M7(J]Y 47=<LB>Y70,5PD /C\*#"N K0]NT?XJAJ1Q@7* V^2F:2!0]).J:)2
MA7WC'+L?&AP7LW:MJ61<L1J#4A7<O'D%BTA*L^<6%=I4A:U<3;I["93=2"+:
MLUJ_^MZP[XAH&1#[*4QK%.?6Y>:W^-W''P]H3!M\,A78S[>H+"\TO3:&5C*:
M?C 8/'." [G9U-DEWG^,\S&'MQK'I4W@Q(%&B["6,%&:[Q+&.4+1%^&]__ZY
MDZ9!\UMWCA4[Q89$04N5H6Y%42M;?-);:K#"Z@=W/6ZU0?1=<ZQUPO@0#@Z"
MSJ0'SF+(1.HB-I3=E3IZU,Z4U9:+=>MP0SP$K__&*Z:9(GQFYVV4B$A')*$B
M+55:R#7TBS#4#-/0'&F4P2KGE<4S2O &F\MVH=R9M^#ODAA.2SKVB(L@X,0*
MY@X='4]"?0)D2EM=NQ\'6]\!=XQ5L6:KQ8ZF2K15$5?L)K:9',_9C:,V$;7-
M]L+E/%U-?.!/ZBY).7CDVVGN8^$KO!IE21').D+E)(76**54[\4XSGD1E!SC
MZ"QW=S 2ZR]D'DB/VNS3W\97Z#%3I6RN>0L9/C)T9;:LCT )FYKT5LIH$8E2
M9$_6[EU7#GPA$-(X[/U90=Y8&[[YFE36[76'(@95+1RZF$3LQD/"-:7CPW!"
M#/!5.H1MW@-69=N]\<PQXKUU0\= 827M"\R\N(>R=0L]K.1J7#!.LCY]A*X7
M_!D&M(O6GA56V9S>3AGM"\O]SK!38QM6U_?TSIUY7+Q!$B\;6J<[$NWG5-#E
M4)2Z'=&K*^JST%\[14_=(XYK5,8UC29D3J_)XG5:!Y3Q-WVE@L,]LGB5(76[
M,+B1U!DES&,EA";BNG<"(TI2)$(9D#!]XV!\1CQ?:Q=9^A7G?"M-NJD=<N9M
MBRLS:B*H3MK9MBU+:H)6,0HI?'NL<$Y4_N8,1*/AU5B$-*/.+@\+?!$KBWB)
M=MU!2>@+@E!<>\F_F)Y*/(\#S@K*58-"HV3$I(A_U<2K:"@6)$BFE6%N<_H3
MABA-D>0LUP42;.SWC7B8<=\<[>5(Q2WJE)Q>,5DV;]-<9S_17;(MNY\2IK14
M[*^PU2"4E/C7Q$^!#$9?P\-1!!UMT#6;-2&6:/$%-SP11L\=LC>5B9?_,-(<
MU4T/SHW.(5J0CA/U=U^LW9+B4A >FZM$YL0 ]8$V8,1I8[T/!]?F:S\*C(\I
MY;[DRG*F3M(I,U_?8M*JS'1,^,';H[:PW%&34))1 5L2'Z$D16JHMLA/$L Q
MV-;X!VF7]?%CY44.3VQ:W;*IO!+><T4SD*[XR<Q(Q92RD69)5@^)MO[*3,&6
M82]"D#JB6V"$FJHL?8E*TC'+AHRU_H . =P_)<Z- I-7](-R?JO,@DY'147(
MMJ*RN+:H%*U!0>?4DLZ%(9^$N 7S/&.!CGW-:5W<G).O!O9BL')Z[4L&IMS.
M\K'5XC=3$\VSY2<M[I_KGDP'@6Q*=2SVQI;P#/< )KNLYE"%A2; )+&+(I5V
M,_40<MA)2/C1U8W6.9(L]B[>Y"#XU<RF6I+5SAF\05'=YDY!I7%9M\+2@J",
M@II%F7=)D:>R=94QFB.KP M[;I<]8:C-T*S 4^GQY,6HE/.+[**5S5N[F]M7
MOF)(=GC1G!5RRJ1V^W*8];.L8+4G%A2"UDA!123..OKM/$#ZK'2'V?0 S&+[
M1:*/5Y4CJNV@_.[8GG=;:M$.K^1LBL:VCE]>1?9?U).,@IP-Z\*<GIZ\GO2&
M*5IEYRJG(5HW)(8^L!D(1_ KR+-\VVPRSR(KNP2W"D(R!?\Z3BOM9,5A*(["
MD4LY()4FE\0$F]?68!-O/@DI&;$81(01Q5C0/]%Y&M2ZXD8WPGG B;7!35O8
M3(?[1<+7$K-'F\(E$<RFE2G!5%5<P<Q,(J,@YL_JQ#3/V%V$RWJ(7-7-LAXZ
M+_NZ?I=AZ^^8J;G#CUN4;&UJZ63O@"X<9]IY0O5K7+Q5@L(6:+NT,KY;7E4I
M1O63:T3<44^*!5-WEW$A%$D0S,L)Q^FN_U[;)_<J5?#<ZA+;<\6QW,5;FSXG
M;'%61;%??434^+?%47HTXF_-E1BDG[3N%F3%1MF(ZYE5+S^5.W^6HA$K!\FV
M\D4[Z:R%34Q?:2U&^!"1H<09FH,#*Y,3RCB(+2>X1*#(Y'HB0L$PLA(4>>/9
M!7M$M9DWX;[BF,6 G& VW9MMWBP;,JGR5E;3\8P=Z4W)M,5-JF'GAU\4E%:=
M=Z0^$1 D1K^UL<^*]'V@8#@W*$>?4Q\G65H'I?O']"C,(.]3FG%XR-N;)>4E
MW%7>C/A 5#>7(N++*S(7DB&T<8<MT^[S4\ CC(+A2?NS]P (^'2;("-?B#KM
M<&^[E^UMO_7FFK$#/[-+4RZ4E-X56I2TY,RK,A;I30V@"C(#21BAV)7Z7CA"
M6 .<_"0OD0JWJ60>_! WWMX_OIPT/&-7EM&K_IWD,K2^.8><^[KD?UW\CUNE
M'O]ONV B=8F)1DC#FTF)(_67F#]5-E9J4R4J1:/C",L:0^G1F9!%4!.I8@HB
M<(N(A+H,0.\)17"TKJL#ZY:8'F.:8=;GM*D7V46^%3Q-)/82\<\C5XA_<7XU
M3 P5S@12!PE!2X#Z8?-I#!C20/B9SP Y-P  IX/$[+!;(K3XCN89C95H)\/0
ME<Y>C5EZ9IAZ:+/9]6O]7O!V69F$<VJ4A)1Q%LI?;#*.N=UZ3#IQTIM78RI^
MAZ!];A;V8]QQO(4&*Z.^9H$7%Z<,#-DM<:KKHPIX3(.V%U6VPW6CYVFLMBG'
M:/-+:7_RM)+">O1VV1GP _4A _+1T"] 4I#3C6<%A5Z%U_U,$M"O>G7>S7(V
M0U,^3B91&H=FY13&C-*?$V])'L(2;MX17@UPP'&$(]&+!_I)*$1=L\[#@Y@Q
M) ?@\M)ERE:G96#?6X(>LZ2:ENU(EZ!*#4@++EHI&9(<8AE!-AP2QQ"\WMVC
M.ZB?.#E.)AVN=VH?M+$63]6;'U96:>AO8[ 8HWG+;\6'-/P_-H:4(\L/9U79
M91J-]6GDC(F^HDFE;BO-E3J8P[-/D?#;^_KQ.8\..5LI=A;P805W"!/$I&V]
MO!Q:3LIGNEW7WG&2XB2_EA1P<%6L):_@HI<8W:0+0-AXE!>1W^PI*""1D"C]
M8J^E3C&I[84067J\2W/'?B<7SE0AN/+ZQGVJY7OG@S0IMUBKL5']8.&@PA/"
M5&]L<'YR/=O$7-5-/S!7K98\>G0N? 4EW;P^P*HZ8M*A""LXF@<G/*^*("?"
M6*Z+4Q8[T*(2M'U<%#_"92 <(M%6IS=<HV&].(%;9_3&T7/25IBS=9 E(U.T
MW*IR,"H1<4&BW#E96?=-^0OPF62;-7Z/"&F:QT8FWW\.I>,2;2%O%27S,#&'
MJ!9(T96Q.%)Q3O+BUJ)6*K4>']?(D2"3+&(YR@1V8H#/T,6\O1CQW1R7%GA?
M[_WN ]CR]/'NF*)6N__/[+N*@'^(/[:,G*,4\>:6-TM3H[Q$4NGW0$<YT:#!
M1OH;L8\?Y'Q&3;8PG;KA%.0/CCJFX0JUR=Z%1JT6Q\=+KW3%S67MFO&I@S.P
M73G);C7K!G2O7CI/5;8OLZ?.[3H_/DYY1%1@:<,M*0[^X!5M.YI'4 =DI["<
M<Y?:--=SLVH_GBC7M/BVJ"UV7)=D>UBTF=+)< *J[>^C16T.#HG\V8=CG0D/
M]7YS;6.Z2Q(,$6+/C2TOO=2X IQB['W5G49 GAT_,5 JG9/OKU8?FJ+A64A[
M,B$R_)0\97@</%5PRJ3OWJ5K48^BKHT'7P=U<?S<0$0Z>X6TAH\B&\Y%&VN)
MY&T6E-R;7KBFJM#8S?Q4B 6R5PN4)(B;@T06+""D&8/C;[).E(Y>@U',T)@(
MI.B='JC^&($C".O[UTU[7KTZ5\::=J1(]@R3%3;W+9L?*[4J\"8[*WABZ1?]
M;A/,CJD</,@D3T\\&C4$:PNR7]?)QE->:LU5')1?4=HH57HBLM*=$(OC%:Q;
MN"1>2/8F?7I4[?=SS@QU=:T251"]X@$7#A8!HI]GBU$(MY-4!(TB.;41X+A+
M,*7&^XF5.3)EP<4G!D")+-SH)%QXTLE4?4$NJ955<8TT+;5H\FK@A6""+\C1
MQF^9;\,U%Q"(TQK .;EKNH.U10H/KND@6C]GCC:*BJDJ@]CHS,_0W=@:T\?=
MX"UC_A8V2MH@KAH,:__-B1-!'V?;9*T9D0ZN</-3' Z B<7CQ18\S>-DS(C>
M"4[@ (;Y\4P8?(I1,V4'M^@=(V.2;]%PFFJ_A4<VD*-!66@1O!?M?%V:4P?%
M=FFU%SX:G-<>U8<PX<WE7%Q?WIW/:_"$Z%DL5"BR=EE):?7C5P/;F00&E/$V
MD%.Q%'OK(#U,$&44$WP&F_DN(EPXP#&KA)V3W*H\/[R&TX+L:M!O\Q#OEL=U
M)XW;Z$?&O";^E?655A.>AD.K4J3)-1?Z6J7T8J+XBP@:M]E><*VW#-,D[BCO
MW1#^LM\VHR"+4,4Y6J[9XT(WVS!3@J/K9$U5AZI5%+KK7("<J:E^#G.LM5OL
MLNUXN8IC.;3)%H<,:N?6DZPB(,P@N#]AY 07LKLH"\4/P0-^XI'.SJJJV_Q+
MQKQU:*VR1E4K&H]4-CZ>73(BPH(D/"9!3 P'+.>XJ?O&2(#3*82YH_+TH/XZ
M7'ME775JL>"#6<]4 4.V[T!5_-(TT;.CW<2(\F@!PFA_M_^/9UE2D/GI6%.R
M2D=EVI$]=9RR%/M)%=D]=!N'+M,V)-+^IGZL%L4H#IRQD7V7G( KA&51LT7'
ME/[%L,C^\I[Z!VFK^;EUDTMUVE@_*NN^>-8(NNC]:L4/W%OWUPPI59=:Y^R&
MR?7<>J[<W,)!SH5Y+D?(:J5&KJ1:7O?H_"!E\-\)/VL_+!NKX'ZQ>/GK4>$G
M0(K#*:\@5X_-3N\(&\LX!47')?SLMX#B:PT1>')JYUR%PY^1R+\!:[EH::YL
M51K73Y5=F)-7Y;.4(#5Q=E <N5W795%"&31*KTX;P.G;!^NGVP_D?FG\J BS
M+7Y/;+NH]M7?].PM=ZN<X"!S\AD]Z_7;DDR?[0WM%.5#T];8U?BP"M)JM?5#
M614H+VBPQ/IEZFY)?%UHE47B;(S;P?= "A:#S*@I^Y-SLY9UB3?%2ITMI+YM
MO3HY(V2JJHB%,TFS >_G)I<9?TS&$6J67$UI9!>=D>8\N"R=Q?%22BN_@%:C
M3N7L]_)913B$2]:9*-&F<TUBR[8F[=*\XV1;@J=X9-2^ [P>5N :Q5BCS@!\
M%GF&M#9APH@ ,AN6_&CZ!DW6'+M ?#L.@I:MV\A'+'R'T\OW)!M$_E:&[J-+
M1\J12KZ!%XO%1O!X""<.3X@'. 9LR*_1M*(4U?H9(WSLU;&#O8&Q;O''C:49
M35[TJ846]-Z5#"M'D2OUKT3I_"4ZNIU1J=%!9!%28NL6R A\HJJ-@<DV[=@Y
MUTH%U[G,5-VQLK1P52K#TG*KU1/Q:03D$SC]W'!"FTD\T7['CEYQJ^DY;JZR
MUJUJ56_NLKR>8?>6]=.+3%8VX *[:P/L1%G6*4E9:J]35%6*^F2AT2:)PR#3
MB=06W-4%W?&)]\Y[Q4EEU<@"2T=.JWW#$V;,7KJS%:E16;N\*#E3>IR9GLA/
MP#EG9SHH[91S7_F'GI>R'.D2+;RY4=HG?U2(J!&F53AX@CCIPPSONVU;-=I:
M\3_Z'-HM(^FF)U59CV1"8@XTJG#*J(T?V_3@1C@(PZ#+TU9"A5?&X&2M-)?;
M8L@02][1KI MYOZ<"-5G\UE112PB3+Z>H;7$K2X^,R^G"!G:4"8XU"LRTRD;
M/_*08!V,JVC0 R%>::,7U6%V)BA*6)A]W@9I]VCW.+# X>(74NQYVJV[ODL;
MZ9<UUI[$3.O.M.A$\-@.-_5[6VZ$<)_JL4NF<<!1I$>'*0E?8M)&#N32-%?X
ML5)XC1YI%JMC;9VW%MES ^+;QBZJ^:&J:AYAE^<,*JJGT&.CW/UW5NQ^9*O"
M%%7<4[=Z7V[/TA2M!A'3Y+4GD4.;A5<E_.3&E:-'<.)8"W6A);5E/^=ZM=ON
M%+Q<4%?5<W:M6'A<V"1O4J>R;J510;NG@7<VQ32V*BYNYSTFK^M08Q<8V-\?
MB</%%2C:$= *]YF.GBD[]RR6G+[<S,2FOZ$03=H$NAE2%DH<(T0]'4T8$QO$
M)^DRD:$F2<=L$N_-BRB02;N ($M9&J'1>KC3&HE;!9FD4>B#.<JN8O;C:Q6+
MF;2^N$J45:&R\PLONGUT86!5)V,'_(B4@U"F9Y9PR!*478N"=TB/CFN^,16Z
MWT>7;7[4:E<]KVPL-%,]M9^RR.:[8*W$,14IVM()F&V &1ACIV%- WO4G2Y2
MLT.]KD4./ 2H*>_ZLB#(*S,.*J]P'-W0Z^^1QCFTG8W!MW"[:"_YFJ6^7.2,
MW3BK=IA?K6O^6>=^G%.>^W7ND2Y':84#Y36Z^+,[?HI9J<5T7XS#:>+DR3;X
M_+>X:Z1==_Z/<II6&;1%H?6#U@UP6WDF.?,K$N(X#-[UP5 BQJ\WXP1N%63!
M./(*2)HB='GP(;"C"$E54;V!UQ$A 5*.J"@S6_T33IY8;3/+T1*VF(PK.V7=
M\DOE5'B62M)"KU3530NJXQ9V:)S1#(IX!=80A5#,56Q-H<#L!'"96F>-91>W
M*NKCH27/L"T^50);@S8;C_?KE] FR\IN7HF_ %LOYZ?$A@2/KLTDAU3JJS_4
M18AXT,V_&+N'YR=W!C=3.#^-0N$MK )#0V3%CSD/>*;%5Q\U=:<_!(M6'MTB
M\8(LN*A< &UZ%>4NM&@I6L6(Q3UJ^]/[ZRDJ4Q@H.=!T-Z9/6M#FHT7$3EL,
M?-VS)Q<',QS];U]'WM;-_^"Z:JOB$=A S=26-6T.*QCHV1MC#,O^Q\R@64)_
M804C[*V%46K,$2K)#&A<H7C.SO*D8RITO(1S7]7AL:A?M11J\3HJF4(_K<#O
M#.IY8ZR'#Q\H@?A[NFTU#?'&Y]85L*3F"27,EO3.2\3&:EL3ENS#%284!IO)
MF]I3#DU93@5)AU!PN<#&DDH05- R>14(<9^S"4@&'DQ 'U$P5&IW+V.#QW^M
M)2B(SS,*[<?SC?CFYTL/%)49QR&J>T:O7:1N<68-1RUU91]31E;&E!%40@\W
M@)=T/H2%P4Q4[03G23PF5X;[)@85S BGGAKT@\'LO]O _[9X>GIZ+2??ZH"7
MEP 'RJ J$J'(D(XIDL?# A3C@BA!Q']! 123 ,6 70 ST/O3#]P=@>/E=Q_8
MMS7Q_<N&PQRB"J^L"U0-70:)G,REY"-]HR2RHBRS9C5^I(3BM 07NIFLHR?5
M^,PN;<+6HZ("$5CH5?:U5*:]% Z)D_9Q4V+V*&]W*,FPX6\)3I -.&,SF^=I
M'BZS*><.O'C>0J^WQW9;1*+O-;:3U*7/UZ^WQ&[]G2ZH;>]LL1!1T<]D(6U/
M I^)WFJ4=7:2D_FCS@4_@JB,A\F%OX!I0KZ;(2R$#-X'RK-Z"CXMNZOC*FS!
M$2Z\$8?$'J>[Y]R(F]ZZSL+I8D^-YIN3S@_E/Q>N*>=?3,4.%A)<F_XFN"/C
M4K1OI)%@;-3.?[8HH+,&=LN2^O1!,0= 00(T,&]G5Z",.$=<7_VJ9D4=^6/Y
M?-%.-_P(Y!$;&6E*01Z@UH)D ;P L%L#M/]&[<?_YO%7)) G $$5YP"%<V\W
MPRJF\"Z  P! S/0[@,[Z5R$; Y0.O32^O@$*D(L^IX=;3!%=@,<AP./IW:>+
M. \ E0?P%AP!@A<3R(.\]S&&;S'<2#U# KF+"13]WAY.\7OY5Q[W4/Q.<L!R
M.$[\3F(SS_]1] #USS#7J2_Y#YY0>9Z00*4.O>W4XT=$N<P%Z,I_- BMY H\
MO7UW$;M)?<Q^@$%GSW_V_Q>E7Z?>_O\FHD2&Y(98&(0E!/G 1G*J(AQD!XBA
M+CZ;E5&NV<$+4'5&P$KAPMI3M7V,%?XIE>RX5U1.)/>PL" <=HNUJFQ.E<Y7
M\:6?"_Q!,H9,/:R8UYT?927:J+N,J*A"C(E=LCA!24X\KMI&^3Y=G% [E$=7
ML$=C8UB8Z3;T#8;YN-YD&9>U&1XEK$B(.4!LA$C,9_B?D9/_'Y$C+, K#'8Q
M0,.U5&>!Z@Q[?F13LZ2%VZ?(P,^&@YP1P+]:PI!%# O]X9>]1\ '<#\@!?4
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M*OP:H[=GLO'F[GO:]D];SKOBG%_[]B]@SCXOZHEDU3X7N(!X57+VV47RTC(
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MW7M___G^\W_GWN?<ARJFNVNE=]6J5=4]TTT??SH> X@T5-15 ! (#>0%\@*
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M\0F9EP%\*H)TD&8X_3D.?$5+%ZSHC("!A7D$N:%\_/Q@$1$>?B%A$1%^+K
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MA6A+]UUL"C;UX/H 98A-R'W[;7RU)IL(GN$2E<#$(IZDY\\"WMM;$+P[D91
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MJ;W$,#0\S1_XV,SLG6G;9X)G%)MAR/V;)E3Q[177[SZ25"9 9@Z^GK/_4%#
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M\ (X OQ7;]>QM<9&I(Y4]%%^D7SJ.IP&AU*&=O(E3PXM?%PPMVK>\C[P8O3
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M_#(W9',?6:AM+>[L.!5U%0\&%IEQM"Z-$=?T=[%E7GUV"[%UN=B>IR;9VG&
MRYAL])SY#2H2CF6*_GMZFHS6*^'M0N&?2)X;V:KOJ4F9LMC'97,V&F$T%I"0
MZ:K7#T7EK0#W<&*W51^"1I.%*TI+U9Z-OWLPJ%*\V3]L/JN9J=!7N:A5+!\G
M\I *MHBV&17XJH-[+?_I1+#:I,9U=0VO0FC-K$.4F=F6BEA#7Q%<N7/--L2H
M[Z/>E*6_/_0!)="5B6-QFQLGTC[8PS5V0RV#.AC7SZ7J7?N8+A-B8Y;T<<3(
MX@%GW^TGK!"SW#I93/?SHSY14E=,QVE-"R_O2/<>KD\? Y37_/2!$+U$8MVF
ME(\S-Q_JC/(8>@CB%6]37A49]7[U-+WQM4:V9PM1V S6*HCR_F-6G5AQ^\LO
M[\ ^7(FXS'A15\NZUT#Q*AF1[A<EQ%H4B"1=1T%E&L''E+IX1)P<P=7CYLMV
M\>6(Q=Q%Y=%S<R:Q$@[:+"V0WBM:'VJK[$3EM;,>*.0:O((]B>)SO$1PO=4]
MI>;N^N(^SU#9>5EV13B+>[QC2(ZJ3NO$@C*]*! H%<0)E=<0AA?-8W%-&OLR
M=<P-9T4/9I5;%*APCV%4!S!S3$U%D^#Y[:=[4*:^;GC"^,BCV/Z1R0S!*D%N
ML?DW=XD&*>VC-.^.4![SG@U5.*5*TMM+6C6MJO! $S=X,9Z!A!H[=5FJ2Z#M
M<(1-6XU5@:;UX'D.O.XP@?"W_1SQ%.3)A0M:=*RI+(4\XS(0=H/"<I'VKU?=
M6^ &LO)<LPTVZ35Q#UD$XK*9UN[I8^KSX87BJ(>_)@7CUR?MP>D&/+M,^SVU
MVQ;-YMZ.S&CTE_(LD>8.NLX9;5TL_USAU2C3'NVXN%BC=9]=.N4)S,ZY%ZV(
M[6#]X3@'I01:6RS+4Q&!2CJ7<OW/)(418Y/46F;@->DGSQ 1TV(.)/@,@[61
M6C5-Y$P(GIS.KU8>42[2,T8+]29UN) H"%!'Q,_Z$0,9Y7(S]=IMU:(R:/JU
MZW/;U.)9IK0LWC.&%3V?W9SG*+YDSW%O;#Z;=K"+&2?Y,G">V3D^39-;+NP8
MJ Q<]N]6AFLA1ZCV/HVZVF/#.]QU:+BFS1DYDH8;U0SU#+NN&FH!FAB8"BRZ
M-%:Z03& /QL3=3234[#T(/0CYVRU&)L7=2T&5^E8*H\N",^IB7;0 (SPYCC'
M%(R%\U8%@]I2?4A:Q 'JR4@[L8\GD,@0SO_\VWRQ6[]E[]37I,)83GZ$STO!
MI^]40_/8RC2,PY6-N>*_N0];&ZA1,+<32CS:QW1E(A%EHJ)98Q3;;40@EUB?
M^OJ)N5[N=2;:RL\=6GEGO-7^#-+WSM;HF=V')RZM-PJ,  C>PWAO]?O6-N9J
M6137V\34-ARLA;TKS@M6<VFAJS[.Z7JGU5%*2F][]8F-[=52;.HXSN8 05$5
M^<Q\LN";!IA=&C#QN0$V77 A;KR&A3^C(S4UH2_2V+;=Y\VS_&\L;S<?2(JD
MCCNQ#&I55[ST_CKU='WI^:.2J!IW2'L/GKK"N?S4&B6QA2IE:->^>>M5[QJ!
M9F,"TVD70P9<]R5=6\^D_ \+I5Q7:<RR<"RA;E'AA<S4&RT+Y/2F&[@:D. I
MT!MEC +QU\PT7YFO%Q!)Q$8_17]I<5OIID\+B4MJ=O$7L<$O(NDSA+,?"PGH
M)?RW+OKT5DDDQJ4IK$X7O:5.-6SP8P. ";FN_=).MX5B2%J--M>6+:[-_35R
M?B/=A1R[V*B%- K,URKT\;32&V(%W_+D2NFXA=G&U6,G6BL-J+.4\2!$4?2X
M3&0!:9<3XN4ZH=C]8O-).8F-0[:-7/,BQA?O]SS8(WCY6KOU&3RHR+1*,7!8
MPE5K=E&B#;++G6(W^.CC/#R_N547P^?<BP=.Z [7W(N@[R=B(BU\(KE)(2+H
MHME\X0_*^M,MB%6I7OA(*C^*CO(BV+S3'W?)@"0Z3GUM>,W.4BL_)NJ#?B@S
M.$?!%GS/RR-XHR*BIK60\P&OT C1UP>FO,'"^HBEQUXN4WV?1=X9&W7P$6=S
M#SX6W@_JAX_'$</]*%9<)V@-T)B;.Y9%J?-?7#32>E6ER_7\,!QJQXF>-:%#
MVV_7<D%<\3618KDZQ3L.%X%I^T0U7+=@ED12X+S537KN* Q@;# +G5&:J7[^
M*6/>OAEVG_/F'?;R?N=N4>-7H!Q)Q/@U?351;(@GUQIB[<EE<+XZ$4F^&H!3
M_,;!['5!$B3/F7X/>\U.P_^2V9'GX]V#SV\?[(8V*QY(Q);[F*N7:"?0'T)W
M^LV_B;#.[G+\_1<N,Z'Y7<IOF]>;%/.E=G(T2<+5)U2PK^"[L+\G2*,LCEUH
M9<C%)B(%*65/OL4DYWAW#BY/M\UZAT[K;0'=D8/&Z5W&S<:/[_VD@IHDCP&Z
M@]5"Y#&P72)[P6]W]OOMV?&2HOU$)5OJL1R'#A& T\LM-_^<!E@7!'! \*@[
M>]B C;OZ!NF8DU)!?@;&'YBXIF(@%M7R N\X(MV-=+G(ZJ(-G[HVN-&1C7_[
MAEW&6, >%(FYVA._*G\-':&:-8@I" _3OV^FG!4W1<\T85KZ\9RD1:(VI *1
M;Z!+?O4%1$^[8I-2;GH.4L.=Y:2IO;.P\N1BJI8^+U.F XTP::N8N%R.Z6JT
M[KU%5S()S<*[NM.\;<03&L9J_D+)2M">NB(2B\]?F72M4YJH1(+56&[JB7X3
MT:P+U<%)#VG]%L Q*9;0)(8;@,QV<2=U;EUEW2%_,#EIRK E+^HJ9,M>ZSF4
MS4 P0FPI)HX,P8,P?+60R"=+AUS* H2R?8#U] !_R%@@S(XKG9/C \LLS1=U
M77H(IC71'%EJ'FZ. FB(7/$NCM+>2QQ=3,XE8W>%BWR-]1V]4FQL5UQ)O!_J
M*Y,;-)$K"#7I8OJQ124R2Y;"/J8QB;;Q5V8CC9Q9II@^W*S:R?Z@/!&"H6<&
M"2ZP4Y/DH^F=#$ZGS'^%<)EW^>9G^%&T77>:AMWTHW91=$'&*SBA@K3-PH.+
M]XIL9\/)5<0>4"&>*BN1:;:6<S23UV=8&8"@5')@RK<,V5Y=5+71T50AYU\W
MRCPBS7J23=NFF]*&%QR7+2]_.X]M4CM$+1'"E]\.HY?G9R-[S6%<WFSVE6+(
M1.5K;$LEN?&U&OX*_2^BY"EY;BD<;.DO[4(?%+@6E#7><S,4[[S)'\9"SMEE
M8//((L[D$W%H=W"U8"4T/C&3K9Y517<NL5T+_R8\:;RL,Z_(X*Z\0;.N)@M?
M<(%/[K[/,<#;9EJA9F* Y#5XJR39RR<$B20KT]=>6 T4[[S1[<(1VD#+*A%$
M8>4"9]6=)FMLY@_+*QEDG\]R0%*I6@[@)PJKY3VWZ>S5=>Q_R0R@,?DCC;68
M(&  I*]YGUX./0M ;]*/6)^(7.QJ,^VZ_QE[3[_US@%'[81B-O^(3\/Z0*UY
M2KEZP0N6V4Y.]1P%*DRCI-!XSEA*)0(Y+OL@ 08Y0)3#CVQ,BLR+ %//V-,+
M6^;.,+O\&BTR^^ISW$$EATK=@*SJ\BH]@F>FF9+$9 9&<T1DF%3D^GHZ,0#\
M@Y^5Y\8:%N@\NU$(K#@KRNRJ%._G=G%YD4ZFR]:YY'N+,?QAL6ZIY+HN!;B4
MS0(W'NNS) :\A:Q9TK";>>)_-MMK3" /L<;\$MFT:G-C;+F6ZY%%13<2"[/I
M2ZO/?6-IT_R>72R^1S&S&AN,TW!^)SWHI<!PZJ9J'(:V\*3TC@PP"VF('OQ>
M2%:T4C-_ "F]%W] \Z07,>0-_N//C(^E;M'Y)S^]Q0"V7?JLT_/EA;?5+M7X
MMY30EWP(*;P9L2#&EM2XTA"LFRR1GYCO?F)J-IB!Z"7I(ZV>Q4BD%>KM(Q)(
M/)\< Y\3Z\E((X-7)]KC6ZD_U='Y63P?TLCR]Y+M_2+GW51C78.U.+J22T@$
M]T-C8QHC8U#'MI%# [#B2FZ6.GZ8OK)**4Y9\8(1.40K4:]A98M;J5-NK_R^
M7^D^1.3R@AK1H;*Z;%0"6>I%2* 73"C:)@@KPRXF"L+U(G=6)9:#<3K1//3>
MMRPZ.Q \>G5ETJO7VUCKK4"IBEKG"L8U?TTJTG>)C<^(H1J)+T)MIF/(-2UO
M6^/KDFE.&I*%Z?)+J$:0%23BZC^%L'U"8^NV?[E<H))D$GACDQ:(D__\F9"[
M\YO$N09_(L-=YLEC@ F#K&1%JB+@'F24A/O0/A3H9I<-$*J]DO5![&NYSBVS
M-24 0"_C\$O#Y,4DM(KO2\(M)$IWP,*,>"QIE5(<SB^H$B>(R*_+PZ'Z5DTF
M-PZP8#2FWP2("<^SFR8,/+]A*9[!=X]?58^B.$X(=N]A8[NH=9I5!_H#&"DI
M0S>MGGUT@#[\$8;:?=ZVGOAM!;.Q_G<#'2[UR=+1 JS1[O>3,A[D3CLF9 UU
M43,]Y?K6RL*@I%G6)Z#$'ZR-9XE"$"R5*?1X_[">VPC&,MEE;<(NKB[IA1U$
M$C(L(R^_\+A:5%[BX?50#@:%-1> #2W.??SM0?3LFWJM5%:2 H?&Z*$I^C;&
M"Y=SR\VD0A/EK,M],!;Z''&I'V/.BK;QQ)4D.5GK(PH;MXX!LMBFSEG#X5QF
M!<;LA]Z)/9[EA2"-_'[WQ,[D> (H%;(3P<'"WJ)A_.:M]^+%?@K^'3<CKJ0<
M)9,*6_N\9_:?R1JR0L##Y,$QZG%2>$JMD#@I +7F6JO9EHZ6*3>F7/TZDI+!
MV?*XUZ/9\4XFMOQC8?[D BG@4EQ TU@=]1IZ-H?H].A K9TO\MHQ,/WP<[;+
MINR;V[(' NM[$M/95"^V+J2!B%8G6E9P7)>(>VKBZ5*'14E42TDCZ^-RBR#(
M<D>STJ3.>ELMG">A_O>O$@@CN,E->>+)G$:NN[/RQR[&3>09E%2;5G$OUAF8
MYTX,'1PY[!R80%[.#8I>+ MU$]F.C!/'Q])LGR$2#P:#I97XQD<TX')2BBV1
M\'A,=CU,.<H8)C3YE<>O?(*R;\>5+]% MQXX#=)PY*WV9;RH#*660_<#B9?=
M2)!#KP-4WT41TW!D5Y(RX["^RB)=\S?7>PX7,F"HO?91AER?5\$^XB9!MT"0
M'^C\J@EJB5H9>X6-WE*AD6K0*I4?77;W[I#D2Q\M5^$&!"L_OD^MKK9U1U]"
MF@1N0"#1F*8\M6G;^98@YC'/E4GT*')UH-$/:D=*6S+7<+60#O9^WW"'_%;=
MTQ Y=H: !].;C]O;C:@U[G$/V&3=+JPNL@GM&C<51KXDF!BB;"U*W*&54$QF
M5L92V7V?EA[Y4/7^3>$ENMZ=T'?OA>DD**;ZI"H_#XO;5&GH5K)7&7V\;F=G
M$E7)B2</#ONH?L_K<:$+47^PSW.H$9_ASG/=I]UYTV-+W:O\B]$W.OP1=!21
M"CBB\DS!\G,$,=A@QH(8]=@8A(^M]^S@%U0MLX._O?C\.>PYY0V,-:%W:CA.
ME6&I!D_ 'A."3 .5%,,MH%"7P1$9]!SM#L' FP3EI V39,< >;I5;)V,VNVH
M+6P_K/@4)ORZ!#^Y8)J&!M9]A^ O591,'-"J(F_VN+>(V(E7KS'%@B.O:HA5
M:F"M$D^BIRJIIA'WI 3[I1K$A=\%(J][[ PP7/.@56HB<=JFBZ9'![*N3_4D
M;(8$U#'AF_;6;5XJG#PHR71=ZDG)?/00PT,N$JG:9D[RV0-?^Y;T2V@,L!'B
M]Z(Z8%*#F5_)^^85!#,?Z$'7G"9@,>9)4H!^@Q1'CE6 )"4UH(ZJI'M),DH_
MBVQP$U<AJ@X1M_M>&Y+P!B5?YK)B%1F,XT6(1GTS^XJ?E1R?M8[/3>':FS/\
M^$YO/N!;=[)J-G=>3SD9=D4"'EI_'!R_A'0T^CK7YC@P912^$P.T?_BZNN.0
MO:V>@M,R7;RR:KSV]7%,B53?=_B457E'Z(MTSA61Y&AR3'X@R>B!@='YDM*W
MY^M!:@E.[RZAV5&W9R789,F%%-SQ[J._P]&(X^JZ%J&-+]--@\M:6BNLW58.
M<&=BR4UIHI<Q=L^)\LLRN\<\7Q(G)6M;7*9CL8HB16=-\0O$J//"J+O\X-P:
M, (V!]/12B<Y&>$"K0#-ZS35BMF2@8;P=E^UB[Q'P^%'#AN%Q@B)F6KA2>B'
M1V_)6JN?I59IJRB7W!!*?H@?D:\V.T[\)(+JW.:U#&A!LIS[X"OJ]$?P1\97
MV*].UK8W=#5FR,C<H>^*[%HFM-A!77S?,B/<5%KNFNDDTSL&THNLZ>JSNBJP
M9_8<8G/NU!;Y7J3;N'0Q9<_8) GR:\UC!JT2@28B9."RNY$R*[38#1J&R)\W
M4_YU%2/DD4)OE8GDK<]F ]6YT,J/7419\Z/VI9O8/CP:_MLM['^JVH#4ZY>0
MC(].A[>V'FTKUQ[9.249$^KOSS0< PV\LIDE]I!9TW87VCLC8C.#+;TSOSZ9
M5W?+7T/_'ZLA!G ;0QRU@-.URJQ,8M<ALS$ /##M=8*X//YG7PE+6.^8R[AD
M C[T]U;39*/<T%WG]S 1R$^+FY$3BC*U N5[#+DJ.2_[>N)^U$GT]YY_MGKB
MM>5N!V OSVJ4Q.6<U@($:!I,Y_OOQ>V_JLI%@WO;B[Q+#WP/>@:%2FASM[N"
MCH% ,U_5ZWW9/35Q/?]./7W00#96PX#RRP[V &DM7;*87M!R!%[SW0/&O$N%
M QMXD[-II?-TS4&'6,V_]S2^($V+9V%MJ=6'-M'_Y@[_>W2I>(WD9B[+"Q4-
M& ?\E[ZL:9D4<Q%8-?7R79\.?>1N-$W^[E,)>W%]C4PLFPON4A'L&_W(1\3H
M=$N#%/S\%&SQ&)BP6M<EGW.1Q68(I 6BT6G-C=%;GHP ID6<W(,^L3$',:OC
M>5ARTIMBVP-1W#LU3E1HBTI)9J]M@W& B(>.21Q<@Z\_04W$T.+?VF>!"]WB
MU8;5(S'%P]#00%VINY#^S?/G[CUSTM&H-BW>?%&^8"XG#U%\5"3T2BR>09PB
MOW$@:Y>E&]D)GGA]2?TC=[17[K#7C!-\_&%<];4*GX_U;!!#4"/3V,:F\8R%
M-/VU-UO35[MRJU')%XQ52Q_)>4>WEK)DOWSXQ3&0)YM::T_':*85=$!5L<6]
MOBYK2*>FLGR[0;#+=9T_"" D/)23Y4ESJF6[>@Q8&RO2F$!=I=^K]& -'W+(
M])IIZ1Q05AX#,F.^AW>O^\80UZRNOU\?%?W&=G-E?T&(UNC@B=NXY"O?IL&(
MV6/ 1=)YL4GGBVW;TV/ 7\2W_<V=6Z&E:PI5/HOO8V_?\H01=HT<@O)EC*6>
M'/$-'P/,3AM\IQA[*TV/R@:.@5)RG<D ^'[TA*!VL-=.>= :H>Q6[9J]S&#J
M:7]JKU7-?[BMT\7ZDGTK:<V91<RJ"S@&7E[W-:>3O2\;0UIS#-C8/"9\DJ*Z
M$YBY6#6%O]AH?/,8$(7[SBF?P$0<\-^0W:A"/WIES.@MO^W;$@A[O/^> 7TE
MN&5V:VC-?Z?)W7>=^TC-UM>WH.AVV*X(W8I-U\'^W?4W''=G<5$.TY5R??/S
MK1O'D-GQ()!=[#W!H))2]:!I*G3.#O6?M&VK)-T2M%&;_7+=^SEAM,[D??C^
M'D+KZ&O0_NAV8.[BBRF<MGV&FDBLQ<RC>S(5NE+ANR('5RK3,(?H]O90@?*X
M0^L5XR+SD.\8F#Q4'71MQQT,+NDZ@M5NDCM7=L7>><5O(PV7/09NE,BVX0RO
M[-K8+:E^PK?<V1]-E_77WQI<"Q#<4O18A(_(?D-U6$8K1Z;9\1B(\SWJ-CQ2
MTU[>!7:F4B:EQ"CXOH[+BKKL?YW:N'&[>%<A[";Y9^):FY9-]$'!>7(ZNS26
MT0<4ONTG0+DG3M$MM8EO?U8BG+),7T/UF.X8:"UI.P:2JG8?L*39E:*D17Y*
M5_D<BK,< S<54=,_ZDCF4&;PCF[%46O),1!;-5^['X#OG9E-&'VB0^%U#(3Y
MSER@3/=6$+T-@%;?B5&O3PQ9R>(0NJP3)@CM.^TJO%\E'Q'=J4$-HEZ81Y]/
MSJODNZF4%5T'L/JM8-_INQ,GZ7)P>UUJF[:>0@]]ZA@ ;^W?N2.,WCX:Q]5%
M;'H,L+1LLOBW#L2:I0C:+2(F9JL+(K,8/89E2[EF*HY6@PD/QRSH'G1]ZT4-
MS3G+1F/7DVRYH]V,&GTOT9!]RHHCR-CMU[4=!H2H\+T"!+EF@O>O*A&F=7)A
MN,FBIHRN_#CG*W_6\N=[5_B7"WQR#I(C=WAMH$<"8\? @.WH-?4-"[BLX(QD
MA%YD^Z.0<U QCB'!3UEFX#:B&[/O,X*+\B4S#3 TD7[GZM^[C(D!V[<>1?,(
MC&NS]0DWNPUKS6\M.G$_MN1Y4AGX,/>%@;SB#8&L>[AZTB(Q#G6WWZR(GEMY
MF-BPO'(4UYFR.+4Y*(KGI,WV,O#3.37C&^.-S*H@_I"VNN+.H"@?4&DW%" 8
MXURG,=;_]_]'Y&K5YO(7XV&2 [H-+3C=UYYJ[[11&;HC*J]#&M?OSYO^.]7P
M_*2LW)$6NZZY(UT7>2UA3?BE=>)P-^+:D+0HPHP7$G8[A] & \9CX%ZYK);V
M8RVW_)]G2DX%68.&?<);X4?Y3YUGGM_/5G@ND[EN1+P75_OIQ5$U?NYAY^ML
MTJ>;A$E5+2_$\EZD*-M8"E+1\-,^;79?72NZV,9GGJ%>UC8HZ!VZ&/]--UM<
M4BF\Q^JNGYQBB_:^3EG?XB/;O"_71DTDWWVY9BH0],DU6MW$Z\M-#H471G%Y
M:GQRPJIN3CJ*3B8/(WW=<D:? C9K;5.#0Y74.]EK$I\U>M_?SV?!>1MNG[73
M144T)M><,)EN0:LXQFW@<V0C)-X)6J E *W=UG#N)^R*0!LK;=("$M[/&NG-
M'SKX!,BO% M..;1;"(BMAZS)XIMM0VGR&Y?NY S4-%C<=C..K[Z>7_VRUBQ0
M\95,O*]Z(3E&J"6@&<#6R &[SI5.+G0I*Z:0(^^>750S[?L>L7/WVD!2[ V3
MB2WU1G('19&;SE>)I_3;;[V[['2SA:S8_K,L_@B1*XO7XZFZP\K% ?L63^_=
M9_A+ZH)0-FJHA1GE)%>8U^H!/C+6VE 7)S8Z\A;^Y[8O[%TVQDJ:;7<[,26&
M:]7?MH\1X.L,NZ3Z2=;6BZCX=!C=2F,?,>3&NST17OV$>H54HN,SQK8WP=CR
M*YW@UHX;4"YK!"CH(K0BV&\GG"+/'&#'I[YW$S>V(>\M R:(#G6QSJ[Q6*9N
MAW-5/ZCJ@!2V4<$?6?0Q [4::3%*N38>=5AM-]"5$"YVCF>FZKV_)M[P,"=N
M<)_:_+P%4LE R%MLB4 )&NV2:Q-3GFN)-E:6I9\7Q":EF\$.ZL>HNR_>__)V
MVHI5N9A.T)CS$5Y96^<H:725N:/1/"WD5='U)W#^YA1()5-4AEMR/1-UP+H4
M4_#CX/HY03"E'C]9 Q9)M!"^]9Z(7CDOY6M;];R2S_.J[/<Z4L!E5IWZ.>6J
M[*W6[]/TL//$5_@=MC#K%50_Y1).8!^0V_H_O\.B>2M'\,-L87M+7!])9$4)
MF\;=>[&%HR2$-Q^5S;7XW,[-3T \.\\N*Z[8S$_TX7V*6EN;3':_WHVV6*N0
M 9>7!4T)][4$0 '>+U\0R&63;H18NUS ) &^:M.U'9##UF[++<V/QG#<&:35
M#\-8;2%CM_:+R[WR.D83%-$W(;X4PD\>5$:@_.6.JXE3JF! ,P7V4[1'14EI
MM'*J+SDN4TXQ-EY\<\_1@ZM/-XCMI3Q(*6@6'$_/3THE!:H/ 5))OZZR8.]P
MM':*^+5UE;XRZN^*Z^+8>L+A&U[]^/\A[BV8XORZ;=\&&G<-!&N:QB6X0W!H
M@KL'=VW<$C2X-=T)'J0A>' /%J3QX!XDN 9- B&Y_W?7V??L<V^=JO?<VE6W
MYA=8]52M-7]CK3'F@V])]HKV4V*D/&ZK(&L(X\\CLR_MX[3I#[G?>J3:,0A$
M#2-9%^4Q?V<7?=_:L0X1;!? CQW&+.!^C/IN8DVU_?OU;O6SX]" >V*WQ];P
M<@K MQZ.44R2II#Y%&B@G_04Q#!LG,[;>5D;)M>6^4TP%C*?!/3)-S<])U 9
M#QS+'H2N7:G)=T@#28IQFZ1CLFIB!1!5[#B4*_^L.PF81OE%ZB_@D[$<V7-S
M1O'A07O1%N\]GK%/ QHKW[RX?+$"PH4#F 2G3K-!GDOVFWDLE3^=ABCI9*U*
M[7ZYF 76;@Z-JLUQDYA]<CA$21&V^9@BQZK4-+=DK2P1N(/R?3*&WTFQ#QZ3
M7"@;_@*PS=2G]LVBA'OC8U--9&I"M%P=N;\5<A H=E!EU7Q-.2-?W4TGR8#A
M%:X74)(KJO:\0XS\').3DBR9WNP)>E$%7B@5(1..)V'@K+$IAT,A!MS%4VR8
M9"4,4?* C'_V<+G<D B6!&6966CL;^C=[QLF8YD/O"36DCNPDB),U890PQ(8
MX)VOG$3J*(4[AMUZ;U/^D'V8=K'0D)^QJLW6;KH!4[]:-2C&J^=[MTE8C%,*
M7#U34/? 327%L-WT\\SHF^,M$D)-'?Q#K ]?\QC[_VG?Q@_^1]3-/Q"]W'>3
M92,_UY+(5AOQ%[T.(!?H[ZP#OAR5E12%@L,<NOB7[FDC\,3.5Y@+2N@WXK(J
MB9I#5[OR) !,:Z)L1)CPW"EI="^UQ.M?5>-'SN$W:WNU@GO>8\X"S,[A>CLD
M'\,VYN_FKC1CHEIL>4?"5EMQ(+97'C1"4?I6"A _3/O5FY3DYBSRLW>L-+K\
M!<BJ\$"-3@%JH2HV%F-LH)*Q#N"[>;F$CKQ<+3=:V?O/MVN&L&JWM3%OI/L0
MI\5E&]4S1.)SH@U@(AP7M753ZL(AF(D#P^86QMP-[3::2M<9FKO-06@VA^<]
ME34S1'([42U"]:LIN-M@T7M27O15A@L*NE0(S=)^*&ZD!!\'TI*K"/,?I P]
M??.H*9H?$78INV<R%D9HX/7/;FM%G<O1?&(GF;N\+,P(^U!9W:'IG#SGY8@8
M;M^*9<$VJ'!3,2TR'.,X%HRT>P!GQ''BIWZ1Y\1-B$\<_M=!Y]V@S7S^L.!X
M???\6:L[\YKSF"V 1&HGN@P#0VKR2!(LN.8M'47>7##A6G% _-;*>\R>$]@@
M$]?5S3O:93OR7<OT>?BZE+$S/6>PV,S'#8(X 4@2085C"@XW Z)$M^/J=7_#
MY!U;$<9O(X>(3<KGSS^*=AX@WO,0"S'[I4J@1!EF19/[Y*.0$!DC3 6)7V*K
M?Z:J6MQN'OLU'NU:K(T&7T#6N;!>)K[1&W/MH21+HTIUF#\ABP:S@4OLHCI3
M^](3_/VGF+[X&W7N9Y8>==IMJBN=-#39+>B R%!E V-DQH@<+@((/@2#W:=A
M6,9H<$_+]PF96^=<8"^=Q]?2T,=54_-1C?DO(6Z[W$Q)27;R,?6IT4]NV>ZQ
MKMP;+*BM_BW)_:_2<Q?[\^GAQ4/)YE^ 2.LD3WSEX_7V7\#VN_<S2Z)<_G5[
M_YY:U?VJ=$.Z.XO$$?OT^U+ZZF!".([^PB^ZX3WS0^G/FRGGE>.HFTF8__32
MOX3UGQA'@U*-D_])-,:QKRKC[YA^T#\:V&Q.>Q)JQ'E$J.W7L-YRO6[P>_2A
MT[GDL";F+(BO"%_HE>U+IVT<EOG.H!89WWLS5!\9$O:Y,#P\/G)7$AMV6_K4
M<^1/6CBN2\K2_OOPA[46SY+ !K6B)9O=_8/B-P/WJL-J4Z4Y]4].ZKTVFIR\
M2A>MQLJ=MHXYG2%@(%5\TW,3[*FY\*WW+V8$6/<R<?XY9&;S>I6J?0?>?-&@
MH) W$<&.F(47QV;1_C"6R*Y?E07G2633&M>XA1 4^[K4(&S?\ZXV25W1178*
MN70%+&W0/W>%$(+4ZJBUDA=WP2<%;'A;;]-&^PSQ@13XFR. ="\9NZ:R5A$M
M*-:L;UEC!80Z<Q( Q^7-(</#U,P@MF!*WZAU(.)P[7"223EFB16)T+>FPTN@
M6UZCKP1@KTF_.AJH]V(6T1)#"QC2@QU3CHP6,*@H,=.*A^* L8]+(KM,AX,[
M"B/6/3BUU9L-@6N!$W%P8X*W#6/R<BGX$X6_(W%?<4]7A1I[BQ%]8J3G4ZKE
M2-T_6/T,6JF'QE4F/TE/6NE.^JAP\D:[@,SD@K!16P+/+MTN>D3(4?*@'@.R
MBSB'* ?]&/S&*"R<-'4>O<IG6'25O U\WX$'<<)R9)A9#/E&OD'S]2I0Z9V7
MV;W=D6:0=7;4* 7Q2T&9LRHF\E-I) 6TL:&JZ9W/Y/C;5+Q,[65[BF ;+SN4
M@X*=?R5?9\9[=0>2'><1>^E@9D,MD4GSE6KYSPGFAOW"Z-6W66/:4.TQB)V#
M<U>(6O:UUKN9Q];39VD[3X?7/WXL+5"FT3=EJGSI>@PON=*SA5+G2,/@A"_
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M!0[^<,S/$&*P;(<<HUSBW1*/UN-KDS_")O?4!=H%/-6&9+M V>TR'MP(CZ[
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M^\N8*FA8T0@7QWV%/_<%P5F*$B041=5>/\\%R2A^H-WDD%:84 M<WK=XLK+
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M$K.E6B@C"RZ%+7;(#4M)MUFZ%F.ED S+OOM+SKSRB_?[ ?ML=;1$<2VK*FV
M>@U$4J8C)0115BZ0]WC7JTJ'S^S=C DER\>8RJRZ':AF#DB+:U0-=G3,<WV]
M$!WGRAVYTQ!@F%*JE#>(IOR#@#;WAE05=/UG0Y<99R/[',:8$[8\$H<%]W<D
MJB32(?0O+;, ?8IX4TB>< Q8@C#G/ ]6&&.Z1*M<[H797*(X)K"-2\E _>DE
M,+XBNTF057+:5B471-:EGUDLZ&5VN@UFH:U02V^.6&@O&F?6V*X9JUE]_89)
MWLSZ7GAG(C .-N5]&71MJ,= GR+MO8N#HS+N/'B5,N(F(W=2EA3I\W @<X6J
M/$Q53$-2X5QJ &%"@ @HB]='V1JN=)S7>R8O]?H"ZTOS<PD,SK^W<:<G)2?!
M9/BBTC,@S'F>/WN2FVU/B_!SMY&QW1!E,LQ0$*CT>F+^@/W18[1';H("HF$U
M758_2Q?_%O1"52F^_4S@JY_T__V\Z9@>5/4J2)/X\:.O@?5;II\LAZX7#O,R
MHBKLX'AX>P.SGQ6;[35,)EV,E0M$7L.-LN"+M:+%5N<-X!Y7%N8#$9W0(M C
MNL4$TJ,S>ZS2,%K];2_U\&=IL)'[Y%TNI,OJG$<+4%VBMD\P(0#CRID,;.PQ
MMVX.R6]SEXXS6Q.W?DBD9O_<TMR:$.RMWET+"(=7 '^22,#4S3H_H)E%1(2Y
M@JXW:=.[BH99Y5G!.(YNPOZ\U%/<]8H@/DUMIU'-4YO%"@\'CGP.=D1[*743
M D@B!CW@:OM1ZJA 8Q[8W-*>DA!37)?D#)V9U3%GKA$(-7#51\M/+?KW7G=(
M[A5';FO 7HLF)-Z -EG.A71&G6XU<O!@37Z4&9%WEKM^IMCEPT*S+XZ4^A[@
M1P"*R/!#FT%&L,R3T\97C@&0EVN%S%;IAY7C>NR I/E),\+PF,;.AB#O0?IZ
M'?<M^G4X3^ _TLEB'NNC(<[@/H "8ZPMIG^FKBJ,5F=+3D5@ORA0L1N4>706
M3NRC,7Q5\9>TK/Y/<[J$\K?K,+%4J:99V6P/62ZYY"MUS,5MDZ66/R/JZ"&5
MM'_F-X]'4A;9)AT).<G+R?)2\+/LV+"/--Y6FPP6->)S+P+QEU,0&!@GDW&D
M:1T#A@(%/>U$G]&*@_:3QXR.%WH_<.!])YBR3J2SP( &8SLVW8"+CM.Q93\_
MI=J D>8TLP$;8;-&(F&WCH>R,0K_.ONW[!EIN APDP^4EI];GXPMM^Q7#Y+H
M<?"R:/[26&<\Y1:R>*"-OXVX'_I_\>\: YHK:;O^G3^7RH]DS.2P4PO\H[&)
M2RTV!9[K"N$Z:>]ZS?>"EQ7E_TU0?/Q?!46K3XW!V)@-VG^Z=LC\@DWG)XO'
M.O7#8M9XLJ@I_7Y5>CUGM1]N>O/E.J*5EMM-V=.-OJMZ> %\:KOU[/WE[OT8
MAEO3O;B-JL6KTY=YEQRC= ^&I4<\5G@JV"-A#4?X*F/#/A6T1<>\5S>LY-GY
M+J73*/95+L:($I\T@F6O:94%9S'2$(D>HT1#;0\QIAO*BNR8:!,P"<98;,8!
MX\^][Y[@F.YP\>^N""72_,2"Q1HP*R]Y<K;+)2*T'O<%.-^3GUO.^GGP8F[1
MRM3'@8A!6#:4?-8D!NFT"IH0*#_XUCD1[8TJ9"1UKTZ%3IJ;&)72[1O VNT,
MC8='W@X15^=G>G-]$84'5L,G]G[Z4+/][%%$^1 3 WPJG+/AB8>FAUF;K)9U
MX24^^MB*_?,:B#9HYG:_>02S9."73EIM]D*-67:3HH1T9!T!FD4)G+1<@E\'
MAY8A$;)KG+!M0,@=WX3(Q2^L41>):D-AMI5?#H)VH#N8>F%TJ(@:R0CU?XYP
MIDKHXUV:PB2,.HA8K:[0@7NS2L]KBC;+5<%0!@TG0@\)&#PR"[KB>S[1._'A
M3$@%9@%#!W1IG9!CQP>XZSTOH_P2QY'>MSN45(Y@Y?X]S:?-+K9 B16$YYIQ
MX^4@D^^E5[7^.=S"-/.*SU//MIRHTM[;D EC-2T!:^<Q)1)1_.:M\@#][2ZP
M(0&%%TPSS%KGAM!I"F7_4XI_PX=ISB/)++"8:]X]PVP38C#%UT==BR-PD&]W
M(6%C@IPQ)(<J& K9Y>+6*75)I*D8MA+P>@^9M]+.-6(2G6[:L(UCD^YH)^]1
MM=XKE2UD"RHH.>BE/P9Z-7]725U7(\HV2E.WD<3\3%O4@\B/*".!RNRT^F^R
MSIKJ5EBYJ1Y*<J^!H6^&X,BD*A^PBI8M:E1>7J'N6Z=7:=9Z@65>9LI&&?Q)
M*I]".4[5K $'?S^19&^(?3[;19?>0\6/2:U>J<H@A8 9E2?BAP]Q.0N=!%(5
MT)9>](E_M1GD@A9?M+KXF;6!?1&:$&..5CC$@ST(E(B"Q$=MMRTB+)N^ '@W
ML3*Y6[HD6"8[T9B%$HZ,FDAUR8+X.=WT:L[!?-9!"7KXXTA:.,T9>5MB_LIK
MQ6':+A7@(&1)X2M40,QMV.DQ/N)]6^:?4@5=OGR6^E]QE"*=$'QQ9WF,+2 V
M_OBTMF&UG%^%<^/:W1P9->OOY$I)IFL$T?E=_+^9<=B_^FWF'^GIH)I#\;.H
MB,7=07A0Q&1=(0_)315:R1YLS]\^4ZL!7PYFB-ZU*/$U;A]VF=0339_+\D 8
M)@)Y 0C)Z9HNJ]1GYU_Y_TCW3=]:3K&D\I*%R)V/J7^O^IUF?Y6J)-R%]8G'
MWLP:71IS/F-@#U0]P)(SBT  AT\90D#Q()6.ON6GQ9'PJ_7:R^CW24?>_^9(
M/@TY3=A82BECAA'@23*W.43)I8P(!P2HN5/P]C5IVOHV1)C1Q:MVL>ADO&4J
M.1O*SOM4\$U$75?0>ODNE7B$YS<'&)JC+&3&<AU2@FNV'H>@G$QKLH'L&1Q[
M<6OU]YU%<_QA?4A;T)G%&_\ZY$1B$Y9 ]?A R(GHE>7A\8\??UWWTBY&;"J*
MXPMF*XN.6"RM8[=R&?I:TZ8:+( 7+=E%@CKF^>Y/7+;)#0;)UV:"L)E2@0J7
M? !1^-,/=,(XW!H\7-T3S>D5_AO7'T,6P\XAQ6T3$P/Y*.#@\SA>,AY13A=C
MGT2[+RS+%X<:U#-(JO#P]G)@1(D6B&OFYG0X>[#[<ADIV?6(V+.7VQ+H3,#L
M7 3,20+Y%V--._Q*2&92E4RDO"3/*/U0F/^EP83&1O&"AX"NGR0OO:,K#)#"
M0,@\H]WML"@>K>:D>O;NPI4MW ;.SL$T:VI:G9&?VUIV\7S=0NJ0\;=#4!UG
MUT?;5"_7+3R%G@4CF9C;%,<Q>XA('H"S\:T_X,9-'D'GL([^'6+KWRO6[^-S
MO?58EEMR$@C@"R9^;0S:* BA*J=W2U3+T=8[PZ#=6'AI35A>E["318T6O34=
MB_;E(%F@2G1!FKA9$F"<U+U)+G=+15U%034IELP40Y\GZO;\,GY<*;34 D"
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MT>'X!Z TC9^[VZ-I?$L<JQ]IK3^W('WNHL$^5.ZDTNO_&,70-4>)_>39.*M
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MB+)R1!2"0I"(&>.5>UFQU=XJW1!ZX(5?X#".]A\&O !L=\-O/*M9K_<WW%\
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MJ6]@M!YB$Y;EN:K$W5TB*JA#5,RE?+P)4RH$&00@]&1%(XS02S^D4[/PS1?
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MNZ1&,!H?V0X26@RU!]@-A%O\G*& .Y9[0\LWSF>HP8MV<>9]]0TK*RH3ROY
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MU_G7Z!\$@H5H/89+!O3U"S"Z6S:W.0>+EO7+#1U:Y\(1:5'/EO!I$1V0HI7
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M-19JXG#](LL/Z%U -BK"3W?T% ?&7]R[^EO V>0^4#W%0V=HK+DE5M[.BUE
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MV:JZU!EQ^/&%W[>\P0\6@]8O\LI3FIR%^%S*Z4W#5$D%PE$FJGA7RE9!B>"
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M!N[\L((>E<LU8-5HO6_D?B@QS_[G,@//HN28:@S*#=)<K](Y_--=#=_NDX+
MS4BM04@)CPOR7PR.O_\V#KQOZ^AS*A,ZJF=\6T/.;C9(YOC:Y[FRU7S>'134
M$RM-B]N=.*DBDK@HV4'A4GS&@ZB#?Z(5-:"M3"MZ_ZUVZMJ3"97R*,J-)ZY+
M.]N%@:"APC$-].@&T4&1Z[V&V59C%^]*6S%!,(K$9=4J?<[&22OW:';[C;H<
M5"4<['>^N6$J7<A4'2^F3U\:U W7,:WO&C$=T#')L($8$ BUWU+^_\"YK^W/
M& D@S)IU9*Z^QSOE+T0IS X=T&D?Z!UVNS\<VN.,3&,IYTXJQ1W+1*E;:/=^
M>KGUS6&<XHKL 4O3Z#^Z'&M)>Z+P$0-(@.? 9&?,:J<X]FOAD]+5T35N1'+8
MW=;)R#] .Z,^YJ><DG\!:?RF/]Y"'G7H_Z\%THIKRW]?[OX%W$W/?[_,1D0>
MA9PET1W=!?#5G]CZ>'DIBD\E(-A>B,S:7F/R)L2#S$B1/L9HAV>M6/[*DP1I
MR^8"0V+74<?=L5$LIY@TN%=ER6%FT%#,X*"N<>.Y;R:,8^DBWD5E]L^O;0.M
MS;#I1&-21O'8+<_T7"+2N<)]R#&@RDH.B&S=UM+TVRWBX'IU*PB%)5'AZ^"
MDD!HL!O@;SD+O[LTDQW)Y@2+#Y%D<Z@.J[!D0 ^/T(5>&6]X.&>_L[JPI*IP
M-%PJI?=*&2_4W]QA2BSOW(!8\.?:IG?377V%D_U=6YMV]=6 3#"H9^H<ML,H
MA<D*523 94.WIUOC_7N</N]H3#;K[&/KY0G-B76O+T7_N%,:0^B&9TM<M6,H
MH$+ 0V\N2)<"_6C8,*!6&PQ*!A+(VGQ#(:9>GQG,NQ/<[*==BNFL,Y)>Z@\(
M['G:+<-IT8SCJ,Q UIDT>\625"B9(1#6A,M"TK>.1W^1_E6);3;@&5C@%&!*
MP!'%1:!&E!IQNPS+IV(+)G&31!/3%WB=#/8P ]?QLC!!(E$E]EH?9 E<A>.1
M<7]A"<7PKBU+;$UQ)@W7.^#N&CO(*/?W.'T5Z5#)Z?B'!!&9_872  =4ANIO
M^>CN@80D^[!=FCM&M$7+6+\O"LKN?(8N'4%-#W2U,19#CR-\M\]\YYM%24JW
M*::JDR/! X;T,Z<L94-P )O8(290%A,+&>F.V8_P[3/1.Z&FM<Z <$]1$XH>
M/W_#"]]M>\?:HO%<#:48-)5!)_S."BU-,$P8Q?X-GOUVU3WM/".4P0=[Y-ON
MK>=D-P GE/M+#:XE: \(F4AU:^+'NVDPV:4(2Y$BA UJ31&,MTQT16Y@H"4K
MJFRE?, D X#BLG55%:FK;XU/E6[I:2LC[YNF,T:^L4AA.:+>JQ/1VPJ7)LI?
M3[1"K019M/ZH#2HQK^OMF&<'L;T4_K2[V.JXK7H:92/2WM,7<O[V/6T=(GXA
MKZPG0)\HVD-?RN:9,D"BP1J#E@OK4BL.A(*%>.'H00J$_4^S^T'O(Y9&$GJ<
M&E[^S);$N0]MZ"09X$01I:**-)<*J8>6/92&MC$!  ,CZ3/WG:LY9<E0K$LE
MOTAA&CW;*9B2!+FF?(F0-0>#$K8<4DEZ(@6IA#$BDA=>T)<VD#G@FASN'BP,
MF=,2MOG*/"9.MS1,.M)_J,JJ]KYGVL,_!V$?D5Y+5!& O.FL2&EF")'.-O1E
M1=;"MYOY6)UB>#(FQ*- -Z1_G:5[^'QK9D&;^YL;:%EG?) J&SN(Z$XHF<O^
M)H]*R$JCBLLBK(+WC?YW&/4/E\RP8,EDN.4;^L*GJ3%7M@NQXG-JD=,J%S^_
MNG>\L&ZK!K$VLGF3*2)$404BO8=? !M)7IF#!1O"*-\?$)N:/F1H,I*VC663
M:OAANL^S=O3BG1R5.$)[R,H_9<5[&;/6S51<-)E;L4A;K3LE-I9DA"@$B%PL
M[5<!^/EA _<I[_FRW]ZWZNP''O["M:_S_8F=6F?9URI#]J(U:ICZA5\L 7S!
M;^@XO)8"ZF26A7RR?E)_G>XF85%EE06&SGA##L?*K/-]F^>RBSAHF/)"NJQH
M0H>Z->)C-R5)C:904 #NXMB>!/WJ4A\\@4C1P(E=8+59"G<![O6+:.\R?Q^Q
M:>/JCM\?X,?TWS<GPQQT8P6/",8S6,G$EBT^47/C'NN78_):\?;_LG ^'C(L
MD# FW<-B1QGDIWCT"_6TG&&%+1*$E6%> Y7A8Y77JLLD9:1EWZZ0E0P&YY:Q
M(&-+T0Y9?(2L#\0G7J48<1(O=&I>92$Z1DS\K]N&<AO;!%P,XS*V]#7MWBOJ
M6E[ D<#2L.1S(E0S\X2)T]__ F@ZX\)<.XR U%*;1MRU4A]]_Z02C=!_EZ9J
M3H",2"LG;5'PHVE_<^5",\&U>%PP#*] $!!_9,(4'0N(Y'%+PJSG(KW'(&:(
MY0<XWUYG./@?<CAM&=:UIZL?]NY24E>Y"B6G>52RURD"LS,-^\J/WN;8A]=R
MEWRIK5*PM,VV@Q$,54\GZ<DV)'\_PY-G @3-=-2HZSM90P:96%FKF:]5+1"=
MBY6P4$F&S&#F;WLW-J"C,9'KK]OWLXDY5;:;>&4-]J:H%_F6X:C/.)V"1M>&
M8@_:SHOJATI*KE6*V(H$1K#/,,!C3MF'B';HY[PMI[:3P9U0_9(X[=FX]^\L
M&>*+(S_3-]'WP^[L1P6<9YNECY5/2')]O@DJ5E42O_%HI023( E-3E(I.[J%
M\J:0QM#U84P^S8YCFW8%]M2DK_SS9=K>;M6OK$.+8W[,D Q.)7G&"%&,@Q-C
MUZ!\NT]Y&)UZ<ZK=J*CUWJ1_TD<[)<U+#F"*UWS"B[/.VWA;T=9H;DC17U3L
MD%.GCT9:Y?GG\S6V1SH25C0]KF5^6%")Q,WOQ][,B^S1Y[(@"Q\W#[]R8?/7
M^G?#]2+I>1I*MG0.S"V:(:.%P>Y9NERCCTSS5?L[#51NE;HY9]QPZZE5;8L:
M]&#_5)_%A&/L:M+;B#&A41%E&A**V(ER;&' .5V/%"$,J@X5B[00!B =Q&RA
M(KOC3NSE?![^#13*(ZLZY.M>\JEBWZ)2((HREC[IL0@XYRG-D+2M2?8 JG$S
M=0?LSNAWH[AJJK-?"\3F?4'"- VY.OCP-<[\*36ZW$4[!<F^&#I9W0N_U=#3
MNHZ.C6$9@:!+_DZ&$64IJB(Q(?$F_*01N .$$%E,D;6-D/U6\G",VYIF<U 3
MI QPE'CD2(_CJ.W.GY7BK%(C?60)A152 =W=5Z^\O3ZYM.BZ.NZ<-U=N6@XA
MC70XRM!W3\7N6^ZP9D!%&?/HP[27F6DQ7*F#,=_G*F+A &DU& @IQOP#?NX&
M!CV&.C?<_+C&/H))O:\O*NN;HW-@5%0T@IE)KRX:PNZ%Y^2<[WJ?/\\7*)S@
MV\S>W-.*'YW5>EVMH+?W_+X7?7AIB?CP2!$__LMON6!]WF?1XKA>)X>FO6'O
MKKCB@8V\:L8=:;A45E+X;'A>P]C@$9U2:.AJ:+8P[L=4ZCU9)68_))S'4F4_
M!M6H'$9]#":[9"$X!9)@B]DION)J$J.X\EJ?HD?1UTE.@,P<JRU))FI<B:+I
MBR!,8-5,DE&6&$G?Q;1ULBK\3, OSU^(8C&/"8R,9/PD6J.72$1#;$H=&0^Z
M/BJIJ$5LPEPQ2#A971%$7,R$1#('XHYF8D8&<<>\IKJ5L=WH3":/<LN$D0@A
M[0L?#0 P3@'X7)R^'S[>PUIYGY0_-?[LW+O(0?\;8&N@Q69Q\8G_\X<JQ3]Q
M!9?!4_]L7VYJ@:84JL77ZUYN,(5'==0 'TY]DGXP7))M8P;XW1/@H98<2DA(
M8)\ZF 8XBT-HGTJ#>*\:9B+_!7B?^$XND2J=0(\-$>9T?5(,[SDXQ\@UB2>$
MO,-6ZT_R!*TK'#DC&!=X$2LLI=I$X %_K[PV1J'<R;PY@0$4\3]!:2]A4R[8
MIA=K MEY\.OE]+HE^R.N'7YG(JW'1+K5;;_EYN+"QK0DV2D8$CW#6*B+S8;\
MPLG>.KFT86U&@**<"^J![.E%RI?^.'I9C'VLK-848@?RJKQ"#5X;I6K9Z YS
M' I#<C=)9507VA@>;W0)&(.X5%V I8G?IWV?W2[KS>=+S3X(+GOQX6RIQ#A[
M+Y&2&B R!@NJSJK^HXGT?OUY'^0>OM)##-6R)P6DU$XJ\F2,KZQJJT.EL95U
M;F<MI,@N.&7W?-+K1[FU=!4B4&5W+"/*P*$\(&EWS9C\GEQ/8>&$6;%\-]'L
MV='GR*>T"+AI<]#J[N+55M.)6%]J7C5%Y+(T#:MT-$8>^$*X6G1)@#M=W[KR
MNRZ/UUCC N_5B6Z30--XULL1>8_<ID-[E-SG3'DIRX%@&.<L2:J>J@4GZOXX
MO'2081'5D]DN=V*/@L?BN"&CZ<&GCL'4?L5%GS&2D\I/%]IK*U1.<.#&^L[#
M^V %1$"DGCHC\3V$/[G#IH<"XKCPM^1]$O?Q<*#O/?E=6H\6PY4'$7X.01QG
M-7XI\7O"F3<9<BH<WC2ICWFN>FA22-4P>"8<&HJ;I7S%X!$JC_X':%,UEFO]
M1OFVJGS>K?E],4^)[EIZ,*=BVT X0*YH7'-NDZ08FR@"A>)4AX'EAC/":2<?
M;?C%NC#74W-B?3P)9/] Y'2DQZ0[YOQM8[TWT%.?Z5VN/&8'!FNA9K-Z, 8Q
M002RG^9,$E3R(9,J>N;=S+Q1XJ/HLU"%:M^1*N6"UQ:HR;D]TTMMH_M!SQ8M
M>"O.R=F=CXALC0>EMX $1M25??&9TJK%YLUEVD]U<9?,7=6-Q2V^AC\P?$0#
MXH,6:6]GX_AFG4BL/=/A>$TVQ5G@Y8CU'&R!F%0K+F,4)D"'A,4C420>6L9?
MQU2[7B?\"T"Y*^^J-V&LB:K7=.:HW?02Q 5Y%X77G5'"LL$&]4CJTC$G#B!B
MXW>(&XJ_2AW;3?%YK&G:.$;4(S5^_FA6$7K7:RK$I4V61(E0OGPL8I]-'L^S
M*G/63((I:CP3'( 45>DD]H:\) BNZG&4>-/IBQ*3OW+;T*KKR.ZD66E@U/UA
ML?:;=?DJ\51A^SH8CR"M"F(0;$ &0']G%ILXYMYCM#]'N%V*HZ<GBDUTN9&S
MP;"<"@/7'!N#3GI%5-&MA/GA^P-R&X79#J'%5L$17,8(65(I(0+)F-2#4.A'
MM6Y7_+D-/]$U# +ZE?%K^&S;%*W[?4_[\K\ \ZT0XV(*Q80!/W-4,+D^3S$H
M-ZK':75RT-JF#7/&)[&<:H',<H*1<_G7)<GP>%4*1ESESG$L?:^':HLG\_:<
M-BF!R)\&6"X:402 F;>1X@2$#"%"';R)ITTUEN _$MQ8RVUV4%[,=U'45,%H
MPR&[Y316M\,3*KQL/H*RFA93J<.%3[51Q)S1,VQV\M?=@A[J$9Y\+3J3^CN2
MG[ZD,N$0#JN;O?38,4?*M;C:%M/7\(II@!*742/5RP$T2)@&<&^0_ 6-3_PD
MW*WI>6WQ7CSAC/(N,J%ZHZC&9XO6^Z1E/G*3SBDR5\E9J#"<#HUGS5:3Y3MV
MO/Z;V;AW7\U![G1F?;0"E*67B&ULY0BT.<-G+)3LFJWZ0=RL)1T=@^M#&G$:
M2JVG/J%'[@#3U9.5>V4P5B[<@Y&>@1SX=),LFF#KZIT3-)B-]W7D_835$^L&
M8YR B=P0":7!TLQE EBY"L=M(:V,3?\=6@TW"LTUFS<L'7=[K W\WZMD"WC,
M4,&G@U0VU4\)^*P+^:[?Y"HD1\*=K2!FWC6[W\Q#HTQ;7YA8AI*!?Q:>@];T
MF03'/5\?C>:PCQ0*#IEJ=Y;XRJF6TX^L9@5&R1K:SUASI9?+_90FT4#LG4RX
MJ<BL8[,!;%-+PJ>^C;>72?0-.KI+;@_P=,BJF@%?FG])FN(#]]2Y4I=&E/X2
MH?FW-4>LC-(!AD4HE+HPYJ,RTJQ$-!%/"@,![E&=AV]8<%N%;^(^3X\"Y7+]
M3J?5V2VEW4C[8S6(HT(K VIOYFUGH*A0+#MJG;!_]G[=.%]X"/>"I">G$CN<
MH0I\N6,OL?!-DW[!_!MF.T],?2PVM4%U=7V\!;LD#Y1YD=[B'1&BEN7,+VD]
M!#23<-3/C=*+?7N_VO\<O)LQ7+=^OE;=UMAAV"$2D>-39(7)(8,9D(>2T\(*
M^_M]#EF2UX-4B>Q'NWL)1(=@14G.8$$KB7:#?D2G=+FA4'L0/3>G.<GY!-$M
MOR]+U9YB#\Z$))- [3 ]B9DD,W5&?BI/S.''[+YSFMW[<$<NU^/]+-CM=:>X
MZ>C7EO/7<>T3*P2-Q4EEN[U2JU!L _70?FUC#K]KWSN+2\@X/0F=@,_OL*-N
M<'9\EHU=K_TLT]/'0:[3<R)8,@E5O]0*8=K+XN'))/M70PX$\I=6Q4J6AF:!
MB?/S^WMB%_?%4=0/EB^I%?Y9)[OZ,5T_-[5YTA.Q79?^>_^1<T>5#S$M5O5C
MN;$"ZWC,38!DU[(WTB_2@R&^J=1!=#2FE"'#RS\P4#LKR]HDS)*:,JB). #D
MF:Y/YXVOQ4T*(>%6S(!*LJM'@SR0HIFP\AZPJ(>X'^(QZSG#QGWPW!A[&NQ$
MI V7G9><#^O8]:V?6B4.822<,%%=$K@4+ \;.]2,'/Q'XEKA1-5 $IN6.[Y3
M</(.N9/6]VA$)"J$-GG?=]\/"8__2T_0E_[J/S;#F<:3_P)BY3<&-+:&>QZ=
MA%$FA.[P4()__A_K5AO9)$$VWX"LU7\!5#ZO.G$,;Z^__@6,;N*[F_Q^\CTW
M7)'"DY391?X0I:AK-!OM0K@O*Q-"6\#SXO9:[PMXV \Z.A4[5_[!?;&;MYYO
M1C?Q$HW *.#JI361!"!= 3[0@*]?_G3F0OYN5/O W%'FHP-\[Q\(S@H^N?P)
M_.5:F?BK0#W^-DSTJ5YR.YB>[A0(=)84IO5]?GG<IQ5[?#S7O);X( A)V159
MP_NN9ALU0T,W@"_VXG']X=,_7Q5]S45+/O>+MF0W>*DEHCQ@S!\<C$=%__)X
M/-=X>OTU@O5WTT=V/(4656% H2+QB\LG3C&Q+RYFKJR$XKLW46[7EZK?"Z(Z
M,9(!8$F K-C? OR/1QO7BRD[8>3!W'NT_:WH5<&/!V?+*./1^-28C_,=200
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M$#-T_L*ZVVKH=Z!^-[SY'T9NG78>FQ$8:XX_+3->I/\Q5J:02 *"3\2"F1P
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M"N?*#V0!&^:$=]!'(H:N/?XG&GZI(MX J1@< ('[)\ ?W'71J"NJ/.?SI>
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MWJF\A+IK\7 22SV  SQRCN#*5-'K]<%?[W_%9(Q1$CMP<H23DW&I=)Z3;F#
M18I%<BCFF>+Z'@FS'@9D/5ZZX-E6LS Z ),O"/UY6I7.^FW&T%)"2EXL7N,[
M_SI1$<)SN$>R (M0]QVISHQF %#0LPU>:AB:BM @$YNRY$XN%3 0>7H:_X1S
MV0"B@8;<AG!9P-(:O-P 9)-'TF;A+'['=[!-L6_R/[\S5/'=WM[!$8:#UO;X
M7%YB<"!8&]'UK_D*T>$24^TZWB%AG@*?W$)#5MS']=H%ZALKQ1/)5PLXVTSF
MOT?[#-A=0%2_(=XD,->818N8@Z@35;>LP*X5G6'^!G0EY B'M  :K V.P#X$
M*Q$V^<FH2MG[^R>6F!.B<*?641-/!=OBJNFYN9SY\37F;'GJOMNTS \[=.0%
M=K'"@/&/Z$=(T5XPSUZ_H'I7-X]G__4!J[>G ,.-[C'8+"SNI:9JS&)6(7*1
MBG<?/V,@'!P7,C)L)[47J!A"\B@;+PQ7OVN898CD"]]V\EF*'$&&D 97Z8I1
MX'ON3N48J7K9_>XI1:UKX,(6@F:IK#E+I?3[]K!,L;/-<0[?)6I4A=5'G3Q)
MROJ?YT132]3;LZT]MVYWK0L^+QMV5-#6GDQFKY8, [Y&;!=TA6#I2KI[H:&[
M4V_..TNRC";TOT^0G=B<OV9<>;[BW=@8>R_"/;!??\C\=/F;LW';_OGBX=!7
MXKH!^*3;)K3JNKYAQPL&'L>\ 5K(N N3'[Z^ ;#ZW_YV,NO#'US;+]^ 5^QN
MGH"'GZEO@*@WP$J4D(+"BT>*;)1,T>E]1WS$;_E#(B#CCI0!E/1%)\IUOT(?
MIIW)Z'7.%B<S9?09[J*$XEXJ0F1WA*GI]+[&*R E:_JY$GI$;$WB_11Z*YWI
M;,]!-+6\^:C9)K*_LO>T>7W>Y"TR@>N]2KHV?I 9/6'^JMXOT4$$W(\:UQ?.
M\]!V R"/;KH# #]+WP#;+SB;]X+GWXFWOB9^E9>B97V ]8)RZ/]5\\>Y#==-
M?^7#V&M)UN0+TW/4@<MYSZNJ%^;K*:\C:(>^BB_$\FI\'H]*X;)];CUB/.I>
M1U40[E';JWJY[_S6O_3>\0UP$WSV R-M\*56;\?;PY-DU^W$MG]M/? -P%W8
MJ?_EVQN@OK7[9=KK%:$. 8Y_0!![\8%-@K]GZ'F@<?O'&R YTW-Z@RN_B5]
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MZYR.<7C;9VM3I.24=,>-?X7YH:0-H1KS/'I(&R PKH8EA:=&F3%B47:KL8G
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M\'!<)"T_(LBH8O+()Q-CP'7)%6-1VM$*ELS\YLH9VSD8-%#O2DA56<4K6%6
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M&3>55RU.$Y.<E@.^!5KE?43_-II2B1UO$%]I:UCA6AQS1U17WC&TIW/Z6E$
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M:,<\^VUC([R,:FZX(=;4^[UI#2U#'XO"(*1BUJJ^%Y56SY )%E72?J[.7WR
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MSW6=?3M.^<XD.B5H82+?C7V^J1)33O@=FO( ^.H],:W$&';:;?"!\#$P>+B
M!P3.^#(SF14UXD$V0@_*)%M;'GI_9LC]':UDHQ%-W.'-;U1$FG%:-,DQS9RZ
MFO)LFEQ2UQ"'#HNL%DJ4C\Y#Q@/YADNG][?C G1:UP@%]KT7F#VV)/,0J/K<
ME>*HXQ6TW#[U8"'!TKPUT)QM\^>T#$^T1(MS;VK)5J_;3$\=;P)Y4;,CX<Z"
MT8+]S66YH[^\J N]C-;QBE,J[HXE=L5&V<>Q5M49"O7 %,-+-ND@3/Q*HH]^
M6<K18F U,1F51 H\&5&&7WD,H>GL\3L\&"3B/&A*V,D%=#[Q?5AP2"'(0?&5
M_QW3UOX3TP93/&ZM!T?9DN$VC'G]7F4,+GZYVGP#;"9E3M[AT==5['[.1QIP
MO[P] -]GUM"A!F%N^%!24@W@ N#%^R_V._G%Q=VGCVYN9HS8&Q[.'WX7Y)Y^
M&(DC#)N.U>WIK+$,M7 <FB[AO&K1U'RW&H0EEFT='VF%7##)6Z?C\_A+X +?
M+B_UUH&1QJ%1[A/'7+0/#&W:KEC6Z3C$6_9>??2/Q_;C[EK)-OYHKF1-,R>G
M>I\%\R&7VD[!S9P2L=]H(45B.JJZU18Q/345-K%G\/*&X(=\+R8)2^;KVV&Y
MP68CC*6:7G@,B:[[\@JKP9L#XSR-4LU^C"$:\$+N/CIRUQ7V<\ *-<'!40-4
MM\2R04:*+D&"X;1/.[5SL20_JF+AB';6C/PRW;V]QN_7Y3?1L<72T["- ?"G
MLI%?@KVF_8Q2DKO2O2.B657)@.(TIWQ])K8,EEC@!"%J]'6@%\D' W,K7SO%
MN"2<1$I^"4($(2DP(;4H3R'YYI^"0F<Y)8HF2!6S_%K_TH6D;,]"$/0[*/".
M9W!A06F+(3Q]69G1PL,GL,)[F H98T'UR'G>5%[0T-2D1ZU,#V52!\R43HC
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M+9@6Y"L)LH)6BW1C,05O:[M</&;DSP)>=?G:2KKM%^UB'=O1>F9K7=/[VD,
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M-4$):-I-"/]OZ;1(\H!6USSDERDVGJT1='1S(@0CH&-'$?O5H*Y..IES :Q
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M??2^>/R=A/E#>I72"8GS@I)!QDPXEJ9^4@WS01(-BSS+@R2"X2X<-%;?#WI
MO3C?E%O+"A!TA/8)($>5!,$3&-^#+(N?DB&])]/I('FO>R.=W\8:3')" =?+
ME# Y0.BJS.99D8$VL@S^]!@G0;YBZF]>B''R,= 0ZM7(IEW$I38$\<,8]R4%
M=L)OP;0@+2RI]?:@8]0K;PX,*1Y  :U&7B#YB@R+4!6,.Y^U*&67L:AZ81:W
MA"Z)>EFU]?JL@B:@I?U]PW7#@+.$"$A1M@.YO8D--Z%$$YB D/;E*DI9)X3:
MFZ_+T5_>>WZ@\=.3,&1R!U\&W:&>WS7M%#M3C:!;M;_;81_! WPM>TZG$;R:
M&9,7P;O(5M_-QT&#J(>1_G0NL78$_:M]@1"'(,YA821AD<>O!+6K\>4 O7;.
MP8:H*$$'G*\*_MSC'T117$EYG4Q2.BLA?L3[_/M[>RB%;?VXT.\HYU&["_T5
M)8*]7'.<?]_H-[NA>^I#0>P6='/[CZD"/M"-?E<YBYS<Z#\55DH60?M -_I/
MO:EE[9(R'V_TP]+CC9MSM7-O&[ \N9W=Z=>Z77/^')/)Y8_:]!U.)K"[E^A>
MW@(0[7OCTY0PH87"GXOYEN/;]APE2<2U$52 _;FK[R N:F_/4;B%C:BV4OT&
MI*V!LG KWVO:?+$9W/"GLA;:G]1_3^D?K)AMY2VY26'^J*61&A"J9FP-0(U@
M4H^,;>M"$Y1'68,=9!'RHI#!CC; 2\0>)0%VE(H&K>B!-@=&U*W"<I?"P!_R
M?%GG7+&HO+G:_I1]$,U 9UE. [9EN2]>7E*:#YXHD9?@T6W*EA4?SR)71\KV
MFF> S$:6!2XQJX*7JZZ4"\'33$@?#^7DZI>#\2@3POTS](L'0F<7Y#%_@,^I
M<EKPGF>PNGLQ3&Q>R,!ZE#-A2TQU$3E^"P8-^QJ83.>:+*V!\2AA@EV>?+$<
M[!*FM!=P,BLDKX3F,4P73&2-Y J<Y]DN$[?^M72<"!P9$B1=2[70<W5HB+-(
M25%V*=6"J]I$C<OV<8Y&Q))W*=7"'GIN) LJ]S+5@MWT<# CN[FBB&Q.*P#[
MEV2A<1HR (250$97V]*3BVTL_B50:$4.]D3HA"4ODR.T31,'QB;J?6WAB!!9
MS ($-K(:"&YG,QL]8R\N+Z&,R"+B6^!JD[0 87M^W_7B!=3J@;*1H<":*R"@
M5?U*Z>Y__A #X/?%=FF8\R8.&XD*+!%QF^8D&P7OS'99 1F3[#9-PO+JIJSZ
MIDYS!MKO*^<R\@P0VD@[8(G6BX(\I.OBGBO)%#=B /V^["BC4(G+QOU_[M)4
MY_0^2RE-WZH0C""$'=WZEF($<.,L2^D[ZVR"-:O)J]C*V[UILR5:&[?^G4^N
M=?\;)%'+:9;W(J:(CSCA2K ZRRD@@'+YXP5V.*2L[[OJ$?@>Y\]K/930KVF2
M/VN<^;9X.U."CT?TZG%N5P$V$AFX#9C1!68>4J/[9J8J'^,)]"8'.^!M9":P
MGV /)!S2TA]29;,9U:6RE.X":6MFXOB=[TW&MSY 9]D :E.DC&)9.0Z\3O)4
MX6;0:,DZI#=WE)I8:!K@%-?D6SA^>+'0Y3Y[\<NL_JW0$V3P"M;1O+G%9.8:
M,D<I(&UN9>P^MP&;">*<>8HS, "AQ^6P+2!)"':A5^D-%@[M&XV$!ML/EZ>!
M?92E:"&,,CW!VH.UQ&Y&AC3W@$Q[BA.X#<F]R";@.ORC?^!#I0T1 VM\22'8
MOL7O+.  Q'5D>34.[2@5N*UKON2V+^$[533V@:8%C;N_0W]# OC/@*WX3]4H
M%$<\2Y]G(A\>]7THAZLUH6B"L7#G7E_OPBZN:%&+BU;\5D^5FOK?A&3A=OWN
M&,"><UQ2H9J,4&[(4P*6_E40QE.Q^2-^N(+6Z\RDI8/$HWOP:U*JXY(XC]>P
ML%,;R?2MP] F&&?E[3$YPI[[W)"EO'YAX3:\?K5VD66V5AB]FJ\[L[43"._N
MHKJ^NJ7IC5:>J*7&VML)-"A0\Z;([BZ5NU,T]ES31N-V+X!;6@=&-(6!G;^/
MID%YGG[Y9Q&_L*%[]JYQ!U:C=8G^L.]#S@TC4\L(FHV+XZX)U;IFJ=&Z1HV=
M;,.('T.*>6 ]NJF^,XJQ9UL<KI7SM(6;[5HKY&+"^I6D3S1X>8[#8"JQ!(7/
M5\A.?4CJIVT9:H!Q=Z%=CY[J3&A5/K$;2?9\C0@K09^FMCD4J0&YN[J.0Q'V
MC.B.*^6LUSX3WS=6^^F-QJSV0I ]7\19F!;<:%?)T^/]O4/4*";]LV8U"AN7
MT[FJOB 30BF)AA/X+XN:3K-<?H]#HQ43&C6(W$SU>FALW%J74G!%6(#:-U"6
M0NO+!YEHN DR&BEZ"X"-:^FR2+QY5;,+,@N2*+M*Z1UYJE-]L:HN]P2XCEG
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MK-O54@UN*YLON?4(9J>:QK92+*A<:9CL*CK9Z-K@P>%1]]RK A3((<?&U]I
M:F_N#U8:%*AY4V3K5:]VH&CL&::-QI4U+=J'#?-=K='O15;F6V,YEQ5A!?6Q
MY%F0D6B8? WH'R0OPZI8KE[R-GVO0MW*UOL\WG8O!8N$\*&NAI6X#^=J<A8O
MO:R-D-/XZ8G0;R#50UJ'XUW$TV)M*R#H.X9O8:!0(ZT;<M\,ID=EPKBX+W]
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M*56V[ 8]'E-DZR6JA,/@M-@%+NADOGO/IY+\0LS,&-P?-W_#8?F0W>$([P\
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M@0'VN50-L?3=-6N(F1_M("8'+TQZBGY)R4GE.8]A7?R(,?^L=CD:1N[(33R
MGUX6+$Z*1%I$B)LERM>*-!5G1Y$S<$7&!91C][*;&X,^T5/L!7HVSN(3)NIA
MAU$8Y/D+S,\3LV>T/.,F2&!=1\4.XQ)%]!7MMCV=6P+4 _L&BO@05BCD'F@R
M^:2GM/ZX-V<Q]0O5/O1/Y& !WWIIO$/WN"P3=@6&\WT!IIU:]O66T>J<RQ-T
M[M(9/84L>DMA?4E^G19E?F3G-\$/5W]&\,BM4/,E1#^U0NT]Q+VTI**;??@L
M<KHBFY*G@,:-/_.Z:POQXDRG(KW+@<GTPX_SDL?%#[L^Z!'Y<6WVQZYWJ/,'
M,,L(<#'/@<;/J)@ KQ :!!W/D+&$BG?ON'JXS$G.=QY+,;-J4)BQO"B?X66]
MQ3.#>U OB_ @RK@;ZDB<34-.\R+:LE9OZPUNJ64X-I1PM/=O*+'H4-_.PS _
MXFC0TJ&A<:A+NI'W8K)96^1D0;%TXHX9/_YZP&GA=T$Q(J:K $:X.(3[U1%#
M1%M+"XUXUQ$Y!+QV[+US'SG/TFB4):T18SA8S%)@ADX7^&;<N#7TD/>[6HFL
MK+R4P*V)EX]98A]IPV9SY!7GP\?-MSZ>[;H&(!*CKD&'0UP_X#W$#><O+/SL
MDKN5S_<PO/.RS./-L80A/F1$!_60']&70VT8PVGOB%KUP2,SB:)4?GC6SPJ)
M/8$!9GWY4:0I6*YB-K,J9K-@,9M"</DA(_MP8#<77,7__/;[MV_?OH.%A]U1
M_"MZ_]]6__7MVQ7Y-8T4.GM[5G460V:DB/XV:QXNPRWM/[^#?N#.F;7E-QWW
M1"-I.#WZ\2V[OZ7$5SCDOV6WNN1OI/L#ICDS$F\!!_[FP:=%'&U:NL9RM%UQ
M^KQA1/CZ0@+6!P5TBXV_K0+4Y4;/>]SZ,,9DH>8_^7W/,32Z?%'QY.=11,/-
M@N0VB*/K]#(XQ&4@*UIAI'"Y:5:.NK?[K%LB: KOL'AC3]OF,2,_D*9G9.2A
M?.1.=]!ZO/2VT'JP. 3Z'2Z#.,71AR!/R;I4D,W]<7^DYU9N1C28MR%V"'\K
M7KIXJHA0187>"'25+?W.CUJ,XD@<?N3_U9$]PKI:8@\OQP\\>+8B&C>@48]^
M4\=/.3KCE#U_:)))T58KEJYV^@A9Z]<;AC&OVT<(WX\T9$B0O<R0P< A:&]S
M'BYGA5MI:X?0E8^VBX2ZU8( /&3DF$4[ HJE'H=WX&R@#@=^6@Z.Y2[+XW_@
MZ%\AS!$K/ \^54*#LZY6:$#F]>@[Z,CK^:A[VA'73SB-%1<LG*9HG6H56YF3
M1SW@[8;5V"]X('-0HG*'T08_QFDJT<N)!F[QQ&;,L'':,Z%^W0?V;H,%IH/0
M&!4SZ8+2/TAP(T_[X#U4SW;XS-(,S?1P6WFK7WO*!Y56V:+2WRTV&58_NL3J
M<?'0COS=>IMY--V&4U1*0Z!\/SV>@E7*U4*";<?!TW"W;HE-EUI8%+@L+.Z'
MN@U=:E%WC#WHT ;>KW@LQ^D5U=+I[J%6.M<N8_OX6?(R*TK=\[E..Y<1?)T1
M*A^PT@;^S;/U>+,M^0=[;%M &I6BR,*8^IZ?XW*'KB%M ]PRL8H&:][::S2?
M#"R] #X94IS;V;_@)+I.'_)C4=IM;714SBVP:O0*<PS-S^+TK 2"637 -DQ[
M$!?7Z1,N>#*A':&!.U5*A?BB[M^.:^$D-^I:+#G7!_OGD8KVSG7 _"B2M;-Y
M#^ER5V(>=S7>@+;W&FRB!8<<U_Z?;%X&Q0XR=9'_P)GZ*4AH[JZR"A$SWB[:
MT;N\<K3DJ(<D0L#RK\$_!-(5>"/K*%5*[NEB\@3.O%Y1#L%8[]YR",#<7F9"
MY,\']B#*_)I!T=[MA:9TQ)*+06B'>$//3QF&CGH)+]2TV)!<0:J!X6MO8[NG
M\;>7,>]A_'C_38-LO]$/%N);,3VVD<VY<VP:0>D!C=;^,I?H4\)N*:X\/<YF
MKN]U@Q^#Y ,M^G?^-585=>ZU<E3?JS^ZWETGM$"L"3FGD49><M9H1"F6^%+(
M<=;*G%?9/HA5A=O:39Q6VZS'I:BK^84U\#:=,NGU*V6V13=^%2CR4E@!R$]=
MZT]^]=<[7%25-A3**FWE(@NF='3]P.ZGN. U:6[S.,O1+0V8\:BX&K'6>1_5
M,G4WWTHM5K1S/^=*?5;/ND<-UXI7,?-3Z?HI >XVQ97MR/P$OML45I955%[I
M2BH[\CB-XJ)@7/" X84$!0^I"CT$3=[BYV^#?)W3,E01]8$1"T,'J?=!677@
M+<I>PY,Q\)[0(F)H&35/J$KHF3(M(1!_%'-<E^J(_!5Z4[_DG_XYF.65I&N^
M_#T>,"F9_CV!2<.<YX-FKU+(CB2T,1<:&N?9F^4CE[Y +_CCFQ6BS6<T H,*
M@@SAXY:,9!<4&!V@X8HF[SBF?H-XC0B29T'6P,?/=G+$NFE%[6=S.<#XMO>8
M"UPNQ['%2KQ216F2W/A:&4^:F>H97KTHHC=QBJ(L28*\0,M8'@<HDF8WO:"%
ML;?'/Z\?. XY9XI4/H^9K=';G#)10^%=Z^U9:!\Q@_E8&*[W YC@^M[C@NH]
M^^U2E%VE&\8C<U\Q?"HWVXT,4>R*PJ=2UZ.V<QLM)'F"W=C;FAS/,_2Q6FP<
M?%N#^5/XI6IO&_Q&S6TCWU]&S1$;=NL>_&7/'+ ][.?,7.#F?0KV,&=O>5ZA
M@9 TY%]<T/:W[; :L ,V$7KS(5OLOWJ^XX5LA4]@9&D;XE-846V+E^,6MMT-
MVRF)9W4W[HEU1)[57+E!4ZGX<O(R63.PI!WR6!9D^^2EJ;-^>VQ6 L]J;!<@
M8:3TK-#Z  .55GL/E#B%%>MP"9]*;LU,6],7$OQAJ2\V.N\W!*1SD+!<P+54
M_H[ AN6C?^Q=P!H^EH7J:+N8%= "2893[+*\1$,603.I;Z70FUNE9LRY#HZK
MU#&,G8Z6+&3UL$6:E;[X73^NTS#;X_LZL-N<PD!)X5!%U*/NI[^ EJANNI"Z
MS@:Q=X%CD+G3:KAI=L!Y4!*XLE'Q=ZH6R+&@=5KYULQ)ORAL0X,XM-YPLN\6
M BWK&>J7A;6<'H=P^QC$.?6(GT=_.[(T-NOM;T&>!ZGV^:>!SB',3!QT(0;M
M^05.0P'/1BJ:Z=;Q/S,.4OP(%P^F=7PH(Y<[\A.&=$-;8(G%+Q$^(IS'3P%4
M#T//C%J7*]'-)MX/;RZM@I4B=2V"E18YM 8_!W%ZDQ7%.A6R6FFL@**]0^U7
MC;@+*&B'WD#+[U"6(J&QKVV[[<CY*@B((_JPX%QC6O!TD:]%C@WB"UQ0%+][
M7[UEQ(5<GRXS\H6\A+S-5WA3_A:7NW:%7@G 3^G,Q:O(4WBU6Q#76R1TAJ W
M!-VA3GUIUZOEI*RKEIE0X#S-2HS.]$6IYUU$_;#\7_[I3T2[_G5FQ@W&<I&S
M[>3I\,G6K'Y?O Q3%F7A$;X;P..=N6>:E5F%N>7)J2!"$);1[^J9+3,4--:.
M_-3&A&C[(K!]-*NM" ORY>]%9(Q>M*K<N#3E;+7Y R>O['D3AX:!QM$29!IY
MKXA7E3.8$M0'+E21^%A+1O/ \AZ?+>JXY8$A5\;02DM$F^=.16Q,V]!9N<,'
M,A2ZT8>R/$%MT#IYMV.6FS="T9'^-N9=0E,^>\/-U%2G29SB/$B@F$&TC],8
MG%P *^[UTITK390N3YA&+GIG34;!:G"T:*H,CWZ<,*=Q$K0Y64+61TN ]<Z>
M=NARJ"E5I=,J+/DB*.*0C.\J3HZE-M# 2.E04\Q<]+)P5;5WZU#Z%:)4%'&<
MSH^R#&?F,R8+958([T97:%,S$\F9<:DNEBCKJHLEQ!RJRV\X?MR13Y^3+7KP
MB#\?]QN<K[=T=,)MK[T6C>W0H7*-YKD+TZHCQ'M"K"O8,/1C&ERHHZ6_='(!
MG 5< /W8AX4I[FEX[^KS:6!W6J.^/N:_/)"=;!&$L,.^QPGYUJ-A%2\^$C$*
M5$7'<:"KS3CWAQV:C=EEV#^X-.[A%R00KQ#_Z J9-\@%N^\0O\T\,*WN?9DB
MYT*UV(<OP6GI5G&[=LV-UKH,!<(EN_R#BS)=V$^[G<L0G\X(95OB*HJ'W;TN
MJ22US>AC/GK8V'O+_G;R0)V&1\E0VPN%DD'6:9J*HH0*MY7V:[2KW]1I8HK>
M./N)$6C]O;0N'S+;E>R#C5)9C)AEQF_B_);@2E(!HI^S08X&EXD%JRA5LF?O
M%6BVB!*UI'>9<-"2HU[RP3KH& ZO N6W/$Q_(1&C@V:L7^A^P'2Y#6S/<5#@
M*\S^>YWVAW>7)<G'+'\.<IWW97!/;@/A!W(IB=^BE.A-U<=W$((@ARMTA7A?
MON/GQ\RN)*Y^S-0ZM:9D/.Q)U16]0F-YXYDK[#-^IG_2[0]L.W!J3RUYZAM4
MR.S(*!$CY7GTFUQ7A)ZU\!1*/)XYX2&@MZC/T:-OO+2+>= X3'7ZZ]H0O?&4
MN%FG][[>]!I>P,Z<D^[ 9JD,\M*(=?U +X*$1BH$)0UQV.#'.(6+)ETVMXF&
M_R$UOL88-GB<+B8)G<V[XK$/B:7Q:V(:N^/F;S@L'[);<JR'V+D['.'] 1QJ
MJK*V@WMP%-LVC"M=FDC$Z=%#AJH>4-/%:NH"M_:Q;Z?Q>!Z2/5W):^Y<)D%1
MH'.4Y5&<PL-BODH5G/<R0WG=HZ\8LA%(%2/*?,'4)K[LM*GDQX]X?R!G29A.
ML&E"?'23-U2<T$,%YF9F?86:*383E-\3-O%=>O][^!Y'0[;PO[(,CPO=P1M9
MJ\(E&WMST<8FP>3](4N++%_:_M[(V_GC8TX--CJT*E$L<'\O5RK+[;U<HWQX
M3YG-(W:3((86.)<7.[2D\^$M57"@,.Y-.X^5$ ?-@M(3JIL"EU&;[6$HJR<:
MVKN,T%2,V 09KU44K<3="UK4R=IE'>THHN6*@N0VB*/K]#(XQ&60?,+@S=%@
MQ4#GLNJV@8/>2E:W1T!P1D[%G 1]841>460U(;TJV3:SX30RKB1PQE$5FFN$
MDXK :22:8LS]"#+6$-71X2K<N-FN6@^<'(B/^R.+P;K"VSCT6SY,#Y)^])0.
M(7XJB!AA+6GKIVJ($A,M1] 2[)]2O)KJ%-ZP(-Q]7P;%[F.2/1?#(APD9'X"
M&V3CU\8S  &B%,N+8E!.AB9X03D3;B,J81BW>?841SBZ>/FEP&0Y_QBG01H2
MJW<>EO$3?>9JDVUM1&=N8S.'\RJ++*1 K+I!FQ?T!GI"<?H=JCM#36\+0>OX
MJ9;$*HZ<9Z?YR;,0XXB&,5=^LO7VEK[DQK=)$%(MU*#9M@.GV<HM>>HGQV:$
M[!&!Z#;DQ*BF]I6\_%3.<ASB^(FH(67QP-DZJ-ARF_I["!3[&<"'X-"EA@4O
M-$D5#\.KQD8#0G5ZI25SJ4WZ\?>0QIO7H96-'E$27UD2![+1R6YQ(,=W3RI_
MPKB]:K,%['LZ;(%Y3VOC'3[4@Q.?]T!J(<O54=^%I_71P)=^A7S34!-U_Z[]
MR(ZF?O._3 YED#4&ZT53>A'BZLG18I[)#<6E;JFT >7H")_J0W=\TT'7YI1L
M>8/D]KA)XK"R5C_G\I=J8SIQ%.<SF#?++5G,^D 'VDF=MF>%'J$?]VFAYN*3
M]X%8)VBMY]-5I,\XQ(K!/A[A:A/OXQ^VWA;PD8OV8A;J@8NS@\78NDK5"6ST
MDFPN=R4>L_J.7W&=NS8G<6DNU)4YC0O3VW/TT[@,@<N#P.6VYBU0\K9,G^SI
MOMA9-KV?B>&Z92>)A\R03&9$'QZWO#K.E(:]Z@!!#PBZ0+P/B'77IFKQN1$T
MSJ)I'^AF"L=N T=-97L7J#TRSY#U&*)J%"HD:><CNS$?H2&C\>VD[L6128S'
M#]5++E]Q[I7Y>R>?^,$Y>TU2;?S+OMY *-9&5E]CHLMM;6?^=X1Z7@?N#.O.
M7LWEML546VZH+.9YD<B>!-$+1?(T"%[4V<:>2WJV.3+&>!FDQ9]K-/@<KX:G
MGVOX/<''+&]*+['PK.N4%I/BM:149QI[>E?GF0$<*:^YMUDNE->BSQX!<J8"
M6RYV=Z?P1ZU#A ]9$9=X&?7"1H&P=23S@D"KX]@),_70*O- P9<=RVV2/6NP
M6=+)#%BG"]MXKJL$;U-L/+6=^5^N];P.7+;KSE[-QM-BJBU7/(MY7B2R)T'T
M0I$\#8(7M?&TY[*U\6QR5BYZXZG!YW@U]!.XM8U+0_9CL9';.]UF;,:\QROX
M,3E&-!M#EM.L*=U4R)_)G&=I2;Z>L.KG)28#]Q=ZI6<O\13=H<:&Y(*V PRG
M[WZKVH(%..&!J3C!K;3'#]ETNZ9Y/N?TE?$L\NH_3JX_ RI7?PCU,Y63/[_.
M/=J<T.L_C)X/=TYSV5:'*S;NRO9J-$Y-XC0[K7+<_32T]?F1M5W-L,(,"^4?
M-/I74@3=A*1^@EP]C+PF=*Z5E.<[L%B(AG3B-8VSAC?+#,[-$E#GMUB$_1\^
MC^:LS:9)] I32$1X).:F*5(["* R<J_0E/)C"4I.BVY\E2 ^D:UJ_$NH"3$$
M:6854L/,J_)<'=M10F1<EU!16/M8>%@W7I5)RY^E4I$^V&FA"6B+(<4R[V@I
M"C:(5<[38D*PQR#3K'1F6'I5OML<0\20N2"VF=2KDO7XL%0L3C=]6>RA!Y'!
M#%4C7^8Z)<>565WDH/*]N8,S75%%M.9!-$Q1Y!WXWN#)>++?XE'J*M9ZA6@'
M2UF%+)FKN>!AQLM2(!WJK+9Z2LB-CMM1[BBK4F1W.$B:94X1O3.X%T<Q/,.Y
M4VI+U07H2M Y3I#]#NV&[G><GXVF8;0Z(B7J(YZK,)Z1F!2#>7P"TB:D9P'
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MWS#4B,+1^1/9#CQBLBW8X'R]92G'A)1!%IO(X5TYU) 1?/:R@O(N$.\#L4[
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MW^*X/.;XO#A@(L"T7&_9[?QY&@FARLHE:^+^'1F'*26B70BY">'=HX<,-1]
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M=J;N0B4<Q_G8I](F29;V1:G2@-SM,Z#F85<[->%"("9'"X8< AAR/*@\3_+
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M5GIL*B@T"CR%?5,I@O+H[H*&BJ>O%TD@'I?"EK4Y;Y?_5(-A17 <OJUT^E3
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M'4X"8D1S\ 8&Q^/%.%<)21D5M@,Q(A_U:+.K@,>N6I$MXL16[PZ24LQN +)
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M2MB^H"]Z=5ATW@.D.I8=.C@=(&^J6PA8W?\XX"ZC.V:,G@YLB5A;D[ZB_W'
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MZBX=Q^)6OY"\FGEODVPIEUT)9CW=/\/<B6L&LYX.D*=MF20EN_$&BI_!K(U
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MZ61_;\].(IN,,/S\ZMBP$L^9=#;!WB8 5L@@YVD*S$Y37$R:&,X.Y7MOI4#
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MA7R,I46IIE:PL-J5^*Z4:KD<([^1Y"GUGF>A[T6"VYFYSU=2.,-.QU,:\HI
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MQQBP\*D&O+-:4;G8<8S!Y4R#Z15,: 4CV?4"B\<H]!=%TH1E[5F/TDG-CF
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MOW@3X&C:\.W2U$WJ,U\%Q5 7W5=0:>R.[:ZA,BT%A1MP(=:88?!'D>5T1VM
M=[1>1H6S.V');;6HC<BLJ@9D^^)VL#LQP?TM;@<&K\I0/Q;]1+O\Z&7DW_\;
M4$L! A0#%     @ 2(M_5$9488AT; ( !+$5  \              ( !
M &0R-3$R-S%D,3!K+FAT;5!+ 0(4 Q0    ( $B+?U0*GA[&SP<  &,>   1
M              "  :%L @!D,C4Q,C<Q9&5X,S$Q+FAT;5!+ 0(4 Q0    (
M $B+?U1'4JZKR <  -\=   1              "  9]T @!D,C4Q,C<Q9&5X
M,S$R+FAT;5!+ 0(4 Q0    ( $B+?U3R#TZJHP0  '\2   1
M  "  99\ @!D,C4Q,C<Q9&5X,S(Q+FAT;5!+ 0(4 Q0    ( $B+?U2TYM!Y
M,P0   </   1              "  6B! @!D,C4Q,C<Q9&5X,S(R+FAT;5!+
M 0(4 Q0    ( $B+?U2;J+]EUBL  $3%   0              "  <J% @!D
M,C4Q,C<Q9&5X-#(N:'1M4$L! A0#%     @ 2(M_5/%P3X0XF@$ 9>X! !$
M             ( !SK$" &<R-3$R-S%G,3%X.#,N:G!G4$L! A0#%     @
M2(M_5(L4UYPS/ $ ?),! !$              ( !-4P$ &<R-3$R-S%G-#%V
M.#,N:G!G4$L! A0#%     @ 2(M_5)#>ZM9%9@$ V[D! !$
M ( !EX@% &<R-3$R-S%G-#EH-SDN:G!G4$L! A0#%     @ 2(M_5#ANTD-H
MP   )!4! !$              ( !"^\& &<R-3$R-S%G-CAU-S4N:G!G4$L!
M A0#%     @ 2(M_5-C7NN2%BP$ S^4! !$              ( !HJ\' &<R
M-3$R-S%G.#1E,30N:G!G4$L! A0#%     @ 2(M_5/*.-[X1$@  G+   !
M             ( !5CL) '-E<RTR,#(Q,3(S,2YX<V102P$"% ,4    " !(
MBW]4R:R=%#$(   E8@  %               @ &530D <V5S+3(P,C$Q,C,Q
M7V-A;"YX;6Q02P$"% ,4    " !(BW]4^;#*S?M,  #=$ 4 %
M    @ 'X50D <V5S+3(P,C$Q,C,Q7V1E9BYX;6Q02P$"% ,4    " !(BW]4
M0Y6<7XU=  !4R 0 %               @ $EHPD <V5S+3(P,C$Q,C,Q7VQA
M8BYX;6Q02P$"% ,4    " !(BW]4D_/7H2E,  #9/04 %
M@ 'D  H <V5S+3(P,C$Q,C,Q7W!R92YX;6Q02P4&     !  $ #X P  /TT*
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
